<Products xmlns="https://assets.hpra.ie/products//xml/Human" xsi:schemaLocation="https://assets.hpra.ie/products//xml/Human https://assets.hpra.ie/products//xml/Human.xsd" schemaVersion="1.0" datePublished="2026-08-18T02:30:17" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <Product>
    <DrugIDPK>PA0237/019/001</DrugIDPK>
    <LicenceNumber>PA0237/019/001</LicenceNumber>
    <ProductName>CO TRIMOXAZOLE</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>10/02/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/019/003</DrugIDPK>
    <LicenceNumber>PA0237/019/003</LicenceNumber>
    <ProductName>CO-TRIMOXAZOLE</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>10/02/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/019/002</DrugIDPK>
    <LicenceNumber>PA0237/019/002</LicenceNumber>
    <ProductName>CO-TRIMOXAZOLE</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>10/02/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/005/002</DrugIDPK>
    <LicenceNumber>PA0167/005/002</LicenceNumber>
    <ProductName>0.1% w/v Lidocaine Hydrochloride in 5% w/v Glucose Intravenous Infusion BP</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>14/02/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lidocaine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Glucose, anhydrous</ActiveSubstance>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/08/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/051/005A</DrugIDPK>
    <LicenceNumber>PA0167/051/005A</LicenceNumber>
    <ProductName>0.15% w/v Potassium Chloride and 5.0% w/v Glucose Intravenous Infusion BP</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Intravenous Inf Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/10/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/004/001A</DrugIDPK>
    <LicenceNumber>PA0167/004/001A</LicenceNumber>
    <ProductName>0.15% w/v Potassium Chloride, 0.18% w/v Sodium Chloride and 4% w/v Glucose Intravenous Infusion BP, Viaflex Container</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>02/11/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Intravenous Inf Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/10/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/003/006</DrugIDPK>
    <LicenceNumber>PA0179/003/006</LicenceNumber>
    <ProductName>0.18 % w/v Sodium Chloride and 4 % w/v Glucose Intravenous Infusion BP, Solution for Infusion</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glucose</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/002/009</DrugIDPK>
    <LicenceNumber>PA0179/002/009</LicenceNumber>
    <ProductName>0.18% SODIUM CHLORIDE</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/003/002</DrugIDPK>
    <LicenceNumber>PA0179/003/002</LicenceNumber>
    <ProductName>0.18% SODIUM CHLORIDE/DEXTROSE</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>01/03/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/003/001</DrugIDPK>
    <LicenceNumber>PA0179/003/001</LicenceNumber>
    <ProductName>0.18% SODIUM CHLORIDE/DEXTROSE</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>01/03/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/003/014</DrugIDPK>
    <LicenceNumber>PA0179/003/014</LicenceNumber>
    <ProductName>0.18% SODIUM CHLORIDE/GLUCOSE</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>22/04/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/005/001</DrugIDPK>
    <LicenceNumber>PA0167/005/001</LicenceNumber>
    <ProductName>0.2% w/v Lidocaine Hydrochloride in 5% w/v Glucose Intravenous Infusion BP</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>14/02/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lidocaine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Glucose, anhydrous</ActiveSubstance>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/08/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/051/001A</DrugIDPK>
    <LicenceNumber>PA0167/051/001A</LicenceNumber>
    <ProductName>0.3% w/v Potassium Chloride and 5.0% w/v Glucose Intravenous Infusion BP</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Intravenous Inf Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/05/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/004/005A</DrugIDPK>
    <LicenceNumber>PA0167/004/005A</LicenceNumber>
    <ProductName>0.3% w/v Potassium Chloride, 0.18% w/v Sodium Chloride and 4% w/v Glucose Intravenous Infusion BP</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>02/11/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Intravenous Inf Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Glucose, anhydrous</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/05/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/002/011</DrugIDPK>
    <LicenceNumber>PA0179/002/011</LicenceNumber>
    <ProductName>0.45% SODIUM CHLORIDE</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/002/010</DrugIDPK>
    <LicenceNumber>PA0179/002/010</LicenceNumber>
    <ProductName>0.45% SODIUM CHLORIDE</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/012/001</DrugIDPK>
    <LicenceNumber>PA0167/012/001</LicenceNumber>
    <ProductName>0.9% S/V SODIUM CHLORIDE FOR IRRIGATION</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>09/08/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/002/006</DrugIDPK>
    <LicenceNumber>PA0179/002/006</LicenceNumber>
    <ProductName>0.9% SODIUM CHLORIDE</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>25/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/002/005</DrugIDPK>
    <LicenceNumber>PA0179/002/005</LicenceNumber>
    <ProductName>0.9% SODIUM CHLORIDE</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>22/02/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/002/004</DrugIDPK>
    <LicenceNumber>PA0179/002/004</LicenceNumber>
    <ProductName>0.9% SODIUM CHLORIDE</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>22/02/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/002/003</DrugIDPK>
    <LicenceNumber>PA0179/002/003</LicenceNumber>
    <ProductName>0.9% SODIUM CHLORIDE</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>22/02/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/003/005</DrugIDPK>
    <LicenceNumber>PA0179/003/005</LicenceNumber>
    <ProductName>0.9% SODIUM CHLORIDE/GLUCOSE</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/003/004</DrugIDPK>
    <LicenceNumber>PA0179/003/004</LicenceNumber>
    <ProductName>0.9% SODIUM CHLORIDE/GLUCOSE</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/003/003</DrugIDPK>
    <LicenceNumber>PA0179/003/003</LicenceNumber>
    <ProductName>0.9% SODIUM CHLORIDE/GLUCOSE</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/089/002</DrugIDPK>
    <LicenceNumber>PA0040/089/002</LicenceNumber>
    <ProductName>10-BENZAGEL</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>31/12/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0628/002/001</DrugIDPK>
    <LicenceNumber>PA0628/002/001</LicenceNumber>
    <ProductName>10.10  CLEANING &amp; DISINFECTING</ProductName>
    <PAHolder>Ciba Vision (UK) Ltd</PAHolder>
    <AuthorisedDate>26/06/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROGEN PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0628/003/001</DrugIDPK>
    <LicenceNumber>PA0628/003/001</LicenceNumber>
    <ProductName>10.10 RINSING &amp; NEUTRALISING</ProductName>
    <PAHolder>Ciba Vision (UK) Ltd</PAHolder>
    <AuthorisedDate>16/12/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM PYRUVATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>EDETATE DISODIUM</ActiveSubstance>
      <ActiveSubstance>BORIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM BORATE</ActiveSubstance>
      <ActiveSubstance>PURIFIED WATER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0708/005/002</DrugIDPK>
    <LicenceNumber>PA0708/005/002</LicenceNumber>
    <ProductName>4% BRANCHED CHAIN</ProductName>
    <PAHolder>Clintec Nutrition Limited (UK)</PAHolder>
    <AuthorisedDate>13/11/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/08/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0708/005/001</DrugIDPK>
    <LicenceNumber>PA0708/005/001</LicenceNumber>
    <ProductName>4% BRANCHED CHAIN</ProductName>
    <PAHolder>Clintec Nutrition Limited (UK)</PAHolder>
    <AuthorisedDate>13/11/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEUCINE</ActiveSubstance>
      <ActiveSubstance>ISOLEUCINE</ActiveSubstance>
      <ActiveSubstance>VALINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/07/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/089/001</DrugIDPK>
    <LicenceNumber>PA0040/089/001</LicenceNumber>
    <ProductName>5-BENZAGEL</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>31/12/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0159/003/001</DrugIDPK>
    <LicenceNumber>PA0159/003/001</LicenceNumber>
    <ProductName>A.R.M.</ProductName>
    <PAHolder>Menley &amp; James Laboratories</PAHolder>
    <AuthorisedDate>30/01/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/01/1981</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/019/001</DrugIDPK>
    <LicenceNumber>PA0468/019/001</LicenceNumber>
    <ProductName>AAA MOUTH &amp; THROAT</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/04/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal spray, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/12/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/242/001</DrugIDPK>
    <LicenceNumber>PA2315/242/001</LicenceNumber>
    <ProductName>Abacavir/Lamivudine 600 mg/300 mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>27/10/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Abacavir</ActiveSubstance>
      <ActiveSubstance>Lamivudine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, 4.2)</SupplyComments>
    <WithdrawalDate>06/05/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/284/001</DrugIDPK>
    <LicenceNumber>PA0126/284/001</LicenceNumber>
    <ProductName>Abacavir/Lamivudine Clonmel 600mg/300mg Film-coated Tablets</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>06/05/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Abacavir</ActiveSubstance>
      <ActiveSubstance>Lamivudine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/251/001</DrugIDPK>
    <LicenceNumber>PA0711/251/001</LicenceNumber>
    <ProductName>Abacavir/Lamivudine Rowex 600 mg/300 mg film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>02/09/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lamivudine</ActiveSubstance>
      <ActiveSubstance>Abacavir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/014/001</DrugIDPK>
    <LicenceNumber>PA1986/014/001</LicenceNumber>
    <ProductName>Abacavir/Lamivudine Teva 600 mg/300 mg film-coated tablets</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>07/10/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Abacavir</ActiveSubstance>
      <ActiveSubstance>Lamivudine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/236/001</DrugIDPK>
    <LicenceNumber>PA2315/236/001</LicenceNumber>
    <ProductName>Abacavir Accord 300 mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>13/11/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Abacavir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0735/004/001</DrugIDPK>
    <LicenceNumber>PA0735/004/001</LicenceNumber>
    <ProductName>ABDOSCAN</ProductName>
    <PAHolder>GE Healthcare AS</PAHolder>
    <AuthorisedDate>25/07/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERRISTENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0827/005/001</DrugIDPK>
    <LicenceNumber>PA0827/005/001</LicenceNumber>
    <ProductName>Abelcet</ProductName>
    <PAHolder>Cephalon UK Limited</PAHolder>
    <AuthorisedDate>21/05/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amphotericin b</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0823/030/001</DrugIDPK>
    <LicenceNumber>PA0823/030/001</LicenceNumber>
    <ProductName>ABIDEC</ProductName>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>01/04/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>ERGOCALCIFEROL</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/050/001</DrugIDPK>
    <LicenceNumber>PPA1562/050/001</LicenceNumber>
    <ProductName>Abidec Multivitamin</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>22/07/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Vitamin a palmitate</ActiveSubstance>
      <ActiveSubstance>Ergocalciferol</ActiveSubstance>
      <ActiveSubstance>Thiamine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Riboflavin sodium phosphate</ActiveSubstance>
      <ActiveSubstance>Pyridoxine hydrochloride </ActiveSubstance>
      <ActiveSubstance>Nicotinamide</ActiveSubstance>
      <ActiveSubstance>Ascorbic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/02/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/04/276/21</DrugIDPK>
    <LicenceNumber>EU/1/04/276/21</LicenceNumber>
    <ProductName>Abilify</ProductName>
    <PAHolder>Otsuka Pharmaceutical Netherlands B.V.</PAHolder>
    <AuthorisedDate>20/06/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aripiprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0711/304/001</DrugIDPK>
    <LicenceNumber>PA0711/304/001</LicenceNumber>
    <ProductName>Abiraterone 250 mg film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>18/06/2021</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Abiraterone acetate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/05/313/1-9</DrugIDPK>
    <LicenceNumber>EU/1/05/313/1-9</LicenceNumber>
    <ProductName>Ablavar</ProductName>
    <PAHolder>TMC Pharma Services Ltd</PAHolder>
    <AuthorisedDate>03/10/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Gadofosveset trisodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/24/1880/003</DrugIDPK>
    <LicenceNumber>EU/1/24/1880/003</LicenceNumber>
    <ProductName>Absimky 130 mg Concentrate for solution for infusion</ProductName>
    <PAHolder>Accord Healthcare S.L.U.</PAHolder>
    <AuthorisedDate>12/12/2024</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ustekinumab</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>15/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/24/1880/001</DrugIDPK>
    <LicenceNumber>EU/1/24/1880/001</LicenceNumber>
    <ProductName>Absimky 45 mg Solution for injection</ProductName>
    <PAHolder>Accord Healthcare S.L.U.</PAHolder>
    <AuthorisedDate>12/12/2024</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection in pre-filled syringe</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ustekinumab</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>15/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/24/1880/002</DrugIDPK>
    <LicenceNumber>EU/1/24/1880/002</LicenceNumber>
    <ProductName>Absimky 90 mg Solution for injection</ProductName>
    <PAHolder>Accord Healthcare S.L.U.</PAHolder>
    <AuthorisedDate>12/12/2024</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection in pre-filled syringe</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ustekinumab</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>15/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/010/001</DrugIDPK>
    <LicenceNumber>PA0126/010/001</LicenceNumber>
    <ProductName>ABSORBINE ARTHRITIC PAIN</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>25/08/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/06/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/041/001</DrugIDPK>
    <LicenceNumber>PA0037/041/001</LicenceNumber>
    <ProductName>ABSTEM</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>08/07/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBIMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/07/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1049/006/001</DrugIDPK>
    <LicenceNumber>PA1049/006/001</LicenceNumber>
    <ProductName>Abstral</ProductName>
    <PAHolder>Kyowa Kirin Limited</PAHolder>
    <AuthorisedDate>22/05/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Sublingual tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fentanyl</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/09/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/171/002</DrugIDPK>
    <LicenceNumber>PA0577/171/002</LicenceNumber>
    <ProductName>Acarbose 100 mg Tablets</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>18/01/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acarbose</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/06/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/171/001</DrugIDPK>
    <LicenceNumber>PA0577/171/001</LicenceNumber>
    <ProductName>Acarbose 50 mg Tablets</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>18/01/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acarbose</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/06/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1773/001/001</DrugIDPK>
    <LicenceNumber>PA1773/001/001</LicenceNumber>
    <ProductName>Acarbose Tecnimede</ProductName>
    <PAHolder>Multigeneris GmbH</PAHolder>
    <AuthorisedDate>13/01/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acarbose</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1773/001/002</DrugIDPK>
    <LicenceNumber>PA1773/001/002</LicenceNumber>
    <ProductName>Acarbose Tecnimede</ProductName>
    <PAHolder>Multigeneris GmbH</PAHolder>
    <AuthorisedDate>13/01/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acarbose</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/007/003</DrugIDPK>
    <LicenceNumber>PA0711/007/003</LicenceNumber>
    <ProductName>ACC</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>11/11/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acetylcysteine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/007/005</DrugIDPK>
    <LicenceNumber>PA0711/007/005</LicenceNumber>
    <ProductName>ACC</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>21/12/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acetylcysteine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/05/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/007/006</DrugIDPK>
    <LicenceNumber>PA0711/007/006</LicenceNumber>
    <ProductName>ACC</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>21/12/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acetylcysteine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/05/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/007/004</DrugIDPK>
    <LicenceNumber>PA0711/007/004</LicenceNumber>
    <ProductName>ACC Hard Gelatin</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>07/11/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acetylcysteine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/044/001</DrugIDPK>
    <LicenceNumber>PPA1328/044/001</LicenceNumber>
    <ProductName>Accolate</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>06/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Zafirlukast</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/001/002</DrugIDPK>
    <LicenceNumber>PA0970/001/002</LicenceNumber>
    <ProductName>ACCOLATE</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Zafirlukast</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/198/001</DrugIDPK>
    <LicenceNumber>PPA0465/198/001</LicenceNumber>
    <ProductName>ACCOLATE</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>08/06/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Zafirlukast</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/001/001</DrugIDPK>
    <LicenceNumber>PA0970/001/001</LicenceNumber>
    <ProductName>Accolate 20 mg film-coated tablets</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>03/01/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Zafirlukast</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/11/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/045/001</DrugIDPK>
    <LicenceNumber>PPA1328/045/001</LicenceNumber>
    <ProductName>Accupro</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>20/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Quinapril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/045/002</DrugIDPK>
    <LicenceNumber>PPA1328/045/002</LicenceNumber>
    <ProductName>Accupro</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>08/12/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Quinapril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/045/003</DrugIDPK>
    <LicenceNumber>PPA1328/045/003</LicenceNumber>
    <ProductName>Accupro</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>11/03/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Quinapril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/003/002</DrugIDPK>
    <LicenceNumber>PPA1447/003/002</LicenceNumber>
    <ProductName>Accupro</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Quinapril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/02/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/003/001</DrugIDPK>
    <LicenceNumber>PPA1447/003/001</LicenceNumber>
    <ProductName>ACCUPRO</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>25/07/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Quinapril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/02/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0056/045/004</DrugIDPK>
    <LicenceNumber>PA0056/045/004</LicenceNumber>
    <ProductName>ACCUPRO</ProductName>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>09/08/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>QUINAPRIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/05/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/007/002</DrugIDPK>
    <LicenceNumber>PA0822/007/002</LicenceNumber>
    <ProductName>Accupro 10 mg film-coated tablets</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>09/08/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Quinagolide hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/09/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/135/002</DrugIDPK>
    <LicenceNumber>PPA0465/135/002</LicenceNumber>
    <ProductName>Accupro 10 mg film-coated tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>12/11/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Quinapril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/007/003</DrugIDPK>
    <LicenceNumber>PA0822/007/003</LicenceNumber>
    <ProductName>Accupro 20 mg film-coated tablets</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>09/08/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Quinagolide hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/09/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/135/003</DrugIDPK>
    <LicenceNumber>PPA0465/135/003</LicenceNumber>
    <ProductName>Accupro 20 mg film-coated tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>12/11/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Quinapril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/007/004</DrugIDPK>
    <LicenceNumber>PA0822/007/004</LicenceNumber>
    <ProductName>Accupro 40 mg film-coated tablets</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>16/12/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Quinagolide hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/09/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/007/001</DrugIDPK>
    <LicenceNumber>PA0822/007/001</LicenceNumber>
    <ProductName>Accupro 5 mg film-coated tablets</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>09/08/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Quinagolide hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/09/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/135/001</DrugIDPK>
    <LicenceNumber>PPA0465/135/001</LicenceNumber>
    <ProductName>Accupro 5 mg film-coated tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>12/11/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Quinapril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/008/001</DrugIDPK>
    <LicenceNumber>PA0822/008/001</LicenceNumber>
    <ProductName>Accuretic</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Quinapril hydrochloride</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0056/066/003</DrugIDPK>
    <LicenceNumber>PA0056/066/003</LicenceNumber>
    <ProductName>ACCURETIC</ProductName>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>16/04/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/08/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/008/002</DrugIDPK>
    <LicenceNumber>PA0822/008/002</LicenceNumber>
    <ProductName>Accuretic 20 mg/12.5 mg film-coated tablets</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>16/04/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
      <ActiveSubstance>Quinagolide hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/09/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0813/001/001</DrugIDPK>
    <LicenceNumber>PA0813/001/001</LicenceNumber>
    <ProductName>ACCUSITE INJECTABLE GEL</ProductName>
    <PAHolder>Matrix Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>25/07/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOROURACIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/10/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/094/001</DrugIDPK>
    <LicenceNumber>PA0126/094/001</LicenceNumber>
    <ProductName>Aceomel 12.5mg Tablets</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>10/06/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/10/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/094/002</DrugIDPK>
    <LicenceNumber>PA0126/094/002</LicenceNumber>
    <ProductName>Aceomel 25mg Tablets</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>10/06/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/10/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/094/003</DrugIDPK>
    <LicenceNumber>PA0126/094/003</LicenceNumber>
    <ProductName>Aceomel 50mg Tablets</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>10/06/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/10/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/167/001</DrugIDPK>
    <LicenceNumber>PPA1151/167/001</LicenceNumber>
    <ProductName>Acerycal</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>27/01/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/167/002</DrugIDPK>
    <LicenceNumber>PPA1151/167/002</LicenceNumber>
    <ProductName>Acerycal</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>27/01/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/167/003</DrugIDPK>
    <LicenceNumber>PPA1151/167/003</LicenceNumber>
    <ProductName>Acerycal</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>27/01/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/167/004</DrugIDPK>
    <LicenceNumber>PPA1151/167/004</LicenceNumber>
    <ProductName>Acerycal</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>27/01/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/065/001</DrugIDPK>
    <LicenceNumber>PPA1463/065/001</LicenceNumber>
    <ProductName>Acerycal</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>31/08/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/06/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/065/002</DrugIDPK>
    <LicenceNumber>PPA1463/065/002</LicenceNumber>
    <ProductName>Acerycal</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>31/08/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/06/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/065/003</DrugIDPK>
    <LicenceNumber>PPA1463/065/003</LicenceNumber>
    <ProductName>Acerycal</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>31/08/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/06/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/065/004</DrugIDPK>
    <LicenceNumber>PPA1463/065/004</LicenceNumber>
    <ProductName>Acerycal</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>31/08/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/06/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/071/001</DrugIDPK>
    <LicenceNumber>PPA1500/071/001</LicenceNumber>
    <ProductName>Acerycal</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>03/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1500/071/002</DrugIDPK>
    <LicenceNumber>PPA1500/071/002</LicenceNumber>
    <ProductName>Acerycal</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>03/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1500/071/003</DrugIDPK>
    <LicenceNumber>PPA1500/071/003</LicenceNumber>
    <ProductName>Acerycal</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>03/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1500/071/004</DrugIDPK>
    <LicenceNumber>PPA1500/071/004</LicenceNumber>
    <ProductName>Acerycal</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>03/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1596/033/001</DrugIDPK>
    <LicenceNumber>PPA1596/033/001</LicenceNumber>
    <ProductName>Acerycal</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>04/03/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/033/002</DrugIDPK>
    <LicenceNumber>PPA1596/033/002</LicenceNumber>
    <ProductName>Acerycal</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>04/03/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/033/003</DrugIDPK>
    <LicenceNumber>PPA1596/033/003</LicenceNumber>
    <ProductName>Acerycal</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>04/03/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/033/004</DrugIDPK>
    <LicenceNumber>PPA1596/033/004</LicenceNumber>
    <ProductName>Acerycal</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>04/03/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/283/002</DrugIDPK>
    <LicenceNumber>PPA0465/283/002</LicenceNumber>
    <InterchangeableListCode>IC0041-017-002</InterchangeableListCode>
    <ProductName>Acerycal 10 mg/10 mg tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>20/04/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/283/004</DrugIDPK>
    <LicenceNumber>PPA0465/283/004</LicenceNumber>
    <InterchangeableListCode>IC0041-016-002</InterchangeableListCode>
    <ProductName>Acerycal 10 mg/5 mg tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>27/04/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/071/004</DrugIDPK>
    <LicenceNumber>PPA1562/071/004</LicenceNumber>
    <InterchangeableListCode>IC0041-017-002</InterchangeableListCode>
    <ProductName>Acerycal 10mg/10mg Tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>11/11/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1633/035/004</DrugIDPK>
    <LicenceNumber>PPA1633/035/004</LicenceNumber>
    <ProductName>ACERYCAL 10mg/10mg tablets</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>30/01/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/06/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/071/003</DrugIDPK>
    <LicenceNumber>PPA1562/071/003</LicenceNumber>
    <InterchangeableListCode>IC0041-016-002</InterchangeableListCode>
    <ProductName>Acerycal 10mg/5mg Tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>11/11/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1633/035/003</DrugIDPK>
    <LicenceNumber>PPA1633/035/003</LicenceNumber>
    <ProductName>ACERYCAL 10mg/5mg tablets</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>30/01/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/06/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/283/003</DrugIDPK>
    <LicenceNumber>PPA0465/283/003</LicenceNumber>
    <InterchangeableListCode>IC0041-013-002</InterchangeableListCode>
    <ProductName>Acerycal 5 mg/10 mg tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>27/04/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/283/001</DrugIDPK>
    <LicenceNumber>PPA0465/283/001</LicenceNumber>
    <InterchangeableListCode>IC0041-012-002</InterchangeableListCode>
    <ProductName>Acerycal 5 mg/5 mg tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>20/04/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/071/002</DrugIDPK>
    <LicenceNumber>PPA1562/071/002</LicenceNumber>
    <InterchangeableListCode>IC0041-013-002</InterchangeableListCode>
    <ProductName>Acerycal 5mg/10mg Tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>11/11/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1633/035/002</DrugIDPK>
    <LicenceNumber>PPA1633/035/002</LicenceNumber>
    <ProductName>ACERYCAL 5mg/10mg tablets</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>30/01/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/06/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/071/001</DrugIDPK>
    <LicenceNumber>PPA1562/071/001</LicenceNumber>
    <InterchangeableListCode>IC0041-012-002</InterchangeableListCode>
    <ProductName>Acerycal 5mg/5mg Tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>11/11/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1633/035/001</DrugIDPK>
    <LicenceNumber>PPA1633/035/001</LicenceNumber>
    <ProductName>ACERYCAL 5mg/5mg tablets</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>30/01/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/06/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0317/001/002</DrugIDPK>
    <LicenceNumber>PA0317/001/002</LicenceNumber>
    <ProductName>ACETARD</ProductName>
    <PAHolder>A/S Alfred Benzon</PAHolder>
    <AuthorisedDate>01/11/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/11/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0317/001/001</DrugIDPK>
    <LicenceNumber>PA0317/001/001</LicenceNumber>
    <ProductName>ACETARD</ProductName>
    <PAHolder>A/S Alfred Benzon</PAHolder>
    <AuthorisedDate>23/04/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/11/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0144/010/001</DrugIDPK>
    <LicenceNumber>PA0144/010/001</LicenceNumber>
    <ProductName>Acetoxyl</ProductName>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>09/08/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzoyl Peroxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/05/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0144/010/003</DrugIDPK>
    <LicenceNumber>PA0144/010/003</LicenceNumber>
    <ProductName>Acetoxyl 10</ProductName>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>09/08/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzoyl Peroxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/05/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0144/010/002</DrugIDPK>
    <LicenceNumber>PA0144/010/002</LicenceNumber>
    <ProductName>Acetoxyl 5</ProductName>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>09/08/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzoyl Peroxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/05/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA23138/003/001</DrugIDPK>
    <LicenceNumber>PA23138/003/001</LicenceNumber>
    <ProductName>Acetylcysteine Stirling Anglian 600 mg effervescent tablets</ProductName>
    <PAHolder>Stirling Anglian Pharmaceuticals Ireland Limited</PAHolder>
    <AuthorisedDate>19/07/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acetylcysteine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/10/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/010/009</DrugIDPK>
    <LicenceNumber>PA0137/010/009</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/010/008</DrugIDPK>
    <LicenceNumber>PA0137/010/008</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/010/007</DrugIDPK>
    <LicenceNumber>PA0137/010/007</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/010/006</DrugIDPK>
    <LicenceNumber>PA0137/010/006</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/010/003</DrugIDPK>
    <LicenceNumber>PA0137/010/003</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/010/001</DrugIDPK>
    <LicenceNumber>PA0137/010/001</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/025/001</DrugIDPK>
    <LicenceNumber>PA0037/025/001</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/010/007</DrugIDPK>
    <LicenceNumber>PA0037/010/007</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/010/006</DrugIDPK>
    <LicenceNumber>PA0037/010/006</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/010/003</DrugIDPK>
    <LicenceNumber>PA0037/010/003</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/010/002</DrugIDPK>
    <LicenceNumber>PA0037/010/002</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/010/001</DrugIDPK>
    <LicenceNumber>PA0037/010/001</LicenceNumber>
    <ProductName>ACHROMYCIN</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/025/003</DrugIDPK>
    <LicenceNumber>PA0037/025/003</LicenceNumber>
    <ProductName>ACHROMYCIN  V</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/010/004</DrugIDPK>
    <LicenceNumber>PA0037/010/004</LicenceNumber>
    <ProductName>ACHROMYCIN 1%</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/010/004</DrugIDPK>
    <LicenceNumber>PA0137/010/004</LicenceNumber>
    <ProductName>ACHROMYCIN EYE/EAR OINTMENT</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/010/008</DrugIDPK>
    <LicenceNumber>PA0037/010/008</LicenceNumber>
    <ProductName>ACHROMYCIN IV</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/010/005</DrugIDPK>
    <LicenceNumber>PA0137/010/005</LicenceNumber>
    <ProductName>ACHROMYCIN OPHTH. (SUSPENSION)</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/010/005</DrugIDPK>
    <LicenceNumber>PA0037/010/005</LicenceNumber>
    <ProductName>ACHROMYCIN OPHTHALMIC OIL  (SUSPENSION)</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/025/002</DrugIDPK>
    <LicenceNumber>PA0137/025/002</LicenceNumber>
    <ProductName>ACHROMYCIN V</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/025/002</DrugIDPK>
    <LicenceNumber>PA0037/025/002</LicenceNumber>
    <ProductName>ACHROMYCIN V</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/02/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0748/019/001</DrugIDPK>
    <LicenceNumber>PA0748/019/001</LicenceNumber>
    <ProductName>ACI-JEL THERAPEUTIC VAGINAL JELLY</ProductName>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>01/04/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acetic acid, glacial</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/017/003</DrugIDPK>
    <LicenceNumber>PA0711/017/003</LicenceNumber>
    <ProductName>Acic Lyophilisate</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>02/05/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not Currently Available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aciclovir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0876/001/001</DrugIDPK>
    <LicenceNumber>PA0876/001/001</LicenceNumber>
    <ProductName>Aciclovir</ProductName>
    <PAHolder>TAD Pharma GmbH</PAHolder>
    <AuthorisedDate>22/01/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aciclovir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1046/004/001</DrugIDPK>
    <LicenceNumber>PA1046/004/001</LicenceNumber>
    <ProductName>ACICLOVIR</ProductName>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>18/09/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aciclovir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1046/004/002</DrugIDPK>
    <LicenceNumber>PA1046/004/002</LicenceNumber>
    <ProductName>ACICLOVIR</ProductName>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aciclovir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/07/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1046/004/003</DrugIDPK>
    <LicenceNumber>PA1046/004/003</LicenceNumber>
    <ProductName>ACICLOVIR DISPERSIBLE BP</ProductName>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>07/07/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aciclovir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/013/003</DrugIDPK>
    <LicenceNumber>PA0167/013/003</LicenceNumber>
    <ProductName>ACID CITRATE DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>07/05/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/013/001</DrugIDPK>
    <LicenceNumber>PA0167/013/001</LicenceNumber>
    <ProductName>ACID CITRATE DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>13/06/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/09/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/066/001</DrugIDPK>
    <LicenceNumber>PA0167/066/001</LicenceNumber>
    <ProductName>ACID CITRATE DEXTROSE/ADENINE-ANTICOAGULANT</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>13/11/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>ADENINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/09/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/021/001</DrugIDPK>
    <LicenceNumber>PA0167/021/001</LicenceNumber>
    <ProductName>ACID CITRATE DEXTROSE BP FORMULA A</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>14/04/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/09/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/021/002</DrugIDPK>
    <LicenceNumber>PA0167/021/002</LicenceNumber>
    <ProductName>ACID CITRATE DEXTROSE FORMULA A</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>13/07/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/09/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/112/001</DrugIDPK>
    <LicenceNumber>PA0281/112/001</LicenceNumber>
    <ProductName>Acidopine</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Famotidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/07/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0590/007/002</DrugIDPK>
    <LicenceNumber>PA0590/007/002</LicenceNumber>
    <ProductName>Acnecide 10% w/w Gel</ProductName>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>17/04/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzoyl Peroxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/06/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23176/054/001</DrugIDPK>
    <LicenceNumber>PPA23176/054/001</LicenceNumber>
    <ProductName>Acnecide 5% w/w Gel</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>28/10/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzoyl Peroxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0590/007/004</DrugIDPK>
    <LicenceNumber>PA0590/007/004</LicenceNumber>
    <ProductName>Acnecide Wash 10 % w/w Gel</ProductName>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>31/10/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzoyl peroxide hydrous</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/06/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0144/028/001</DrugIDPK>
    <LicenceNumber>PA0144/028/001</LicenceNumber>
    <ProductName>Acnegel</ProductName>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>25/05/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzoyl Peroxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/05/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0943/008/001</DrugIDPK>
    <LicenceNumber>PA0943/008/001</LicenceNumber>
    <ProductName>Acnisal 2% w/w Cutaneous Solution</ProductName>
    <PAHolder>Alliance Pharmaceuticals Ltd.</PAHolder>
    <AuthorisedDate>22/12/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Salicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/10/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/06/344/02</DrugIDPK>
    <LicenceNumber>EU/1/06/344/02</LicenceNumber>
    <ProductName>Acomplia</ProductName>
    <PAHolder>Sanofi aventis</PAHolder>
    <AuthorisedDate>19/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rimonabant</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/06/344/1-9</DrugIDPK>
    <LicenceNumber>EU/1/06/344/1-9</LicenceNumber>
    <ProductName>ACOMPLIA</ProductName>
    <PAHolder>Sanofi aventis</PAHolder>
    <AuthorisedDate>19/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIMONABANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>HOR0407/013/001</DrugIDPK>
    <LicenceNumber>HOR0407/013/001</LicenceNumber>
    <ProductName>Aconite</ProductName>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>10/09/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aconitum napellus</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1286/042/001</DrugIDPK>
    <LicenceNumber>PA1286/042/001</LicenceNumber>
    <ProductName>Acoxxel</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>16/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/08/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1286/042/002</DrugIDPK>
    <LicenceNumber>PA1286/042/002</LicenceNumber>
    <ProductName>Acoxxel</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>16/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/08/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1286/042/003</DrugIDPK>
    <LicenceNumber>PA1286/042/003</LicenceNumber>
    <ProductName>Acoxxel</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>16/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/08/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1286/042/004</DrugIDPK>
    <LicenceNumber>PA1286/042/004</LicenceNumber>
    <ProductName>Acoxxel</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>16/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/08/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0043/015/001</DrugIDPK>
    <LicenceNumber>PA0043/015/001</LicenceNumber>
    <ProductName>ACRIFLEX</ProductName>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>20/03/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2131/001/001</DrugIDPK>
    <LicenceNumber>PA2131/001/001</LicenceNumber>
    <ProductName>ACT-HIB</ProductName>
    <PAHolder>Sanofi Pasteur</PAHolder>
    <AuthorisedDate>25/11/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Haemophilus influenzae type b, conjugate with tetanus protein</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/07/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0544/015/002</DrugIDPK>
    <LicenceNumber>PA0544/015/002</LicenceNumber>
    <ProductName>ACT-HIB DTP</ProductName>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>30/04/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>BORDETELLA PERTUSSIS</ActiveSubstance>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0544/015/001</DrugIDPK>
    <LicenceNumber>PA0544/015/001</LicenceNumber>
    <ProductName>ACT-HIB DTP</ProductName>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>30/04/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>BORDETELLA PERTUSSIS</ActiveSubstance>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0544/015/003</DrugIDPK>
    <LicenceNumber>PA0544/015/003</LicenceNumber>
    <ProductName>ACT-HIB DTP D.C.</ProductName>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>03/04/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>BORDETELLA PERTUSSIS</ActiveSubstance>
      <ActiveSubstance>HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0417/013/001</DrugIDPK>
    <LicenceNumber>PA0417/013/001</LicenceNumber>
    <ProductName>ACTAL</ProductName>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>25/02/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alexitol sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0417/015/001</DrugIDPK>
    <LicenceNumber>PA0417/015/001</LicenceNumber>
    <ProductName>Actal Pastils</ProductName>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>27/07/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Hydrotalcite</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/121/001</DrugIDPK>
    <LicenceNumber>PA1380/121/001</LicenceNumber>
    <ProductName>Actelsar</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>17/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Telmisartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/121/002</DrugIDPK>
    <LicenceNumber>PA1380/121/002</LicenceNumber>
    <ProductName>Actelsar</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>17/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Telmisartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/121/003</DrugIDPK>
    <LicenceNumber>PA1380/121/003</LicenceNumber>
    <ProductName>Actelsar</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>17/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Telmisartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0224/003/001</DrugIDPK>
    <LicenceNumber>PA0224/003/001</LicenceNumber>
    <ProductName>ACTH/CMC/PL</ProductName>
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/021/004</DrugIDPK>
    <LicenceNumber>PA0468/021/004</LicenceNumber>
    <ProductName>ACTHAR</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>30/01/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CORTICOTROPHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/01/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/021/002</DrugIDPK>
    <LicenceNumber>PA0468/021/002</LicenceNumber>
    <ProductName>ACTHAR</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/04/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CORTICOTROPHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/021/001</DrugIDPK>
    <LicenceNumber>PA0468/021/001</LicenceNumber>
    <ProductName>ACTHAR</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/04/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CORTICOTROPHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0010/009/002</DrugIDPK>
    <LicenceNumber>PA0010/009/002</LicenceNumber>
    <ProductName>ACTHAR</ProductName>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CORTICOTROPHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0010/009/001</DrugIDPK>
    <LicenceNumber>PA0010/009/001</LicenceNumber>
    <ProductName>ACTHAR</ProductName>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CORTICOTROPHIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/021/003</DrugIDPK>
    <LicenceNumber>PA0468/021/003</LicenceNumber>
    <ProductName>Acthar Gel</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Corticotrophin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/014/001</DrugIDPK>
    <LicenceNumber>PA0017/014/001</LicenceNumber>
    <ProductName>ACTIDIL</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIPROLIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/014/002</DrugIDPK>
    <LicenceNumber>PA0017/014/002</LicenceNumber>
    <ProductName>ACTIDIL ELIXIR</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIPROLIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0645/001/001</DrugIDPK>
    <LicenceNumber>PA0645/001/001</LicenceNumber>
    <ProductName>ACTIDOSE-AQUA</ProductName>
    <PAHolder>Paddock Laboratories Inc. Ltd</PAHolder>
    <AuthorisedDate>10/05/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHARCOAL, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/05/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/210/001</DrugIDPK>
    <LicenceNumber>PPA1151/210/001</LicenceNumber>
    <ProductName>Actifed 60mg/2.5mg tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>07/02/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIPROLIDINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Sale through pharmacies only in packs containing not more than 12 units per pack. Packs containing more than 720mg pseudoephedrine are subject to medical prescription.

Not more than one pack of pseudoephedrine containing medicinal products should be sup</SupplyComments>
    <WithdrawalDate>19/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/013/003</DrugIDPK>
    <LicenceNumber>PA0017/013/003</LicenceNumber>
    <ProductName>ACTIFED COMPOUND LINCTUS</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIPROLIDINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/013/004</DrugIDPK>
    <LicenceNumber>PA0017/013/004</LicenceNumber>
    <ProductName>ACTIFED EXPECTORANT</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/11/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIPROLIDINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/043/004</DrugIDPK>
    <LicenceNumber>PA0007/043/004</LicenceNumber>
    <ProductName>ACTILYSE</ProductName>
    <PAHolder>Boehringer Ingelheim Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alteplase</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/10/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0946/002/001</DrugIDPK>
    <LicenceNumber>PA0946/002/001</LicenceNumber>
    <ProductName>ACTINAC</ProductName>
    <PAHolder>Peckforton Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>01/04/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
      <ActiveSubstance>BUTOXYETHYL NICOTINATE</ActiveSubstance>
      <ActiveSubstance>ALLANTOIN</ActiveSubstance>
      <ActiveSubstance>SULFUR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/11/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/042/001</DrugIDPK>
    <LicenceNumber>PA0678/042/001</LicenceNumber>
    <ProductName>ACTIPROFEN</ProductName>
    <PAHolder>Haleon Ireland Limited</PAHolder>
    <AuthorisedDate>24/03/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/10/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/195/005</DrugIDPK>
    <LicenceNumber>PA0749/195/005</LicenceNumber>
    <ProductName>Actiq 1200 micrograms compressed lozenge with integral oromucosal applicator</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>23/01/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenge</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>29/05/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/195/006</DrugIDPK>
    <LicenceNumber>PA0749/195/006</LicenceNumber>
    <ProductName>Actiq 1600 micrograms compressed lozenge with integral oromucosal applicator</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>23/01/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenge</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>29/05/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/407/001</DrugIDPK>
    <LicenceNumber>PPA0465/407/001</LicenceNumber>
    <ProductName>Actiq 200 micrograms compressed lozenge with integral oromucosal applicator</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>15/05/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Compressed lozenge</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fentanyl</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>31/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/195/004</DrugIDPK>
    <LicenceNumber>PA0749/195/004</LicenceNumber>
    <ProductName>Actiq 800 micrograms compressed lozenge with integral oromucosal applicator</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>23/01/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Compressed lozenge</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fentanyl</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>11/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0669/005/001</DrugIDPK>
    <LicenceNumber>PA0669/005/001</LicenceNumber>
    <ProductName>ACTIRA</ProductName>
    <PAHolder>Bayer AG</PAHolder>
    <AuthorisedDate>10/12/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MOXIFLOXACIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0218/052/002</DrugIDPK>
    <LicenceNumber>PA0218/052/002</LicenceNumber>
    <ProductName>Activelle</ProductName>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Estradiol</ActiveSubstance>
      <ActiveSubstance>Norethisterone acetate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/06/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/046/001</DrugIDPK>
    <LicenceNumber>PPA1328/046/001</LicenceNumber>
    <ProductName>Activelle</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>29/09/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Estradiol hemihydrate</ActiveSubstance>
      <ActiveSubstance>Norethisterone acetate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/199/001</DrugIDPK>
    <LicenceNumber>PPA0465/199/001</LicenceNumber>
    <ProductName>Activelle 1 mg/0.5 mg film-coated tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>19/10/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Estradiol</ActiveSubstance>
      <ActiveSubstance>Norethisterone acetate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/017/001</DrugIDPK>
    <LicenceNumber>PPA1328/017/001</LicenceNumber>
    <ProductName>Actonel</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>13/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Risedronate sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/165/002</DrugIDPK>
    <LicenceNumber>PPA0465/165/002</LicenceNumber>
    <ProductName>Actonel 5 mg film-coated tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>12/01/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Risedronate sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22668/001/001</DrugIDPK>
    <LicenceNumber>PA22668/001/001</LicenceNumber>
    <ProductName>Actonel Combi 35mg + 500mg film-coated tablets</ProductName>
    <PAHolder>Theramex Ireland Limited</PAHolder>
    <AuthorisedDate>18/03/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Risedronate sodium</ActiveSubstance>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/01/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1392/028/001</DrugIDPK>
    <LicenceNumber>DPR1392/028/001</LicenceNumber>
    <ProductName>Actonel Once a Week</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>10/12/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Risedronate sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1463/001/001</DrugIDPK>
    <LicenceNumber>DPR1463/001/001</LicenceNumber>
    <ProductName>Actonel Once a Week</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>31/01/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Risedronate sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1500/005/001</DrugIDPK>
    <LicenceNumber>DPR1500/005/001</LicenceNumber>
    <ProductName>Actonel Once a Week</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>22/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Risedronate sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1151/021/001</DrugIDPK>
    <LicenceNumber>PPA1151/021/001</LicenceNumber>
    <ProductName>Actonel Once a Week</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>16/02/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Risedronate sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/017/002</DrugIDPK>
    <LicenceNumber>PPA1328/017/002</LicenceNumber>
    <ProductName>Actonel Once a Week</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>03/08/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Risedronate sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/004/001</DrugIDPK>
    <LicenceNumber>PPA1447/004/001</LicenceNumber>
    <ProductName>Actonel Once a Week</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>05/09/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Risedronate sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/015/001</DrugIDPK>
    <LicenceNumber>PPA1500/015/001</LicenceNumber>
    <ProductName>Actonel Once a Week</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>12/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Risedronate sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/015/001</DrugIDPK>
    <LicenceNumber>PPA1562/015/001</LicenceNumber>
    <ProductName>Actonel Once a Week</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>09/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Risedronate sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/03/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1592/001/001</DrugIDPK>
    <LicenceNumber>PPA1592/001/001</LicenceNumber>
    <ProductName>Actonel Once a Week</ProductName>
    <PAHolder>Pharma First Limited</PAHolder>
    <AuthorisedDate>29/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Risedronate sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/09/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1473/011/001</DrugIDPK>
    <LicenceNumber>PPA1473/011/001</LicenceNumber>
    <ProductName>ACTONEL Once a Week</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>09/01/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Risedronate sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/05/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/023/001</DrugIDPK>
    <LicenceNumber>PPA1463/023/001</LicenceNumber>
    <ProductName>Actonel Once a Week 35 mg film-coated tablets</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>03/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Risedronate sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/02/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/001/001</DrugIDPK>
    <LicenceNumber>PPA1596/001/001</LicenceNumber>
    <ProductName>Actonel Once a Week 35mg Film-coated tablets</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>09/04/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Risedronate sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1633/002/001</DrugIDPK>
    <LicenceNumber>PPA1633/002/001</LicenceNumber>
    <ProductName>Actonel Once A Week 35mg Film-coated Tablets</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>09/04/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Risedronate sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/06/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/090/001</DrugIDPK>
    <LicenceNumber>PPA1328/090/001</LicenceNumber>
    <ProductName>Actonel Plus</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>17/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Risedronate sodium</ActiveSubstance>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Colecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/041/001</DrugIDPK>
    <LicenceNumber>PPA1659/041/001</LicenceNumber>
    <ProductName>Actonel Plus Ca &amp; D</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>26/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Risedronate sodium</ActiveSubstance>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Colecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/305/001</DrugIDPK>
    <LicenceNumber>PPA0465/305/001</LicenceNumber>
    <ProductName>Actonel Plus Ca &amp; D 35 mg film-coated tablets + 1000 mg/880 IU Effervescent Granules</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>08/03/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent granules + film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Risedronate sodium</ActiveSubstance>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Colecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22668/002/001</DrugIDPK>
    <LicenceNumber>PA22668/002/001</LicenceNumber>
    <ProductName>Actonel Plus Ca &amp; D 35mg film-coated tablets + 1000mg/880 IU effervescent granules</ProductName>
    <PAHolder>Theramex Ireland Limited</PAHolder>
    <AuthorisedDate>12/10/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent granules + film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Risedronate sodium</ActiveSubstance>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Colecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/01/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1635/003/002</DrugIDPK>
    <LicenceNumber>PA1635/003/002</LicenceNumber>
    <ProductName>Actonel Plus Ca &amp; D Tablet 35mg and 500mg/400 IU film-coated tablets</ProductName>
    <PAHolder>Teva NI Limited</PAHolder>
    <AuthorisedDate>04/07/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Risedronate sodium</ActiveSubstance>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Cholecalciferol concentrate </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0593/011/002</DrugIDPK>
    <LicenceNumber>PA0593/011/002</LicenceNumber>
    <ProductName>ACTOPRIL</ProductName>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>10/12/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/05/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0593/011/001</DrugIDPK>
    <LicenceNumber>PA0593/011/001</LicenceNumber>
    <ProductName>Actopril Tablets 12.5mg.</ProductName>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>10/12/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/05/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0593/011/003</DrugIDPK>
    <LicenceNumber>PA0593/011/003</LicenceNumber>
    <ProductName>Actopril Tablets 50mg</ProductName>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>10/12/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/05/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0218/025/001</DrugIDPK>
    <LicenceNumber>PA0218/025/001</LicenceNumber>
    <ProductName>ACTRAPID</ProductName>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Insulin human</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/12/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0218/025/007</DrugIDPK>
    <LicenceNumber>PA0218/025/007</LicenceNumber>
    <ProductName>ACTRAPID FLEXPEN</ProductName>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Insulin human</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/10/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0218/025/006</DrugIDPK>
    <LicenceNumber>PA0218/025/006</LicenceNumber>
    <ProductName>ACTRAPID INNOLET</ProductName>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Insulin human</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/10/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0218/025/003</DrugIDPK>
    <LicenceNumber>PA0218/025/003</LicenceNumber>
    <ProductName>ACTRAPID NOVOLET</ProductName>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Insulin human</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0218/025/005</DrugIDPK>
    <LicenceNumber>PA0218/025/005</LicenceNumber>
    <ProductName>ACTRAPID NOVOLET</ProductName>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Insulin human</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/12/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0218/025/004</DrugIDPK>
    <LicenceNumber>PA0218/025/004</LicenceNumber>
    <ProductName>ACTRAPID PENFILL</ProductName>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Insulin human</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/12/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0218/025/002</DrugIDPK>
    <LicenceNumber>PA0218/025/002</LicenceNumber>
    <ProductName>ACTRAPID PENFILL</ProductName>
    <PAHolder>Novo Nordisk A/S</PAHolder>
    <AuthorisedDate>08/05/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INSULIN HUMAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/037/001</DrugIDPK>
    <LicenceNumber>PPA1562/037/001</LicenceNumber>
    <ProductName>Acular</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>12/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ketorolac trometamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/01/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/019/001</DrugIDPK>
    <LicenceNumber>PPA1447/019/001</LicenceNumber>
    <ProductName>ACULAR</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>14/11/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ketorolac trometamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/03/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/142/001</DrugIDPK>
    <LicenceNumber>PPA1151/142/001</LicenceNumber>
    <ProductName>Acular 0.5% w/v eye drops, solution</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>03/12/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ketorolac trometamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/061/001</DrugIDPK>
    <LicenceNumber>PA0057/061/001</LicenceNumber>
    <ProductName>Acupan</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nefopam hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/08/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/017/001</DrugIDPK>
    <LicenceNumber>PPA1562/017/001</LicenceNumber>
    <ProductName>Acupan</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>05/02/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nefopam hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1332/019/001</DrugIDPK>
    <LicenceNumber>PA1332/019/001</LicenceNumber>
    <ProductName>Acupan 30mg Film-Coated Tablets</ProductName>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>19/02/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nefopam hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/02/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0593/015/001</DrugIDPK>
    <LicenceNumber>PA0593/015/001</LicenceNumber>
    <ProductName>Acyclostad</ProductName>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>27/11/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acyclovir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/04/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/20/1476/001</DrugIDPK>
    <LicenceNumber>EU/1/20/1476/001</LicenceNumber>
    <ProductName>Adakveo</ProductName>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>28/10/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Crizanlizumab</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>21/08/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/012/002</DrugIDPK>
    <LicenceNumber>PPA0465/012/002</LicenceNumber>
    <ProductName>ADALAT</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>12/08/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/11/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/012/001</DrugIDPK>
    <LicenceNumber>PPA0465/012/001</LicenceNumber>
    <ProductName>ADALAT</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>15/01/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0384/001/001</DrugIDPK>
    <LicenceNumber>PPA0384/001/001</LicenceNumber>
    <ProductName>ADALAT</ProductName>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>15/07/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/10/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/025/002</DrugIDPK>
    <LicenceNumber>PA1410/025/002</LicenceNumber>
    <ProductName>Adalat 10 mg soft capsules</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>25/05/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/09/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/025/001</DrugIDPK>
    <LicenceNumber>PA1410/025/001</LicenceNumber>
    <ProductName>Adalat 5 mg soft capsules</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>26/02/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/09/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/003/006</DrugIDPK>
    <LicenceNumber>PA0021/003/006</LicenceNumber>
    <ProductName>ADALAT BIPHASIC</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>06/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/04/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/047/001</DrugIDPK>
    <LicenceNumber>PPA1328/047/001</LicenceNumber>
    <ProductName>Adalat LA</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>13/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/047/002</DrugIDPK>
    <LicenceNumber>PPA1328/047/002</LicenceNumber>
    <ProductName>Adalat LA</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>13/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/047/003</DrugIDPK>
    <LicenceNumber>PPA1328/047/003</LicenceNumber>
    <ProductName>Adalat LA</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>13/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/037/001</DrugIDPK>
    <LicenceNumber>PPA1500/037/001</LicenceNumber>
    <ProductName>Adalat LA</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>08/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/037/002</DrugIDPK>
    <LicenceNumber>PPA1500/037/002</LicenceNumber>
    <ProductName>Adalat LA</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>08/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/037/003</DrugIDPK>
    <LicenceNumber>PPA1500/037/003</LicenceNumber>
    <ProductName>Adalat LA</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>08/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/036/001</DrugIDPK>
    <LicenceNumber>PPA1562/036/001</LicenceNumber>
    <ProductName>Adalat LA</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/039/001</DrugIDPK>
    <LicenceNumber>PPA1659/039/001</LicenceNumber>
    <ProductName>Adalat LA</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>02/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/039/002</DrugIDPK>
    <LicenceNumber>PPA1659/039/002</LicenceNumber>
    <ProductName>Adalat LA</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>02/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/039/003</DrugIDPK>
    <LicenceNumber>PPA1659/039/003</LicenceNumber>
    <ProductName>Adalat LA</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>02/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/025/005</DrugIDPK>
    <LicenceNumber>PA1410/025/005</LicenceNumber>
    <ProductName>Adalat LA 20 mg Prolonged-Release Tablet</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>04/03/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/058/001</DrugIDPK>
    <LicenceNumber>PPA1463/058/001</LicenceNumber>
    <ProductName>Adalat LA 20 mg Prolonged-Release Tablet</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>05/04/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/08/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/035/002</DrugIDPK>
    <LicenceNumber>PPA1596/035/002</LicenceNumber>
    <ProductName>Adalat LA 20mg Prolonged-Release Tablet</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>21/01/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/012/007</DrugIDPK>
    <LicenceNumber>PPA0465/012/007</LicenceNumber>
    <ProductName>Adalat LA 20mg Prolonged-release Tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>22/12/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/025/006</DrugIDPK>
    <LicenceNumber>PA1410/025/006</LicenceNumber>
    <ProductName>Adalat LA 30 mg Prolonged-Release Tablet</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>11/04/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/036/002</DrugIDPK>
    <LicenceNumber>PPA1562/036/002</LicenceNumber>
    <ProductName>Adalat LA 30 mg Prolonged-Release Tablet</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/11/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/058/002</DrugIDPK>
    <LicenceNumber>PPA1463/058/002</LicenceNumber>
    <ProductName>Adalat LA 30 mg Prolonged-Release Tablet</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>05/04/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/08/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/012/005</DrugIDPK>
    <LicenceNumber>PPA0465/012/005</LicenceNumber>
    <ProductName>Adalat LA 30 mg Prolonged-Release Tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>14/12/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1473/005/001</DrugIDPK>
    <LicenceNumber>PPA1473/005/001</LicenceNumber>
    <ProductName>Adalat LA 30mg Prolonged Release Tablet</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>09/01/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/03/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/047/002</DrugIDPK>
    <LicenceNumber>PPA1151/047/002</LicenceNumber>
    <ProductName>Adalat LA 30mg Prolonged-Release Tablet</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>19/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/035/001</DrugIDPK>
    <LicenceNumber>PPA1596/035/001</LicenceNumber>
    <ProductName>Adalat LA 30mg Prolonged-Release Tablet</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>21/01/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/025/007</DrugIDPK>
    <LicenceNumber>PA1410/025/007</LicenceNumber>
    <ProductName>Adalat LA 60 mg Prolonged-Release Tablet</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>11/04/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/036/003</DrugIDPK>
    <LicenceNumber>PPA1562/036/003</LicenceNumber>
    <ProductName>Adalat LA 60 mg Prolonged-Release Tablet</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/11/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/058/003</DrugIDPK>
    <LicenceNumber>PPA1463/058/003</LicenceNumber>
    <ProductName>Adalat LA 60 mg Prolonged-Release Tablet</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>05/04/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/08/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/012/006</DrugIDPK>
    <LicenceNumber>PPA0465/012/006</LicenceNumber>
    <ProductName>Adalat LA 60 mg Prolonged-release Tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>14/12/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1473/005/002</DrugIDPK>
    <LicenceNumber>PPA1473/005/002</LicenceNumber>
    <ProductName>Adalat LA 60mg Prolonged Release Tablet</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>09/01/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/03/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/035/003</DrugIDPK>
    <LicenceNumber>PPA1596/035/003</LicenceNumber>
    <ProductName>Adalat LA 60mg Prolonged-Release Tablet</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>21/01/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/047/004</DrugIDPK>
    <LicenceNumber>PPA1328/047/004</LicenceNumber>
    <ProductName>Adalat Retard</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>13/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/058/001</DrugIDPK>
    <LicenceNumber>PPA1447/058/001</LicenceNumber>
    <ProductName>Adalat Retard</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>05/02/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/02/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/036/004</DrugIDPK>
    <LicenceNumber>PPA1562/036/004</LicenceNumber>
    <ProductName>Adalat Retard</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>12/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/012/004B</DrugIDPK>
    <LicenceNumber>PPA0465/012/004B</LicenceNumber>
    <ProductName>ADALAT RETARD</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>23/06/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/12/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/012/003C</DrugIDPK>
    <LicenceNumber>PPA0465/012/003C</LicenceNumber>
    <ProductName>ADALAT RETARD</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>12/08/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/08/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/012/003B</DrugIDPK>
    <LicenceNumber>PPA0465/012/003B</LicenceNumber>
    <ProductName>ADALAT RETARD</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>12/08/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/08/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/012/003A</DrugIDPK>
    <LicenceNumber>PPA0465/012/003A</LicenceNumber>
    <ProductName>ADALAT RETARD</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>12/08/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/08/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/025/003</DrugIDPK>
    <LicenceNumber>PA1410/025/003</LicenceNumber>
    <ProductName>Adalat Retard 10 mg Prolonged-Release tablets</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>06/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/09/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/025/004</DrugIDPK>
    <LicenceNumber>PA1410/025/004</LicenceNumber>
    <ProductName>Adalat Retard 20 mg Prolonged-Release tablets</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>15/04/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/09/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/036/005</DrugIDPK>
    <LicenceNumber>PPA1562/036/005</LicenceNumber>
    <ProductName>Adalat Retard 20 mg Prolonged-Release tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>12/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/11/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/012/003</DrugIDPK>
    <LicenceNumber>PPA0465/012/003</LicenceNumber>
    <ProductName>Adalat Retard 20 mg Prolonged-Release Tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>12/08/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/047/001</DrugIDPK>
    <LicenceNumber>PPA1151/047/001</LicenceNumber>
    <ProductName>Adalat Retard 20 mg Prolonged-Release Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>07/03/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/003/012</DrugIDPK>
    <LicenceNumber>PA0021/003/012</LicenceNumber>
    <ProductName>ADALAT SA</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>13/10/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/04/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/003/011</DrugIDPK>
    <LicenceNumber>PA0021/003/011</LicenceNumber>
    <ProductName>ADALAT SA</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>13/10/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/04/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/003/010</DrugIDPK>
    <LicenceNumber>PA0021/003/010</LicenceNumber>
    <ProductName>ADALAT SA</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>13/10/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/04/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/106/003</DrugIDPK>
    <LicenceNumber>PA1077/106/003</LicenceNumber>
    <ProductName>Adartrel</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>16/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ropinirole hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/106/001</DrugIDPK>
    <LicenceNumber>PA1077/106/001</LicenceNumber>
    <ProductName>ADARTREL 0.25 mg film-coated tablets</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>16/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ropinirole hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/106/002</DrugIDPK>
    <LicenceNumber>PA1077/106/002</LicenceNumber>
    <ProductName>ADARTREL 0.5mg film-coated tablets</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>16/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ropinirole hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/106/004</DrugIDPK>
    <LicenceNumber>PA1077/106/004</LicenceNumber>
    <ProductName>ADARTREL 2mg film-coated tablets</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>16/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ropinirole hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/018/001</DrugIDPK>
    <LicenceNumber>PA0002/018/001</LicenceNumber>
    <ProductName>Adcortyl in Orabase 0.1% w/w oromucosal paste</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal paste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Triamcinolone acetonide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1328/003/001</DrugIDPK>
    <LicenceNumber>DPR1328/003/001</LicenceNumber>
    <ProductName>Adcortyl in Orobase</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>06/03/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal paste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Triamcinolone acetonide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0002/018/002</DrugIDPK>
    <LicenceNumber>PA0002/018/002</LicenceNumber>
    <ProductName>Adcortyl Intra-articular/Intra-Dermal Injection 10mg/ml suspension for injection, 1 ml</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Triamcinolone acetonide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/018/003</DrugIDPK>
    <LicenceNumber>PA0002/018/003</LicenceNumber>
    <ProductName>Adcortyl Intra-articular/Intradermal Injection 10 mg/ml, Suspension for Injection, 5ml</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Triamcinolone acetonide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/08/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1338/007/001</DrugIDPK>
    <LicenceNumber>PA1338/007/001</LicenceNumber>
    <ProductName>Adcus 3mg/ml Solution for Infusion</ProductName>
    <PAHolder>Focus Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>11/01/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Adenosine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0187/002/001</DrugIDPK>
    <LicenceNumber>PA0187/002/001</LicenceNumber>
    <ProductName>ADDAMEL</ProductName>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0973/001/001</DrugIDPK>
    <LicenceNumber>PA0973/001/001</LicenceNumber>
    <ProductName>ADDIFLU SUSPENSION FOR INJECTION</ProductName>
    <PAHolder>Sanofi Pasteur MSD S.p.A.</PAHolder>
    <AuthorisedDate>01/09/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/BRISBANE/59/2007 (H1N1) - LIKE STRAIN (A/BRISBANE/59/2007, IVR-148) PH.EUR</ActiveSubstance>
      <ActiveSubstance>A/brisbane/10/2007 (h3n2) - like strain (a/uruguay/716/2007,nymc x-175-c)</ActiveSubstance>
      <ActiveSubstance>B/brisbane/60/2008 - like strain (b/brisbane/60/2008)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2059/023/001</DrugIDPK>
    <LicenceNumber>PA2059/023/001</LicenceNumber>
    <ProductName>Additrace, concentrate for solution for infusion</ProductName>
    <PAHolder>Fresenius Kabi Deutschland GmbH</PAHolder>
    <AuthorisedDate>16/05/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ferric chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Zinc chloride</ActiveSubstance>
      <ActiveSubstance>Manganese chloride tetrahydrate</ActiveSubstance>
      <ActiveSubstance>Copper chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Chromium trichloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Sodium selenite anhydrous</ActiveSubstance>
      <ActiveSubstance>Sodium molybdate dihydrate</ActiveSubstance>
      <ActiveSubstance>Sodium fluoride</ActiveSubstance>
      <ActiveSubstance>Potassium iodide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/03/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/140/001</DrugIDPK>
    <LicenceNumber>PA0540/140/001</LicenceNumber>
    <ProductName>Adenoscan</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>07/09/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Adenosine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/035/001</DrugIDPK>
    <LicenceNumber>PA1339/035/001</LicenceNumber>
    <ProductName>Adenosine 30mg/10ml solution for infusion</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>04/10/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Adenosine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription</SupplyComments>
    <WithdrawalDate>04/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/034/001</DrugIDPK>
    <LicenceNumber>PA1339/034/001</LicenceNumber>
    <ProductName>Adenosine 3mg/ml solution for injection</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>04/10/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Adenosine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription</SupplyComments>
    <WithdrawalDate>04/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1338/008/001</DrugIDPK>
    <LicenceNumber>PA1338/008/001</LicenceNumber>
    <ProductName>Adenosine 3mg/ml Solution for Injection</ProductName>
    <PAHolder>Focus Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>11/01/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Adenosine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0114/077/001</DrugIDPK>
    <LicenceNumber>PA0114/077/001</LicenceNumber>
    <ProductName>ADIZEM PLUS</ProductName>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>25/07/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/04/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0913/014/008</DrugIDPK>
    <LicenceNumber>PA0913/014/008</LicenceNumber>
    <ProductName>Adizem-XL</ProductName>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>19/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/02/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/007/010</DrugIDPK>
    <LicenceNumber>PA0044/007/010</LicenceNumber>
    <ProductName>ADMUNE (FLUVAC)</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/007/009</DrugIDPK>
    <LicenceNumber>PA0044/007/009</LicenceNumber>
    <ProductName>ADMUNE (FLUVAC)</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/007/005</DrugIDPK>
    <LicenceNumber>PA0044/007/005</LicenceNumber>
    <ProductName>ADMUNE MULTIDOSE</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/007/003</DrugIDPK>
    <LicenceNumber>PA0044/007/003</LicenceNumber>
    <ProductName>ADMUNE MULTIDOSE</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/007/004</DrugIDPK>
    <LicenceNumber>PA0044/007/004</LicenceNumber>
    <ProductName>ADMUNE SINGLE DOSE</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0255/002/001</DrugIDPK>
    <LicenceNumber>PA0255/002/001</LicenceNumber>
    <ProductName>ADRENALINE</ProductName>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>25/01/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22684/001/002</DrugIDPK>
    <LicenceNumber>PA22684/001/002</LicenceNumber>
    <ProductName>Adrenaline (Epinephrine) 1:10,000 Sterile Solution Minijet</ProductName>
    <PAHolder>DLRC Pharma Services Limited</PAHolder>
    <AuthorisedDate>25/01/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Adrenaline</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22684/001/001</DrugIDPK>
    <LicenceNumber>PA22684/001/001</LicenceNumber>
    <ProductName>Adrenaline (Epinephrine) Injection 1:1,000 Minijet (1ml)</ProductName>
    <PAHolder>DLRC Pharma Services Limited</PAHolder>
    <AuthorisedDate>25/01/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Adrenaline</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0277/009/001</DrugIDPK>
    <LicenceNumber>PA0277/009/001</LicenceNumber>
    <ProductName>ADRENALINE 1 IN 1000 EYE</ProductName>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>20/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0236/008/002</DrugIDPK>
    <LicenceNumber>PA0236/008/002</LicenceNumber>
    <ProductName>ADRIAMYCIN</ProductName>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>18/12/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/05/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0236/008/001</DrugIDPK>
    <LicenceNumber>PA0236/008/001</LicenceNumber>
    <ProductName>ADRIAMYCIN</ProductName>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>18/12/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/05/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/077/001</DrugIDPK>
    <LicenceNumber>PA0167/077/001</LicenceNumber>
    <ProductName>ADSOL RED CELL PRESERVATION</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>07/05/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MANNITOL</ActiveSubstance>
      <ActiveSubstance>ADENINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/09/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1001/001/002</DrugIDPK>
    <LicenceNumber>PA1001/001/002</LicenceNumber>
    <ProductName>ADSORBED DIPHTHERIA &amp; TETANUS VACCINE</ProductName>
    <PAHolder>Chiron Vaccines Limited</PAHolder>
    <AuthorisedDate>02/12/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1001/001/001</DrugIDPK>
    <LicenceNumber>PA1001/001/001</LicenceNumber>
    <ProductName>ADSORBED DIPHTHERIA &amp; TETANUS VACCINE</ProductName>
    <PAHolder>Chiron Vaccines Limited</PAHolder>
    <AuthorisedDate>02/12/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/049/002</DrugIDPK>
    <LicenceNumber>PA0044/049/002</LicenceNumber>
    <ProductName>ADSORBED DIPHTHERIA &amp; TETANUS VACCINE</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA AND TETANUS TOXOIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/07/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/049/001</DrugIDPK>
    <LicenceNumber>PA0044/049/001</LicenceNumber>
    <ProductName>ADSORBED DIPHTHERIA &amp; TETANUS VACCINE</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA AND TETANUS TOXOIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/07/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0544/004/003</DrugIDPK>
    <LicenceNumber>PA0544/004/003</LicenceNumber>
    <ProductName>ADSORBED DIPHTHERIA &amp; TETANUS VACCINE BP 10 DOSE</ProductName>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>20/09/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0544/004/001</DrugIDPK>
    <LicenceNumber>PA0544/004/001</LicenceNumber>
    <ProductName>Adsorbed Diphtheria &amp; Tetanus Vaccine BP Ampoule</ProductName>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diphtheria toxoid</ActiveSubstance>
      <ActiveSubstance>Tetanus toxoid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0544/004/002</DrugIDPK>
    <LicenceNumber>PA0544/004/002</LicenceNumber>
    <ProductName>Adsorbed Diphtheria and Tetanus Vaccine BP Syringe</ProductName>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diphtheria toxoid</ActiveSubstance>
      <ActiveSubstance>Tetanus toxoid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0365/058/002</DrugIDPK>
    <LicenceNumber>PA0365/058/002</LicenceNumber>
    <ProductName>ADSORBED DIPHTHERIA TETANUS &amp; PERTUSSIS</ProductName>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>02/12/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/07/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/036/001</DrugIDPK>
    <LicenceNumber>PA0044/036/001</LicenceNumber>
    <ProductName>ADSORBED DIPHTHERIA TETANUS &amp; PERTUSSIS</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/07/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0365/058/001</DrugIDPK>
    <LicenceNumber>PA0365/058/001</LicenceNumber>
    <ProductName>ADSORBED DIPHTHERIA TETANUS &amp; PERTUSSIS VACCINE BP</ProductName>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>02/12/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>PERTUSSIS VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1001/003/001</DrugIDPK>
    <LicenceNumber>PA1001/003/001</LicenceNumber>
    <ProductName>ADSORBED DIPHTHERIA VACCINE BP (CHILD)</ProductName>
    <PAHolder>Chiron Vaccines Limited</PAHolder>
    <AuthorisedDate>02/12/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0544/001/001</DrugIDPK>
    <LicenceNumber>PA0544/001/001</LicenceNumber>
    <ProductName>Adsorbed Tetanus</ProductName>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tetanus toxoid</ActiveSubstance>
      <ActiveSubstance>Aluminium hydroxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/06/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0544/001/003</DrugIDPK>
    <LicenceNumber>PA0544/001/003</LicenceNumber>
    <ProductName>ADSORBED TETANUS 10 DOSE</ProductName>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>12/06/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0544/001/002</DrugIDPK>
    <LicenceNumber>PA0544/001/002</LicenceNumber>
    <ProductName>Adsorbed Tetanus Syringe</ProductName>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>12/06/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tetanus toxoid</ActiveSubstance>
      <ActiveSubstance>Aluminium hydroxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/06/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1001/002/002</DrugIDPK>
    <LicenceNumber>PA1001/002/002</LicenceNumber>
    <ProductName>ADSORBED TETANUS VACCINE</ProductName>
    <PAHolder>Chiron Vaccines Limited</PAHolder>
    <AuthorisedDate>02/12/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1001/002/001</DrugIDPK>
    <LicenceNumber>PA1001/002/001</LicenceNumber>
    <ProductName>ADSORBED TETANUS VACCINE BP</ProductName>
    <PAHolder>Chiron Vaccines Limited</PAHolder>
    <AuthorisedDate>02/12/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0258/017/002</DrugIDPK>
    <LicenceNumber>PA0258/017/002</LicenceNumber>
    <ProductName>ADULT KAO-C DIARRHOEA</ProductName>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Kaolin, light</ActiveSubstance>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/01/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0258/026/001</DrugIDPK>
    <LicenceNumber>PA0258/026/001</LicenceNumber>
    <ProductName>ADULT MELTUS</ProductName>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>17/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SUCROSE</ActiveSubstance>
      <ActiveSubstance>HONEY</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/09/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1025/013/003</DrugIDPK>
    <LicenceNumber>PA1025/013/003</LicenceNumber>
    <ProductName>Advantan  0.1% w/w Fatty Ointment</ProductName>
    <PAHolder>LEO Pharma A/S</PAHolder>
    <AuthorisedDate>03/04/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methylprednisolone aceponate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/09/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1025/013/002</DrugIDPK>
    <LicenceNumber>PA1025/013/002</LicenceNumber>
    <ProductName>Advantan 0.1% w/w Ointment</ProductName>
    <PAHolder>LEO Pharma A/S</PAHolder>
    <AuthorisedDate>03/04/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methylprednisolone aceponate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/09/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1025/013/001</DrugIDPK>
    <LicenceNumber>PA1025/013/001</LicenceNumber>
    <ProductName>Advantan cream 0.1% w/w</ProductName>
    <PAHolder>LEO Pharma A/S</PAHolder>
    <AuthorisedDate>03/04/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methylprednisolone aceponate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/09/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/163/003</DrugIDPK>
    <LicenceNumber>PA0822/163/003</LicenceNumber>
    <ProductName>Advil</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>01/06/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/08/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/163/002</DrugIDPK>
    <LicenceNumber>PA0822/163/002</LicenceNumber>
    <ProductName>Advil 200 mg Tablets</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>09/07/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription if compliant with the following restrictions: maximum strength: 200 mg, maximum pack size: 50, maximum dose: 400 mg; maximum daily dose: 1200 mg, limited indications.</SupplyComments>
    <WithdrawalDate>30/11/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0172/029/004</DrugIDPK>
    <LicenceNumber>PA0172/029/004</LicenceNumber>
    <ProductName>ADVIL JUNIOR</ProductName>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>17/07/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/02/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/163/004</DrugIDPK>
    <LicenceNumber>PA0822/163/004</LicenceNumber>
    <ProductName>Advil Maximum Strength</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>01/06/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription, supply through pharmacies only and promotion to the public subject to the following restrictions: maximum strength 400 mg, maximum pack size 25, maximum dose: 400 mg, maximum daily dose 1200 mg, limited indicati</SupplyComments>
    <WithdrawalDate>30/08/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/002</DrugIDPK>
    <LicenceNumber>EU/1/00/160/002</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/003</DrugIDPK>
    <LicenceNumber>EU/1/00/160/003</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/004</DrugIDPK>
    <LicenceNumber>EU/1/00/160/004</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/005</DrugIDPK>
    <LicenceNumber>EU/1/00/160/005</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/006</DrugIDPK>
    <LicenceNumber>EU/1/00/160/006</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/007</DrugIDPK>
    <LicenceNumber>EU/1/00/160/007</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/008</DrugIDPK>
    <LicenceNumber>EU/1/00/160/008</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/009</DrugIDPK>
    <LicenceNumber>EU/1/00/160/009</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/010</DrugIDPK>
    <LicenceNumber>EU/1/00/160/010</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/011</DrugIDPK>
    <LicenceNumber>EU/1/00/160/011</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/012</DrugIDPK>
    <LicenceNumber>EU/1/00/160/012</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/013</DrugIDPK>
    <LicenceNumber>EU/1/00/160/013</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/015</DrugIDPK>
    <LicenceNumber>EU/1/00/160/015</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme BV</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/016</DrugIDPK>
    <LicenceNumber>EU/1/00/160/016</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme BV</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/017</DrugIDPK>
    <LicenceNumber>EU/1/00/160/017</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme BV</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/018</DrugIDPK>
    <LicenceNumber>EU/1/00/160/018</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme BV</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/019</DrugIDPK>
    <LicenceNumber>EU/1/00/160/019</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme BV</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/020</DrugIDPK>
    <LicenceNumber>EU/1/00/160/020</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme BV</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/021</DrugIDPK>
    <LicenceNumber>EU/1/00/160/021</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme BV</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/022</DrugIDPK>
    <LicenceNumber>EU/1/00/160/022</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/023</DrugIDPK>
    <LicenceNumber>EU/1/00/160/023</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/024</DrugIDPK>
    <LicenceNumber>EU/1/00/160/024</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/025</DrugIDPK>
    <LicenceNumber>EU/1/00/160/025</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/026</DrugIDPK>
    <LicenceNumber>EU/1/00/160/026</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/027</DrugIDPK>
    <LicenceNumber>EU/1/00/160/027</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/028</DrugIDPK>
    <LicenceNumber>EU/1/00/160/028</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/029</DrugIDPK>
    <LicenceNumber>EU/1/00/160/029</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/030</DrugIDPK>
    <LicenceNumber>EU/1/00/160/030</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/031</DrugIDPK>
    <LicenceNumber>EU/1/00/160/031</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/032</DrugIDPK>
    <LicenceNumber>EU/1/00/160/032</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/033</DrugIDPK>
    <LicenceNumber>EU/1/00/160/033</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/034</DrugIDPK>
    <LicenceNumber>EU/1/00/160/034</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/37-48</DrugIDPK>
    <LicenceNumber>EU/1/00/160/37-48</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/49-60</DrugIDPK>
    <LicenceNumber>EU/1/00/160/49-60</LicenceNumber>
    <ProductName>Aerius</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/160/014</DrugIDPK>
    <LicenceNumber>EU/1/00/160/014</LicenceNumber>
    <ProductName>AERIUS</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme BV</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/16/1122/001-002</DrugIDPK>
    <LicenceNumber>EU/1/16/1122/001-002</LicenceNumber>
    <ProductName>Aerivio Spiromax</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>18/08/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fluticasone propionate</ActiveSubstance>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/10/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/056/003</DrugIDPK>
    <LicenceNumber>PA0057/056/003</LicenceNumber>
    <ProductName>AEROBEC 100 AUTOHALER</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>22/04/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/04/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/056/004</DrugIDPK>
    <LicenceNumber>PA0057/056/004</LicenceNumber>
    <ProductName>AEROBEC 250 INHALER</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>22/04/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/04/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/056/001</DrugIDPK>
    <LicenceNumber>PA0057/056/001</LicenceNumber>
    <ProductName>AEROBEC 50 AUTOHALER</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>24/01/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/04/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0568/014/001</DrugIDPK>
    <LicenceNumber>PA0568/014/001</LicenceNumber>
    <ProductName>AERODIOL 150 micrograms/dose, nasal spray solution</ProductName>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>23/03/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal spray, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Estradiol hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/05/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/054/003</DrugIDPK>
    <LicenceNumber>PA0057/054/003</LicenceNumber>
    <ProductName>AEROLIN</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>13/11/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/054/002</DrugIDPK>
    <LicenceNumber>PA0057/054/002</LicenceNumber>
    <ProductName>AEROLIN</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>13/11/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/054/001</DrugIDPK>
    <LicenceNumber>PA0057/054/001</LicenceNumber>
    <ProductName>AEROLIN</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>13/11/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/054/006</DrugIDPK>
    <LicenceNumber>PA0057/054/006</LicenceNumber>
    <ProductName>Aerolin Autohaler</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/034/001</DrugIDPK>
    <LicenceNumber>PA0436/034/001</LicenceNumber>
    <ProductName>Aerolin Autohaler CFC-Free 100 micrograms per metered dose Pressurised Inhalation Suspension</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>08/03/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/054/005</DrugIDPK>
    <LicenceNumber>PA0057/054/005</LicenceNumber>
    <ProductName>AEROLIN INHALER</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>16/01/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/054/004</DrugIDPK>
    <LicenceNumber>PA0057/054/004</LicenceNumber>
    <ProductName>AEROLIN INHALER</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>13/11/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0303/002/002</DrugIDPK>
    <LicenceNumber>PA0303/002/002</LicenceNumber>
    <ProductName>AEROPAX</ProductName>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>20/01/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/02/1986</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0303/002/001</DrugIDPK>
    <LicenceNumber>PA0303/002/001</LicenceNumber>
    <ProductName>AEROPAX EMULSION</ProductName>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>20/01/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/02/1986</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/003/001</DrugIDPK>
    <LicenceNumber>PA0017/003/001</LicenceNumber>
    <ProductName>AEROSPORIN</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYMYXIN B SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/106/001</DrugIDPK>
    <LicenceNumber>PA0167/106/001</LicenceNumber>
    <ProductName>AErrane (isoflurane), inhalation vapour, liquid</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>02/12/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation vapour, liquid</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Isoflurane </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/04/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1241/011/001</DrugIDPK>
    <LicenceNumber>PA1241/011/001</LicenceNumber>
    <ProductName>Affex</ProductName>
    <PAHolder>Astellas Pharma Co. Limited</PAHolder>
    <AuthorisedDate>30/09/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/01/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0277/006/002</DrugIDPK>
    <LicenceNumber>PA0277/006/002</LicenceNumber>
    <ProductName>AFRAZINE NOSE</ProductName>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>20/06/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYMETAZOLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/09/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0277/006/003</DrugIDPK>
    <LicenceNumber>PA0277/006/003</LicenceNumber>
    <ProductName>AFRAZINE NOSE SPRAY</ProductName>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>20/07/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYMETAZOLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/09/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0277/006/001</DrugIDPK>
    <LicenceNumber>PA0277/006/001</LicenceNumber>
    <ProductName>AFRAZINE PAEDIATRIC NOSE</ProductName>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>20/07/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYMETAZOLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0056/050/001</DrugIDPK>
    <LicenceNumber>PA0056/050/001</LicenceNumber>
    <ProductName>AGAROL</ProductName>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>26/03/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOLPHTHALEIN</ActiveSubstance>
      <ActiveSubstance>PARAFFIN, LIQUID</ActiveSubstance>
      <ActiveSubstance>GELIDIUM AMANSII</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/08/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/102/001</DrugIDPK>
    <LicenceNumber>PA0073/102/001</LicenceNumber>
    <ProductName>Agelan Tablets 2.5 mg</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>25/02/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDAPAMIDE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/12/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/148/002</DrugIDPK>
    <LicenceNumber>EU/1/00/148/002</LicenceNumber>
    <ProductName>Agenerase-amprenavir</ProductName>
    <PAHolder>Glaxo Group Limited</PAHolder>
    <AuthorisedDate>20/10/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amprenavir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/148/003</DrugIDPK>
    <LicenceNumber>EU/1/00/148/003</LicenceNumber>
    <ProductName>Agenerase-amprenavir</ProductName>
    <PAHolder>Glaxo Group Limited</PAHolder>
    <AuthorisedDate>20/10/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amprenavir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/148/004</DrugIDPK>
    <LicenceNumber>EU/1/00/148/004</LicenceNumber>
    <ProductName>Agenerase-amprenavir</ProductName>
    <PAHolder>Glaxo Group Limited</PAHolder>
    <AuthorisedDate>20/10/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amprenavir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/148/001</DrugIDPK>
    <LicenceNumber>EU/1/00/148/001</LicenceNumber>
    <ProductName>AGENERASE-AMPRENAVIR</ProductName>
    <PAHolder>Glaxo Group Limited</PAHolder>
    <AuthorisedDate>20/10/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amprenavir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA1720/001/002</DrugIDPK>
    <LicenceNumber>PA1720/001/002</LicenceNumber>
    <ProductName>AGGRASTAT</ProductName>
    <PAHolder>Correvio (UK) Ltd</PAHolder>
    <AuthorisedDate>18/11/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tirofiban hydrochloride monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1720/001/001</DrugIDPK>
    <LicenceNumber>PA1720/001/001</LicenceNumber>
    <ProductName>AGGRASTAT 250 micrograms/ml concentrate for solution for infusion</ProductName>
    <PAHolder>Correvio (UK) Ltd</PAHolder>
    <AuthorisedDate>26/07/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tirofiban hydrochloride monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1288/002/001</DrugIDPK>
    <LicenceNumber>PA1288/002/001</LicenceNumber>
    <ProductName>Agiolax 52%w/w, 2.2%w/w and 6.74-13.2%w/w Granules</ProductName>
    <PAHolder>Madaus GmbH</PAHolder>
    <AuthorisedDate>03/01/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Senna - tinnevelly / indian</ActiveSubstance>
      <ActiveSubstance>Ispaghula husks</ActiveSubstance>
      <ActiveSubstance>Ispaghula</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/07/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1288/004/001</DrugIDPK>
    <LicenceNumber>PA1288/004/001</LicenceNumber>
    <ProductName>Agiolax Pico</ProductName>
    <PAHolder>Madaus GmbH</PAHolder>
    <AuthorisedDate>30/11/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenge</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium picosulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/017/001</DrugIDPK>
    <LicenceNumber>PA2315/017/001</LicenceNumber>
    <ProductName>Agomelatine Accord 25 mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>21/12/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Agomelatine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/281/001</DrugIDPK>
    <LicenceNumber>PA0711/281/001</LicenceNumber>
    <ProductName>Agomelatine Rowex 25mg Film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>14/06/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Agomelatine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/047/001</DrugIDPK>
    <LicenceNumber>PA1986/047/001</LicenceNumber>
    <ProductName>Agomelatine Teva 25 mg Film Coated Tablets</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>01/06/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AGOMELATINE UREA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0301/046/001</DrugIDPK>
    <LicenceNumber>PA0301/046/001</LicenceNumber>
    <ProductName>AGRIPPAL AMPOULE</ProductName>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>15/02/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/05/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2032/001/001</DrugIDPK>
    <LicenceNumber>PA2032/001/001</LicenceNumber>
    <ProductName>Agrippal Suspension for injection in pre-filled syringe, Influenza Vaccine Surface Antigen, Inactivated(2017/2018 season)</ProductName>
    <PAHolder>Seqirus S.r.l.</PAHolder>
    <AuthorisedDate>19/02/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection in pre-filled syringe</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/Guangdong-Maonan/SWL 1536/2019 (H1N1)pdm09-like strain (A/Guangdong-Maonan/SWL 1536/2019, CNIC-1909)</ActiveSubstance>
      <ActiveSubstance>A/Hong Kong/2671/2019 (H3N2)-like strain (A/Hong Kong/2671/2019, IVR-208)</ActiveSubstance>
      <ActiveSubstance>B/Washington/02/2019-like strain (B/Washington/02/2019, wild type)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/12/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0206/029/001</DrugIDPK>
    <LicenceNumber>PA0206/029/001</LicenceNumber>
    <ProductName>Aidex First Aid Antiseptic Cream Aminoacridine Hydrochloride 0.1% w/w,Benzocaine 0.1% w/w,Phenoxyethanol 1.0% w/w</ProductName>
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate>11/02/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aminacrine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Benzocaine</ActiveSubstance>
      <ActiveSubstance>Phenoxyethanol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0185/037/001</DrugIDPK>
    <LicenceNumber>PA0185/037/001</LicenceNumber>
    <ProductName>AILAX</ProductName>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Danthron</ActiveSubstance>
      <ActiveSubstance>Poloxamer 188</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0185/037/002</DrugIDPK>
    <LicenceNumber>PA0185/037/002</LicenceNumber>
    <ProductName>AILAX FORTE</ProductName>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Danthron</ActiveSubstance>
      <ActiveSubstance>Poloxamer</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/16/1123/001-002</DrugIDPK>
    <LicenceNumber>EU/1/16/1123/001-002</LicenceNumber>
    <ProductName>Airexar Spiromax</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>18/08/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fluticasone propionate</ActiveSubstance>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/04/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/124/001</DrugIDPK>
    <LicenceNumber>PPA1463/124/001</LicenceNumber>
    <ProductName>AirFluSal Forspiro 50 microgram/250 microgram/dose, inhalation powder, predispensed</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>01/02/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation powder, pre-dispensed</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Salmeterol</ActiveSubstance>
      <ActiveSubstance>Fluticasone propionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23176/004/002</DrugIDPK>
    <LicenceNumber>PPA23176/004/002</LicenceNumber>
    <ProductName>AirFluSal Forspiro 50 microgram/500 microgram/dose, inhalation powder, predispensed</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>19/05/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation powder, pre-dispensed</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
      <ActiveSubstance>Fluticasone propionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/124/002</DrugIDPK>
    <LicenceNumber>PPA1463/124/002</LicenceNumber>
    <ProductName>AirFluSal Forspiro 50 microgram/500 microgram/dose, inhalation powder, predispensed</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>01/02/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation powder, pre-dispensed</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Salmeterol</ActiveSubstance>
      <ActiveSubstance>Fluticasone propionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23176/004/001</DrugIDPK>
    <LicenceNumber>PPA23176/004/001</LicenceNumber>
    <ProductName>AirFluSal® Forspiro® 50 microgram/250 microgram/dose, inhalation powder, predispensed</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>19/05/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation powder, pre-dispensed</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Salmeterol</ActiveSubstance>
      <ActiveSubstance>Fluticasone propionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/033/002</DrugIDPK>
    <LicenceNumber>PA0436/033/002</LicenceNumber>
    <ProductName>Airomir Autohaler 100 micrograms per metered dose, pressurised inhalation suspension</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>08/03/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/033/001</DrugIDPK>
    <LicenceNumber>PA0436/033/001</LicenceNumber>
    <ProductName>Airomir Inhaler 100 micrograms per metered dose pr</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>19/09/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0968/003/001</DrugIDPK>
    <LicenceNumber>PA0968/003/001</LicenceNumber>
    <ProductName>Airtal 100mg Film-coated Tablets</ProductName>
    <PAHolder>Almirall, S.A.</PAHolder>
    <AuthorisedDate>08/01/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aceclofenac</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Not applicable</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Not applicable</SupplyLegalStatus>
    <PromotionLegalStatus>Not applicable</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/028/004</DrugIDPK>
    <LicenceNumber>PA0086/028/004</LicenceNumber>
    <ProductName>AKFEN (GUANFACINE HCL)</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>05/06/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/028/003</DrugIDPK>
    <LicenceNumber>PA0086/028/003</LicenceNumber>
    <ProductName>AKFEN (GUANFACINE HCL)</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>05/06/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/028/002</DrugIDPK>
    <LicenceNumber>PA0086/028/002</LicenceNumber>
    <ProductName>AKFEN (GUANFACINE HCL)</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>05/06/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUANFACINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/04/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/028/001</DrugIDPK>
    <LicenceNumber>PA0086/028/001</LicenceNumber>
    <ProductName>AKFEN (GUANFACINE HCL)</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>05/06/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0769/018/001</DrugIDPK>
    <LicenceNumber>PA0769/018/001</LicenceNumber>
    <ProductName>AKINETON</ProductName>
    <PAHolder>Knoll Limited</PAHolder>
    <AuthorisedDate>01/04/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>BIPERIDEN LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23176/010/001</DrugIDPK>
    <LicenceNumber>PPA23176/010/001</LicenceNumber>
    <ProductName>Akineton 2mg Tablets</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>28/07/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Biperiden hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0557/002/001</DrugIDPK>
    <LicenceNumber>PA0557/002/001</LicenceNumber>
    <ProductName>Aknemin</ProductName>
    <PAHolder>Surtech International Ltd</PAHolder>
    <AuthorisedDate>14/06/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Minocycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/07/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0557/002/002</DrugIDPK>
    <LicenceNumber>PA0557/002/002</LicenceNumber>
    <ProductName>Aknemin</ProductName>
    <PAHolder>Surtech International Ltd</PAHolder>
    <AuthorisedDate>14/06/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Minocycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/07/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0043/033/001</DrugIDPK>
    <LicenceNumber>PA0043/033/001</LicenceNumber>
    <ProductName>Aknemycin</ProductName>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>21/02/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Erythromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0114/039/001</DrugIDPK>
    <LicenceNumber>PA0114/039/001</LicenceNumber>
    <ProductName>AKROTHERM</ProductName>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HISTAMINE</ActiveSubstance>
      <ActiveSubstance>ACETYLCHOLINE CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHOLESTEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/01/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0095/001/001</DrugIDPK>
    <LicenceNumber>PA0095/001/001</LicenceNumber>
    <ProductName>ALANA BABY CREAM</ProductName>
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>22/10/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/09/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/016/001</DrugIDPK>
    <LicenceNumber>PA0049/016/001</LicenceNumber>
    <ProductName>ALAVAC-P</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/02/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/021/001</DrugIDPK>
    <LicenceNumber>PA0049/021/001</LicenceNumber>
    <ProductName>ALAVAC-S</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/02/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0148/016/001</DrugIDPK>
    <LicenceNumber>PA0148/016/001</LicenceNumber>
    <ProductName>Albalon Liquifilm Eye Drops Solution</ProductName>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>01/11/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Naphazoline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/10/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/007/001</DrugIDPK>
    <LicenceNumber>PA0016/007/001</LicenceNumber>
    <ProductName>ALBAMYCIN T</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NOVOBIOCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/007/002</DrugIDPK>
    <LicenceNumber>PA0016/007/002</LicenceNumber>
    <ProductName>ALBAMYCIN T PAEDIATRIC</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NOVOBIOCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0012/041/003</DrugIDPK>
    <LicenceNumber>PA0012/041/003</LicenceNumber>
    <ProductName>ALBUCID</ProductName>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFACETAMIDE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/01/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0012/041/001</DrugIDPK>
    <LicenceNumber>PA0012/041/001</LicenceNumber>
    <ProductName>ALBUCID</ProductName>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFACETAMIDE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/02/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/001/001</DrugIDPK>
    <LicenceNumber>PA0167/001/001</LicenceNumber>
    <ProductName>ALBUMIN 20%W/V (BUMINATE 20%W/V)</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Human albumin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/04/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0521/002/006</DrugIDPK>
    <LicenceNumber>PA0521/002/006</LicenceNumber>
    <ProductName>ALBUMIN HUMAN 20%</ProductName>
    <PAHolder>Octapharma Limited</PAHolder>
    <AuthorisedDate>14/07/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/07/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0521/002/005</DrugIDPK>
    <LicenceNumber>PA0521/002/005</LicenceNumber>
    <ProductName>ALBUMIN HUMAN 20%</ProductName>
    <PAHolder>Octapharma Limited</PAHolder>
    <AuthorisedDate>14/07/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/10/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0521/002/007</DrugIDPK>
    <LicenceNumber>PA0521/002/007</LicenceNumber>
    <ProductName>ALBUMIN HUMAN 200g/L</ProductName>
    <PAHolder>Octapharma Limited</PAHolder>
    <AuthorisedDate>14/07/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Human albumin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0521/002/001</DrugIDPK>
    <LicenceNumber>PA0521/002/001</LicenceNumber>
    <ProductName>ALBUMIN HUMAN 50g/L</ProductName>
    <PAHolder>Octapharma Limited</PAHolder>
    <AuthorisedDate>14/07/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Human albumin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0217/005/001</DrugIDPK>
    <LicenceNumber>PA0217/005/001</LicenceNumber>
    <ProductName>ALBUMIN NORDISK</ProductName>
    <PAHolder>Nordisk Gentofte A/S</PAHolder>
    <AuthorisedDate>15/04/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/04/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0010/022/005A</DrugIDPK>
    <LicenceNumber>PA0010/022/005A</LicenceNumber>
    <ProductName>ALBUMINAR 20</ProductName>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>11/06/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/06/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0010/022/004</DrugIDPK>
    <LicenceNumber>PA0010/022/004</LicenceNumber>
    <ProductName>ALBUMINAR 20</ProductName>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>11/06/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/03/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0010/022/008A</DrugIDPK>
    <LicenceNumber>PA0010/022/008A</LicenceNumber>
    <ProductName>ALBUMINAR 25</ProductName>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>11/06/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/06/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0010/022/007</DrugIDPK>
    <LicenceNumber>PA0010/022/007</LicenceNumber>
    <ProductName>ALBUMINAR 25</ProductName>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>11/06/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/03/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0010/022/002A</DrugIDPK>
    <LicenceNumber>PA0010/022/002A</LicenceNumber>
    <ProductName>ALBUMINAR 5</ProductName>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>11/06/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/06/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0010/022/010</DrugIDPK>
    <LicenceNumber>PA0010/022/010</LicenceNumber>
    <ProductName>ALBUMINAR-5</ProductName>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>05/01/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0521/008/001</DrugIDPK>
    <LicenceNumber>PA0521/008/001</LicenceNumber>
    <ProductName>ALBUMINATIV</ProductName>
    <PAHolder>Octapharma Limited</PAHolder>
    <AuthorisedDate>10/10/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Human albumin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0521/008/002</DrugIDPK>
    <LicenceNumber>PA0521/008/002</LicenceNumber>
    <ProductName>ALBUMINATIV</ProductName>
    <PAHolder>Octapharma Limited</PAHolder>
    <AuthorisedDate>14/06/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Human albumin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1112/002/001</DrugIDPK>
    <LicenceNumber>PA1112/002/001</LicenceNumber>
    <ProductName>ALBUREX</ProductName>
    <PAHolder>ZLB GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Human albumin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1112/002/002</DrugIDPK>
    <LicenceNumber>PA1112/002/002</LicenceNumber>
    <ProductName>ALBUREX</ProductName>
    <PAHolder>ZLB GmbH</PAHolder>
    <AuthorisedDate>25/06/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Human albumin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/05/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0849/005/002</DrugIDPK>
    <LicenceNumber>PA0849/005/002</LicenceNumber>
    <ProductName>Albutein 20%</ProductName>
    <PAHolder>Instituto Grifols S.A.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Human albumin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0849/005/003</DrugIDPK>
    <LicenceNumber>PA0849/005/003</LicenceNumber>
    <ProductName>Albutein 25%</ProductName>
    <PAHolder>Instituto Grifols S.A.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Human albumin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0849/005/001</DrugIDPK>
    <LicenceNumber>PA0849/005/001</LicenceNumber>
    <ProductName>Albutein 5%</ProductName>
    <PAHolder>Instituto Grifols S.A.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Human albumin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/020/001</DrugIDPK>
    <LicenceNumber>PA0046/020/001</LicenceNumber>
    <ProductName>ALCABUTAZONE LEO</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1470/005/006</DrugIDPK>
    <LicenceNumber>PA1470/005/006</LicenceNumber>
    <ProductName>Alcartis 10 mg orodispersible tablets</ProductName>
    <PAHolder>EGIS Pharmaceuticals PLC</PAHolder>
    <AuthorisedDate>26/02/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aripiprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/02/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1470/005/002</DrugIDPK>
    <LicenceNumber>PA1470/005/002</LicenceNumber>
    <ProductName>Alcartis 10 mg tablets</ProductName>
    <PAHolder>EGIS Pharmaceuticals PLC</PAHolder>
    <AuthorisedDate>26/02/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aripiprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/02/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1470/005/007</DrugIDPK>
    <LicenceNumber>PA1470/005/007</LicenceNumber>
    <ProductName>Alcartis 15 mg orodispersible tablets</ProductName>
    <PAHolder>EGIS Pharmaceuticals PLC</PAHolder>
    <AuthorisedDate>26/02/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aripiprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/02/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1470/005/003</DrugIDPK>
    <LicenceNumber>PA1470/005/003</LicenceNumber>
    <ProductName>Alcartis 15 mg tablets</ProductName>
    <PAHolder>EGIS Pharmaceuticals PLC</PAHolder>
    <AuthorisedDate>26/02/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aripiprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/02/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1470/005/008</DrugIDPK>
    <LicenceNumber>PA1470/005/008</LicenceNumber>
    <ProductName>Alcartis 30 mg orodispersible tablets</ProductName>
    <PAHolder>EGIS Pharmaceuticals PLC</PAHolder>
    <AuthorisedDate>26/02/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aripiprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/02/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1470/005/004</DrugIDPK>
    <LicenceNumber>PA1470/005/004</LicenceNumber>
    <ProductName>Alcartis 30 mg tablets</ProductName>
    <PAHolder>EGIS Pharmaceuticals PLC</PAHolder>
    <AuthorisedDate>26/02/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aripiprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/03/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1470/005/005</DrugIDPK>
    <LicenceNumber>PA1470/005/005</LicenceNumber>
    <ProductName>Alcartis 5 mg orodispersible tablets</ProductName>
    <PAHolder>EGIS Pharmaceuticals PLC</PAHolder>
    <AuthorisedDate>26/02/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aripiprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/02/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1470/005/001</DrugIDPK>
    <LicenceNumber>PA1470/005/001</LicenceNumber>
    <ProductName>Alcartis 5 mg tablets</ProductName>
    <PAHolder>EGIS Pharmaceuticals PLC</PAHolder>
    <AuthorisedDate>26/02/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aripiprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/02/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/006/002</DrugIDPK>
    <LicenceNumber>PA0050/006/002</LicenceNumber>
    <ProductName>ALCOBON</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>31/05/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUCYTOSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0590/001/001</DrugIDPK>
    <LicenceNumber>PA0590/001/001</LicenceNumber>
    <ProductName>Alcoderm</ProductName>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Liquid paraffin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/07/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0590/001/002</DrugIDPK>
    <LicenceNumber>PA0590/001/002</LicenceNumber>
    <ProductName>Alcoderm Lotion</ProductName>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Liquid paraffin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/07/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/081/001</DrugIDPK>
    <LicenceNumber>PA0017/081/001</LicenceNumber>
    <ProductName>ALCOPAR</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BEPHENIUM HYDROXYNAPHTHOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/015/001</DrugIDPK>
    <LicenceNumber>PA0936/015/001</LicenceNumber>
    <ProductName>Aldactide 25mg/25mg Film-coated tablets</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>30/05/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Spironolactone</ActiveSubstance>
      <ActiveSubstance>Hydroflumethiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/015/002</DrugIDPK>
    <LicenceNumber>PA0936/015/002</LicenceNumber>
    <ProductName>Aldactide 50mg/50mg Film-coated tablets</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>30/05/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Spironolactone</ActiveSubstance>
      <ActiveSubstance>Hydroflumethiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/014/002B</DrugIDPK>
    <LicenceNumber>PPA0465/014/002B</LicenceNumber>
    <ProductName>ALDACTONE</ProductName>
    <PAHolder>P.B.S Sales  Limited</PAHolder>
    <AuthorisedDate>28/09/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPIRONOLACTONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/11/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/014/002A</DrugIDPK>
    <LicenceNumber>PPA0465/014/002A</LicenceNumber>
    <ProductName>ALDACTONE</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>28/09/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPIRONOLACTONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/11/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1633/030/001</DrugIDPK>
    <LicenceNumber>PPA1633/030/001</LicenceNumber>
    <ProductName>Aldactone 25 mg Film-coated Tablets</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>13/09/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Spironolactone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/06/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23176/043/001</DrugIDPK>
    <LicenceNumber>PPA23176/043/001</LicenceNumber>
    <ProductName>Aldactone 25 mg Film-coated Tablets</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>03/06/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Spironolactone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/197/001</DrugIDPK>
    <LicenceNumber>PPA1151/197/001</LicenceNumber>
    <ProductName>Aldactone 25mg Film-coated Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>01/08/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Spironolactone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/133/001</DrugIDPK>
    <LicenceNumber>PPA1562/133/001</LicenceNumber>
    <ProductName>Aldactone 25mg Film-coated Tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>24/10/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Spironolactone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This authorisation permits the holder to parallel-distribute product marketed in Ireland under the product authorisation number PA0822/110/001.</SupplyComments>
    <WithdrawalDate>16/02/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/014/001B</DrugIDPK>
    <LicenceNumber>PPA0465/014/001B</LicenceNumber>
    <ProductName>ALDACTONE TABLETS 25 MG</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>29/08/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/11/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/014/001A</DrugIDPK>
    <LicenceNumber>PPA0465/014/001A</LicenceNumber>
    <ProductName>ALDACTONE TABLETS 25 MG</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>28/09/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPIRONOLACTONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/11/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0001/025/001</DrugIDPK>
    <LicenceNumber>PA0001/025/001</LicenceNumber>
    <ProductName>ALDAFRUSE</ProductName>
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>01/07/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SPIRONOLACTONE</ActiveSubstance>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/07/1986</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1473/001/001</DrugIDPK>
    <LicenceNumber>DPR1473/001/001</LicenceNumber>
    <ProductName>Aldomet</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>26/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methyldopa</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0035/051/001</DrugIDPK>
    <LicenceNumber>PA0035/051/001</LicenceNumber>
    <ProductName>Aldomet</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methyldopa</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/051/005</DrugIDPK>
    <LicenceNumber>PA0035/051/005</LicenceNumber>
    <ProductName>Aldomet</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>17/02/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methyldopa</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/02/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/011/002B</DrugIDPK>
    <LicenceNumber>PPA0465/011/002B</LicenceNumber>
    <ProductName>ALDOMET</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>28/09/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/12/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/011/002A</DrugIDPK>
    <LicenceNumber>PPA0465/011/002A</LicenceNumber>
    <ProductName>ALDOMET</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>28/09/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/12/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/011/001B</DrugIDPK>
    <LicenceNumber>PPA0465/011/001B</LicenceNumber>
    <ProductName>ALDOMET</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>28/09/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/12/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/011/001A</DrugIDPK>
    <LicenceNumber>PPA0465/011/001A</LicenceNumber>
    <ProductName>ALDOMET</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>28/09/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/12/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0384/004/001</DrugIDPK>
    <LicenceNumber>PPA0384/004/001</LicenceNumber>
    <ProductName>ALDOMET</ProductName>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>23/01/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/10/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1691/012/001</DrugIDPK>
    <LicenceNumber>PA1691/012/001</LicenceNumber>
    <ProductName>Aldomet 250 mg Film-coated Tablets</ProductName>
    <PAHolder>Aspen Pharma Trading Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anhydrous methyldopa</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1691/012/002</DrugIDPK>
    <LicenceNumber>PA1691/012/002</LicenceNumber>
    <ProductName>Aldomet 500 mg Film-coated Tablets</ProductName>
    <PAHolder>Aspen Pharma Trading Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anhydrous methyldopa</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1130/020/001</DrugIDPK>
    <LicenceNumber>PA1130/020/001</LicenceNumber>
    <ProductName>Alendromax 10mg Tablets</ProductName>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>28/11/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium alendronate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/08/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1130/020/002</DrugIDPK>
    <LicenceNumber>PA1130/020/002</LicenceNumber>
    <ProductName>Alendromax Once Weekly 70mg Tablets</ProductName>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>28/11/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium alendronate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/08/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/259/001</DrugIDPK>
    <LicenceNumber>PA0711/259/001</LicenceNumber>
    <InterchangeableListCode>IC0052-103-002</InterchangeableListCode>
    <ProductName>Alendronate/Colecalciferol Rowex 70 mg/5600 IU tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>16/09/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alendronic acid</ActiveSubstance>
      <ActiveSubstance>Vitamin d3</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/11/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/020/002</DrugIDPK>
    <LicenceNumber>PA2315/020/002</LicenceNumber>
    <InterchangeableListCode>IC0052-103-002</InterchangeableListCode>
    <ProductName>Alendronic acid/Cholecalciferol Accord 70 mg/5600 IU tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>15/03/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alendronic acid</ActiveSubstance>
      <ActiveSubstance>Vitamin d3</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/020/001</DrugIDPK>
    <LicenceNumber>PA2315/020/001</LicenceNumber>
    <InterchangeableListCode>IC0052-102-002</InterchangeableListCode>
    <ProductName>Alendronic acid/Cholecalciferol Accord 70mg/2800IU tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>15/03/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alendronic acid</ActiveSubstance>
      <ActiveSubstance>Vitamin d3</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1390/035/001</DrugIDPK>
    <LicenceNumber>PA1390/035/001</LicenceNumber>
    <ProductName>Alendronic Acid 10 mg Tablets</ProductName>
    <PAHolder>Accord  Healthcare Limited</PAHolder>
    <AuthorisedDate>18/02/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alendronic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/09/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0565/058/001</DrugIDPK>
    <LicenceNumber>PPA0565/058/001</LicenceNumber>
    <ProductName>Alendronic Acid 70 mg Tablets Once Weekly</ProductName>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>29/05/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alendronic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1330/002/001</DrugIDPK>
    <LicenceNumber>PA1330/002/001</LicenceNumber>
    <ProductName>Alendronic Acid 70mg 'once weekly'</ProductName>
    <PAHolder>Gedeon Richter Plc</PAHolder>
    <AuthorisedDate>19/12/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alendronic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/05/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1513/004/001</DrugIDPK>
    <LicenceNumber>PA1513/004/001</LicenceNumber>
    <ProductName>Alendronic Acid Apotex Once Weekly 70 mg Tablets</ProductName>
    <PAHolder>Apotex Europe B.V.</PAHolder>
    <AuthorisedDate>24/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alendronate sodium trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1050/019/001</DrugIDPK>
    <LicenceNumber>PA1050/019/001</LicenceNumber>
    <ProductName>Alendronic Acid Ceft</ProductName>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>13/07/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium alendronate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1271/006/001</DrugIDPK>
    <LicenceNumber>PA1271/006/001</LicenceNumber>
    <ProductName>Alendronic Acid Once Weekly</ProductName>
    <PAHolder>Laboratorios Davur S.L.U.</PAHolder>
    <AuthorisedDate>04/06/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alendronate monosodium trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/102/001</DrugIDPK>
    <LicenceNumber>PA0711/102/001</LicenceNumber>
    <InterchangeableListCode>IC0051-101-002</InterchangeableListCode>
    <ProductName>Alendronic Acid Once Weekly 70 mg Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>24/07/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alendronic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/032/001</DrugIDPK>
    <LicenceNumber>PA2315/032/001</LicenceNumber>
    <InterchangeableListCode>IC0051-101-002</InterchangeableListCode>
    <ProductName>Alendronic Acid Once Weekly 70 mg Tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>18/02/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alendronic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/079/001</DrugIDPK>
    <LicenceNumber>PA0822/079/001</LicenceNumber>
    <ProductName>Alendronic Acid Pfizer 70 mg Tablets</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>23/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium alendronate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/065/001</DrugIDPK>
    <LicenceNumber>PA0822/065/001</LicenceNumber>
    <ProductName>Alesse</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>24/09/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levonorgestrel</ActiveSubstance>
      <ActiveSubstance>Ethinylestradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/055/001</DrugIDPK>
    <LicenceNumber>PA0021/055/001</LicenceNumber>
    <ProductName>ALEVE</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>19/12/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Naproxen sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/03/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/036/004</DrugIDPK>
    <LicenceNumber>PA0019/036/004</LicenceNumber>
    <ProductName>ALEXAN</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>22/07/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/08/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/036/003</DrugIDPK>
    <LicenceNumber>PA0019/036/003</LicenceNumber>
    <ProductName>ALEXAN</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>22/07/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/08/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/036/002</DrugIDPK>
    <LicenceNumber>PA0019/036/002</LicenceNumber>
    <ProductName>ALEXAN</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>10/02/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/08/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/036/001</DrugIDPK>
    <LicenceNumber>PA0019/036/001</LicenceNumber>
    <ProductName>ALEXAN</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>10/02/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/08/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2165/006/001</DrugIDPK>
    <LicenceNumber>PA2165/006/001</LicenceNumber>
    <ProductName>Alfentanil 500 micrograms/ml solution for injection/infusion</ProductName>
    <PAHolder>AS Kalceks</PAHolder>
    <AuthorisedDate>13/09/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alfentanil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>01/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/083/001</DrugIDPK>
    <LicenceNumber>PA0711/083/001</LicenceNumber>
    <ProductName>Alfu</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>28/04/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alfuzosin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/09/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/083/002</DrugIDPK>
    <LicenceNumber>PA0711/083/002</LicenceNumber>
    <ProductName>Alfuzosin hydrochloride Rowex 10 mg prolonged-release tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>28/04/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alfuzosin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/163/001</DrugIDPK>
    <LicenceNumber>PA0540/163/001</LicenceNumber>
    <ProductName>Alfuzosin Winthrop 10mg Prolonged Release Tablets</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>10/08/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alfuzosin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/003/001</DrugIDPK>
    <LicenceNumber>PA0468/003/001</LicenceNumber>
    <ProductName>ALGICON</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>20/10/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Magnesium alginate</ActiveSubstance>
      <ActiveSubstance>Aluminium hydroxide-magnesium carbonate gel</ActiveSubstance>
      <ActiveSubstance>Magnesium carbonate</ActiveSubstance>
      <ActiveSubstance>Potassium bicarbonate</ActiveSubstance>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/04/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/003/002</DrugIDPK>
    <LicenceNumber>PA0468/003/002</LicenceNumber>
    <ProductName>ALGICON</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>13/10/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM ALGINATE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE-MAGNESIUM CARBONATE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/041/001</DrugIDPK>
    <LicenceNumber>PA0022/041/001</LicenceNumber>
    <ProductName>ALGIPAN  (SPRAY)</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>18/08/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHYLENE GLYCOL MONOSTEARATE</ActiveSubstance>
      <ActiveSubstance>METHYL NICOTINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/06/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/014/001</DrugIDPK>
    <LicenceNumber>PA0022/014/001</LicenceNumber>
    <ProductName>Algipan Rub</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Hydroxyethyl Salicylate </ActiveSubstance>
      <ActiveSubstance>Methyl nicotinate</ActiveSubstance>
      <ActiveSubstance>Capsicin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/05/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0277/027/001</DrugIDPK>
    <LicenceNumber>PA0277/027/001</LicenceNumber>
    <ProductName>ALGISPRAY  (SPRAY)</ProductName>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>25/07/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYL STEARATE</ActiveSubstance>
      <ActiveSubstance>DIETHYLAMINE SALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0060/046/002</DrugIDPK>
    <LicenceNumber>PA0060/046/002</LicenceNumber>
    <ProductName>Algitec</ProductName>
    <PAHolder>SmithKline and French</PAHolder>
    <AuthorisedDate>03/01/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cimetidine </ActiveSubstance>
      <ActiveSubstance>Sodium alginate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/01/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0060/046/001</DrugIDPK>
    <LicenceNumber>PA0060/046/001</LicenceNumber>
    <ProductName>ALGITEC CHEWTAB</ProductName>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>07/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
      <ActiveSubstance>ALGINIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/04/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA23176/009/001</DrugIDPK>
    <LicenceNumber>PA23176/009/001</LicenceNumber>
    <ProductName>Alimemazine tartrate 10 mg film-coated tablets</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>18/12/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALIMEMAZINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/04/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/153/001</DrugIDPK>
    <LicenceNumber>PA0073/153/001</LicenceNumber>
    <ProductName>Alimemazine tartrate 10mg Film-coated tablets</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>23/01/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALIMEMAZINE TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/153/002</DrugIDPK>
    <LicenceNumber>PA0073/153/002</LicenceNumber>
    <ProductName>Alimemazine tartrate 30mg/5ml Syrup</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>30/01/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Trimeprazine (alimemazine) tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/153/003</DrugIDPK>
    <LicenceNumber>PA0073/153/003</LicenceNumber>
    <ProductName>Alimemazine tartrate 7.5mg/5ml Syrup</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>30/01/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Trimeprazine (alimemazine) tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1532/002/001</DrugIDPK>
    <LicenceNumber>PA1532/002/001</LicenceNumber>
    <ProductName>Alipza</ProductName>
    <PAHolder>Kowa Pharmaceutical Europe Co. Ltd</PAHolder>
    <AuthorisedDate>05/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pitavastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/02/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1532/002/002</DrugIDPK>
    <LicenceNumber>PA1532/002/002</LicenceNumber>
    <ProductName>Alipza</ProductName>
    <PAHolder>Kowa Pharmaceutical Europe Co. Ltd</PAHolder>
    <AuthorisedDate>05/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pitavastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/02/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1532/002/003</DrugIDPK>
    <LicenceNumber>PA1532/002/003</LicenceNumber>
    <ProductName>Alipza 1mg film-coated tablets</ProductName>
    <PAHolder>Kowa Pharmaceutical Europe Co. Ltd</PAHolder>
    <AuthorisedDate>05/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pitavastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/02/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/08/474/1-3</DrugIDPK>
    <LicenceNumber>EU/1/08/474/1-3</LicenceNumber>
    <ProductName>Alisade 27.5 micrograms/spray</ProductName>
    <PAHolder>Glaxo Group Limited</PAHolder>
    <AuthorisedDate>06/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal spray, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fluticasone furoate (micronised)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA1410/033/001</DrugIDPK>
    <LicenceNumber>PA1410/033/001</LicenceNumber>
    <ProductName>Alka Antacid</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>24/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Hydrotalcite</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/03/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/052/001</DrugIDPK>
    <LicenceNumber>PA0021/052/001</LicenceNumber>
    <ProductName>Alka Rapid Crystals</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>11/02/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aspirin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/02/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0079/008/001</DrugIDPK>
    <LicenceNumber>PA0079/008/001</LicenceNumber>
    <ProductName>ALKA-SELTZER</ProductName>
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/11/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/012/002</DrugIDPK>
    <LicenceNumber>PA0046/012/002</LicenceNumber>
    <ProductName>ALKASID</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM ALUMINUM SILICATE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/012/001</DrugIDPK>
    <LicenceNumber>PA0046/012/001</LicenceNumber>
    <ProductName>ALKASID (SUSPENSION)</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM ALUMINUM SILICATE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/051/001</DrugIDPK>
    <LicenceNumber>PA1077/051/001</LicenceNumber>
    <ProductName>Alkeran</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Melphalan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/051/003</DrugIDPK>
    <LicenceNumber>PA1077/051/003</LicenceNumber>
    <ProductName>Alkeran</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Melphalan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/04/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/001/001</DrugIDPK>
    <LicenceNumber>PA0086/001/001</LicenceNumber>
    <ProductName>ALLBEE WITH C</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>24/10/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/001/003</DrugIDPK>
    <LicenceNumber>PA0086/001/003</LicenceNumber>
    <ProductName>Allbee with C 300</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Thiamine mononitrate</ActiveSubstance>
      <ActiveSubstance>Riboflavine e101</ActiveSubstance>
      <ActiveSubstance>Pyridoxine hydrochloride </ActiveSubstance>
      <ActiveSubstance>Nicotinamide</ActiveSubstance>
      <ActiveSubstance>Calcium pantothenate</ActiveSubstance>
      <ActiveSubstance>Ascorbic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/07/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/001/002</DrugIDPK>
    <LicenceNumber>PA0086/001/002</LicenceNumber>
    <ProductName>ALLBEE WITH C 550</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>17/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VITAMIN B NOS</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/11/1979</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0306/001/001</DrugIDPK>
    <LicenceNumber>PA0306/001/001</LicenceNumber>
    <ProductName>ALLCOCKS POROUS PLASTER</ProductName>
    <PAHolder>Richards &amp; Appleby Ltd</PAHolder>
    <AuthorisedDate>28/10/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/05/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/024/003</DrugIDPK>
    <LicenceNumber>PA0047/024/003</LicenceNumber>
    <ProductName>ALLEGRON</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORTRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/06/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/024/002</DrugIDPK>
    <LicenceNumber>PA0047/024/002</LicenceNumber>
    <ProductName>ALLEGRON</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORTRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/04/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/024/001</DrugIDPK>
    <LicenceNumber>PA0047/024/001</LicenceNumber>
    <ProductName>ALLEGRON</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORTRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/04/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0030/035/001</DrugIDPK>
    <LicenceNumber>PA0030/035/001</LicenceNumber>
    <ProductName>AllerEze</ProductName>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clemastine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0398/001/002</DrugIDPK>
    <LicenceNumber>PA0398/001/002</LicenceNumber>
    <ProductName>ALLEREZE ELIXIR</ProductName>
    <PAHolder>Intercare Products Ltd</PAHolder>
    <AuthorisedDate>16/01/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0030/036/001</DrugIDPK>
    <LicenceNumber>PA0030/036/001</LicenceNumber>
    <ProductName>ALLEREZE PLUS</ProductName>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>03/04/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLEMASTINE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/12/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/023/001</DrugIDPK>
    <LicenceNumber>PA0049/023/001</LicenceNumber>
    <ProductName>ALLERGEN DIAGNOSTICS (INTRADERMAL TEST SOLUTIONS)</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/02/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/022/001</DrugIDPK>
    <LicenceNumber>PA0049/022/001</LicenceNumber>
    <ProductName>ALLERGEN DIAGNOSTICS (PRICK TEST SOLUTIONS)</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/02/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/034</DrugIDPK>
    <LicenceNumber>EU/1/00/159/034</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/033</DrugIDPK>
    <LicenceNumber>EU/1/00/159/033</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/032</DrugIDPK>
    <LicenceNumber>EU/1/00/159/032</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/031</DrugIDPK>
    <LicenceNumber>EU/1/00/159/031</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/030</DrugIDPK>
    <LicenceNumber>EU/1/00/159/030</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/029</DrugIDPK>
    <LicenceNumber>EU/1/00/159/029</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/028</DrugIDPK>
    <LicenceNumber>EU/1/00/159/028</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/027</DrugIDPK>
    <LicenceNumber>EU/1/00/159/027</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/026</DrugIDPK>
    <LicenceNumber>EU/1/00/159/026</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/025</DrugIDPK>
    <LicenceNumber>EU/1/00/159/025</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/024</DrugIDPK>
    <LicenceNumber>EU/1/00/159/024</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/023</DrugIDPK>
    <LicenceNumber>EU/1/00/159/023</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/022</DrugIDPK>
    <LicenceNumber>EU/1/00/159/022</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/021</DrugIDPK>
    <LicenceNumber>EU/1/00/159/021</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/020</DrugIDPK>
    <LicenceNumber>EU/1/00/159/020</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/019</DrugIDPK>
    <LicenceNumber>EU/1/00/159/019</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/018</DrugIDPK>
    <LicenceNumber>EU/1/00/159/018</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/017</DrugIDPK>
    <LicenceNumber>EU/1/00/159/017</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/016</DrugIDPK>
    <LicenceNumber>EU/1/00/159/016</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/015</DrugIDPK>
    <LicenceNumber>EU/1/00/159/015</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/014</DrugIDPK>
    <LicenceNumber>EU/1/00/159/014</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/013</DrugIDPK>
    <LicenceNumber>EU/1/00/159/013</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>15/01/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/012</DrugIDPK>
    <LicenceNumber>EU/1/00/159/012</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>15/01/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/011</DrugIDPK>
    <LicenceNumber>EU/1/00/159/011</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>15/01/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/010</DrugIDPK>
    <LicenceNumber>EU/1/00/159/010</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>15/01/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/009</DrugIDPK>
    <LicenceNumber>EU/1/00/159/009</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>15/01/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/008</DrugIDPK>
    <LicenceNumber>EU/1/00/159/008</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>15/01/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/007</DrugIDPK>
    <LicenceNumber>EU/1/00/159/007</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>15/01/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/006</DrugIDPK>
    <LicenceNumber>EU/1/00/159/006</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>15/01/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/005</DrugIDPK>
    <LicenceNumber>EU/1/00/159/005</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>15/01/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/004</DrugIDPK>
    <LicenceNumber>EU/1/00/159/004</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>15/01/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/003</DrugIDPK>
    <LicenceNumber>EU/1/00/159/003</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>15/01/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/002</DrugIDPK>
    <LicenceNumber>EU/1/00/159/002</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>15/01/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/159/001</DrugIDPK>
    <LicenceNumber>EU/1/00/159/001</LicenceNumber>
    <ProductName>ALLEX</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>15/01/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESLORATIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0050/042/001</DrugIDPK>
    <LicenceNumber>PA0050/042/001</LicenceNumber>
    <ProductName>ALLOFERIN AMPOULES</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALCURONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/013/001</DrugIDPK>
    <LicenceNumber>PA0577/013/001</LicenceNumber>
    <ProductName>Allopurinol</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>13/12/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Allopurinol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/03/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/013/002</DrugIDPK>
    <LicenceNumber>PA0577/013/002</LicenceNumber>
    <ProductName>Allopurinol</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>13/12/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Allopurinol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/03/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/038/001</DrugIDPK>
    <LicenceNumber>PA0006/038/001</LicenceNumber>
    <ProductName>ALLOPURINOL</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>25/07/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Allopurinol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/08/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/038/002</DrugIDPK>
    <LicenceNumber>PA0006/038/002</LicenceNumber>
    <ProductName>ALLOPURINOL</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>25/07/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Allopurinol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/08/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/021/001</DrugIDPK>
    <LicenceNumber>PA0282/021/001</LicenceNumber>
    <ProductName>ALLOPURINOL</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>01/12/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Allopurinol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/09/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/021/002</DrugIDPK>
    <LicenceNumber>PA0282/021/002</LicenceNumber>
    <ProductName>ALLOPURINOL</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>01/12/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Allopurinol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/09/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/028/002</DrugIDPK>
    <LicenceNumber>PA0038/028/002</LicenceNumber>
    <ProductName>ALLOPURINOL</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>27/06/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/03/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/028/001</DrugIDPK>
    <LicenceNumber>PA0038/028/001</LicenceNumber>
    <ProductName>ALLOPURINOL</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>27/06/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/03/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/045/002</DrugIDPK>
    <LicenceNumber>PA0022/045/002</LicenceNumber>
    <ProductName>ALLOPURINOL</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>20/11/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/05/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/045/001</DrugIDPK>
    <LicenceNumber>PA0022/045/001</LicenceNumber>
    <ProductName>ALLOPURINOL</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>20/11/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLOPURINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/05/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/056/001</DrugIDPK>
    <LicenceNumber>PA2315/056/001</LicenceNumber>
    <ProductName>Allopurinol 100mg Tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>06/03/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Allopurinol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/056/002</DrugIDPK>
    <LicenceNumber>PA2315/056/002</LicenceNumber>
    <ProductName>Allopurinol 300mg Tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>06/03/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Allopurinol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/013/001</DrugIDPK>
    <LicenceNumber>PA0408/013/001</LicenceNumber>
    <ProductName>Allopurinol Tablets BP 100mg</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>09/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Allopurinol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/013/002</DrugIDPK>
    <LicenceNumber>PA0408/013/002</LicenceNumber>
    <ProductName>Allopurinol Tablets BP 300mg</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>25/02/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Allopurinol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/099/002</DrugIDPK>
    <LicenceNumber>PA0749/099/002</LicenceNumber>
    <ProductName>Allopurinol Teva</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>10/09/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Allopurinol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0079/010/001</DrugIDPK>
    <LicenceNumber>PA0079/010/001</LicenceNumber>
    <ProductName>ALLPYRAL ALLERGEN</ProductName>
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALLERGENEXTRACT, GR\NALGER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/014/001</DrugIDPK>
    <LicenceNumber>PA1410/014/001</LicenceNumber>
    <ProductName>Allurene 1 mg/2 mg film-coated tablets</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>05/03/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Estradiol</ActiveSubstance>
      <ActiveSubstance>Drospirenone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/10/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0289/007/001</DrugIDPK>
    <LicenceNumber>PA0289/007/001</LicenceNumber>
    <ProductName>ALLURINOL 300</ProductName>
    <PAHolder>Lipha Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>09/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/020/001</DrugIDPK>
    <LicenceNumber>PA0086/020/001</LicenceNumber>
    <ProductName>ALMASILATE (SUSPENSION)</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>21/01/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALMASILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/01/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1005/001/002</DrugIDPK>
    <LicenceNumber>PA1005/001/002</LicenceNumber>
    <ProductName>Almirid 20mg Tablets</ProductName>
    <PAHolder>Polichem S.A.</PAHolder>
    <AuthorisedDate>04/02/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dihydroergotamine mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1005/001/001</DrugIDPK>
    <LicenceNumber>PA1005/001/001</LicenceNumber>
    <ProductName>Almirid 5mg Capsules</ProductName>
    <PAHolder>Polichem S.A.</PAHolder>
    <AuthorisedDate>04/02/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dihydroergocryptine mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/043/005</DrugIDPK>
    <LicenceNumber>PA0237/043/005</LicenceNumber>
    <ProductName>ALMODAN</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>21/04/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/043/004</DrugIDPK>
    <LicenceNumber>PA0237/043/004</LicenceNumber>
    <ProductName>ALMODAN</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>21/04/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/043/003</DrugIDPK>
    <LicenceNumber>PA0237/043/003</LicenceNumber>
    <ProductName>ALMODAN</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>21/04/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/043/002</DrugIDPK>
    <LicenceNumber>PA0237/043/002</LicenceNumber>
    <ProductName>ALMODAN</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>21/04/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/043/001</DrugIDPK>
    <LicenceNumber>PA0237/043/001</LicenceNumber>
    <ProductName>ALMODAN</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>21/04/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0688/028/001</DrugIDPK>
    <LicenceNumber>PA0688/028/001</LicenceNumber>
    <ProductName>Almotriptan 12.5mg Film-coated tablets</ProductName>
    <PAHolder>Chanelle Medical Unlimited Company</PAHolder>
    <AuthorisedDate>15/11/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Almotriptan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/17/1261/001</DrugIDPK>
    <LicenceNumber>EU/1/17/1261/001</LicenceNumber>
    <ProductName>Alofisel</ProductName>
    <PAHolder>Takeda Pharma A/S</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Expanded human allogeneic mesenchymal adult stem</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>13/12/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0896/001/001</DrugIDPK>
    <LicenceNumber>PA0896/001/001</LicenceNumber>
    <ProductName>Alomide 0.1% w/v Eye Drops, Solution</ProductName>
    <PAHolder>Novartis Ireland Limited</PAHolder>
    <AuthorisedDate>16/12/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lodoxamide tromethamine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/02/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0290/063/002</DrugIDPK>
    <LicenceNumber>PA0290/063/002</LicenceNumber>
    <ProductName>Alomide Allergy 0.1% w/v Eye drops, solution</ProductName>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>03/06/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lodoxamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0185/022/001</DrugIDPK>
    <LicenceNumber>PA0185/022/001</LicenceNumber>
    <ProductName>ALOMIDE OPHTHALMIC</ProductName>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>13/12/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LODOXAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/02/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0056/031/001</DrugIDPK>
    <LicenceNumber>PA0056/031/001</LicenceNumber>
    <ProductName>ALOPHEN</ProductName>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALOIN</ActiveSubstance>
      <ActiveSubstance>PHENOLPHTHALEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/08/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0170/019/003</DrugIDPK>
    <LicenceNumber>PA0170/019/003</LicenceNumber>
    <ProductName>ALORA</ProductName>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>27/11/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/07/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0170/019/002</DrugIDPK>
    <LicenceNumber>PA0170/019/002</LicenceNumber>
    <ProductName>ALORA</ProductName>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>27/11/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/07/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0170/019/001</DrugIDPK>
    <LicenceNumber>PA0170/019/001</LicenceNumber>
    <ProductName>ALORA</ProductName>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>27/11/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/07/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/003/021</DrugIDPK>
    <LicenceNumber>PA0073/003/021</LicenceNumber>
    <ProductName>ALORBAT</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>03/12/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/003/014</DrugIDPK>
    <LicenceNumber>PA0073/003/014</LicenceNumber>
    <ProductName>ALORBAT</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>23/11/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/11/1978</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/003/011</DrugIDPK>
    <LicenceNumber>PA0073/003/011</LicenceNumber>
    <ProductName>ALORBAT</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>27/06/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/003/010</DrugIDPK>
    <LicenceNumber>PA0073/003/010</LicenceNumber>
    <ProductName>ALORBAT</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>03/11/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/11/1981</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/003/009</DrugIDPK>
    <LicenceNumber>PA0073/003/009</LicenceNumber>
    <ProductName>ALORBAT</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>03/11/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/003/008</DrugIDPK>
    <LicenceNumber>PA0073/003/008</LicenceNumber>
    <ProductName>ALORBAT</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>03/11/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0054/026/010</DrugIDPK>
    <LicenceNumber>PA0054/026/010</LicenceNumber>
    <ProductName>ALORBAT</ProductName>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>06/02/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/01/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0054/026/008</DrugIDPK>
    <LicenceNumber>PA0054/026/008</LicenceNumber>
    <ProductName>ALORBAT</ProductName>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>06/02/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/01/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0054/026/009</DrugIDPK>
    <LicenceNumber>PA0054/026/009</LicenceNumber>
    <ProductName>ALORBAT - SYRINGE</ProductName>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>06/02/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/01/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/003/020</DrugIDPK>
    <LicenceNumber>PA0073/003/020</LicenceNumber>
    <ProductName>ALORBAT (DISPOSABLE SYRINGE)</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>03/12/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/003/015</DrugIDPK>
    <LicenceNumber>PA0073/003/015</LicenceNumber>
    <ProductName>ALORBAT (DISPOSABLE SYRINGE)</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>23/11/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/003/012</DrugIDPK>
    <LicenceNumber>PA0073/003/012</LicenceNumber>
    <ProductName>ALORBAT (DISPOSABLE SYRINGE)</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>27/06/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0073/003/022</DrugIDPK>
    <LicenceNumber>PA0073/003/022</LicenceNumber>
    <ProductName>ALORBAT MULTIDOSE</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>03/12/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/003/016</DrugIDPK>
    <LicenceNumber>PA0073/003/016</LicenceNumber>
    <ProductName>ALORBAT MULTIDOSE</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>23/11/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/003/013</DrugIDPK>
    <LicenceNumber>PA0073/003/013</LicenceNumber>
    <ProductName>ALORBAT MULTIDOSE</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>27/06/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0048/035/001</DrugIDPK>
    <LicenceNumber>PA0048/035/001</LicenceNumber>
    <ProductName>ALPHA KERI BATH</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>04/05/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Bath Additive</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARAFFIN, LIQUID</ActiveSubstance>
      <ActiveSubstance>LANOLIN OIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/05/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/001/002</DrugIDPK>
    <LicenceNumber>PA0035/001/002</LicenceNumber>
    <ProductName>ALPHACILLIN</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>30/09/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIVAMPICILLIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/01/1980</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/001/003</DrugIDPK>
    <LicenceNumber>PA0035/001/003</LicenceNumber>
    <ProductName>ALPHACILLIN PAEDIATRIC</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>30/09/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIVAMPICILLIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/01/1980</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0943/004/001</DrugIDPK>
    <LicenceNumber>PA0943/004/001</LicenceNumber>
    <ProductName>Alphaderm 1% &amp; 10% w/w Cream</ProductName>
    <PAHolder>Alliance Pharmaceuticals Ltd.</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Urea</ActiveSubstance>
      <ActiveSubstance>Hydrocortisone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/002/001</DrugIDPK>
    <LicenceNumber>DPR0465/002/001</LicenceNumber>
    <ProductName>Alphagan</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>08/02/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Brimonidine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1328/020/001</DrugIDPK>
    <LicenceNumber>DPR1328/020/001</LicenceNumber>
    <ProductName>Alphagan</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>02/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Brimonidine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1400/001/001</DrugIDPK>
    <LicenceNumber>DPR1400/001/001</LicenceNumber>
    <ProductName>Alphagan</ProductName>
    <PAHolder>Mirapharm</PAHolder>
    <AuthorisedDate>22/03/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Brimonidine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1463/007/001</DrugIDPK>
    <LicenceNumber>DPR1463/007/001</LicenceNumber>
    <ProductName>Alphagan</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>01/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Brimonidine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/05/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1473/002/001</DrugIDPK>
    <LicenceNumber>DPR1473/002/001</LicenceNumber>
    <ProductName>Alphagan</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>26/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Brimonidine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1500/010/001</DrugIDPK>
    <LicenceNumber>DPR1500/010/001</LicenceNumber>
    <ProductName>Alphagan</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>29/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Brimonidine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1562/008/001</DrugIDPK>
    <LicenceNumber>DPR1562/008/001</LicenceNumber>
    <ProductName>Alphagan</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>26/02/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Brimonidine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1592/001/001</DrugIDPK>
    <LicenceNumber>DPR1592/001/001</LicenceNumber>
    <ProductName>Alphagan</ProductName>
    <PAHolder>Pharma First Limited</PAHolder>
    <AuthorisedDate>24/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Brimonidine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1601/003/001</DrugIDPK>
    <LicenceNumber>DPR1601/003/001</LicenceNumber>
    <ProductName>Alphagan</ProductName>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>27/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Brimonidine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1447/085/001</DrugIDPK>
    <LicenceNumber>PPA1447/085/001</LicenceNumber>
    <ProductName>Alphagan</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>17/12/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Brimonidine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/090/001</DrugIDPK>
    <LicenceNumber>PPA1562/090/001</LicenceNumber>
    <ProductName>Alphagan</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>09/11/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Brimonidine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/048/001</DrugIDPK>
    <LicenceNumber>PPA1659/048/001</LicenceNumber>
    <ProductName>Alphagan</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>26/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Brimonidine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23176/007/001</DrugIDPK>
    <LicenceNumber>PPA23176/007/001</LicenceNumber>
    <ProductName>Alphagan 0.2% w/v (2 mg/ml) eye drops, solution</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>31/03/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Brimonidine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1392/044/001</DrugIDPK>
    <LicenceNumber>DPR1392/044/001</LicenceNumber>
    <ProductName>Alphagan Eye Drops Solution</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>10/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Brimonidine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1596/015/001</DrugIDPK>
    <LicenceNumber>DPR1596/015/001</LicenceNumber>
    <ProductName>Alphagan Eye Drops Solution</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>30/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Brimonidine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0149/014/002</DrugIDPK>
    <LicenceNumber>PA0149/014/002</LicenceNumber>
    <ProductName>ALPHAMIN</ProductName>
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate>20/07/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/11/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0149/014/001</DrugIDPK>
    <LicenceNumber>PA0149/014/001</LicenceNumber>
    <ProductName>ALPHAMIN</ProductName>
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate>20/07/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/11/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0789/008/001</DrugIDPK>
    <LicenceNumber>PA0789/008/001</LicenceNumber>
    <ProductName>Alpharubicin</ProductName>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/04/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/081/001</DrugIDPK>
    <LicenceNumber>PA0678/081/001</LicenceNumber>
    <ProductName>Alphosyl</ProductName>
    <PAHolder>Haleon Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Coal tar extract</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/10/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/078/001</DrugIDPK>
    <LicenceNumber>PA0678/078/001</LicenceNumber>
    <ProductName>ALPHOSYL</ProductName>
    <PAHolder>Haleon Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alcoholic coal tar extract</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/11/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/087/001</DrugIDPK>
    <LicenceNumber>PA0678/087/001</LicenceNumber>
    <ProductName>ALPHOSYL HC</ProductName>
    <PAHolder>Haleon Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Hydrocortisone</ActiveSubstance>
      <ActiveSubstance>Coal tar</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/03/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/081/002</DrugIDPK>
    <LicenceNumber>PA0678/081/002</LicenceNumber>
    <ProductName>Alphosyl Lotion</ProductName>
    <PAHolder>Haleon Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alcoholic coal tar extract</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/11/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/18/1269/001</DrugIDPK>
    <LicenceNumber>EU/1/18/1269/001</LicenceNumber>
    <ProductName>Alpivab</ProductName>
    <PAHolder>Biocryst UK Ltd c/o Morgan Lewis &amp; Bockius</PAHolder>
    <AuthorisedDate>13/04/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Peramivir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/11/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/055/001</DrugIDPK>
    <LicenceNumber>PA0016/055/001</LicenceNumber>
    <ProductName>Alprazolam</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alprazolam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/055/002</DrugIDPK>
    <LicenceNumber>PA0016/055/002</LicenceNumber>
    <ProductName>Alprazolam</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alprazolam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/055/003</DrugIDPK>
    <LicenceNumber>PA0016/055/003</LicenceNumber>
    <ProductName>Alprazolam</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alprazolam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/140/003</DrugIDPK>
    <LicenceNumber>PA0711/140/003</LicenceNumber>
    <InterchangeableListCode>IC0094-039-002</InterchangeableListCode>
    <ProductName>Alprazolam 1 mg tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>17/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alprazolam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1327/001/001</DrugIDPK>
    <LicenceNumber>PA1327/001/001</LicenceNumber>
    <ProductName>Alprox</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>30/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alprazolam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/06/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0303/025/002</DrugIDPK>
    <LicenceNumber>PA0303/025/002</LicenceNumber>
    <ProductName>ALPROX</ProductName>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>03/01/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALPRAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/051/001</DrugIDPK>
    <LicenceNumber>PA0022/051/001</LicenceNumber>
    <ProductName>ALREDASE</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>11/02/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOLRESTAT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/002/002</DrugIDPK>
    <LicenceNumber>PA0021/002/002</LicenceNumber>
    <ProductName>ALRHEUMAT</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>21/08/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/02/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/002/001</DrugIDPK>
    <LicenceNumber>PA0021/002/001</LicenceNumber>
    <ProductName>ALRHEUMAT</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>02/07/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/03/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0303/024/4</DrugIDPK>
    <LicenceNumber>PA0303/024/4</LicenceNumber>
    <ProductName>ALSUCRAL</ProductName>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>13/12/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUCRALFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0303/024/004</DrugIDPK>
    <LicenceNumber>PA0303/024/004</LicenceNumber>
    <ProductName>ALSUCRAL</ProductName>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>13/12/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUCRALFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/08/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0303/024/003</DrugIDPK>
    <LicenceNumber>PA0303/024/003</LicenceNumber>
    <ProductName>ALSUCRAL</ProductName>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>13/12/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUCRALFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/08/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0303/024/002</DrugIDPK>
    <LicenceNumber>PA0303/024/002</LicenceNumber>
    <ProductName>ALSUCRAL</ProductName>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>13/12/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUCRALFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/08/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0303/024/001</DrugIDPK>
    <LicenceNumber>PA0303/024/001</LicenceNumber>
    <ProductName>ALSUCRAL</ProductName>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>13/12/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUCRALFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/026/002</DrugIDPK>
    <LicenceNumber>PA0006/026/002</LicenceNumber>
    <ProductName>ALTACITE</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>25/11/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROTALCITE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/02/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/026/001</DrugIDPK>
    <LicenceNumber>PA0006/026/001</LicenceNumber>
    <ProductName>ALTACITE</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>25/11/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROTALCITE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/004/002</DrugIDPK>
    <LicenceNumber>PA0006/004/002</LicenceNumber>
    <ProductName>ALTACITE PLUS</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>23/12/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROTALCITE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/02/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/004/001</DrugIDPK>
    <LicenceNumber>PA0006/004/001</LicenceNumber>
    <ProductName>ALTACITE PLUS</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>21/09/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROTALCITE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/02/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/07/390/1-4</DrugIDPK>
    <LicenceNumber>EU/1/07/390/1-4</LicenceNumber>
    <ProductName>Altargo</ProductName>
    <PAHolder>Glaxo Group Limited</PAHolder>
    <AuthorisedDate>24/05/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Retapamulin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/02/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1876/004/001</DrugIDPK>
    <LicenceNumber>PA1876/004/001</LicenceNumber>
    <ProductName>altavitaD3 400 IU soft capsules</ProductName>
    <PAHolder>Consilient Health Limited</PAHolder>
    <AuthorisedDate>02/09/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/07/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1876/007/001</DrugIDPK>
    <LicenceNumber>PA1876/007/001</LicenceNumber>
    <ProductName>altavitaD3 5,600 IU soft capsules</ProductName>
    <PAHolder>Consilient Health Limited</PAHolder>
    <AuthorisedDate>07/10/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Colecalciferol concentrate (oily form)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/07/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1876/004/002</DrugIDPK>
    <LicenceNumber>PA1876/004/002</LicenceNumber>
    <ProductName>AltavitaD3 800IU soft capsules</ProductName>
    <PAHolder>Consilient Health Limited</PAHolder>
    <AuthorisedDate>16/03/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cholecalciferol (02)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/07/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0065/015/001</DrugIDPK>
    <LicenceNumber>PA0065/015/001</LicenceNumber>
    <ProductName>ALTHESIN</ProductName>
    <PAHolder>Duncan, Flockhard &amp; Co. Limited</PAHolder>
    <AuthorisedDate>10/02/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/03/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/001/001</DrugIDPK>
    <LicenceNumber>PA0057/001/001</LicenceNumber>
    <ProductName>ALU-CAPS</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>17/01/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/04/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/032/001</DrugIDPK>
    <LicenceNumber>PA0057/032/001</LicenceNumber>
    <ProductName>ALU-TAB</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>31/01/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL, DRIED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/015/001</DrugIDPK>
    <LicenceNumber>PA0022/015/001</LicenceNumber>
    <ProductName>ALUDROX</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/09/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0231/008/001</DrugIDPK>
    <LicenceNumber>PA0231/008/001</LicenceNumber>
    <ProductName>ALUDROX LIQUID</ProductName>
    <PAHolder>Unicliffe Limited</PAHolder>
    <AuthorisedDate>27/11/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0231/006/001</DrugIDPK>
    <LicenceNumber>PA0231/006/001</LicenceNumber>
    <ProductName>ALUDROX MH</ProductName>
    <PAHolder>Unicliffe Limited</PAHolder>
    <AuthorisedDate>01/04/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE MAGNESIUM CARBONATE CO-DRIED GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/039/002</DrugIDPK>
    <LicenceNumber>PA0022/039/002</LicenceNumber>
    <ProductName>ALUDROX PLUS</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/039/001</DrugIDPK>
    <LicenceNumber>PA0022/039/001</LicenceNumber>
    <ProductName>ALUDROX PLUS</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>30/09/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/002/002</DrugIDPK>
    <LicenceNumber>PA0022/002/002</LicenceNumber>
    <ProductName>ALUDROX S A  (SUSPENSION)</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>01/09/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMBUTONIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/002/001</DrugIDPK>
    <LicenceNumber>PA0022/002/001</LicenceNumber>
    <ProductName>ALUDROX S A  (SUSPENSION)</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SECBUTABARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/09/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0622/021/001</DrugIDPK>
    <LicenceNumber>PA0622/021/001</LicenceNumber>
    <ProductName>ALUMINIUM HYDROXIDE</ProductName>
    <PAHolder>Sterling Health Limited</PAHolder>
    <AuthorisedDate>29/03/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALGINIC ACID</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL, DRIED</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM TRISILICATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/09/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/015/004</DrugIDPK>
    <LicenceNumber>PA0007/015/004</LicenceNumber>
    <ProductName>Alupent</ProductName>
    <PAHolder>Boehringer Ingelheim Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Orciprenaline sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/015/003</DrugIDPK>
    <LicenceNumber>PA0007/015/003</LicenceNumber>
    <ProductName>ALUPENT</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ORCIPRENALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/02/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/015/008</DrugIDPK>
    <LicenceNumber>PA0007/015/008</LicenceNumber>
    <ProductName>ALUPENT AMPOULES</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ORCIPRENALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/015/002</DrugIDPK>
    <LicenceNumber>PA0007/015/002</LicenceNumber>
    <ProductName>Alupent Expectorant</ProductName>
    <PAHolder>Boehringer Ingelheim Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Orciprenaline sulfate</ActiveSubstance>
      <ActiveSubstance>Bromhexine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/015/001</DrugIDPK>
    <LicenceNumber>PA0007/015/001</LicenceNumber>
    <ProductName>ALUPENT EXPECTORANT</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ORCIPRENALINE</ActiveSubstance>
      <ActiveSubstance>BROMHEXINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/03/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/015/007</DrugIDPK>
    <LicenceNumber>PA0007/015/007</LicenceNumber>
    <ProductName>ALUPENT INHALANT</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ORCIPRENALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/03/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/015/005</DrugIDPK>
    <LicenceNumber>PA0007/015/005</LicenceNumber>
    <ProductName>ALUPENT METERED AEROSOL</ProductName>
    <PAHolder>Boehringer Ingelheim Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ORCIPRENALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/02/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/015/009</DrugIDPK>
    <LicenceNumber>PA0007/015/009</LicenceNumber>
    <ProductName>ALUPENT OBSTETRIC AMPOULES</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ORCIPRENALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/03/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1255/001/001</DrugIDPK>
    <LicenceNumber>PA1255/001/001</LicenceNumber>
    <ProductName>Alutard Avanz</ProductName>
    <PAHolder>ALK-Abello A/S</PAHolder>
    <AuthorisedDate>11/08/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aluminium hydroxide</ActiveSubstance>
      <ActiveSubstance>Allergan phleum pratense</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1255/001/002</DrugIDPK>
    <LicenceNumber>PA1255/001/002</LicenceNumber>
    <ProductName>Alutard Avanz</ProductName>
    <PAHolder>ALK-Abello A/S</PAHolder>
    <AuthorisedDate>11/08/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Allergan phleum pratense</ActiveSubstance>
      <ActiveSubstance>Aluminium hydroxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1255/001/003</DrugIDPK>
    <LicenceNumber>PA1255/001/003</LicenceNumber>
    <ProductName>Alutard Avanz</ProductName>
    <PAHolder>ALK-Abello A/S</PAHolder>
    <AuthorisedDate>11/08/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Allergan phleum pratense</ActiveSubstance>
      <ActiveSubstance>Aluminium hydroxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0473/004/002</DrugIDPK>
    <LicenceNumber>PA0473/004/002</LicenceNumber>
    <ProductName>ALVEOLEX</ProductName>
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate>14/12/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLCYSTEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/03/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0473/004/001</DrugIDPK>
    <LicenceNumber>PA0473/004/001</LicenceNumber>
    <ProductName>ALVEOLEX GRANULES</ProductName>
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate>14/12/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLCYSTEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/03/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1352/010/002</DrugIDPK>
    <LicenceNumber>PA1352/010/002</LicenceNumber>
    <ProductName>Alverine citrate 120mg Capsules</ProductName>
    <PAHolder>Auden Mckenzie (Pharma Division) Ltd</PAHolder>
    <AuthorisedDate>04/12/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALVERINE CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22965/001/002</DrugIDPK>
    <LicenceNumber>PA22965/001/002</LicenceNumber>
    <ProductName>Alverine citrate 120mg capsules, hard</ProductName>
    <PAHolder>Incepta Euro Limited</PAHolder>
    <AuthorisedDate>11/03/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALVERINE CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/10/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1352/010/001</DrugIDPK>
    <LicenceNumber>PA1352/010/001</LicenceNumber>
    <ProductName>Alverine citrate 60mg Capsules</ProductName>
    <PAHolder>Auden Mckenzie (Pharma Division) Ltd</PAHolder>
    <AuthorisedDate>04/12/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALVERINE CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22965/001/001</DrugIDPK>
    <LicenceNumber>PA22965/001/001</LicenceNumber>
    <ProductName>Alverine citrate 60mg capsules, hard</ProductName>
    <PAHolder>Incepta Euro Limited</PAHolder>
    <AuthorisedDate>11/03/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALVERINE CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/10/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1993/001/001</DrugIDPK>
    <LicenceNumber>PA1993/001/001</LicenceNumber>
    <ProductName>Alverine Mayoly Spindler 60mg Hard Capsules</ProductName>
    <PAHolder>Laboratoires Mayoly Spindler</PAHolder>
    <AuthorisedDate>05/06/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALVERINE CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/07/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1421/002/001</DrugIDPK>
    <LicenceNumber>PA1421/002/001</LicenceNumber>
    <ProductName>Alvesco</ProductName>
    <PAHolder>Takeda GmbH</PAHolder>
    <AuthorisedDate>19/12/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciclesonide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0187/060/001</DrugIDPK>
    <LicenceNumber>PA0187/060/001</LicenceNumber>
    <ProductName>ALYRANE INHALATION ANAESTHETIC</ProductName>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>08/08/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Vapour Liquid</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENFLURANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/01/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/070/001</DrugIDPK>
    <LicenceNumber>PA0408/070/001</LicenceNumber>
    <ProductName>Alzmeran XL</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>03/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alfuzosin hydrochloride</ActiveSubstance>
      <ActiveSubstance>Lactose anhydrous</ActiveSubstance>
      <ActiveSubstance>Colloidal anhydrous silica</ActiveSubstance>
      <ActiveSubstance>Povidone (pvp k-30)</ActiveSubstance>
      <ActiveSubstance>Talc</ActiveSubstance>
      <ActiveSubstance>Magnesium stearate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/203/003</DrugIDPK>
    <LicenceNumber>PA0749/203/003</LicenceNumber>
    <ProductName>Alztev 13.3 mg/24h transdermal patch</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>24/07/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rivastigmine base</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/104/001A</DrugIDPK>
    <LicenceNumber>PPA0465/104/001A</LicenceNumber>
    <ProductName>Amaryl</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>30/06/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/06/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/104/002A</DrugIDPK>
    <LicenceNumber>PPA0465/104/002A</LicenceNumber>
    <ProductName>Amaryl</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>30/06/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/06/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/104/003A</DrugIDPK>
    <LicenceNumber>PPA0465/104/003A</LicenceNumber>
    <ProductName>Amaryl</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>30/06/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/06/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/104/004</DrugIDPK>
    <LicenceNumber>PPA0465/104/004</LicenceNumber>
    <ProductName>Amaryl</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>22/07/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/07/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/048/001</DrugIDPK>
    <LicenceNumber>PPA1328/048/001</LicenceNumber>
    <ProductName>Amaryl</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>13/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/048/002</DrugIDPK>
    <LicenceNumber>PPA1328/048/002</LicenceNumber>
    <ProductName>Amaryl</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>13/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/048/003</DrugIDPK>
    <LicenceNumber>PPA1328/048/003</LicenceNumber>
    <ProductName>Amaryl</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>22/12/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/063/001</DrugIDPK>
    <LicenceNumber>PPA1500/063/001</LicenceNumber>
    <ProductName>Amaryl</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>25/06/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/063/002</DrugIDPK>
    <LicenceNumber>PPA1500/063/002</LicenceNumber>
    <ProductName>Amaryl</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>25/06/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/028/005</DrugIDPK>
    <LicenceNumber>PA0540/028/005</LicenceNumber>
    <ProductName>AMARYL</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>22/07/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/05/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/028/001</DrugIDPK>
    <LicenceNumber>PA0540/028/001</LicenceNumber>
    <ProductName>Amaryl 1 mg tablet</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>29/11/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/10/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/063/001</DrugIDPK>
    <LicenceNumber>PPA1151/063/001</LicenceNumber>
    <ProductName>Amaryl 1mg Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>01/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/028/002</DrugIDPK>
    <LicenceNumber>PA0540/028/002</LicenceNumber>
    <ProductName>Amaryl 2 mg tablet</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>22/07/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/01/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/063/002</DrugIDPK>
    <LicenceNumber>PPA1151/063/002</LicenceNumber>
    <ProductName>Amaryl 2mg Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>11/04/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/028/003</DrugIDPK>
    <LicenceNumber>PA0540/028/003</LicenceNumber>
    <ProductName>Amaryl 3 mg tablet</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>29/11/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/10/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/028/004</DrugIDPK>
    <LicenceNumber>PA0540/028/004</LicenceNumber>
    <ProductName>Amaryl 4 mg tablet</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>22/07/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/01/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/063/003</DrugIDPK>
    <LicenceNumber>PPA1151/063/003</LicenceNumber>
    <ProductName>Amaryl 4mg Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>11/04/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/033/003</DrugIDPK>
    <LicenceNumber>PA0016/033/003</LicenceNumber>
    <ProductName>AMBAXIN</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>09/03/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/033/002</DrugIDPK>
    <LicenceNumber>PA0016/033/002</LicenceNumber>
    <ProductName>AMBAXIN</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>09/03/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/033/001</DrugIDPK>
    <LicenceNumber>PA0016/033/001</LicenceNumber>
    <ProductName>AMBAXIN</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>09/03/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BACAMPICILLIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/07/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22717/001/002</DrugIDPK>
    <LicenceNumber>PA22717/001/002</LicenceNumber>
    <ProductName>Ambrisentan betapharm 10 mg film-coated tablets.</ProductName>
    <PAHolder>Betapharm Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>20/12/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ambrisentan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>07/04/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22717/001/001</DrugIDPK>
    <LicenceNumber>PA22717/001/001</LicenceNumber>
    <ProductName>Ambrisentan betapharm 5 mg film-coated tablets.</ProductName>
    <PAHolder>Betapharm Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>20/12/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ambrisentan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>07/04/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/300/002</DrugIDPK>
    <LicenceNumber>PA0711/300/002</LicenceNumber>
    <ProductName>Ambrisentan Rowex 10 mg film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>20/12/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ambrisentan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>06/10/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/300/001</DrugIDPK>
    <LicenceNumber>PA0711/300/001</LicenceNumber>
    <ProductName>Ambrisentan Rowex 5 mg film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>20/12/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ambrisentan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>06/10/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/306/002</DrugIDPK>
    <LicenceNumber>PA0711/306/002</LicenceNumber>
    <ProductName>Ambrisentan Rowex Limited 10 mg film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>07/01/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ambrisentan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/306/001</DrugIDPK>
    <LicenceNumber>PA0711/306/001</LicenceNumber>
    <ProductName>Ambrisentan Rowex Limited 5 mg film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>07/01/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ambrisentan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/158/001</DrugIDPK>
    <LicenceNumber>PA0749/158/001</LicenceNumber>
    <ProductName>Ambrobene 3 mg/ml Oral Solution</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>03/05/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ambroxol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/04/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/158/002</DrugIDPK>
    <LicenceNumber>PA0749/158/002</LicenceNumber>
    <ProductName>Ambrobene Extra Strength 6 mg/ml Oral Solution</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>03/05/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ambroxol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/04/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/027/001</DrugIDPK>
    <LicenceNumber>PA0711/027/001</LicenceNumber>
    <ProductName>Ambrol</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>07/03/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ambroxol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0240/027/001</DrugIDPK>
    <LicenceNumber>PA0240/027/001</LicenceNumber>
    <ProductName>AMERSCAN DMSA AGENT</ProductName>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>26/11/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not Currently Available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Succimer</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/04/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0240/023/001</DrugIDPK>
    <LicenceNumber>PA0240/023/001</LicenceNumber>
    <ProductName>Amerscan Heptonate II Agent</ProductName>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>29/10/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Stannous fluoride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/10/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0240/022/001</DrugIDPK>
    <LicenceNumber>PA0240/022/001</LicenceNumber>
    <ProductName>Amerscan Medronate II Agent 6.25 milligrams kit for radiopharmaceutical preparation</ProductName>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>05/02/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methylene diphosphonic acid di- and trisodium salt</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Restricted to hospital dispensing.</SupplyComments>
    <WithdrawalDate>01/01/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0240/028/001</DrugIDPK>
    <LicenceNumber>PA0240/028/001</LicenceNumber>
    <ProductName>Amerscan Pentetate II Agent</ProductName>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>17/09/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium trisodium pentetate</ActiveSubstance>
      <ActiveSubstance>Stannous chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/04/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/010/002</DrugIDPK>
    <LicenceNumber>PA0047/010/002</LicenceNumber>
    <ProductName>AMESEC</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>AMINOPHYLLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/004/009</DrugIDPK>
    <LicenceNumber>PA0062/004/009</LicenceNumber>
    <ProductName>AMFIPEN</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/004/008</DrugIDPK>
    <LicenceNumber>PA0062/004/008</LicenceNumber>
    <ProductName>AMFIPEN</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/004/007</DrugIDPK>
    <LicenceNumber>PA0062/004/007</LicenceNumber>
    <ProductName>AMFIPEN</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/004/006</DrugIDPK>
    <LicenceNumber>PA0062/004/006</LicenceNumber>
    <ProductName>AMFIPEN</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/004/005</DrugIDPK>
    <LicenceNumber>PA0062/004/005</LicenceNumber>
    <ProductName>AMFIPEN</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/004/002</DrugIDPK>
    <LicenceNumber>PA0062/004/002</LicenceNumber>
    <ProductName>AMFIPEN</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/004/001</DrugIDPK>
    <LicenceNumber>PA0062/004/001</LicenceNumber>
    <ProductName>AMFIPEN</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/004/004</DrugIDPK>
    <LicenceNumber>PA0062/004/004</LicenceNumber>
    <ProductName>AMFIPEN 250</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/004/010</DrugIDPK>
    <LicenceNumber>PA0062/004/010</LicenceNumber>
    <ProductName>AMFIPEN SYRUP</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/004/003</DrugIDPK>
    <LicenceNumber>PA0062/004/003</LicenceNumber>
    <ProductName>AMFIPEN SYRUP</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/004/011</DrugIDPK>
    <LicenceNumber>PA0062/004/011</LicenceNumber>
    <ProductName>AMFIPEN SYRUP FORTE</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/032/001</DrugIDPK>
    <LicenceNumber>PA0437/032/001</LicenceNumber>
    <ProductName>AMIKACIN</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for parenteral use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMIKACIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/08/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/004/006</DrugIDPK>
    <LicenceNumber>PA0048/004/006</LicenceNumber>
    <ProductName>AMIKIN</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings)</PAHolder>
    <AuthorisedDate>17/07/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMIKACIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/004/003</DrugIDPK>
    <LicenceNumber>PA0048/004/003</LicenceNumber>
    <ProductName>AMIKIN</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>15/07/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMIKACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/05/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/004/002</DrugIDPK>
    <LicenceNumber>PA0048/004/002</LicenceNumber>
    <ProductName>AMIKIN</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>15/07/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMIKACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/05/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/004/001</DrugIDPK>
    <LicenceNumber>PA0048/004/001</LicenceNumber>
    <ProductName>AMIKIN</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>15/07/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMIKACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/05/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2255/001/001</DrugIDPK>
    <LicenceNumber>PA2255/001/001</LicenceNumber>
    <ProductName>Amikin Injection 100 mg/2 ml</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>15/07/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMIKACIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/004/005</DrugIDPK>
    <LicenceNumber>PA0048/004/005</LicenceNumber>
    <ProductName>AMIKIN VIALS</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>15/07/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMIKACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/027/001</DrugIDPK>
    <LicenceNumber>PA0282/027/001</LicenceNumber>
    <ProductName>Amilco</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/06/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/043/001</DrugIDPK>
    <LicenceNumber>PA0282/043/001</LicenceNumber>
    <ProductName>AMILORIDE</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>15/10/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/08/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0365/038/002</DrugIDPK>
    <LicenceNumber>PA0365/038/002</LicenceNumber>
    <ProductName>AMILORIDE AND HYDROCHLOROTHIAZIDE</ProductName>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>17/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0365/038/001</DrugIDPK>
    <LicenceNumber>PA0365/038/001</LicenceNumber>
    <ProductName>AMILORIDE AND HYDROCHLOROTHIAZIDE</ProductName>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>17/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0176/045/001</DrugIDPK>
    <LicenceNumber>PA0176/045/001</LicenceNumber>
    <ProductName>AMILORIDE HYDROCHLORIDE</ProductName>
    <PAHolder>Accord-UK Ltd</PAHolder>
    <AuthorisedDate>23/06/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/08/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0187/008/001</DrugIDPK>
    <LicenceNumber>PA0187/008/001</LicenceNumber>
    <ProductName>AMINESS</ProductName>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>23/12/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/09/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/002/003</DrugIDPK>
    <LicenceNumber>PA0126/002/003</LicenceNumber>
    <ProductName>AMINOFUSIN</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>21/09/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/002/002</DrugIDPK>
    <LicenceNumber>PA0126/002/002</LicenceNumber>
    <ProductName>AMINOFUSIN</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>21/09/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/002/001</DrugIDPK>
    <LicenceNumber>PA0126/002/001</LicenceNumber>
    <ProductName>AMINOFUSIN</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>21/09/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0054/008/002</DrugIDPK>
    <LicenceNumber>PA0054/008/002</LicenceNumber>
    <ProductName>AMINOFUSIN</ProductName>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>01/09/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/10/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0054/008/003</DrugIDPK>
    <LicenceNumber>PA0054/008/003</LicenceNumber>
    <ProductName>AMINOFUSIN FORTE</ProductName>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>21/09/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/10/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0054/036/003</DrugIDPK>
    <LicenceNumber>PA0054/036/003</LicenceNumber>
    <ProductName>AMINOFUSIN L FORTE</ProductName>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>10/10/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>CARBOHYDRATES NOS</ActiveSubstance>
      <ActiveSubstance>VITAMINS NOS</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0054/036/002</DrugIDPK>
    <LicenceNumber>PA0054/036/002</LicenceNumber>
    <ProductName>AMINOFUSIN L1000</ProductName>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>10/10/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>CARBOHYDRATES NOS</ActiveSubstance>
      <ActiveSubstance>VITAMINS NOS</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/07/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0054/036/001</DrugIDPK>
    <LicenceNumber>PA0054/036/001</LicenceNumber>
    <ProductName>AMINOFUSIN L600</ProductName>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>04/07/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>CARBOHYDRATES NOS</ActiveSubstance>
      <ActiveSubstance>VITAMINS NOS</ActiveSubstance>
      <ActiveSubstance>ELECTROLYTES NOS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0054/008/001</DrugIDPK>
    <LicenceNumber>PA0054/008/001</LicenceNumber>
    <ProductName>AMINOFUSIN L600</ProductName>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>21/09/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/10/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0236/018/001</DrugIDPK>
    <LicenceNumber>PA0236/018/001</LicenceNumber>
    <ProductName>AMINOGLUTETHIMI DE</ProductName>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>13/03/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0255/013/002</DrugIDPK>
    <LicenceNumber>PA0255/013/002</LicenceNumber>
    <ProductName>AMINOPHYLLINE</ProductName>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>10/10/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/039/003</DrugIDPK>
    <LicenceNumber>PA0038/039/003</LicenceNumber>
    <ProductName>AMINOPHYLLINE</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>10/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/07/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/039/002</DrugIDPK>
    <LicenceNumber>PA0038/039/002</LicenceNumber>
    <ProductName>AMINOPHYLLINE</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>10/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/07/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/039/001</DrugIDPK>
    <LicenceNumber>PA0038/039/001</LicenceNumber>
    <ProductName>AMINOPHYLLINE</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>10/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/07/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0255/013/001</DrugIDPK>
    <LicenceNumber>PA0255/013/001</LicenceNumber>
    <ProductName>AMINOPHYLLINE INJ</ProductName>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>10/10/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/09/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/039/001</DrugIDPK>
    <LicenceNumber>PA0179/039/001</LicenceNumber>
    <ProductName>Aminoplasmal</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Isoleucine</ActiveSubstance>
      <ActiveSubstance>Leucine </ActiveSubstance>
      <ActiveSubstance>Lysine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Methionine</ActiveSubstance>
      <ActiveSubstance>Phenylalanine</ActiveSubstance>
      <ActiveSubstance>Threonine</ActiveSubstance>
      <ActiveSubstance>Tryptophan</ActiveSubstance>
      <ActiveSubstance>Valine</ActiveSubstance>
      <ActiveSubstance>Arginine </ActiveSubstance>
      <ActiveSubstance>Histidine</ActiveSubstance>
      <ActiveSubstance>Alanine</ActiveSubstance>
      <ActiveSubstance>Proline</ActiveSubstance>
      <ActiveSubstance>Aspartic Acid</ActiveSubstance>
      <ActiveSubstance>Asparagine</ActiveSubstance>
      <ActiveSubstance>Acetylcysteine</ActiveSubstance>
      <ActiveSubstance>Glutamic acid </ActiveSubstance>
      <ActiveSubstance>Ornithine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Serine</ActiveSubstance>
      <ActiveSubstance>Tyrosine</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
      <ActiveSubstance>Acetyltyrosine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/03/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/040/001</DrugIDPK>
    <LicenceNumber>PA0179/040/001</LicenceNumber>
    <ProductName>Aminoplasmal - E</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Isoleucine</ActiveSubstance>
      <ActiveSubstance>Leucine </ActiveSubstance>
      <ActiveSubstance>Lysine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Methionine</ActiveSubstance>
      <ActiveSubstance>Phenylalanine</ActiveSubstance>
      <ActiveSubstance>Threonine</ActiveSubstance>
      <ActiveSubstance>Tryptophan</ActiveSubstance>
      <ActiveSubstance>Valine</ActiveSubstance>
      <ActiveSubstance>Arginine </ActiveSubstance>
      <ActiveSubstance>Histidine</ActiveSubstance>
      <ActiveSubstance>Alanine</ActiveSubstance>
      <ActiveSubstance>Proline</ActiveSubstance>
      <ActiveSubstance>Aspartic Acid</ActiveSubstance>
      <ActiveSubstance>Asparagine</ActiveSubstance>
      <ActiveSubstance>Acetylcysteine</ActiveSubstance>
      <ActiveSubstance>Glutamic acid </ActiveSubstance>
      <ActiveSubstance>Ornithine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Serine</ActiveSubstance>
      <ActiveSubstance>Tyrosine</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
      <ActiveSubstance>Sodium acetate trihydrate </ActiveSubstance>
      <ActiveSubstance>Potassium acetate</ActiveSubstance>
      <ActiveSubstance>Magnesium acetate tetrahydrate</ActiveSubstance>
      <ActiveSubstance>Sodium dihydrogen phosphate dihydrate</ActiveSubstance>
      <ActiveSubstance>Sodium hydroxide </ActiveSubstance>
      <ActiveSubstance>Malic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/03/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/020/001</DrugIDPK>
    <LicenceNumber>PA0179/020/001</LicenceNumber>
    <ProductName>Aminoplasmal 10% E without Carbohydrates Solution</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>08/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Leucine </ActiveSubstance>
      <ActiveSubstance>Isoleucine</ActiveSubstance>
      <ActiveSubstance>Lysine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Methionine</ActiveSubstance>
      <ActiveSubstance>Phenylalanine</ActiveSubstance>
      <ActiveSubstance>Threonine</ActiveSubstance>
      <ActiveSubstance>Tryptophan</ActiveSubstance>
      <ActiveSubstance>Valine</ActiveSubstance>
      <ActiveSubstance>Arginine </ActiveSubstance>
      <ActiveSubstance>Histidine</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
      <ActiveSubstance>Alanine</ActiveSubstance>
      <ActiveSubstance>Proline</ActiveSubstance>
      <ActiveSubstance>Aspartic Acid</ActiveSubstance>
      <ActiveSubstance>Aspargine monohydrate</ActiveSubstance>
      <ActiveSubstance>Acetylcysteine</ActiveSubstance>
      <ActiveSubstance>Glutamic acid </ActiveSubstance>
      <ActiveSubstance>Ornithine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Serine</ActiveSubstance>
      <ActiveSubstance>Tyrosine</ActiveSubstance>
      <ActiveSubstance>Sodium acetate trihydrate </ActiveSubstance>
      <ActiveSubstance>Potassium acetate</ActiveSubstance>
      <ActiveSubstance>Magnesium acetate tetrahydrate</ActiveSubstance>
      <ActiveSubstance>Sodium dihydrogen phosphate</ActiveSubstance>
      <ActiveSubstance>Malic acid</ActiveSubstance>
      <ActiveSubstance>N-ACETYLTYROSINE PH. EUR.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/11/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/019/001</DrugIDPK>
    <LicenceNumber>PA0179/019/001</LicenceNumber>
    <ProductName>Aminoplasmal 5% E without Carbohydrates Solution f</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>08/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Isoleucine</ActiveSubstance>
      <ActiveSubstance>Leucine </ActiveSubstance>
      <ActiveSubstance>Lysine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Methionine</ActiveSubstance>
      <ActiveSubstance>Phenylalanine</ActiveSubstance>
      <ActiveSubstance>Threonine</ActiveSubstance>
      <ActiveSubstance>Tryptophan</ActiveSubstance>
      <ActiveSubstance>Valine</ActiveSubstance>
      <ActiveSubstance>Arginine </ActiveSubstance>
      <ActiveSubstance>Histidine</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
      <ActiveSubstance>Alanine</ActiveSubstance>
      <ActiveSubstance>Proline</ActiveSubstance>
      <ActiveSubstance>Aspartic Acid</ActiveSubstance>
      <ActiveSubstance>Aspargine monohydrate</ActiveSubstance>
      <ActiveSubstance>Acetylcysteine</ActiveSubstance>
      <ActiveSubstance>Glutamic acid </ActiveSubstance>
      <ActiveSubstance>Ornithine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Serine</ActiveSubstance>
      <ActiveSubstance>Tyrosine</ActiveSubstance>
      <ActiveSubstance>Sodium acetate trihydrate </ActiveSubstance>
      <ActiveSubstance>Potassium acetate</ActiveSubstance>
      <ActiveSubstance>Magnesium acetate tetrahydrate</ActiveSubstance>
      <ActiveSubstance>Sodium dihydrogen phosphate dihydrate</ActiveSubstance>
      <ActiveSubstance>Malic acid</ActiveSubstance>
      <ActiveSubstance>N-ACETYLTYROSINE PH. EUR.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/11/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/017/001</DrugIDPK>
    <LicenceNumber>PA0179/017/001</LicenceNumber>
    <ProductName>AMINOPLASMAL L-10</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>08/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/016/001</DrugIDPK>
    <LicenceNumber>PA0179/016/001</LicenceNumber>
    <ProductName>AMINOPLASMAL L-5</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>08/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
      <ActiveSubstance>SORBITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/018/002</DrugIDPK>
    <LicenceNumber>PA0179/018/002</LicenceNumber>
    <ProductName>AMINOPLASMAL PED</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>08/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/018/001</DrugIDPK>
    <LicenceNumber>PA0179/018/001</LicenceNumber>
    <ProductName>AMINOPLASMAL PED</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>08/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0143/005/002</DrugIDPK>
    <LicenceNumber>PA0143/005/002</LicenceNumber>
    <ProductName>AMINOPLEX 12</ProductName>
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>20/10/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0143/005/001</DrugIDPK>
    <LicenceNumber>PA0143/005/001</LicenceNumber>
    <ProductName>AMINOPLEX 12</ProductName>
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>20/10/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0143/012/002</DrugIDPK>
    <LicenceNumber>PA0143/012/002</LicenceNumber>
    <ProductName>AMINOPLEX 24</ProductName>
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>13/11/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0143/012/001</DrugIDPK>
    <LicenceNumber>PA0143/012/001</LicenceNumber>
    <ProductName>AMINOPLEX 24</ProductName>
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>13/11/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0143/006/001</DrugIDPK>
    <LicenceNumber>PA0143/006/001</LicenceNumber>
    <ProductName>AMINOPLEX 5 NEW</ProductName>
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>20/10/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/05/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0566/002/005</DrugIDPK>
    <LicenceNumber>PA0566/002/005</LicenceNumber>
    <ProductName>Aminoven 16, solution for infusion, polypropylene infusion bag</ProductName>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>27/05/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Proline</ActiveSubstance>
      <ActiveSubstance>Taurine</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
      <ActiveSubstance>Serine</ActiveSubstance>
      <ActiveSubstance>Tryptophan</ActiveSubstance>
      <ActiveSubstance>Threonine</ActiveSubstance>
      <ActiveSubstance>Arginine </ActiveSubstance>
      <ActiveSubstance>Lysine acetate</ActiveSubstance>
      <ActiveSubstance>Histidine</ActiveSubstance>
      <ActiveSubstance>Alanine</ActiveSubstance>
      <ActiveSubstance>Phenylalanine</ActiveSubstance>
      <ActiveSubstance>Tyrosine</ActiveSubstance>
      <ActiveSubstance>Isoleucine</ActiveSubstance>
      <ActiveSubstance>Valine</ActiveSubstance>
      <ActiveSubstance>Methionine</ActiveSubstance>
      <ActiveSubstance>Leucine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0566/002/006</DrugIDPK>
    <LicenceNumber>PA0566/002/006</LicenceNumber>
    <ProductName>Aminoven 25, solution for infusion, polypropylene infusion bag</ProductName>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>27/05/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alanine</ActiveSubstance>
      <ActiveSubstance>Valine</ActiveSubstance>
      <ActiveSubstance>Histidine</ActiveSubstance>
      <ActiveSubstance>Arginine </ActiveSubstance>
      <ActiveSubstance>Isoleucine</ActiveSubstance>
      <ActiveSubstance>Taurine</ActiveSubstance>
      <ActiveSubstance>Methionine</ActiveSubstance>
      <ActiveSubstance>Leucine </ActiveSubstance>
      <ActiveSubstance>Threonine</ActiveSubstance>
      <ActiveSubstance>Serine</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
      <ActiveSubstance>Tyrosine</ActiveSubstance>
      <ActiveSubstance>Proline</ActiveSubstance>
      <ActiveSubstance>Phenylalanine</ActiveSubstance>
      <ActiveSubstance>Lysine acetate</ActiveSubstance>
      <ActiveSubstance>Tryptophan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0566/014/001</DrugIDPK>
    <LicenceNumber>PA0566/014/001</LicenceNumber>
    <ProductName>AMINOVEN 3.5% Glucose/Electrolytes</ProductName>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>26/11/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tyrosine</ActiveSubstance>
      <ActiveSubstance>Isoleucine</ActiveSubstance>
      <ActiveSubstance>Leucine </ActiveSubstance>
      <ActiveSubstance>Lysine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Methionine, active</ActiveSubstance>
      <ActiveSubstance>Phenylalanine</ActiveSubstance>
      <ActiveSubstance>Threonine</ActiveSubstance>
      <ActiveSubstance>Tryptophan</ActiveSubstance>
      <ActiveSubstance>Valine</ActiveSubstance>
      <ActiveSubstance>Arginine </ActiveSubstance>
      <ActiveSubstance>Histidine</ActiveSubstance>
      <ActiveSubstance>Alanine</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
      <ActiveSubstance>Proline</ActiveSubstance>
      <ActiveSubstance>Serine</ActiveSubstance>
      <ActiveSubstance>Taurine</ActiveSubstance>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Zinc chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/08/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0566/002/004</DrugIDPK>
    <LicenceNumber>PA0566/002/004</LicenceNumber>
    <ProductName>Aminoven 8, solution for infusion, polypropylene infusion bag</ProductName>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>27/05/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Leucine </ActiveSubstance>
      <ActiveSubstance>Arginine </ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
      <ActiveSubstance>Lysine acetate</ActiveSubstance>
      <ActiveSubstance>Methionine</ActiveSubstance>
      <ActiveSubstance>Taurine</ActiveSubstance>
      <ActiveSubstance>Phenylalanine</ActiveSubstance>
      <ActiveSubstance>Isoleucine</ActiveSubstance>
      <ActiveSubstance>Histidine</ActiveSubstance>
      <ActiveSubstance>Tyrosine</ActiveSubstance>
      <ActiveSubstance>Threonine</ActiveSubstance>
      <ActiveSubstance>Valine</ActiveSubstance>
      <ActiveSubstance>Proline</ActiveSubstance>
      <ActiveSubstance>Alanine</ActiveSubstance>
      <ActiveSubstance>Serine</ActiveSubstance>
      <ActiveSubstance>Tryptophan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1046/003/001</DrugIDPK>
    <LicenceNumber>PA1046/003/001</LicenceNumber>
    <ProductName>Amiodarone</ProductName>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>17/10/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amiodarone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1046/003/002</DrugIDPK>
    <LicenceNumber>PA1046/003/002</LicenceNumber>
    <ProductName>Amiodarone</ProductName>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>17/10/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amiodarone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1294/005/001</DrugIDPK>
    <LicenceNumber>PA1294/005/001</LicenceNumber>
    <ProductName>Amiodarone 50 mg/ml Concentrate for solution for injection/infusion</ProductName>
    <PAHolder>Stragen UK Limited</PAHolder>
    <AuthorisedDate>19/12/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amiodarone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/08/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/210/001</DrugIDPK>
    <LicenceNumber>PA2315/210/001</LicenceNumber>
    <ProductName>Amiodarone hydrochloride 30 mg/ml concentrate for solution for injection/infusion</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>24/09/2021</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amiodarone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0235/001/004</DrugIDPK>
    <LicenceNumber>PA0235/001/004</LicenceNumber>
    <ProductName>AMIPAQUE</ProductName>
    <PAHolder>Nycomed (UK) Limited</PAHolder>
    <AuthorisedDate>19/03/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRIZAMIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CALCIUM EDETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/03/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0235/001/001</DrugIDPK>
    <LicenceNumber>PA0235/001/001</LicenceNumber>
    <ProductName>AMIPAQUE VIALS</ProductName>
    <PAHolder>Nycomed (UK) Limited</PAHolder>
    <AuthorisedDate>09/11/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRIZAMIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CALCIUM EDETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0235/001/002</DrugIDPK>
    <LicenceNumber>PA0235/001/002</LicenceNumber>
    <ProductName>AMIPAQUE VIALS SOLVENT</ProductName>
    <PAHolder>Nycomed (UK) Limited</PAHolder>
    <AuthorisedDate>09/11/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1046/013/001</DrugIDPK>
    <LicenceNumber>PA1046/013/001</LicenceNumber>
    <ProductName>Amisulpride</ProductName>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>29/10/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amisulpride </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1046/013/002</DrugIDPK>
    <LicenceNumber>PA1046/013/002</LicenceNumber>
    <ProductName>Amisulpride</ProductName>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>29/10/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amisulpride </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1046/013/003</DrugIDPK>
    <LicenceNumber>PA1046/013/003</LicenceNumber>
    <ProductName>Amisulpride</ProductName>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>29/10/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amisulpride </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1046/013/004</DrugIDPK>
    <LicenceNumber>PA1046/013/004</LicenceNumber>
    <ProductName>Amisulpride</ProductName>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>29/10/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amisulpride </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1338/006/001</DrugIDPK>
    <LicenceNumber>PA1338/006/001</LicenceNumber>
    <ProductName>Amisulpride 100mg/ml oral solution</ProductName>
    <PAHolder>Focus Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>03/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amisulpride </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/089/001</DrugIDPK>
    <LicenceNumber>PA1380/089/001</LicenceNumber>
    <ProductName>Amisulpride Actavis 400mg film-coated Tablets</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amisulpride </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/125/002</DrugIDPK>
    <LicenceNumber>PA0577/125/002</LicenceNumber>
    <ProductName>Amisulpride Mylan</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>28/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amisulpride </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/02/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/125/004</DrugIDPK>
    <LicenceNumber>PA0577/125/004</LicenceNumber>
    <ProductName>Amisulpride Mylan</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>28/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amisulpride </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/125/003</DrugIDPK>
    <LicenceNumber>PA0577/125/003</LicenceNumber>
    <ProductName>Amisulpride Mylan 200 mg Tablets</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>28/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amisulpride </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/125/001</DrugIDPK>
    <LicenceNumber>PA0577/125/001</LicenceNumber>
    <ProductName>Amisulpride Mylan 50 mg Tablets</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>28/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amisulpride </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/075/001</DrugIDPK>
    <LicenceNumber>PA0749/075/001</LicenceNumber>
    <ProductName>Amisulpride Teva</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>17/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amisulpride </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/075/002</DrugIDPK>
    <LicenceNumber>PA0749/075/002</LicenceNumber>
    <ProductName>Amisulpride Teva</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>17/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amisulpride </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/075/003</DrugIDPK>
    <LicenceNumber>PA0749/075/003</LicenceNumber>
    <ProductName>Amisulpride Teva</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>17/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amisulpride </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/075/004</DrugIDPK>
    <LicenceNumber>PA0749/075/004</LicenceNumber>
    <ProductName>Amisulpride Teva</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>17/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amisulpride </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1547/011/001</DrugIDPK>
    <LicenceNumber>PA1547/011/001</LicenceNumber>
    <ProductName>Amitiza 24 Microgram Soft Capsules</ProductName>
    <PAHolder>Takeda UK Limited</PAHolder>
    <AuthorisedDate>13/02/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lubiprostone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0102/010/003</DrugIDPK>
    <LicenceNumber>PA0102/010/003</LicenceNumber>
    <ProductName>AMITRIPTYLINE</ProductName>
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>10/03/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/02/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0102/010/002</DrugIDPK>
    <LicenceNumber>PA0102/010/002</LicenceNumber>
    <ProductName>AMITRIPTYLINE</ProductName>
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>10/03/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/02/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0102/010/001</DrugIDPK>
    <LicenceNumber>PA0102/010/001</LicenceNumber>
    <ProductName>AMITRIPTYLINE</ProductName>
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>10/03/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/02/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/006/002</DrugIDPK>
    <LicenceNumber>PA0282/006/002</LicenceNumber>
    <ProductName>AMITRIPTYLINE B P</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>19/12/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/11/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/006/001</DrugIDPK>
    <LicenceNumber>PA0282/006/001</LicenceNumber>
    <ProductName>AMITRIPTYLINE B P</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>19/12/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/11/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/037/001</DrugIDPK>
    <LicenceNumber>PA0281/037/001</LicenceNumber>
    <ProductName>AMIZIDE</ProductName>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>07/04/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/122/001</DrugIDPK>
    <LicenceNumber>PA0281/122/001</LicenceNumber>
    <ProductName>Amlid</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>22/07/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/122/002</DrugIDPK>
    <LicenceNumber>PA0281/122/002</LicenceNumber>
    <ProductName>Amlid</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>22/07/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/062/001</DrugIDPK>
    <LicenceNumber>PA0577/062/001</LicenceNumber>
    <ProductName>Amlist</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>19/11/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/062/002</DrugIDPK>
    <LicenceNumber>PA0577/062/002</LicenceNumber>
    <ProductName>Amlist</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>19/11/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/078/001</DrugIDPK>
    <LicenceNumber>PA0711/078/001</LicenceNumber>
    <ProductName>Amlodipine</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>07/10/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/03/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/078/003</DrugIDPK>
    <LicenceNumber>PA0711/078/003</LicenceNumber>
    <ProductName>Amlodipine</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>07/10/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/03/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1347/106/004</DrugIDPK>
    <LicenceNumber>PA1347/106/004</LicenceNumber>
    <ProductName>Amlodipine/Valsartan/Hydrochlorothiazide Krka 10 mg/160 mg/25 mg film-coated tablets</ProductName>
    <PAHolder>KRKA, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>16/10/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine</ActiveSubstance>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1347/106/005</DrugIDPK>
    <LicenceNumber>PA1347/106/005</LicenceNumber>
    <ProductName>Amlodipine/Valsartan/Hydrochlorothiazide Krka 10 mg/320 mg/25 mg film-coated tablets</ProductName>
    <PAHolder>KRKA, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>16/10/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine</ActiveSubstance>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/291/002</DrugIDPK>
    <LicenceNumber>PA0711/291/002</LicenceNumber>
    <ProductName>Amlodipine/Valsartan/Hydrochlorothiazide Rowex 10 mg/160 mg/12.5 mg Film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>19/08/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/07/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/291/004</DrugIDPK>
    <LicenceNumber>PA0711/291/004</LicenceNumber>
    <ProductName>Amlodipine/Valsartan/Hydrochlorothiazide Rowex 10 mg/160 mg/25 mg Film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>19/08/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/07/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/291/005</DrugIDPK>
    <LicenceNumber>PA0711/291/005</LicenceNumber>
    <ProductName>Amlodipine/Valsartan/Hydrochlorothiazide Rowex 10 mg/320 mg/25 mg Film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>19/08/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/07/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/291/001</DrugIDPK>
    <LicenceNumber>PA0711/291/001</LicenceNumber>
    <ProductName>Amlodipine/Valsartan/Hydrochlorothiazide Rowex 5 mg/160 mg/12.5 mg Film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>19/08/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/07/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/291/003</DrugIDPK>
    <LicenceNumber>PA0711/291/003</LicenceNumber>
    <ProductName>Amlodipine/Valsartan/Hydrochlorothiazide Rowex 5 mg/160 mg/25 mg Film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>19/08/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/07/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/253/003</DrugIDPK>
    <LicenceNumber>PA0711/253/003</LicenceNumber>
    <InterchangeableListCode>IC0042-084-003</InterchangeableListCode>
    <ProductName>Amlodipine/Valsartan Rowex 10 mg/160 mg Film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>02/09/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine</ActiveSubstance>
      <ActiveSubstance>Valsartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/07/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/253/002</DrugIDPK>
    <LicenceNumber>PA0711/253/002</LicenceNumber>
    <InterchangeableListCode>IC0042-086-003</InterchangeableListCode>
    <ProductName>Amlodipine/Valsartan Rowex 5 mg/160 mg Film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>02/09/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine</ActiveSubstance>
      <ActiveSubstance>Valsartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/07/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/253/001</DrugIDPK>
    <LicenceNumber>PA0711/253/001</LicenceNumber>
    <InterchangeableListCode>IC0042-087-003</InterchangeableListCode>
    <ProductName>Amlodipine/Valsartan Rowex 5 mg/80 mg Film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>02/09/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine</ActiveSubstance>
      <ActiveSubstance>Valsartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/07/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/013/003</DrugIDPK>
    <LicenceNumber>PA1986/013/003</LicenceNumber>
    <ProductName>Amlodipine/Valsartan Teva 10 mg/160 mg Film-coated Tablets</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>16/09/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/013/002</DrugIDPK>
    <LicenceNumber>PA1986/013/002</LicenceNumber>
    <ProductName>Amlodipine/Valsartan Teva 5 mg/160 mg Film-coated Tablets</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>16/09/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/013/001</DrugIDPK>
    <LicenceNumber>PA1986/013/001</LicenceNumber>
    <ProductName>Amlodipine/Valsartan Teva 5 mg/80 mg Film-coated Tablets</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>16/09/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1809/018/002</DrugIDPK>
    <LicenceNumber>PA1809/018/002</LicenceNumber>
    <ProductName>Amlodipine 10 mg tablets</ProductName>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>14/11/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
      <ActiveSubstance>Amlodipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/06/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0565/059/002</DrugIDPK>
    <LicenceNumber>PPA0565/059/002</LicenceNumber>
    <ProductName>Amlodipine 10 mg tablets</ProductName>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>31/07/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine as amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0688/009/002</DrugIDPK>
    <LicenceNumber>PA0688/009/002</LicenceNumber>
    <ProductName>Amlodipine 10mg Capsules</ProductName>
    <PAHolder>Chanelle Medical Unlimited Company</PAHolder>
    <AuthorisedDate>13/11/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/03/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22741/001/001</DrugIDPK>
    <LicenceNumber>PA22741/001/001</LicenceNumber>
    <InterchangeableListCode>IC0045-047-019</InterchangeableListCode>
    <ProductName>Amlodipine 1mg/ml Oral Solution</ProductName>
    <PAHolder>Perrigo Pharma International Designated Activity Company</PAHolder>
    <AuthorisedDate>27/02/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22741/001/002</DrugIDPK>
    <LicenceNumber>PA22741/001/002</LicenceNumber>
    <ProductName>Amlodipine 2mg/ml Oral Solution</ProductName>
    <PAHolder>Perrigo Pharma International Designated Activity Company</PAHolder>
    <AuthorisedDate>27/02/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0688/009/001</DrugIDPK>
    <LicenceNumber>PA0688/009/001</LicenceNumber>
    <ProductName>Amlodipine 5 mg Capsules</ProductName>
    <PAHolder>Chanelle Medical Unlimited Company</PAHolder>
    <AuthorisedDate>13/11/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/03/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1809/018/001</DrugIDPK>
    <LicenceNumber>PA1809/018/001</LicenceNumber>
    <ProductName>Amlodipine 5 mg tablets</ProductName>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>14/11/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
      <ActiveSubstance>Amlodipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/06/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/439/001</DrugIDPK>
    <LicenceNumber>PPA0465/439/001</LicenceNumber>
    <ProductName>Amlodipine 5 mg tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>16/03/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0565/059/001</DrugIDPK>
    <LicenceNumber>PPA0565/059/001</LicenceNumber>
    <ProductName>Amlodipine 5 mg tablets</ProductName>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>31/07/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine as amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1050/005/001</DrugIDPK>
    <LicenceNumber>PA1050/005/001</LicenceNumber>
    <InterchangeableListCode>IC0045-001-008</InterchangeableListCode>
    <ProductName>Amlodipine Aurobindo</ProductName>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>10/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/07/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1050/005/002</DrugIDPK>
    <LicenceNumber>PA1050/005/002</LicenceNumber>
    <InterchangeableListCode>IC0045-002-008</InterchangeableListCode>
    <ProductName>Amlodipine Aurobindo</ProductName>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>10/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/07/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/095/002</DrugIDPK>
    <LicenceNumber>PA0711/095/002</LicenceNumber>
    <ProductName>AMOCLAV Duo</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>22/12/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/04/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0107/003/001</DrugIDPK>
    <LicenceNumber>PA0107/003/001</LicenceNumber>
    <ProductName>AMODEX</ProductName>
    <PAHolder>Pharmacia Biosystems Limited</PAHolder>
    <AuthorisedDate>17/01/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINO ACIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/03/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0593/004/001</DrugIDPK>
    <LicenceNumber>PA0593/004/001</LicenceNumber>
    <ProductName>AMOLIN</ProductName>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>16/05/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/08/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0593/004/002</DrugIDPK>
    <LicenceNumber>PA0593/004/002</LicenceNumber>
    <ProductName>AMOLIN</ProductName>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>16/05/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/08/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0593/004/003</DrugIDPK>
    <LicenceNumber>PA0593/004/003</LicenceNumber>
    <ProductName>AMOLIN</ProductName>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>16/05/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/08/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0294/013/003</DrugIDPK>
    <LicenceNumber>PA0294/013/003</LicenceNumber>
    <ProductName>AMOLIN</ProductName>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>19/01/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/01/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0294/013/002</DrugIDPK>
    <LicenceNumber>PA0294/013/002</LicenceNumber>
    <ProductName>AMOLIN</ProductName>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>24/02/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0294/013/001</DrugIDPK>
    <LicenceNumber>PA0294/013/001</LicenceNumber>
    <ProductName>AMOLIN</ProductName>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>24/02/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/081/002</DrugIDPK>
    <LicenceNumber>PA0281/081/002</LicenceNumber>
    <ProductName>Amoxicillin</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/081/001</DrugIDPK>
    <LicenceNumber>PA0281/081/001</LicenceNumber>
    <ProductName>Amoxicillin  Mixture</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/187/001</DrugIDPK>
    <LicenceNumber>PA0711/187/001</LicenceNumber>
    <ProductName>Amoxicillin/Clavulanic acid</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/05/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/095/001</DrugIDPK>
    <LicenceNumber>PA0711/095/001</LicenceNumber>
    <ProductName>Amoxicillin/Clavulanic Acid 250/125mg Film-coated</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>22/12/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/08/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1832/002/001</DrugIDPK>
    <LicenceNumber>PA1832/002/001</LicenceNumber>
    <ProductName>Amoxicillin/Clavulanic acid DSM-Sinochem 500 mg/125 mg film-coated tablets</ProductName>
    <PAHolder>Centrient Pharmaceuticals Netherlands B.V</PAHolder>
    <AuthorisedDate>03/09/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/09/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1832/002/002</DrugIDPK>
    <LicenceNumber>PA1832/002/002</LicenceNumber>
    <ProductName>Amoxicillin/Clavulanic acid DSM-Sinochem 875 mg/125 mg film-coated tablets</ProductName>
    <PAHolder>Centrient Pharmaceuticals Netherlands B.V</PAHolder>
    <AuthorisedDate>03/09/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/09/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1832/003/001</DrugIDPK>
    <LicenceNumber>PA1832/003/001</LicenceNumber>
    <ProductName>Amoxicillin/Clavulanic acid Sinochem DSM 500 mg/125 mg film-coated tablets</ProductName>
    <PAHolder>Centrient Pharmaceuticals Netherlands B.V</PAHolder>
    <AuthorisedDate>03/09/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clavulanic acid (as potassium clavulanate, diluted : cellulose, microcrystalline(1:1))</ActiveSubstance>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1832/001/001</DrugIDPK>
    <LicenceNumber>PA1832/001/001</LicenceNumber>
    <ProductName>Amoxicillin DSM Sinochem Pharmaceuticals 250 mg hard capsules</ProductName>
    <PAHolder>Centrient Pharmaceuticals Netherlands B.V</PAHolder>
    <AuthorisedDate>26/07/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin (as trihydrate)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/11/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0111/004/001</DrugIDPK>
    <LicenceNumber>PA0111/004/001</LicenceNumber>
    <ProductName>Amoxicillin Sandoz</ProductName>
    <PAHolder>Sandoz GmbH</PAHolder>
    <AuthorisedDate>23/02/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/01/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0111/004/002</DrugIDPK>
    <LicenceNumber>PA0111/004/002</LicenceNumber>
    <ProductName>Amoxicillin Sandoz</ProductName>
    <PAHolder>Sandoz GmbH</PAHolder>
    <AuthorisedDate>23/02/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/01/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/033/003</DrugIDPK>
    <LicenceNumber>PA1077/033/003</LicenceNumber>
    <ProductName>Amoxil</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXYCILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/11/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/008/002B</DrugIDPK>
    <LicenceNumber>PPA0465/008/002B</LicenceNumber>
    <ProductName>Amoxil</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA0465/008/002C</DrugIDPK>
    <LicenceNumber>PPA0465/008/002C</LicenceNumber>
    <ProductName>Amoxil</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>12/08/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/033/002</DrugIDPK>
    <LicenceNumber>PA1077/033/002</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>10/12/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/01/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/008/003</DrugIDPK>
    <LicenceNumber>PPA0465/008/003</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>15/10/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/10/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/008/002A</DrugIDPK>
    <LicenceNumber>PPA0465/008/002A</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>12/08/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/08/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/008/001B</DrugIDPK>
    <LicenceNumber>PPA0465/008/001B</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>12/08/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/01/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/008/001A</DrugIDPK>
    <LicenceNumber>PPA0465/008/001A</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>12/08/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/08/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/006/027</DrugIDPK>
    <LicenceNumber>PA0049/006/027</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>08/08/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/06/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/006/026</DrugIDPK>
    <LicenceNumber>PA0049/006/026</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>08/08/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/06/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/006/025</DrugIDPK>
    <LicenceNumber>PA0049/006/025</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>08/08/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/06/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/006/024</DrugIDPK>
    <LicenceNumber>PA0049/006/024</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>08/08/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/06/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/006/022</DrugIDPK>
    <LicenceNumber>PA0049/006/022</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>18/01/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/09/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/006/021</DrugIDPK>
    <LicenceNumber>PA0049/006/021</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>18/01/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/09/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/006/020</DrugIDPK>
    <LicenceNumber>PA0049/006/020</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>18/01/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/09/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/006/019</DrugIDPK>
    <LicenceNumber>PA0049/006/019</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>18/01/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/09/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/006/018</DrugIDPK>
    <LicenceNumber>PA0049/006/018</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>18/01/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/09/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/006/017</DrugIDPK>
    <LicenceNumber>PA0049/006/017</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>18/01/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/09/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/006/014</DrugIDPK>
    <LicenceNumber>PA0049/006/014</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/006/011</DrugIDPK>
    <LicenceNumber>PA0049/006/011</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/006/010</DrugIDPK>
    <LicenceNumber>PA0049/006/010</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/006/009</DrugIDPK>
    <LicenceNumber>PA0049/006/009</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/006/008</DrugIDPK>
    <LicenceNumber>PA0049/006/008</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/006/005</DrugIDPK>
    <LicenceNumber>PA0049/006/005</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/006/004</DrugIDPK>
    <LicenceNumber>PA0049/006/004</LicenceNumber>
    <ProductName>AMOXIL</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/04/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/033/006</DrugIDPK>
    <LicenceNumber>PA1077/033/006</LicenceNumber>
    <ProductName>Amoxil 3g Powder for Oral Suspension Sachets</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>17/12/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/033/001</DrugIDPK>
    <LicenceNumber>PA1077/033/001</LicenceNumber>
    <ProductName>Amoxil Capsules 250 mg</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/01/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/008/004</DrugIDPK>
    <LicenceNumber>PPA0465/008/004</LicenceNumber>
    <ProductName>AMOXIL FORTE</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>15/10/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/10/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/033/008</DrugIDPK>
    <LicenceNumber>PA1077/033/008</LicenceNumber>
    <ProductName>Amoxil Forte Syrup 250 mg/ 5ml</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/033/005</DrugIDPK>
    <LicenceNumber>PA1077/033/005</LicenceNumber>
    <ProductName>Amoxil Paediatric 125 mg/1.25 ml Powder for Oral Suspension</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>08/08/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/02/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/033/007</DrugIDPK>
    <LicenceNumber>PA1077/033/007</LicenceNumber>
    <ProductName>Amoxil Syrup 125 mg/ 5 ml</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/006/012</DrugIDPK>
    <LicenceNumber>PA0049/006/012</LicenceNumber>
    <ProductName>AMOXIL VIAL</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/090/001</DrugIDPK>
    <LicenceNumber>PA0126/090/001</LicenceNumber>
    <ProductName>Amoxycillin</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/12/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/090/002</DrugIDPK>
    <LicenceNumber>PA0126/090/002</LicenceNumber>
    <ProductName>Amoxycillin</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/12/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/014/001</DrugIDPK>
    <LicenceNumber>PA0711/014/001</LicenceNumber>
    <ProductName>AMOXYCILLIN</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>11/07/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0365/025/002</DrugIDPK>
    <LicenceNumber>PA0365/025/002</LicenceNumber>
    <ProductName>AMOXYCILLIN</ProductName>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>19/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0365/025/001</DrugIDPK>
    <LicenceNumber>PA0365/025/001</LicenceNumber>
    <ProductName>AMOXYCILLIN</ProductName>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>19/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/039/004</DrugIDPK>
    <LicenceNumber>PA0282/039/004</LicenceNumber>
    <ProductName>AMOXYCILLIN</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>19/11/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/08/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/039/003</DrugIDPK>
    <LicenceNumber>PA0282/039/003</LicenceNumber>
    <ProductName>AMOXYCILLIN</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>19/11/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/08/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/039/002</DrugIDPK>
    <LicenceNumber>PA0282/039/002</LicenceNumber>
    <ProductName>AMOXYCILLIN BP</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>19/11/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/08/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/039/001</DrugIDPK>
    <LicenceNumber>PA0282/039/001</LicenceNumber>
    <ProductName>AMOXYCILLIN BP</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>19/11/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/08/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0298/010/005</DrugIDPK>
    <LicenceNumber>PA0298/010/005</LicenceNumber>
    <ProductName>AMOXYCILLIN Sachet Sugar Free</ProductName>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate>21/10/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/04/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1475/001/001</DrugIDPK>
    <LicenceNumber>PA1475/001/001</LicenceNumber>
    <ProductName>Amphocil powder</ProductName>
    <PAHolder>Samaritan Pharmaceuticals Ireland, Inc., Limited</PAHolder>
    <AuthorisedDate>29/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amphotericin b</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA1475/001/002</DrugIDPK>
    <LicenceNumber>PA1475/001/002</LicenceNumber>
    <ProductName>Amphocil powder</ProductName>
    <PAHolder>Samaritan Pharmaceuticals Ireland, Inc., Limited</PAHolder>
    <AuthorisedDate>29/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amphotericin b</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0237/046/007</DrugIDPK>
    <LicenceNumber>PA0237/046/007</LicenceNumber>
    <ProductName>AMPIBERK</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>21/12/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/046/006</DrugIDPK>
    <LicenceNumber>PA0237/046/006</LicenceNumber>
    <ProductName>AMPIBERK</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>21/12/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/046/005</DrugIDPK>
    <LicenceNumber>PA0237/046/005</LicenceNumber>
    <ProductName>AMPIBERK</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>21/12/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/046/004</DrugIDPK>
    <LicenceNumber>PA0237/046/004</LicenceNumber>
    <ProductName>AMPIBERK</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>21/12/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/046/003</DrugIDPK>
    <LicenceNumber>PA0237/046/003</LicenceNumber>
    <ProductName>AMPIBERK</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>21/12/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/046/002</DrugIDPK>
    <LicenceNumber>PA0237/046/002</LicenceNumber>
    <ProductName>AMPIBERK</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>21/12/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/046/001</DrugIDPK>
    <LicenceNumber>PA0237/046/001</LicenceNumber>
    <ProductName>AMPIBERK</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>21/12/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0493/003/001</DrugIDPK>
    <LicenceNumber>PA0493/003/001</LicenceNumber>
    <ProductName>Ampicillin</ProductName>
    <PAHolder>Regent Laboratories Limited</PAHolder>
    <AuthorisedDate>29/01/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ampicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/07/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0493/003/002</DrugIDPK>
    <LicenceNumber>PA0493/003/002</LicenceNumber>
    <ProductName>Ampicillin</ProductName>
    <PAHolder>Regent Laboratories Limited</PAHolder>
    <AuthorisedDate>29/01/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ampicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/07/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0298/001/001</DrugIDPK>
    <LicenceNumber>PA0298/001/001</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate>29/05/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ampicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/07/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0298/001/002</DrugIDPK>
    <LicenceNumber>PA0298/001/002</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate>29/05/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ampicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/07/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/008/001</DrugIDPK>
    <LicenceNumber>PA0405/008/001</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>12/05/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ampicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/03/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/008/002</DrugIDPK>
    <LicenceNumber>PA0405/008/002</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>12/05/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ampicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/04/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0432/003/003</DrugIDPK>
    <LicenceNumber>PA0432/003/003</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>20/05/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0432/003/002</DrugIDPK>
    <LicenceNumber>PA0432/003/002</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>20/05/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0399/002/004</DrugIDPK>
    <LicenceNumber>PA0399/002/004</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <PAHolder>Parle &amp; Hickey Ltd</PAHolder>
    <AuthorisedDate>27/06/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/09/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0399/002/003</DrugIDPK>
    <LicenceNumber>PA0399/002/003</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <PAHolder>Parle &amp; Hickey Ltd</PAHolder>
    <AuthorisedDate>27/06/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/09/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0399/002/001</DrugIDPK>
    <LicenceNumber>PA0399/002/001</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <PAHolder>Parle &amp; Hickey Ltd</PAHolder>
    <AuthorisedDate>27/06/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/09/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0365/006/002</DrugIDPK>
    <LicenceNumber>PA0365/006/002</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>09/07/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0365/006/001</DrugIDPK>
    <LicenceNumber>PA0365/006/001</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>09/07/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0337/001/002</DrugIDPK>
    <LicenceNumber>PA0337/001/002</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>31/01/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0337/001/001</DrugIDPK>
    <LicenceNumber>PA0337/001/001</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>31/01/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/004/005</DrugIDPK>
    <LicenceNumber>PA0282/004/005</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>12/04/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/004/002</DrugIDPK>
    <LicenceNumber>PA0282/004/002</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>03/08/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/004/001</DrugIDPK>
    <LicenceNumber>PA0282/004/001</LicenceNumber>
    <ProductName>AMPICILLIN</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>03/08/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0337/001/004</DrugIDPK>
    <LicenceNumber>PA0337/001/004</LicenceNumber>
    <ProductName>AMPICILLIN 125 MG/5 ML</ProductName>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>31/01/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0337/001/003</DrugIDPK>
    <LicenceNumber>PA0337/001/003</LicenceNumber>
    <ProductName>AMPICILLIN 125 MG/5 ML</ProductName>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>31/01/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0337/001/006</DrugIDPK>
    <LicenceNumber>PA0337/001/006</LicenceNumber>
    <ProductName>AMPICILLIN 250 MG/5 ML FORTE</ProductName>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>31/01/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0337/001/005</DrugIDPK>
    <LicenceNumber>PA0337/001/005</LicenceNumber>
    <ProductName>AMPICILLIN 250 MG/5 ML FORTE</ProductName>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>31/01/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/004/004</DrugIDPK>
    <LicenceNumber>PA0282/004/004</LicenceNumber>
    <ProductName>AMPICILLIN MIXTURE B.P.C.</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>06/05/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/09/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/004/003</DrugIDPK>
    <LicenceNumber>PA0282/004/003</LicenceNumber>
    <ProductName>AMPICILLIN MIXTURE B.P.C.</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>15/08/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/09/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0298/002/001</DrugIDPK>
    <LicenceNumber>PA0298/002/001</LicenceNumber>
    <ProductName>AMPICILLIN Oral Suspension BP</ProductName>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate>04/07/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ampicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/07/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0298/002/002</DrugIDPK>
    <LicenceNumber>PA0298/002/002</LicenceNumber>
    <ProductName>AMPICILLIN Oral Suspension BP</ProductName>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate>04/07/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ampicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/07/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/004/006</DrugIDPK>
    <LicenceNumber>PA0282/004/006</LicenceNumber>
    <ProductName>AMPICILLIN SYRUP B P</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>12/04/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/009/004</DrugIDPK>
    <LicenceNumber>PA0281/009/004</LicenceNumber>
    <ProductName>AMPICILLIN SYRUP B P C</ProductName>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>15/04/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0399/002/002</DrugIDPK>
    <LicenceNumber>PA0399/002/002</LicenceNumber>
    <ProductName>AMPICILLIN TRIHYDRATE</ProductName>
    <PAHolder>Parle &amp; Hickey Ltd</PAHolder>
    <AuthorisedDate>27/06/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/09/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/007/001</DrugIDPK>
    <LicenceNumber>PA0049/007/001</LicenceNumber>
    <ProductName>AMPICLOX</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ampicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>Cloxacillin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/10/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/007/003</DrugIDPK>
    <LicenceNumber>PA0049/007/003</LicenceNumber>
    <ProductName>AMPICLOX</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ampicillin sodium</ActiveSubstance>
      <ActiveSubstance>Cloxacillin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/10/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/007/004</DrugIDPK>
    <LicenceNumber>PA0049/007/004</LicenceNumber>
    <ProductName>AMPICLOX</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN SODIUM</ActiveSubstance>
      <ActiveSubstance>CLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/007/005</DrugIDPK>
    <LicenceNumber>PA0049/007/005</LicenceNumber>
    <ProductName>AMPICLOX NEONATAL</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ampicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>Cloxacillin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/10/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/007/006</DrugIDPK>
    <LicenceNumber>PA0049/007/006</LicenceNumber>
    <ProductName>AMPLICOX</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ampicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>Cloxacillin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/10/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/007/007</DrugIDPK>
    <LicenceNumber>PA0049/007/007</LicenceNumber>
    <ProductName>AMPLICOX</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/02/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0736/043/001</DrugIDPK>
    <LicenceNumber>PA0736/043/001</LicenceNumber>
    <ProductName>Ampres 10mg/ml solution for injection</ProductName>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>13/07/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chloroprocaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/06/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0736/043/002</DrugIDPK>
    <LicenceNumber>PA0736/043/002</LicenceNumber>
    <ProductName>Ampres 20 mg/ml solution for injection</ProductName>
    <PAHolder>B. Braun Melsungen AG</PAHolder>
    <AuthorisedDate>26/06/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chloroprocaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/06/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1591/002/001</DrugIDPK>
    <LicenceNumber>PA1591/002/001</LicenceNumber>
    <ProductName>Amsidine 75 mg/1.5 ml Concentrate and Solvent for Concentrate for Solution for Infusion</ProductName>
    <PAHolder>Eurocept International BV</PAHolder>
    <AuthorisedDate>17/08/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate and solvent for concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amsacrine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/049/003</DrugIDPK>
    <LicenceNumber>PA0073/049/003</LicenceNumber>
    <ProductName>AMYLINE</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>30/08/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/08/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/049/002</DrugIDPK>
    <LicenceNumber>PA0073/049/002</LicenceNumber>
    <ProductName>AMYLINE</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>07/01/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/049/001</DrugIDPK>
    <LicenceNumber>PA0073/049/001</LicenceNumber>
    <ProductName>AMYLINE</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>07/01/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0060/010/001</DrugIDPK>
    <LicenceNumber>PA0060/010/001</LicenceNumber>
    <ProductName>AMYLOZINE SPANSULE</ProductName>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/009/010</DrugIDPK>
    <LicenceNumber>PA0047/009/010</LicenceNumber>
    <ProductName>AMYTAL</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/02/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/009/006</DrugIDPK>
    <LicenceNumber>PA0047/009/006</LicenceNumber>
    <ProductName>AMYTAL</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/009/005</DrugIDPK>
    <LicenceNumber>PA0047/009/005</LicenceNumber>
    <ProductName>AMYTAL</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/009/004</DrugIDPK>
    <LicenceNumber>PA0047/009/004</LicenceNumber>
    <ProductName>AMYTAL</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/009/003</DrugIDPK>
    <LicenceNumber>PA0047/009/003</LicenceNumber>
    <ProductName>AMYTAL</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/009/002</DrugIDPK>
    <LicenceNumber>PA0047/009/002</LicenceNumber>
    <ProductName>AMYTAL</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/009/001</DrugIDPK>
    <LicenceNumber>PA0047/009/001</LicenceNumber>
    <ProductName>AMYTAL</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/009/009</DrugIDPK>
    <LicenceNumber>PA0047/009/009</LicenceNumber>
    <ProductName>AMYTAL SODIUM</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/009/008</DrugIDPK>
    <LicenceNumber>PA0047/009/008</LicenceNumber>
    <ProductName>AMYTAL SODIUM</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/009/007</DrugIDPK>
    <LicenceNumber>PA0047/009/007</LicenceNumber>
    <ProductName>AMYTAL SODIUM</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0980/003/001</DrugIDPK>
    <LicenceNumber>PA0980/003/001</LicenceNumber>
    <ProductName>ANABACT</ProductName>
    <PAHolder>Cambridge Healthcare Supplies Limited</PAHolder>
    <AuthorisedDate>13/11/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Metronidazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/11/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0172/004/002</DrugIDPK>
    <LicenceNumber>PA0172/004/002</LicenceNumber>
    <ProductName>ANADIN ANALGESIC</ProductName>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0172/004/001</DrugIDPK>
    <LicenceNumber>PA0172/004/001</LicenceNumber>
    <ProductName>ANADIN ANALGESIC</ProductName>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/02/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/076/001</DrugIDPK>
    <LicenceNumber>PPA1447/076/001</LicenceNumber>
    <ProductName>Anadin Extra</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acetylsalicylic acid</ActiveSubstance>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
      <ActiveSubstance>Caffeine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>Retail sale through pharmacies only in blister packs containing not more than 24 unit dosage forms. Not more than two such packs should be supplied in the course of any one retail transaction unless a valid prescription exists. The indications should be ap</SupplyComments>
    <WithdrawalDate>29/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/166/001</DrugIDPK>
    <LicenceNumber>PA0822/166/001</LicenceNumber>
    <ProductName>Anadin Extra Film-coated TabletsAspirin 300mgParacetamol 200mgCaffeine 45mg</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>28/02/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acetylsalicylic acid</ActiveSubstance>
      <ActiveSubstance>Caffeine</ActiveSubstance>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>Retail sale through pharmacies only in blister packs containing not more than 24 unit dosage forms.  Not more than two such packs should be supplied in the course of any one retail transaction unless a valid prescription exists.
The indications should be</SupplyComments>
    <WithdrawalDate>30/11/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0143/009/004</DrugIDPK>
    <LicenceNumber>PA0143/009/004</LicenceNumber>
    <ProductName>ANAFLEX</ProductName>
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYNOXYLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0143/009/003</DrugIDPK>
    <LicenceNumber>PA0143/009/003</LicenceNumber>
    <ProductName>ANAFLEX</ProductName>
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYNOXYLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0143/009/002</DrugIDPK>
    <LicenceNumber>PA0143/009/002</LicenceNumber>
    <ProductName>ANAFLEX</ProductName>
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYNOXYLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0143/009/001</DrugIDPK>
    <LicenceNumber>PA0143/009/001</LicenceNumber>
    <ProductName>ANAFLEX</ProductName>
    <PAHolder>Geistlich Sons Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYNOXYLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/084/004</DrugIDPK>
    <LicenceNumber>PA0013/084/004</LicenceNumber>
    <ProductName>ANAFRANIL</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOMIPRAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0011/005/002</DrugIDPK>
    <LicenceNumber>PA0011/005/002</LicenceNumber>
    <ProductName>ANAFRANIL</ProductName>
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>10/11/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOMIPRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/10/1986</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/084/002</DrugIDPK>
    <LicenceNumber>PA0013/084/002</LicenceNumber>
    <ProductName>Anafranil 10mg Capsules</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clomipramine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/07/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/084/003</DrugIDPK>
    <LicenceNumber>PA0013/084/003</LicenceNumber>
    <ProductName>Anafranil 25mg Capsules</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clomipramine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/07/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/084/001</DrugIDPK>
    <LicenceNumber>PA0013/084/001</LicenceNumber>
    <ProductName>Anafranil 50mg Capsules</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>25/04/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clomipramine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/07/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/084/005</DrugIDPK>
    <LicenceNumber>PA0013/084/005</LicenceNumber>
    <ProductName>ANAFRANIL AMPOULES</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOMIPRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/012/001</DrugIDPK>
    <LicenceNumber>PA0468/012/001</LicenceNumber>
    <ProductName>ANANASE</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/04/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMELAINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/05/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/012/002</DrugIDPK>
    <LicenceNumber>PA0468/012/002</LicenceNumber>
    <ProductName>ANANASE FORTE</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/04/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMELAINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/12/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/003/001</DrugIDPK>
    <LicenceNumber>PA0057/003/001</LicenceNumber>
    <ProductName>ANAPAX FAMILY COUGH</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>05/03/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/1979</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1072/001/003</DrugIDPK>
    <LicenceNumber>PA1072/001/003</LicenceNumber>
    <ProductName>Anapen</ProductName>
    <PAHolder>Lincoln Medical Ltd</PAHolder>
    <AuthorisedDate>05/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Adrenaline (epinephrine)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0844/003/001</DrugIDPK>
    <LicenceNumber>PA0844/003/001</LicenceNumber>
    <ProductName>Anapolon</ProductName>
    <PAHolder>Cambridge Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Oxymetholone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0033/019/001</DrugIDPK>
    <LicenceNumber>PA0033/019/001</LicenceNumber>
    <ProductName>ANAPOLON</ProductName>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYMETHOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1487/001/001</DrugIDPK>
    <LicenceNumber>PA1487/001/001</LicenceNumber>
    <InterchangeableListCode>IC0011-039-003</InterchangeableListCode>
    <ProductName>Anastrozol</ProductName>
    <PAHolder>Welding GmbH &amp; Co. KG</PAHolder>
    <AuthorisedDate>06/08/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrozole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/08/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/078/001</DrugIDPK>
    <LicenceNumber>PA0408/078/001</LicenceNumber>
    <ProductName>Anastrozole</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>23/04/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrozole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/10/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0585/036/001</DrugIDPK>
    <LicenceNumber>PA0585/036/001</LicenceNumber>
    <ProductName>Anastrozole</ProductName>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>24/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrozole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/031/001</DrugIDPK>
    <LicenceNumber>PA1063/031/001</LicenceNumber>
    <ProductName>Anastrozole 1 mg film-coated tablets</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>27/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrozole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/032/001</DrugIDPK>
    <LicenceNumber>PA1063/032/001</LicenceNumber>
    <ProductName>Anastrozole 1 mg film-coated tablets</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>27/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrozole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2059/027/001</DrugIDPK>
    <LicenceNumber>PA2059/027/001</LicenceNumber>
    <InterchangeableListCode>IC0011-039-003</InterchangeableListCode>
    <ProductName>Anastrozole 1 mg film-coated tablets</ProductName>
    <PAHolder>Fresenius Kabi Deutschland GmbH</PAHolder>
    <AuthorisedDate>21/10/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrozole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/05/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/011/001</DrugIDPK>
    <LicenceNumber>PA2315/011/001</LicenceNumber>
    <InterchangeableListCode>IC0011-039-003</InterchangeableListCode>
    <ProductName>Anastrozole 1 mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>23/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrozole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/06/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0074/068/001</DrugIDPK>
    <LicenceNumber>PA0074/068/001</LicenceNumber>
    <InterchangeableListCode>IC0011-039-003</InterchangeableListCode>
    <ProductName>Anastrozole 1 mg Film-coated tablets</ProductName>
    <PAHolder>Rowa Pharmaceuticals Limited,</PAHolder>
    <AuthorisedDate>27/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrozole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/03/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0565/060/001</DrugIDPK>
    <LicenceNumber>PPA0565/060/001</LicenceNumber>
    <InterchangeableListCode>IC0011-039-003</InterchangeableListCode>
    <ProductName>Anastrozole 1 mg Film-coated Tablets</ProductName>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>01/05/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrozole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/12/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1130/015/001</DrugIDPK>
    <LicenceNumber>PA1130/015/001</LicenceNumber>
    <ProductName>Anastrozole Arrow</ProductName>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>06/03/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1436/010/001</DrugIDPK>
    <LicenceNumber>PA1436/010/001</LicenceNumber>
    <InterchangeableListCode>IC0011-039-003</InterchangeableListCode>
    <ProductName>Anastrozole Bluefish 1 mg film-coated tablets</ProductName>
    <PAHolder>Bluefish Pharmaceuticals AB</PAHolder>
    <AuthorisedDate>25/03/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrozole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/05/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1506/001/001</DrugIDPK>
    <LicenceNumber>PA1506/001/001</LicenceNumber>
    <ProductName>Anastrozole Docpharma</ProductName>
    <PAHolder>Docpharma NV</PAHolder>
    <AuthorisedDate>22/12/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1217/004/001</DrugIDPK>
    <LicenceNumber>PA1217/004/001</LicenceNumber>
    <ProductName>Anastrozole Hikma</ProductName>
    <PAHolder>Hikma Farmacêutica (Portugal) S.A.</PAHolder>
    <AuthorisedDate>02/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/030/001</DrugIDPK>
    <LicenceNumber>PA1063/030/001</LicenceNumber>
    <ProductName>Anastrozole Niche</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>27/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrozole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/03/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1507/001/001</DrugIDPK>
    <LicenceNumber>PA1507/001/001</LicenceNumber>
    <ProductName>Anastrozole Progen 1 mg film-coated tablets</ProductName>
    <PAHolder>Progen s.r.l.,</PAHolder>
    <AuthorisedDate>22/12/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrozole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/09/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1914/001/001</DrugIDPK>
    <LicenceNumber>PA1914/001/001</LicenceNumber>
    <InterchangeableListCode>IC0011-039-003</InterchangeableListCode>
    <ProductName>Anastrozole Zaphyr Pharmaceuticals 1 mg film-coated tablets</ProductName>
    <PAHolder>Zaphyr Pharmaceuticals Ireland Limited</PAHolder>
    <AuthorisedDate>27/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrozole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/016/007</DrugIDPK>
    <LicenceNumber>PA0002/016/007</LicenceNumber>
    <ProductName>ANATENSOL DECANOATE</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0002/016/001</DrugIDPK>
    <LicenceNumber>PA0002/016/001</LicenceNumber>
    <ProductName>ANATENSOL DECANOATE</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0290/078/001</DrugIDPK>
    <LicenceNumber>PA0290/078/001</LicenceNumber>
    <ProductName>Anatera</ProductName>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>05/10/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fluorescein</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0065/014/001</DrugIDPK>
    <LicenceNumber>PA0065/014/001</LicenceNumber>
    <ProductName>ANCOLOXIN</ProductName>
    <PAHolder>Duncan, Flockhard &amp; Co. Limited</PAHolder>
    <AuthorisedDate>05/03/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2010/048/001</DrugIDPK>
    <LicenceNumber>PA2010/048/001</LicenceNumber>
    <ProductName>Ancotil 2.5g/250ml Solution for Infusion</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>08/06/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Flucytosine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/11/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/048/001</DrugIDPK>
    <LicenceNumber>PA0678/048/001</LicenceNumber>
    <ProductName>Andrews Antacid Tablets</ProductName>
    <PAHolder>Haleon Ireland Limited</PAHolder>
    <AuthorisedDate>04/03/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Magnesium carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/03/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/048/002</DrugIDPK>
    <LicenceNumber>PA0678/048/002</LicenceNumber>
    <ProductName>Andrews Antacid Tablets Fruit Flavour</ProductName>
    <PAHolder>Haleon Ireland Limited</PAHolder>
    <AuthorisedDate>04/03/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Heavy magnesium carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/03/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0012/005/001</DrugIDPK>
    <LicenceNumber>PA0012/005/001</LicenceNumber>
    <ProductName>Androcur 50 mg Tablets</ProductName>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cyproterone acetate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/04/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1054/001/001</DrugIDPK>
    <LicenceNumber>PA1054/001/001</LicenceNumber>
    <ProductName>Androgel 25 mg, transdermal gel in sachet</ProductName>
    <PAHolder>Laboratoires Besins International</PAHolder>
    <AuthorisedDate>03/06/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal gel in sachet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Testosterone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/05/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/018/001</DrugIDPK>
    <LicenceNumber>PA1077/018/001</LicenceNumber>
    <ProductName>Andropatch</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>15/04/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Testosterone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0303/030/001</DrugIDPK>
    <LicenceNumber>PA0303/030/001</LicenceNumber>
    <ProductName>ANDROSTAT</ProductName>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>21/03/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/02/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0028/051/002</DrugIDPK>
    <LicenceNumber>PA0028/051/002</LicenceNumber>
    <ProductName>ANDURSIL</ProductName>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>28/05/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>ANTIFOAM M</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/06/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0028/051/001</DrugIDPK>
    <LicenceNumber>PA0028/051/001</LicenceNumber>
    <ProductName>ANDURSIL</ProductName>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>25/05/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>ANTIFOAM M</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1691/033/001</DrugIDPK>
    <LicenceNumber>PA1691/033/001</LicenceNumber>
    <ProductName>Anectine 50mg/ml solution for injection or infusion</ProductName>
    <PAHolder>Aspen Pharma Trading Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Suxamethonium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/044/002</DrugIDPK>
    <LicenceNumber>PA0017/044/002</LicenceNumber>
    <ProductName>ANECTINE INJECTION</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/072/002</DrugIDPK>
    <LicenceNumber>PA0050/072/002</LicenceNumber>
    <ProductName>ANEXATE</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>18/02/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUMAZENIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/07/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/013/001</DrugIDPK>
    <LicenceNumber>PA0048/013/001</LicenceNumber>
    <ProductName>ANGETTES 75</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/002/004</DrugIDPK>
    <LicenceNumber>PA0050/002/004</LicenceNumber>
    <ProductName>ANGIAM</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>21/11/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUFURALOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/07/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/002/003</DrugIDPK>
    <LicenceNumber>PA0050/002/003</LicenceNumber>
    <ProductName>ANGIAM</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>21/11/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUFURALOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/07/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/002/002</DrugIDPK>
    <LicenceNumber>PA0050/002/002</LicenceNumber>
    <ProductName>ANGIAM</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>21/11/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUFURALOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/07/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/002/001</DrugIDPK>
    <LicenceNumber>PA0050/002/001</LicenceNumber>
    <ProductName>ANGIAM</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>21/11/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUFURALOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/07/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0114/027/001</DrugIDPK>
    <LicenceNumber>PA0114/027/001</LicenceNumber>
    <ProductName>ANGICREM</ProductName>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>12/05/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/039/003</DrugIDPK>
    <LicenceNumber>PA0048/039/003</LicenceNumber>
    <ProductName>ANGIERS JUNIOR PARACETAMOL</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>26/06/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/11/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/039/002</DrugIDPK>
    <LicenceNumber>PA0048/039/002</LicenceNumber>
    <ProductName>ANGIERS PARACETAMOL ELIXIR</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>24/05/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0012/033/002</DrugIDPK>
    <LicenceNumber>PA0012/033/002</LicenceNumber>
    <ProductName>ANGIOGRAFIN</ProductName>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEGLUMINE AMIDOTRIZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/05/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0012/033/001</DrugIDPK>
    <LicenceNumber>PA0012/033/001</LicenceNumber>
    <ProductName>ANGIOGRAFIN 65%</ProductName>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEGLUMINE AMIDOTRIZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/05/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/04/289/001</DrugIDPK>
    <LicenceNumber>EU/1/04/289/001</LicenceNumber>
    <ProductName>Angiox</ProductName>
    <PAHolder>The Medicines Company UK Limited</PAHolder>
    <AuthorisedDate>20/09/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bivalirudin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>14/09/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/022/001</DrugIDPK>
    <LicenceNumber>PA0006/022/001</LicenceNumber>
    <ProductName>ANGIPLEX</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>17/12/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/08/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/067/001</DrugIDPK>
    <LicenceNumber>PA0017/067/001</LicenceNumber>
    <ProductName>ANGISED</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLYCERYL TRINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/10/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0743/002/001</DrugIDPK>
    <LicenceNumber>PA0743/002/001</LicenceNumber>
    <ProductName>Angitil SR</ProductName>
    <PAHolder>Chiesi Limited</PAHolder>
    <AuthorisedDate>13/12/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0278/007/002</DrugIDPK>
    <LicenceNumber>PA0278/007/002</LicenceNumber>
    <ProductName>Anhydrol</ProductName>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aluminium chloride hexahydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1463/048/001</DrugIDPK>
    <LicenceNumber>DPR1463/048/001</LicenceNumber>
    <ProductName>Anhydrol Forte 20%</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>07/06/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not assigned</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aluminium chloride hexahydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>None</SupplyComments>
    <WithdrawalDate>11/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0172/004/007</DrugIDPK>
    <LicenceNumber>PA0172/004/007</LicenceNumber>
    <ProductName>Aniall 500/50 mg Tablets</ProductName>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>07/09/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acetylsalicylic acid</ActiveSubstance>
      <ActiveSubstance>Caffeine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/02/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/228/001</DrugIDPK>
    <LicenceNumber>PA0577/228/001</LicenceNumber>
    <ProductName>Anidulafungin 100 mg powder for concentrate for solution for infusion</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>14/02/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anidulafungin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>13/04/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2059/071/001</DrugIDPK>
    <LicenceNumber>PA2059/071/001</LicenceNumber>
    <ProductName>Anidulafungin Fresenius Kabi 100 mg powder for concentrate for solution for infusion</ProductName>
    <PAHolder>Fresenius Kabi Deutschland GmbH</PAHolder>
    <AuthorisedDate>24/07/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anidulafungin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>30/11/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0363/008/001</DrugIDPK>
    <LicenceNumber>PA0363/008/001</LicenceNumber>
    <ProductName>ANTABUSE EFFERVESCENT</ProductName>
    <PAHolder>Alpharma ApS</PAHolder>
    <AuthorisedDate>16/02/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISULFIRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/073/001</DrugIDPK>
    <LicenceNumber>PA0073/073/001</LicenceNumber>
    <ProductName>ANTAROL</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>01/11/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Propranolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/073/002</DrugIDPK>
    <LicenceNumber>PA0073/073/002</LicenceNumber>
    <ProductName>ANTAROL</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>01/11/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Propranolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/073/003</DrugIDPK>
    <LicenceNumber>PA0073/073/003</LicenceNumber>
    <ProductName>ANTAROL</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>01/11/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Propranolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/082/001</DrugIDPK>
    <LicenceNumber>PA0017/082/001</LicenceNumber>
    <ProductName>ANTEPAR</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>16/12/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1473/023/001</DrugIDPK>
    <LicenceNumber>DPR1473/023/001</LicenceNumber>
    <ProductName>Antepsin</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>21/04/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sucralfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/023/002</DrugIDPK>
    <LicenceNumber>DPR1473/023/002</LicenceNumber>
    <ProductName>Antepsin</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>21/04/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sucralfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0950/001/002</DrugIDPK>
    <LicenceNumber>PA0950/001/002</LicenceNumber>
    <ProductName>Antepsin</ProductName>
    <PAHolder>Chugai Pharma UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sucralfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/02/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/053/003</DrugIDPK>
    <LicenceNumber>PA0022/053/003</LicenceNumber>
    <ProductName>ANTEPSIN</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>18/05/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUCRALFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/053/002</DrugIDPK>
    <LicenceNumber>PA0022/053/002</LicenceNumber>
    <ProductName>ANTEPSIN</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>18/05/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUCRALFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/053/001</DrugIDPK>
    <LicenceNumber>PA0022/053/001</LicenceNumber>
    <ProductName>ANTEPSIN</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>18/05/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUCRALFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22641/001/001</DrugIDPK>
    <LicenceNumber>PA22641/001/001</LicenceNumber>
    <ProductName>Antepsin 1 g/5 ml Oral Suspension</ProductName>
    <PAHolder>Chugai Pharma France</PAHolder>
    <AuthorisedDate>31/03/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sucralfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/09/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22641/001/002</DrugIDPK>
    <LicenceNumber>PA22641/001/002</LicenceNumber>
    <ProductName>Antepsin 1 g Tablets</ProductName>
    <PAHolder>Chugai Pharma France</PAHolder>
    <AuthorisedDate>31/03/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sucralfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/09/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/038/001</DrugIDPK>
    <LicenceNumber>PA0040/038/001</LicenceNumber>
    <ProductName>ANTHICAL</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/05/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/070/001</DrugIDPK>
    <LicenceNumber>PPA1447/070/001</LicenceNumber>
    <ProductName>Anthisan</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>08/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mepyramine maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/02/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/013/001</DrugIDPK>
    <LicenceNumber>PA0540/013/001</LicenceNumber>
    <ProductName>ANTHISAN PLUS STING RELIEF (SPRAY)</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>07/01/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous spray, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mepyramine maleate</ActiveSubstance>
      <ActiveSubstance>Benzocaine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0144/017/004</DrugIDPK>
    <LicenceNumber>PA0144/017/004</LicenceNumber>
    <ProductName>Anthranol 0.4</ProductName>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>01/10/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dithranol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/05/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0144/017/001</DrugIDPK>
    <LicenceNumber>PA0144/017/001</LicenceNumber>
    <ProductName>Anthranol 1.0</ProductName>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>23/03/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dithranol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/05/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0144/017/002</DrugIDPK>
    <LicenceNumber>PA0144/017/002</LicenceNumber>
    <ProductName>Anthranol 2.0</ProductName>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>23/03/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dithranol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/05/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0144/017/003</DrugIDPK>
    <LicenceNumber>PA0144/017/003</LicenceNumber>
    <ProductName>ANTHRANOL 3.0</ProductName>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>15/10/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DITHRANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/10/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/034/001</DrugIDPK>
    <LicenceNumber>PA0126/034/001</LicenceNumber>
    <ProductName>ANTI-HIST</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>11/05/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/07/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0723/001/001</DrugIDPK>
    <LicenceNumber>PA0723/001/001</LicenceNumber>
    <ProductName>ANTIBIOTIC SIMPLEX BONE CEMENT</ProductName>
    <PAHolder>Howmedica International IRL.</PAHolder>
    <AuthorisedDate>29/12/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN GLUCEPTATE</ActiveSubstance>
      <ActiveSubstance>COLISTIN SULFOMETHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/01/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/024/001</DrugIDPK>
    <LicenceNumber>PA0167/024/001</LicenceNumber>
    <ProductName>ANTICOAGULANT 4% SODIUM CITRATE SOLUTION</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>19/07/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/060/001</DrugIDPK>
    <LicenceNumber>PA0073/060/001</LicenceNumber>
    <ProductName>Antimet</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>13/05/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Metoclopramide hydrochloride </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/12/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/060/002</DrugIDPK>
    <LicenceNumber>PA0073/060/002</LicenceNumber>
    <ProductName>Antimet</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>26/10/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Metoclopramide hydrochloride </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/10/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/060/003</DrugIDPK>
    <LicenceNumber>PA0073/060/003</LicenceNumber>
    <ProductName>ANTIMET</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>26/10/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/02/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0004/056/001</DrugIDPK>
    <LicenceNumber>PA0004/056/001</LicenceNumber>
    <ProductName>ANTISEPTIC THROAT DROPS MENTHOL AND EUCALYPTUS</ProductName>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>17/05/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenge</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amylmetacresol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/01/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0004/055/001</DrugIDPK>
    <LicenceNumber>PA0004/055/001</LicenceNumber>
    <ProductName>Antiseptic Throat Lozenges Orange &amp; Menthol</ProductName>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>17/05/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenge</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amylmetacresol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/12/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/074/004</DrugIDPK>
    <LicenceNumber>PA0073/074/004</LicenceNumber>
    <ProductName>ANTOXOL</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>19/10/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/08/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/074/003</DrugIDPK>
    <LicenceNumber>PA0073/074/003</LicenceNumber>
    <ProductName>ANTOXOL</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>19/10/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/08/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/074/002</DrugIDPK>
    <LicenceNumber>PA0073/074/002</LicenceNumber>
    <ProductName>ANTOXOL</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>19/10/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/08/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/074/001</DrugIDPK>
    <LicenceNumber>PA0073/074/001</LicenceNumber>
    <ProductName>ANTOXOL</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>19/10/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXPRENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/08/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/020/002</DrugIDPK>
    <LicenceNumber>PA0062/020/002</LicenceNumber>
    <ProductName>ANTRADERM</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>30/07/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/020/003</DrugIDPK>
    <LicenceNumber>PA0062/020/003</LicenceNumber>
    <ProductName>ANTRADERM FORTE</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>30/07/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/020/001</DrugIDPK>
    <LicenceNumber>PA0062/020/001</LicenceNumber>
    <ProductName>ANTRADERM MILD</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>30/07/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/086/001</DrugIDPK>
    <LicenceNumber>PA0073/086/001</LicenceNumber>
    <ProductName>ANTRIMOX</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>02/04/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/04/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/086/002</DrugIDPK>
    <LicenceNumber>PA0073/086/002</LicenceNumber>
    <ProductName>ANTRIMOX (SUSPENSION)</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>24/09/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0011/012/002</DrugIDPK>
    <LicenceNumber>PA0011/012/002</LicenceNumber>
    <ProductName>ANTURAN</ProductName>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>07/07/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFINPYRAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/009/002</DrugIDPK>
    <LicenceNumber>PA0822/009/002</LicenceNumber>
    <ProductName>ANUGESIC HC</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>15/03/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppository</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pramocaine hydrochloride</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
      <ActiveSubstance>Benzyl benzoate</ActiveSubstance>
      <ActiveSubstance>Bismuth oxide</ActiveSubstance>
      <ActiveSubstance>Balsam peru</ActiveSubstance>
      <ActiveSubstance>Zinc oxide</ActiveSubstance>
      <ActiveSubstance>Bismuth subgallate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/02/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/009/001</DrugIDPK>
    <LicenceNumber>PA0822/009/001</LicenceNumber>
    <ProductName>Anugesic HC Cream</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzyl benzoate</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
      <ActiveSubstance>Bismuth oxide</ActiveSubstance>
      <ActiveSubstance>Balsam peru</ActiveSubstance>
      <ActiveSubstance>Pramocaine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Zinc oxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/06/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/030/001</DrugIDPK>
    <LicenceNumber>PA0049/030/001</LicenceNumber>
    <ProductName>ANXON</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>10/02/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETAZOLAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/06/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/029/002</DrugIDPK>
    <LicenceNumber>PA0540/029/002</LicenceNumber>
    <ProductName>Anzemet</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dolasetron mesylate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0540/029/003</DrugIDPK>
    <LicenceNumber>PA0540/029/003</LicenceNumber>
    <ProductName>Anzemet</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dolasetron mesylate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0540/029/001</DrugIDPK>
    <LicenceNumber>PA0540/029/001</LicenceNumber>
    <ProductName>Anzemet Injection</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dolasetron mesylate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0628/001/001</DrugIDPK>
    <LicenceNumber>PA0628/001/001</LicenceNumber>
    <ProductName>AOSEPT</ProductName>
    <PAHolder>Ciba Vision (UK) Ltd</PAHolder>
    <AuthorisedDate>15/10/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROGEN PEROXIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/18/1292/001</DrugIDPK>
    <LicenceNumber>EU/1/18/1292/001</LicenceNumber>
    <ProductName>Apealea</ProductName>
    <PAHolder>Inceptua AB</PAHolder>
    <AuthorisedDate>20/11/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paclitaxel</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>09/02/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/109/001</DrugIDPK>
    <LicenceNumber>PA0678/109/001</LicenceNumber>
    <ProductName>Apfen Plus 200mg/12.8mg Film-Coated Tablets</ProductName>
    <PAHolder>Haleon Ireland Limited</PAHolder>
    <AuthorisedDate>09/03/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
      <ActiveSubstance>Codeine phosphate hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription, supply through pharmacies only and promotion to the healthcare professionals only subject to the following restrictions: For ibuprofen: maximum strength 200 mg, maximum dose: 400 mg, maximum daily dose 1200 mg,</SupplyComments>
    <WithdrawalDate>08/03/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2010/054/001</DrugIDPK>
    <LicenceNumber>PA2010/054/001</LicenceNumber>
    <ProductName>APHTHEAL 5% w/w Oromucosal Paste</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>12/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal paste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlexanox</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/02/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA23229/001/001</DrugIDPK>
    <LicenceNumber>PA23229/001/001</LicenceNumber>
    <ProductName>Apictro 250 mg soft capsules</ProductName>
    <PAHolder>Neuraxpharm Ireland Limited</PAHolder>
    <AuthorisedDate>26/11/2021</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ethosuximide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA23229/002/001</DrugIDPK>
    <LicenceNumber>PA23229/002/001</LicenceNumber>
    <ProductName>Apictro 50 mg/ml oral solution</ProductName>
    <PAHolder>Neuraxpharm Ireland Limited</PAHolder>
    <AuthorisedDate>03/12/2021</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ethosuximide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR1149/002/001</DrugIDPK>
    <LicenceNumber>HOR1149/002/001</LicenceNumber>
    <ProductName>Apis mel</ProductName>
    <PAHolder>A. Nelson &amp; Company Limited</PAHolder>
    <AuthorisedDate>03/12/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Infus/Pdr/Oral Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Apis mellifica</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR0407/047/001</DrugIDPK>
    <LicenceNumber>HOR0407/047/001</LicenceNumber>
    <ProductName>Apis mel Tablets</ProductName>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>16/01/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Apis mellifica</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/033/001</DrugIDPK>
    <LicenceNumber>PA0022/033/001</LicenceNumber>
    <ProductName>APISATE</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>01/04/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMFEPRAMONE</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/052/001</DrugIDPK>
    <LicenceNumber>PA0436/052/001</LicenceNumber>
    <InterchangeableListCode>IC0124-018-003</InterchangeableListCode>
    <ProductName>Apixaban 2.5 mg Film-coated Tablets</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>04/11/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Apixaban</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/05/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/052/002</DrugIDPK>
    <LicenceNumber>PA0436/052/002</LicenceNumber>
    <InterchangeableListCode>IC0124-001-003</InterchangeableListCode>
    <ProductName>Apixaban 5 mg Film-coated Tablets</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>04/11/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Apixaban</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/05/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1390/042/002</DrugIDPK>
    <LicenceNumber>PA1390/042/002</LicenceNumber>
    <ProductName>Apodespan PR</ProductName>
    <PAHolder>Accord  Healthcare Limited</PAHolder>
    <AuthorisedDate>01/02/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carbidopa</ActiveSubstance>
      <ActiveSubstance>Levodopa</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/09/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0757/008/001</DrugIDPK>
    <LicenceNumber>PA0757/008/001</LicenceNumber>
    <ProductName>Apomorphine Hydrochloride</ProductName>
    <PAHolder>Archimedes Pharma UK Limited</PAHolder>
    <AuthorisedDate>05/02/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Apomorphine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2262/002/001</DrugIDPK>
    <LicenceNumber>PA2262/002/001</LicenceNumber>
    <ProductName>Apomorphine hydrochloride 5 mg/ml solution for infusion</ProductName>
    <PAHolder>Evolan Pharma AB</PAHolder>
    <AuthorisedDate>26/10/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Apomorphine hydrochloride hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/10/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/064/001</DrugIDPK>
    <LicenceNumber>PA0013/064/001</LicenceNumber>
    <ProductName>APRESOLINE</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDRALAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/12/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/064/002</DrugIDPK>
    <LicenceNumber>PA0013/064/002</LicenceNumber>
    <ProductName>APRESOLINE</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDRALAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/09/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1142/015/001</DrugIDPK>
    <LicenceNumber>PA1142/015/001</LicenceNumber>
    <ProductName>Apresoline Ampoules 20 mg Powder for concentrate for solution for injection or infusion</ProductName>
    <PAHolder>Amdipharm Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for concentrate for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDRALAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>The reconstituted powder must be diluted before use.</SupplyComments>
    <WithdrawalDate>15/12/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/046/002</DrugIDPK>
    <LicenceNumber>EU/1/97/046/002</LicenceNumber>
    <ProductName>Aprovel</ProductName>
    <PAHolder>Sanofi Winthrop Industrie</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Irbesartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/046/003</DrugIDPK>
    <LicenceNumber>EU/1/97/046/003</LicenceNumber>
    <ProductName>Aprovel</ProductName>
    <PAHolder>Sanofi Winthrop Industrie</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Irbesartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/046/005</DrugIDPK>
    <LicenceNumber>EU/1/97/046/005</LicenceNumber>
    <ProductName>Aprovel</ProductName>
    <PAHolder>Sanofi Winthrop Industrie</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Irbesartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/046/006</DrugIDPK>
    <LicenceNumber>EU/1/97/046/006</LicenceNumber>
    <ProductName>Aprovel</ProductName>
    <PAHolder>Sanofi Winthrop Industrie</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Irbesartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/046/008</DrugIDPK>
    <LicenceNumber>EU/1/97/046/008</LicenceNumber>
    <ProductName>Aprovel</ProductName>
    <PAHolder>Sanofi Winthrop Industrie</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Irbesartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/046/009</DrugIDPK>
    <LicenceNumber>EU/1/97/046/009</LicenceNumber>
    <ProductName>Aprovel</ProductName>
    <PAHolder>Sanofi Winthrop Industrie</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Irbesartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/024/001</DrugIDPK>
    <LicenceNumber>PA0237/024/001</LicenceNumber>
    <ProductName>APS ALLOPURINOL</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>09/11/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/025/002</DrugIDPK>
    <LicenceNumber>PA0237/025/002</LicenceNumber>
    <ProductName>APS DIPYRIDAMOLE</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>09/11/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/025/001</DrugIDPK>
    <LicenceNumber>PA0237/025/001</LicenceNumber>
    <ProductName>APS DIPYRIDAMOLE</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>09/11/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/020/004</DrugIDPK>
    <LicenceNumber>PA0237/020/004</LicenceNumber>
    <ProductName>APS PROPRANOLOL</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>23/07/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/020/003</DrugIDPK>
    <LicenceNumber>PA0237/020/003</LicenceNumber>
    <ProductName>APS PROPRANOLOL</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>23/07/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/020/002</DrugIDPK>
    <LicenceNumber>PA0237/020/002</LicenceNumber>
    <ProductName>APS PROPRANOLOL</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>23/07/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/020/001</DrugIDPK>
    <LicenceNumber>PA0237/020/001</LicenceNumber>
    <ProductName>APS PROPRANOLOL</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>23/07/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/021/004</DrugIDPK>
    <LicenceNumber>PA0237/021/004</LicenceNumber>
    <ProductName>APSOLOX</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>27/01/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/021/003</DrugIDPK>
    <LicenceNumber>PA0237/021/003</LicenceNumber>
    <ProductName>APSOLOX</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>27/01/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/021/002</DrugIDPK>
    <LicenceNumber>PA0237/021/002</LicenceNumber>
    <ProductName>APSOLOX</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>27/01/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/021/001</DrugIDPK>
    <LicenceNumber>PA0237/021/001</LicenceNumber>
    <ProductName>APSOLOX</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>27/01/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22906/003/001</DrugIDPK>
    <LicenceNumber>PA22906/003/001</LicenceNumber>
    <ProductName>Aquasept Skin Cleanser 20mg/ml Cutaneous Solution</ProductName>
    <PAHolder>Ayrton Saunders (Ireland) Limited</PAHolder>
    <AuthorisedDate>22/04/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Triclosan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/01/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/016/001</DrugIDPK>
    <LicenceNumber>PA0037/016/001</LicenceNumber>
    <ProductName>AQUATAIN</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>25/08/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHOXYLATED STEARYL ALCOHOL</ActiveSubstance>
      <ActiveSubstance>GLYCEROL</ActiveSubstance>
      <ActiveSubstance>SORBITOL SOLUTION 70 %</ActiveSubstance>
      <ActiveSubstance>ISOPROPYL PALMITATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/07/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0484/018/001</DrugIDPK>
    <LicenceNumber>PA0484/018/001</LicenceNumber>
    <ProductName>AQUEOUS</ProductName>
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>15/10/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EMULSIFYING WAX</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/056/002</DrugIDPK>
    <LicenceNumber>PA0237/056/002</LicenceNumber>
    <ProductName>ARBRALENE</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>03/05/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/056/001</DrugIDPK>
    <LicenceNumber>PA0237/056/001</LicenceNumber>
    <ProductName>ARBRALENE</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>03/05/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/012/003</DrugIDPK>
    <LicenceNumber>DPR0465/012/003</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>21/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/01/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/012/004</DrugIDPK>
    <LicenceNumber>DPR0465/012/004</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>04/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/01/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1328/026/001</DrugIDPK>
    <LicenceNumber>DPR1328/026/001</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>03/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1328/026/002</DrugIDPK>
    <LicenceNumber>DPR1328/026/002</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>03/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1328/026/003</DrugIDPK>
    <LicenceNumber>DPR1328/026/003</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>03/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1328/026/004</DrugIDPK>
    <LicenceNumber>DPR1328/026/004</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>24/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1328/026/005</DrugIDPK>
    <LicenceNumber>DPR1328/026/005</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>24/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1328/026/006</DrugIDPK>
    <LicenceNumber>DPR1328/026/006</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>29/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/012/003</DrugIDPK>
    <LicenceNumber>DPR1392/012/003</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>12/02/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1447/002/001</DrugIDPK>
    <LicenceNumber>DPR1447/002/001</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>07/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1463/020/001</DrugIDPK>
    <LicenceNumber>DPR1463/020/001</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>15/07/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/06/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1463/020/002</DrugIDPK>
    <LicenceNumber>DPR1463/020/002</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>15/07/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/06/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1463/020/003</DrugIDPK>
    <LicenceNumber>DPR1463/020/003</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>08/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/06/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1473/033/001</DrugIDPK>
    <LicenceNumber>DPR1473/033/001</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/04/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1473/033/002</DrugIDPK>
    <LicenceNumber>DPR1473/033/002</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/04/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1500/016/001</DrugIDPK>
    <LicenceNumber>DPR1500/016/001</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>29/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1500/016/002</DrugIDPK>
    <LicenceNumber>DPR1500/016/002</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>29/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1500/016/003</DrugIDPK>
    <LicenceNumber>DPR1500/016/003</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>29/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1601/023/001</DrugIDPK>
    <LicenceNumber>DPR1601/023/001</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>04/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1601/023/002</DrugIDPK>
    <LicenceNumber>DPR1601/023/002</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>04/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1601/023/003</DrugIDPK>
    <LicenceNumber>DPR1601/023/003</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>04/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1633/009/001</DrugIDPK>
    <LicenceNumber>DPR1633/009/001</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>05/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/06/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1633/009/002</DrugIDPK>
    <LicenceNumber>DPR1633/009/002</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>05/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/06/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1633/009/003</DrugIDPK>
    <LicenceNumber>DPR1633/009/003</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>05/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/06/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/070/001</DrugIDPK>
    <LicenceNumber>PPA1500/070/001</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>17/12/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/070/002</DrugIDPK>
    <LicenceNumber>PPA1500/070/002</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>17/12/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/023/001</DrugIDPK>
    <LicenceNumber>PPA1659/023/001</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>15/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/023/002</DrugIDPK>
    <LicenceNumber>PPA1659/023/002</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>15/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/023/003</DrugIDPK>
    <LicenceNumber>PPA1659/023/003</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>15/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/023/004</DrugIDPK>
    <LicenceNumber>PPA1659/023/004</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>15/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1915/011/001</DrugIDPK>
    <LicenceNumber>PPA1915/011/001</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>Chemilines Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>02/08/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1915/011/002</DrugIDPK>
    <LicenceNumber>PPA1915/011/002</LicenceNumber>
    <ProductName>Arcoxia</ProductName>
    <PAHolder>Chemilines Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>02/08/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR0465/012/001</DrugIDPK>
    <LicenceNumber>DPR0465/012/001</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>10/10/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/01/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/012/002</DrugIDPK>
    <LicenceNumber>DPR0465/012/002</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>10/10/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/01/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1392/012/001</DrugIDPK>
    <LicenceNumber>DPR1392/012/001</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>23/08/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/012/002</DrugIDPK>
    <LicenceNumber>DPR1392/012/002</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>23/08/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/033/003</DrugIDPK>
    <LicenceNumber>DPR1473/033/003</LicenceNumber>
    <ProductName>ARCOXIA</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/04/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/176/003</DrugIDPK>
    <LicenceNumber>PPA0465/176/003</LicenceNumber>
    <InterchangeableListCode>IC0108-167-003</InterchangeableListCode>
    <ProductName>Arcoxia 120 mg film-coated tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>07/04/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/137/004</DrugIDPK>
    <LicenceNumber>PPA1151/137/004</LicenceNumber>
    <InterchangeableListCode>IC0108-167-003</InterchangeableListCode>
    <ProductName>Arcoxia 120 mg film-coated tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>08/04/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/080/004</DrugIDPK>
    <LicenceNumber>PPA1562/080/004</LicenceNumber>
    <InterchangeableListCode>IC0108-167-003</InterchangeableListCode>
    <ProductName>Arcoxia 120 mg film-coated tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>03/11/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/12/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1633/045/004</DrugIDPK>
    <LicenceNumber>PPA1633/045/004</LicenceNumber>
    <InterchangeableListCode>IC0108-167-003</InterchangeableListCode>
    <ProductName>Arcoxia 120 mg film-coated tablets</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>03/02/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/137/001</DrugIDPK>
    <LicenceNumber>PPA1151/137/001</LicenceNumber>
    <InterchangeableListCode>IC0108-033-003</InterchangeableListCode>
    <ProductName>Arcoxia 30 mg film-coated tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>06/08/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This authorisation permits the holder to parallel-distribute product marketed in Ireland under the product authorisation number PA1997/001/001.</SupplyComments>
    <WithdrawalDate>25/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/080/003</DrugIDPK>
    <LicenceNumber>PPA1562/080/003</LicenceNumber>
    <InterchangeableListCode>IC0108-033-003</InterchangeableListCode>
    <ProductName>Arcoxia 30 mg film-coated tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>24/09/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/12/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1633/045/001</DrugIDPK>
    <LicenceNumber>PPA1633/045/001</LicenceNumber>
    <InterchangeableListCode>IC0108-033-003</InterchangeableListCode>
    <ProductName>Arcoxia 30 mg film-coated tablets</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>22/07/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/137/002</DrugIDPK>
    <LicenceNumber>PPA1151/137/002</LicenceNumber>
    <InterchangeableListCode>IC0108-127-003</InterchangeableListCode>
    <ProductName>Arcoxia 60 mg film-coated tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>06/08/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/080/001</DrugIDPK>
    <LicenceNumber>PPA1562/080/001</LicenceNumber>
    <InterchangeableListCode>IC0108-127-003</InterchangeableListCode>
    <ProductName>Arcoxia 60 mg film-coated tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>01/06/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/12/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1633/045/002</DrugIDPK>
    <LicenceNumber>PPA1633/045/002</LicenceNumber>
    <InterchangeableListCode>IC0108-127-003</InterchangeableListCode>
    <ProductName>Arcoxia 60 mg film-coated tablets</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>04/05/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/043/001</DrugIDPK>
    <LicenceNumber>PPA1596/043/001</LicenceNumber>
    <ProductName>Arcoxia 60 mg Film-coated Tablets</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>08/04/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/176/002</DrugIDPK>
    <LicenceNumber>PPA0465/176/002</LicenceNumber>
    <InterchangeableListCode>IC0108-166-003</InterchangeableListCode>
    <ProductName>Arcoxia 90 mg film-coated tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>07/04/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/137/003</DrugIDPK>
    <LicenceNumber>PPA1151/137/003</LicenceNumber>
    <InterchangeableListCode>IC0108-166-003</InterchangeableListCode>
    <ProductName>Arcoxia 90 mg film-coated tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>28/06/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/080/002</DrugIDPK>
    <LicenceNumber>PPA1562/080/002</LicenceNumber>
    <InterchangeableListCode>IC0108-166-003</InterchangeableListCode>
    <ProductName>Arcoxia 90 mg film-coated tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>01/06/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/12/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1633/045/003</DrugIDPK>
    <LicenceNumber>PPA1633/045/003</LicenceNumber>
    <InterchangeableListCode>IC0108-166-003</InterchangeableListCode>
    <ProductName>Arcoxia 90 mg film-coated tablets</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>04/05/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/043/002</DrugIDPK>
    <LicenceNumber>PPA1596/043/002</LicenceNumber>
    <ProductName>Arcoxia 90 mg Film-coated Tablets</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>08/04/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1392/056/001</DrugIDPK>
    <LicenceNumber>DPR1392/056/001</LicenceNumber>
    <ProductName>Arcoxia Film Coated Tablets</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>11/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1392/056/002</DrugIDPK>
    <LicenceNumber>DPR1392/056/002</LicenceNumber>
    <ProductName>Arcoxia Film Coated Tablets</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>11/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1392/056/003</DrugIDPK>
    <LicenceNumber>DPR1392/056/003</LicenceNumber>
    <ProductName>Arcoxia Film Coated Tablets</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>11/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1596/022/001</DrugIDPK>
    <LicenceNumber>DPR1596/022/001</LicenceNumber>
    <ProductName>Arcoxia Film Coated Tablets</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>04/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1596/022/002</DrugIDPK>
    <LicenceNumber>DPR1596/022/002</LicenceNumber>
    <ProductName>Arcoxia Film Coated Tablets</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>04/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1596/022/003</DrugIDPK>
    <LicenceNumber>DPR1596/022/003</LicenceNumber>
    <ProductName>Arcoxia Film Coated Tablets</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>04/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etoricoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0818/002/001</DrugIDPK>
    <LicenceNumber>PA0818/002/001</LicenceNumber>
    <ProductName>ARDUAN</ProductName>
    <PAHolder>Medimpex (UK) Limited</PAHolder>
    <AuthorisedDate>13/11/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPECURONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0374/003/001</DrugIDPK>
    <LicenceNumber>PA0374/003/001</LicenceNumber>
    <ProductName>ARDUAN</ProductName>
    <PAHolder>Organon Teknika Ltd</PAHolder>
    <AuthorisedDate>13/11/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPECURONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0013/090/002</DrugIDPK>
    <LicenceNumber>PA0013/090/002</LicenceNumber>
    <ProductName>AREDIA</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>11/11/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pamidronate disodium pentahydrat</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/090/004</DrugIDPK>
    <LicenceNumber>PA0013/090/004</LicenceNumber>
    <ProductName>AREDIA</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>05/07/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pamidronate disodium pentahydrat</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0028/060/001</DrugIDPK>
    <LicenceNumber>PA0028/060/001</LicenceNumber>
    <ProductName>AREDIA</ProductName>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>21/08/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAMIDRONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/090/001</DrugIDPK>
    <LicenceNumber>PA0013/090/001</LicenceNumber>
    <ProductName>AREDIA DRY POWDER</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAMIDRONATE DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/090/003</DrugIDPK>
    <LicenceNumber>PA0013/090/003</LicenceNumber>
    <ProductName>AREDIA DRY POWDER</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>05/07/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PAMIDRONATE DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/03/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0855/015/002</DrugIDPK>
    <LicenceNumber>PA0855/015/002</LicenceNumber>
    <ProductName>ARELIX</ProductName>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>12/05/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIRETANIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/11/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0855/015/001</DrugIDPK>
    <LicenceNumber>PA0855/015/001</LicenceNumber>
    <ProductName>ARELIX</ProductName>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>13/12/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIRETANIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/11/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/030/003</DrugIDPK>
    <LicenceNumber>PA0540/030/003</LicenceNumber>
    <ProductName>Arelix 6mg Tablets</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>12/05/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Piretanide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/08/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0023/045/001</DrugIDPK>
    <LicenceNumber>PA0023/045/001</LicenceNumber>
    <ProductName>ARELIX-K</ProductName>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>19/10/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIRETANIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/10/624/001</DrugIDPK>
    <LicenceNumber>EU/1/10/624/001</LicenceNumber>
    <ProductName>Arepanrix</ProductName>
    <PAHolder>GlaxoSmithKline Biologicals S.A.</PAHolder>
    <AuthorisedDate>23/03/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension and Emulsion for emulsion for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/california/7/2009 (h1n1)v like strain (x-179a)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0050/046/001</DrugIDPK>
    <LicenceNumber>PA0050/046/001</LicenceNumber>
    <ProductName>ARFONAD</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETAPHAN CAMSILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR1149/003/001</DrugIDPK>
    <LicenceNumber>HOR1149/003/001</LicenceNumber>
    <ProductName>ARGENT. NIT.</ProductName>
    <PAHolder>A. Nelson &amp; Company Limited</PAHolder>
    <AuthorisedDate>29/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Infus/Pdr/Oral Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Argentum nitricum</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR0407/001/001</DrugIDPK>
    <LicenceNumber>HOR0407/001/001</LicenceNumber>
    <ProductName>Argentum nitricum (Argent. nit.)</ProductName>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>20/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Argentum nitricum</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/108/001</DrugIDPK>
    <LicenceNumber>PPA0465/108/001</LicenceNumber>
    <ProductName>Aricept</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>19/09/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/108/002</DrugIDPK>
    <LicenceNumber>PPA0465/108/002</LicenceNumber>
    <ProductName>Aricept</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>19/09/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/087/001</DrugIDPK>
    <LicenceNumber>PPA1328/087/001</LicenceNumber>
    <ProductName>Aricept</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>13/03/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/087/002</DrugIDPK>
    <LicenceNumber>PPA1328/087/002</LicenceNumber>
    <ProductName>Aricept</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>13/03/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/039/001</DrugIDPK>
    <LicenceNumber>PPA1500/039/001</LicenceNumber>
    <ProductName>Aricept</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>20/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/018/001</DrugIDPK>
    <LicenceNumber>PPA1562/018/001</LicenceNumber>
    <ProductName>Aricept</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>12/02/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/05/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/129/001</DrugIDPK>
    <LicenceNumber>PPA1562/129/001</LicenceNumber>
    <ProductName>Aricept</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>17/10/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/09/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/129/002</DrugIDPK>
    <LicenceNumber>PPA1562/129/002</LicenceNumber>
    <ProductName>Aricept</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>17/10/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/09/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/001/001</DrugIDPK>
    <LicenceNumber>PPA1659/001/001</LicenceNumber>
    <ProductName>Aricept</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/001/002</DrugIDPK>
    <LicenceNumber>PPA1659/001/002</LicenceNumber>
    <ProductName>Aricept</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/037/001</DrugIDPK>
    <LicenceNumber>PPA1151/037/001</LicenceNumber>
    <ProductName>ARICEPT</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>11/01/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/09/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/037/002</DrugIDPK>
    <LicenceNumber>PPA1151/037/002</LicenceNumber>
    <ProductName>ARICEPT</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>14/09/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/09/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/010/001</DrugIDPK>
    <LicenceNumber>PPA1447/010/001</LicenceNumber>
    <ProductName>ARICEPT</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>04/07/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/07/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/010/002</DrugIDPK>
    <LicenceNumber>PPA1447/010/002</LicenceNumber>
    <ProductName>ARICEPT</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>04/07/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/07/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/426/002</DrugIDPK>
    <LicenceNumber>PPA0465/426/002</LicenceNumber>
    <ProductName>ARICEPT 10 mg film coated tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>20/01/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/047/002</DrugIDPK>
    <LicenceNumber>PPA1596/047/002</LicenceNumber>
    <ProductName>Aricept 10mg Film-coated Tablets</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>23/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/426/001</DrugIDPK>
    <LicenceNumber>PPA0465/426/001</LicenceNumber>
    <ProductName>ARICEPT 5 mg film coated tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>20/01/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/047/001</DrugIDPK>
    <LicenceNumber>PPA1596/047/001</LicenceNumber>
    <ProductName>Aricept 5mg Film-coated Tablets</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>23/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/002/004</DrugIDPK>
    <LicenceNumber>PA0822/002/004</LicenceNumber>
    <InterchangeableListCode>IC0062-002-015</InterchangeableListCode>
    <ProductName>ARICEPT EVESS 10 mg orodispersible tablet</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>02/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/12/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/002/003</DrugIDPK>
    <LicenceNumber>PA0822/002/003</LicenceNumber>
    <InterchangeableListCode>IC0062-001-015</InterchangeableListCode>
    <ProductName>ARICEPT EVESS 5 mg orodispersible tablet</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>02/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/12/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/04/283/11-12</DrugIDPK>
    <LicenceNumber>EU/1/04/283/11-12</LicenceNumber>
    <InterchangeableListCode>IC0091-127-006</InterchangeableListCode>
    <ProductName>Ariclaim</ProductName>
    <PAHolder>Eli Lilly Nederland B.V.</PAHolder>
    <AuthorisedDate>14/12/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duloxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/07/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/04/283/1-6</DrugIDPK>
    <LicenceNumber>EU/1/04/283/1-6</LicenceNumber>
    <ProductName>Ariclaim</ProductName>
    <PAHolder>Eli Lilly Nederland B.V.</PAHolder>
    <AuthorisedDate>17/07/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duloxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/07/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/04/283/8-10</DrugIDPK>
    <LicenceNumber>EU/1/04/283/8-10</LicenceNumber>
    <InterchangeableListCode>IC0091-033-006</InterchangeableListCode>
    <ProductName>Ariclaim</ProductName>
    <PAHolder>Eli Lilly Nederland B.V.</PAHolder>
    <AuthorisedDate>14/12/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duloxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/07/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1001/004/001</DrugIDPK>
    <LicenceNumber>PA1001/004/001</LicenceNumber>
    <ProductName>ARILVAX YELLOW FEVER VACCINE LIVE B.P.</ProductName>
    <PAHolder>Chiron Vaccines Limited</PAHolder>
    <AuthorisedDate>02/12/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Susp for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>YELLOW FEVER VIRUS STRAIN 17D</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1392/009/001</DrugIDPK>
    <LicenceNumber>DPR1392/009/001</LicenceNumber>
    <ProductName>Arimidex</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>01/08/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrozole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/009/002</DrugIDPK>
    <LicenceNumber>DPR1392/009/002</LicenceNumber>
    <ProductName>Arimidex</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>29/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrozole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1328/155/001</DrugIDPK>
    <LicenceNumber>PPA1328/155/001</LicenceNumber>
    <ProductName>Arimidex</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>23/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/069/001</DrugIDPK>
    <LicenceNumber>PPA1500/069/001</LicenceNumber>
    <ProductName>Arimidex</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>29/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrozole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1633/031/001</DrugIDPK>
    <LicenceNumber>PPA1633/031/001</LicenceNumber>
    <InterchangeableListCode>IC0011-039-003</InterchangeableListCode>
    <ProductName>Arimidex</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>13/09/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/161/001</DrugIDPK>
    <LicenceNumber>PPA1151/161/001</LicenceNumber>
    <InterchangeableListCode>IC0011-039-003</InterchangeableListCode>
    <ProductName>Arimidex 1 mg film-coated tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>21/10/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrozole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/050/001</DrugIDPK>
    <LicenceNumber>PPA1596/050/001</LicenceNumber>
    <ProductName>Arimidex 1mg Film-coated Tablets</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>08/07/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anastrazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/034/001</DrugIDPK>
    <LicenceNumber>PA0749/034/001</LicenceNumber>
    <ProductName>Aripez</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>01/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/034/002</DrugIDPK>
    <LicenceNumber>PA0749/034/002</LicenceNumber>
    <ProductName>Aripez</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>01/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/034/003</DrugIDPK>
    <LicenceNumber>PA0749/034/003</LicenceNumber>
    <ProductName>Aripez</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>10/09/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/06/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/034/004</DrugIDPK>
    <LicenceNumber>PA0749/034/004</LicenceNumber>
    <ProductName>Aripez</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>10/09/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/06/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/099/004</DrugIDPK>
    <LicenceNumber>PA0577/099/004</LicenceNumber>
    <ProductName>Aripil Orotab 10 mg Orodispersible tablets</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>16/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/04/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/099/003</DrugIDPK>
    <LicenceNumber>PA0577/099/003</LicenceNumber>
    <ProductName>Aripil Orotab 5 mg Orodispersible tablets</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>16/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/04/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/240/001</DrugIDPK>
    <LicenceNumber>PA0281/240/001</LicenceNumber>
    <InterchangeableListCode>IC0092-047-019</InterchangeableListCode>
    <ProductName>Aripiprazole 1mg/ml oral solution</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>18/09/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aripiprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/026/002</DrugIDPK>
    <LicenceNumber>PA2315/026/002</LicenceNumber>
    <ProductName>Aripiprazole Accord Healthcare 10 mg tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>10/07/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aripiprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/026/003</DrugIDPK>
    <LicenceNumber>PA2315/026/003</LicenceNumber>
    <InterchangeableListCode>IC0092-032-056</InterchangeableListCode>
    <ProductName>Aripiprazole Accord Healthcare 15 mg tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>10/07/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aripiprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/026/004</DrugIDPK>
    <LicenceNumber>PA2315/026/004</LicenceNumber>
    <InterchangeableListCode>IC0092-033-056</InterchangeableListCode>
    <ProductName>Aripiprazole Accord Healthcare 30 mg tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>10/07/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aripiprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/026/001</DrugIDPK>
    <LicenceNumber>PA2315/026/001</LicenceNumber>
    <InterchangeableListCode>IC0092-001-002</InterchangeableListCode>
    <ProductName>Aripiprazole Accord Healthcare 5 mg tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>10/07/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aripiprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1050/026/001</DrugIDPK>
    <LicenceNumber>PA1050/026/001</LicenceNumber>
    <ProductName>Aripiprazole Milpharm</ProductName>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>26/06/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aripiprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/07/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1050/026/002</DrugIDPK>
    <LicenceNumber>PA1050/026/002</LicenceNumber>
    <ProductName>Aripiprazole Milpharm</ProductName>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>26/06/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aripiprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/07/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1050/026/003</DrugIDPK>
    <LicenceNumber>PA1050/026/003</LicenceNumber>
    <ProductName>Aripiprazole Milpharm</ProductName>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>26/06/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aripiprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/07/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1050/026/004</DrugIDPK>
    <LicenceNumber>PA1050/026/004</LicenceNumber>
    <ProductName>Aripiprazole Milpharm</ProductName>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>26/06/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aripiprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/07/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/058/003</DrugIDPK>
    <LicenceNumber>PA1339/058/003</LicenceNumber>
    <InterchangeableListCode>IC0092-002-056</InterchangeableListCode>
    <ProductName>Aripiprazole Wockhardt 10mg tablets</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>09/10/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aripiprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/058/004</DrugIDPK>
    <LicenceNumber>PA1339/058/004</LicenceNumber>
    <InterchangeableListCode>IC0092-032-056</InterchangeableListCode>
    <ProductName>Aripiprazole Wockhardt 15mg tablets</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>09/10/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aripiprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/058/005</DrugIDPK>
    <LicenceNumber>PA1339/058/005</LicenceNumber>
    <InterchangeableListCode>IC0092-033-056</InterchangeableListCode>
    <ProductName>Aripiprazole Wockhardt 30mg tablets</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>09/10/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aripiprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/058/002</DrugIDPK>
    <LicenceNumber>PA1339/058/002</LicenceNumber>
    <InterchangeableListCode>IC0092-001-002</InterchangeableListCode>
    <ProductName>Aripiprazole Wockhardt 5mg tablets</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>09/10/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aripiprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/017/002</DrugIDPK>
    <LicenceNumber>PA0549/017/002</LicenceNumber>
    <ProductName>Aristiga 10 mg/5 mg prolonged release tablet</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>10/03/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALOXONE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/017/003</DrugIDPK>
    <LicenceNumber>PA0549/017/003</LicenceNumber>
    <ProductName>Aristiga 20 mg/10mg prolonged release tablet</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>10/03/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NALOXONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/017/004</DrugIDPK>
    <LicenceNumber>PA0549/017/004</LicenceNumber>
    <ProductName>Aristiga 40 mg/20 mg prolonged release tablet</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>10/03/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALOXONE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/017/001</DrugIDPK>
    <LicenceNumber>PA0549/017/001</LicenceNumber>
    <ProductName>Aristiga 5 mg/2.5 mg prolonged release tablet</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>10/03/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NALOXONE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/002/002</DrugIDPK>
    <LicenceNumber>PA0037/002/002</LicenceNumber>
    <ProductName>ARISTOCORT A</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>17/02/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/02/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/002/001</DrugIDPK>
    <LicenceNumber>PA0037/002/001</LicenceNumber>
    <ProductName>ARISTOCORT A</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>17/02/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/02/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/036/001</DrugIDPK>
    <LicenceNumber>PA1063/036/001</LicenceNumber>
    <ProductName>Arizime</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>28/05/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/036/002</DrugIDPK>
    <LicenceNumber>PA1063/036/002</LicenceNumber>
    <ProductName>Arizime</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>28/05/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/114/002</DrugIDPK>
    <LicenceNumber>PA0577/114/002</LicenceNumber>
    <InterchangeableListCode>IC0007-002-038</InterchangeableListCode>
    <ProductName>Arkolamyl 10 mg Orodispersible Tablets</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>16/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Olanzapine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/07/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/114/003</DrugIDPK>
    <LicenceNumber>PA0577/114/003</LicenceNumber>
    <InterchangeableListCode>IC0007-032-038</InterchangeableListCode>
    <ProductName>Arkolamyl 15 mg Orodispersible Tablets</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>16/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Olanzapine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/07/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/114/004</DrugIDPK>
    <LicenceNumber>PA0577/114/004</LicenceNumber>
    <InterchangeableListCode>IC0007-003-038</InterchangeableListCode>
    <ProductName>Arkolamyl 20 mg Orodispersible Tablets</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>16/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Olanzapine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/07/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/114/001</DrugIDPK>
    <LicenceNumber>PA0577/114/001</LicenceNumber>
    <InterchangeableListCode>IC0007-001-038</InterchangeableListCode>
    <ProductName>Arkolamyl 5 mg Orodispersible Tablets</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>16/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Olanzapine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/07/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1450/001/001</DrugIDPK>
    <LicenceNumber>PA1450/001/001</LicenceNumber>
    <ProductName>Arkovox</ProductName>
    <PAHolder>Laboratoires ARKOPHARMA</PAHolder>
    <AuthorisedDate>10/01/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ivy leaf dry extract (hedera helix l.) (4-6:1) extraction solvent: ethanol 30% v/v</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/03/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0010/003/001</DrugIDPK>
    <LicenceNumber>PA0010/003/001</LicenceNumber>
    <ProductName>ARMODIAR</ProductName>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>09/09/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
      <ActiveSubstance>SORBITOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/06/1986</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0010/004/001</DrugIDPK>
    <LicenceNumber>PA0010/004/001</LicenceNumber>
    <ProductName>ARMODIAR WITH NEOMYCIN</ProductName>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>09/09/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>SORBITOL</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/11/1981</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1688/017/003</DrugIDPK>
    <LicenceNumber>PA1688/017/003</LicenceNumber>
    <ProductName>Armoneve 10 mg/5 mg prolonged-release tablets</ProductName>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>05/03/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>Naloxone hydrochloride dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/10/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1688/017/004</DrugIDPK>
    <LicenceNumber>PA1688/017/004</LicenceNumber>
    <ProductName>Armoneve 15 mg/7.5 mg prolonged-release tablets</ProductName>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>05/03/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>Naloxone hydrochloride dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>29/10/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1688/017/001</DrugIDPK>
    <LicenceNumber>PA1688/017/001</LicenceNumber>
    <ProductName>Armoneve 2.5 mg/1.25 mg prolonged-release tablets</ProductName>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>05/03/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>Naloxone hydrochloride dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>29/10/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1688/017/005</DrugIDPK>
    <LicenceNumber>PA1688/017/005</LicenceNumber>
    <ProductName>Armoneve 20 mg/10 mg prolonged-release tablets</ProductName>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>05/03/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>Naloxone hydrochloride dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>29/10/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1688/017/006</DrugIDPK>
    <LicenceNumber>PA1688/017/006</LicenceNumber>
    <ProductName>Armoneve 30 mg/15 mg prolonged-release tablets</ProductName>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>05/03/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>Naloxone hydrochloride dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>29/10/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1688/017/007</DrugIDPK>
    <LicenceNumber>PA1688/017/007</LicenceNumber>
    <ProductName>Armoneve 40 mg/20 mg prolonged-release tablets</ProductName>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>05/03/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>Naloxone hydrochloride dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>29/10/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1688/017/002</DrugIDPK>
    <LicenceNumber>PA1688/017/002</LicenceNumber>
    <ProductName>Armoneve 5 mg/2.5 mg prolonged-release tablets</ProductName>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>05/03/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>Naloxone hydrochloride dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>29/10/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR0407/014/001</DrugIDPK>
    <LicenceNumber>HOR0407/014/001</LicenceNumber>
    <ProductName>Arnica - Tablets</ProductName>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>11/06/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Arnica montana</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0407/001/001</DrugIDPK>
    <LicenceNumber>PA0407/001/001</LicenceNumber>
    <ProductName>Arnica Ointment</ProductName>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>04/11/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Arnica montana</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/042/001</DrugIDPK>
    <LicenceNumber>PPA1659/042/001</LicenceNumber>
    <ProductName>Aromasin</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>12/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Exemestane</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1841/001/001</DrugIDPK>
    <LicenceNumber>PPA1841/001/001</LicenceNumber>
    <ProductName>Aromasin</ProductName>
    <PAHolder>Haemato Pharm AG</PAHolder>
    <AuthorisedDate>30/11/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Exemestane</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/178/001</DrugIDPK>
    <LicenceNumber>PPA1151/178/001</LicenceNumber>
    <ProductName>Aromasin 25 mg coated tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>25/05/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Exemestane</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/155/001</DrugIDPK>
    <LicenceNumber>PPA1562/155/001</LicenceNumber>
    <ProductName>Aromasin 25 mg coated tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>17/04/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Exemestane</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/02/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1995/001/001</DrugIDPK>
    <LicenceNumber>PA1995/001/001</LicenceNumber>
    <ProductName>Arovi 10,000 IU (100 mg)/1 mL solution for injection in pre-filled syringe</ProductName>
    <PAHolder>Laboratorios Farmacéuticos ROVI, S.A.</PAHolder>
    <AuthorisedDate>27/07/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection in pre-filled syringe</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enoxaparin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1995/001/002</DrugIDPK>
    <LicenceNumber>PA1995/001/002</LicenceNumber>
    <ProductName>Arovi 2,000 IU (20 mg)/0.2 mL solution for injection in pre-filled syringe</ProductName>
    <PAHolder>Laboratorios Farmacéuticos ROVI, S.A.</PAHolder>
    <AuthorisedDate>27/07/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection in pre-filled syringe</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enoxaparin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1995/001/003</DrugIDPK>
    <LicenceNumber>PA1995/001/003</LicenceNumber>
    <ProductName>Arovi 4,000 IU (40 mg)/0.4 mL solution for injection in pre-filled syringe</ProductName>
    <PAHolder>Laboratorios Farmacéuticos ROVI, S.A.</PAHolder>
    <AuthorisedDate>27/07/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection in pre-filled syringe</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enoxaparin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1995/001/004</DrugIDPK>
    <LicenceNumber>PA1995/001/004</LicenceNumber>
    <ProductName>Arovi 6,000 IU (60 mg)/0.6 mL solution for injection in pre-filled syringe</ProductName>
    <PAHolder>Laboratorios Farmacéuticos ROVI, S.A.</PAHolder>
    <AuthorisedDate>27/07/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection in pre-filled syringe</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enoxaparin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1995/001/005</DrugIDPK>
    <LicenceNumber>PA1995/001/005</LicenceNumber>
    <ProductName>Arovi 8,000 IU (80 mg)/0.8 mL solution for injection in pre-filled syringe</ProductName>
    <PAHolder>Laboratorios Farmacéuticos ROVI, S.A.</PAHolder>
    <AuthorisedDate>27/07/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection in pre-filled syringe</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enoxaparin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0312/002/001</DrugIDPK>
    <LicenceNumber>PA0312/002/001</LicenceNumber>
    <ProductName>ARPICOLIN</ProductName>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>21/01/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCYCLIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/05/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0312/002/002</DrugIDPK>
    <LicenceNumber>PA0312/002/002</LicenceNumber>
    <ProductName>ARPICOLIN SYRUP</ProductName>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>21/01/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROCYCLIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/05/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0568/025/005</DrugIDPK>
    <LicenceNumber>PA0568/025/005</LicenceNumber>
    <ProductName>Arplexam 10mg/2.5mg/10mg film-coated tablets</ProductName>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>28/03/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Indapamide</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0568/025/004</DrugIDPK>
    <LicenceNumber>PA0568/025/004</LicenceNumber>
    <ProductName>Arplexam 10mg/2.5mg/5mg film-coated tablets</ProductName>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>28/03/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Indapamide</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0568/025/001</DrugIDPK>
    <LicenceNumber>PA0568/025/001</LicenceNumber>
    <ProductName>Arplexam 2.5mg/0.625mg/5mg film-coated tablets</ProductName>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>28/03/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Indapamide</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0568/025/003</DrugIDPK>
    <LicenceNumber>PA0568/025/003</LicenceNumber>
    <ProductName>Arplexam 5mg/1.25mg/10mg film-coated tablets</ProductName>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>28/03/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Indapamide</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0568/025/002</DrugIDPK>
    <LicenceNumber>PA0568/025/002</LicenceNumber>
    <ProductName>Arplexam 5mg/1.25mg/5mg film-coated tablets</ProductName>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>28/03/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Indapamide</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR1149/005/001</DrugIDPK>
    <LicenceNumber>HOR1149/005/001</LicenceNumber>
    <ProductName>ARSEN. ALB.</ProductName>
    <PAHolder>A. Nelson &amp; Company Limited</PAHolder>
    <AuthorisedDate>14/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Infus/Pdr/Oral Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acidum arsenicosum</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/20/1427/001-002</DrugIDPK>
    <LicenceNumber>EU/1/20/1427/001-002</LicenceNumber>
    <ProductName>Arsenic Trioxide Mylan</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Arsenic trioxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>14/04/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR1154/004/001</DrugIDPK>
    <LicenceNumber>HOR1154/004/001</LicenceNumber>
    <ProductName>ARSENICUM ALBUM</ProductName>
    <PAHolder>Helios Homeopathy Ltd</PAHolder>
    <AuthorisedDate>22/12/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not assigned</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Arsenicum album</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/06/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR0407/002/001</DrugIDPK>
    <LicenceNumber>HOR0407/002/001</LicenceNumber>
    <ProductName>Arsenicum album (Arsen. alb.)</ProductName>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>20/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Arsenicum album</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/050/001</DrugIDPK>
    <LicenceNumber>PA0037/050/001</LicenceNumber>
    <ProductName>Artane</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzhexol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/050/002</DrugIDPK>
    <LicenceNumber>PA0037/050/002</LicenceNumber>
    <ProductName>Artane</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzhexol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23176/023/001</DrugIDPK>
    <LicenceNumber>PPA23176/023/001</LicenceNumber>
    <ProductName>Artelac Preservative Free Single Dose Unit</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>31/01/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution in single-dose container</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Hypromellose</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/207/001</DrugIDPK>
    <LicenceNumber>PPA1151/207/001</LicenceNumber>
    <ProductName>Artelac Preservative Free Single Dose Unit</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>04/07/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Hypromellose</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/10/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/099/001</DrugIDPK>
    <LicenceNumber>PPA1463/099/001</LicenceNumber>
    <ProductName>Artelac Preservative Free Single Dose Unit 3.2 mg/ml Eye Drops Solution</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>17/10/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution in single-dose container</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Hypromellose</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/07/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0568/001/001</DrugIDPK>
    <LicenceNumber>PA0568/001/001</LicenceNumber>
    <ProductName>Artexal</ProductName>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>13/04/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tertatolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/07/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/066/001</DrugIDPK>
    <LicenceNumber>PA0037/066/001</LicenceNumber>
    <ProductName>ARTHITREX</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>10/06/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1521/001/001</DrugIDPK>
    <LicenceNumber>PA1521/001/001</LicenceNumber>
    <ProductName>Arthriaid</ProductName>
    <PAHolder>FMC Pharma Ltd</PAHolder>
    <AuthorisedDate>22/07/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glucosamine sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1521/001/002</DrugIDPK>
    <LicenceNumber>PA1521/001/002</LicenceNumber>
    <ProductName>Arthriaid</ProductName>
    <PAHolder>FMC Pharma Ltd</PAHolder>
    <AuthorisedDate>22/07/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glucosamine sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1521/001/003</DrugIDPK>
    <LicenceNumber>PA1521/001/003</LicenceNumber>
    <ProductName>Arthriaid</ProductName>
    <PAHolder>FMC Pharma Ltd</PAHolder>
    <AuthorisedDate>22/07/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glucosamine sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/149/004</DrugIDPK>
    <LicenceNumber>PA0126/149/004</LicenceNumber>
    <ProductName>Arthrimel Once Daily</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>13/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glucosamine sulphate sodium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/11/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0114/058/002</DrugIDPK>
    <LicenceNumber>PA0114/058/002</LicenceNumber>
    <ProductName>ARTHRIN</ProductName>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>25/09/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0114/058/001</DrugIDPK>
    <LicenceNumber>PA0114/058/001</LicenceNumber>
    <ProductName>ARTHRIN</ProductName>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>27/02/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NAPROXEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/163/001</DrugIDPK>
    <LicenceNumber>PPA1328/163/001</LicenceNumber>
    <ProductName>Arthrotec</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>17/02/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
      <ActiveSubstance>Misoprostol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/074/001</DrugIDPK>
    <LicenceNumber>PPA1500/074/001</LicenceNumber>
    <ProductName>Arthrotec</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>18/02/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
      <ActiveSubstance>Misoprostol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/035/001</DrugIDPK>
    <LicenceNumber>PPA1562/035/001</LicenceNumber>
    <ProductName>Arthrotec</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>15/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
      <ActiveSubstance>Misoprostol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/01/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/035/002</DrugIDPK>
    <LicenceNumber>PPA1562/035/002</LicenceNumber>
    <ProductName>Arthrotec</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>15/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
      <ActiveSubstance>Misoprostol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/01/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/040/001</DrugIDPK>
    <LicenceNumber>PPA1659/040/001</LicenceNumber>
    <ProductName>Arthrotec</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>12/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac</ActiveSubstance>
      <ActiveSubstance>Misoprostol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/199/001</DrugIDPK>
    <LicenceNumber>PPA1151/199/001</LicenceNumber>
    <InterchangeableListCode>IC0058-109-021</InterchangeableListCode>
    <ProductName>Arthrotec 50 modified-release tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>29/05/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
      <ActiveSubstance>Misoprostol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/199/002</DrugIDPK>
    <LicenceNumber>PPA1151/199/002</LicenceNumber>
    <InterchangeableListCode>IC0058-113-021</InterchangeableListCode>
    <ProductName>Arthrotec 75 modified-release tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>29/05/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Misoprostol</ActiveSubstance>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/179/001</DrugIDPK>
    <LicenceNumber>PPA1562/179/001</LicenceNumber>
    <InterchangeableListCode>IC0058-113-021</InterchangeableListCode>
    <ProductName>Arthrotec 75 modified-release tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>01/03/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Misoprostol</ActiveSubstance>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/04/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2115/003/001</DrugIDPK>
    <LicenceNumber>PA2115/003/001</LicenceNumber>
    <ProductName>Articaine hydrochloride/Epinephrine NewLine Pharma 40 mg/mL + 0.01 mg/mL, solution for injection</ProductName>
    <PAHolder>NewLine Pharma, S.L.</PAHolder>
    <AuthorisedDate>26/06/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Articaine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Adrenaline tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/131/002</DrugIDPK>
    <LicenceNumber>PA0167/131/002</LicenceNumber>
    <ProductName>ARTISS Powders and Solvent for Sealant</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>03/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for sealant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium chloride</ActiveSubstance>
      <ActiveSubstance>Aprotinin solution, bovine</ActiveSubstance>
      <ActiveSubstance>Human thrombin</ActiveSubstance>
      <ActiveSubstance>Human fibrinogen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0082/001/001</DrugIDPK>
    <LicenceNumber>PA0082/001/001</LicenceNumber>
    <ProductName>ARVIN</ProductName>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>27/01/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/12/1986</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/079/001</DrugIDPK>
    <LicenceNumber>PA0038/079/001</LicenceNumber>
    <ProductName>Arythmol</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Propafenone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/11/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/048/001</DrugIDPK>
    <LicenceNumber>PA1986/048/001</LicenceNumber>
    <ProductName>Arythmol</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>23/06/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Propafenone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/048/002</DrugIDPK>
    <LicenceNumber>PA1986/048/002</LicenceNumber>
    <ProductName>Arythmol</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>23/06/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Propafenone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/249/001</DrugIDPK>
    <LicenceNumber>PPA0465/249/001</LicenceNumber>
    <ProductName>Arythmol</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>01/04/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Propafenone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/049/001</DrugIDPK>
    <LicenceNumber>PPA1328/049/001</LicenceNumber>
    <ProductName>Arythmol</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>09/01/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Propafenone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/044/001</DrugIDPK>
    <LicenceNumber>PPA1562/044/001</LicenceNumber>
    <ProductName>Arythmol</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>04/02/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Propafenone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/079/004</DrugIDPK>
    <LicenceNumber>PA0038/079/004</LicenceNumber>
    <ProductName>Arythmol SR</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>10/03/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Propafenone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/079/005</DrugIDPK>
    <LicenceNumber>PA0038/079/005</LicenceNumber>
    <ProductName>Arythmol SR</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>10/03/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Propafenone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/079/006</DrugIDPK>
    <LicenceNumber>PA0038/079/006</LicenceNumber>
    <ProductName>Arythmol SR</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>10/03/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Propafenone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/10/625/1-2</DrugIDPK>
    <LicenceNumber>EU/1/10/625/1-2</LicenceNumber>
    <ProductName>Arzerra</ProductName>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>19/04/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ofatumumab</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>25/02/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0360/007/001</DrugIDPK>
    <LicenceNumber>PA0360/007/001</LicenceNumber>
    <ProductName>ASACOL</ProductName>
    <PAHolder>J B Tillotts Limited</PAHolder>
    <AuthorisedDate>29/06/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/107/001</DrugIDPK>
    <LicenceNumber>PPA1151/107/001</LicenceNumber>
    <ProductName>Asacolon 400 mg Gastro-resistant Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>19/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mesalazine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1097/008/001</DrugIDPK>
    <LicenceNumber>PPA1097/008/001</LicenceNumber>
    <ProductName>Asacolon 400 mg Gastro-Resistant Tablets</ProductName>
    <PAHolder>Lexon (UK) Ltd</PAHolder>
    <AuthorisedDate>19/05/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mesalazine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/09/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1097/008/002</DrugIDPK>
    <LicenceNumber>PPA1097/008/002</LicenceNumber>
    <ProductName>Asacolon 800 mg Gastro-resistant Tablets</ProductName>
    <PAHolder>Lexon (UK) Ltd</PAHolder>
    <AuthorisedDate>19/05/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mesalazine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/107/003</DrugIDPK>
    <LicenceNumber>PPA1151/107/003</LicenceNumber>
    <ProductName>Asacolon 800mg Gastro-resistant Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>01/07/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mesalazine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This authorisation permits the holder to parallel-distribute product marketed in Ireland under the product authorisation number PA2018/001/002.</SupplyComments>
    <WithdrawalDate>25/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/117/001</DrugIDPK>
    <LicenceNumber>PPA1463/117/001</LicenceNumber>
    <ProductName>Asacolon 800mg Gastro-resistant Tablets</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>06/04/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mesalazine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/013/001</DrugIDPK>
    <LicenceNumber>PA0007/013/001</LicenceNumber>
    <ProductName>ASASANTIN</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>22/05/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/04/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/013/002</DrugIDPK>
    <LicenceNumber>PA0007/013/002</LicenceNumber>
    <ProductName>Asasantin Retard</ProductName>
    <PAHolder>Boehringer Ingelheim Ltd</PAHolder>
    <AuthorisedDate>09/03/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dipyridamole</ActiveSubstance>
      <ActiveSubstance>Acetylsalicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/07/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/214/001</DrugIDPK>
    <LicenceNumber>PPA0465/214/001</LicenceNumber>
    <ProductName>Asasantin Retard</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>03/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dipyridamole</ActiveSubstance>
      <ActiveSubstance>Acetylsalicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/12/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/045/001</DrugIDPK>
    <LicenceNumber>PPA1500/045/001</LicenceNumber>
    <ProductName>Asasantin Retard</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>06/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dipyridamole</ActiveSubstance>
      <ActiveSubstance>Acetylsalicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/038/001</DrugIDPK>
    <LicenceNumber>PPA1562/038/001</LicenceNumber>
    <ProductName>Asasantin Retard</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>29/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dipyridamole</ActiveSubstance>
      <ActiveSubstance>Acetylsalicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/02/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1633/019/001</DrugIDPK>
    <LicenceNumber>PPA1633/019/001</LicenceNumber>
    <ProductName>Asasantin Retard</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>15/06/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dipyridamole</ActiveSubstance>
      <ActiveSubstance>Acetylsalicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/069/001</DrugIDPK>
    <LicenceNumber>PPA1328/069/001</LicenceNumber>
    <ProductName>ASASANTIN Retard 200 mg /25 mg Modified-release Ha</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>23/02/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dipyridamole</ActiveSubstance>
      <ActiveSubstance>Acetylsalicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/10/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/128/001</DrugIDPK>
    <LicenceNumber>PPA1151/128/001</LicenceNumber>
    <ProductName>Asasantin Retard 200mg/25mg Modified Release Hard Capsules</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>27/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aspirin</ActiveSubstance>
      <ActiveSubstance>Dipyridamole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/062/001</DrugIDPK>
    <LicenceNumber>PA0040/062/001</LicenceNumber>
    <ProductName>ASCABIOL</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzyl benzoate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1058/001/001</DrugIDPK>
    <LicenceNumber>PA1058/001/001</LicenceNumber>
    <ProductName>Ascal</ProductName>
    <PAHolder>MEDA Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>03/01/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carbasalate calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1332/011/001</DrugIDPK>
    <LicenceNumber>PA1332/011/001</LicenceNumber>
    <ProductName>Ascal</ProductName>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>13/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carbasalate calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/06/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1332/012/001</DrugIDPK>
    <LicenceNumber>PA1332/012/001</LicenceNumber>
    <ProductName>Ascal</ProductName>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>13/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carbasalate calcium</ActiveSubstance>
      <ActiveSubstance>Calcium</ActiveSubstance>
      <ActiveSubstance>Urea</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/04/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/008/001</DrugIDPK>
    <LicenceNumber>PA0408/008/001</LicenceNumber>
    <ProductName>Ascorbic Acid</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>20/09/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ascorbic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/09/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/024/001</DrugIDPK>
    <LicenceNumber>PA0468/024/001</LicenceNumber>
    <ProductName>ASCRIPTIN</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/04/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE DRIED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/091/001</DrugIDPK>
    <LicenceNumber>PA0040/091/001</LicenceNumber>
    <ProductName>ASCRIPTIN A/D</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>24/07/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/039/004</DrugIDPK>
    <LicenceNumber>PA0037/039/004</LicenceNumber>
    <ProductName>ASENDIS</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>08/09/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/09/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/039/003</DrugIDPK>
    <LicenceNumber>PA0037/039/003</LicenceNumber>
    <ProductName>ASENDIS</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>10/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/039/002</DrugIDPK>
    <LicenceNumber>PA0037/039/002</LicenceNumber>
    <ProductName>ASENDIS</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>10/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/039/001</DrugIDPK>
    <LicenceNumber>PA0037/039/001</LicenceNumber>
    <ProductName>ASENDIS</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>10/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/038/002</DrugIDPK>
    <LicenceNumber>PA0049/038/002</LicenceNumber>
    <ProductName>ASERBINE</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOIC ACID</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/038/001</DrugIDPK>
    <LicenceNumber>PA0049/038/001</LicenceNumber>
    <ProductName>ASERBINE</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOIC ACID</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0618/019/002</DrugIDPK>
    <LicenceNumber>PA0618/019/002</LicenceNumber>
    <ProductName>Asilone</ProductName>
    <PAHolder>Seton Products Ltd</PAHolder>
    <AuthorisedDate>11/10/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Light magnesium oxide</ActiveSubstance>
      <ActiveSubstance>Aluminium hydroxide</ActiveSubstance>
      <ActiveSubstance>Dimethicone 350 </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/10/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0618/019/003</DrugIDPK>
    <LicenceNumber>PA0618/019/003</LicenceNumber>
    <ProductName>Asilone Antacid</ProductName>
    <PAHolder>Seton Products Ltd</PAHolder>
    <AuthorisedDate>11/10/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aluminium hydroxide</ActiveSubstance>
      <ActiveSubstance>Dimethicone 350 </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/10/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0618/019/001</DrugIDPK>
    <LicenceNumber>PA0618/019/001</LicenceNumber>
    <ProductName>Asilone Antacid Liquid</ProductName>
    <PAHolder>Seton Products Ltd</PAHolder>
    <AuthorisedDate>11/10/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Light magnesium oxide</ActiveSubstance>
      <ActiveSubstance>Aluminium hydroxide</ActiveSubstance>
      <ActiveSubstance>Dimethicone 350 </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/10/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0082/030/001</DrugIDPK>
    <LicenceNumber>PA0082/030/001</LicenceNumber>
    <ProductName>ASILONE ORANGE</ProductName>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>05/10/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIMETICONE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL, DRIED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/08/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1638/010/002</DrugIDPK>
    <LicenceNumber>PA1638/010/002</LicenceNumber>
    <ProductName>Asmabec Clickhaler 100 micrograms.  Inhalation pow</ProductName>
    <PAHolder>RPH Pharmaceuticals AB</PAHolder>
    <AuthorisedDate>19/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1638/010/003</DrugIDPK>
    <LicenceNumber>PA1638/010/003</LicenceNumber>
    <ProductName>Asmabec Clickhaler 250 micrograms.  Inhalation pow</ProductName>
    <PAHolder>RPH Pharmaceuticals AB</PAHolder>
    <AuthorisedDate>19/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1638/010/001</DrugIDPK>
    <LicenceNumber>PA1638/010/001</LicenceNumber>
    <ProductName>Asmabec Clickhaler 50 micrograms.  Inhalation powd</ProductName>
    <PAHolder>RPH Pharmaceuticals AB</PAHolder>
    <AuthorisedDate>19/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1638/011/001</DrugIDPK>
    <LicenceNumber>PA1638/011/001</LicenceNumber>
    <ProductName>Asmasal Clickhaler</ProductName>
    <PAHolder>RPH Pharmaceuticals AB</PAHolder>
    <AuthorisedDate>27/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/023/001</DrugIDPK>
    <LicenceNumber>PA0237/023/001</LicenceNumber>
    <ProductName>ASMAVEN INHALER</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>10/06/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/142/001</DrugIDPK>
    <LicenceNumber>PA0077/142/001</LicenceNumber>
    <ProductName>ASPEGIC 100</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>24/07/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLATE LYSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/10/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/142/003</DrugIDPK>
    <LicenceNumber>PA0077/142/003</LicenceNumber>
    <ProductName>ASPEGIC 1000</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>24/07/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLATE LYSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/10/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/142/002</DrugIDPK>
    <LicenceNumber>PA0077/142/002</LicenceNumber>
    <ProductName>ASPEGIC 500</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>24/07/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLATE LYSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/10/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0291/001/001</DrugIDPK>
    <LicenceNumber>PA0291/001/001</LicenceNumber>
    <ProductName>ASPERCREME</ProductName>
    <PAHolder>Thompson Medical Co. Ltd</PAHolder>
    <AuthorisedDate>23/06/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>TROLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/06/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/025/001</DrugIDPK>
    <LicenceNumber>PA0073/025/001</LicenceNumber>
    <ProductName>Aspirin</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aspirin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0176/015/003</DrugIDPK>
    <LicenceNumber>PA0176/015/003</LicenceNumber>
    <ProductName>Aspirin</ProductName>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>27/08/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acetylsalicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/08/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0176/015/002</DrugIDPK>
    <LicenceNumber>PA0176/015/002</LicenceNumber>
    <ProductName>ASPIRIN</ProductName>
    <PAHolder>Accord-UK Ltd</PAHolder>
    <AuthorisedDate>27/08/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/08/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0063/005/001</DrugIDPK>
    <LicenceNumber>PA0063/005/001</LicenceNumber>
    <ProductName>ASPIRIN</ProductName>
    <PAHolder>Wigglesworth (1982) Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0688/002/001</DrugIDPK>
    <LicenceNumber>PA0688/002/001</LicenceNumber>
    <ProductName>Aspirin (Acetylsalicylic acid) Tablets 300 mg</ProductName>
    <PAHolder>Chanelle Medical Unlimited Company</PAHolder>
    <AuthorisedDate>16/09/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aspirin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>Retail sale through pharmacies only in blister packs containing not more than 50 dose units.</SupplyComments>
    <WithdrawalDate>14/05/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0258/006/001</DrugIDPK>
    <LicenceNumber>PA0258/006/001</LicenceNumber>
    <ProductName>ASPIRIN &amp; CODEINE</ProductName>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/05/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0063/008/001</DrugIDPK>
    <LicenceNumber>PA0063/008/001</LicenceNumber>
    <ProductName>ASPIRIN &amp; CODEINE</ProductName>
    <PAHolder>Wigglesworth (1982) Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/246/001</DrugIDPK>
    <LicenceNumber>PA0126/246/001</LicenceNumber>
    <ProductName>Aspirin 75mg gastro-resistant tablets</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>14/02/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acetyl salicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/04/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0465/057/001</DrugIDPK>
    <LicenceNumber>PA0465/057/001</LicenceNumber>
    <ProductName>Aspirin EC 300mg, gastro-resistant tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>17/07/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acetylsalicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>To provide prior to marketing, 3 months stability data of at least three batches to the IMB for review and marketing will not occur until this has been carried out. The commitment should include that the studies of those batches will continue to shelf life</SupplyComments>
    <WithdrawalDate>18/12/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/051/001</DrugIDPK>
    <LicenceNumber>PA0021/051/001</LicenceNumber>
    <ProductName>Aspirin Migraine</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>13/07/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acetylsalicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/07/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/247/001</DrugIDPK>
    <LicenceNumber>PA0711/247/001</LicenceNumber>
    <ProductName>Aspirin Rowex 75mg gastro-resistant tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>08/05/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acetylsalicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/091/003</DrugIDPK>
    <LicenceNumber>PA0077/091/003</LicenceNumber>
    <ProductName>ASPRIN</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>15/11/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/11/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/091/002</DrugIDPK>
    <LicenceNumber>PA0077/091/002</LicenceNumber>
    <ProductName>ASPRIN</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>15/11/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/11/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0063/007/001</DrugIDPK>
    <LicenceNumber>PA0063/007/001</LicenceNumber>
    <ProductName>ASPRIN JUNIOR</ProductName>
    <PAHolder>Wigglesworth (1982) Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/058/001</DrugIDPK>
    <LicenceNumber>PA0021/058/001</LicenceNumber>
    <ProductName>Aspro</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>01/07/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acetylsalicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/09/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/036/001</DrugIDPK>
    <LicenceNumber>PA1410/036/001</LicenceNumber>
    <ProductName>Aspro C Effervescent Tablets</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>24/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acetylsalicylic acid</ActiveSubstance>
      <ActiveSubstance>Ascorbic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments>General sale in blister packs containing not more than 24 unit dosage forms.    
Retail sale through pharmacies only in blister packs containing not more than 50 unit dosage forms.

The indications should be appropriate for self-diagnosis and self-treat</SupplyComments>
    <WithdrawalDate>26/08/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0032/003/002</DrugIDPK>
    <LicenceNumber>PA0032/003/002</LicenceNumber>
    <ProductName>ASPRO CLEAR</ProductName>
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>18/11/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0032/007/002</DrugIDPK>
    <LicenceNumber>PA0032/007/002</LicenceNumber>
    <ProductName>ASPRO EXTRA STRENGH</ProductName>
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>10/06/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/152/001</DrugIDPK>
    <LicenceNumber>PA0050/152/001</LicenceNumber>
    <ProductName>ASPRO TABLETS</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>01/04/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA1332/039/001</DrugIDPK>
    <LicenceNumber>PA1332/039/001</LicenceNumber>
    <ProductName>Astepro 1 mg/ml Nasal Spray, Solution</ProductName>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>05/10/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal spray, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Azelastine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/09/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/041/001</DrugIDPK>
    <LicenceNumber>PA0437/041/001</LicenceNumber>
    <ProductName>ASTRIX</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>28/04/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0997/001/001</DrugIDPK>
    <LicenceNumber>PA0997/001/001</LicenceNumber>
    <ProductName>AT 10 250 micrograms/ml Oral Drops, Solution</ProductName>
    <PAHolder>Intrapharm Laboratories Limited</PAHolder>
    <AuthorisedDate>26/03/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dihydrotachysterol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/02/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/030/005</DrugIDPK>
    <LicenceNumber>PA0970/030/005</LicenceNumber>
    <ProductName>Atacand</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>22/07/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/018/001</DrugIDPK>
    <LicenceNumber>PPA1328/018/001</LicenceNumber>
    <ProductName>Atacand</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>20/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/02/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/018/002</DrugIDPK>
    <LicenceNumber>PPA1328/018/002</LicenceNumber>
    <ProductName>Atacand</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>20/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/038/001</DrugIDPK>
    <LicenceNumber>PPA1447/038/001</LicenceNumber>
    <ProductName>Atacand</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>21/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/033/002</DrugIDPK>
    <LicenceNumber>PPA1500/033/002</LicenceNumber>
    <ProductName>Atacand</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>09/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1500/033/003</DrugIDPK>
    <LicenceNumber>PPA1500/033/003</LicenceNumber>
    <ProductName>Atacand</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>09/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1328/018/003</DrugIDPK>
    <LicenceNumber>PPA1328/018/003</LicenceNumber>
    <ProductName>ATACAND</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>06/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/109/001</DrugIDPK>
    <LicenceNumber>PPA1151/109/001</LicenceNumber>
    <InterchangeableListCode>IC0009-038-002</InterchangeableListCode>
    <ProductName>Atacand 16mg tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>19/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/030/001</DrugIDPK>
    <LicenceNumber>PA0970/030/001</LicenceNumber>
    <ProductName>Atacand 2 mg tablets</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>23/01/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/109/002</DrugIDPK>
    <LicenceNumber>PPA1151/109/002</LicenceNumber>
    <InterchangeableListCode>IC0009-008-002</InterchangeableListCode>
    <ProductName>Atacand 4 mg tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>12/10/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/116/003</DrugIDPK>
    <LicenceNumber>PPA0465/116/003</LicenceNumber>
    <InterchangeableListCode>IC0009-008-002</InterchangeableListCode>
    <ProductName>Atacand 4mg Tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>04/11/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This authorisation permits the holder to parallel-distribute only the product marketed in Ireland under the product authorisation PA 0970/030/002.</SupplyComments>
    <WithdrawalDate>31/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/031/003</DrugIDPK>
    <LicenceNumber>PPA1463/031/003</LicenceNumber>
    <InterchangeableListCode>IC0009-008-002</InterchangeableListCode>
    <ProductName>Atacand 4mg Tablets</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>09/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/109/003</DrugIDPK>
    <LicenceNumber>PPA1151/109/003</LicenceNumber>
    <InterchangeableListCode>IC0009-009-002</InterchangeableListCode>
    <ProductName>Atacand 8 mg tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>12/10/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/052/001</DrugIDPK>
    <LicenceNumber>PPA1328/052/001</LicenceNumber>
    <ProductName>Atacand Plus</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>13/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1915/006/001</DrugIDPK>
    <LicenceNumber>PPA1915/006/001</LicenceNumber>
    <InterchangeableListCode>IC0029-036-002</InterchangeableListCode>
    <ProductName>Atacand Plus</ProductName>
    <PAHolder>Chemilines Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>02/08/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1151/110/001</DrugIDPK>
    <LicenceNumber>PPA1151/110/001</LicenceNumber>
    <ProductName>Atacand Plus 16/12.5mg tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>19/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/10/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/003/002</DrugIDPK>
    <LicenceNumber>PA0019/003/002</LicenceNumber>
    <ProductName>ATARAX</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROXYZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/003/001</DrugIDPK>
    <LicenceNumber>PA0019/003/001</LicenceNumber>
    <ProductName>ATARAX</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROXYZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/016/001</DrugIDPK>
    <LicenceNumber>PA0047/016/001</LicenceNumber>
    <ProductName>ATASORB-N (SUSPENSION)</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPREOMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/193/001</DrugIDPK>
    <LicenceNumber>PA2315/193/001</LicenceNumber>
    <ProductName>Atazanavir Accord 200 mg hard capsules</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>28/06/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atazanavir sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>14/03/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/193/002</DrugIDPK>
    <LicenceNumber>PA2315/193/002</LicenceNumber>
    <ProductName>Atazanavir Accord 300 mg hard capsules</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>28/06/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atazanavir sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/03/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/19/1353/001</DrugIDPK>
    <LicenceNumber>EU/1/19/1353/001</LicenceNumber>
    <ProductName>Atazanavir Krka 150 mg Hard capsule</ProductName>
    <PAHolder>KRKA, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>25/03/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atazanavir sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/02/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/19/1353/002</DrugIDPK>
    <LicenceNumber>EU/1/19/1353/002</LicenceNumber>
    <ProductName>Atazanavir Krka 200 mg Hard capsule</ProductName>
    <PAHolder>KRKA, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>25/03/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atazanavir sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/02/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/19/1353/003-004</DrugIDPK>
    <LicenceNumber>EU/1/19/1353/003-004</LicenceNumber>
    <ProductName>Atazanavir Krka 300 mg Hard capsule</ProductName>
    <PAHolder>KRKA, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>25/03/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atazanavir sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/02/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/287/003</DrugIDPK>
    <LicenceNumber>PA0711/287/003</LicenceNumber>
    <ProductName>Atazanavir Rowex 200 mg Capsules hard</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>22/03/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atazanavir sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>08/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/028/001</DrugIDPK>
    <LicenceNumber>PA1986/028/001</LicenceNumber>
    <ProductName>Atazanavir Teva 150 mg Capsules, hard</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>30/10/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atazanavir sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/028/002</DrugIDPK>
    <LicenceNumber>PA1986/028/002</LicenceNumber>
    <ProductName>Atazanavir Teva 200 mg Capsules, hard</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>30/10/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atazanavir sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/028/003</DrugIDPK>
    <LicenceNumber>PA1986/028/003</LicenceNumber>
    <ProductName>Atazanavir Teva 300 mg Capsules, hard</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>30/10/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atazanavir sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/026/001</DrugIDPK>
    <LicenceNumber>PA0711/026/001</LicenceNumber>
    <ProductName>ATE-NIFE</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>18/09/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/055/001</DrugIDPK>
    <LicenceNumber>PPA1151/055/001</LicenceNumber>
    <ProductName>ATECOR</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>07/03/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/12/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/055/002</DrugIDPK>
    <LicenceNumber>PPA1151/055/002</LicenceNumber>
    <ProductName>ATECOR</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>07/03/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/12/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/055/003</DrugIDPK>
    <LicenceNumber>PPA1151/055/003</LicenceNumber>
    <ProductName>ATECOR</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>07/03/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/12/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/194/002</DrugIDPK>
    <LicenceNumber>PA0577/194/002</LicenceNumber>
    <ProductName>Atenetic 100 mg/25 mg Film-coated Tablets</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>21/05/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
      <ActiveSubstance>Chlorthalidone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/08/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/194/001</DrugIDPK>
    <LicenceNumber>PA0577/194/001</LicenceNumber>
    <ProductName>Atenetic 50 mg/12.5 mg Film-coated Tablets</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>21/05/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chlorthalidone</ActiveSubstance>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/08/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/019/002</DrugIDPK>
    <LicenceNumber>PA0405/019/002</LicenceNumber>
    <ProductName>Ateni 100mg Film-coated Tablets</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>09/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/019/001</DrugIDPK>
    <LicenceNumber>PA0405/019/001</LicenceNumber>
    <ProductName>Ateni 50mg Film-coated Tablets</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>09/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/117/001</DrugIDPK>
    <LicenceNumber>PA0073/117/001</LicenceNumber>
    <ProductName>Atenogen</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>22/03/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/08/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/117/002</DrugIDPK>
    <LicenceNumber>PA0073/117/002</LicenceNumber>
    <ProductName>Atenogen</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>22/03/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/08/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/117/003</DrugIDPK>
    <LicenceNumber>PA0073/117/003</LicenceNumber>
    <ProductName>Atenogen</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>03/10/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/08/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/152/001</DrugIDPK>
    <LicenceNumber>PA0073/152/001</LicenceNumber>
    <ProductName>Atenolol</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>18/10/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/10/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/152/002</DrugIDPK>
    <LicenceNumber>PA0073/152/002</LicenceNumber>
    <ProductName>Atenolol</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>18/10/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/10/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/047/001</DrugIDPK>
    <LicenceNumber>PA0282/047/001</LicenceNumber>
    <ProductName>Atenolol</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>21/01/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/047/002</DrugIDPK>
    <LicenceNumber>PA0282/047/002</LicenceNumber>
    <ProductName>Atenolol</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>21/01/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0476/005/002</DrugIDPK>
    <LicenceNumber>PA0476/005/002</LicenceNumber>
    <ProductName>Atenolol</ProductName>
    <PAHolder>Olinka (UK) Limited</PAHolder>
    <AuthorisedDate>16/08/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/08/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0476/005/003</DrugIDPK>
    <LicenceNumber>PA0476/005/003</LicenceNumber>
    <ProductName>Atenolol</ProductName>
    <PAHolder>Olinka (UK) Limited</PAHolder>
    <AuthorisedDate>16/08/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/08/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/004/002</DrugIDPK>
    <LicenceNumber>PA0577/004/002</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>17/11/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/11/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/004/001</DrugIDPK>
    <LicenceNumber>PA0577/004/001</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <PAHolder>McDermott Laboratories Ltd t/a Gerard Laboratories</PAHolder>
    <AuthorisedDate>17/11/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/11/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/010/002</DrugIDPK>
    <LicenceNumber>PA0436/010/002</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>19/04/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/010/001</DrugIDPK>
    <LicenceNumber>PA0436/010/001</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>19/04/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0365/022/002</DrugIDPK>
    <LicenceNumber>PA0365/022/002</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>15/12/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0365/022/001</DrugIDPK>
    <LicenceNumber>PA0365/022/001</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>15/12/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/028/002</DrugIDPK>
    <LicenceNumber>PA0237/028/002</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>08/12/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/028/001</DrugIDPK>
    <LicenceNumber>PA0237/028/001</LicenceNumber>
    <ProductName>ATENOLOL</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>08/12/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22697/004/001</DrugIDPK>
    <LicenceNumber>PA22697/004/001</LicenceNumber>
    <ProductName>Atenolol 5 mg/ml Oral Solution</ProductName>
    <PAHolder>Syri Pharma Limited t/a Thame Laboratories</PAHolder>
    <AuthorisedDate>09/10/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/01/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/105/003</DrugIDPK>
    <LicenceNumber>PA1380/105/003</LicenceNumber>
    <ProductName>Atenolol Actavis 100 mg film-coated tablets</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>25/03/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/105/001</DrugIDPK>
    <LicenceNumber>PA1380/105/001</LicenceNumber>
    <ProductName>Atenolol Actavis 25 mg film-coated tablets</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>25/03/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/105/002</DrugIDPK>
    <LicenceNumber>PA1380/105/002</LicenceNumber>
    <ProductName>Atenolol Actavis 50 mg film-coated tablets</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>25/03/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/047/003</DrugIDPK>
    <LicenceNumber>PA0282/047/003</LicenceNumber>
    <ProductName>ATENOLOL BP</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>08/01/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/08/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/038/001</DrugIDPK>
    <LicenceNumber>PA0016/038/001</LicenceNumber>
    <ProductName>ATGAM STERILE</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Equine gamma globulin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/001/001</DrugIDPK>
    <LicenceNumber>PA0022/001/001</LicenceNumber>
    <ProductName>ATIVAN</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lorazepam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/07/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/001/002</DrugIDPK>
    <LicenceNumber>PA0022/001/002</LicenceNumber>
    <ProductName>ATIVAN</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lorazepam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/07/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/001/004</DrugIDPK>
    <LicenceNumber>PA0022/001/004</LicenceNumber>
    <ProductName>ATIVAN</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lorazepam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/001/005</DrugIDPK>
    <LicenceNumber>PA0022/001/005</LicenceNumber>
    <ProductName>ATIVAN</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lorazepam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/186/007</DrugIDPK>
    <LicenceNumber>PA1380/186/007</LicenceNumber>
    <ProductName>Atomoxetine</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>11/03/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atomoxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/103/001</DrugIDPK>
    <LicenceNumber>PA0405/103/001</LicenceNumber>
    <ProductName>Atomoxetine 10 mg hard capsules</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>24/11/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atomoxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/103/007</DrugIDPK>
    <LicenceNumber>PA0405/103/007</LicenceNumber>
    <ProductName>Atomoxetine 100 mg hard capsules</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>24/11/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atomoxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/186/001</DrugIDPK>
    <LicenceNumber>PA1380/186/001</LicenceNumber>
    <ProductName>Atomoxetine 10mg Hard capsules</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>11/03/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atomoxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/103/002</DrugIDPK>
    <LicenceNumber>PA0405/103/002</LicenceNumber>
    <ProductName>Atomoxetine 18 mg hard capsules</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>24/11/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atomoxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/186/002</DrugIDPK>
    <LicenceNumber>PA1380/186/002</LicenceNumber>
    <ProductName>Atomoxetine 18 mg Hard capsules</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>11/03/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atomoxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/103/003</DrugIDPK>
    <LicenceNumber>PA0405/103/003</LicenceNumber>
    <ProductName>Atomoxetine 25 mg hard capsules</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>24/11/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atomoxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/186/003</DrugIDPK>
    <LicenceNumber>PA1380/186/003</LicenceNumber>
    <ProductName>Atomoxetine 25 mg Hard capsules</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>11/03/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atomoxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/103/004</DrugIDPK>
    <LicenceNumber>PA0405/103/004</LicenceNumber>
    <ProductName>Atomoxetine 40 mg hard capsules</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>24/11/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atomoxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/186/004</DrugIDPK>
    <LicenceNumber>PA1380/186/004</LicenceNumber>
    <ProductName>Atomoxetine 40mg Hard capsules</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>11/03/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atomoxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/103/005</DrugIDPK>
    <LicenceNumber>PA0405/103/005</LicenceNumber>
    <ProductName>Atomoxetine 60 mg hard capsules</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>24/11/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atomoxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/186/005</DrugIDPK>
    <LicenceNumber>PA1380/186/005</LicenceNumber>
    <ProductName>Atomoxetine 60mg Hard capsules</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>11/03/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atomoxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/103/006</DrugIDPK>
    <LicenceNumber>PA0405/103/006</LicenceNumber>
    <ProductName>Atomoxetine 80 mg hard capsules</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>24/11/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atomoxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/186/006</DrugIDPK>
    <LicenceNumber>PA1380/186/006</LicenceNumber>
    <ProductName>Atomoxetine 80mg Hard capsules</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>11/03/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atomoxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/192/001</DrugIDPK>
    <LicenceNumber>PA0711/192/001</LicenceNumber>
    <ProductName>Atorvastatin</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/192/002</DrugIDPK>
    <LicenceNumber>PA0711/192/002</LicenceNumber>
    <ProductName>Atorvastatin</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/192/003</DrugIDPK>
    <LicenceNumber>PA0711/192/003</LicenceNumber>
    <ProductName>Atorvastatin</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/042/002</DrugIDPK>
    <LicenceNumber>PA1063/042/002</LicenceNumber>
    <ProductName>Atorvastatin</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>07/05/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0565/051/001</DrugIDPK>
    <LicenceNumber>PPA0565/051/001</LicenceNumber>
    <InterchangeableListCode>IC0001-002-003</InterchangeableListCode>
    <ProductName>Atorvastatin</ProductName>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>07/11/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0565/051/002</DrugIDPK>
    <LicenceNumber>PPA0565/051/002</LicenceNumber>
    <InterchangeableListCode>IC0001-003-003</InterchangeableListCode>
    <ProductName>Atorvastatin</ProductName>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>07/11/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0565/051/003</DrugIDPK>
    <LicenceNumber>PPA0565/051/003</LicenceNumber>
    <InterchangeableListCode>IC0001-004-003</InterchangeableListCode>
    <ProductName>Atorvastatin</ProductName>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>07/11/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0565/051/004</DrugIDPK>
    <LicenceNumber>PPA0565/051/004</LicenceNumber>
    <InterchangeableListCode>IC0001-005-003</InterchangeableListCode>
    <ProductName>Atorvastatin</ProductName>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>07/11/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2261/004/001</DrugIDPK>
    <LicenceNumber>PA2261/004/001</LicenceNumber>
    <InterchangeableListCode>IC0001-002-003</InterchangeableListCode>
    <ProductName>Atorvastatin 10 mg film-coated tablets</ProductName>
    <PAHolder>Dexcel Pharma GmbH</PAHolder>
    <AuthorisedDate>05/12/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/06/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/042/001</DrugIDPK>
    <LicenceNumber>PA1063/042/001</LicenceNumber>
    <ProductName>Atorvastatin 10 mg film-coated tablets</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>07/05/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/007/001</DrugIDPK>
    <LicenceNumber>PA2315/007/001</LicenceNumber>
    <InterchangeableListCode>IC0001-002-003</InterchangeableListCode>
    <ProductName>Atorvastatin 10 mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>18/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin-calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/093/001</DrugIDPK>
    <LicenceNumber>PA0749/093/001</LicenceNumber>
    <ProductName>Atorvastatin 10 mg Film-coated Tablets</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>27/08/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0688/021/001</DrugIDPK>
    <LicenceNumber>PA0688/021/001</LicenceNumber>
    <ProductName>Atorvastatin 10mg film-coated tablets</ProductName>
    <PAHolder>Chanelle Medical Unlimited Company</PAHolder>
    <AuthorisedDate>29/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/09/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0565/061/001</DrugIDPK>
    <LicenceNumber>PPA0565/061/001</LicenceNumber>
    <ProductName>Atorvastatin 10mg film-coated tablets</ProductName>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>12/06/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2261/004/002</DrugIDPK>
    <LicenceNumber>PA2261/004/002</LicenceNumber>
    <InterchangeableListCode>IC0001-003-003</InterchangeableListCode>
    <ProductName>Atorvastatin 20 mg film-coated tablets</ProductName>
    <PAHolder>Dexcel Pharma GmbH</PAHolder>
    <AuthorisedDate>05/12/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/06/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/007/002</DrugIDPK>
    <LicenceNumber>PA2315/007/002</LicenceNumber>
    <InterchangeableListCode>IC0001-003-003</InterchangeableListCode>
    <ProductName>Atorvastatin 20 mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>18/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin-calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/093/002</DrugIDPK>
    <LicenceNumber>PA0749/093/002</LicenceNumber>
    <ProductName>Atorvastatin 20 mg Film-coated Tablets</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>27/08/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0688/021/002</DrugIDPK>
    <LicenceNumber>PA0688/021/002</LicenceNumber>
    <ProductName>Atorvastatin 20mg film-coated tablets</ProductName>
    <PAHolder>Chanelle Medical Unlimited Company</PAHolder>
    <AuthorisedDate>29/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/09/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0565/061/002</DrugIDPK>
    <LicenceNumber>PPA0565/061/002</LicenceNumber>
    <ProductName>Atorvastatin 20mg film-coated tablets</ProductName>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>12/06/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2261/004/003</DrugIDPK>
    <LicenceNumber>PA2261/004/003</LicenceNumber>
    <InterchangeableListCode>IC0001-004-003</InterchangeableListCode>
    <ProductName>Atorvastatin 40 mg film-coated tablets</ProductName>
    <PAHolder>Dexcel Pharma GmbH</PAHolder>
    <AuthorisedDate>05/12/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/06/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/042/003</DrugIDPK>
    <LicenceNumber>PA1063/042/003</LicenceNumber>
    <ProductName>Atorvastatin 40 mg film-coated tablets</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>07/05/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/007/003</DrugIDPK>
    <LicenceNumber>PA2315/007/003</LicenceNumber>
    <InterchangeableListCode>IC0001-004-003</InterchangeableListCode>
    <ProductName>Atorvastatin 40 mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>18/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin-calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/093/003</DrugIDPK>
    <LicenceNumber>PA0749/093/003</LicenceNumber>
    <ProductName>Atorvastatin 40 mg Film-coated Tablets</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>27/08/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0688/021/003</DrugIDPK>
    <LicenceNumber>PA0688/021/003</LicenceNumber>
    <ProductName>Atorvastatin 40mg film-coated tablets</ProductName>
    <PAHolder>Chanelle Medical Unlimited Company</PAHolder>
    <AuthorisedDate>29/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/09/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0565/061/003</DrugIDPK>
    <LicenceNumber>PPA0565/061/003</LicenceNumber>
    <ProductName>Atorvastatin 40mg film-coated tablets</ProductName>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>12/06/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/093/004</DrugIDPK>
    <LicenceNumber>PA0749/093/004</LicenceNumber>
    <ProductName>Atorvastatin 80 mg Film-coated Tablets</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>27/08/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/007/004</DrugIDPK>
    <LicenceNumber>PA2315/007/004</LicenceNumber>
    <InterchangeableListCode>IC0001-005-003</InterchangeableListCode>
    <ProductName>Atorvastatin 80 mg Film-coated Tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>07/09/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0688/021/004</DrugIDPK>
    <LicenceNumber>PA0688/021/004</LicenceNumber>
    <ProductName>Atorvastatin 80mg film-coated tablets</ProductName>
    <PAHolder>Chanelle Medical Unlimited Company</PAHolder>
    <AuthorisedDate>29/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/09/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0565/061/004</DrugIDPK>
    <LicenceNumber>PPA0565/061/004</LicenceNumber>
    <ProductName>Atorvastatin 80mg film-coated tablets</ProductName>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>12/06/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/023/001</DrugIDPK>
    <LicenceNumber>PA1380/023/001</LicenceNumber>
    <ProductName>Atorvastatin Actavis</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>11/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastastin magnesium trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/03/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/023/002</DrugIDPK>
    <LicenceNumber>PA1380/023/002</LicenceNumber>
    <ProductName>Atorvastatin Actavis</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>11/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastastin magnesium trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/03/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/023/003</DrugIDPK>
    <LicenceNumber>PA1380/023/003</LicenceNumber>
    <ProductName>Atorvastatin Actavis</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>11/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastastin magnesium trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/03/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0995/010/001</DrugIDPK>
    <LicenceNumber>PA0995/010/001</LicenceNumber>
    <ProductName>Atorvastatin Billev Pharma</ProductName>
    <PAHolder>Billev Pharma ApS</PAHolder>
    <AuthorisedDate>25/05/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/03/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0995/010/002</DrugIDPK>
    <LicenceNumber>PA0995/010/002</LicenceNumber>
    <ProductName>Atorvastatin Billev Pharma</ProductName>
    <PAHolder>Billev Pharma ApS</PAHolder>
    <AuthorisedDate>25/05/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/03/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0995/010/003</DrugIDPK>
    <LicenceNumber>PA0995/010/003</LicenceNumber>
    <ProductName>Atorvastatin Billev Pharma</ProductName>
    <PAHolder>Billev Pharma ApS</PAHolder>
    <AuthorisedDate>25/05/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/03/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1304/004/001</DrugIDPK>
    <LicenceNumber>PA1304/004/001</LicenceNumber>
    <ProductName>Atorvastatin Biokanol</ProductName>
    <PAHolder>Biokanol Pharma GmbH</PAHolder>
    <AuthorisedDate>20/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1304/004/002</DrugIDPK>
    <LicenceNumber>PA1304/004/002</LicenceNumber>
    <ProductName>Atorvastatin Biokanol</ProductName>
    <PAHolder>Biokanol Pharma GmbH</PAHolder>
    <AuthorisedDate>20/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1304/004/003</DrugIDPK>
    <LicenceNumber>PA1304/004/003</LicenceNumber>
    <ProductName>Atorvastatin Biokanol</ProductName>
    <PAHolder>Biokanol Pharma GmbH</PAHolder>
    <AuthorisedDate>20/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1304/004/004</DrugIDPK>
    <LicenceNumber>PA1304/004/004</LicenceNumber>
    <ProductName>Atorvastatin Biokanol</ProductName>
    <PAHolder>Biokanol Pharma GmbH</PAHolder>
    <AuthorisedDate>20/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1832/005/001</DrugIDPK>
    <LicenceNumber>PA1832/005/001</LicenceNumber>
    <ProductName>Atorvastatin Centrient 10 mg film-coated tablets</ProductName>
    <PAHolder>Centrient Pharmaceuticals Netherlands B.V</PAHolder>
    <AuthorisedDate>20/10/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/11/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1832/005/002</DrugIDPK>
    <LicenceNumber>PA1832/005/002</LicenceNumber>
    <InterchangeableListCode>IC0001-003-003</InterchangeableListCode>
    <ProductName>Atorvastatin Centrient 20 mg film-coated tablets</ProductName>
    <PAHolder>Centrient Pharmaceuticals Netherlands B.V</PAHolder>
    <AuthorisedDate>20/10/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/11/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1832/005/003</DrugIDPK>
    <LicenceNumber>PA1832/005/003</LicenceNumber>
    <InterchangeableListCode>IC0001-033-003</InterchangeableListCode>
    <ProductName>Atorvastatin Centrient 30 mg film-coated tablets</ProductName>
    <PAHolder>Centrient Pharmaceuticals Netherlands B.V</PAHolder>
    <AuthorisedDate>20/10/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/11/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1832/005/004</DrugIDPK>
    <LicenceNumber>PA1832/005/004</LicenceNumber>
    <InterchangeableListCode>IC0001-004-003</InterchangeableListCode>
    <ProductName>Atorvastatin Centrient 40 mg film-coated tablets</ProductName>
    <PAHolder>Centrient Pharmaceuticals Netherlands B.V</PAHolder>
    <AuthorisedDate>20/10/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/11/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1832/005/005</DrugIDPK>
    <LicenceNumber>PA1832/005/005</LicenceNumber>
    <InterchangeableListCode>IC0001-127-003</InterchangeableListCode>
    <ProductName>Atorvastatin Centrient 60 mg film-coated tablets</ProductName>
    <PAHolder>Centrient Pharmaceuticals Netherlands B.V</PAHolder>
    <AuthorisedDate>20/10/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/11/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1832/005/006</DrugIDPK>
    <LicenceNumber>PA1832/005/006</LicenceNumber>
    <InterchangeableListCode>IC0001-005-003</InterchangeableListCode>
    <ProductName>Atorvastatin Centrient 80 mg film-coated tablets</ProductName>
    <PAHolder>Centrient Pharmaceuticals Netherlands B.V</PAHolder>
    <AuthorisedDate>20/10/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/11/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA23172/001/001</DrugIDPK>
    <LicenceNumber>PA23172/001/001</LicenceNumber>
    <ProductName>Atorvastatin Genericon 10 mg film-coated tablets</ProductName>
    <PAHolder>Genericon Pharma Gesellschaft m.b.H.</PAHolder>
    <AuthorisedDate>28/10/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/12/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA23172/001/002</DrugIDPK>
    <LicenceNumber>PA23172/001/002</LicenceNumber>
    <ProductName>Atorvastatin Genericon 20 mg film-coated tablets</ProductName>
    <PAHolder>Genericon Pharma Gesellschaft m.b.H.</PAHolder>
    <AuthorisedDate>28/10/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/12/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA23172/001/003</DrugIDPK>
    <LicenceNumber>PA23172/001/003</LicenceNumber>
    <ProductName>Atorvastatin Genericon 40 mg film-coated tablets</ProductName>
    <PAHolder>Genericon Pharma Gesellschaft m.b.H.</PAHolder>
    <AuthorisedDate>28/10/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/12/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA23172/001/004</DrugIDPK>
    <LicenceNumber>PA23172/001/004</LicenceNumber>
    <ProductName>Atorvastatin Genericon 80 mg film-coated tablets</ProductName>
    <PAHolder>Genericon Pharma Gesellschaft m.b.H.</PAHolder>
    <AuthorisedDate>28/10/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/12/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1740/002/001</DrugIDPK>
    <LicenceNumber>PA1740/002/001</LicenceNumber>
    <InterchangeableListCode>IC0001-002-003</InterchangeableListCode>
    <ProductName>Atorvastatin Pfizer 10 mg film coated tablets</ProductName>
    <PAHolder>Pfizer Ireland Pharmaceuticals</PAHolder>
    <AuthorisedDate>28/10/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/11/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1740/002/002</DrugIDPK>
    <LicenceNumber>PA1740/002/002</LicenceNumber>
    <InterchangeableListCode>IC0001-003-003</InterchangeableListCode>
    <ProductName>Atorvastatin Pfizer 20 mg film coated tablets</ProductName>
    <PAHolder>Pfizer Ireland Pharmaceuticals</PAHolder>
    <AuthorisedDate>28/10/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/11/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1740/002/003</DrugIDPK>
    <LicenceNumber>PA1740/002/003</LicenceNumber>
    <InterchangeableListCode>IC0001-004-003</InterchangeableListCode>
    <ProductName>Atorvastatin Pfizer 40 mg film coated tablets</ProductName>
    <PAHolder>Pfizer Ireland Pharmaceuticals</PAHolder>
    <AuthorisedDate>28/10/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/11/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1740/002/004</DrugIDPK>
    <LicenceNumber>PA1740/002/004</LicenceNumber>
    <InterchangeableListCode>IC0001-005-003</InterchangeableListCode>
    <ProductName>Atorvastatin Pfizer 80 mg film coated tablets</ProductName>
    <PAHolder>Pfizer Ireland Pharmaceuticals</PAHolder>
    <AuthorisedDate>28/10/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/11/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1368/013/004</DrugIDPK>
    <LicenceNumber>PA1368/013/004</LicenceNumber>
    <InterchangeableListCode>IC0001-005-003</InterchangeableListCode>
    <ProductName>Atorvastatin Pharmathen</ProductName>
    <PAHolder>Pharmathen S.A.</PAHolder>
    <AuthorisedDate>03/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/09/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1368/013/001</DrugIDPK>
    <LicenceNumber>PA1368/013/001</LicenceNumber>
    <ProductName>Atorvastatin Pharmathen 10 mg film-coated tablets</ProductName>
    <PAHolder>Pharmathen S.A.</PAHolder>
    <AuthorisedDate>03/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1368/013/002</DrugIDPK>
    <LicenceNumber>PA1368/013/002</LicenceNumber>
    <ProductName>Atorvastatin Pharmathen 20 mg film-coated tablets</ProductName>
    <PAHolder>Pharmathen S.A.</PAHolder>
    <AuthorisedDate>03/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1368/013/003</DrugIDPK>
    <LicenceNumber>PA1368/013/003</LicenceNumber>
    <ProductName>Atorvastatin Pharmathen 40 mg film-coated tablets</ProductName>
    <PAHolder>Pharmathen S.A.</PAHolder>
    <AuthorisedDate>03/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atorvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/105/001</DrugIDPK>
    <LicenceNumber>PA2315/105/001</LicenceNumber>
    <ProductName>Atosiban Accord 37.5mg/5ml Concentrate for Solution for Infusion</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>11/09/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atosiban</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/105/002</DrugIDPK>
    <LicenceNumber>PA2315/105/002</LicenceNumber>
    <ProductName>Atosiban Accord 6.75 mg Solution for Injection in pre-filled syringe</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>27/07/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection in pre-filled syringe</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atosiban</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal products on “restricted” medical prescription, reserved for use in certain specialised areas (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>29/11/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/177/001</DrugIDPK>
    <LicenceNumber>PPA1562/177/001</LicenceNumber>
    <ProductName>Atovaquone/Proguanil Hydrochloride 250 mg/100 mg film-coated tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>02/09/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROGUANIL HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>Atovaquone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/02/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/042/001</DrugIDPK>
    <LicenceNumber>PA0437/042/001</LicenceNumber>
    <ProductName>ATRACURIUM BESILATE</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>15/06/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atracurium besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/042/002</DrugIDPK>
    <LicenceNumber>PA0437/042/002</LicenceNumber>
    <ProductName>ATRACURIUM BESILATE, vial</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>15/06/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atracurium besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/064/001</DrugIDPK>
    <LicenceNumber>PA0038/064/001</LicenceNumber>
    <ProductName>ATRACURIUM BESYLATE 2.5ML</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>27/06/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATRACURIUM BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/06/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/064/002</DrugIDPK>
    <LicenceNumber>PA0038/064/002</LicenceNumber>
    <ProductName>ATRACURIUM BESYLATE 5.0ML</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>27/06/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATRACURIUM BESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/06/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1501/001/001</DrugIDPK>
    <LicenceNumber>PA1501/001/001</LicenceNumber>
    <ProductName>Atridox 44 mg powder and solvent for gingival gel, pre-filled syringes</ProductName>
    <PAHolder>Tolmar GmbH</PAHolder>
    <AuthorisedDate>31/03/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for gingival gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/05/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/07/430/001</DrugIDPK>
    <LicenceNumber>EU/1/07/430/001</LicenceNumber>
    <ProductName>Atripla</ProductName>
    <PAHolder>Gilead Sciences Ireland UC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Efavirenz</ActiveSubstance>
      <ActiveSubstance>Emtricitabine</ActiveSubstance>
      <ActiveSubstance>Tenofovir disoproxil fumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal  product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>15/11/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0301/011/001</DrugIDPK>
    <LicenceNumber>PA0301/011/001</LicenceNumber>
    <ProductName>ATROFORD</ProductName>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>15/03/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/05/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0051/022/001</DrugIDPK>
    <LicenceNumber>PA0051/022/001</LicenceNumber>
    <ProductName>ATROMID-S</ProductName>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOFIBRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/032/001</DrugIDPK>
    <LicenceNumber>PA0006/032/001</LicenceNumber>
    <ProductName>ATROPINE</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>26/07/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/12/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0277/010/002</DrugIDPK>
    <LicenceNumber>PA0277/010/002</LicenceNumber>
    <ProductName>ATROPINE EYE OINTMENT</ProductName>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>19/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22684/002/001</DrugIDPK>
    <LicenceNumber>PA22684/002/001</LicenceNumber>
    <ProductName>Atropine Injection BP Minijet 100 microgram/ml Solution for Injection</ProductName>
    <PAHolder>DLRC Pharma Services Limited</PAHolder>
    <AuthorisedDate>08/09/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atropine sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/036/001</DrugIDPK>
    <LicenceNumber>PA0073/036/001</LicenceNumber>
    <ProductName>Atropine Sulfate 600 micrograms/ml Solution for Injection</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atropine sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/12/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0367/005/001</DrugIDPK>
    <LicenceNumber>PA0367/005/001</LicenceNumber>
    <ProductName>ATROPINE SULPHATE</ProductName>
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate>03/06/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0277/010/001</DrugIDPK>
    <LicenceNumber>PA0277/010/001</LicenceNumber>
    <ProductName>ATROPINE SULPHATE</ProductName>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>19/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0255/006/001</DrugIDPK>
    <LicenceNumber>PA0255/006/001</LicenceNumber>
    <ProductName>ATROPINE SULPHATE</ProductName>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>08/09/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/05/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/173/001</DrugIDPK>
    <LicenceNumber>PPA0465/173/001</LicenceNumber>
    <ProductName>Atrovent  UDV's</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>09/01/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ipratropium bromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/070/001</DrugIDPK>
    <LicenceNumber>PPA1328/070/001</LicenceNumber>
    <ProductName>Atrovent 250 UDVs</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>29/06/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ipratropium bromide monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/02/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/173/003</DrugIDPK>
    <LicenceNumber>PPA0465/173/003</LicenceNumber>
    <ProductName>Atrovent 250 UDVs 250 micrograms/ 1ml Nebuliser Solution</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>11/12/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ipratropium bromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/070/002</DrugIDPK>
    <LicenceNumber>PPA1328/070/002</LicenceNumber>
    <ProductName>Atrovent 500 UDVs</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>29/06/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ipratropium bromide monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/02/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/002/005</DrugIDPK>
    <LicenceNumber>PA0007/002/005</LicenceNumber>
    <ProductName>ATROVENT AEROCAPS</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>13/10/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation powder, hard capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/07/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/002/006</DrugIDPK>
    <LicenceNumber>PA0007/002/006</LicenceNumber>
    <ProductName>ATROVENT AUTOHALER</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>13/06/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/10/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/002/003</DrugIDPK>
    <LicenceNumber>PA0007/002/003</LicenceNumber>
    <ProductName>ATROVENT FORTE</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>13/03/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/03/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/002/001</DrugIDPK>
    <LicenceNumber>PA0007/002/001</LicenceNumber>
    <ProductName>ATROVENT METERED DOSE INHALER</ProductName>
    <PAHolder>Boehringer Ingelheim Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ipratropium bromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/002/002</DrugIDPK>
    <LicenceNumber>PA0007/002/002</LicenceNumber>
    <ProductName>ATROVENT NEBULISER</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>01/11/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/05/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/173/002</DrugIDPK>
    <LicenceNumber>PPA0465/173/002</LicenceNumber>
    <ProductName>Atrovent UDV's</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>09/01/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ipratropium bromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/06/355/1-3</DrugIDPK>
    <LicenceNumber>EU/1/06/355/1-3</LicenceNumber>
    <ProductName>ATryn</ProductName>
    <PAHolder>Laboratoire francais du Fractionnement et des Biotechnolgies</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Antithrombin alfa</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>20/02/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0544/022/001</DrugIDPK>
    <LicenceNumber>PA0544/022/001</LicenceNumber>
    <ProductName>Attenuvax Vaccine</ProductName>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Measles virus - enders edmonston strain</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1352/020/002</DrugIDPK>
    <LicenceNumber>PA1352/020/002</LicenceNumber>
    <ProductName>Audaval</ProductName>
    <PAHolder>Auden Mckenzie (Pharma Division) Ltd</PAHolder>
    <AuthorisedDate>05/10/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone valerate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/10/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1352/020/003</DrugIDPK>
    <LicenceNumber>PA1352/020/003</LicenceNumber>
    <ProductName>Audaval RD</ProductName>
    <PAHolder>Auden Mckenzie (Pharma Division) Ltd</PAHolder>
    <AuthorisedDate>05/10/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone valerate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/10/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1352/020/004</DrugIDPK>
    <LicenceNumber>PA1352/020/004</LicenceNumber>
    <ProductName>Audaval RD</ProductName>
    <PAHolder>Auden Mckenzie (Pharma Division) Ltd</PAHolder>
    <AuthorisedDate>05/10/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone valerate (as betamethasone)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/10/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/027/001</DrugIDPK>
    <LicenceNumber>PA0037/027/001</LicenceNumber>
    <ProductName>AUDICORT</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/01/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/062/001</DrugIDPK>
    <LicenceNumber>PA0037/062/001</LicenceNumber>
    <ProductName>AUDICORT EAR</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Triamcinolone acetonide</ActiveSubstance>
      <ActiveSubstance>Neomycin umdecylenate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/03/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/027/001</DrugIDPK>
    <LicenceNumber>PA0137/027/001</LicenceNumber>
    <ProductName>AUDICORT EAR SOLUTION</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/093/008</DrugIDPK>
    <LicenceNumber>PA1077/093/008</LicenceNumber>
    <ProductName>Augmentin</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>06/09/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/047/001A</DrugIDPK>
    <LicenceNumber>PPA0465/047/001A</LicenceNumber>
    <ProductName>Augmentin</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>14/04/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/089/001</DrugIDPK>
    <LicenceNumber>PPA1328/089/001</LicenceNumber>
    <ProductName>Augmentin</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>08/05/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/01/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/015/001</DrugIDPK>
    <LicenceNumber>PPA1463/015/001</LicenceNumber>
    <ProductName>Augmentin</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>17/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/05/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1473/015/001</DrugIDPK>
    <LicenceNumber>PPA1473/015/001</LicenceNumber>
    <ProductName>Augmentin</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>19/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Co-amoxiclav</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/10/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/009/001</DrugIDPK>
    <LicenceNumber>PPA1562/009/001</LicenceNumber>
    <ProductName>Augmentin</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>16/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/009/002</DrugIDPK>
    <LicenceNumber>PPA1562/009/002</LicenceNumber>
    <ProductName>Augmentin</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>17/08/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/015/001</DrugIDPK>
    <LicenceNumber>PPA1659/015/001</LicenceNumber>
    <ProductName>Augmentin</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/050/001</DrugIDPK>
    <LicenceNumber>PPA1328/050/001</LicenceNumber>
    <InterchangeableListCode>IC0037-073-014</InterchangeableListCode>
    <ProductName>AUGMENTIN</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>09/01/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/002/001</DrugIDPK>
    <LicenceNumber>PPA1447/002/001</LicenceNumber>
    <ProductName>AUGMENTIN</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>06/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/012/008</DrugIDPK>
    <LicenceNumber>PA0678/012/008</LicenceNumber>
    <ProductName>AUGMENTIN 1000/62.5 mg Prolonged Release Film-Coat</ProductName>
    <PAHolder>Haleon Ireland Limited</PAHolder>
    <AuthorisedDate>25/02/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>Amoxicillin sodium</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/10/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/050/001</DrugIDPK>
    <LicenceNumber>PPA1151/050/001</LicenceNumber>
    <InterchangeableListCode>IC0037-074-003</InterchangeableListCode>
    <ProductName>Augmentin 250 mg/125 mg Film-Coated Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>11/01/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/050/003</DrugIDPK>
    <LicenceNumber>PPA1151/050/003</LicenceNumber>
    <InterchangeableListCode>IC0037-073-003</InterchangeableListCode>
    <ProductName>Augmentin 500 mg/125 mg Film-coated Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>06/08/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23176/017/001</DrugIDPK>
    <LicenceNumber>PPA23176/017/001</LicenceNumber>
    <InterchangeableListCode>IC0037-072-003</InterchangeableListCode>
    <ProductName>Augmentin 875 mg/125 mg film-coated tablets</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>16/03/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/047/002</DrugIDPK>
    <LicenceNumber>PPA0465/047/002</LicenceNumber>
    <ProductName>Augmentin Duo</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>27/07/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1633/017/001</DrugIDPK>
    <LicenceNumber>PPA1633/017/001</LicenceNumber>
    <InterchangeableListCode>IC0037-076-034</InterchangeableListCode>
    <ProductName>Augmentin Duo</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>02/03/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/019/002</DrugIDPK>
    <LicenceNumber>PA1077/019/002</LicenceNumber>
    <InterchangeableListCode>IC0037-076-034</InterchangeableListCode>
    <ProductName>Augmentin DUO 400 mg/57 mg /5 ml Powder for Oral Suspension</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>19/02/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/04/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/019/001</DrugIDPK>
    <LicenceNumber>PA1077/019/001</LicenceNumber>
    <ProductName>Augmentin Duo Sachets</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/03/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/093/009</DrugIDPK>
    <LicenceNumber>PA1077/093/009</LicenceNumber>
    <ProductName>Augmentin ES</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>10/11/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/01/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/093/002</DrugIDPK>
    <LicenceNumber>PA1077/093/002</LicenceNumber>
    <ProductName>Augmentin Intravenous 1000mg/200mg powder for solution for injection or infusion</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/07/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/093/001</DrugIDPK>
    <LicenceNumber>PA1077/093/001</LicenceNumber>
    <ProductName>Augmentin Intravenous 500mg/100mg powder for solution for injection or infusion</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/07/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin sodium</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/093/003</DrugIDPK>
    <LicenceNumber>PA1077/093/003</LicenceNumber>
    <ProductName>AUGMENTIN JUNIOR</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>28/07/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/07/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/035/004</DrugIDPK>
    <LicenceNumber>PA0049/035/004</LicenceNumber>
    <ProductName>AUGMENTIN JUNIOR</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>28/07/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/035/003</DrugIDPK>
    <LicenceNumber>PA0049/035/003</LicenceNumber>
    <ProductName>AUGMENTIN JUNIOR</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>28/07/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/093/006</DrugIDPK>
    <LicenceNumber>PA1077/093/006</LicenceNumber>
    <ProductName>Augmentin Junior 125mg/62.5mg per 5ml Powder for Oral Suspension</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>28/07/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/093/005</DrugIDPK>
    <LicenceNumber>PA1077/093/005</LicenceNumber>
    <ProductName>AUGMENTIN PAEDIATRIC</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>28/07/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/07/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/035/008</DrugIDPK>
    <LicenceNumber>PA0049/035/008</LicenceNumber>
    <ProductName>AUGMENTIN PAEDIATRIC</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>28/07/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLAVULANIC ACID</ActiveSubstance>
      <ActiveSubstance>AMOXICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/284/001</DrugIDPK>
    <LicenceNumber>PPA0465/284/001</LicenceNumber>
    <InterchangeableListCode>IC0037-076-034</InterchangeableListCode>
    <ProductName>Augmentin-Duo</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>05/04/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/050/002</DrugIDPK>
    <LicenceNumber>PPA1328/050/002</LicenceNumber>
    <ProductName>Augmentin-Duo</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>11/07/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/015/002</DrugIDPK>
    <LicenceNumber>PPA1463/015/002</LicenceNumber>
    <ProductName>Augmentin-Duo</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>11/05/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/02/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/050/002</DrugIDPK>
    <LicenceNumber>PPA1151/050/002</LicenceNumber>
    <InterchangeableListCode>IC0037-076-034</InterchangeableListCode>
    <ProductName>Augmentin-Duo 400 mg/57 mg/5 ml Powder for Oral Suspension</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>17/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0294/018/003</DrugIDPK>
    <LicenceNumber>PA0294/018/003</LicenceNumber>
    <ProductName>Aulin</ProductName>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>10/12/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nimesulide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/11/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/110/001A</DrugIDPK>
    <LicenceNumber>PPA0465/110/001A</LicenceNumber>
    <ProductName>AULIN</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>20/01/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nimesulide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/051/001</DrugIDPK>
    <LicenceNumber>PPA1328/051/001</LicenceNumber>
    <ProductName>Aulin 100mg Granules</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>01/12/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nimesulide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/10/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/051/002</DrugIDPK>
    <LicenceNumber>PPA1328/051/002</LicenceNumber>
    <ProductName>Aulin 100mg Tablets</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>01/12/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nimesulide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/10/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0018/007/001</DrugIDPK>
    <LicenceNumber>PA0018/007/001</LicenceNumber>
    <ProductName>AURALGICIN</ProductName>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENAZONE</ActiveSubstance>
      <ActiveSubstance>EPHEDRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0137/028/001</DrugIDPK>
    <LicenceNumber>PA0137/028/001</LicenceNumber>
    <ProductName>AURECORT OINTMENT</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORTETRACYCLINE</ActiveSubstance>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/028/002</DrugIDPK>
    <LicenceNumber>PA0037/028/002</LicenceNumber>
    <ProductName>AUREOCORT</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/028/001</DrugIDPK>
    <LicenceNumber>PA0037/028/001</LicenceNumber>
    <ProductName>AUREOCORT</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORTETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>TRIAMCINOLONE ACETONIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/05/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/012/001</DrugIDPK>
    <LicenceNumber>PA0137/012/001</LicenceNumber>
    <ProductName>AUREOMYCIN</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/012/003</DrugIDPK>
    <LicenceNumber>PA0037/012/003</LicenceNumber>
    <ProductName>AUREOMYCIN</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>05/07/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORTETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/06/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/012/002</DrugIDPK>
    <LicenceNumber>PA0037/012/002</LicenceNumber>
    <ProductName>AUREOMYCIN</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORTETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/012/001</DrugIDPK>
    <LicenceNumber>PA0037/012/001</LicenceNumber>
    <ProductName>AUREOMYCIN</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORTETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/012/002</DrugIDPK>
    <LicenceNumber>PA0137/012/002</LicenceNumber>
    <ProductName>AUREOMYCIN OPHTHALMIC</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/06/349/01</DrugIDPK>
    <LicenceNumber>EU/1/06/349/01</LicenceNumber>
    <ProductName>Avaglim</ProductName>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>27/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosiglitazone</ActiveSubstance>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/08/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/06/349/02</DrugIDPK>
    <LicenceNumber>EU/1/06/349/02</LicenceNumber>
    <ProductName>Avaglim</ProductName>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>27/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosiglitazone</ActiveSubstance>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/08/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/06/349/03</DrugIDPK>
    <LicenceNumber>EU/1/06/349/03</LicenceNumber>
    <ProductName>Avaglim</ProductName>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>27/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosiglitazone</ActiveSubstance>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/08/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/06/349/04</DrugIDPK>
    <LicenceNumber>EU/1/06/349/04</LicenceNumber>
    <ProductName>Avaglim</ProductName>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>27/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
      <ActiveSubstance>Rosiglitazone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/08/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/06/349/05</DrugIDPK>
    <LicenceNumber>EU/1/06/349/05</LicenceNumber>
    <ProductName>Avaglim</ProductName>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>27/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosiglitazone</ActiveSubstance>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/08/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/06/349/06</DrugIDPK>
    <LicenceNumber>EU/1/06/349/06</LicenceNumber>
    <ProductName>Avaglim</ProductName>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>27/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosiglitazone</ActiveSubstance>
      <ActiveSubstance>Glimepiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/08/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/03/258/10-X</DrugIDPK>
    <LicenceNumber>EU/1/03/258/10-X</LicenceNumber>
    <ProductName>AVANDAMET</ProductName>
    <PAHolder>SmithKline Beecham Plc</PAHolder>
    <AuthorisedDate>02/09/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosiglitazone</ActiveSubstance>
      <ActiveSubstance>Metformin Hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1328/144/001</DrugIDPK>
    <LicenceNumber>PPA1328/144/001</LicenceNumber>
    <ProductName>Avelox</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>18/02/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Moxifloxacin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/087/001</DrugIDPK>
    <LicenceNumber>PPA1562/087/001</LicenceNumber>
    <ProductName>Avelox</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>24/09/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Moxifloxacin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/158/001</DrugIDPK>
    <LicenceNumber>PPA1562/158/001</LicenceNumber>
    <ProductName>Avelox</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>31/07/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Moxifloxacin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/06/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/027/002</DrugIDPK>
    <LicenceNumber>PA1410/027/002</LicenceNumber>
    <ProductName>AVELOX</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>02/11/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Moxifloxacin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/027/003</DrugIDPK>
    <LicenceNumber>PA1410/027/003</LicenceNumber>
    <ProductName>Avelox 400 mg/250 ml solution for infusion</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>04/04/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Moxifloxacin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/027/001</DrugIDPK>
    <LicenceNumber>PA1410/027/001</LicenceNumber>
    <ProductName>Avelox 400 mg film-coated tablets</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>10/12/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Moxifloxacin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1097/025/001</DrugIDPK>
    <LicenceNumber>PPA1097/025/001</LicenceNumber>
    <ProductName>Avelox 400 mg film-coated tablets</ProductName>
    <PAHolder>Lexon (UK) Ltd</PAHolder>
    <AuthorisedDate>21/07/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Moxifloxacin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/10/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/118/001</DrugIDPK>
    <LicenceNumber>PPA1463/118/001</LicenceNumber>
    <ProductName>Avelox 400 mg film-coated tablets</ProductName>
    <PAHolder>IMED Healthcare Ltd.,</PAHolder>
    <AuthorisedDate>16/03/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Moxifloxacin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/06/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0407/003/001</DrugIDPK>
    <LicenceNumber>PA0407/003/001</LicenceNumber>
    <ProductName>Avena Sativa Comp.</ProductName>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>11/10/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Humulus lupulus</ActiveSubstance>
      <ActiveSubstance>Avena sativa</ActiveSubstance>
      <ActiveSubstance>Passiflora incarnata</ActiveSubstance>
      <ActiveSubstance>Valeriana officinalis</ActiveSubstance>
      <ActiveSubstance>Coffee prepared</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>TR2309/012/001</DrugIDPK>
    <LicenceNumber>TR2309/012/001</LicenceNumber>
    <ProductName>AvenaCalm Avena sativa oral drops</ProductName>
    <PAHolder>A.Vogel Ireland Limited</PAHolder>
    <AuthorisedDate>01/07/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral drops, solution</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/025/003</DrugIDPK>
    <LicenceNumber>PA0047/025/003</LicenceNumber>
    <ProductName>AVENTYL</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORTRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/025/002</DrugIDPK>
    <LicenceNumber>PA0047/025/002</LicenceNumber>
    <ProductName>AVENTYL</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORTRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/025/001</DrugIDPK>
    <LicenceNumber>PA0047/025/001</LicenceNumber>
    <ProductName>AVENTYL</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORTRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/029/001</DrugIDPK>
    <LicenceNumber>PA0970/029/001</LicenceNumber>
    <ProductName>Avloclor Tablets 250 mg</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>01/04/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chloroquine phosphate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0051/008/001</DrugIDPK>
    <LicenceNumber>PA0051/008/001</LicenceNumber>
    <ProductName>AVLOSULFON</ProductName>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DAPSONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/01/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/134/001</DrugIDPK>
    <LicenceNumber>PPA1328/134/001</LicenceNumber>
    <ProductName>Avodart</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>12/02/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dutasteride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1473/046/001</DrugIDPK>
    <LicenceNumber>PPA1473/046/001</LicenceNumber>
    <ProductName>Avodart</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>16/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dutasteride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/048/001</DrugIDPK>
    <LicenceNumber>PPA1500/048/001</LicenceNumber>
    <ProductName>Avodart</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>19/02/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dutasteride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/082/001</DrugIDPK>
    <LicenceNumber>PPA1562/082/001</LicenceNumber>
    <ProductName>Avodart</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>20/07/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dutasteride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/131/001</DrugIDPK>
    <LicenceNumber>PPA1562/131/001</LicenceNumber>
    <ProductName>Avodart 0.5 mg soft capsules</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>17/10/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dutasteride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This authorisation permits the holder to parallel-distribute product marketed in Ireland under the product authorisation number PA1077/104/001.</SupplyComments>
    <WithdrawalDate>16/02/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/002/001</DrugIDPK>
    <LicenceNumber>PPA1596/002/001</LicenceNumber>
    <ProductName>Avodart 0.5mg soft capsules</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>30/04/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dutasteride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/038/001</DrugIDPK>
    <LicenceNumber>PPA1463/038/001</LicenceNumber>
    <ProductName>Avodart 0.5mg Soft Capsules</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>25/06/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dutasteride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0903/002/001</DrugIDPK>
    <LicenceNumber>PA0903/002/001</LicenceNumber>
    <ProductName>Avomine</ProductName>
    <PAHolder>Manx Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Promethazine teoclate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/033/001</DrugIDPK>
    <LicenceNumber>EU/1/97/033/001</LicenceNumber>
    <ProductName>Avonex</ProductName>
    <PAHolder>Biogen Idec Ltd</PAHolder>
    <AuthorisedDate>13/03/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Interferon beta - 1a</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/033/002</DrugIDPK>
    <LicenceNumber>EU/1/97/033/002</LicenceNumber>
    <ProductName>Avonex</ProductName>
    <PAHolder>Biogen Netherlands B.V.</PAHolder>
    <AuthorisedDate>22/01/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Interferon beta - 1a</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>30/06/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/063/001</DrugIDPK>
    <LicenceNumber>PA0970/063/001</LicenceNumber>
    <ProductName>Axanum</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>31/08/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acetylsalicylic acid</ActiveSubstance>
      <ActiveSubstance>Esomeprazole magnesium trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1226/004/001</DrugIDPK>
    <LicenceNumber>PA1226/004/001</LicenceNumber>
    <ProductName>AXID</ProductName>
    <PAHolder>Flynn Pharma Limited</PAHolder>
    <AuthorisedDate>12/08/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nizatidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1226/004/002</DrugIDPK>
    <LicenceNumber>PA1226/004/002</LicenceNumber>
    <ProductName>AXID</ProductName>
    <PAHolder>Flynn Pharma Limited</PAHolder>
    <AuthorisedDate>12/08/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nizatidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/11/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/071/001</DrugIDPK>
    <LicenceNumber>PPA1328/071/001</LicenceNumber>
    <ProductName>AXID</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>18/05/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nizatidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/01/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0172/027/001</DrugIDPK>
    <LicenceNumber>PA0172/027/001</LicenceNumber>
    <ProductName>Axid AP</ProductName>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nizatidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/03/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/213/001</DrugIDPK>
    <LicenceNumber>PA0749/213/001</LicenceNumber>
    <ProductName>Axympa 180 mg Gastro-resistant Tablets</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>13/09/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mycophenolic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>05/07/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/213/002</DrugIDPK>
    <LicenceNumber>PA0749/213/002</LicenceNumber>
    <ProductName>Axympa 360 mg Gastro-resistant Tablets</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>13/09/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mycophenolic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>05/07/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0501/001/001</DrugIDPK>
    <LicenceNumber>PA0501/001/001</LicenceNumber>
    <ProductName>Ayrtons Antiseptic Ointment</ProductName>
    <PAHolder>Ayrton Saunders Ltd</PAHolder>
    <AuthorisedDate>26/11/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Zinc oxide</ActiveSubstance>
      <ActiveSubstance>Dichlorobenzyl alcohol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/19/1382/001</DrugIDPK>
    <LicenceNumber>EU/1/19/1382/001</LicenceNumber>
    <ProductName>Azacitidine Celgene</ProductName>
    <PAHolder>Celgene Europe B.V.</PAHolder>
    <AuthorisedDate>02/09/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Azacitidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription. (See Annex I: Summary of Product Characteristics, 4.2)</SupplyComments>
    <WithdrawalDate>19/05/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1774/003/001</DrugIDPK>
    <LicenceNumber>PA1774/003/001</LicenceNumber>
    <ProductName>Azacitidine EVER Pharma 25 mg/ml powder for suspension for injection</ProductName>
    <PAHolder>EVER Valinject GmbH</PAHolder>
    <AuthorisedDate>25/06/2021</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Azacitidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>31/10/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/052/006</DrugIDPK>
    <LicenceNumber>PA0002/052/006</LicenceNumber>
    <ProductName>AZACTAM</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>05/03/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZTREONAM</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/052/005</DrugIDPK>
    <LicenceNumber>PA0002/052/005</LicenceNumber>
    <ProductName>AZACTAM</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>05/03/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZTREONAM</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/052/004</DrugIDPK>
    <LicenceNumber>PA0002/052/004</LicenceNumber>
    <ProductName>AZACTAM</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>05/03/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZTREONAM</ActiveSubstance>
      <ActiveSubstance>ARGININE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/052/001</DrugIDPK>
    <LicenceNumber>PA0002/052/001</LicenceNumber>
    <ProductName>Azactam 500 mg Powder for Solution for Injection or Infusion, vial</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>05/03/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aztreonam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0516/019/001</DrugIDPK>
    <LicenceNumber>PA0516/019/001</LicenceNumber>
    <ProductName>AZALAN</ProductName>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>16/01/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESALAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/01/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/104/001</DrugIDPK>
    <LicenceNumber>PA0281/104/001</LicenceNumber>
    <ProductName>Azathioprine</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Azathioprine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/04/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1128/004/001</DrugIDPK>
    <LicenceNumber>PA1128/004/001</LicenceNumber>
    <ProductName>Azathioprine 50mg film-coated Tablets</ProductName>
    <PAHolder>Relon Chem Limited</PAHolder>
    <AuthorisedDate>23/11/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Azathioprine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/02/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1648/003/001</DrugIDPK>
    <LicenceNumber>PA1648/003/001</LicenceNumber>
    <ProductName>Azelastine Hydrochloride 0.5mg/ml Eye Drops, Solution</ProductName>
    <PAHolder>Brown &amp; Burk UK LTD</PAHolder>
    <AuthorisedDate>22/03/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Azelastine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/05/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/023/002</DrugIDPK>
    <LicenceNumber>PA0281/023/002</LicenceNumber>
    <ProductName>AZEPAM</ProductName>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>22/12/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/09/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/023/001</DrugIDPK>
    <LicenceNumber>PA0281/023/001</LicenceNumber>
    <ProductName>AZEPAM</ProductName>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>22/12/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/09/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2167/001/001</DrugIDPK>
    <LicenceNumber>PA2167/001/001</LicenceNumber>
    <ProductName>Azilsartan medoxomil/Chlortalidone 40 mg /12.5 mg Film-coated Tablets</ProductName>
    <PAHolder>Takeda Pharma A/S</PAHolder>
    <AuthorisedDate>04/08/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZILSARTAN MEDOXOMIL POTASSIUM</ActiveSubstance>
      <ActiveSubstance>Chlortalidone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2167/001/002</DrugIDPK>
    <LicenceNumber>PA2167/001/002</LicenceNumber>
    <ProductName>Azilsartan medoxomil/Chlortalidone 40 mg/25 mg Film-coated tablets</ProductName>
    <PAHolder>Takeda Pharma A/S</PAHolder>
    <AuthorisedDate>04/08/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZILSARTAN MEDOXOMIL POTASSIUM</ActiveSubstance>
      <ActiveSubstance>Chlortalidone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/142/001</DrugIDPK>
    <LicenceNumber>PA2315/142/001</LicenceNumber>
    <InterchangeableListCode>IC0113-130-009</InterchangeableListCode>
    <ProductName>Azithromycin 250 mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>16/11/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Azithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/08/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/038/002</DrugIDPK>
    <LicenceNumber>PA1339/038/002</LicenceNumber>
    <ProductName>Azithromycin 250mg Film-coated Tablets</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>20/10/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Azithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/038/003</DrugIDPK>
    <LicenceNumber>PA1339/038/003</LicenceNumber>
    <ProductName>Azithromycin 500mg Film-coated Tablets</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>20/10/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Azithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/138/002</DrugIDPK>
    <LicenceNumber>PA1380/138/002</LicenceNumber>
    <ProductName>Azithromycin Actavis 500 mg Film-coated Tablets</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>16/11/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Azithromycin dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/093/001</DrugIDPK>
    <LicenceNumber>PA0019/093/001</LicenceNumber>
    <ProductName>Azithromycin Pfizer</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>19/07/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Azithromycin dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/093/002</DrugIDPK>
    <LicenceNumber>PA0019/093/002</LicenceNumber>
    <ProductName>Azithromycin Pfizer</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>19/07/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Azithromycin dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/039/001</DrugIDPK>
    <LicenceNumber>PA0749/039/001</LicenceNumber>
    <ProductName>Azithromycin Teva</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>14/09/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Azithromycin dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/06/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/002</DrugIDPK>
    <LicenceNumber>EU/1/00/157/002</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/003</DrugIDPK>
    <LicenceNumber>EU/1/00/157/003</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/004</DrugIDPK>
    <LicenceNumber>EU/1/00/157/004</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/005</DrugIDPK>
    <LicenceNumber>EU/1/00/157/005</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/006</DrugIDPK>
    <LicenceNumber>EU/1/00/157/006</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/007</DrugIDPK>
    <LicenceNumber>EU/1/00/157/007</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/008</DrugIDPK>
    <LicenceNumber>EU/1/00/157/008</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/009</DrugIDPK>
    <LicenceNumber>EU/1/00/157/009</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/010</DrugIDPK>
    <LicenceNumber>EU/1/00/157/010</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/011</DrugIDPK>
    <LicenceNumber>EU/1/00/157/011</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/012</DrugIDPK>
    <LicenceNumber>EU/1/00/157/012</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/013</DrugIDPK>
    <LicenceNumber>EU/1/00/157/013</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/015</DrugIDPK>
    <LicenceNumber>EU/1/00/157/015</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/016</DrugIDPK>
    <LicenceNumber>EU/1/00/157/016</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/017</DrugIDPK>
    <LicenceNumber>EU/1/00/157/017</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/018</DrugIDPK>
    <LicenceNumber>EU/1/00/157/018</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/019</DrugIDPK>
    <LicenceNumber>EU/1/00/157/019</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/020</DrugIDPK>
    <LicenceNumber>EU/1/00/157/020</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/021</DrugIDPK>
    <LicenceNumber>EU/1/00/157/021</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/022</DrugIDPK>
    <LicenceNumber>EU/1/00/157/022</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/023</DrugIDPK>
    <LicenceNumber>EU/1/00/157/023</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/024</DrugIDPK>
    <LicenceNumber>EU/1/00/157/024</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/025</DrugIDPK>
    <LicenceNumber>EU/1/00/157/025</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/026</DrugIDPK>
    <LicenceNumber>EU/1/00/157/026</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/027</DrugIDPK>
    <LicenceNumber>EU/1/00/157/027</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/028</DrugIDPK>
    <LicenceNumber>EU/1/00/157/028</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/029</DrugIDPK>
    <LicenceNumber>EU/1/00/157/029</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/030</DrugIDPK>
    <LicenceNumber>EU/1/00/157/030</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/031</DrugIDPK>
    <LicenceNumber>EU/1/00/157/031</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/032</DrugIDPK>
    <LicenceNumber>EU/1/00/157/032</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/033</DrugIDPK>
    <LicenceNumber>EU/1/00/157/033</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/034</DrugIDPK>
    <LicenceNumber>EU/1/00/157/034</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/35-46</DrugIDPK>
    <LicenceNumber>EU/1/00/157/35-46</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/47-58</DrugIDPK>
    <LicenceNumber>EU/1/00/157/47-58</LicenceNumber>
    <ProductName>Azomyr</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/00/157/014</DrugIDPK>
    <LicenceNumber>EU/1/00/157/014</LicenceNumber>
    <ProductName>AZOMYR</ProductName>
    <PAHolder>N.V. Organon</PAHolder>
    <AuthorisedDate>16/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>12/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/047/001</DrugIDPK>
    <LicenceNumber>PA0281/047/001</LicenceNumber>
    <ProductName>AZOPINE</ProductName>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>07/03/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZATHIOPRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/066/001</DrugIDPK>
    <LicenceNumber>PA0577/066/001</LicenceNumber>
    <ProductName>Azromax</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>13/05/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Azithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/02/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/066/002</DrugIDPK>
    <LicenceNumber>PA0577/066/002</LicenceNumber>
    <ProductName>Azromax</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>13/05/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Azithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/02/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/006/001</DrugIDPK>
    <LicenceNumber>PA0073/006/001</LicenceNumber>
    <ProductName>B VIT C</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>06/07/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VITAMIN B NOS</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/04/1981</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0555/009/001</DrugIDPK>
    <LicenceNumber>PA0555/009/001</LicenceNumber>
    <ProductName>Babylax 1.8 g Rectal Solution</ProductName>
    <PAHolder>Bausch &amp; Lomb UK Limited</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glycerol 85%</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/09/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/029/002</DrugIDPK>
    <LicenceNumber>PA0405/029/002</LicenceNumber>
    <ProductName>Baclopar</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>21/11/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Baclofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/015/002</DrugIDPK>
    <LicenceNumber>PA0437/015/002</LicenceNumber>
    <ProductName>BACTERIOSTATIC DILUENT</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>27/08/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZYL ALCOHOL</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/015/001</DrugIDPK>
    <LicenceNumber>PA0437/015/001</LicenceNumber>
    <ProductName>BACTERIOSTATIC DILUENT</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>23/05/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZYL ALCOHOL</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/021/001</DrugIDPK>
    <LicenceNumber>PA0437/021/001</LicenceNumber>
    <ProductName>Bacteriostatic Water</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for parenteral use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzyl alcohol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/021/002</DrugIDPK>
    <LicenceNumber>PA0437/021/002</LicenceNumber>
    <ProductName>Bacteriostatic Water</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for parenteral use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzyl alcohol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/021/003</DrugIDPK>
    <LicenceNumber>PA0437/021/003</LicenceNumber>
    <ProductName>Bacteriostatic Water</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for parenteral use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzyl alcohol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0518/001/001</DrugIDPK>
    <LicenceNumber>PA0518/001/001</LicenceNumber>
    <ProductName>BACTICLENS</ProductName>
    <PAHolder>T.J. Smith &amp; Nephew</PAHolder>
    <AuthorisedDate>10/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0518/004/001</DrugIDPK>
    <LicenceNumber>PA0518/004/001</LicenceNumber>
    <ProductName>BACTIGRAS</ProductName>
    <PAHolder>T.J. Smith &amp; Nephew</PAHolder>
    <AuthorisedDate>25/01/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/10/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/003/007</DrugIDPK>
    <LicenceNumber>PA0050/003/007</LicenceNumber>
    <ProductName>BACTRIM</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>30/09/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/02/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/003/006</DrugIDPK>
    <LicenceNumber>PA0050/003/006</LicenceNumber>
    <ProductName>BACTRIM</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>28/01/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/003/002</DrugIDPK>
    <LicenceNumber>PA0050/003/002</LicenceNumber>
    <ProductName>BACTRIM</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>28/01/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/003/003</DrugIDPK>
    <LicenceNumber>PA0050/003/003</LicenceNumber>
    <ProductName>BACTRIM ADULT (SUSPENSION)</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>28/01/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/003/005</DrugIDPK>
    <LicenceNumber>PA0050/003/005</LicenceNumber>
    <ProductName>BACTRIM PAEDIATRIC</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>28/01/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/003/008</DrugIDPK>
    <LicenceNumber>PA0050/003/008</LicenceNumber>
    <ProductName>BACTRIM ROCHE</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>17/01/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/11/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/003/001</DrugIDPK>
    <LicenceNumber>PA0050/003/001</LicenceNumber>
    <ProductName>BACTRIM ROCHE DRAPSULES</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>28/01/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/003/004</DrugIDPK>
    <LicenceNumber>PA0050/003/004</LicenceNumber>
    <ProductName>BACTRIM ROCHE PAEDIATRIC</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>28/01/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/312/001</DrugIDPK>
    <LicenceNumber>PPA0465/312/001</LicenceNumber>
    <ProductName>Bactroban 2% w/w Nasal Ointment</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>26/07/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mupirocin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/312/002</DrugIDPK>
    <LicenceNumber>PPA0465/312/002</LicenceNumber>
    <ProductName>Bactroban 2% w/w Ointment</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>06/08/2021</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mupirocin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/169/001</DrugIDPK>
    <LicenceNumber>PPA1151/169/001</LicenceNumber>
    <ProductName>Bactroban Nasal Ointment 2.0% w/w</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>17/02/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mupirocin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0953/006/001</DrugIDPK>
    <LicenceNumber>PA0953/006/001</LicenceNumber>
    <ProductName>Balance 1.5% glucose, 1.25mmol/l calcium</ProductName>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>05/10/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for peritoneal dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Glucose anhydrous </ActiveSubstance>
      <ActiveSubstance>Sodium lactate </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0953/005/001</DrugIDPK>
    <LicenceNumber>PA0953/005/001</LicenceNumber>
    <ProductName>Balance 1.5% glucose, 1.75mmol/l calcium</ProductName>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>19/09/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for peritoneal dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Glucose anhydrous </ActiveSubstance>
      <ActiveSubstance>Sodium lactate </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0953/006/002</DrugIDPK>
    <LicenceNumber>PA0953/006/002</LicenceNumber>
    <ProductName>Balance 2.3% glucose, 1.25mmol/l calcium</ProductName>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>05/10/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for peritoneal dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Glucose anhydrous </ActiveSubstance>
      <ActiveSubstance>Sodium lactate </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0953/005/003</DrugIDPK>
    <LicenceNumber>PA0953/005/003</LicenceNumber>
    <ProductName>Balance 2.3% glucose, 1.75mmol/l calcium</ProductName>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>19/09/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for peritoneal dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Glucose anhydrous </ActiveSubstance>
      <ActiveSubstance>Sodium lactate </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0953/006/003</DrugIDPK>
    <LicenceNumber>PA0953/006/003</LicenceNumber>
    <ProductName>Balance 4.25% glucose, 1.25mmol/l calcium</ProductName>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>05/10/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for peritoneal dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Glucose anhydrous </ActiveSubstance>
      <ActiveSubstance>Sodium lactate solution</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0953/005/002</DrugIDPK>
    <LicenceNumber>PA0953/005/002</LicenceNumber>
    <ProductName>Balance 4.25% glucose, 1.75mmol/l calcium</ProductName>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>19/09/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for peritoneal dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Glucose anhydrous </ActiveSubstance>
      <ActiveSubstance>Sodium lactate solution</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0100/015/002</DrugIDPK>
    <LicenceNumber>PA0100/015/002</LicenceNumber>
    <ProductName>BALMOSA</ProductName>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/09/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1443/001/001</DrugIDPK>
    <LicenceNumber>PA1443/001/001</LicenceNumber>
    <ProductName>Balmosa Cream</ProductName>
    <PAHolder>Galen Consumer Ltd.</PAHolder>
    <AuthorisedDate>23/11/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mentol</ActiveSubstance>
      <ActiveSubstance>Camphor</ActiveSubstance>
      <ActiveSubstance>Methyl salicylate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/09/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0043/028/001</DrugIDPK>
    <LicenceNumber>PA0043/028/001</LicenceNumber>
    <ProductName>BALNEUM</ProductName>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>01/04/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Bath additive</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Soya bean oil </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/10/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0043/030/001</DrugIDPK>
    <LicenceNumber>PA0043/030/001</LicenceNumber>
    <ProductName>BALNEUM PLUS</ProductName>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>20/04/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Bath additive</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Soya oil</ActiveSubstance>
      <ActiveSubstance>Macrogol fatty acids ethers</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/10/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0043/029/001</DrugIDPK>
    <LicenceNumber>PA0043/029/001</LicenceNumber>
    <ProductName>BALNEUM WITH TAR</ProductName>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>06/02/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Bath Additive</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SOYA OIL</ActiveSubstance>
      <ActiveSubstance>COAL TAR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/02/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0043/031/001</DrugIDPK>
    <LicenceNumber>PA0043/031/001</LicenceNumber>
    <ProductName>BALTAR</ProductName>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>10/03/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/04/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0206/012/001</DrugIDPK>
    <LicenceNumber>PA0206/012/001</LicenceNumber>
    <ProductName>BAMBINO</ProductName>
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CASTOR OIL</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/183/001</DrugIDPK>
    <LicenceNumber>PA1380/183/001</LicenceNumber>
    <ProductName>Bandida</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>13/01/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fluconazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/041/001</DrugIDPK>
    <LicenceNumber>PA0040/041/001</LicenceNumber>
    <ProductName>BANISTYL</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/11/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/079/001</DrugIDPK>
    <LicenceNumber>PA0017/079/001</LicenceNumber>
    <ProductName>BANOCIDE</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIETHYLCARBAMAZINE CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0488/005/002</DrugIDPK>
    <LicenceNumber>PA0488/005/002</LicenceNumber>
    <ProductName>BARATOL</ProductName>
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>25/02/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDORAMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/10/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0488/005/001</DrugIDPK>
    <LicenceNumber>PA0488/005/001</LicenceNumber>
    <ProductName>BARATOL</ProductName>
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>25/02/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDORAMIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/10/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1022/016/001</DrugIDPK>
    <LicenceNumber>PA1022/016/001</LicenceNumber>
    <ProductName>Baricat</ProductName>
    <PAHolder>Bracco UK Limited</PAHolder>
    <AuthorisedDate>12/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cachet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Barium sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Restricted to hospital dispensing</SupplyComments>
    <WithdrawalDate>13/03/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1037/001/001</DrugIDPK>
    <LicenceNumber>PA1037/001/001</LicenceNumber>
    <ProductName>Baricol</ProductName>
    <PAHolder>E-Z-EM Nederland B.V.</PAHolder>
    <AuthorisedDate>17/12/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Barium sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/009/001</DrugIDPK>
    <LicenceNumber>PA0126/009/001</LicenceNumber>
    <ProductName>BARITOP G. POWDER</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>11/12/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/09/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/032/001</DrugIDPK>
    <LicenceNumber>PA0540/032/001</LicenceNumber>
    <ProductName>Batrafen</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>12/11/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOPIROX OLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/032/002</DrugIDPK>
    <LicenceNumber>PA0540/032/002</LicenceNumber>
    <ProductName>Batrafen</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>12/11/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOPIROX OLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/032/006</DrugIDPK>
    <LicenceNumber>PA0540/032/006</LicenceNumber>
    <ProductName>Batrafen</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>09/01/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLOPIROX OLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/032/005</DrugIDPK>
    <LicenceNumber>PA0540/032/005</LicenceNumber>
    <ProductName>Batrafen 10mg/g</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>26/08/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciclopirox</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/08/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/032/004</DrugIDPK>
    <LicenceNumber>PA0540/032/004</LicenceNumber>
    <ProductName>Batrafen Nail Lacquer</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>31/05/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not Currently Available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciclopirox</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/04/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0555/004/001</DrugIDPK>
    <LicenceNumber>PA0555/004/001</LicenceNumber>
    <ProductName>BAUSCH &amp; LOMB AEROSOL SALINE</ProductName>
    <PAHolder>Bausch &amp; Lomb UK Limited</PAHolder>
    <AuthorisedDate>25/02/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/02/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0555/002/001</DrugIDPK>
    <LicenceNumber>PA0555/002/001</LicenceNumber>
    <ProductName>BAUSCH &amp; LOMB DAILY CLEANER</ProductName>
    <PAHolder>Bausch &amp; Lomb UK Limited</PAHolder>
    <AuthorisedDate>25/02/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SORBIC ACID</ActiveSubstance>
      <ActiveSubstance>EDETATE DISODIUM</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BORATE</ActiveSubstance>
      <ActiveSubstance>HYPROMELLOSE</ActiveSubstance>
      <ActiveSubstance>PURIFIED WATER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/02/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0555/003/001</DrugIDPK>
    <LicenceNumber>PA0555/003/001</LicenceNumber>
    <ProductName>BAUSCH &amp; LOMB FIZZICLEAN CLEANING</ProductName>
    <PAHolder>Bausch &amp; Lomb UK Limited</PAHolder>
    <AuthorisedDate>25/02/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/02/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0555/001/001</DrugIDPK>
    <LicenceNumber>PA0555/001/001</LicenceNumber>
    <ProductName>BAUSCH &amp; LOMB SALINE</ProductName>
    <PAHolder>Bausch &amp; Lomb UK Limited</PAHolder>
    <AuthorisedDate>25/02/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SORBIC ACID</ActiveSubstance>
      <ActiveSubstance>EDETATE DISODIUM</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>BORIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM BORATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/02/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/111/001</DrugIDPK>
    <LicenceNumber>PA0167/111/001</LicenceNumber>
    <ProductName>BAXTER PROPOFOL</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Propofol </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/111/002</DrugIDPK>
    <LicenceNumber>PA0167/111/002</LicenceNumber>
    <ProductName>BAXTER PROPOFOL</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Propofol </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/005/001</DrugIDPK>
    <LicenceNumber>PA0021/005/001</LicenceNumber>
    <ProductName>BAYCARON</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEFRUSIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/006/001</DrugIDPK>
    <LicenceNumber>PA0021/006/001</LicenceNumber>
    <ProductName>Bayer Aspirin</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aspirin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/09/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/061/001</DrugIDPK>
    <LicenceNumber>PA0021/061/001</LicenceNumber>
    <ProductName>Bayer Multivitamin &amp; Mineral Effervescent Tablets</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>13/10/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ascorbic acid</ActiveSubstance>
      <ActiveSubstance>Thiamine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Riboflavin</ActiveSubstance>
      <ActiveSubstance>Nicotinamide</ActiveSubstance>
      <ActiveSubstance>Calcium pantothenate</ActiveSubstance>
      <ActiveSubstance>Pyridoxine hydrochloride </ActiveSubstance>
      <ActiveSubstance>Cyanocobalamin</ActiveSubstance>
      <ActiveSubstance>Folic acid</ActiveSubstance>
      <ActiveSubstance>Biotin</ActiveSubstance>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Magnesium carbonate</ActiveSubstance>
      <ActiveSubstance>Magnesium sulfate</ActiveSubstance>
      <ActiveSubstance>Zinc citrate trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/061/002</DrugIDPK>
    <LicenceNumber>PA0021/061/002</LicenceNumber>
    <ProductName>Bayer Multivitamin &amp; Mineral Film Coated Tablets</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>02/12/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ascorbic acid</ActiveSubstance>
      <ActiveSubstance>Thiamine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Riboflavin</ActiveSubstance>
      <ActiveSubstance>Nicotinamide</ActiveSubstance>
      <ActiveSubstance>Calcium pantothenate</ActiveSubstance>
      <ActiveSubstance>Pyridoxine hydrochloride </ActiveSubstance>
      <ActiveSubstance>Cyanocobalamin</ActiveSubstance>
      <ActiveSubstance>Folic acid</ActiveSubstance>
      <ActiveSubstance>Biotin</ActiveSubstance>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Magnesium carbonate</ActiveSubstance>
      <ActiveSubstance>Magnesium oxide</ActiveSubstance>
      <ActiveSubstance>Zinc citrate trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/05/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/017/001</DrugIDPK>
    <LicenceNumber>PA0021/017/001</LicenceNumber>
    <ProductName>BAYOLIN</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>22/07/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARINOID</ActiveSubstance>
      <ActiveSubstance>ETHYLENE GLYCOL MONOSTEARATE</ActiveSubstance>
      <ActiveSubstance>BENZYL NICOTINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/06/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/038/001</DrugIDPK>
    <LicenceNumber>PA0021/038/001</LicenceNumber>
    <ProductName>Baythrom</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>19/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aspirin</ActiveSubstance>
      <ActiveSubstance>Citric acid</ActiveSubstance>
      <ActiveSubstance>Sodium hydrogen carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/09/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/055/001</DrugIDPK>
    <LicenceNumber>PA0022/055/001</LicenceNumber>
    <ProductName>BC 500</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Thiamine mononitrate</ActiveSubstance>
      <ActiveSubstance>Riboflavin</ActiveSubstance>
      <ActiveSubstance>Nicotinamide</ActiveSubstance>
      <ActiveSubstance>Pyridoxine hydrochloride </ActiveSubstance>
      <ActiveSubstance>Calcium pantothenate</ActiveSubstance>
      <ActiveSubstance>Sodium ascorbate</ActiveSubstance>
      <ActiveSubstance>Cyanocobalamin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/056/001</DrugIDPK>
    <LicenceNumber>PA0022/056/001</LicenceNumber>
    <ProductName>BC 500 WITH IRON</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>23/05/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PANTOTHENATE</ActiveSubstance>
      <ActiveSubstance>FERROUS FUMARATE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/045/004</DrugIDPK>
    <LicenceNumber>PA0044/045/004</LicenceNumber>
    <ProductName>BCG PERCUTANEOUS</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/05/1981</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0365/001/002</DrugIDPK>
    <LicenceNumber>PA0365/001/002</LicenceNumber>
    <ProductName>BCG VACCINE</ProductName>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>12/12/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BCG VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/12/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1001/007/001</DrugIDPK>
    <LicenceNumber>PA1001/007/001</LicenceNumber>
    <ProductName>BCG VACCINE INTRADERMAL</ProductName>
    <PAHolder>Chiron Vaccines Limited</PAHolder>
    <AuthorisedDate>12/12/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BCG VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/021/013</DrugIDPK>
    <LicenceNumber>PA0436/021/013</LicenceNumber>
    <ProductName>Beclazone 50 micrograms Easi-Breathe CFC-Free Inhaler Pressurised Inhalation Solution</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>14/11/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/021/006</DrugIDPK>
    <LicenceNumber>PA0436/021/006</LicenceNumber>
    <ProductName>Beclazone Easi-Breathe Inhaler</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/021/007</DrugIDPK>
    <LicenceNumber>PA0436/021/007</LicenceNumber>
    <ProductName>Beclazone Easi-Breathe Inhaler</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/021/008</DrugIDPK>
    <LicenceNumber>PA0436/021/008</LicenceNumber>
    <ProductName>Beclazone Easi-Breathe Inhaler</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/021/003</DrugIDPK>
    <LicenceNumber>PA0436/021/003</LicenceNumber>
    <ProductName>BECLAZONE INHALER</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>26/07/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/07/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/021/002</DrugIDPK>
    <LicenceNumber>PA0436/021/002</LicenceNumber>
    <ProductName>BECLAZONE INHALER</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>26/07/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/07/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/021/001</DrugIDPK>
    <LicenceNumber>PA0436/021/001</LicenceNumber>
    <ProductName>BECLAZONE INHALER</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>26/07/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/07/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0899/017/002</DrugIDPK>
    <LicenceNumber>PA0899/017/002</LicenceNumber>
    <ProductName>BECLO-RHINO ALLERGY</ProductName>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>10/11/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal spray, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclomethasone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0899/017/001</DrugIDPK>
    <LicenceNumber>PA0899/017/001</LicenceNumber>
    <ProductName>Beclo-Rhino Aqueous</ProductName>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>14/05/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal spray, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/05/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0795/001/003</DrugIDPK>
    <LicenceNumber>PA0795/001/003</LicenceNumber>
    <ProductName>BECLOMET EASYHALER</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>20/04/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/12/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0795/001/002</DrugIDPK>
    <LicenceNumber>PA0795/001/002</LicenceNumber>
    <ProductName>BECLOMET EASYHALER</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>20/04/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/12/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0795/001/001</DrugIDPK>
    <LicenceNumber>PA0795/001/001</LicenceNumber>
    <ProductName>BECLOMET EASYHALER</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>06/03/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/12/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0508/001/001</DrugIDPK>
    <LicenceNumber>PA0508/001/001</LicenceNumber>
    <ProductName>BECLOMETHASONE 100 PHARBITA</ProductName>
    <PAHolder>B.V. Pharbita</PAHolder>
    <AuthorisedDate>16/05/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0508/001/002</DrugIDPK>
    <LicenceNumber>PA0508/001/002</LicenceNumber>
    <ProductName>BECLOMETHASONE 200 PHARBITA</ProductName>
    <PAHolder>B.V. Pharbita</PAHolder>
    <AuthorisedDate>16/05/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0508/001/003</DrugIDPK>
    <LicenceNumber>PA0508/001/003</LicenceNumber>
    <ProductName>BECLOMETHASONE 400 PHARBITA</ProductName>
    <PAHolder>B.V. Pharbita</PAHolder>
    <AuthorisedDate>16/05/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/064/001</DrugIDPK>
    <LicenceNumber>PA0057/064/001</LicenceNumber>
    <ProductName>BECLOMETHASONE 50UG</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>08/01/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/024/003</DrugIDPK>
    <LicenceNumber>PA0436/024/003</LicenceNumber>
    <ProductName>BECLOMETHASONE DIPROPIONATE INHALER</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>07/10/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/07/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/024/002</DrugIDPK>
    <LicenceNumber>PA0436/024/002</LicenceNumber>
    <ProductName>BECLOMETHASONE DIPROPIONATE INHALER</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>07/10/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/07/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/024/001</DrugIDPK>
    <LicenceNumber>PA0436/024/001</LicenceNumber>
    <ProductName>BECLOMETHASONE DIPROPIONATE INHALER</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>07/10/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/07/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0024/019/003</DrugIDPK>
    <LicenceNumber>PA0024/019/003</LicenceNumber>
    <ProductName>Becodisks</ProductName>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>21/02/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/03/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/040/001</DrugIDPK>
    <LicenceNumber>PA1077/040/001</LicenceNumber>
    <ProductName>Becodisks</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/040/002</DrugIDPK>
    <LicenceNumber>PA1077/040/002</LicenceNumber>
    <ProductName>Becodisks</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/072/001A</DrugIDPK>
    <LicenceNumber>PPA0465/072/001A</LicenceNumber>
    <ProductName>Beconase 50 micrograms Aqueous Nasal Spray</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>13/07/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal spray, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/041/001</DrugIDPK>
    <LicenceNumber>PA1077/041/001</LicenceNumber>
    <ProductName>Beconase Aqueous</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>15/10/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal spray, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1071/011/001A</DrugIDPK>
    <LicenceNumber>PPA1071/011/001A</LicenceNumber>
    <ProductName>Beconase Aqueous</ProductName>
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate>08/08/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal spray, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/10/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/019/001</DrugIDPK>
    <LicenceNumber>PPA1328/019/001</LicenceNumber>
    <ProductName>Beconase Aqueous</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>14/08/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal spray, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1473/016/001</DrugIDPK>
    <LicenceNumber>PPA1473/016/001</LicenceNumber>
    <ProductName>Beconase Aqueous Nasal Spray</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>24/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal spray, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0024/012/001</DrugIDPK>
    <LicenceNumber>PA0024/012/001</LicenceNumber>
    <ProductName>BECONASE NASAL  (SPRAY)</ProductName>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>21/05/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/054/001</DrugIDPK>
    <LicenceNumber>PA0050/054/001</LicenceNumber>
    <ProductName>BECOSYM</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/059/001</DrugIDPK>
    <LicenceNumber>PA0021/059/001</LicenceNumber>
    <ProductName>Becosym Forte</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>02/12/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Thiamine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Nicotinamide</ActiveSubstance>
      <ActiveSubstance>Pyridoxine hydrochloride </ActiveSubstance>
      <ActiveSubstance>Riboflavine e101</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/09/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/054/002</DrugIDPK>
    <LicenceNumber>PA0050/054/002</LicenceNumber>
    <ProductName>BECOSYM SYRUP</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/12/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0024/005/005</DrugIDPK>
    <LicenceNumber>PA0024/005/005</LicenceNumber>
    <ProductName>Becotide 100</ProductName>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0024/005/010</DrugIDPK>
    <LicenceNumber>PA0024/005/010</LicenceNumber>
    <ProductName>BECOTIDE 100 EASI BREATHE INHALER</ProductName>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>02/05/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1071/010/002A</DrugIDPK>
    <LicenceNumber>PPA1071/010/002A</LicenceNumber>
    <ProductName>Becotide 100 Inhaler</ProductName>
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/10/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0024/005/004</DrugIDPK>
    <LicenceNumber>PA0024/005/004</LicenceNumber>
    <ProductName>Becotide 250</ProductName>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0024/005/011</DrugIDPK>
    <LicenceNumber>PA0024/005/011</LicenceNumber>
    <ProductName>BECOTIDE 250 EASI-BREATHE INHALER</ProductName>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>02/05/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/041/004A</DrugIDPK>
    <LicenceNumber>PPA0465/041/004A</LicenceNumber>
    <ProductName>Becotide 250 Inhaler</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>20/12/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclomethasone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/041/004D</DrugIDPK>
    <LicenceNumber>PPA0465/041/004D</LicenceNumber>
    <ProductName>BECOTIDE 250 INHALER</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclomethasone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA0465/041/004C</DrugIDPK>
    <LicenceNumber>PPA0465/041/004C</LicenceNumber>
    <ProductName>BECOTIDE 250 INHALER</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>20/12/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA0465/041/004B</DrugIDPK>
    <LicenceNumber>PPA0465/041/004B</LicenceNumber>
    <ProductName>BECOTIDE 250 INHALER</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>20/12/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0024/005/009</DrugIDPK>
    <LicenceNumber>PA0024/005/009</LicenceNumber>
    <ProductName>BECOTIDE 50 EASI-BREATHE INHALER</ProductName>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate>02/05/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1071/010/001A</DrugIDPK>
    <LicenceNumber>PPA1071/010/001A</LicenceNumber>
    <ProductName>Becotide 50 Inhaler</ProductName>
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/10/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/042/008</DrugIDPK>
    <LicenceNumber>PA1077/042/008</LicenceNumber>
    <ProductName>Becotide Evohaler</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>07/01/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/12/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/077/001</DrugIDPK>
    <LicenceNumber>PPA1328/077/001</LicenceNumber>
    <ProductName>Becotide Evohaler</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>11/01/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/040/001</DrugIDPK>
    <LicenceNumber>PPA1500/040/001</LicenceNumber>
    <ProductName>Becotide Evohaler</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>12/02/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/041/006</DrugIDPK>
    <LicenceNumber>PPA0465/041/006</LicenceNumber>
    <ProductName>Becotide Evohaler 250 micrograms, Pressurised Inhalation Solution</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>19/10/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This authorisation permits the holder to parallel-distribute product marketed in Ireland under the product authorisation number 1077/42/9.</SupplyComments>
    <WithdrawalDate>31/01/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/204/001</DrugIDPK>
    <LicenceNumber>PPA1151/204/001</LicenceNumber>
    <ProductName>Becotide Evohaler 250 micrograms, Pressurised Inhalation Solution</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>25/10/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/041/005</DrugIDPK>
    <LicenceNumber>PPA0465/041/005</LicenceNumber>
    <ProductName>Becotide Evohaler 50 micrograms, Pressurised Inhalation Solution</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>27/04/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/204/002</DrugIDPK>
    <LicenceNumber>PPA1151/204/002</LicenceNumber>
    <ProductName>Becotide Evohaler 50 micrograms, Pressurised Inhalation Solution</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>24/01/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0024/005/001</DrugIDPK>
    <LicenceNumber>PA0024/005/001</LicenceNumber>
    <ProductName>BECOTIDE INHALER</ProductName>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/041/002A</DrugIDPK>
    <LicenceNumber>PPA0465/041/002A</LicenceNumber>
    <ProductName>Becotide Inhaler 100 mcg</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>03/01/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/041/002B</DrugIDPK>
    <LicenceNumber>PPA0465/041/002B</LicenceNumber>
    <ProductName>BECOTIDE INHALER 100MCG</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>03/01/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA0465/041/001A</DrugIDPK>
    <LicenceNumber>PPA0465/041/001A</LicenceNumber>
    <ProductName>Becotide Inhaler 50mcg</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>08/05/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/041/001G</DrugIDPK>
    <LicenceNumber>PPA0465/041/001G</LicenceNumber>
    <ProductName>BECOTIDE INHALER 50MCG</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>08/05/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA0465/041/001F</DrugIDPK>
    <LicenceNumber>PPA0465/041/001F</LicenceNumber>
    <ProductName>BECOTIDE INHALER 50MCG</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>08/05/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA0465/041/001E</DrugIDPK>
    <LicenceNumber>PPA0465/041/001E</LicenceNumber>
    <ProductName>BECOTIDE INHALER 50MCG</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>08/05/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA0465/041/001D</DrugIDPK>
    <LicenceNumber>PPA0465/041/001D</LicenceNumber>
    <ProductName>BECOTIDE INHALER 50MCG</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>08/05/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA0465/041/001C</DrugIDPK>
    <LicenceNumber>PPA0465/041/001C</LicenceNumber>
    <ProductName>BECOTIDE INHALER 50MCG</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>08/05/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA0465/041/001B</DrugIDPK>
    <LicenceNumber>PPA0465/041/001B</LicenceNumber>
    <ProductName>BECOTIDE INHALER 50MCG</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>08/05/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0024/005/002</DrugIDPK>
    <LicenceNumber>PA0024/005/002</LicenceNumber>
    <ProductName>Becotide Rotacaps</ProductName>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Powder, Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/05/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0024/005/003</DrugIDPK>
    <LicenceNumber>PA0024/005/003</LicenceNumber>
    <ProductName>Becotide Rotacaps</ProductName>
    <PAHolder>Allen and Hanburys Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Powder, Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/05/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/041/003C</DrugIDPK>
    <LicenceNumber>PPA0465/041/003C</LicenceNumber>
    <ProductName>BECOTIDE ROTACAPS</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>18/08/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/12/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/041/003B</DrugIDPK>
    <LicenceNumber>PPA0465/041/003B</LicenceNumber>
    <ProductName>BECOTIDE ROTACAPS</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>18/08/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/12/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/041/003A</DrugIDPK>
    <LicenceNumber>PPA0465/041/003A</LicenceNumber>
    <ProductName>BECOTIDE ROTACAPS</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>18/08/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/12/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/106/002</DrugIDPK>
    <LicenceNumber>PA0678/106/002</LicenceNumber>
    <ProductName>Beechams Cold &amp; Flu Blackcurrant Powder</ProductName>
    <PAHolder>Haleon Ireland Limited</PAHolder>
    <AuthorisedDate>20/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
      <ActiveSubstance>Ascorbic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>General sale in a maximum pack size of 10 sachets. Only one pack should be supplied on each occasion of purchase.</SupplyComments>
    <WithdrawalDate>14/12/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/106/003</DrugIDPK>
    <LicenceNumber>PA0678/106/003</LicenceNumber>
    <ProductName>Beechams Cold &amp; Flu Lemon with Honey</ProductName>
    <PAHolder>Haleon Ireland Limited</PAHolder>
    <AuthorisedDate>20/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
      <ActiveSubstance>Ascorbic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>General sale in a maximum pack size of 10 sachets.</SupplyComments>
    <WithdrawalDate>14/12/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/060/001</DrugIDPK>
    <LicenceNumber>PA0678/060/001</LicenceNumber>
    <ProductName>BEECHAMS COLD RELIEF</ProductName>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>05/06/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/01/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/053/001</DrugIDPK>
    <LicenceNumber>PA0678/053/001</LicenceNumber>
    <ProductName>BEECHAMS HOT LEMON DECONGESTANT</ProductName>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>23/04/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/01/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/104/001</DrugIDPK>
    <LicenceNumber>PA0678/104/001</LicenceNumber>
    <ProductName>Beechams Max Strength Cold and Flu</ProductName>
    <PAHolder>Haleon Ireland Limited</PAHolder>
    <AuthorisedDate>02/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/12/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0379/004/002</DrugIDPK>
    <LicenceNumber>PA0379/004/002</LicenceNumber>
    <ProductName>BEECHAMS POWDERS (REFORMULATION)</ProductName>
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate>31/01/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0379/004/003</DrugIDPK>
    <LicenceNumber>PA0379/004/003</LicenceNumber>
    <ProductName>BEECHAMS POWDERS IN TABLET FORM</ProductName>
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate>18/11/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/09/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0877/001/001</DrugIDPK>
    <LicenceNumber>PA0877/001/001</LicenceNumber>
    <ProductName>Begrivac</ProductName>
    <PAHolder>GSK Vaccines GmbH</PAHolder>
    <AuthorisedDate>03/04/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/california/7/2009 (h1n1) - derived strain used nymc x-181 reass</ActiveSubstance>
      <ActiveSubstance>A/perth/16/2009 (h3n2) - like strain used nymc x-187 reass</ActiveSubstance>
      <ActiveSubstance>B/brisbane/60/2008 - like strain (b/brisbane/60/2008)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0877/001/002</DrugIDPK>
    <LicenceNumber>PA0877/001/002</LicenceNumber>
    <ProductName>Begrivac</ProductName>
    <PAHolder>GSK Vaccines GmbH</PAHolder>
    <AuthorisedDate>03/04/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/california/7/2009 (h1n1) - derived strain used nymc x-181 reass</ActiveSubstance>
      <ActiveSubstance>A/perth/16/2009 (h3n2) - like strain used nymc x-187 reass</ActiveSubstance>
      <ActiveSubstance>B/brisbane/60/2008</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0023/043/001</DrugIDPK>
    <LicenceNumber>PA0023/043/001</LicenceNumber>
    <ProductName>BEGRIVAC - F (PREFILLED SYRINGE)</ProductName>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>01/11/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/WUHAN\359\95 - LIKE STRAIN - (H3N2)</ActiveSubstance>
      <ActiveSubstance>B/BEIJING /184/93-LIKE STRAIN</ActiveSubstance>
      <ActiveSubstance>B/YAMAGATA 16/88</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/06/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0023/043/003</DrugIDPK>
    <LicenceNumber>PA0023/043/003</LicenceNumber>
    <ProductName>BEGRIVAC - F AMPOULE</ProductName>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>01/11/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/WUHAN\359\95 - LIKE STRAIN - (H3N2)</ActiveSubstance>
      <ActiveSubstance>B/BEIJING /184/93-LIKE STRAIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/06/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0023/043/002</DrugIDPK>
    <LicenceNumber>PA0023/043/002</LicenceNumber>
    <ProductName>BEGRIVAC - S MULTIDOSE</ProductName>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>01/11/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/12/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0434/001/003</DrugIDPK>
    <LicenceNumber>PA0434/001/003</LicenceNumber>
    <ProductName>BEKUNIS HERBAL</ProductName>
    <PAHolder>Roha Arzneimittel GmbH &amp; Co. K.G</PAHolder>
    <AuthorisedDate>25/02/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/02/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/064/003</DrugIDPK>
    <LicenceNumber>PA0057/064/003</LicenceNumber>
    <ProductName>BELCLOMETHASONE</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>08/01/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/10/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/064/002</DrugIDPK>
    <LicenceNumber>PA0057/064/002</LicenceNumber>
    <ProductName>BELCLOMETHASONE 100 UG</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>08/01/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BECLOMETASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1824/021/001</DrugIDPK>
    <LicenceNumber>PA1824/021/001</LicenceNumber>
    <ProductName>Belkyra 10 mg/ml solution for injection</ProductName>
    <PAHolder>AbbVie Limited</PAHolder>
    <AuthorisedDate>02/06/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Deoxycholic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>30/06/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0206/011/001</DrugIDPK>
    <LicenceNumber>PA0206/011/001</LicenceNumber>
    <ProductName>BELLADONNA POROUS PLASTER ON RED FLANNELETTE</ProductName>
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated Dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BELLADONNA ALKALOIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR0407/019/001</DrugIDPK>
    <LicenceNumber>HOR0407/019/001</LicenceNumber>
    <ProductName>Belladonna Tablets</ProductName>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>11/06/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atropa belladonna</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1185/003/001</DrugIDPK>
    <LicenceNumber>PA1185/003/001</LicenceNumber>
    <ProductName>Bellcalcid Calcium Carbonate 1500mg and Colecalsif</ProductName>
    <PAHolder>BellPharma Limited</PAHolder>
    <AuthorisedDate>22/12/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0408/061/001</DrugIDPK>
    <LicenceNumber>PA0408/061/001</LicenceNumber>
    <ProductName>Bellcital 10 mg Tablets</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>25/02/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/07/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/061/002</DrugIDPK>
    <LicenceNumber>PA0408/061/002</LicenceNumber>
    <ProductName>Bellcital 20 mg Tablets</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>25/02/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/07/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/061/003</DrugIDPK>
    <LicenceNumber>PA0408/061/003</LicenceNumber>
    <ProductName>Bellcital 40 mg Tablets</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>25/02/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/07/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/007/001</DrugIDPK>
    <LicenceNumber>PA0013/007/001</LicenceNumber>
    <ProductName>BELLERGAL</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BELLADONNA ALKALOIDS</ActiveSubstance>
      <ActiveSubstance>ERGOTAMINE TARTRATE</ActiveSubstance>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/03/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/008/001</DrugIDPK>
    <LicenceNumber>PA0013/008/001</LicenceNumber>
    <ProductName>BELLERGAL RETARD</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BELLADONNA ALKALOIDS</ActiveSubstance>
      <ActiveSubstance>ERGOTAMINE TARTRATE</ActiveSubstance>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/07/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1185/001/001</DrugIDPK>
    <LicenceNumber>PA1185/001/001</LicenceNumber>
    <ProductName>Bellformin</ProductName>
    <PAHolder>BellPharma Limited</PAHolder>
    <AuthorisedDate>10/12/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Metformin Hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA1185/001/002</DrugIDPK>
    <LicenceNumber>PA1185/001/002</LicenceNumber>
    <ProductName>Bellformin</ProductName>
    <PAHolder>BellPharma Limited</PAHolder>
    <AuthorisedDate>10/12/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Metformin Hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0408/054/001</DrugIDPK>
    <LicenceNumber>PA0408/054/001</LicenceNumber>
    <ProductName>Bellimcor</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>29/06/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/03/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/054/002</DrugIDPK>
    <LicenceNumber>PA0408/054/002</LicenceNumber>
    <ProductName>Bellimcor</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>29/06/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/03/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/057/001</DrugIDPK>
    <LicenceNumber>PA0408/057/001</LicenceNumber>
    <ProductName>Bellisin</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>11/07/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lisinopril Dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/07/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/057/002</DrugIDPK>
    <LicenceNumber>PA0408/057/002</LicenceNumber>
    <ProductName>Bellisin</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>11/07/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lisinopril Dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/07/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/057/003</DrugIDPK>
    <LicenceNumber>PA0408/057/003</LicenceNumber>
    <ProductName>Bellisin</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>11/07/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lisinopril Dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/07/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/057/004</DrugIDPK>
    <LicenceNumber>PA0408/057/004</LicenceNumber>
    <ProductName>Bellisin</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>11/07/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lisinopril Dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/07/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0565/047/001</DrugIDPK>
    <LicenceNumber>PPA0565/047/001</LicenceNumber>
    <ProductName>Bellisin</ProductName>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>29/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lisinopril Dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0967/007/001</DrugIDPK>
    <LicenceNumber>PA0967/007/001</LicenceNumber>
    <ProductName>BellPrav</ProductName>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>14/09/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pravastatin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/08/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0967/007/002</DrugIDPK>
    <LicenceNumber>PA0967/007/002</LicenceNumber>
    <ProductName>BellPrav</ProductName>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>14/09/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pravastatin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/08/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0967/007/003</DrugIDPK>
    <LicenceNumber>PA0967/007/003</LicenceNumber>
    <ProductName>BellPrav</ProductName>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>14/09/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pravastatin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/08/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/092/001</DrugIDPK>
    <LicenceNumber>PA0408/092/001</LicenceNumber>
    <ProductName>Bellramil</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>07/10/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ramipril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/07/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/092/002</DrugIDPK>
    <LicenceNumber>PA0408/092/002</LicenceNumber>
    <ProductName>Bellramil</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>07/10/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ramipril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/07/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/092/003</DrugIDPK>
    <LicenceNumber>PA0408/092/003</LicenceNumber>
    <ProductName>Bellramil</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>07/10/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ramipril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/07/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0967/006/001</DrugIDPK>
    <LicenceNumber>PA0967/006/001</LicenceNumber>
    <ProductName>Bellramil</ProductName>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>27/07/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ramipril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/06/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0967/001/001</DrugIDPK>
    <LicenceNumber>PA0967/001/001</LicenceNumber>
    <ProductName>Bellran</ProductName>
    <PAHolder>Ranbaxy (UK) Limited</PAHolder>
    <AuthorisedDate>21/07/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ranitidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/091/001</DrugIDPK>
    <LicenceNumber>PA0408/091/001</LicenceNumber>
    <ProductName>Bellsert</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>07/10/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sertraline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/091/002</DrugIDPK>
    <LicenceNumber>PA0408/091/002</LicenceNumber>
    <ProductName>Bellsert</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>07/10/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sertraline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/053/001</DrugIDPK>
    <LicenceNumber>PA0408/053/001</LicenceNumber>
    <ProductName>Bellvirax</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>27/05/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aciclovir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/10/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/053/002</DrugIDPK>
    <LicenceNumber>PA0408/053/002</LicenceNumber>
    <ProductName>Bellvirax</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>27/05/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aciclovir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/10/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/053/003</DrugIDPK>
    <LicenceNumber>PA0408/053/003</LicenceNumber>
    <ProductName>Bellvirax</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>27/05/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aciclovir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/10/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/055/001</DrugIDPK>
    <LicenceNumber>PA0408/055/001</LicenceNumber>
    <ProductName>Bellzac 20 mg Capsules</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>03/12/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/055/002</DrugIDPK>
    <LicenceNumber>PA0050/055/002</LicenceNumber>
    <ProductName>BENADON</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/055/001</DrugIDPK>
    <LicenceNumber>PA0050/055/001</LicenceNumber>
    <ProductName>BENADON</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0823/015/001</DrugIDPK>
    <LicenceNumber>PA0823/015/001</LicenceNumber>
    <ProductName>Benadryl</ProductName>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diphenhydramine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0823/016/001</DrugIDPK>
    <LicenceNumber>PA0823/016/001</LicenceNumber>
    <ProductName>Benadryl Skin Allergy Relief CreamDiphenhydramine hydrochloride 1.0% w/wZinc Oxide 8.0% w/wRacemic Camphor 0.1% w/w</ProductName>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diphenhydramine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Zinc oxide</ActiveSubstance>
      <ActiveSubstance>Camphor</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/07/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0823/016/002</DrugIDPK>
    <LicenceNumber>PA0823/016/002</LicenceNumber>
    <ProductName>BENADRYL SKIN ALLERGY RELIEF LOTION</ProductName>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>01/04/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diphenhydramine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Zinc oxide</ActiveSubstance>
      <ActiveSubstance>Camphor</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/11/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/072/002</DrugIDPK>
    <LicenceNumber>PA0405/072/002</LicenceNumber>
    <ProductName>Bendamustine 100mg Powder for Concentrate for Solution for Infusion</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>21/08/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bendamustine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/072/001</DrugIDPK>
    <LicenceNumber>PA0405/072/001</LicenceNumber>
    <ProductName>Bendamustine 25 mg Powder for Concentrate for Solution for Infusion</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>21/08/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bendamustine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0623/015/001</DrugIDPK>
    <LicenceNumber>PA0623/015/001</LicenceNumber>
    <ProductName>Bendamustine Medac</ProductName>
    <PAHolder>medac Gesellschaft für klinische Spezialpräparate mbH</PAHolder>
    <AuthorisedDate>21/08/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bendamustine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/08/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0623/015/002</DrugIDPK>
    <LicenceNumber>PA0623/015/002</LicenceNumber>
    <ProductName>Bendamustine Medac</ProductName>
    <PAHolder>medac Gesellschaft für klinische Spezialpräparate mbH</PAHolder>
    <AuthorisedDate>21/08/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bendamustine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/08/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/030/001</DrugIDPK>
    <LicenceNumber>PA0408/030/001</LicenceNumber>
    <ProductName>Bendrofluazide</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>24/02/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bendrofluazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/02/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/018/001</DrugIDPK>
    <LicenceNumber>PA0282/018/001</LicenceNumber>
    <ProductName>BENDROFLUAZIDE</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>01/11/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0176/023/002</DrugIDPK>
    <LicenceNumber>PA0176/023/002</LicenceNumber>
    <ProductName>BENDROFLUAZIDE</ProductName>
    <PAHolder>Accord-UK Ltd</PAHolder>
    <AuthorisedDate>20/09/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENDROFLUMETHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/08/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0176/023/001</DrugIDPK>
    <LicenceNumber>PA0176/023/001</LicenceNumber>
    <ProductName>BENDROFLUAZIDE</ProductName>
    <PAHolder>Accord-UK Ltd</PAHolder>
    <AuthorisedDate>20/09/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENDROFLUMETHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/08/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/047/002</DrugIDPK>
    <LicenceNumber>EU/1/97/047/002</LicenceNumber>
    <ProductName>BeneFIX</ProductName>
    <PAHolder>Pfizer Europe MA EEIG</PAHolder>
    <AuthorisedDate>27/08/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Factor ix, human recombinant</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal  product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>29/04/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/047/003</DrugIDPK>
    <LicenceNumber>EU/1/97/047/003</LicenceNumber>
    <ProductName>BeneFIX</ProductName>
    <PAHolder>Pfizer Europe MA EEIG</PAHolder>
    <AuthorisedDate>27/08/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Factor ix, human recombinant</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>29/04/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/047/001</DrugIDPK>
    <LicenceNumber>EU/1/97/047/001</LicenceNumber>
    <ProductName>BENEFIX</ProductName>
    <PAHolder>Pfizer Europe MA EEIG</PAHolder>
    <AuthorisedDate>27/08/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Factor ix, human recombinant</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>29/04/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/012/001</DrugIDPK>
    <LicenceNumber>PA0035/012/001</LicenceNumber>
    <ProductName>BENEMID</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROBENECID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1595/004/001</DrugIDPK>
    <LicenceNumber>PA1595/004/001</LicenceNumber>
    <ProductName>Beneprav</ProductName>
    <PAHolder>Daiichi Sankyo Ireland Ltd</PAHolder>
    <AuthorisedDate>09/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pravastatin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/06/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1595/004/002</DrugIDPK>
    <LicenceNumber>PA1595/004/002</LicenceNumber>
    <ProductName>Beneprav</ProductName>
    <PAHolder>Daiichi Sankyo Ireland Ltd</PAHolder>
    <AuthorisedDate>09/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pravastatin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/06/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1595/004/003</DrugIDPK>
    <LicenceNumber>PA1595/004/003</LicenceNumber>
    <ProductName>Beneprav</ProductName>
    <PAHolder>Daiichi Sankyo Ireland Ltd</PAHolder>
    <AuthorisedDate>09/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pravastatin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/06/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/030/001</DrugIDPK>
    <LicenceNumber>PA0050/030/001</LicenceNumber>
    <ProductName>BENEROC</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>11/12/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MULTIVITAMINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/060/001</DrugIDPK>
    <LicenceNumber>PA0021/060/001</LicenceNumber>
    <ProductName>Benerva</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>02/12/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Thiamine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/09/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/060/002</DrugIDPK>
    <LicenceNumber>PA0021/060/002</LicenceNumber>
    <ProductName>Benerva</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>02/12/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Thiamine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/09/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/056/007</DrugIDPK>
    <LicenceNumber>PA0050/056/007</LicenceNumber>
    <ProductName>BENERVA</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/12/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/056/006</DrugIDPK>
    <LicenceNumber>PA0050/056/006</LicenceNumber>
    <ProductName>BENERVA</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/056/003</DrugIDPK>
    <LicenceNumber>PA0050/056/003</LicenceNumber>
    <ProductName>BENERVA</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/056/002</DrugIDPK>
    <LicenceNumber>PA0050/056/002</LicenceNumber>
    <ProductName>BENERVA</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/12/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/056/001</DrugIDPK>
    <LicenceNumber>PA0050/056/001</LicenceNumber>
    <ProductName>BENERVA</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/12/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/056/008</DrugIDPK>
    <LicenceNumber>PA0050/056/008</LicenceNumber>
    <ProductName>BENERVA AMPOULES</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/12/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/059/001</DrugIDPK>
    <LicenceNumber>PA0050/059/001</LicenceNumber>
    <ProductName>BENERVA COMPOUND</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/12/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/151/001</DrugIDPK>
    <LicenceNumber>PPA1328/151/001</LicenceNumber>
    <ProductName>Benetor</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>15/07/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Olmesartan medoxomil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/151/002</DrugIDPK>
    <LicenceNumber>PPA1328/151/002</LicenceNumber>
    <ProductName>Benetor</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>15/07/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Olmesartan medoxomil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/151/003</DrugIDPK>
    <LicenceNumber>PPA1328/151/003</LicenceNumber>
    <ProductName>Benetor</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>15/07/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Olmesartan medoxomil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1595/001/001</DrugIDPK>
    <LicenceNumber>PA1595/001/001</LicenceNumber>
    <ProductName>Benetor 10 mg film-coated tablets</ProductName>
    <PAHolder>Daiichi Sankyo Ireland Ltd</PAHolder>
    <AuthorisedDate>19/09/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Olmesartan medoxomil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1595/001/002</DrugIDPK>
    <LicenceNumber>PA1595/001/002</LicenceNumber>
    <ProductName>Benetor 20 mg film-coated tablets</ProductName>
    <PAHolder>Daiichi Sankyo Ireland Ltd</PAHolder>
    <AuthorisedDate>19/09/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Olmesartan medoxomil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1595/001/003</DrugIDPK>
    <LicenceNumber>PA1595/001/003</LicenceNumber>
    <ProductName>Benetor 40 mg film-coated tablets</ProductName>
    <PAHolder>Daiichi Sankyo Ireland Ltd</PAHolder>
    <AuthorisedDate>19/09/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Olmesartan medoxomil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/152/001</DrugIDPK>
    <LicenceNumber>PPA1328/152/001</LicenceNumber>
    <ProductName>Benetor Plus</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>29/07/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Olmesartan medoxomil</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/152/002</DrugIDPK>
    <LicenceNumber>PPA1328/152/002</LicenceNumber>
    <ProductName>Benetor Plus</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>29/07/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Olmesartan medoxomil</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1595/002/001</DrugIDPK>
    <LicenceNumber>PA1595/002/001</LicenceNumber>
    <ProductName>Benetor Plus 20 mg/12.5 mg film-coated tablets</ProductName>
    <PAHolder>Daiichi Sankyo Ireland Ltd</PAHolder>
    <AuthorisedDate>12/05/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Olmesartan medoxomil</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1595/002/002</DrugIDPK>
    <LicenceNumber>PA1595/002/002</LicenceNumber>
    <ProductName>Benetor Plus 20 mg/25 mg film-coated tablets</ProductName>
    <PAHolder>Daiichi Sankyo Ireland Ltd</PAHolder>
    <AuthorisedDate>12/05/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Olmesartan medoxomil</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1595/002/003</DrugIDPK>
    <LicenceNumber>PA1595/002/003</LicenceNumber>
    <ProductName>Benetor Plus 40 mg/12.5 mg film-coated tablets</ProductName>
    <PAHolder>Daiichi Sankyo Ireland Ltd</PAHolder>
    <AuthorisedDate>06/08/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Olmesartan medoxomil</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1595/002/004</DrugIDPK>
    <LicenceNumber>PA1595/002/004</LicenceNumber>
    <ProductName>Benetor Plus 40 mg/25 mg film-coated tablets</ProductName>
    <PAHolder>Daiichi Sankyo Ireland Ltd</PAHolder>
    <AuthorisedDate>06/08/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Olmesartan medoxomil</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0096/008/001</DrugIDPK>
    <LicenceNumber>PA0096/008/001</LicenceNumber>
    <ProductName>BENGUES BALSAM</ProductName>
    <PAHolder>Bengue &amp; Company Limited</PAHolder>
    <AuthorisedDate>13/12/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/137/001</DrugIDPK>
    <LicenceNumber>PA1380/137/001</LicenceNumber>
    <ProductName>Benifema</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>29/11/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desogestrel</ActiveSubstance>
      <ActiveSubstance>Ethinylestradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/04/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/008/003</DrugIDPK>
    <LicenceNumber>PA0077/008/003</LicenceNumber>
    <ProductName>BENORAL</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>20/08/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENORILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/008/002</DrugIDPK>
    <LicenceNumber>PA0077/008/002</LicenceNumber>
    <ProductName>BENORAL</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>18/07/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENORILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/07/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/008/001</DrugIDPK>
    <LicenceNumber>PA0077/008/001</LicenceNumber>
    <ProductName>BENORAL</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>06/07/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENORILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1046/005/001</DrugIDPK>
    <LicenceNumber>PA1046/005/001</LicenceNumber>
    <ProductName>Benorilate</ProductName>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benorylate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/10/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1046/005/002</DrugIDPK>
    <LicenceNumber>PA1046/005/002</LicenceNumber>
    <ProductName>Benorilate Mixture</ProductName>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benorylate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/10/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/084/003</DrugIDPK>
    <LicenceNumber>PA0050/084/003</LicenceNumber>
    <ProductName>BENOXID</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>25/11/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/084/001</DrugIDPK>
    <LicenceNumber>PA0050/084/001</LicenceNumber>
    <ProductName>BENOXID</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>25/11/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0144/024/002</DrugIDPK>
    <LicenceNumber>PA0144/024/002</LicenceNumber>
    <ProductName>BENOXYL 10</ProductName>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>01/10/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
      <ActiveSubstance>SULFUR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0144/002/001</DrugIDPK>
    <LicenceNumber>PA0144/002/001</LicenceNumber>
    <ProductName>BENOXYL 20</ProductName>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0144/024/001</DrugIDPK>
    <LicenceNumber>PA0144/024/001</LicenceNumber>
    <ProductName>BENOXYL 5</ProductName>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>01/10/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFUR</ActiveSubstance>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0828/006/001</DrugIDPK>
    <LicenceNumber>PA0828/006/001</LicenceNumber>
    <ProductName>BENPERIDOL</ProductName>
    <PAHolder>Concord Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>07/03/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/11/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/049/001</DrugIDPK>
    <LicenceNumber>PA0577/049/001</LicenceNumber>
    <ProductName>Benph</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>05/09/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Terazosin monohydrochloride dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/10/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/049/002</DrugIDPK>
    <LicenceNumber>PA0577/049/002</LicenceNumber>
    <ProductName>Benph</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>05/09/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Terazosin monohydrochloride dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/10/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/049/003</DrugIDPK>
    <LicenceNumber>PA0577/049/003</LicenceNumber>
    <ProductName>Benph</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>05/09/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Terazosin monohydrochloride dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/10/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/049/004</DrugIDPK>
    <LicenceNumber>PA0577/049/004</LicenceNumber>
    <ProductName>Benph</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>05/09/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Terazosin monohydrochloride dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/10/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/160/001</DrugIDPK>
    <LicenceNumber>PA0126/160/001</LicenceNumber>
    <ProductName>Benprotan</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>15/12/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alfuzosin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/03/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/160/002</DrugIDPK>
    <LicenceNumber>PA0126/160/002</LicenceNumber>
    <ProductName>Benprotan</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>15/12/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alfuzosin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/05/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/113/001</DrugIDPK>
    <LicenceNumber>PA0013/113/001</LicenceNumber>
    <ProductName>Bentifen</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>24/03/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOTIFEN FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/113/002</DrugIDPK>
    <LicenceNumber>PA0013/113/002</LicenceNumber>
    <ProductName>BENTIFEN SINGLE DOSE UNIT</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>24/03/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KETOTIFEN FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1483/001/001</DrugIDPK>
    <LicenceNumber>PA1483/001/001</LicenceNumber>
    <ProductName>Bentome</ProductName>
    <PAHolder>Medana Pharma SA</PAHolder>
    <AuthorisedDate>25/04/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Omeprazole </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/08/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1483/001/002</DrugIDPK>
    <LicenceNumber>PA1483/001/002</LicenceNumber>
    <ProductName>Bentome</ProductName>
    <PAHolder>Medana Pharma SA</PAHolder>
    <AuthorisedDate>25/04/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Omeprazole </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/08/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1483/001/003</DrugIDPK>
    <LicenceNumber>PA1483/001/003</LicenceNumber>
    <ProductName>Bentome</ProductName>
    <PAHolder>Medana Pharma SA</PAHolder>
    <AuthorisedDate>25/04/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Omeprazole </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/08/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0823/001/001</DrugIDPK>
    <LicenceNumber>PA0823/001/001</LicenceNumber>
    <ProductName>Benylin Children’s Coughs and Colds 5mg/0.625mg per 5ml Syrup</ProductName>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>20/03/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIPROLIDINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>Dextromethorphan hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/10/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/264/001</DrugIDPK>
    <LicenceNumber>PPA1151/264/001</LicenceNumber>
    <ProductName>Benylin Day &amp; Night Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>12/01/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diphenhydramine hydrochloride</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>Sale through pharmacies only in packs containing not more than 16 units per pack. Packs containing more than 720mg pseudoephedrine are subject to medical prescription.

Not more than one pack of pseudoephedrine containing medicinal products should be sup</SupplyComments>
    <WithdrawalDate>01/09/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0056/012/001</DrugIDPK>
    <LicenceNumber>PA0056/012/001</LicenceNumber>
    <ProductName>BENYLIN DECONGESTANT</ProductName>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>10/11/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0823/034/001</DrugIDPK>
    <LicenceNumber>PA0823/034/001</LicenceNumber>
    <ProductName>Benylin Four Flu</ProductName>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>02/06/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diphenhydramine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>Sale through pharmacies only in packs containing not more than 200ml per pack. Packs containing more than 720mg pseudoephedrine are subject to medical prescription.

Not more than one pack of pseudoephedrine containing medicinal products should be suppli</SupplyComments>
    <WithdrawalDate>12/04/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/411/001</DrugIDPK>
    <LicenceNumber>PPA0465/411/001</LicenceNumber>
    <ProductName>Benylin Four Flu</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>01/07/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diphenhydramine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>Sale through pharmacies only in packs containing not more than 24 units per pack. Packs containing more than 720mg pseudoephedrine are subject to medical prescription.

Not more than one pack of pseudoephedrine containing medicinal products should be sup</SupplyComments>
    <WithdrawalDate>31/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/130/001</DrugIDPK>
    <LicenceNumber>PPA1151/130/001</LicenceNumber>
    <ProductName>Benylin Four Flu Film-Coated Tablets. Paracetamol 500mg Diphenhydramine hydrochloride 12.5mg Pseudoephedrine hydrochloride 22.5mg</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>25/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diphenhydramine</ActiveSubstance>
      <ActiveSubstance>Pseudoephedrine</ActiveSubstance>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0056/034/001</DrugIDPK>
    <LicenceNumber>PA0056/034/001</LicenceNumber>
    <ProductName>BENYLIN MENTHOLATED LINCTUS</ProductName>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>10/10/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/09/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0056/010/001</DrugIDPK>
    <LicenceNumber>PA0056/010/001</LicenceNumber>
    <ProductName>BENYLIN PAEDIATRIC</ProductName>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>01/08/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0330/058/002</DrugIDPK>
    <LicenceNumber>PA0330/058/002</LicenceNumber>
    <ProductName>Benylin Sore Throat Relief Berry Flavour 8 mg Compressed Lozenge</ProductName>
    <PAHolder>Johnson &amp; Johnson (Ireland) Limited</PAHolder>
    <AuthorisedDate>08/04/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Compressed lozenge</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzocaine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/01/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0330/058/001</DrugIDPK>
    <LicenceNumber>PA0330/058/001</LicenceNumber>
    <ProductName>Benylin Sore Throat Relief Mint Flavour 8 mg Compressed Lozenge</ProductName>
    <PAHolder>Johnson &amp; Johnson (Ireland) Limited</PAHolder>
    <AuthorisedDate>08/04/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Compressed lozenge</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzocaine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/01/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0823/011/001</DrugIDPK>
    <LicenceNumber>PA0823/011/001</LicenceNumber>
    <ProductName>BENYLIN WITH CODEINE</ProductName>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>04/03/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diphenhydramine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Codeine phosphate hemihydrate</ActiveSubstance>
      <ActiveSubstance>Levomenthol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/03/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0979/049/001</DrugIDPK>
    <LicenceNumber>PA0979/049/001</LicenceNumber>
    <ProductName>Benzalkonium Chloride Reckitt Benckiser 0.20%w/w Cutaneous Spray solution</ProductName>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>20/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous spray, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzalkonium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/10/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0271/012/001</DrugIDPK>
    <LicenceNumber>PA0271/012/001</LicenceNumber>
    <ProductName>Benzamycin</ProductName>
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>23/09/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzoyl peroxide hydrous</ActiveSubstance>
      <ActiveSubstance>Erythromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1155/007/001</DrugIDPK>
    <LicenceNumber>PA1155/007/001</LicenceNumber>
    <ProductName>Benzoyl Peroxide</ProductName>
    <PAHolder>Ferndale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>24/06/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzoyl Peroxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1155/007/002</DrugIDPK>
    <LicenceNumber>PA1155/007/002</LicenceNumber>
    <ProductName>Benzoyl Peroxide</ProductName>
    <PAHolder>Ferndale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>24/06/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzoyl Peroxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2158/001/001</DrugIDPK>
    <LicenceNumber>PA2158/001/001</LicenceNumber>
    <ProductName>Benzydamine Hydrochloride 0.15% w/v Oromucosal Spray</ProductName>
    <PAHolder>ABDI FARMA Unipessoal Lda.</PAHolder>
    <AuthorisedDate>09/02/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal spray, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZYDAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/03/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0484/002/001</DrugIDPK>
    <LicenceNumber>PA0484/002/001</LicenceNumber>
    <ProductName>BENZYL BENZOATE</ProductName>
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>29/03/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZYL BENZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0095/018/001</DrugIDPK>
    <LicenceNumber>PA0095/018/001</LicenceNumber>
    <ProductName>BENZYL BENZOATE APPLICATION B.P.</ProductName>
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>27/04/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZYL BENZOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/12/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/003/001</DrugIDPK>
    <LicenceNumber>PA0022/003/001</LicenceNumber>
    <ProductName>BEPLETE</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/09/1977</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/24/1838/001</DrugIDPK>
    <LicenceNumber>EU/1/24/1838/001</LicenceNumber>
    <ProductName>BEQVEZ</ProductName>
    <PAHolder>Pfizer Europe MA EEIG</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fidanacogene Elaparvovec</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>15/05/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/051/001</DrugIDPK>
    <LicenceNumber>PA0237/051/001</LicenceNumber>
    <ProductName>BERKAMIL</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>17/02/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/048/004</DrugIDPK>
    <LicenceNumber>PA0237/048/004</LicenceNumber>
    <ProductName>BERKATENS</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>16/12/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/11/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/048/003</DrugIDPK>
    <LicenceNumber>PA0237/048/003</LicenceNumber>
    <ProductName>BERKATENS</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>16/12/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/11/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/048/002</DrugIDPK>
    <LicenceNumber>PA0237/048/002</LicenceNumber>
    <ProductName>BERKATENS</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>16/12/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/11/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/048/001</DrugIDPK>
    <LicenceNumber>PA0237/048/001</LicenceNumber>
    <ProductName>BERKATENS</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>16/12/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/11/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0082/008/002</DrugIDPK>
    <LicenceNumber>PA0082/008/002</LicenceNumber>
    <ProductName>BERKFURIN</ProductName>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITROFURANTOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/12/1986</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0082/008/001</DrugIDPK>
    <LicenceNumber>PA0082/008/001</LicenceNumber>
    <ProductName>BERKFURIN</ProductName>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITROFURANTOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/12/1986</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/091/001</DrugIDPK>
    <LicenceNumber>PA0281/091/001</LicenceNumber>
    <ProductName>BERKMYCEN</ProductName>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>23/04/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/05/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0082/007/003</DrugIDPK>
    <LicenceNumber>PA0082/007/003</LicenceNumber>
    <ProductName>BERKMYCEN</ProductName>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0082/007/001</DrugIDPK>
    <LicenceNumber>PA0082/007/001</LicenceNumber>
    <ProductName>BERKMYCEN</ProductName>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/038/004</DrugIDPK>
    <LicenceNumber>PA0237/038/004</LicenceNumber>
    <ProductName>BERKOLOL</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>03/01/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/038/003</DrugIDPK>
    <LicenceNumber>PA0237/038/003</LicenceNumber>
    <ProductName>BERKOLOL</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>03/01/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/038/002</DrugIDPK>
    <LicenceNumber>PA0237/038/002</LicenceNumber>
    <ProductName>BERKOLOL</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>03/01/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/038/001</DrugIDPK>
    <LicenceNumber>PA0237/038/001</LicenceNumber>
    <ProductName>BERKOLOL</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>03/01/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/143/001</DrugIDPK>
    <LicenceNumber>PA0050/143/001</LicenceNumber>
    <ProductName>Berocca</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ascorbic acid</ActiveSubstance>
      <ActiveSubstance>Thiamine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Riboflavin e101</ActiveSubstance>
      <ActiveSubstance>Nicotinamide</ActiveSubstance>
      <ActiveSubstance>Pyridoxine hydrochloride </ActiveSubstance>
      <ActiveSubstance>Cyanocobalamin</ActiveSubstance>
      <ActiveSubstance>Biotin</ActiveSubstance>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Magnesium carbonate</ActiveSubstance>
      <ActiveSubstance>Magnesium sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/04/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/033/003</DrugIDPK>
    <LicenceNumber>PA0007/033/003</LicenceNumber>
    <ProductName>BEROTEC</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>07/05/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOTEROL HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/07/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/033/002</DrugIDPK>
    <LicenceNumber>PA0007/033/002</LicenceNumber>
    <ProductName>BEROTEC</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>07/05/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOTEROL HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/07/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/033/005</DrugIDPK>
    <LicenceNumber>PA0007/033/005</LicenceNumber>
    <ProductName>BEROTEC 100 INHALER CFC-FREE</ProductName>
    <PAHolder>Boehringer Ingelheim Ltd</PAHolder>
    <AuthorisedDate>17/12/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fenoterol hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/033/001</DrugIDPK>
    <LicenceNumber>PA0007/033/001</LicenceNumber>
    <ProductName>BEROTEC METERED DOSE INHALER</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>07/05/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOTEROL HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/04/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/026/001</DrugIDPK>
    <LicenceNumber>PA1410/026/001</LicenceNumber>
    <ProductName>Beta – Adalat 20mg/50mg Capsules</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>03/10/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
      <ActiveSubstance>Atenolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/07/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/050/001</DrugIDPK>
    <LicenceNumber>PA0044/050/001</LicenceNumber>
    <ProductName>BETA-CORLAN</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/07/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1097/018/002</DrugIDPK>
    <LicenceNumber>PPA1097/018/002</LicenceNumber>
    <ProductName>Beta-Prograne 160 mg prolonged-release capsules</ProductName>
    <PAHolder>Lexon (UK) Ltd</PAHolder>
    <AuthorisedDate>17/07/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Propranolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/182/001</DrugIDPK>
    <LicenceNumber>PPA1562/182/001</LicenceNumber>
    <ProductName>Beta-Prograne 160mg Prolonged-Release Capsules</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>02/09/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Propranolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/04/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1392/042/001</DrugIDPK>
    <LicenceNumber>DPR1392/042/001</LicenceNumber>
    <ProductName>Betacap Scalp Application</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>10/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone valerate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1175/002/013</DrugIDPK>
    <LicenceNumber>PA1175/002/013</LicenceNumber>
    <ProductName>Betadine</ProductName>
    <PAHolder>Medlock Medical Ltd</PAHolder>
    <AuthorisedDate>11/02/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Povidone-iodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/10/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0114/002/013</DrugIDPK>
    <LicenceNumber>PA0114/002/013</LicenceNumber>
    <ProductName>BETADINE  AEROSOL SPRAY</ProductName>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/01/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1688/021/005</DrugIDPK>
    <LicenceNumber>PA1688/021/005</LicenceNumber>
    <ProductName>Betadine 10 mg/ml Gargle and Mouthwash</ProductName>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Mouthwash</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Iodinated povidone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1688/021/006</DrugIDPK>
    <LicenceNumber>PA1688/021/006</LicenceNumber>
    <ProductName>Betadine 10% w/w Ointment</ProductName>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1688/021/002</DrugIDPK>
    <LicenceNumber>PA1688/021/002</LicenceNumber>
    <ProductName>Betadine 100 mg/ml Antiseptic Paint</ProductName>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>15/03/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Iodinated povidone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1688/021/007</DrugIDPK>
    <LicenceNumber>PA1688/021/007</LicenceNumber>
    <ProductName>Betadine 40mg/ml Shampoo</ProductName>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>25/11/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Povidone iodinated</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1688/021/001</DrugIDPK>
    <LicenceNumber>PA1688/021/001</LicenceNumber>
    <ProductName>Betadine Alcoholic 100 mg/ml Cutaneous Solution</ProductName>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Iodinated povidone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1175/002/016</DrugIDPK>
    <LicenceNumber>PA1175/002/016</LicenceNumber>
    <ProductName>Betadine Antiseptic Swab</ProductName>
    <PAHolder>Medlock Medical Ltd</PAHolder>
    <AuthorisedDate>11/02/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Povidone-iodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/10/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1175/002/015</DrugIDPK>
    <LicenceNumber>PA1175/002/015</LicenceNumber>
    <ProductName>Betadine Antiseptic Tulle</ProductName>
    <PAHolder>Medlock Medical Ltd</PAHolder>
    <AuthorisedDate>08/06/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Povidone-iodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/06/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0696/002/006</DrugIDPK>
    <LicenceNumber>PA0696/002/006</LicenceNumber>
    <ProductName>Betadine Antiseptic Wipes</ProductName>
    <PAHolder>Seton Healthcare Group PLC</PAHolder>
    <AuthorisedDate>01/04/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Povidone-iodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/05/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1688/021/004</DrugIDPK>
    <LicenceNumber>PA1688/021/004</LicenceNumber>
    <ProductName>Betadine Dry Powder 25 mg/g cutaneous spray</ProductName>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>17/01/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous spray, powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Povidone-iodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0696/002/009</DrugIDPK>
    <LicenceNumber>PA0696/002/009</LicenceNumber>
    <ProductName>Betadine Ear</ProductName>
    <PAHolder>Seton Healthcare Group PLC</PAHolder>
    <AuthorisedDate>27/07/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Povidone-iodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1175/002/018</DrugIDPK>
    <LicenceNumber>PA1175/002/018</LicenceNumber>
    <ProductName>Betadine Mistette</ProductName>
    <PAHolder>Medlock Medical Ltd</PAHolder>
    <AuthorisedDate>11/02/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous spray, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Povidone-iodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/10/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0696/002/013</DrugIDPK>
    <LicenceNumber>PA0696/002/013</LicenceNumber>
    <ProductName>Betadine Scalp &amp; Skin Cleanser</ProductName>
    <PAHolder>Seton Healthcare Group PLC</PAHolder>
    <AuthorisedDate>01/04/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Povidone-iodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/05/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0114/002/002</DrugIDPK>
    <LicenceNumber>PA0114/002/002</LicenceNumber>
    <ProductName>BETADINE SKIN CLEANSER</ProductName>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>29/07/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1688/021/008</DrugIDPK>
    <LicenceNumber>PA1688/021/008</LicenceNumber>
    <ProductName>Betadine Skin Cleanser 40mg/ml cutaneous solution</ProductName>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>25/11/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Povidone-iodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1688/021/009</DrugIDPK>
    <LicenceNumber>PA1688/021/009</LicenceNumber>
    <ProductName>Betadine Surgical Scrub 75 mg/ml Cutaneous Solution</ProductName>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Iodinated povidone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1175/002/017</DrugIDPK>
    <LicenceNumber>PA1175/002/017</LicenceNumber>
    <ProductName>Betadine Swabsticks</ProductName>
    <PAHolder>Medlock Medical Ltd</PAHolder>
    <AuthorisedDate>11/02/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous stick</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Povidone-iodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/10/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0696/002/019</DrugIDPK>
    <LicenceNumber>PA0696/002/019</LicenceNumber>
    <ProductName>BETADINE VAGINAL</ProductName>
    <PAHolder>Seton Healthcare Group PLC</PAHolder>
    <AuthorisedDate>01/04/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Povidone-iodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/07/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1175/002/009</DrugIDPK>
    <LicenceNumber>PA1175/002/009</LicenceNumber>
    <ProductName>BETADINE VAGINAL</ProductName>
    <PAHolder>Medlock Medical Ltd</PAHolder>
    <AuthorisedDate>11/02/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Povidone-iodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/10/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0696/002/020</DrugIDPK>
    <LicenceNumber>PA0696/002/020</LicenceNumber>
    <ProductName>BETADINE VAGINAL CLEANSING KIT</ProductName>
    <PAHolder>Seton Healthcare Group PLC</PAHolder>
    <AuthorisedDate>01/04/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Povidone-iodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/07/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/95/003/002</DrugIDPK>
    <LicenceNumber>EU/1/95/003/002</LicenceNumber>
    <ProductName>Betaferon</ProductName>
    <PAHolder>Schering AG</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Interferon beta-1b</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>03/06/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/95/003/003</DrugIDPK>
    <LicenceNumber>EU/1/95/003/003</LicenceNumber>
    <ProductName>Betaferon</ProductName>
    <PAHolder>Bayer AG</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Interferon beta-1b</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>03/06/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/95/003/004</DrugIDPK>
    <LicenceNumber>EU/1/95/003/004</LicenceNumber>
    <ProductName>Betaferon</ProductName>
    <PAHolder>Schering AG</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Interferon beta-1b</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>03/06/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1473/024/001</DrugIDPK>
    <LicenceNumber>DPR1473/024/001</LicenceNumber>
    <ProductName>Betagan</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>21/04/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levobunolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1500/021/001</DrugIDPK>
    <LicenceNumber>DPR1500/021/001</LicenceNumber>
    <ProductName>Betagan</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>06/11/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levobunolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1562/019/001</DrugIDPK>
    <LicenceNumber>DPR1562/019/001</LicenceNumber>
    <ProductName>Betagan</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>12/04/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levobunolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/05/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1601/002/001</DrugIDPK>
    <LicenceNumber>DPR1601/002/001</LicenceNumber>
    <ProductName>Betagan</ProductName>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>27/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levobunolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1328/137/001</DrugIDPK>
    <LicenceNumber>PPA1328/137/001</LicenceNumber>
    <ProductName>Betagan</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>03/09/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levobunolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/056/001</DrugIDPK>
    <LicenceNumber>PPA1562/056/001</LicenceNumber>
    <ProductName>Betagan</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>26/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levobunolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/210/001</DrugIDPK>
    <LicenceNumber>PPA0465/210/001</LicenceNumber>
    <ProductName>BETAGAN</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>18/01/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levobunolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/01/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0148/040/001</DrugIDPK>
    <LicenceNumber>PA0148/040/001</LicenceNumber>
    <ProductName>Betagan 0.5% w/v Eye Drops, Solution</ProductName>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>05/03/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levobunolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/06/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0148/040/003</DrugIDPK>
    <LicenceNumber>PA0148/040/003</LicenceNumber>
    <ProductName>Betagan Ophthalmic</ProductName>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levobunolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1328/001/001</DrugIDPK>
    <LicenceNumber>DPR1328/001/001</LicenceNumber>
    <ProductName>Betagan Unit Dose Eye Drops Solution</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>06/02/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levobunolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA2007/001/002</DrugIDPK>
    <LicenceNumber>PA2007/001/002</LicenceNumber>
    <ProductName>Betahecon 16mg Tablets</ProductName>
    <PAHolder>BGP Products Ltd</PAHolder>
    <AuthorisedDate>29/09/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betahistine dihydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/05/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2007/001/001</DrugIDPK>
    <LicenceNumber>PA2007/001/001</LicenceNumber>
    <ProductName>Betahecon 8 mg Tablets</ProductName>
    <PAHolder>BGP Products Ltd</PAHolder>
    <AuthorisedDate>29/09/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betahistine dihydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/05/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/032/002</DrugIDPK>
    <LicenceNumber>PA0970/032/002</LicenceNumber>
    <ProductName>Betaloc</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>26/05/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/032/003</DrugIDPK>
    <LicenceNumber>PA0970/032/003</LicenceNumber>
    <ProductName>Betaloc</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>29/05/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/200/001</DrugIDPK>
    <LicenceNumber>PPA0465/200/001</LicenceNumber>
    <ProductName>Betaloc</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>13/07/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/020/001</DrugIDPK>
    <LicenceNumber>PPA1328/020/001</LicenceNumber>
    <ProductName>Betaloc</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>11/08/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/01/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/020/002</DrugIDPK>
    <LicenceNumber>PPA1328/020/002</LicenceNumber>
    <ProductName>Betaloc</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>21/12/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/053/001</DrugIDPK>
    <LicenceNumber>PPA1328/053/001</LicenceNumber>
    <ProductName>Betaloc</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>29/09/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/033/001</DrugIDPK>
    <LicenceNumber>PA0970/033/001</LicenceNumber>
    <ProductName>Betaloc 200mg Prolonged Release Tablets</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>02/04/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/03/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/044/002</DrugIDPK>
    <LicenceNumber>PA0282/044/002</LicenceNumber>
    <ProductName>BETAMETHASONE VALERATE</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>05/06/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/044/001</DrugIDPK>
    <LicenceNumber>PA0282/044/001</LicenceNumber>
    <ProductName>BETAMETHASONE VALERATE B P</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>05/06/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0689/001/001</DrugIDPK>
    <LicenceNumber>PA0689/001/001</LicenceNumber>
    <ProductName>BETANETA</ProductName>
    <PAHolder>Shire Pharmaceutical Contracts Limited</PAHolder>
    <AuthorisedDate>13/07/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/05/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0789/009/001</DrugIDPK>
    <LicenceNumber>PA0789/009/001</LicenceNumber>
    <ProductName>Betarubicin</ProductName>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/04/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0009/044/003</DrugIDPK>
    <LicenceNumber>PA0009/044/003</LicenceNumber>
    <ProductName>BETAZOK</ProductName>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>09/05/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/08/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0009/044/002</DrugIDPK>
    <LicenceNumber>PA0009/044/002</LicenceNumber>
    <ProductName>BETAZOK</ProductName>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>09/05/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/08/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/034/001</DrugIDPK>
    <LicenceNumber>PA0970/034/001</LicenceNumber>
    <ProductName>Betazok 100 mg Prolonged-release Film-coated Table</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>23/08/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Metoprolol succinate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>ZZZ Not applicable</SupplyLegalStatus>
    <PromotionLegalStatus>Unknown</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/09/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1096/002/001</DrugIDPK>
    <LicenceNumber>PA1096/002/001</LicenceNumber>
    <ProductName>Betim</ProductName>
    <PAHolder>Valeant Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Timolol Maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/04/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/001/006</DrugIDPK>
    <LicenceNumber>PA0046/001/006</LicenceNumber>
    <ProductName>BETIM EYE</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>11/07/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/1979</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/001/004</DrugIDPK>
    <LicenceNumber>PA0046/001/004</LicenceNumber>
    <ProductName>BETIM EYE DROPS</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>11/07/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/1979</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/001/003</DrugIDPK>
    <LicenceNumber>PA0046/001/003</LicenceNumber>
    <ProductName>BETIM LEO</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>03/03/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/02/1981</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/001/001</DrugIDPK>
    <LicenceNumber>PA0046/001/001</LicenceNumber>
    <ProductName>BETIM LEO</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>03/03/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/02/1981</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0365/066/001</DrugIDPK>
    <LicenceNumber>PA0365/066/001</LicenceNumber>
    <ProductName>BETNELAN</ProductName>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>27/10/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/05/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1638/001/002</DrugIDPK>
    <LicenceNumber>PA1638/001/002</LicenceNumber>
    <ProductName>BETNESOL</ProductName>
    <PAHolder>RPH Pharmaceuticals AB</PAHolder>
    <AuthorisedDate>12/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/07/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1638/001/003</DrugIDPK>
    <LicenceNumber>PA1638/001/003</LicenceNumber>
    <ProductName>Betnesol 500 microgram Soluble Tablets</ProductName>
    <PAHolder>RPH Pharmaceuticals AB</PAHolder>
    <AuthorisedDate>13/08/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Soluble tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0365/046/002</DrugIDPK>
    <LicenceNumber>PA0365/046/002</LicenceNumber>
    <ProductName>BETNESOL-N 0.01% w/w, 3500 IU/ml Eye Ointment</ProductName>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>13/08/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>Neomycin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/024/001</DrugIDPK>
    <LicenceNumber>PA0044/024/001</LicenceNumber>
    <ProductName>BETNOVATE A</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE VALERATE</ActiveSubstance>
      <ActiveSubstance>CHLORTETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/09/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/022/002</DrugIDPK>
    <LicenceNumber>PA0044/022/002</LicenceNumber>
    <ProductName>BETNOVATE C</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE VALERATE</ActiveSubstance>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/023/002</DrugIDPK>
    <LicenceNumber>PA0044/023/002</LicenceNumber>
    <ProductName>BETNOVATE N</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>27/10/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone valerate</ActiveSubstance>
      <ActiveSubstance>Neomycin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/08/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/001/004</DrugIDPK>
    <LicenceNumber>PA1077/001/004</LicenceNumber>
    <ProductName>Betnovate RD (Ready Diluted) 0.025% w/w Cream</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>24/08/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone valerate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/11/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/001/005</DrugIDPK>
    <LicenceNumber>PA1077/001/005</LicenceNumber>
    <ProductName>Betnovate RD (Ready Diluted) 0.025% w/w Ointment</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>24/08/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone valerate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/11/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/025/001</DrugIDPK>
    <LicenceNumber>PA0044/025/001</LicenceNumber>
    <ProductName>BETNOVATE RECTAL</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/08/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/142/001</DrugIDPK>
    <LicenceNumber>PPA0465/142/001</LicenceNumber>
    <ProductName>Betnovate Scalp Application</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>12/11/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone valerate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/059/001</DrugIDPK>
    <LicenceNumber>PPA1447/059/001</LicenceNumber>
    <ProductName>Betnovate Scalp Application</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>22/12/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone valerate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/02/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/002/001</DrugIDPK>
    <LicenceNumber>PA1077/002/001</LicenceNumber>
    <ProductName>Betnovate-C 0.1%/3% w/w Cream</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>27/10/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone</ActiveSubstance>
      <ActiveSubstance>Clioquinol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/11/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/003/001</DrugIDPK>
    <LicenceNumber>PA1077/003/001</LicenceNumber>
    <ProductName>Betnovate-N 0.1%/0.5% w/w Cream</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>09/07/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone valerate</ActiveSubstance>
      <ActiveSubstance>Neomycin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/08/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0301/005/001</DrugIDPK>
    <LicenceNumber>PA0301/005/001</LicenceNumber>
    <ProductName>BETOPIC CREAM</ProductName>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>22/03/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE VALERATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/05/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/029/001</DrugIDPK>
    <LicenceNumber>DPR0465/029/001</LicenceNumber>
    <ProductName>Betoptic</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>07/05/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betaxolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/019/001</DrugIDPK>
    <LicenceNumber>DPR1392/019/001</LicenceNumber>
    <ProductName>Betoptic</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>23/11/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betaxolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1447/010/001</DrugIDPK>
    <LicenceNumber>DPR1447/010/001</LicenceNumber>
    <ProductName>Betoptic</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>13/09/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betaxolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1463/002/001</DrugIDPK>
    <LicenceNumber>DPR1463/002/001</LicenceNumber>
    <ProductName>Betoptic</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>31/01/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betaxolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/003/001</DrugIDPK>
    <LicenceNumber>DPR1473/003/001</LicenceNumber>
    <ProductName>Betoptic</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>26/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betaxolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1500/004/001</DrugIDPK>
    <LicenceNumber>DPR1500/004/001</LicenceNumber>
    <ProductName>Betoptic</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>22/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betaxolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1562/002/001</DrugIDPK>
    <LicenceNumber>DPR1562/002/001</LicenceNumber>
    <ProductName>Betoptic</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>27/02/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betaxolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1601/001/001</DrugIDPK>
    <LicenceNumber>DPR1601/001/001</LicenceNumber>
    <ProductName>Betoptic</ProductName>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>27/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betaxolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1447/039/001</DrugIDPK>
    <LicenceNumber>PPA1447/039/001</LicenceNumber>
    <ProductName>Betoptic</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>25/02/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betaxolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/02/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/047/001</DrugIDPK>
    <LicenceNumber>PPA1562/047/001</LicenceNumber>
    <ProductName>Betoptic</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>13/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betaxolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/01/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1328/019/001</DrugIDPK>
    <LicenceNumber>DPR1328/019/001</LicenceNumber>
    <ProductName>BETOPTIC</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>30/03/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betaxolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0290/061/002</DrugIDPK>
    <LicenceNumber>PA0290/061/002</LicenceNumber>
    <ProductName>Betoptic 0.25% w/v Eye Drops, Suspension</ProductName>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>21/10/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betaxolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/07/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/143/001</DrugIDPK>
    <LicenceNumber>PPA0465/143/001</LicenceNumber>
    <ProductName>Betoptic 0.5% w/v Eye Drops, solution</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>10/06/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betaxolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0896/003/001</DrugIDPK>
    <LicenceNumber>PA0896/003/001</LicenceNumber>
    <ProductName>Betoptic 0.5% w/v Eye Drops, Solution</ProductName>
    <PAHolder>Novartis Ireland Limited</PAHolder>
    <AuthorisedDate>27/08/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betaxolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/02/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/170/001</DrugIDPK>
    <LicenceNumber>PPA1151/170/001</LicenceNumber>
    <ProductName>Betoptic 0.5% w/v Eye Drops, Solution</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>04/11/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betaxolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/10/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1596/009/001</DrugIDPK>
    <LicenceNumber>DPR1596/009/001</LicenceNumber>
    <ProductName>Betoptic Eye Drops Solution</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>29/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betaxolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0896/003/002</DrugIDPK>
    <LicenceNumber>PA0896/003/002</LicenceNumber>
    <ProductName>Betoptic Suspension Single Dose 0.25% w/v, Eye Drops</ProductName>
    <PAHolder>Novartis Ireland Limited</PAHolder>
    <AuthorisedDate>13/07/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betaxolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/02/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/001/005</DrugIDPK>
    <LicenceNumber>PA0046/001/005</LicenceNumber>
    <ProductName>BETRIM EYE DROP</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>11/07/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/1979</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/072/001</DrugIDPK>
    <LicenceNumber>PPA1328/072/001</LicenceNumber>
    <ProductName>Bettamousse</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>12/01/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous foam</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone valerate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/209/001</DrugIDPK>
    <LicenceNumber>PPA0465/209/001</LicenceNumber>
    <ProductName>Bettamousse 1mg/g (0.1% w/w) Cutaneous Foam</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>22/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous foam</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/040/003</DrugIDPK>
    <LicenceNumber>PA1986/040/003</LicenceNumber>
    <ProductName>Bevacomb 10 mg/160 mg Film-coated Tablets</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>10/03/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/040/002</DrugIDPK>
    <LicenceNumber>PA1986/040/002</LicenceNumber>
    <ProductName>Bevacomb 5 mg/160 mg Film-coated Tablets</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>10/03/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/040/001</DrugIDPK>
    <LicenceNumber>PA1986/040/001</LicenceNumber>
    <ProductName>Bevacomb 5 mg/80mg Film-coated Tablets</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>10/03/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/003/001</DrugIDPK>
    <LicenceNumber>PA0281/003/001</LicenceNumber>
    <ProductName>BEXALIN EXPECTORANT</ProductName>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>25/08/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>AMMONIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>CHLOROFORM</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/08/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0966/017/001</DrugIDPK>
    <LicenceNumber>PA0966/017/001</LicenceNumber>
    <ProductName>Bexmirt 15mg Ordispersible Tablets</ProductName>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>14/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mirtazapine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0966/017/002</DrugIDPK>
    <LicenceNumber>PA0966/017/002</LicenceNumber>
    <ProductName>Bexmirt 30mg Orodispersible Tablets</ProductName>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>14/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mirtazapine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0966/017/003</DrugIDPK>
    <LicenceNumber>PA0966/017/003</LicenceNumber>
    <ProductName>Bexmirt 45mg Orodispersible Tablets</ProductName>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>14/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mirtazapine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/02/239/1-24</DrugIDPK>
    <LicenceNumber>EU/1/02/239/1-24</LicenceNumber>
    <ProductName>BEXTRA</ProductName>
    <PAHolder>Pharmacia-Pfizer EEIG</PAHolder>
    <AuthorisedDate>27/03/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valdecoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0966/013/001</DrugIDPK>
    <LicenceNumber>PA0966/013/001</LicenceNumber>
    <ProductName>BexZis 30mg Film-coated Tablets</ProductName>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>21/10/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mirtazapine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/06/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0568/008/002</DrugIDPK>
    <LicenceNumber>PA0568/008/002</LicenceNumber>
    <ProductName>Bi Preterax</ProductName>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>14/08/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril tert-butylamine salt</ActiveSubstance>
      <ActiveSubstance>Indapamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/09/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0441/022/001</DrugIDPK>
    <LicenceNumber>PA0441/022/001</LicenceNumber>
    <ProductName>BIACTOL</ProductName>
    <PAHolder>Procter &amp; Gamble (Health &amp; Beauty Care) Limited</PAHolder>
    <AuthorisedDate>16/04/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/034/002</DrugIDPK>
    <LicenceNumber>PA0035/034/002</LicenceNumber>
    <ProductName>BIAVAX II VACCINE</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>10/05/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RUBELLAVIRUS</ActiveSubstance>
      <ActiveSubstance>MUMPS VACCINE (LIVE ATTENUATED)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/02/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0992/001/001</DrugIDPK>
    <LicenceNumber>PA0992/001/001</LicenceNumber>
    <ProductName>BICAFLAC BUFFER SOLUTION</ProductName>
    <PAHolder>Edwards Lifesciences Germany</PAHolder>
    <AuthorisedDate>02/11/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for haemofiltration</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium hydrogen carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0992/003/001</DrugIDPK>
    <LicenceNumber>PA0992/003/001</LicenceNumber>
    <ProductName>BICAFLAC ELECTROLYTE SOLUTION WITH</ProductName>
    <PAHolder>Edwards Lifesciences Germany</PAHolder>
    <AuthorisedDate>02/11/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for haemofiltration</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Calcium chloride</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride</ActiveSubstance>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
      <ActiveSubstance>Glucose anhydrous </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0992/002/001</DrugIDPK>
    <LicenceNumber>PA0992/002/001</LicenceNumber>
    <ProductName>BICAFLAC ELECTROLYTE SOLUTION WITHOUT POTASSIUM</ProductName>
    <PAHolder>Edwards Lifesciences Germany</PAHolder>
    <AuthorisedDate>02/11/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not Currently Available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Calcium chloride</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride</ActiveSubstance>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/015/001</DrugIDPK>
    <LicenceNumber>PA0915/015/001</LicenceNumber>
    <ProductName>Bicalinn</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>12/09/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0585/033/001</DrugIDPK>
    <LicenceNumber>PA0585/033/001</LicenceNumber>
    <ProductName>Bicalutamide</ProductName>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>14/11/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0585/033/002</DrugIDPK>
    <LicenceNumber>PA0585/033/002</LicenceNumber>
    <ProductName>Bicalutamide</ProductName>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>14/11/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1330/004/001</DrugIDPK>
    <LicenceNumber>PA1330/004/001</LicenceNumber>
    <ProductName>Bicalutamide</ProductName>
    <PAHolder>Gedeon Richter Plc</PAHolder>
    <AuthorisedDate>28/11/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
      <ActiveSubstance>Lactose monohydrate</ActiveSubstance>
      <ActiveSubstance>Sodium starch glycollate</ActiveSubstance>
      <ActiveSubstance>Povidone K30</ActiveSubstance>
      <ActiveSubstance>Colloidal anhydrous silica</ActiveSubstance>
      <ActiveSubstance>Magnesium stearate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/08/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2059/030/002</DrugIDPK>
    <LicenceNumber>PA2059/030/002</LicenceNumber>
    <ProductName>Bicalutamide 150 mg film-coated tablets</ProductName>
    <PAHolder>Fresenius Kabi Deutschland GmbH</PAHolder>
    <AuthorisedDate>25/11/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/05/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1330/004/002</DrugIDPK>
    <LicenceNumber>PA1330/004/002</LicenceNumber>
    <ProductName>Bicalutamide 150 mg Film-coated tablets</ProductName>
    <PAHolder>Gedeon Richter Plc</PAHolder>
    <AuthorisedDate>22/08/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
      <ActiveSubstance>Lactose monohydrate</ActiveSubstance>
      <ActiveSubstance>Sodium starch glycollate</ActiveSubstance>
      <ActiveSubstance>Povidone K30</ActiveSubstance>
      <ActiveSubstance>Colloidal anhydrous silica</ActiveSubstance>
      <ActiveSubstance>Magnesium stearate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/08/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23176/038/001</DrugIDPK>
    <LicenceNumber>PPA23176/038/001</LicenceNumber>
    <InterchangeableListCode>IC0137-023-003</InterchangeableListCode>
    <ProductName>Bicalutamide 50 mg film-coated tablets</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>06/11/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2059/030/001</DrugIDPK>
    <LicenceNumber>PA2059/030/001</LicenceNumber>
    <ProductName>Bicalutamide 50mg Film-coated tablets</ProductName>
    <PAHolder>Fresenius Kabi Deutschland GmbH</PAHolder>
    <AuthorisedDate>28/01/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/05/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/153/001</DrugIDPK>
    <LicenceNumber>PA1380/153/001</LicenceNumber>
    <ProductName>Bicalutamide Actavis</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>07/11/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1375/001/001</DrugIDPK>
    <LicenceNumber>PA1375/001/001</LicenceNumber>
    <ProductName>Bicalutamide Avansor 50mg Film-Coated Tablets</ProductName>
    <PAHolder>Avansor Pharma Oy</PAHolder>
    <AuthorisedDate>10/08/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1391/001/001</DrugIDPK>
    <LicenceNumber>PA1391/001/001</LicenceNumber>
    <ProductName>Bicalutamide Farmaprojects</ProductName>
    <PAHolder>Farmaprojects S.A.</PAHolder>
    <AuthorisedDate>04/07/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1217/003/001</DrugIDPK>
    <LicenceNumber>PA1217/003/001</LicenceNumber>
    <ProductName>Bicalutamide Hikma</ProductName>
    <PAHolder>Hikma Farmacêutica (Portugal) S.A.</PAHolder>
    <AuthorisedDate>12/02/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0840/006/001</DrugIDPK>
    <LicenceNumber>PA0840/006/001</LicenceNumber>
    <ProductName>Bicalutamide Synthon 50mg film-coated tablets</ProductName>
    <PAHolder>Synthon BV</PAHolder>
    <AuthorisedDate>10/08/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/07/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/048/001</DrugIDPK>
    <LicenceNumber>PA0281/048/001</LicenceNumber>
    <ProductName>BICART SODIUM BICARBONATE</ProductName>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>19/04/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>PDR for Soln for Haemodialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0479/002/001</DrugIDPK>
    <LicenceNumber>PA0479/002/001</LicenceNumber>
    <ProductName>BICART, SODIUM BICARBONATE COLUMN</ProductName>
    <PAHolder>Gambro UK Limited</PAHolder>
    <AuthorisedDate>04/03/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for haemodialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0953/004/001</DrugIDPK>
    <LicenceNumber>PA0953/004/001</LicenceNumber>
    <ProductName>bicaVera</ProductName>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>28/11/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for peritoneal dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium hydrogen carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0953/004/002</DrugIDPK>
    <LicenceNumber>PA0953/004/002</LicenceNumber>
    <ProductName>bicaVera</ProductName>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>28/11/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for peritoneal dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium hydrogen carbonate</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0953/004/003</DrugIDPK>
    <LicenceNumber>PA0953/004/003</LicenceNumber>
    <ProductName>bicaVera</ProductName>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>28/11/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for peritoneal dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium hydrogen carbonate</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/016/001</DrugIDPK>
    <LicenceNumber>PA0048/016/001</LicenceNumber>
    <ProductName>BiCNU 100 mg Powder and Solvent for Solution for I</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings)</PAHolder>
    <AuthorisedDate>06/02/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carmustine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/02/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0211/018/001</DrugIDPK>
    <LicenceNumber>PA0211/018/001</LicenceNumber>
    <ProductName>BIDOPLEX ELIXIR</ProductName>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>14/03/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0865/004/002</DrugIDPK>
    <LicenceNumber>PA0865/004/002</LicenceNumber>
    <ProductName>BIFRIL 15 mg film-coated tablets</ProductName>
    <PAHolder>Menarini International Operations Luxembourg S.A.</PAHolder>
    <AuthorisedDate>04/03/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Zofenopril calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/02/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0865/004/003</DrugIDPK>
    <LicenceNumber>PA0865/004/003</LicenceNumber>
    <ProductName>BIFRIL 30 mg film-coated tablets</ProductName>
    <PAHolder>Menarini International Operations Luxembourg S.A.</PAHolder>
    <AuthorisedDate>04/03/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Zofenopril calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/02/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0865/004/004</DrugIDPK>
    <LicenceNumber>PA0865/004/004</LicenceNumber>
    <ProductName>BIFRIL 60 mg film-coated tablets</ProductName>
    <PAHolder>Menarini International Operations Luxembourg S.A.</PAHolder>
    <AuthorisedDate>04/03/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Zofenopril calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/02/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0865/004/001</DrugIDPK>
    <LicenceNumber>PA0865/004/001</LicenceNumber>
    <ProductName>BIFRIL 7.5 mg film-coated tablets</ProductName>
    <PAHolder>Menarini International Operations Luxembourg S.A.</PAHolder>
    <AuthorisedDate>04/03/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Zofenopril calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/02/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0865/013/001</DrugIDPK>
    <LicenceNumber>PA0865/013/001</LicenceNumber>
    <ProductName>Bifril Plus 30 mg/12.5 mg film-coated tablets</ProductName>
    <PAHolder>Menarini International Operations Luxembourg S.A.</PAHolder>
    <AuthorisedDate>13/05/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Zofenopril calcium</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1332/048/001</DrugIDPK>
    <LicenceNumber>PA1332/048/001</LicenceNumber>
    <ProductName>Bileni</ProductName>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>22/02/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal spray, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Azelastine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Fluticasone propionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/04/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0054/047/001</DrugIDPK>
    <LicenceNumber>PA0054/047/001</LicenceNumber>
    <ProductName>BILIMIRO</ProductName>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>21/01/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOPANOIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/12/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0012/074/001</DrugIDPK>
    <LicenceNumber>PA0012/074/001</LicenceNumber>
    <ProductName>BILISCOPIN</ProductName>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>25/10/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTROXATE MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/10/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0012/048/004</DrugIDPK>
    <LicenceNumber>PA0012/048/004</LicenceNumber>
    <ProductName>BILISCOPIN</ProductName>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>19/03/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTROXATE MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/01/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0012/048/003</DrugIDPK>
    <LicenceNumber>PA0012/048/003</LicenceNumber>
    <ProductName>BILISCOPIN</ProductName>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>19/03/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTROXATE MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/02/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0012/048/002</DrugIDPK>
    <LicenceNumber>PA0012/048/002</LicenceNumber>
    <ProductName>BILISCOPIN</ProductName>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>19/03/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTROXATE MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/01/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0012/048/001</DrugIDPK>
    <LicenceNumber>PA0012/048/001</LicenceNumber>
    <ProductName>BILISCOPIN</ProductName>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>26/02/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTROXATE MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/01/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/005/001</DrugIDPK>
    <LicenceNumber>PA0077/005/001</LicenceNumber>
    <ProductName>BILOPAQUE</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>25/04/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM TYROPANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/04/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0012/035/001</DrugIDPK>
    <LicenceNumber>PA0012/035/001</LicenceNumber>
    <ProductName>BILOPTIN</ProductName>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM IOPODATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/12/804/001-010</DrugIDPK>
    <LicenceNumber>EU/1/12/804/001-010</LicenceNumber>
    <ProductName>Bindren</ProductName>
    <PAHolder>Mitsubishi Pharma Europe Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Colestilan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/03/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/12/804/011-013</DrugIDPK>
    <LicenceNumber>EU/1/12/804/011-013</LicenceNumber>
    <ProductName>Bindren</ProductName>
    <PAHolder>Mitsubishi Pharma Europe Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Colestilan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/03/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/12/804/014-016</DrugIDPK>
    <LicenceNumber>EU/1/12/804/014-016</LicenceNumber>
    <ProductName>Bindren</ProductName>
    <PAHolder>Mitsubishi Pharma Europe Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Colestilan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/03/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1097/045/001</DrugIDPK>
    <LicenceNumber>PPA1097/045/001</LicenceNumber>
    <InterchangeableListCode>IC0051-101-057</InterchangeableListCode>
    <ProductName>Binosto Once Weekly 70 mg Effervescent Tablets</ProductName>
    <PAHolder>Lexon (UK) Ltd</PAHolder>
    <AuthorisedDate>27/04/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium alendronate trihydrate (micronised)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0059/016/001</DrugIDPK>
    <LicenceNumber>PA0059/016/001</LicenceNumber>
    <ProductName>BINOVUM</ProductName>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>27/02/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0748/028/001</DrugIDPK>
    <LicenceNumber>PA0748/028/001</LicenceNumber>
    <ProductName>BINOVUM ORAL CONTRACEPTIVE</ProductName>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>25/08/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/11/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0800/001/003</DrugIDPK>
    <LicenceNumber>PA0800/001/003</LicenceNumber>
    <ProductName>BIOCLATE 1000</ProductName>
    <PAHolder>CSL Behring GmbH</PAHolder>
    <AuthorisedDate>20/09/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII, HUMAN RECOMBINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/05/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0800/001/001</DrugIDPK>
    <LicenceNumber>PA0800/001/001</LicenceNumber>
    <ProductName>BIOCLATE 250</ProductName>
    <PAHolder>CSL Behring GmbH</PAHolder>
    <AuthorisedDate>20/09/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII, HUMAN RECOMBINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/05/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0800/001/002</DrugIDPK>
    <LicenceNumber>PA0800/001/002</LicenceNumber>
    <ProductName>BIOCLATE 500</ProductName>
    <PAHolder>CSL Behring GmbH</PAHolder>
    <AuthorisedDate>20/09/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII, HUMAN RECOMBINANT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/05/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/001/001</DrugIDPK>
    <LicenceNumber>PA1063/001/001</LicenceNumber>
    <ProductName>BioDol</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>28/06/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0023/027/001</DrugIDPK>
    <LicenceNumber>PA0023/027/001</LicenceNumber>
    <ProductName>BIOFERRIN COMPLEX</ProductName>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>01/04/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HAEMOGLOBINUM SICC.</ActiveSubstance>
      <ActiveSubstance>LIVER EXTRACT</ActiveSubstance>
      <ActiveSubstance>IRON</ActiveSubstance>
      <ActiveSubstance>COBALT</ActiveSubstance>
      <ActiveSubstance>MANGANESE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/079/001</DrugIDPK>
    <LicenceNumber>PA0077/079/001</LicenceNumber>
    <ProductName>BIOGASTRONE</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBENOXOLONE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/08/450/1-4</DrugIDPK>
    <LicenceNumber>EU/1/08/450/1-4</LicenceNumber>
    <ProductName>Biograstim</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>15/09/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Filgrastim</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>23/09/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/08/450/5-8</DrugIDPK>
    <LicenceNumber>EU/1/08/450/5-8</LicenceNumber>
    <ProductName>Biograstim</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate>15/09/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Filgrastim</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>23/09/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0039/007/001</DrugIDPK>
    <LicenceNumber>PA0039/007/001</LicenceNumber>
    <ProductName>BIOMYDRIN</ProductName>
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/12/1986</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/139/002</DrugIDPK>
    <LicenceNumber>PA0050/139/002</LicenceNumber>
    <ProductName>Biovital</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ferric sodium citrate</ActiveSubstance>
      <ActiveSubstance>Thiamine mononitrate</ActiveSubstance>
      <ActiveSubstance>Ascorbic acid</ActiveSubstance>
      <ActiveSubstance>Riboflavin</ActiveSubstance>
      <ActiveSubstance>Manganese citrate</ActiveSubstance>
      <ActiveSubstance>Pyridoxine hydrochloride </ActiveSubstance>
      <ActiveSubstance>Nicotinamide</ActiveSubstance>
      <ActiveSubstance>Cyanocobalamin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/10/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/139/001</DrugIDPK>
    <LicenceNumber>PA0050/139/001</LicenceNumber>
    <ProductName>BIOVITAL</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>10/07/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERRIC SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN SODIUM PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>MANGANESE CITRATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/011/001</DrugIDPK>
    <LicenceNumber>PA1063/011/001</LicenceNumber>
    <ProductName>Biozac</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>04/05/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOXETINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/04/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/008/001</DrugIDPK>
    <LicenceNumber>PA0915/008/001</LicenceNumber>
    <ProductName>BIRAVID</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>29/10/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/08/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/14/948/002</DrugIDPK>
    <LicenceNumber>EU/1/14/948/002</LicenceNumber>
    <ProductName>BiResp Spiromax Teva</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>19/11/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Budesonide</ActiveSubstance>
      <ActiveSubstance>Formoterol fumarate dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0172/016/002</DrugIDPK>
    <LicenceNumber>PA0172/016/002</LicenceNumber>
    <ProductName>BISMAG ANTACID</ProductName>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>10/01/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/03/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0172/016/001</DrugIDPK>
    <LicenceNumber>PA0172/016/001</LicenceNumber>
    <ProductName>BISMAG ANTACID</ProductName>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>10/01/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/03/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0369/001/001</DrugIDPK>
    <LicenceNumber>PA0369/001/001</LicenceNumber>
    <ProductName>BISMAG-LAC</ProductName>
    <PAHolder>Professor Dr. Med. Much. A.G.</PAHolder>
    <AuthorisedDate>24/09/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGALDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0100/047/003</DrugIDPK>
    <LicenceNumber>PA0100/047/003</LicenceNumber>
    <ProductName>Bisodol Antacid</ProductName>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium hydrogen carbonate</ActiveSubstance>
      <ActiveSubstance>Magnesium carbonate light</ActiveSubstance>
      <ActiveSubstance>Magnesium carbonate heavy</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/11/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0172/022/001</DrugIDPK>
    <LicenceNumber>PA0172/022/001</LicenceNumber>
    <ProductName>BISODOL EXTRA</ProductName>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>28/10/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/070/001</DrugIDPK>
    <LicenceNumber>PA1986/070/001</LicenceNumber>
    <ProductName>Bisodol Extra Strong Mint Chewable TabletsCalcium carbonate 522mgMagnesium carbonate light 68mgSodium hydrogen carbonate 64mg</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>23/08/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Magnesium carbonate light</ActiveSubstance>
      <ActiveSubstance>Sodium hydrogen carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0100/048/001</DrugIDPK>
    <LicenceNumber>PA0100/048/001</LicenceNumber>
    <ProductName>Bisodol Heartburn</ProductName>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>23/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Magaldrate</ActiveSubstance>
      <ActiveSubstance>Alginic acid</ActiveSubstance>
      <ActiveSubstance>Sodium bicarbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0100/047/002</DrugIDPK>
    <LicenceNumber>PA0100/047/002</LicenceNumber>
    <ProductName>Bisodol Spearmint</ProductName>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>09/05/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Light magnesium carbonate</ActiveSubstance>
      <ActiveSubstance>Sodium bicarbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/005/001</DrugIDPK>
    <LicenceNumber>PA0007/005/001</LicenceNumber>
    <ProductName>BISOLVOMYCIN</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMHEXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>OXYTETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/05/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/025/001</DrugIDPK>
    <LicenceNumber>PA0007/025/001</LicenceNumber>
    <ProductName>BISOLVON</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>14/11/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMHEXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/08/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/025/003</DrugIDPK>
    <LicenceNumber>PA0007/025/003</LicenceNumber>
    <ProductName>BISOLVON AMPOULES</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>17/11/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMHEXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/08/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/164/002</DrugIDPK>
    <LicenceNumber>PA0281/164/002</LicenceNumber>
    <InterchangeableListCode>IC0065-002-014</InterchangeableListCode>
    <ProductName>Bisopine 10 mg Tablets</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>08/12/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/06/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/164/001</DrugIDPK>
    <LicenceNumber>PA0281/164/001</LicenceNumber>
    <InterchangeableListCode>IC0065-001-014</InterchangeableListCode>
    <ProductName>Bisopine 5 mg Tablets</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>08/12/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/06/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/058/001</DrugIDPK>
    <LicenceNumber>PA0822/058/001</LicenceNumber>
    <ProductName>Bisoprolol</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>25/11/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/058/002</DrugIDPK>
    <LicenceNumber>PA0822/058/002</LicenceNumber>
    <ProductName>Bisoprolol</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>25/11/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/007/001</DrugIDPK>
    <LicenceNumber>PA0819/007/001</LicenceNumber>
    <ProductName>BISOPROLOL</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/007/002</DrugIDPK>
    <LicenceNumber>PA0819/007/002</LicenceNumber>
    <ProductName>BISOPROLOL</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/154/002</DrugIDPK>
    <LicenceNumber>PA0577/154/002</LicenceNumber>
    <ProductName>Bisoprolol 10 mg film-coated tablets</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>10/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/04/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/154/001</DrugIDPK>
    <LicenceNumber>PA0577/154/001</LicenceNumber>
    <ProductName>Bisoprolol 5 mg film-coated tablets</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>10/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/04/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/095/001</DrugIDPK>
    <LicenceNumber>PA0281/095/001</LicenceNumber>
    <ProductName>Bisoprolol Fumarate</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>08/02/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/06/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/095/002</DrugIDPK>
    <LicenceNumber>PA0281/095/002</LicenceNumber>
    <ProductName>Bisoprolol Fumarate</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>08/02/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/06/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/044/002</DrugIDPK>
    <LicenceNumber>PA1063/044/002</LicenceNumber>
    <ProductName>Bisoprolol Fumarate</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>16/04/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/04/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/044/003</DrugIDPK>
    <LicenceNumber>PA1063/044/003</LicenceNumber>
    <ProductName>Bisoprolol Fumarate</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>16/04/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/04/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/097/002</DrugIDPK>
    <LicenceNumber>PA2315/097/002</LicenceNumber>
    <InterchangeableListCode>IC0065-002-014</InterchangeableListCode>
    <ProductName>Bisoprolol Fumarate 10mg tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>26/01/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/11/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/097/001</DrugIDPK>
    <LicenceNumber>PA2315/097/001</LicenceNumber>
    <InterchangeableListCode>IC0065-001-014</InterchangeableListCode>
    <ProductName>Bisoprolol Fumarate 5 mg tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>26/01/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/11/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/062/001</DrugIDPK>
    <LicenceNumber>PA0822/062/001</LicenceNumber>
    <ProductName>Bisprolol Pfizer</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>05/12/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/062/002</DrugIDPK>
    <LicenceNumber>PA0822/062/002</LicenceNumber>
    <ProductName>Bisprolol Pfizer</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>05/12/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/062/003</DrugIDPK>
    <LicenceNumber>PA0822/062/003</LicenceNumber>
    <ProductName>Bisprolol Pfizer</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>05/12/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/062/004</DrugIDPK>
    <LicenceNumber>PA0822/062/004</LicenceNumber>
    <ProductName>Bisprolol Pfizer</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>05/12/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/062/005</DrugIDPK>
    <LicenceNumber>PA0822/062/005</LicenceNumber>
    <ProductName>Bisprolol Pfizer</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>05/12/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/062/006</DrugIDPK>
    <LicenceNumber>PA0822/062/006</LicenceNumber>
    <ProductName>Bisprolol Pfizer</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>05/12/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1809/024/001</DrugIDPK>
    <LicenceNumber>PA1809/024/001</LicenceNumber>
    <ProductName>Bivalirudin Cipla</ProductName>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>01/07/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln/Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bivalirudin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>09/08/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/20/1474/001</DrugIDPK>
    <LicenceNumber>EU/1/20/1474/001</LicenceNumber>
    <ProductName>Blenrep</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>25/08/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Belantamab Mafodotin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription. (See Annex I: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>16/04/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0937/008/001</DrugIDPK>
    <LicenceNumber>PA0937/008/001</LicenceNumber>
    <ProductName>BLEOMYCIN</ProductName>
    <PAHolder>Pharmachemie BV</PAHolder>
    <AuthorisedDate>13/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bleomycin sulphate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/03/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0115/004/001</DrugIDPK>
    <LicenceNumber>PA0115/004/001</LicenceNumber>
    <ProductName>BLEOMYCIN LUNDBECK</ProductName>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>23/02/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/07/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0115/004/002</DrugIDPK>
    <LicenceNumber>PA0115/004/002</LicenceNumber>
    <ProductName>Bleomycin Lundbeck Injection</ProductName>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bleomycin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/02/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/038/001</DrugIDPK>
    <LicenceNumber>PA0437/038/001</LicenceNumber>
    <ProductName>BLEOMYCIN SULPHATE</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>18/09/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not Currently Available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bleomycin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/06/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0148/022/001</DrugIDPK>
    <LicenceNumber>PA0148/022/001</LicenceNumber>
    <ProductName>Bleph-10</ProductName>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sulphacetamide sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/10/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0148/021/001</DrugIDPK>
    <LicenceNumber>PA0148/021/001</LicenceNumber>
    <ProductName>Blephamide Liquifilm</ProductName>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Prednisolone acetate</ActiveSubstance>
      <ActiveSubstance>SULFACETAMIDE SODIUM</ActiveSubstance>
      <ActiveSubstance>Phenylephrine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/018/002</DrugIDPK>
    <LicenceNumber>PA0137/018/002</LicenceNumber>
    <ProductName>BLEPHAMIDE OPHTHALMIC (SUSPENSION)</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0302/012/001</DrugIDPK>
    <LicenceNumber>PA0302/012/001</LicenceNumber>
    <ProductName>Blistex Cold Sore Cream 100mg/g cream</ProductName>
    <PAHolder>D.D.D. Limited</PAHolder>
    <AuthorisedDate>22/06/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Docosanol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/04/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0302/004/001</DrugIDPK>
    <LicenceNumber>PA0302/004/001</LicenceNumber>
    <ProductName>Blistex Relief Cream</ProductName>
    <PAHolder>D.D.D. Limited</PAHolder>
    <AuthorisedDate>18/01/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Strong ammonia solution</ActiveSubstance>
      <ActiveSubstance>Phenol, liquefied</ActiveSubstance>
      <ActiveSubstance>Ammonia solution, aramatic</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/04/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/044/005</DrugIDPK>
    <LicenceNumber>PA0035/044/005</LicenceNumber>
    <ProductName>Blocadren</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Timolol Maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/044/007</DrugIDPK>
    <LicenceNumber>PA0035/044/007</LicenceNumber>
    <ProductName>BLOCADREN</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/09/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/09/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/044/006</DrugIDPK>
    <LicenceNumber>PA0035/044/006</LicenceNumber>
    <ProductName>BLOCADREN</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/09/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/044/004</DrugIDPK>
    <LicenceNumber>PA0035/044/004</LicenceNumber>
    <ProductName>BLOCADREN</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/09/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/044/011</DrugIDPK>
    <LicenceNumber>PA0035/044/011</LicenceNumber>
    <ProductName>BLOCADREN 0.25MG/ML</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>15/11/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/01/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/044/010</DrugIDPK>
    <LicenceNumber>PA0035/044/010</LicenceNumber>
    <ProductName>BLOCADREN 0.25MG/ML</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>15/11/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/01/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/044/009</DrugIDPK>
    <LicenceNumber>PA0035/044/009</LicenceNumber>
    <ProductName>BLOCADREN 0.25MG/ML</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>15/11/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/01/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/044/008</DrugIDPK>
    <LicenceNumber>PA0035/044/008</LicenceNumber>
    <ProductName>BLOCADREN 0.25MG/ML</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>15/11/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIMOLOL MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/01/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1470/006/002</DrugIDPK>
    <LicenceNumber>PA1470/006/002</LicenceNumber>
    <InterchangeableListCode>IC0164-002-003</InterchangeableListCode>
    <ProductName>Blomensy 10 mg film-coated tablets</ProductName>
    <PAHolder>EGIS Pharmaceuticals PLC</PAHolder>
    <AuthorisedDate>06/01/2023</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rivaroxaban</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/10/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1470/006/003</DrugIDPK>
    <LicenceNumber>PA1470/006/003</LicenceNumber>
    <InterchangeableListCode>IC0164-032-009</InterchangeableListCode>
    <ProductName>Blomensy 15 mg film-coated tablets</ProductName>
    <PAHolder>EGIS Pharmaceuticals PLC</PAHolder>
    <AuthorisedDate>06/01/2023</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rivaroxaban</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/10/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1470/006/001</DrugIDPK>
    <LicenceNumber>PA1470/006/001</LicenceNumber>
    <InterchangeableListCode>IC0164-018-003</InterchangeableListCode>
    <ProductName>Blomensy 2.5 mg film-coated tablets</ProductName>
    <PAHolder>EGIS Pharmaceuticals PLC</PAHolder>
    <AuthorisedDate>06/01/2023</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rivaroxaban</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/10/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1470/006/004</DrugIDPK>
    <LicenceNumber>PA1470/006/004</LicenceNumber>
    <InterchangeableListCode>IC0164-003-009</InterchangeableListCode>
    <ProductName>Blomensy 20 mg film-coated tablets</ProductName>
    <PAHolder>EGIS Pharmaceuticals PLC</PAHolder>
    <AuthorisedDate>06/01/2023</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rivaroxaban</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/10/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2239/014/001</DrugIDPK>
    <LicenceNumber>PA2239/014/001</LicenceNumber>
    <ProductName>Blopress 2 mg Tablets</ProductName>
    <PAHolder>CHEPLAPHARM Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>14/11/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/05/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/048/003</DrugIDPK>
    <LicenceNumber>PA1063/048/003</LicenceNumber>
    <InterchangeableListCode>IC0063-024-014</InterchangeableListCode>
    <ProductName>Blugral 100 mg film-coated tablets</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>11/01/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sildenafil citrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/048/001</DrugIDPK>
    <LicenceNumber>PA1063/048/001</LicenceNumber>
    <InterchangeableListCode>IC0063-022-014</InterchangeableListCode>
    <ProductName>Blugral 25 mg film-coated tablets</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>11/01/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sildenafil citrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/048/002</DrugIDPK>
    <LicenceNumber>PA1063/048/002</LicenceNumber>
    <InterchangeableListCode>IC0063-023-014</InterchangeableListCode>
    <ProductName>Blugral 50 mg film-coated tablets</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>11/01/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sildenafil citrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/042/001</DrugIDPK>
    <LicenceNumber>PA0057/042/001</LicenceNumber>
    <ProductName>BN LINIMENT</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TURPENTINE OIL</ActiveSubstance>
      <ActiveSubstance>STRONG AMMONIA SOLUTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/07/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1261/001/001</DrugIDPK>
    <LicenceNumber>PA1261/001/001</LicenceNumber>
    <ProductName>Bocasan</ProductName>
    <PAHolder>Gillette Group UK Ltd</PAHolder>
    <AuthorisedDate>24/06/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium perborate</ActiveSubstance>
      <ActiveSubstance>Sodium bitartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/01/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/062/001</DrugIDPK>
    <LicenceNumber>PA0046/062/001</LicenceNumber>
    <ProductName>Bocatriol</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>04/02/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcitriol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/062/002</DrugIDPK>
    <LicenceNumber>PA0046/062/002</LicenceNumber>
    <ProductName>Bocatriol</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>04/02/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcitriol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/062/003</DrugIDPK>
    <LicenceNumber>PA0046/062/003</LicenceNumber>
    <ProductName>BOCATRIOL</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>04/02/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITRIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/06/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/039/001</DrugIDPK>
    <LicenceNumber>PA0073/039/001</LicenceNumber>
    <ProductName>Boestrol</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diethylstilbestrol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/03/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/039/002</DrugIDPK>
    <LicenceNumber>PA0073/039/002</LicenceNumber>
    <ProductName>Boestrol</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diethylstilbestrol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/03/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0258/012/001</DrugIDPK>
    <LicenceNumber>PA0258/012/001</LicenceNumber>
    <ProductName>BON VOYAGE</ProductName>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>19/09/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/06/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/03/266/3-4</DrugIDPK>
    <LicenceNumber>EU/1/03/266/3-4</LicenceNumber>
    <ProductName>Bondenza</ProductName>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibandronic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/03/266/5-6</DrugIDPK>
    <LicenceNumber>EU/1/03/266/5-6</LicenceNumber>
    <ProductName>Bondenza</ProductName>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibandronic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/96/012/001</DrugIDPK>
    <LicenceNumber>EU/1/96/012/001</LicenceNumber>
    <ProductName>Bondronat</ProductName>
    <PAHolder>Atnahs Pharma Netherlands B.V.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibandronic acid monosodium monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/96/012/002</DrugIDPK>
    <LicenceNumber>EU/1/96/012/002</LicenceNumber>
    <ProductName>Bondronat</ProductName>
    <PAHolder>Atnahs Pharma Netherlands B.V.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibandronic acid monosodium monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/96/012/003</DrugIDPK>
    <LicenceNumber>EU/1/96/012/003</LicenceNumber>
    <ProductName>Bondronat</ProductName>
    <PAHolder>Atnahs Pharma Netherlands B.V.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibandronic acid monosodium monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/96/012/006</DrugIDPK>
    <LicenceNumber>EU/1/96/012/006</LicenceNumber>
    <ProductName>Bondronat</ProductName>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibandronic acid monosodium monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/96/012/007</DrugIDPK>
    <LicenceNumber>EU/1/96/012/007</LicenceNumber>
    <ProductName>Bondronat</ProductName>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibandronic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/96/012/008</DrugIDPK>
    <LicenceNumber>EU/1/96/012/008</LicenceNumber>
    <ProductName>Bondronat</ProductName>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibandronic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/96/012/005</DrugIDPK>
    <LicenceNumber>EU/1/96/012/005</LicenceNumber>
    <ProductName>BONDRONAT</ProductName>
    <PAHolder>Roche Registration GmbH</PAHolder>
    <AuthorisedDate>01/12/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBANDRONIC ACID MONOSODIUM MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA1380/169/001</DrugIDPK>
    <LicenceNumber>PA1380/169/001</LicenceNumber>
    <ProductName>Bondulc 40 micrograms/ml eye drops, solution</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>14/11/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Travoprost</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/002/001</DrugIDPK>
    <LicenceNumber>PA1410/002/001</LicenceNumber>
    <ProductName>Bonefos</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>21/09/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clodronate disodium tetrahydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/07/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/047/001</DrugIDPK>
    <LicenceNumber>PA0007/047/001</LicenceNumber>
    <ProductName>BONEFOS</ProductName>
    <PAHolder>Boehringer Ingelheim Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clodronate disodium tetrahydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/047/002</DrugIDPK>
    <LicenceNumber>PA0007/047/002</LicenceNumber>
    <ProductName>BONEFOS</ProductName>
    <PAHolder>Boehringer Ingelheim Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clodronate disodium tetrahydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/047/003</DrugIDPK>
    <LicenceNumber>PA0007/047/003</LicenceNumber>
    <ProductName>BONEFOS</ProductName>
    <PAHolder>Boehringer Ingelheim Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clodronate disodium tetrahydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/03/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0074/064/001</DrugIDPK>
    <LicenceNumber>PA0074/064/001</LicenceNumber>
    <ProductName>Bonefurbit 150mg Film-Coated Tablets</ProductName>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>12/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibandronate sodium monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0484/001/001</DrugIDPK>
    <LicenceNumber>PA0484/001/001</LicenceNumber>
    <ProductName>Bonfields Hydrocortisone</ProductName>
    <PAHolder>Foran Healthcare Limited,</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Hydrocortisone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/06/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0484/007/001</DrugIDPK>
    <LicenceNumber>PA0484/007/001</LicenceNumber>
    <ProductName>BONFIELDS SILCOCKS BASE</ProductName>
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>24/02/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EMULSIFYING WAX</ActiveSubstance>
      <ActiveSubstance>PARAFFIN SOFT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/010/001</DrugIDPK>
    <LicenceNumber>DPR0465/010/001</LicenceNumber>
    <ProductName>Bonjela</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>03/08/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Choline salicylate</ActiveSubstance>
      <ActiveSubstance>Cetalkonium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/004/001</DrugIDPK>
    <LicenceNumber>DPR1473/004/001</LicenceNumber>
    <ProductName>Bonjela</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>08/04/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Choline salicylate</ActiveSubstance>
      <ActiveSubstance>Cetalkonium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/005/001</DrugIDPK>
    <LicenceNumber>DPR1392/005/001</LicenceNumber>
    <ProductName>BONJELA</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>20/06/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Choline salicylate</ActiveSubstance>
      <ActiveSubstance>Cetalkonium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1463/017/001</DrugIDPK>
    <LicenceNumber>DPR1463/017/001</LicenceNumber>
    <ProductName>BONJELA</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>04/04/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Choline salicylate</ActiveSubstance>
      <ActiveSubstance>Cetalkonium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0398/007/001</DrugIDPK>
    <LicenceNumber>PA0398/007/001</LicenceNumber>
    <ProductName>BONOMINT</ProductName>
    <PAHolder>Intercare Products Ltd</PAHolder>
    <AuthorisedDate>20/03/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Chewable</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>YELLOW PHENOLPHTHALEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/01/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/96/013/003</DrugIDPK>
    <LicenceNumber>EU/1/96/013/003</LicenceNumber>
    <ProductName>Bonviva</ProductName>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>27/08/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibandronic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/03/265/01-2</DrugIDPK>
    <LicenceNumber>EU/1/03/265/01-2</LicenceNumber>
    <ProductName>BONVIVA 2.5mg FILM-COATED tablets</ProductName>
    <PAHolder>Atnahs Pharma Netherlands B.V.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibandronic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/020/002</DrugIDPK>
    <LicenceNumber>PA1077/020/002</LicenceNumber>
    <ProductName>Boostrix</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diphtheria toxoid</ActiveSubstance>
      <ActiveSubstance>Tetanus toxoid</ActiveSubstance>
      <ActiveSubstance>Pertussis toxoid</ActiveSubstance>
      <ActiveSubstance>Filamentous haemagglutinin</ActiveSubstance>
      <ActiveSubstance>Pertactin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/10/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/101/002</DrugIDPK>
    <LicenceNumber>PA1077/101/002</LicenceNumber>
    <ProductName>Boostrix Polio (glass vials)</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diphtheria toxoid</ActiveSubstance>
      <ActiveSubstance>Tetanus toxoid</ActiveSubstance>
      <ActiveSubstance>Pertussis toxoid</ActiveSubstance>
      <ActiveSubstance>Filamentous haemagglutinin</ActiveSubstance>
      <ActiveSubstance>Pertactin (prn, or 69kda omp)</ActiveSubstance>
      <ActiveSubstance>Polio virus type 1 inactivated</ActiveSubstance>
      <ActiveSubstance>Polio virus type 2 inactivated</ActiveSubstance>
      <ActiveSubstance>Polio virus type 3 inactivated</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/10/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0004/061/002</DrugIDPK>
    <LicenceNumber>PA0004/061/002</LicenceNumber>
    <ProductName>Boots Day Cold &amp; Flu Relief Oral Solution Paracetamol 1000mg/30mg Pholcodine 10mg/30ml Pseudoephedrine Hydrochloride 60mg/30ml</ProductName>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>18/12/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>Pholcodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Sale through pharmacies only in packs containing not more than 240ml per pack. Packs containing more than 720mg pseudoephedrine are subject to medical prescription.

Not more than one pack of pseudoephedrine containing medicinal products should be suppli</SupplyComments>
    <WithdrawalDate>01/12/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0004/025/001</DrugIDPK>
    <LicenceNumber>PA0004/025/001</LicenceNumber>
    <ProductName>BOOTS HEALTHCARE HOT LEMON COLD RELIEF</ProductName>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA23081/004/001</DrugIDPK>
    <LicenceNumber>PA23081/004/001</LicenceNumber>
    <ProductName>Boots Ibuprofen and Codeine 200mg/12.8 mg film-coated tablets</ProductName>
    <PAHolder>Taw Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>17/12/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
      <ActiveSubstance>Codeine phosphate hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription, supply through pharmacies only and promotion to the healthcare professionals only subject to the following restrictions: 

For ibuprofen: maximum strength 200 mg, maximum pack size 50, maximum dose 400 mg, max</SupplyComments>
    <WithdrawalDate>20/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0030/057/001</DrugIDPK>
    <LicenceNumber>PA0030/057/001</LicenceNumber>
    <ProductName>Boots NicAssist</ProductName>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>11/07/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenge</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nicotine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0030/040/001</DrugIDPK>
    <LicenceNumber>PA0030/040/001</LicenceNumber>
    <ProductName>Boots Nicotine Chewing Gum</ProductName>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>14/06/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not Currently Available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nicotine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription, supply through pharmacies only and promotion to the public subject to the following restrictions: maximum dose 4 mg, maximum daily dose 60 mg.</SupplyComments>
    <WithdrawalDate>13/06/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0030/040/002</DrugIDPK>
    <LicenceNumber>PA0030/040/002</LicenceNumber>
    <ProductName>Boots Nicotine Chewing Gum</ProductName>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>14/06/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not Currently Available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nicotine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription, supply through pharmacies only and promotion to the public subject to the following restrictions: maximum dose 4 mg, maximum daily dose 60 mg.</SupplyComments>
    <WithdrawalDate>13/06/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0030/040/004</DrugIDPK>
    <LicenceNumber>PA0030/040/004</LicenceNumber>
    <ProductName>Boots Nicotine Transdermal Patch 24hour</ProductName>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>14/06/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nicotine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0030/040/005</DrugIDPK>
    <LicenceNumber>PA0030/040/005</LicenceNumber>
    <ProductName>Boots Nicotine Transdermal Patch 24hour</ProductName>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>14/06/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nicotine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0030/040/006</DrugIDPK>
    <LicenceNumber>PA0030/040/006</LicenceNumber>
    <ProductName>Boots Nicotine Transdermal Patch 24hour</ProductName>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>14/06/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nicotine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA23081/003/001</DrugIDPK>
    <LicenceNumber>PA23081/003/001</LicenceNumber>
    <ProductName>Boots Pharmaceuticals Bite and Sting Relief Antihistamine 2% w/w Cream</ProductName>
    <PAHolder>Taw Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>09/12/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mepyramine maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/12/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0004/054/001</DrugIDPK>
    <LicenceNumber>PA0004/054/001</LicenceNumber>
    <ProductName>Boots Pharmaceuticals Chesty Cough &amp; Congestion Relief Oral Solution Guaifenesin 100 mg/5 mlPseudoephedrine Hydrochloride 30 mg/5 ml</ProductName>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>12/05/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>Guaiphenesin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>Sale through pharmacies only in packs containing not more than 120ml per pack. Packs containing more than 720mg pseudoephedrine are subject to medical prescription.

Not more than one pack of pseudoephedrine containing medicinal products should be suppli</SupplyComments>
    <WithdrawalDate>01/12/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0004/061/001</DrugIDPK>
    <LicenceNumber>PA0004/061/001</LicenceNumber>
    <ProductName>Boots Pharmaceuticals Day Cold &amp; Flu Relief Hard Capsules Paracetamol 500 mg Pholcodine 5 mg Pseudoephedrine Hydrochloride 30 mg</ProductName>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>04/11/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>Pholcodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Sale through pharmacies only in packs containing not more than 24 units per pack. Packs containing more than 720mg pseudoephedrine are subject to medical prescription.

Not more than one pack of pseudoephedrine containing medicinal products should be sup</SupplyComments>
    <WithdrawalDate>01/12/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA23081/005/001</DrugIDPK>
    <LicenceNumber>PA23081/005/001</LicenceNumber>
    <ProductName>Boots Pharmaceuticals Decongestant 60mg Tablets</ProductName>
    <PAHolder>Taw Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>04/11/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>Sale through pharmacies only in packs containing not more than 12 units per pack. Packs containing more than 720mg pseudoephedrine are subject to medical prescription.

Not more than one pack of pseudoephedrine containing medicinal products should be sup</SupplyComments>
    <WithdrawalDate>07/12/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA23081/002/001</DrugIDPK>
    <LicenceNumber>PA23081/002/001</LicenceNumber>
    <ProductName>Boots Pharmaceuticals Diarrhoea Relief 2 mg Hard Capsules</ProductName>
    <PAHolder>Taw Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>06/12/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Loperamide hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/12/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0004/053/001</DrugIDPK>
    <LicenceNumber>PA0004/053/001</LicenceNumber>
    <ProductName>Boots Pharmaceuticals Dry Cough &amp; Congestion Relief Oral Solution Dextromethorphan Hydrobromide 10 mg/5 mlPseudoephedrine Hydrochloride 30 mg/5 ml</ProductName>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>26/11/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dextromethorphan hydrobromide</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>Sale through pharmacies only in packs containing not more than 120ml per pack. Packs containing more than 720mg pseudoephedrine are subject to medical prescription.

Not more than one pack of pseudoephedrine containing medicinal products should be suppli</SupplyComments>
    <WithdrawalDate>01/12/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0004/057/001</DrugIDPK>
    <LicenceNumber>PA0004/057/001</LicenceNumber>
    <ProductName>Boots Pharmaceuticals Sore Throat Relief Lemon Flavour 0.6 mg Lozenges</ProductName>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>17/05/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenge</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amylmetacresol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/12/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2299/057/001</DrugIDPK>
    <LicenceNumber>PA2299/057/001</LicenceNumber>
    <ProductName>Bortezomib 3.5 mg powder for solution for injection</ProductName>
    <PAHolder>Baxter Holding B.V.</PAHolder>
    <AuthorisedDate>01/04/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bortezomib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>02/04/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/283/001</DrugIDPK>
    <LicenceNumber>PA0711/283/001</LicenceNumber>
    <ProductName>Bortezomib Ebewe 3.5 mg Powder for solution for injection</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>25/08/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bortezomib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>19/09/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/16/1114/001</DrugIDPK>
    <LicenceNumber>EU/1/16/1114/001</LicenceNumber>
    <ProductName>Bortezomib Hospira 3.5 mg powder for solution for injection</ProductName>
    <PAHolder>Pfizer Europe MA EEIG</PAHolder>
    <AuthorisedDate>22/07/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bortezomib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>06/08/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2041/003/001</DrugIDPK>
    <LicenceNumber>PA2041/003/001</LicenceNumber>
    <ProductName>Bortezomib Koanaa 3.5 mg powder for solution for injection</ProductName>
    <PAHolder>Koanaa Healthcare Limited</PAHolder>
    <AuthorisedDate>16/02/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bortezomib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>04/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1347/082/001</DrugIDPK>
    <LicenceNumber>PA1347/082/001</LicenceNumber>
    <ProductName>Bortezomib Krka 1 mg powder for solution for injection</ProductName>
    <PAHolder>KRKA, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>17/05/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bortezomib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See : Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>13/11/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1347/082/002</DrugIDPK>
    <LicenceNumber>PA1347/082/002</LicenceNumber>
    <ProductName>Bortezomib Krka 3.5 mg powder for solution for injection</ProductName>
    <PAHolder>KRKA, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>17/05/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bortezomib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See : Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>13/11/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/073/001</DrugIDPK>
    <LicenceNumber>PA0405/073/001</LicenceNumber>
    <ProductName>Bortezomib Mylan</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>27/11/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bortezomib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>29/03/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/191/001</DrugIDPK>
    <LicenceNumber>PA0577/191/001</LicenceNumber>
    <ProductName>Bortezomib Mylan 3.5 mg powder for solution for injection</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>17/05/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bortezomib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>28/01/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/032/002</DrugIDPK>
    <LicenceNumber>PA1986/032/002</LicenceNumber>
    <ProductName>Bortezomib Teva 2.5mg powder for solution for injection</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>02/11/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bortezomib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>02/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/032/001</DrugIDPK>
    <LicenceNumber>PA1986/032/001</LicenceNumber>
    <ProductName>Bortezomib Teva 3.5 mg Powder for Solution for Injection</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>08/07/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bortezomib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>02/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2260/001/001</DrugIDPK>
    <LicenceNumber>PA2260/001/001</LicenceNumber>
    <ProductName>Bortezomib Waverley 1 mg powder for solution for injection</ProductName>
    <PAHolder>Waverley Pharma Europe Limited</PAHolder>
    <AuthorisedDate>20/03/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bortezomib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>04/11/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2260/001/002</DrugIDPK>
    <LicenceNumber>PA2260/001/002</LicenceNumber>
    <ProductName>Bortezomib Waverley 3.5 mg powder for solution for injection</ProductName>
    <PAHolder>Waverley Pharma Europe Limited</PAHolder>
    <AuthorisedDate>20/03/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bortezomib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>04/11/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0148/055/001</DrugIDPK>
    <LicenceNumber>PA0148/055/001</LicenceNumber>
    <ProductName>BOTOX</ProductName>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>20/07/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOSTRIDIUM BOTULINUM TYP A-ANTITOXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/07/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0114/021/001</DrugIDPK>
    <LicenceNumber>PA0114/021/001</LicenceNumber>
    <ProductName>BRADILAN</ProductName>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICOFURANOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0030/031/001</DrugIDPK>
    <LicenceNumber>PA0030/031/001</LicenceNumber>
    <ProductName>BRADOSOL</ProductName>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>01/04/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOMIPHEN BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0030/037/001</DrugIDPK>
    <LicenceNumber>PA0030/037/001</LicenceNumber>
    <ProductName>BRADOSOL PLUS</ProductName>
    <PAHolder>Novartis Consumer Health UK Limited</PAHolder>
    <AuthorisedDate>08/03/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenge</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Domiphen bromide</ActiveSubstance>
      <ActiveSubstance>Lignocaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/11/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0144/025/003</DrugIDPK>
    <LicenceNumber>PA0144/025/003</LicenceNumber>
    <ProductName>BRASIVOL COARSE</ProductName>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>01/10/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0144/025/001</DrugIDPK>
    <LicenceNumber>PA0144/025/001</LicenceNumber>
    <ProductName>Brasivol Fine</ProductName>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>01/10/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous paste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aluminium oxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/05/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0144/025/002</DrugIDPK>
    <LicenceNumber>PA0144/025/002</LicenceNumber>
    <ProductName>Brasivol Medium</ProductName>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>01/10/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous paste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aluminium oxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/05/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/025/001</DrugIDPK>
    <LicenceNumber>PA0179/025/001</LicenceNumber>
    <ProductName>Braunoderm Coloured</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>05/06/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Povidone-iodine</ActiveSubstance>
      <ActiveSubstance>Isopropanol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/08/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/025/002</DrugIDPK>
    <LicenceNumber>PA0179/025/002</LicenceNumber>
    <ProductName>Braunoderm Non-Coloured</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>08/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Iodinated povidone</ActiveSubstance>
      <ActiveSubstance>Isopropyl alcohol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/08/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/027/001</DrugIDPK>
    <LicenceNumber>PA0179/027/001</LicenceNumber>
    <ProductName>Braunol</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>05/06/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Povidone-iodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/08/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/026/002</DrugIDPK>
    <LicenceNumber>PA0179/026/002</LicenceNumber>
    <ProductName>Braunosan</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>05/06/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Povidone-iodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/08/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/024/001</DrugIDPK>
    <LicenceNumber>PA0179/024/001</LicenceNumber>
    <ProductName>Braunovidon</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>05/06/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Povidone-iodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/08/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1009/019/001</DrugIDPK>
    <LicenceNumber>PA1009/019/001</LicenceNumber>
    <ProductName>BRAVELLE 75 IU powder and solvent for solution for injection</ProductName>
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>09/01/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Urofollitropin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/08/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2010/027/005</DrugIDPK>
    <LicenceNumber>PA2010/027/005</LicenceNumber>
    <ProductName>BREAKYL 1200 microgram buccal film</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>03/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Buccal film</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>03/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2010/027/001</DrugIDPK>
    <LicenceNumber>PA2010/027/001</LicenceNumber>
    <ProductName>BREAKYL 200 microgram buccal film</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>03/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Buccal film</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>03/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2010/027/002</DrugIDPK>
    <LicenceNumber>PA2010/027/002</LicenceNumber>
    <ProductName>BREAKYL 400 microgram buccal film</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>03/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Buccal film</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>03/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2010/027/003</DrugIDPK>
    <LicenceNumber>PA2010/027/003</LicenceNumber>
    <ProductName>BREAKYL 600 microgram buccal film</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>03/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Buccal film</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>03/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2010/027/004</DrugIDPK>
    <LicenceNumber>PA2010/027/004</LicenceNumber>
    <ProductName>BREAKYL 800 microgram buccal film</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>03/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Buccal film</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>03/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2010/027/006</DrugIDPK>
    <LicenceNumber>PA2010/027/006</LicenceNumber>
    <ProductName>BREAKYL Start 200, 400, 600, 800 microgram buccal film</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>03/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Buccal film</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTANYL CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>05/11/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/030/001</DrugIDPK>
    <LicenceNumber>PA0077/030/001</LicenceNumber>
    <ProductName>BREOPRIN</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/053/001</DrugIDPK>
    <LicenceNumber>PA1077/053/001</LicenceNumber>
    <ProductName>BRETYLATE</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>20/12/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BRETYLIUM TOSILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/12/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/068/001</DrugIDPK>
    <LicenceNumber>PA0017/068/001</LicenceNumber>
    <ProductName>BRETYLATE</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BRETYLIUM TOSILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/11/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0200/005/001</DrugIDPK>
    <LicenceNumber>PA0200/005/001</LicenceNumber>
    <ProductName>BRETYLOL</ProductName>
    <PAHolder>Du Pont De Nemours Intern.S.A.</PAHolder>
    <AuthorisedDate>18/05/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BRETYLIUM TOSILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/02/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/099/001</DrugIDPK>
    <LicenceNumber>PA0167/099/001</LicenceNumber>
    <ProductName>Brevibloc 100mg/10ml Solution for Injection</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>08/09/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Esmolol Hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/05/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/099/002</DrugIDPK>
    <LicenceNumber>PA0167/099/002</LicenceNumber>
    <ProductName>Brevibloc Concentrate</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>08/09/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Esmolol Hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/048/001</DrugIDPK>
    <LicenceNumber>PA0040/048/001</LicenceNumber>
    <ProductName>BREVIDIL E</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>25/08/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/049/002</DrugIDPK>
    <LicenceNumber>PA0040/049/002</LicenceNumber>
    <ProductName>BREVIDIL M</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>01/04/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/049/001</DrugIDPK>
    <LicenceNumber>PA0040/049/001</LicenceNumber>
    <ProductName>BREVIDIL M</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>01/04/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/01/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/018/001</DrugIDPK>
    <LicenceNumber>PA0936/018/001</LicenceNumber>
    <ProductName>Brevinor Tablets</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>07/03/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Norethisterone</ActiveSubstance>
      <ActiveSubstance>Ethinylestradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/07/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1465/001/001</DrugIDPK>
    <LicenceNumber>DPR1465/001/001</LicenceNumber>
    <ProductName>Brevoxyl</ProductName>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>25/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzoyl Peroxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1465/027/001</DrugIDPK>
    <LicenceNumber>DPR1465/027/001</LicenceNumber>
    <ProductName>Brevoxyl</ProductName>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>04/12/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzoyl Peroxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0743/010/003</DrugIDPK>
    <LicenceNumber>PA0743/010/003</LicenceNumber>
    <ProductName>BREXIDOL</ProductName>
    <PAHolder>Chiesi Limited</PAHolder>
    <AuthorisedDate>30/08/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Piroxicam beta-cyclodextrin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/09/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0743/010/001</DrugIDPK>
    <LicenceNumber>PA0743/010/001</LicenceNumber>
    <ProductName>BREXIDOL SACHETS</ProductName>
    <PAHolder>Chiesi Limited</PAHolder>
    <AuthorisedDate>14/08/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIROXICAM BETADEX</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/08/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0743/010/002</DrugIDPK>
    <LicenceNumber>PA0743/010/002</LicenceNumber>
    <ProductName>BREXIDOL TABLETS</ProductName>
    <PAHolder>Chiesi Limited</PAHolder>
    <AuthorisedDate>14/08/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Piroxicam beta-cyclodextrin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/08/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/305/002</DrugIDPK>
    <LicenceNumber>PA0711/305/002</LicenceNumber>
    <ProductName>Briaseta 10 mg film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>07/01/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ambrisentan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/09/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/305/001</DrugIDPK>
    <LicenceNumber>PA0711/305/001</LicenceNumber>
    <ProductName>Briaseta 5 mg film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>07/01/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ambrisentan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/09/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/036/007</DrugIDPK>
    <LicenceNumber>PA0970/036/007</LicenceNumber>
    <ProductName>Bricanyl</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Terbutaline sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/036/003</DrugIDPK>
    <LicenceNumber>PA0970/036/003</LicenceNumber>
    <ProductName>BRICANYL</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Terbutaline sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/036/006</DrugIDPK>
    <LicenceNumber>PA0970/036/006</LicenceNumber>
    <ProductName>BRICANYL</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>01/04/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Terbutaline sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/10/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0009/004/002</DrugIDPK>
    <LicenceNumber>PA0009/004/002</LicenceNumber>
    <ProductName>BRICANYL</ProductName>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>12/01/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/01/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0009/006/001</DrugIDPK>
    <LicenceNumber>PA0009/006/001</LicenceNumber>
    <ProductName>BRICANYL COMPOUND</ProductName>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>28/02/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/09/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/035/001</DrugIDPK>
    <LicenceNumber>PA0970/035/001</LicenceNumber>
    <ProductName>BRICANYL EXPECTORANT</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>01/04/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Terbutaline sulfate</ActiveSubstance>
      <ActiveSubstance>Guaiphenesin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/10/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/036/001</DrugIDPK>
    <LicenceNumber>PA0970/036/001</LicenceNumber>
    <ProductName>BRICANYL INHALER</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>01/04/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Terbutaline sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/10/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0009/004/001</DrugIDPK>
    <LicenceNumber>PA0009/004/001</LicenceNumber>
    <ProductName>BRICANYL RESPIRATOR</ProductName>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>14/07/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TERBUTALINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/07/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/036/004</DrugIDPK>
    <LicenceNumber>PA0970/036/004</LicenceNumber>
    <ProductName>Bricanyl Respules</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>01/09/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Terbutaline sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/06/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/037/001</DrugIDPK>
    <LicenceNumber>PA0970/037/001</LicenceNumber>
    <ProductName>Bricanyl SA</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>23/02/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Terbutaline sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/10/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/036/005</DrugIDPK>
    <LicenceNumber>PA0970/036/005</LicenceNumber>
    <ProductName>Bricanyl Spacer Inhaler</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Terbutaline sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/088/001</DrugIDPK>
    <LicenceNumber>PPA0465/088/001</LicenceNumber>
    <ProductName>Bricanyl Turbohaler</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>07/02/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Powder, Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Terbutaline sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/055/001</DrugIDPK>
    <LicenceNumber>PPA1328/055/001</LicenceNumber>
    <ProductName>Bricanyl Turbohaler</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>12/01/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Terbutaline sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/032/001</DrugIDPK>
    <LicenceNumber>PPA1463/032/001</LicenceNumber>
    <ProductName>Bricanyl Turbohaler</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>12/03/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Terbutaline sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/05/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/060/001</DrugIDPK>
    <LicenceNumber>PPA1500/060/001</LicenceNumber>
    <ProductName>Bricanyl Turbohaler</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>20/08/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Terbutaline sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/069/001</DrugIDPK>
    <LicenceNumber>PPA1562/069/001</LicenceNumber>
    <ProductName>Bricanyl Turbohaler</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>07/10/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Terbutaline sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/043/001</DrugIDPK>
    <LicenceNumber>PPA1659/043/001</LicenceNumber>
    <ProductName>Bricanyl Turbohaler</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>26/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Terbutaline sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/175/001</DrugIDPK>
    <LicenceNumber>PPA1151/175/001</LicenceNumber>
    <ProductName>Bricanyl Turbohaler 500 micrograms per metered dose, inhalation powder</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>03/08/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Terbutaline sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1473/029/001</DrugIDPK>
    <LicenceNumber>PPA1473/029/001</LicenceNumber>
    <ProductName>Bricanyl Turbohaler 500 micrograms per metered dose, inhalation powder</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>02/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Terbutaline sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/03/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/217/004</DrugIDPK>
    <LicenceNumber>PA2315/217/004</LicenceNumber>
    <InterchangeableListCode>IC0110-024-001</InterchangeableListCode>
    <ProductName>Brieka 100 mg hard capsules</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>07/08/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pregabalin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/217/005</DrugIDPK>
    <LicenceNumber>PA2315/217/005</LicenceNumber>
    <InterchangeableListCode>IC0110-062-001</InterchangeableListCode>
    <ProductName>Brieka 150 mg hard capsules</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>07/08/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pregabalin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/217/006</DrugIDPK>
    <LicenceNumber>PA2315/217/006</LicenceNumber>
    <InterchangeableListCode>IC0110-067-001</InterchangeableListCode>
    <ProductName>Brieka 200 mg hard capsules</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>07/08/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pregabalin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/217/007</DrugIDPK>
    <LicenceNumber>PA2315/217/007</LicenceNumber>
    <ProductName>Brieka 225 mg Hard Capsules</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>07/08/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pregabalin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/07/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/217/001</DrugIDPK>
    <LicenceNumber>PA2315/217/001</LicenceNumber>
    <InterchangeableListCode>IC0110-022-001</InterchangeableListCode>
    <ProductName>Brieka 25 mg hard capsules</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>07/08/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pregabalin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/02/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/217/008</DrugIDPK>
    <LicenceNumber>PA2315/217/008</LicenceNumber>
    <InterchangeableListCode>IC0110-029-001</InterchangeableListCode>
    <ProductName>Brieka 300 mg hard capsules</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>07/08/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pregabalin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/217/002</DrugIDPK>
    <LicenceNumber>PA2315/217/002</LicenceNumber>
    <InterchangeableListCode>IC0110-023-001</InterchangeableListCode>
    <ProductName>Brieka 50 mg hard capsules</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>07/08/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pregabalin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/217/003</DrugIDPK>
    <LicenceNumber>PA2315/217/003</LicenceNumber>
    <InterchangeableListCode>IC0110-028-001</InterchangeableListCode>
    <ProductName>Brieka 75 mg hard capsules</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>07/08/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pregabalin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/062/003</DrugIDPK>
    <LicenceNumber>PA0047/062/003</LicenceNumber>
    <ProductName>BRIETAL SODIUM</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOHEXITAL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/062/002</DrugIDPK>
    <LicenceNumber>PA0047/062/002</LicenceNumber>
    <ProductName>BRIETAL SODIUM</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/01/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/062/001</DrugIDPK>
    <LicenceNumber>PA0047/062/001</LicenceNumber>
    <ProductName>BRIETAL SODIUM</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHOHEXITAL SODIUM</ActiveSubstance>
      <ActiveSubstance>SODIUM CARBONATE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/01/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/119/001</DrugIDPK>
    <LicenceNumber>PA0711/119/001</LicenceNumber>
    <ProductName>Brimon</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>12/10/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Brimonidine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/02/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/011/001</DrugIDPK>
    <LicenceNumber>PA0013/011/001</LicenceNumber>
    <ProductName>BRINALDIX</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/012/001</DrugIDPK>
    <LicenceNumber>PA0013/012/001</LicenceNumber>
    <ProductName>BRINALDIX K</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPAMIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>DOCUSATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/01/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/011/004</DrugIDPK>
    <LicenceNumber>PA0062/011/004</LicenceNumber>
    <ProductName>BROCADOPA</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/011/003</DrugIDPK>
    <LicenceNumber>PA0062/011/003</LicenceNumber>
    <ProductName>BROCADOPA</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/011/002</DrugIDPK>
    <LicenceNumber>PA0062/011/002</LicenceNumber>
    <ProductName>BROCADOPA</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/011/001</DrugIDPK>
    <LicenceNumber>PA0062/011/001</LicenceNumber>
    <ProductName>BROCADOPA</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/011/005</DrugIDPK>
    <LicenceNumber>PA0062/011/005</LicenceNumber>
    <ProductName>BROCADOPA TEM</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/07/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1097/046/001</DrugIDPK>
    <LicenceNumber>PPA1097/046/001</LicenceNumber>
    <ProductName>Brolene 0.1% w/v Eye Drops Solution</ProductName>
    <PAHolder>Lexon (UK) Ltd</PAHolder>
    <AuthorisedDate>04/05/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Propamidine isetionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/176/001</DrugIDPK>
    <LicenceNumber>PPA1151/176/001</LicenceNumber>
    <ProductName>Brolene 0.1% w/v Eye Drops Solution</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>08/06/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Propamidine isetionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/026/001</DrugIDPK>
    <LicenceNumber>PA0077/026/001</LicenceNumber>
    <ProductName>BROLINCTUS</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMMONIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN</ActiveSubstance>
      <ActiveSubstance>IPECACUANHA FLUID EXTRACT</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/03/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/018/003</DrugIDPK>
    <LicenceNumber>PA0711/018/003</LicenceNumber>
    <ProductName>BROMOX</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>23/01/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMOCRIPTINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/018/002</DrugIDPK>
    <LicenceNumber>PA0711/018/002</LicenceNumber>
    <ProductName>BROMOX</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>23/01/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMOCRIPTINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/018/001</DrugIDPK>
    <LicenceNumber>PA0711/018/001</LicenceNumber>
    <ProductName>BROMOX</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>23/01/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMOCRIPTINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0258/020/001</DrugIDPK>
    <LicenceNumber>PA0258/020/001</LicenceNumber>
    <ProductName>BRONALIN EXPECTORANT</ProductName>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ammonium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium citrate</ActiveSubstance>
      <ActiveSubstance>Diphenhydramine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/11/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0309/003/001</DrugIDPK>
    <LicenceNumber>PA0309/003/001</LicenceNumber>
    <ProductName>BRONCONOVAG</ProductName>
    <PAHolder>Medical &amp; Pharmaceutical Sales C</PAHolder>
    <AuthorisedDate>03/09/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>BROMHEXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0309/003/002</DrugIDPK>
    <LicenceNumber>PA0309/003/002</LicenceNumber>
    <ProductName>BRONCONOVAG EXTEMPORANEOUS (SUSPENSION)</ProductName>
    <PAHolder>Medical &amp; Pharmaceutical Sales C</PAHolder>
    <AuthorisedDate>03/09/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXICILLIN TRIHYDRATE</ActiveSubstance>
      <ActiveSubstance>BROMHEXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0060/004/003</DrugIDPK>
    <LicenceNumber>PA0060/004/003</LicenceNumber>
    <ProductName>BRONSECUR</ProductName>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>24/08/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0060/004/004</DrugIDPK>
    <LicenceNumber>PA0060/004/004</LicenceNumber>
    <ProductName>BRONSECUR LIQUID CONCENTRATE</ProductName>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>24/08/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0062/012/001</DrugIDPK>
    <LicenceNumber>PA0062/012/001</LicenceNumber>
    <ProductName>BRONTINA</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/013/001</DrugIDPK>
    <LicenceNumber>PA0062/013/001</LicenceNumber>
    <ProductName>BRONTISOL</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0398/008/001</DrugIDPK>
    <LicenceNumber>PA0398/008/001</LicenceNumber>
    <ProductName>BROOKLAX</ProductName>
    <PAHolder>Intercare Products Ltd</PAHolder>
    <AuthorisedDate>20/03/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>YELLOW PHENOLPHTHALEIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/01/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/21/1534/001-002</DrugIDPK>
    <LicenceNumber>EU/1/21/1534/001-002</LicenceNumber>
    <ProductName>BroPair® Spiromax®</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>26/03/2021</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
      <ActiveSubstance>Fluticasone propionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/06/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/21/1534/003-004</DrugIDPK>
    <LicenceNumber>EU/1/21/1534/003-004</LicenceNumber>
    <ProductName>BroPair® Spiromax®</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>26/03/2021</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALMETEROL XINAFOATE</ActiveSubstance>
      <ActiveSubstance>Fluticasone propionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/06/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0114/019/001</DrugIDPK>
    <LicenceNumber>PA0114/019/001</LicenceNumber>
    <ProductName>BROVON INHALANT</ProductName>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPINEPHRINE</ActiveSubstance>
      <ActiveSubstance>ATROPINE METHONITRATE</ActiveSubstance>
      <ActiveSubstance>PAPAVERINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/080/001</DrugIDPK>
    <LicenceNumber>PA0038/080/001</LicenceNumber>
    <ProductName>BRUFEN</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>19/10/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/05/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0384/006/001</DrugIDPK>
    <LicenceNumber>PPA0384/006/001</LicenceNumber>
    <ProductName>BRUFEN</ProductName>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>02/12/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/10/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0769/002/007</DrugIDPK>
    <LicenceNumber>PA0769/002/007</LicenceNumber>
    <ProductName>BRUFEN</ProductName>
    <PAHolder>Knoll Limited</PAHolder>
    <AuthorisedDate>18/09/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0004/003/002</DrugIDPK>
    <LicenceNumber>PA0004/003/002</LicenceNumber>
    <ProductName>BRUFEN  (SUSPENSION)</ProductName>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>16/02/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/03/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2010/002/003</DrugIDPK>
    <LicenceNumber>PA2010/002/003</LicenceNumber>
    <ProductName>Brufen 200 mg Effervescent Granules</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>17/05/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>Supply through pharmacies and promotion to the public only if compliant with the following restrictions: maximum strength: 200 mg; maximum pack size 50; maximum dose: 400 mg; maximum daily dose 1200 mg; limited indications.</SupplyComments>
    <WithdrawalDate>18/02/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2010/002/004</DrugIDPK>
    <LicenceNumber>PA2010/002/004</LicenceNumber>
    <ProductName>Brufen 400 mg effervescent Granules</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>18/01/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription, supply through pharmacies only and promotion to the public subject to the following restrictions: maximum strength 400 mg, maximum pack size 24, maximum dose: 400 mg, maximum daily dose 1200 mg, limited indicati</SupplyComments>
    <WithdrawalDate>18/02/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2010/002/005</DrugIDPK>
    <LicenceNumber>PA2010/002/005</LicenceNumber>
    <ProductName>Brufen 600mg Effervescent Granules</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>21/06/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/10/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0769/002/001</DrugIDPK>
    <LicenceNumber>PA0769/002/001</LicenceNumber>
    <ProductName>BRUFEN GRANULES</ProductName>
    <PAHolder>Knoll Limited</PAHolder>
    <AuthorisedDate>28/06/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1071/013/001A</DrugIDPK>
    <LicenceNumber>PPA1071/013/001A</LicenceNumber>
    <ProductName>Brufen Retard</ProductName>
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/10/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0903/001/001</DrugIDPK>
    <LicenceNumber>PA0903/001/001</LicenceNumber>
    <ProductName>Brulidine</ProductName>
    <PAHolder>Manx Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dibromopropamidine isethionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/065/001</DrugIDPK>
    <LicenceNumber>PA0040/065/001</LicenceNumber>
    <ProductName>BRULIDINE</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIBROMPROPAMIDINE ISETIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/03/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/225/002</DrugIDPK>
    <LicenceNumber>PA0711/225/002</LicenceNumber>
    <ProductName>Brupro 200 mg Soft capsules</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>12/06/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription, supply through pharmacies only and promotion to the public subject to the

following restrictions: 200 mg; maximum pack size 50; maximum dose: 400 mg; maximum daily dose 1200 mg; limited indications.</SupplyComments>
    <WithdrawalDate>02/10/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/225/001</DrugIDPK>
    <LicenceNumber>PA0711/225/001</LicenceNumber>
    <ProductName>Brupro for Children</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>07/03/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/09/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/225/003</DrugIDPK>
    <LicenceNumber>PA0711/225/003</LicenceNumber>
    <ProductName>Brupro Max 400 mg, Soft capsules</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>12/06/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription, supply through pharmacies only and promotion to the public subject to the

following restrictions: maximum strength 400 mg, maximum pack size 24, maximum dose: 400 mg, maximum daily dose 1200 mg, limited indic</SupplyComments>
    <WithdrawalDate>02/10/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0696/005/001</DrugIDPK>
    <LicenceNumber>PA0696/005/001</LicenceNumber>
    <ProductName>BRUSH-OFF COLD SORE TREATMENT</ProductName>
    <PAHolder>Seton Healthcare Group PLC</PAHolder>
    <AuthorisedDate>02/06/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Povidone-iodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/07/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR0407/026/001</DrugIDPK>
    <LicenceNumber>HOR0407/026/001</LicenceNumber>
    <ProductName>Bryonia</ProductName>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>10/09/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bryonia</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0290/005/001</DrugIDPK>
    <LicenceNumber>PA0290/005/001</LicenceNumber>
    <ProductName>BSS (Balanced Salt Solution)</ProductName>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Sodium acetate</ActiveSubstance>
      <ActiveSubstance>Sodium citrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/02/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0943/016/001</DrugIDPK>
    <LicenceNumber>PA0943/016/001</LicenceNumber>
    <ProductName>Buccastem</ProductName>
    <PAHolder>Alliance Pharmaceuticals Ltd.</PAHolder>
    <AuthorisedDate>18/12/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Buccal tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Prochlorperazine maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/02/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0129/002/001</DrugIDPK>
    <LicenceNumber>PA0129/002/001</LicenceNumber>
    <ProductName>BUDALE</ProductName>
    <PAHolder>Dales Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/12/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1831/001/001</DrugIDPK>
    <LicenceNumber>PA1831/001/001</LicenceNumber>
    <ProductName>Budesitan 0.5mg/2ml Nebuliser Suspension</ProductName>
    <PAHolder>Breath Limited</PAHolder>
    <AuthorisedDate>28/09/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Budesonide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/01/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1831/001/002</DrugIDPK>
    <LicenceNumber>PA1831/001/002</LicenceNumber>
    <ProductName>Budesitan 1.0mg/2ml Nebuliser Suspension</ProductName>
    <PAHolder>Breath Limited</PAHolder>
    <AuthorisedDate>28/09/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Budesonide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/01/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/14/948/001</DrugIDPK>
    <LicenceNumber>EU/1/14/948/001</LicenceNumber>
    <ProductName>Budesonide/Formoterol Teva</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>19/11/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Formoterol fumarate dihydrate</ActiveSubstance>
      <ActiveSubstance>Budesonide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/14/950/001</DrugIDPK>
    <LicenceNumber>EU/1/14/950/001</LicenceNumber>
    <ProductName>Budesonide/Formoterol Teva Pharma B.V.</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>19/11/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Budesonide</ActiveSubstance>
      <ActiveSubstance>Formoterol fumarate dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/14/950/002</DrugIDPK>
    <LicenceNumber>EU/1/14/950/002</LicenceNumber>
    <ProductName>Budesonide/Formoterol Teva Pharma B.V.</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>19/11/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Budesonide</ActiveSubstance>
      <ActiveSubstance>Formoterol fumarate dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/141/001</DrugIDPK>
    <LicenceNumber>PA0749/141/001</LicenceNumber>
    <ProductName>Budesonide Teva 0.5 mg/2 ml Nebuliser Suspension</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>11/03/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Budesonide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/07/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/207/001</DrugIDPK>
    <LicenceNumber>PA0749/207/001</LicenceNumber>
    <ProductName>Budesonide Teva Pharma 0.25 mg/2 ml Nebuliser Suspension</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>07/03/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Budesonide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/02/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/061/001</DrugIDPK>
    <LicenceNumber>PA0970/061/001</LicenceNumber>
    <ProductName>Budfor</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>07/01/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Budesonide</ActiveSubstance>
      <ActiveSubstance>Formoterol fumatrate dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/061/002</DrugIDPK>
    <LicenceNumber>PA0970/061/002</LicenceNumber>
    <ProductName>Budfor</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>07/01/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Budesonide</ActiveSubstance>
      <ActiveSubstance>Formoterol fumatrate dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/061/003</DrugIDPK>
    <LicenceNumber>PA0970/061/003</LicenceNumber>
    <ProductName>Budfor</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>07/01/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Budesonide</ActiveSubstance>
      <ActiveSubstance>Formoterol fumatrate dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/040/001</DrugIDPK>
    <LicenceNumber>PA0057/040/001</LicenceNumber>
    <ProductName>BUF ACNE</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>11/12/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1327/018/001</DrugIDPK>
    <LicenceNumber>PA1327/018/001</LicenceNumber>
    <ProductName>Bufar Easyhaler, 80 micrograms/4.5 micrograms/inhalation, inhalation powder</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>11/03/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Budesonide</ActiveSubstance>
      <ActiveSubstance>Formoterol fumarate dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/063/001</DrugIDPK>
    <LicenceNumber>PA0073/063/001</LicenceNumber>
    <ProductName>Bufigen</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>13/05/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/02/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/063/002</DrugIDPK>
    <LicenceNumber>PA0073/063/002</LicenceNumber>
    <ProductName>Bufigen</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>13/05/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/02/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/063/003</DrugIDPK>
    <LicenceNumber>PA0073/063/003</LicenceNumber>
    <ProductName>BUFIGEN</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>10/06/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/02/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/001/005</DrugIDPK>
    <LicenceNumber>PA0167/001/005</LicenceNumber>
    <ProductName>BUMINATE 5.0%</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>16/01/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/001/004</DrugIDPK>
    <LicenceNumber>PA0167/001/004</LicenceNumber>
    <ProductName>BUMINATE 5.0%</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>16/01/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/001/003</DrugIDPK>
    <LicenceNumber>PA0167/001/003</LicenceNumber>
    <ProductName>BUNINATE 5/0%</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>16/01/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HUMAN ALBUMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/103/001</DrugIDPK>
    <LicenceNumber>PA0073/103/001</LicenceNumber>
    <ProductName>Bupivacaine &amp; Adrenaline</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>20/01/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Adrenaline acid tartrate</ActiveSubstance>
      <ActiveSubstance>Bupivacaine hydrochloride, monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/01/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/103/002</DrugIDPK>
    <LicenceNumber>PA0073/103/002</LicenceNumber>
    <ProductName>Bupivacaine &amp; Adrenaline</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>20/01/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Adrenaline acid tartrate</ActiveSubstance>
      <ActiveSubstance>Bupivacaine hydrochloride, monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/01/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/058/001</DrugIDPK>
    <LicenceNumber>PA2315/058/001</LicenceNumber>
    <ProductName>Bupivacaine 2.5 mg/ml solution for injection</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>19/05/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bupivacaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/058/002</DrugIDPK>
    <LicenceNumber>PA2315/058/002</LicenceNumber>
    <ProductName>Bupivacaine 5 mg/ml solution for injection</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>19/05/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bupivacaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1897/001/001</DrugIDPK>
    <LicenceNumber>PA1897/001/001</LicenceNumber>
    <ProductName>Bupivacaine Amneal</ProductName>
    <PAHolder>Amneal Pharma Europe Limited</PAHolder>
    <AuthorisedDate>28/06/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bupivacaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/10/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1897/001/002</DrugIDPK>
    <LicenceNumber>PA1897/001/002</LicenceNumber>
    <ProductName>Bupivacaine Amneal</ProductName>
    <PAHolder>Amneal Pharma Europe Limited</PAHolder>
    <AuthorisedDate>28/06/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bupivacaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/10/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2272/001/001</DrugIDPK>
    <LicenceNumber>PA2272/001/001</LicenceNumber>
    <ProductName>Bupivacaine Heavy 5 mg/ml Solution for Injection</ProductName>
    <PAHolder>Panpharma</PAHolder>
    <AuthorisedDate>28/06/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bupivacaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/07/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/091/004</DrugIDPK>
    <LicenceNumber>PA0073/091/004</LicenceNumber>
    <ProductName>Bupivacaine Hydrochloide</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>26/03/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bupivacaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/03/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/091/003</DrugIDPK>
    <LicenceNumber>PA0073/091/003</LicenceNumber>
    <ProductName>Bupivacaine Hydrochloride</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>26/03/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bupivacaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/03/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/091/007</DrugIDPK>
    <LicenceNumber>PA0073/091/007</LicenceNumber>
    <ProductName>Bupivacaine Hydrochloride</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>21/09/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bupivacaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/09/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/091/009</DrugIDPK>
    <LicenceNumber>PA0073/091/009</LicenceNumber>
    <ProductName>Bupivacaine Hydrochloride</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>21/09/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bupivacaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/09/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/091/015</DrugIDPK>
    <LicenceNumber>PA0073/091/015</LicenceNumber>
    <ProductName>Bupivacaine Hydrochloride</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>20/04/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bupivacaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/04/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/091/016</DrugIDPK>
    <LicenceNumber>PA0073/091/016</LicenceNumber>
    <ProductName>Bupivacaine Hydrochloride</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>20/04/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bupivacaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/04/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/112/001</DrugIDPK>
    <LicenceNumber>PA0167/112/001</LicenceNumber>
    <ProductName>Bupivacaine Hydrochloride</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>02/05/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bupivacaine hydrochloride, monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/05/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/112/002</DrugIDPK>
    <LicenceNumber>PA0167/112/002</LicenceNumber>
    <ProductName>Bupivacaine Hydrochloride</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>02/05/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bupivacaine hydrochloride, monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/05/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/019/001</DrugIDPK>
    <LicenceNumber>PA0437/019/001</LicenceNumber>
    <ProductName>BUPIVACAINE HYDROCHLORIDE</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>07/03/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUPIVACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/091/013</DrugIDPK>
    <LicenceNumber>PA0073/091/013</LicenceNumber>
    <ProductName>Bupivacaine Hydrochloride B.P. 0.75% w/v</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>06/04/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bupivacaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/04/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/091/011</DrugIDPK>
    <LicenceNumber>PA0073/091/011</LicenceNumber>
    <ProductName>Bupivacaine Hydrochloride BP 0.375%</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>06/04/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bupivacaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/04/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/019/002</DrugIDPK>
    <LicenceNumber>PA0437/019/002</LicenceNumber>
    <ProductName>BUPIVACINE HYDROCHLORIDE INJECTION</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>07/03/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
      <ActiveSubstance>BUPIVACAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/087/003</DrugIDPK>
    <LicenceNumber>PA1380/087/003</LicenceNumber>
    <ProductName>Buplex Junior</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>26/06/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/05/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/088/004</DrugIDPK>
    <LicenceNumber>PA1380/088/004</LicenceNumber>
    <ProductName>Buplex Rx</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>31/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/10/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0399/003/002</DrugIDPK>
    <LicenceNumber>PA0399/003/002</LicenceNumber>
    <ProductName>BUPROFAN</ProductName>
    <PAHolder>Fannin &amp; Company Ltd</PAHolder>
    <AuthorisedDate>15/08/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/09/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/059/003</DrugIDPK>
    <LicenceNumber>PA0046/059/003</LicenceNumber>
    <ProductName>BURAM FORTE</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>10/06/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUMETANIDE</ActiveSubstance>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/059/001</DrugIDPK>
    <LicenceNumber>PA0046/059/001</LicenceNumber>
    <ProductName>Buram Tablets</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>15/02/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bumetanide</ActiveSubstance>
      <ActiveSubstance>AMILORIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/016/010</DrugIDPK>
    <LicenceNumber>PA0046/016/010</LicenceNumber>
    <ProductName>BURINEX</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>28/04/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUMETANIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/09/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/016/009</DrugIDPK>
    <LicenceNumber>PA0046/016/009</LicenceNumber>
    <ProductName>BURINEX</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>28/04/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUMETANIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/12/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/016/008</DrugIDPK>
    <LicenceNumber>PA0046/016/008</LicenceNumber>
    <ProductName>BURINEX</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>18/04/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUMETANIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/11/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/016/007</DrugIDPK>
    <LicenceNumber>PA0046/016/007</LicenceNumber>
    <ProductName>BURINEX</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>26/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUMETANIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/07/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/016/006</DrugIDPK>
    <LicenceNumber>PA0046/016/006</LicenceNumber>
    <ProductName>BURINEX</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>26/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUMETANIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/016/005</DrugIDPK>
    <LicenceNumber>PA0046/016/005</LicenceNumber>
    <ProductName>BURINEX</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUMETANIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/016/004</DrugIDPK>
    <LicenceNumber>PA0046/016/004</LicenceNumber>
    <ProductName>BURINEX</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUMETANIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/016/001</DrugIDPK>
    <LicenceNumber>PA0046/016/001</LicenceNumber>
    <ProductName>BURINEX</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/017/001</DrugIDPK>
    <LicenceNumber>PA0046/017/001</LicenceNumber>
    <ProductName>BURINEX K</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUMETANIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0258/009/001</DrugIDPK>
    <LicenceNumber>PA0258/009/001</LicenceNumber>
    <ProductName>Burnaid</ProductName>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aminacrine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1465/002/001</DrugIDPK>
    <LicenceNumber>DPR1465/002/001</LicenceNumber>
    <ProductName>Burneze</ProductName>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>25/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous spray, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzocaine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0158/012/001</DrugIDPK>
    <LicenceNumber>PA0158/012/001</LicenceNumber>
    <ProductName>BURNEZE</ProductName>
    <PAHolder>Charwell Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>07/01/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEPYRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1465/028/001</DrugIDPK>
    <LicenceNumber>DPR1465/028/001</LicenceNumber>
    <ProductName>Burneze Spray</ProductName>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>04/12/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous spray, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzocaine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA22702/004/001</DrugIDPK>
    <LicenceNumber>PA22702/004/001</LicenceNumber>
    <ProductName>Burneze Spray</ProductName>
    <PAHolder>LanesHealth (Ireland) Limited</PAHolder>
    <AuthorisedDate>09/07/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous spray, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzocaine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/04/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0058/016/006</DrugIDPK>
    <LicenceNumber>PA0058/016/006</LicenceNumber>
    <ProductName>BURONIL</ProductName>
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>25/11/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELPERONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0058/016/005</DrugIDPK>
    <LicenceNumber>PA0058/016/005</LicenceNumber>
    <ProductName>BURONIL</ProductName>
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>25/11/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELPERONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0058/016/004</DrugIDPK>
    <LicenceNumber>PA0058/016/004</LicenceNumber>
    <ProductName>BURONIL</ProductName>
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>25/11/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELPERONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0058/016/003</DrugIDPK>
    <LicenceNumber>PA0058/016/003</LicenceNumber>
    <ProductName>BURONIL</ProductName>
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>25/11/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELPERONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0058/016/002</DrugIDPK>
    <LicenceNumber>PA0058/016/002</LicenceNumber>
    <ProductName>BURONIL</ProductName>
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>25/11/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MELPERONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/026/002</DrugIDPK>
    <LicenceNumber>PA1986/026/002</LicenceNumber>
    <ProductName>Busiete 10 micrograms/hour transdermal patch</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>25/11/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Buprenorphine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>31/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/026/003</DrugIDPK>
    <LicenceNumber>PA1986/026/003</LicenceNumber>
    <ProductName>Busiete 20 micrograms/hour transdermal patch</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>25/11/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Buprenorphine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>31/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/026/001</DrugIDPK>
    <LicenceNumber>PA1986/026/001</LicenceNumber>
    <ProductName>Busiete 5 micrograms/hour transdermal patch</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>25/11/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Buprenorphine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>31/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/03/254/001</DrugIDPK>
    <LicenceNumber>EU/1/03/254/001</LicenceNumber>
    <ProductName>BUSILVEX</ProductName>
    <PAHolder>Pierre Fabre Medicament</PAHolder>
    <AuthorisedDate>09/07/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Busulfan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/03/254/002</DrugIDPK>
    <LicenceNumber>EU/1/03/254/002</LicenceNumber>
    <ProductName>BUSILVEX</ProductName>
    <PAHolder>Pierre Fabre Medicament</PAHolder>
    <AuthorisedDate>09/07/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Busulfan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>09/01/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0303/027/002</DrugIDPK>
    <LicenceNumber>PA0303/027/002</LicenceNumber>
    <ProductName>BUSORIL</ProductName>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>31/10/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUSPIRONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0303/027/001</DrugIDPK>
    <LicenceNumber>PA0303/027/001</LicenceNumber>
    <ProductName>BUSORIL</ProductName>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>31/10/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUSPIRONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/024/001</DrugIDPK>
    <LicenceNumber>DPR0465/024/001</LicenceNumber>
    <ProductName>Buspar</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>20/01/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Buspirone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR0465/024/002</DrugIDPK>
    <LicenceNumber>DPR0465/024/002</LicenceNumber>
    <ProductName>Buspar</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>20/01/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Buspirone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1500/028/001</DrugIDPK>
    <LicenceNumber>DPR1500/028/001</LicenceNumber>
    <ProductName>Buspar</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>23/03/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Buspirone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1500/028/002</DrugIDPK>
    <LicenceNumber>DPR1500/028/002</LicenceNumber>
    <ProductName>Buspar</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>23/03/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Buspirone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1463/023/001</DrugIDPK>
    <LicenceNumber>DPR1463/023/001</LicenceNumber>
    <ProductName>BUSPAR</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>28/08/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Buspirone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1463/023/002</DrugIDPK>
    <LicenceNumber>DPR1463/023/002</LicenceNumber>
    <ProductName>BUSPAR</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>28/08/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Buspirone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/034/001</DrugIDPK>
    <LicenceNumber>DPR1473/034/001</LicenceNumber>
    <ProductName>BUSPAR</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>22/04/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Buspirone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/034/002</DrugIDPK>
    <LicenceNumber>DPR1473/034/002</LicenceNumber>
    <ProductName>BUSPAR</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>22/04/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Buspirone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0048/041/001</DrugIDPK>
    <LicenceNumber>PA0048/041/001</LicenceNumber>
    <ProductName>BUSPAR</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings)</PAHolder>
    <AuthorisedDate>12/12/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Buspirone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/041/002</DrugIDPK>
    <LicenceNumber>PA0048/041/002</LicenceNumber>
    <ProductName>BUSPAR</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings)</PAHolder>
    <AuthorisedDate>12/12/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Buspirone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0011/021/002</DrugIDPK>
    <LicenceNumber>PA0011/021/002</LicenceNumber>
    <ProductName>BUTACOTE</ProductName>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0011/021/001</DrugIDPK>
    <LicenceNumber>PA0011/021/001</LicenceNumber>
    <ProductName>BUTACOTE</ProductName>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0011/013/003</DrugIDPK>
    <LicenceNumber>PA0011/013/003</LicenceNumber>
    <ProductName>BUTAZOLIDIN</ProductName>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0011/013/002</DrugIDPK>
    <LicenceNumber>PA0011/013/002</LicenceNumber>
    <ProductName>BUTAZOLIDIN</ProductName>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0011/013/001</DrugIDPK>
    <LicenceNumber>PA0011/013/001</LicenceNumber>
    <ProductName>BUTAZOLIDIN</ProductName>
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/07/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0011/018/001</DrugIDPK>
    <LicenceNumber>PA0011/018/001</LicenceNumber>
    <ProductName>BUTAZOLIDIN ALKA</ProductName>
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/06/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0011/020/001</DrugIDPK>
    <LicenceNumber>PA0011/020/001</LicenceNumber>
    <ProductName>BUTAZOLIDIN R WITH XYLOCAINE R</ProductName>
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/06/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0891/004/001</DrugIDPK>
    <LicenceNumber>PA0891/004/001</LicenceNumber>
    <ProductName>Butenafine Hydrochloride 10 mg/g</ProductName>
    <PAHolder>UCB (Pharma) Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Butenafine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/03/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/010/004</DrugIDPK>
    <LicenceNumber>PA0048/010/004</LicenceNumber>
    <ProductName>BUTORPHANOL TARTRATE</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>20/12/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUTORPHANOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/12/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/010/002</DrugIDPK>
    <LicenceNumber>PA0048/010/002</LicenceNumber>
    <ProductName>BUTORPHANOL TARTRATE</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>12/01/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUTORPHANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/010/001</DrugIDPK>
    <LicenceNumber>PA0048/010/001</LicenceNumber>
    <ProductName>BUTORPHANOL TARTRATE</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>12/01/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUTORPHANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0584/002/001</DrugIDPK>
    <LicenceNumber>PA0584/002/001</LicenceNumber>
    <ProductName>Butovent Pulvinal</ProductName>
    <PAHolder>Chiesi Farmaceutici S.p.A.</PAHolder>
    <AuthorisedDate>13/07/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Powder, Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Salbutamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/194/002</DrugIDPK>
    <LicenceNumber>PPA1151/194/002</LicenceNumber>
    <ProductName>BuTrans 10 micrograms/hour transdermal patch</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>15/03/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Buprenorphine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>05/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/194/003</DrugIDPK>
    <LicenceNumber>PPA1151/194/003</LicenceNumber>
    <ProductName>BuTrans 20 micrograms/hour transdermal patch</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>15/03/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Buprenorphine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>05/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/194/001</DrugIDPK>
    <LicenceNumber>PPA1151/194/001</LicenceNumber>
    <ProductName>BuTrans 5 micrograms/hour transdermal patch</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>15/03/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Buprenorphine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>05/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0303/032/002</DrugIDPK>
    <LicenceNumber>PA0303/032/002</LicenceNumber>
    <ProductName>BUVENTOL EASYHALER</ProductName>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>05/09/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0303/032/001</DrugIDPK>
    <LicenceNumber>PA0303/032/001</LicenceNumber>
    <ProductName>BUVENTOL EASYHALER</ProductName>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>05/09/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/026/001</DrugIDPK>
    <LicenceNumber>PA0915/026/001</LicenceNumber>
    <ProductName>By-Madol</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>27/03/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/08/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/016/002</DrugIDPK>
    <LicenceNumber>PA0549/016/002</LicenceNumber>
    <InterchangeableListCode>IC0074-024-030</InterchangeableListCode>
    <ProductName>By-Madol SR 100 mg prolonged-release capsules, hard</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>27/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/016/003</DrugIDPK>
    <LicenceNumber>PA0549/016/003</LicenceNumber>
    <InterchangeableListCode>IC0074-062-030</InterchangeableListCode>
    <ProductName>By-Madol SR 150 mg prolonged-release capsules, hard</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>27/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/016/004</DrugIDPK>
    <LicenceNumber>PA0549/016/004</LicenceNumber>
    <InterchangeableListCode>IC0074-067-030</InterchangeableListCode>
    <ProductName>By-Madol SR 200 mg prolonged-release</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>27/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/016/001</DrugIDPK>
    <LicenceNumber>PA0549/016/001</LicenceNumber>
    <InterchangeableListCode>IC0074-023-030</InterchangeableListCode>
    <ProductName>By-Madol SR 50 mg prolonged-release capsules, hard</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>27/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1457/010/002</DrugIDPK>
    <LicenceNumber>PA1457/010/002</LicenceNumber>
    <ProductName>By-Mycin 100 mg Capsules</ProductName>
    <PAHolder>Fannin Limited</PAHolder>
    <AuthorisedDate>08/09/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline hyclate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1457/010/001</DrugIDPK>
    <LicenceNumber>PA1457/010/001</LicenceNumber>
    <ProductName>By-Mycin 50 mg Capsules</ProductName>
    <PAHolder>Fannin Limited</PAHolder>
    <AuthorisedDate>08/09/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline hyclate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1457/011/002</DrugIDPK>
    <LicenceNumber>PA1457/011/002</LicenceNumber>
    <InterchangeableListCode>IC0084-038-002</InterchangeableListCode>
    <ProductName>By-Vertin 16 mg Tablets</ProductName>
    <PAHolder>Fannin Limited</PAHolder>
    <AuthorisedDate>26/01/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betahistine dihydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1457/011/001</DrugIDPK>
    <LicenceNumber>PA1457/011/001</LicenceNumber>
    <InterchangeableListCode>IC0084-009-002</InterchangeableListCode>
    <ProductName>By-Vertin 8 mg Tablets</ProductName>
    <PAHolder>Fannin Limited</PAHolder>
    <AuthorisedDate>26/01/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betahistine dihydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/028/001</DrugIDPK>
    <LicenceNumber>PA0915/028/001</LicenceNumber>
    <ProductName>ByFluc</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>28/05/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fluconazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/028/002</DrugIDPK>
    <LicenceNumber>PA0915/028/002</LicenceNumber>
    <ProductName>ByFluc</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>28/05/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fluconazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/028/003</DrugIDPK>
    <LicenceNumber>PA0915/028/003</LicenceNumber>
    <ProductName>ByFluc</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>28/05/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fluconazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/131/001</DrugIDPK>
    <LicenceNumber>PA0749/131/001</LicenceNumber>
    <ProductName>ByLans</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>02/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lansoprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/01/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/131/002</DrugIDPK>
    <LicenceNumber>PA0749/131/002</LicenceNumber>
    <ProductName>ByLans</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>02/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lansoprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/01/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0966/016/001</DrugIDPK>
    <LicenceNumber>PA0966/016/001</LicenceNumber>
    <ProductName>Bymot Dispersible Tablets</ProductName>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>25/08/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lamotrigine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/07/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0966/016/002</DrugIDPK>
    <LicenceNumber>PA0966/016/002</LicenceNumber>
    <ProductName>Bymot Dispersible Tablets</ProductName>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>25/08/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lamotrigine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/07/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0966/016/003</DrugIDPK>
    <LicenceNumber>PA0966/016/003</LicenceNumber>
    <ProductName>Bymot Dispersible Tablets</ProductName>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>25/08/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lamotrigine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/07/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0966/016/004</DrugIDPK>
    <LicenceNumber>PA0966/016/004</LicenceNumber>
    <ProductName>Bymot Dispersible Tablets</ProductName>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>25/08/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lamotrigine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/07/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0966/016/005</DrugIDPK>
    <LicenceNumber>PA0966/016/005</LicenceNumber>
    <ProductName>Bymot Dispersible Tablets</ProductName>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>25/08/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lamotrigine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/07/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0966/016/006</DrugIDPK>
    <LicenceNumber>PA0966/016/006</LicenceNumber>
    <ProductName>Bymot Dispersible Tablets</ProductName>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>25/08/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lamotrigine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/07/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0966/015/001</DrugIDPK>
    <LicenceNumber>PA0966/015/001</LicenceNumber>
    <ProductName>BySec 10 mg gastro-resistant hard capsules</ProductName>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>13/05/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Omeprazole </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0966/015/002</DrugIDPK>
    <LicenceNumber>PA0966/015/002</LicenceNumber>
    <ProductName>BySec 20 mg gastro-resistant capsules, hard</ProductName>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>13/05/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Omeprazole </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/032/001</DrugIDPK>
    <LicenceNumber>PA0915/032/001</LicenceNumber>
    <ProductName>Bystat 10 mg Tablets</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>24/03/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pravastatin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/032/002</DrugIDPK>
    <LicenceNumber>PA0915/032/002</LicenceNumber>
    <ProductName>Bystat 20 mg Tablets</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>24/03/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pravastatin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/032/003</DrugIDPK>
    <LicenceNumber>PA0915/032/003</LicenceNumber>
    <ProductName>Bystat 40 mg Tablets</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>24/03/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pravastatin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/009/004</DrugIDPK>
    <LicenceNumber>PA0915/009/004</LicenceNumber>
    <ProductName>ByTrite</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>22/04/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ramipril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/009/001</DrugIDPK>
    <LicenceNumber>PA0915/009/001</LicenceNumber>
    <ProductName>ByTrite 1.25mg Capsules</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>22/04/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ramipril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/009/002</DrugIDPK>
    <LicenceNumber>PA0915/009/002</LicenceNumber>
    <ProductName>ByTrite 2.5mg Capsules</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>22/04/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ramipril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/009/003</DrugIDPK>
    <LicenceNumber>PA0915/009/003</LicenceNumber>
    <ProductName>ByTrite 5mg Capsules</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>22/04/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ramipril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0966/007/003</DrugIDPK>
    <LicenceNumber>PA0966/007/003</LicenceNumber>
    <ProductName>ByZestra 10 mg Tablets</ProductName>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>22/04/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lisinopril Dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/01/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0966/007/001</DrugIDPK>
    <LicenceNumber>PA0966/007/001</LicenceNumber>
    <ProductName>ByZestra 2.5 mg Tablets</ProductName>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>22/04/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lisinopril Dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/01/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0966/007/004</DrugIDPK>
    <LicenceNumber>PA0966/007/004</LicenceNumber>
    <ProductName>ByZestra 20 mg Tablets</ProductName>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>22/04/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lisinopril Dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/01/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0966/007/002</DrugIDPK>
    <LicenceNumber>PA0966/007/002</LicenceNumber>
    <ProductName>ByZestra 5 mg Tablets</ProductName>
    <PAHolder>Ergha Healthcare Ltd</PAHolder>
    <AuthorisedDate>22/04/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lisinopril Dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/01/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0617/002/001</DrugIDPK>
    <LicenceNumber>PA0617/002/001</LicenceNumber>
    <ProductName>C P D ANTICOAGULANT</ProductName>
    <PAHolder>NPBI B.V.</PAHolder>
    <AuthorisedDate>07/08/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACID PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/114/002</DrugIDPK>
    <LicenceNumber>PA0822/114/002</LicenceNumber>
    <ProductName>Cabaser 2 mg Tablet</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>29/10/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cabergoline </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/03/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0187/061/003</DrugIDPK>
    <LicenceNumber>PA0187/061/003</LicenceNumber>
    <ProductName>Cabaser 4mg Tablets</ProductName>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>29/10/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cabergoline </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/08/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/106/001</DrugIDPK>
    <LicenceNumber>PA1986/106/001</LicenceNumber>
    <ProductName>Cabazitaxel 10 mg/ml concentrate for solution for infusion</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>30/09/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cabazitaxel 2-propanol solvate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>16/04/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/096/001</DrugIDPK>
    <LicenceNumber>PA1986/096/001</LicenceNumber>
    <ProductName>Cabazitaxel Teva 10 mg/ml Concentrate for solution for infusion</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>27/11/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cabazitaxel</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription; See section 4.2 of the SmPC</SupplyComments>
    <WithdrawalDate>04/05/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1130/010/001</DrugIDPK>
    <LicenceNumber>PA1130/010/001</LicenceNumber>
    <ProductName>Caberex 1 Milligram Tablets</ProductName>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>08/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cabergoline </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1130/010/002</DrugIDPK>
    <LicenceNumber>PA1130/010/002</LicenceNumber>
    <ProductName>Caberex 2 Milligram Tablets</ProductName>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>08/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cabergoline </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1130/010/003</DrugIDPK>
    <LicenceNumber>PA1130/010/003</LicenceNumber>
    <ProductName>Caberex 4 Milligram Tablets</ProductName>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>08/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cabergoline </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1130/014/001</DrugIDPK>
    <LicenceNumber>PA1130/014/001</LicenceNumber>
    <ProductName>Cabergoline 0.5 Milligram Tablets</ProductName>
    <PAHolder>Arrow Generics Limited</PAHolder>
    <AuthorisedDate>08/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cabergoline </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0170/015/001</DrugIDPK>
    <LicenceNumber>PA0170/015/001</LicenceNumber>
    <ProductName>Cacit</ProductName>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>17/07/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/03/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0170/015/002</DrugIDPK>
    <LicenceNumber>PA0170/015/002</LicenceNumber>
    <ProductName>Cacit</ProductName>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>17/07/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/03/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0170/018/002</DrugIDPK>
    <LicenceNumber>PA0170/018/002</LicenceNumber>
    <ProductName>Cacit D3</ProductName>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>25/09/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/03/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0170/018/001</DrugIDPK>
    <LicenceNumber>PA0170/018/001</LicenceNumber>
    <ProductName>Cacit D3 500mg/440 IU Effervescent Granules for Or</ProductName>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>25/09/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/03/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/005/002</DrugIDPK>
    <LicenceNumber>PA0013/005/002</LicenceNumber>
    <ProductName>CAFERGOT</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERGOTAMINE TARTRATE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/09/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/005/001</DrugIDPK>
    <LicenceNumber>PA0013/005/001</LicenceNumber>
    <ProductName>CAFERGOT</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERGOTAMINE TARTRATE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/09/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/137/002</DrugIDPK>
    <LicenceNumber>PA0050/137/002</LicenceNumber>
    <ProductName>CAL-D-VITA CHEWABLE</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium</ActiveSubstance>
      <ActiveSubstance>Vitamin d3</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/05/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/137/001</DrugIDPK>
    <LicenceNumber>PA0050/137/001</LicenceNumber>
    <ProductName>CAL-D-VITA EFFERVESCENT</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium</ActiveSubstance>
      <ActiveSubstance>Vitamin d3</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/05/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0696/004/001</DrugIDPK>
    <LicenceNumber>PA0696/004/001</LicenceNumber>
    <ProductName>Calaband</ProductName>
    <PAHolder>Seton Healthcare Group PLC</PAHolder>
    <AuthorisedDate>31/10/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Zinc oxide</ActiveSubstance>
      <ActiveSubstance>Calamine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/07/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0074/047/001</DrugIDPK>
    <LicenceNumber>PA0074/047/001</LicenceNumber>
    <ProductName>Calamine</ProductName>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>12/12/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calamine</ActiveSubstance>
      <ActiveSubstance>Zinc oxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/02/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0484/016/001</DrugIDPK>
    <LicenceNumber>PA0484/016/001</LicenceNumber>
    <ProductName>CALAMINE</ProductName>
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>29/01/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALAMINE</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
      <ActiveSubstance>PHENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0258/037/001</DrugIDPK>
    <LicenceNumber>PA0258/037/001</LicenceNumber>
    <ProductName>CALAMINE</ProductName>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate>01/09/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/09/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0074/047/002</DrugIDPK>
    <LicenceNumber>PA0074/047/002</LicenceNumber>
    <ProductName>CALAMINE</ProductName>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>07/05/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALAMINE</ActiveSubstance>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/05/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0095/021/001</DrugIDPK>
    <LicenceNumber>PA0095/021/001</LicenceNumber>
    <ProductName>Calamine B.P.</ProductName>
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>27/04/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calamine</ActiveSubstance>
      <ActiveSubstance>Zinc oxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/04/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/051/001</DrugIDPK>
    <LicenceNumber>PA0281/051/001</LicenceNumber>
    <ProductName>Calamine Lotion BP</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>16/04/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calamine</ActiveSubstance>
      <ActiveSubstance>Zinc oxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/02/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/054/002</DrugIDPK>
    <LicenceNumber>PA0237/054/002</LicenceNumber>
    <ProductName>CALANIF</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>21/04/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/054/001</DrugIDPK>
    <LicenceNumber>PA0237/054/001</LicenceNumber>
    <ProductName>CALANIF</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>21/04/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR1149/008/001</DrugIDPK>
    <LicenceNumber>HOR1149/008/001</LicenceNumber>
    <ProductName>Calc carb</ProductName>
    <PAHolder>A. Nelson &amp; Company Limited</PAHolder>
    <AuthorisedDate>21/04/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Infus/Pdr/Oral Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonicum hahnemanni (conchae)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/04/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR1149/009/001</DrugIDPK>
    <LicenceNumber>HOR1149/009/001</LicenceNumber>
    <ProductName>CALC. FLUOR.</ProductName>
    <PAHolder>A. Nelson &amp; Company Limited</PAHolder>
    <AuthorisedDate>21/04/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Infus/Pdr/Oral Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium fluoratum</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/04/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/057/001</DrugIDPK>
    <LicenceNumber>PA0057/057/001</LicenceNumber>
    <ProductName>CALCICARD</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>19/04/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/04/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/001/002</DrugIDPK>
    <LicenceNumber>DPR0465/001/002</LicenceNumber>
    <ProductName>Calcichew</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>04/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1097/027/001</DrugIDPK>
    <LicenceNumber>PPA1097/027/001</LicenceNumber>
    <ProductName>Calcichew 500mg Chewable Tablets</ProductName>
    <PAHolder>Lexon (UK) Ltd</PAHolder>
    <AuthorisedDate>14/12/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1328/021/001</DrugIDPK>
    <LicenceNumber>DPR1328/021/001</LicenceNumber>
    <ProductName>Calcichew D3 Forte</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>02/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/003/001</DrugIDPK>
    <LicenceNumber>DPR1392/003/001</LicenceNumber>
    <ProductName>Calcichew D3 Forte</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>05/02/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Cholecalciferol (02) 400 internation unit</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1463/004/001</DrugIDPK>
    <LicenceNumber>DPR1463/004/001</LicenceNumber>
    <ProductName>Calcichew D3 Forte</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>01/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/005/001</DrugIDPK>
    <LicenceNumber>DPR1473/005/001</LicenceNumber>
    <ProductName>Calcichew D3 Forte</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>26/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1500/003/001</DrugIDPK>
    <LicenceNumber>DPR1500/003/001</LicenceNumber>
    <ProductName>Calcichew D3 Forte</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>22/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1633/017/001</DrugIDPK>
    <LicenceNumber>DPR1633/017/001</LicenceNumber>
    <ProductName>Calcichew D3 Forte 500 mg/400 IU Chewable/Dispersible Tablets</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>29/05/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable/dispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/06/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/001/001</DrugIDPK>
    <LicenceNumber>DPR0465/001/001</LicenceNumber>
    <ProductName>Calcichew D3 Forte Chewable Tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>07/02/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cholecalciferol (02) 400 internation unit</ActiveSubstance>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1392/069/001</DrugIDPK>
    <LicenceNumber>DPR1392/069/001</LicenceNumber>
    <ProductName>Calcichew D3 Forte Chewable Tablets</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>13/08/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1463/044/001</DrugIDPK>
    <LicenceNumber>DPR1463/044/001</LicenceNumber>
    <ProductName>Calcichew D3 Forte Chewable Tablets</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>29/10/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0535/001/001</DrugIDPK>
    <LicenceNumber>PA0535/001/001</LicenceNumber>
    <ProductName>Calcichew-D3 Chewable Tablets, calcium carbonate/colecalciferol equivalent to 500mg Calcium/200IU colecalciferol</ProductName>
    <PAHolder>Shire Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>16/08/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/08/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1547/007/005</DrugIDPK>
    <LicenceNumber>PA1547/007/005</LicenceNumber>
    <ProductName>Calcichew-D3 Extra 500 mg/1000 IU chewable tablets</ProductName>
    <PAHolder>Takeda UK Limited</PAHolder>
    <AuthorisedDate>10/07/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Cholecalciferol concentrate (powder form)</ActiveSubstance>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
      <ActiveSubstance>All-rac alpha-tocopherol</ActiveSubstance>
      <ActiveSubstance>Medium chain triglycerides</ActiveSubstance>
      <ActiveSubstance>Modified maize starch</ActiveSubstance>
      <ActiveSubstance>Sucrose</ActiveSubstance>
      <ActiveSubstance>Sodium ascorbate</ActiveSubstance>
      <ActiveSubstance>Silica colloidal anhydrous</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/02/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1392/074/001</DrugIDPK>
    <LicenceNumber>DPR1392/074/001</LicenceNumber>
    <ProductName>Calcichew-D3 Forte</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>18/06/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1400/002/001</DrugIDPK>
    <LicenceNumber>DPR1400/002/001</LicenceNumber>
    <ProductName>Calcichew-D3 Forte</ProductName>
    <PAHolder>Mirapharm</PAHolder>
    <AuthorisedDate>22/03/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1633/002/001</DrugIDPK>
    <LicenceNumber>DPR1633/002/001</LicenceNumber>
    <ProductName>Calcichew-D3 Forte</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>03/08/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1328/209/001</DrugIDPK>
    <LicenceNumber>PPA1328/209/001</LicenceNumber>
    <ProductName>Calcichew-D3 Forte</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>24/11/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/024/001</DrugIDPK>
    <LicenceNumber>PPA1659/024/001</LicenceNumber>
    <ProductName>Calcichew-D3 Forte</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/156/002</DrugIDPK>
    <LicenceNumber>PPA0465/156/002</LicenceNumber>
    <ProductName>Calcichew-D3 Forte 500 mg/400 IU Chewable Tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>28/09/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Colecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/100/001</DrugIDPK>
    <LicenceNumber>PPA1562/100/001</LicenceNumber>
    <ProductName>Calcichew-D3 Forte 500 mg/400 IU Chewable Tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>28/06/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Colecalciferol</ActiveSubstance>
      <ActiveSubstance>Calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1547/007/003</DrugIDPK>
    <LicenceNumber>PA1547/007/003</LicenceNumber>
    <ProductName>Calcichew-D3 Forte 500 mg/400 IU Film-coated Tablets</ProductName>
    <PAHolder>Takeda UK Limited</PAHolder>
    <AuthorisedDate>06/01/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Cholecalciferol concentrate (powder form)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/02/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/046/001</DrugIDPK>
    <LicenceNumber>DPR0465/046/001</LicenceNumber>
    <ProductName>Calcichew-D3 Forte Chewable Tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>10/10/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cholecalciferol (02)</ActiveSubstance>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1601/004/001</DrugIDPK>
    <LicenceNumber>DPR1601/004/001</LicenceNumber>
    <ProductName>Calcichew-D3 Forte Chewable Tablets</ProductName>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>28/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1151/155/001</DrugIDPK>
    <LicenceNumber>PPA1151/155/001</LicenceNumber>
    <ProductName>Calcichew-D3 Forte Chewable Tablets, calcium carbonate/colecalciferol equivalent to 500mg Calcium/400 IU colecalciferol</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>28/09/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1562/011/001</DrugIDPK>
    <LicenceNumber>DPR1562/011/001</LicenceNumber>
    <ProductName>Calcichew-D3 Forte Tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>25/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1596/018/001</DrugIDPK>
    <LicenceNumber>DPR1596/018/001</LicenceNumber>
    <ProductName>Calcichew-D3 Forte Tablets</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>04/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0345/002/001</DrugIDPK>
    <LicenceNumber>PA0345/002/001</LicenceNumber>
    <ProductName>Calciforte</ProductName>
    <PAHolder>Laboratoires Grimberg</PAHolder>
    <AuthorisedDate>23/01/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium chloride</ActiveSubstance>
      <ActiveSubstance>Calcium gluconate</ActiveSubstance>
      <ActiveSubstance>Calcium glucoheptonate</ActiveSubstance>
      <ActiveSubstance>Calcium lactate</ActiveSubstance>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Saccharomyces cerevisiae meyen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/05/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0345/002/002</DrugIDPK>
    <LicenceNumber>PA0345/002/002</LicenceNumber>
    <ProductName>Calciforte</ProductName>
    <PAHolder>Laboratoires Grimberg</PAHolder>
    <AuthorisedDate>17/11/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Calcium gluconate</ActiveSubstance>
      <ActiveSubstance>Calcium glucoheptonate</ActiveSubstance>
      <ActiveSubstance>Calcium lactate</ActiveSubstance>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Saccharomyces cerevisiae meyen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/11/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/058/001</DrugIDPK>
    <LicenceNumber>PA0038/058/001</LicenceNumber>
    <ProductName>Calcijex</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcitriol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/058/002</DrugIDPK>
    <LicenceNumber>PA0038/058/002</LicenceNumber>
    <ProductName>Calcijex</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcitriol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/093/001</DrugIDPK>
    <LicenceNumber>PA0711/093/001</LicenceNumber>
    <ProductName>Calcil</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>13/07/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol anhydrous</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/01/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/104/001</DrugIDPK>
    <LicenceNumber>PA0711/104/001</LicenceNumber>
    <ProductName>Calcil 50 microgram/g cream</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>27/07/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol anhydrous</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/10/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/149/001</DrugIDPK>
    <LicenceNumber>PA0711/149/001</LicenceNumber>
    <ProductName>Calcil 50 micrograms/ml Cutaneous Solution</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>08/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol anhydrous</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/07/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/115/001</DrugIDPK>
    <LicenceNumber>PA0077/115/001</LicenceNumber>
    <ProductName>CALCIPARINE</ProductName>
    <PAHolder>Sanofi-aventis Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Heparin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/115/003</DrugIDPK>
    <LicenceNumber>PA0077/115/003</LicenceNumber>
    <ProductName>CALCIPARINE</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>16/06/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HEPARIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/043/001</DrugIDPK>
    <LicenceNumber>PA0057/043/001</LicenceNumber>
    <ProductName>CALCISORB</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CELLULOSE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/10/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/011/001</DrugIDPK>
    <LicenceNumber>PA0468/011/001</LicenceNumber>
    <ProductName>CALCITARE</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/04/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for Soln for Inj</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITONIN, PORCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0257/043/001</DrugIDPK>
    <LicenceNumber>PA0257/043/001</LicenceNumber>
    <ProductName>CALCIUM A.C. &amp; D</ProductName>
    <PAHolder>GR Lane Health Products Ltd</PAHolder>
    <AuthorisedDate>26/03/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL ACETATE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
      <ActiveSubstance>CALCIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/05/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR0407/012/001</DrugIDPK>
    <LicenceNumber>HOR0407/012/001</LicenceNumber>
    <ProductName>Calcium carbonicum Hahnemanii (Calc carb)</ProductName>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>20/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonicum hahnemanni (conchae)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22684/005/001</DrugIDPK>
    <LicenceNumber>PA22684/005/001</LicenceNumber>
    <ProductName>Calcium Chloride Injection Minijet 10% w/v, Solution for Injection</ProductName>
    <PAHolder>DLRC Pharma Services Limited</PAHolder>
    <AuthorisedDate>08/09/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR0407/046/001</DrugIDPK>
    <LicenceNumber>HOR0407/046/001</LicenceNumber>
    <ProductName>Calcium fluoratum (Calc. fluor.)</ProductName>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>20/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium fluoratum</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR0417/001/001</DrugIDPK>
    <LicenceNumber>HOR0417/001/001</LicenceNumber>
    <ProductName>Calcium fluoride</ProductName>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>16/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium fluoride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/115/001</DrugIDPK>
    <LicenceNumber>PA0073/115/001</LicenceNumber>
    <ProductName>Calcium Gluconate</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>01/09/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium gluconate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/06/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/116/001</DrugIDPK>
    <LicenceNumber>PA0073/116/001</LicenceNumber>
    <ProductName>CALCIUM LACTATE</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>01/09/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM LACTATE PENTAHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/045/003</DrugIDPK>
    <LicenceNumber>PA0037/045/003</LicenceNumber>
    <ProductName>Calcium Leucovorin</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium folinate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/07/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/010/002</DrugIDPK>
    <LicenceNumber>PA0437/010/002</LicenceNumber>
    <ProductName>Calcium Leucovorin</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>22/05/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium leucovorin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/06/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/045/001</DrugIDPK>
    <LicenceNumber>PA0037/045/001</LicenceNumber>
    <ProductName>CALCIUM LEUCOVORIN</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium folinate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/11/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/045/006</DrugIDPK>
    <LicenceNumber>PA0037/045/006</LicenceNumber>
    <ProductName>CALCIUM LEUCOVORIN</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>02/09/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM FOLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/06/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/045/005</DrugIDPK>
    <LicenceNumber>PA0037/045/005</LicenceNumber>
    <ProductName>CALCIUM LEUCOVORIN</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>05/08/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM FOLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/045/004</DrugIDPK>
    <LicenceNumber>PA0037/045/004</LicenceNumber>
    <ProductName>CALCIUM LEUCOVORIN</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>05/08/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln Inj/Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM FOLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/045/002</DrugIDPK>
    <LicenceNumber>PA0037/045/002</LicenceNumber>
    <ProductName>CALCIUM LEUCOVORIN</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/05/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR0417/002/001</DrugIDPK>
    <LicenceNumber>HOR0417/002/001</LicenceNumber>
    <ProductName>Calcium phosphate</ProductName>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>16/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium phosphate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR0407/021/001</DrugIDPK>
    <LicenceNumber>HOR0407/021/001</LicenceNumber>
    <ProductName>Calcium Phosphoricum (Calc. phos.)(6C &amp; 30C)</ProductName>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>20/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium phosphoricum</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0952/004/001</DrugIDPK>
    <LicenceNumber>PA0952/004/001</LicenceNumber>
    <ProductName>CALCIUM PLUS D3 HERMES</ProductName>
    <PAHolder>Hermes Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>28/04/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/09/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0952/003/001</DrugIDPK>
    <LicenceNumber>PA0952/003/001</LicenceNumber>
    <ProductName>CALCIUM PLUS VITAMIN D3 HERMES</ProductName>
    <PAHolder>Hermes Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>28/04/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/09/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/076/003</DrugIDPK>
    <LicenceNumber>PA0077/076/003</LicenceNumber>
    <ProductName>CALCIUM RESONIUM</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>17/02/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM POLYSTYRENE SULFONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/01/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/076/002</DrugIDPK>
    <LicenceNumber>PA0077/076/002</LicenceNumber>
    <ProductName>CALCIUM RESONIUM</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>17/02/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM POLYSTYRENE SULFONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/01/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/127/001</DrugIDPK>
    <LicenceNumber>PA0678/127/001</LicenceNumber>
    <ProductName>Calcium Sandoz</ProductName>
    <PAHolder>Haleon Ireland Limited</PAHolder>
    <AuthorisedDate>15/07/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium glubionate</ActiveSubstance>
      <ActiveSubstance>Calcium lactobionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR0417/003/001</DrugIDPK>
    <LicenceNumber>HOR0417/003/001</LicenceNumber>
    <ProductName>Calcium sulphate</ProductName>
    <PAHolder>Seven Seas Ltd</PAHolder>
    <AuthorisedDate>16/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium sulphate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0952/001/001</DrugIDPK>
    <LicenceNumber>PA0952/001/001</LicenceNumber>
    <ProductName>CALCIUM VITAMIN D3 HERMES</ProductName>
    <PAHolder>Hermes Arzneimittel GmbH</PAHolder>
    <AuthorisedDate>28/04/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/09/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/128/001</DrugIDPK>
    <LicenceNumber>PA0678/128/001</LicenceNumber>
    <ProductName>Calcium-D-Sandoz</ProductName>
    <PAHolder>Haleon Ireland Limited</PAHolder>
    <AuthorisedDate>15/07/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/11/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/029/002</DrugIDPK>
    <LicenceNumber>PA0013/029/002</LicenceNumber>
    <ProductName>CALCIUM-SANDOZ</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM GLUBIONATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM LACTOBIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0535/005/001</DrugIDPK>
    <LicenceNumber>PA0535/005/001</LicenceNumber>
    <ProductName>CALCORT</ProductName>
    <PAHolder>Shire Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>15/06/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Deflazacort</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0535/005/003</DrugIDPK>
    <LicenceNumber>PA0535/005/003</LicenceNumber>
    <ProductName>Calcort 30 mg Tablets</ProductName>
    <PAHolder>Shire Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>14/08/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Deflazacort</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>ZZZ Not applicable</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0535/005/002</DrugIDPK>
    <LicenceNumber>PA0535/005/002</LicenceNumber>
    <ProductName>Calcort 6mg Tablets</ProductName>
    <PAHolder>Shire Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>14/08/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Deflazacort</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>ZZZ Not applicable</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0072/007/001</DrugIDPK>
    <LicenceNumber>PA0072/007/001</LicenceNumber>
    <ProductName>CALDEASE MEDICATED</ProductName>
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>08/01/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZINC OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0072/002/002</DrugIDPK>
    <LicenceNumber>PA0072/002/002</LicenceNumber>
    <ProductName>CALDESENE</ProductName>
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM UNDECYLEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/10/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0072/002/001</DrugIDPK>
    <LicenceNumber>PA0072/002/001</LicenceNumber>
    <ProductName>CALDESENE</ProductName>
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM UNDECYLEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/02/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0407/005/001</DrugIDPK>
    <LicenceNumber>PA0407/005/001</LicenceNumber>
    <ProductName>Calendolon</ProductName>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>11/10/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calendula officinalis</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/07/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0407/025/001</DrugIDPK>
    <LicenceNumber>PA0407/025/001</LicenceNumber>
    <ProductName>Calendula Lotion 40% v/v Concentrate for Cutaneous Solution</ProductName>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>11/10/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calendula officinalis</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0865/006/001</DrugIDPK>
    <LicenceNumber>PA0865/006/001</LicenceNumber>
    <ProductName>Calfovit D3 1200mg/800 I.U. powder for oral suspension</ProductName>
    <PAHolder>Menarini International Operations Luxembourg S.A.</PAHolder>
    <AuthorisedDate>28/06/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium phosphate</ActiveSubstance>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1465/039/001</DrugIDPK>
    <LicenceNumber>DPR1465/039/001</LicenceNumber>
    <ProductName>Callous Removal Pads</ProductName>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>18/12/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated plaster</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Salicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0455/006/003</DrugIDPK>
    <LicenceNumber>PA0455/006/003</LicenceNumber>
    <ProductName>Callous Removal Pads</ProductName>
    <PAHolder>Scholl Consumer Products Limited</PAHolder>
    <AuthorisedDate>24/06/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Salicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/12/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1465/023/002</DrugIDPK>
    <LicenceNumber>DPR1465/023/002</LicenceNumber>
    <ProductName>CALLOUS Removal Pads</ProductName>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Impregnated dressing</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Salicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0278/012/001</DrugIDPK>
    <LicenceNumber>PA0278/012/001</LicenceNumber>
    <ProductName>CALLUSOLVE</ProductName>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate>04/07/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>BROMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/025/001</DrugIDPK>
    <LicenceNumber>PA0915/025/001</LicenceNumber>
    <ProductName>CALMAX</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>28/05/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alprazolam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/08/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/025/002</DrugIDPK>
    <LicenceNumber>PA0915/025/002</LicenceNumber>
    <ProductName>CALMAX</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>28/05/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alprazolam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/08/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/025/003</DrugIDPK>
    <LicenceNumber>PA0915/025/003</LicenceNumber>
    <ProductName>CALMAX</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>28/05/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alprazolam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/08/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/041/003</DrugIDPK>
    <LicenceNumber>PA0073/041/003</LicenceNumber>
    <ProductName>CALMIGEN</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>11/06/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/041/002</DrugIDPK>
    <LicenceNumber>PA0073/041/002</LicenceNumber>
    <ProductName>CALMIGEN</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>11/06/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/041/001</DrugIDPK>
    <LicenceNumber>PA0073/041/001</LicenceNumber>
    <ProductName>CALMIGEN</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>11/06/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0063/006/001</DrugIDPK>
    <LicenceNumber>PA0063/006/001</LicenceNumber>
    <ProductName>CALMO RHEUMATIC</ProductName>
    <PAHolder>Wigglesworth (1982) Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0590/008/002</DrugIDPK>
    <LicenceNumber>PA0590/008/002</LicenceNumber>
    <ProductName>CALMURID</ProductName>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>16/11/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>UREA</ActiveSubstance>
      <ActiveSubstance>LACTIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/11/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22743/002/001</DrugIDPK>
    <LicenceNumber>PA22743/002/001</LicenceNumber>
    <ProductName>Calmurid 10%/ 5% w/w Cream</ProductName>
    <PAHolder>Galderma International</PAHolder>
    <AuthorisedDate>28/07/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lactic acid</ActiveSubstance>
      <ActiveSubstance>Urea</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/10/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0823/010/007</DrugIDPK>
    <LicenceNumber>PA0823/010/007</LicenceNumber>
    <ProductName>Calpol</ProductName>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/172/001</DrugIDPK>
    <LicenceNumber>PPA0465/172/001</LicenceNumber>
    <ProductName>Calpol 120mg/5ml Sugar Free Infant Oral Suspension</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>28/04/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/029/001A</DrugIDPK>
    <LicenceNumber>PPA0465/029/001A</LicenceNumber>
    <ProductName>Calpol Infant</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>19/03/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0823/010/001</DrugIDPK>
    <LicenceNumber>PA0823/010/001</LicenceNumber>
    <ProductName>Calpol Six Plus</ProductName>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/029/002A</DrugIDPK>
    <LicenceNumber>PPA0465/029/002A</LicenceNumber>
    <ProductName>CALPOL SIX PLUS</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>19/03/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/12/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0823/010/006</DrugIDPK>
    <LicenceNumber>PA0823/010/006</LicenceNumber>
    <ProductName>CALPOL SUGAR/COLOUR FREE INFANT</ProductName>
    <PAHolder>McNeil Healthcare (Ireland) Ltd</PAHolder>
    <AuthorisedDate>16/02/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>General sale in child resistant packs containing not more than 60ml of the 120mg/5ml unit dosage form.  The product concerned should contain paracetamol as its only active analgesic substance and only one pack should be supplied in the course of any one re</SupplyComments>
    <WithdrawalDate>06/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/075/001</DrugIDPK>
    <LicenceNumber>PPA1447/075/001</LicenceNumber>
    <ProductName>Calpol Sugar Free Infant</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>19/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>Retail sale through pharmacies only in child resistant packs containing not more than 140 ml of the 120mg/5ml unit dosage form.  Not more than two such packs should be supplied in the course of any one retail transaction unless a valid prescription exists.</SupplyComments>
    <WithdrawalDate>29/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0456/001/001</DrugIDPK>
    <LicenceNumber>PA0456/001/001</LicenceNumber>
    <ProductName>CALSALETTES</ProductName>
    <PAHolder>Torbet Laboratories Limited</PAHolder>
    <AuthorisedDate>30/03/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALOIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/07/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/095/001</DrugIDPK>
    <LicenceNumber>PA0540/095/001</LicenceNumber>
    <ProductName>Calsynar</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITONIN, SALMON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/05/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/095/002</DrugIDPK>
    <LicenceNumber>PA0540/095/002</LicenceNumber>
    <ProductName>Calsynar</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITONIN, SALMON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/05/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/022/003</DrugIDPK>
    <LicenceNumber>PA0468/022/003</LicenceNumber>
    <ProductName>CALSYNAR</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>10/10/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITONIN, SALMON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0010/001/003</DrugIDPK>
    <LicenceNumber>PA0010/001/003</LicenceNumber>
    <ProductName>CALSYNAR</ProductName>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>02/02/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITONIN, SALMON</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/02/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0149/009/002</DrugIDPK>
    <LicenceNumber>PA0149/009/002</LicenceNumber>
    <ProductName>CALTHOR</ProductName>
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate>05/06/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/03/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0149/009/001</DrugIDPK>
    <LicenceNumber>PA0149/009/001</LicenceNumber>
    <ProductName>CALTHOR</ProductName>
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate>05/06/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/03/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0149/009/003</DrugIDPK>
    <LicenceNumber>PA0149/009/003</LicenceNumber>
    <ProductName>CALTHOR (SUSPENSION)</ProductName>
    <PAHolder>Ayerst Laboratories Limited</PAHolder>
    <AuthorisedDate>05/06/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/03/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/157/001</DrugIDPK>
    <LicenceNumber>PA0678/157/001</LicenceNumber>
    <ProductName>Caltrate 500 mg/1000 IU, chewable tablets</ProductName>
    <PAHolder>Haleon Ireland Limited</PAHolder>
    <AuthorisedDate>22/06/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Cholecalciferol concentrate </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/08/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/007/001</DrugIDPK>
    <LicenceNumber>PA0046/007/001</LicenceNumber>
    <ProductName>CALVEPEN PAEDIATRIC (SUSPENSION)</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOXYMETHYLPENICILLIN CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/03/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2010/038/001</DrugIDPK>
    <LicenceNumber>PA2010/038/001</LicenceNumber>
    <ProductName>CALVIDIN 600 mg/400 I.U. chewable tablets</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>10/11/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
      <ActiveSubstance>Cholecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/04/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0003/002/001</DrugIDPK>
    <LicenceNumber>PA0003/002/001</LicenceNumber>
    <ProductName>CAM MIXTURE</ProductName>
    <PAHolder>Rybar Laboratories Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/013/002</DrugIDPK>
    <LicenceNumber>PA0468/013/002</LicenceNumber>
    <ProductName>CAMALOX</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>12/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/013/001</DrugIDPK>
    <LicenceNumber>PA0468/013/001</LicenceNumber>
    <ProductName>CAMALOX (SUSPENSION)</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>17/02/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0023/011/003</DrugIDPK>
    <LicenceNumber>PA0023/011/003</LicenceNumber>
    <ProductName>CAMBISON EAR</ProductName>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNAZOLINE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0023/011/002</DrugIDPK>
    <LicenceNumber>PA0023/011/002</LicenceNumber>
    <ProductName>CAMBISON OINTMENT</ProductName>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNAZOLINE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>PREDNISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/11/1980</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0023/011/001</DrugIDPK>
    <LicenceNumber>PA0023/011/001</LicenceNumber>
    <ProductName>CAMBISON OINTMENT</ProductName>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNAZOLINE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/11/1980</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0023/011/004</DrugIDPK>
    <LicenceNumber>PA0023/011/004</LicenceNumber>
    <ProductName>CAMBISON SPRAY</ProductName>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/073/001</DrugIDPK>
    <LicenceNumber>PPA1328/073/001</LicenceNumber>
    <ProductName>CAMPRAL EC</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>30/03/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acamprosate calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/10/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/178/001</DrugIDPK>
    <LicenceNumber>PPA1562/178/001</LicenceNumber>
    <ProductName>Campral EC 333mg Gastro-resistant tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>19/08/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acamprosate calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/04/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/053/001</DrugIDPK>
    <LicenceNumber>PA0019/053/001</LicenceNumber>
    <ProductName>CAMPTO</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>08/10/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Irinotecan hydrochloride trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/05/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/053/002</DrugIDPK>
    <LicenceNumber>PA0019/053/002</LicenceNumber>
    <ProductName>CAMPTO</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>08/10/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Irinotecan hydrochloride trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/05/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1312/004/001</DrugIDPK>
    <LicenceNumber>PA1312/004/001</LicenceNumber>
    <ProductName>Camrata</ProductName>
    <PAHolder>Beacon Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>09/04/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Irinotecan hydrochloride trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/12/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/076/001</DrugIDPK>
    <LicenceNumber>PA0281/076/001</LicenceNumber>
    <ProductName>Canazole Clotrimazole</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>08/12/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/07/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/01/196/002</DrugIDPK>
    <LicenceNumber>EU/1/01/196/002</LicenceNumber>
    <ProductName>Cancidas</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme BV,</PAHolder>
    <AuthorisedDate>24/10/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Caspofungin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>05/05/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0100/008/002</DrugIDPK>
    <LicenceNumber>PA0100/008/002</LicenceNumber>
    <ProductName>CANDEPTIN</ProductName>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDICIDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/12/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0100/008/001</DrugIDPK>
    <LicenceNumber>PA0100/008/001</LicenceNumber>
    <ProductName>CANDEPTIN</ProductName>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CANDICIDIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/12/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/251/001</DrugIDPK>
    <LicenceNumber>PA0126/251/001</LicenceNumber>
    <InterchangeableListCode>IC0029-036-002</InterchangeableListCode>
    <ProductName>Candesartan/Hydrochlorothiazide Clonmel 16mg/12.5mg Tablets</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>05/04/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/121/001</DrugIDPK>
    <LicenceNumber>PA0577/121/001</LicenceNumber>
    <ProductName>Candesartan/Hydrochlorothiazide Mylan</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>27/01/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/01/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/192/001</DrugIDPK>
    <LicenceNumber>PA0749/192/001</LicenceNumber>
    <ProductName>Candesartan/Hydrochlorothiazide Teva 16 mg/12.5 mg Tablets</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>22/03/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/172/002</DrugIDPK>
    <LicenceNumber>PA0749/172/002</LicenceNumber>
    <ProductName>Candesartan/Hydrochlorothiazide Teva Pharma 16 mg/12.5 mg Tablets</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>22/06/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/172/001</DrugIDPK>
    <LicenceNumber>PA0749/172/001</LicenceNumber>
    <ProductName>Candesartan/Hydrochlorothiazide Teva Pharma 8 mg/12.5 mg Tablets</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>22/06/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/075/001</DrugIDPK>
    <LicenceNumber>PA0408/075/001</LicenceNumber>
    <ProductName>Candesartan cilexetil</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>05/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/075/002</DrugIDPK>
    <LicenceNumber>PA0408/075/002</LicenceNumber>
    <ProductName>Candesartan cilexetil</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>05/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/075/003</DrugIDPK>
    <LicenceNumber>PA0408/075/003</LicenceNumber>
    <ProductName>Candesartan cilexetil</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>05/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/075/004</DrugIDPK>
    <LicenceNumber>PA0408/075/004</LicenceNumber>
    <ProductName>Candesartan cilexetil</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>05/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/151/001</DrugIDPK>
    <LicenceNumber>PA2315/151/001</LicenceNumber>
    <InterchangeableListCode>IC0029-036-002</InterchangeableListCode>
    <ProductName>Candesartan Hydrochlorothiazide 16 mg/12.5 mg Tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>20/04/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/01/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/126/001</DrugIDPK>
    <LicenceNumber>PA1380/126/001</LicenceNumber>
    <InterchangeableListCode>IC0029-058-002</InterchangeableListCode>
    <ProductName>Candesartan Hydrochlorothiazide Actavis</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>20/04/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/120/004</DrugIDPK>
    <LicenceNumber>PA0577/120/004</LicenceNumber>
    <ProductName>Candesartan Mylan</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>26/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/06/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/120/003</DrugIDPK>
    <LicenceNumber>PA0577/120/003</LicenceNumber>
    <ProductName>Candesartan Mylan 16mg Tablets</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>26/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/120/001</DrugIDPK>
    <LicenceNumber>PA0577/120/001</LicenceNumber>
    <ProductName>Candesartan Mylan 4mg Tablets</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>26/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/120/002</DrugIDPK>
    <LicenceNumber>PA0577/120/002</LicenceNumber>
    <ProductName>Candesartan Mylan 8mg Tablets</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>26/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/124/001</DrugIDPK>
    <LicenceNumber>PA0749/124/001</LicenceNumber>
    <ProductName>Candesartan Teva</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>21/12/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/124/005</DrugIDPK>
    <LicenceNumber>PA0749/124/005</LicenceNumber>
    <ProductName>Candesartan Teva</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>06/01/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/124/004</DrugIDPK>
    <LicenceNumber>PA0749/124/004</LicenceNumber>
    <InterchangeableListCode>IC0009-038-002</InterchangeableListCode>
    <ProductName>Candesartan Teva 16 mg Tablets</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>06/01/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/05/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/124/002</DrugIDPK>
    <LicenceNumber>PA0749/124/002</LicenceNumber>
    <ProductName>Candesartan Teva 4 mg Tablets</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>21/12/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/124/003</DrugIDPK>
    <LicenceNumber>PA0749/124/003</LicenceNumber>
    <ProductName>Candesartan Teva 8 mg Tablets</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>06/01/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/171/003</DrugIDPK>
    <LicenceNumber>PA0749/171/003</LicenceNumber>
    <ProductName>Candesartan Teva Pharma 16 mg Tablets</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>22/06/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/171/004</DrugIDPK>
    <LicenceNumber>PA0749/171/004</LicenceNumber>
    <ProductName>Candesartan Teva Pharma 32 mg Tablets</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>22/06/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/171/001</DrugIDPK>
    <LicenceNumber>PA0749/171/001</LicenceNumber>
    <ProductName>Candesartan Teva Pharma 4 mg Tablets</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>22/06/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/171/002</DrugIDPK>
    <LicenceNumber>PA0749/171/002</LicenceNumber>
    <ProductName>Candesartan Teva Pharma 8 mg Tablets</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>22/06/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/206/004</DrugIDPK>
    <LicenceNumber>PA0126/206/004</LicenceNumber>
    <ProductName>Candist</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>23/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/07/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/207/001</DrugIDPK>
    <LicenceNumber>PA0126/207/001</LicenceNumber>
    <ProductName>Candist Plus</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>21/10/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/05/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1463/010/004</DrugIDPK>
    <LicenceNumber>DPR1463/010/004</LicenceNumber>
    <ProductName>Canesten</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>29/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1465/003/001</DrugIDPK>
    <LicenceNumber>DPR1465/003/001</LicenceNumber>
    <ProductName>Canesten</ProductName>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>25/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1465/003/002</DrugIDPK>
    <LicenceNumber>DPR1465/003/002</LicenceNumber>
    <ProductName>Canesten</ProductName>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>25/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/043/001</DrugIDPK>
    <LicenceNumber>DPR1473/043/001</LicenceNumber>
    <ProductName>Canesten</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>21/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/043/003</DrugIDPK>
    <LicenceNumber>DPR1473/043/003</LicenceNumber>
    <ProductName>Canesten</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>21/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1562/003/001</DrugIDPK>
    <LicenceNumber>DPR1562/003/001</LicenceNumber>
    <ProductName>Canesten</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>26/02/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0021/004/003</DrugIDPK>
    <LicenceNumber>PA0021/004/003</LicenceNumber>
    <ProductName>Canesten</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/02/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/004/005</DrugIDPK>
    <LicenceNumber>PA0021/004/005</LicenceNumber>
    <ProductName>Canesten</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>14/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous spray, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/048/003</DrugIDPK>
    <LicenceNumber>PPA0465/048/003</LicenceNumber>
    <ProductName>Canesten Combi Pessary &amp; Cream</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>25/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream + pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/082/001</DrugIDPK>
    <LicenceNumber>PPA1447/082/001</LicenceNumber>
    <ProductName>Canesten Combi Pessary &amp; Cream</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream + pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/02/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1328/024/001</DrugIDPK>
    <LicenceNumber>DPR1328/024/001</LicenceNumber>
    <ProductName>Canesten Cream</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>03/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/022/001</DrugIDPK>
    <LicenceNumber>DPR1392/022/001</LicenceNumber>
    <ProductName>Canesten Cream</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>30/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1463/010/002</DrugIDPK>
    <LicenceNumber>DPR1463/010/002</LicenceNumber>
    <ProductName>Canesten Cream</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>02/04/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1465/029/001</DrugIDPK>
    <LicenceNumber>DPR1465/029/001</LicenceNumber>
    <ProductName>Canesten Cream</ProductName>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>03/12/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/06/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1500/017/001</DrugIDPK>
    <LicenceNumber>DPR1500/017/001</LicenceNumber>
    <ProductName>Canesten Cream</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>29/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1562/191/001</DrugIDPK>
    <LicenceNumber>PPA1562/191/001</LicenceNumber>
    <ProductName>Canesten Cream</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>11/11/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/004/006</DrugIDPK>
    <LicenceNumber>PA0021/004/006</LicenceNumber>
    <ProductName>CANESTEN DERMATOLOGICAL</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>21/09/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/02/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/004/001</DrugIDPK>
    <LicenceNumber>DPR0465/004/001</LicenceNumber>
    <ProductName>Canesten HC</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>09/02/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
      <ActiveSubstance>Hydrocortisone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/022/001</DrugIDPK>
    <LicenceNumber>DPR1473/022/001</LicenceNumber>
    <ProductName>Canesten HC</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>07/03/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
      <ActiveSubstance>Hydrocortisone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA0465/246/001</DrugIDPK>
    <LicenceNumber>PPA0465/246/001</LicenceNumber>
    <ProductName>Canesten HC</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>07/05/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
      <ActiveSubstance>Hydrocortisone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/150/001</DrugIDPK>
    <LicenceNumber>PPA1328/150/001</LicenceNumber>
    <ProductName>Canesten HC</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>21/04/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
      <ActiveSubstance>Hydrocortisone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1463/010/001</DrugIDPK>
    <LicenceNumber>DPR1463/010/001</LicenceNumber>
    <ProductName>CANESTEN HC</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>13/03/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
      <ActiveSubstance>Hydrocortisone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1328/025/001</DrugIDPK>
    <LicenceNumber>DPR1328/025/001</LicenceNumber>
    <ProductName>Canesten HC Cream</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>03/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
      <ActiveSubstance>Hydrocortisone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1500/018/001</DrugIDPK>
    <LicenceNumber>DPR1500/018/001</LicenceNumber>
    <ProductName>Canesten HC Cream</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>29/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
      <ActiveSubstance>Hydrocortisone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1562/095/001</DrugIDPK>
    <LicenceNumber>PPA1562/095/001</LicenceNumber>
    <ProductName>Canesten HC Cream</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>14/12/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
      <ActiveSubstance>Hydrocortisone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/01/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/049/001</DrugIDPK>
    <LicenceNumber>PPA1463/049/001</LicenceNumber>
    <ProductName>Canesten HC CreamClotrimazole 1.0%w/wHydrocortisone 1.0%w/w</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>02/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
      <ActiveSubstance>Hydrocortisone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/08/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1392/022/002</DrugIDPK>
    <LicenceNumber>DPR1392/022/002</LicenceNumber>
    <ProductName>Canesten Pessary</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>30/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1465/029/002</DrugIDPK>
    <LicenceNumber>DPR1465/029/002</LicenceNumber>
    <ProductName>Canesten Pessary</ProductName>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>03/12/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1562/003/003</DrugIDPK>
    <LicenceNumber>DPR1562/003/003</LicenceNumber>
    <ProductName>Canesten Pessary</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>26/02/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1562/003/004</DrugIDPK>
    <LicenceNumber>DPR1562/003/004</LicenceNumber>
    <ProductName>Canesten Pessary</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>26/02/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1601/014/001</DrugIDPK>
    <LicenceNumber>DPR1601/014/001</LicenceNumber>
    <ProductName>Canesten Pessary</ProductName>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>03/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/022/003</DrugIDPK>
    <LicenceNumber>DPR1392/022/003</LicenceNumber>
    <ProductName>Canesten Thrush</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>06/05/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1463/010/003</DrugIDPK>
    <LicenceNumber>DPR1463/010/003</LicenceNumber>
    <ProductName>Canesten Thrush</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>02/04/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1465/003/003</DrugIDPK>
    <LicenceNumber>DPR1465/003/003</LicenceNumber>
    <ProductName>Canesten Thrush</ProductName>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>25/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1465/029/003</DrugIDPK>
    <LicenceNumber>DPR1465/029/003</LicenceNumber>
    <ProductName>Canesten Thrush</ProductName>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>03/12/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/043/002</DrugIDPK>
    <LicenceNumber>DPR1473/043/002</LicenceNumber>
    <ProductName>Canesten Thrush</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>21/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1562/003/002</DrugIDPK>
    <LicenceNumber>DPR1562/003/002</LicenceNumber>
    <ProductName>Canesten Thrush</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>26/02/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/04/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1500/017/002</DrugIDPK>
    <LicenceNumber>DPR1500/017/002</LicenceNumber>
    <ProductName>Canesten Thrush Cream</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>29/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1151/201/004</DrugIDPK>
    <LicenceNumber>PPA1151/201/004</LicenceNumber>
    <ProductName>Canesten Thrush Cream</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>07/10/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23176/061/001</DrugIDPK>
    <LicenceNumber>PPA23176/061/001</LicenceNumber>
    <ProductName>Canesten Thrush Cream</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>19/05/2023</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/021/001</DrugIDPK>
    <LicenceNumber>DPR0465/021/001</LicenceNumber>
    <ProductName>Canesten Thrush Vaginal Cream</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>03/09/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1447/001/001</DrugIDPK>
    <LicenceNumber>DPR1447/001/001</LicenceNumber>
    <ProductName>Canesten Thrush Vaginal Cream</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>04/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clotrimazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/03/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/004/007</DrugIDPK>
    <LicenceNumber>PA0021/004/007</LicenceNumber>
    <ProductName>CANESTEN VAGINAL CREAM</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>03/01/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOTRIMAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/162/001</DrugIDPK>
    <LicenceNumber>PA0126/162/001</LicenceNumber>
    <ProductName>Cantaxel</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>01/09/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paclitaxel</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/02/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR0407/048/001</DrugIDPK>
    <LicenceNumber>HOR0407/048/001</LicenceNumber>
    <ProductName>Cantharis Tablets</ProductName>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>28/06/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cantharis </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0130/002/001</DrugIDPK>
    <LicenceNumber>PA0130/002/001</LicenceNumber>
    <ProductName>CANTIL</ProductName>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/04/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0130/002/002</DrugIDPK>
    <LicenceNumber>PA0130/002/002</LicenceNumber>
    <ProductName>CANTIL ELIXIR</ProductName>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/04/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/017/001</DrugIDPK>
    <LicenceNumber>PA0047/017/001</LicenceNumber>
    <ProductName>CAPASTAT</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPREOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0953/001/001</DrugIDPK>
    <LicenceNumber>PA0953/001/001</LicenceNumber>
    <ProductName>CAPD/DPCA 17</ProductName>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>14/06/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium lactate </ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0953/002/001</DrugIDPK>
    <LicenceNumber>PA0953/002/001</LicenceNumber>
    <ProductName>CAPD/DPCA 18</ProductName>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>14/06/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium lactate </ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0953/003/001</DrugIDPK>
    <LicenceNumber>PA0953/003/001</LicenceNumber>
    <ProductName>CAPD/DPCA 19</ProductName>
    <PAHolder>Fresenius Medical Care Deutschland GmbH</PAHolder>
    <AuthorisedDate>14/06/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium lactate </ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2059/031/001</DrugIDPK>
    <LicenceNumber>PA2059/031/001</LicenceNumber>
    <ProductName>Capecitabine 150 mg film-coated tablets</ProductName>
    <PAHolder>Fresenius Kabi Deutschland GmbH</PAHolder>
    <AuthorisedDate>09/11/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Capecitabine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2059/031/002</DrugIDPK>
    <LicenceNumber>PA2059/031/002</LicenceNumber>
    <ProductName>Capecitabine 500 mg film-coated tablets</ProductName>
    <PAHolder>Fresenius Kabi Deutschland GmbH</PAHolder>
    <AuthorisedDate>09/11/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Capecitabine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>26/06/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/115/001</DrugIDPK>
    <LicenceNumber>PA1380/115/001</LicenceNumber>
    <InterchangeableListCode>IC0079-062-003</InterchangeableListCode>
    <ProductName>Capecitabine Actavis 150 mg film-coated tablets</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>07/09/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Capecitabine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>10/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/115/002</DrugIDPK>
    <LicenceNumber>PA1380/115/002</LicenceNumber>
    <InterchangeableListCode>IC0079-117-003</InterchangeableListCode>
    <ProductName>Capecitabine Actavis 500 mg film-coated tablets</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>07/09/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Capecitabine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>10/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1963/004/001</DrugIDPK>
    <LicenceNumber>PA1963/004/001</LicenceNumber>
    <ProductName>Capecitabine Cipla</ProductName>
    <PAHolder>Cipla Europe NV</PAHolder>
    <AuthorisedDate>17/07/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Capecitabine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>01/08/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1963/004/002</DrugIDPK>
    <LicenceNumber>PA1963/004/002</LicenceNumber>
    <ProductName>Capecitabine Cipla</ProductName>
    <PAHolder>Cipla Europe NV</PAHolder>
    <AuthorisedDate>17/07/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Capecitabine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>01/08/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/12/802/015-028</DrugIDPK>
    <LicenceNumber>EU/1/12/802/015-028</LicenceNumber>
    <InterchangeableListCode>IC0079-029-003</InterchangeableListCode>
    <ProductName>Capecitabine medac</ProductName>
    <PAHolder>medac Gesellschaft für klinische Spezialpräparate mbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Capecitabine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>05/05/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/206/001</DrugIDPK>
    <LicenceNumber>PA0711/206/001</LicenceNumber>
    <ProductName>Capecitabine Sandoz 150 mg Film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>17/05/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Capecitabine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>29/08/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/206/002</DrugIDPK>
    <LicenceNumber>PA0711/206/002</LicenceNumber>
    <ProductName>Capecitabine Sandoz 500 mg Film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>17/05/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Capecitabine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>29/08/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/13/831/001</DrugIDPK>
    <LicenceNumber>EU/1/13/831/001</LicenceNumber>
    <ProductName>Capecitabine Sun</ProductName>
    <PAHolder>Sun Phamaceutical Industries Europe B.V.</PAHolder>
    <AuthorisedDate>21/06/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Capecitabine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2) .</SupplyComments>
    <WithdrawalDate>21/06/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/13/831/002</DrugIDPK>
    <LicenceNumber>EU/1/13/831/002</LicenceNumber>
    <ProductName>Capecitabine Sun</ProductName>
    <PAHolder>Sun Phamaceutical Industries Europe B.V.</PAHolder>
    <AuthorisedDate>21/06/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Capecitabine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2) .</SupplyComments>
    <WithdrawalDate>21/06/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/002/001</DrugIDPK>
    <LicenceNumber>PPA0465/002/001</LicenceNumber>
    <ProductName>Capoten</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>28/09/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/002/002</DrugIDPK>
    <LicenceNumber>PPA0465/002/002</LicenceNumber>
    <ProductName>Capoten</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>28/09/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/002/003B</DrugIDPK>
    <LicenceNumber>PPA0465/002/003B</LicenceNumber>
    <ProductName>Capoten</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>25/07/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/056/001</DrugIDPK>
    <LicenceNumber>PPA1328/056/001</LicenceNumber>
    <ProductName>CAPOTEN</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>10/11/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/056/002</DrugIDPK>
    <LicenceNumber>PPA1328/056/002</LicenceNumber>
    <ProductName>CAPOTEN</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>10/11/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/056/003</DrugIDPK>
    <LicenceNumber>PPA1328/056/003</LicenceNumber>
    <ProductName>CAPOTEN</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>10/11/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/10/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/002/003A</DrugIDPK>
    <LicenceNumber>PPA0465/002/003A</LicenceNumber>
    <ProductName>CAPOTEN</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>25/07/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/07/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0384/010/002</DrugIDPK>
    <LicenceNumber>PPA0384/010/002</LicenceNumber>
    <ProductName>CAPOTEN</ProductName>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>04/04/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0384/010/001</DrugIDPK>
    <LicenceNumber>PPA0384/010/001</LicenceNumber>
    <ProductName>CAPOTEN</ProductName>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>18/10/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/039/003</DrugIDPK>
    <LicenceNumber>PA0002/039/003</LicenceNumber>
    <ProductName>CAPOTEN</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>02/04/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/039/004</DrugIDPK>
    <LicenceNumber>PA0002/039/004</LicenceNumber>
    <ProductName>Capoten 12.5 mg Tablets</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>30/09/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/10/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/039/001</DrugIDPK>
    <LicenceNumber>PA0002/039/001</LicenceNumber>
    <ProductName>Capoten 25 mg tablets</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>02/04/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/039/002</DrugIDPK>
    <LicenceNumber>PA0002/039/002</LicenceNumber>
    <ProductName>Capoten 50 mg tablets</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>02/04/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/088/001</DrugIDPK>
    <LicenceNumber>PPA1328/088/001</LicenceNumber>
    <ProductName>Capozide</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>08/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/043/001B</DrugIDPK>
    <LicenceNumber>PPA0465/043/001B</LicenceNumber>
    <ProductName>CAPOZIDE</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>25/09/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0002/053/001</DrugIDPK>
    <LicenceNumber>PA0002/053/001</LicenceNumber>
    <ProductName>CAPOZIDE</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>16/05/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/053/002</DrugIDPK>
    <LicenceNumber>PA0002/053/002</LicenceNumber>
    <ProductName>Capozide (Captopril 50mg/ Hydrochlorothiazide 25mg) Tablets</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>16/05/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/043/001A</DrugIDPK>
    <LicenceNumber>PPA0465/043/001A</LicenceNumber>
    <ProductName>Capozide 50mg/25mg Tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>25/09/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/099/001</DrugIDPK>
    <LicenceNumber>PA0281/099/001</LicenceNumber>
    <ProductName>Caprill</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>03/10/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/05/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/099/002</DrugIDPK>
    <LicenceNumber>PA0281/099/002</LicenceNumber>
    <ProductName>Caprill</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>03/10/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/099/003</DrugIDPK>
    <LicenceNumber>PA0281/099/003</LicenceNumber>
    <ProductName>Caprill</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>03/10/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/099/004</DrugIDPK>
    <LicenceNumber>PA0281/099/004</LicenceNumber>
    <ProductName>Caprill</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>03/10/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/099/005</DrugIDPK>
    <LicenceNumber>PA0281/099/005</LicenceNumber>
    <ProductName>Caprill</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>03/10/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/05/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/130/002</DrugIDPK>
    <LicenceNumber>PA0281/130/002</LicenceNumber>
    <ProductName>Caprin 300 mg Tablets</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>12/05/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acetylsalicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/06/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/130/001</DrugIDPK>
    <LicenceNumber>PA0281/130/001</LicenceNumber>
    <ProductName>Caprin 75 mg  Gastro-resistant Tablets</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>23/06/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aspirin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/04/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/006/001</DrugIDPK>
    <LicenceNumber>PA0819/006/001</LicenceNumber>
    <ProductName>CAPTOHCT-RATIOPHARM</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/006/002</DrugIDPK>
    <LicenceNumber>PA0819/006/002</LicenceNumber>
    <ProductName>CAPTOHCT-RATIOPHARM</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/010/001</DrugIDPK>
    <LicenceNumber>PA0819/010/001</LicenceNumber>
    <ProductName>Captopril</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/010/002</DrugIDPK>
    <LicenceNumber>PA0819/010/002</LicenceNumber>
    <ProductName>Captopril</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/010/003</DrugIDPK>
    <LicenceNumber>PA0819/010/003</LicenceNumber>
    <ProductName>Captopril</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2282/001/002</DrugIDPK>
    <LicenceNumber>PA2282/001/002</LicenceNumber>
    <ProductName>Captopril 25mg/5ml Oral Solution</ProductName>
    <PAHolder>JensonR+ (Ireland) Limited</PAHolder>
    <AuthorisedDate>06/07/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2282/001/001</DrugIDPK>
    <LicenceNumber>PA2282/001/001</LicenceNumber>
    <ProductName>Captopril 5mg/5ml Oral Solution</ProductName>
    <PAHolder>JensonR+ (Ireland) Limited</PAHolder>
    <AuthorisedDate>06/07/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/011/001</DrugIDPK>
    <LicenceNumber>PA0819/011/001</LicenceNumber>
    <ProductName>Captopril-ratiopharm</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/011/002</DrugIDPK>
    <LicenceNumber>PA0819/011/002</LicenceNumber>
    <ProductName>Captopril-ratiopharm</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/011/003</DrugIDPK>
    <LicenceNumber>PA0819/011/003</LicenceNumber>
    <ProductName>Captopril-ratiopharm</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/002/004</DrugIDPK>
    <LicenceNumber>PA0711/002/004</LicenceNumber>
    <ProductName>CAPTOR</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>01/04/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/01/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/002/005</DrugIDPK>
    <LicenceNumber>PA0711/002/005</LicenceNumber>
    <ProductName>CAPTOR</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>01/04/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPTOPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/002/001</DrugIDPK>
    <LicenceNumber>PA0711/002/001</LicenceNumber>
    <ProductName>Captor 12.5mg Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>16/02/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/002/002</DrugIDPK>
    <LicenceNumber>PA0711/002/002</LicenceNumber>
    <ProductName>Captor 25 mg Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>16/02/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/07/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/002/003</DrugIDPK>
    <LicenceNumber>PA0711/002/003</LicenceNumber>
    <ProductName>Captor 50mg Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>16/02/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/025/001</DrugIDPK>
    <LicenceNumber>PA0711/025/001</LicenceNumber>
    <ProductName>Captor-HCT 25 mg/12.5 mg Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>16/10/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/025/003</DrugIDPK>
    <LicenceNumber>PA0711/025/003</LicenceNumber>
    <ProductName>Captor-HCT 50mg/25mg Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>16/10/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Captopril</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/072/001</DrugIDPK>
    <LicenceNumber>PA0002/072/001</LicenceNumber>
    <ProductName>Carace</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>23/02/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lisinopril Dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/072/002</DrugIDPK>
    <LicenceNumber>PA0002/072/002</LicenceNumber>
    <ProductName>Carace</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>23/02/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lisinopril Dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/072/003</DrugIDPK>
    <LicenceNumber>PA0002/072/003</LicenceNumber>
    <ProductName>Carace</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>23/02/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lisinopril Dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/072/006</DrugIDPK>
    <LicenceNumber>PA0002/072/006</LicenceNumber>
    <ProductName>Carace</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>23/04/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lisinopril Dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/04/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/072/005</DrugIDPK>
    <LicenceNumber>PA0002/072/005</LicenceNumber>
    <ProductName>CARACE</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>23/02/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/072/004</DrugIDPK>
    <LicenceNumber>PA0002/072/004</LicenceNumber>
    <ProductName>CARACE</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>23/02/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LISINOPRIL DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/073/001</DrugIDPK>
    <LicenceNumber>PA0002/073/001</LicenceNumber>
    <ProductName>Carace 10 Plus</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>03/01/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lisinopril Dihydrate</ActiveSubstance>
      <ActiveSubstance>Hydrochlorthiazidum</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/073/002</DrugIDPK>
    <LicenceNumber>PA0002/073/002</LicenceNumber>
    <ProductName>Carace 20 Plus</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>03/01/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lisinopril Dihydrate</ActiveSubstance>
      <ActiveSubstance>Hydrochlorthiazidum</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1009/002/001</DrugIDPK>
    <LicenceNumber>PA1009/002/001</LicenceNumber>
    <ProductName>CARBEX</ProductName>
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>11/03/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/12/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/048/003</DrugIDPK>
    <LicenceNumber>PA0035/048/003</LicenceNumber>
    <ProductName>CARBIDOPA</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/048/002</DrugIDPK>
    <LicenceNumber>PA0035/048/002</LicenceNumber>
    <ProductName>CARBIDOPA</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/04/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/048/001</DrugIDPK>
    <LicenceNumber>PA0035/048/001</LicenceNumber>
    <ProductName>CARBIDOPA</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1327/021/001</DrugIDPK>
    <LicenceNumber>PA1327/021/001</LicenceNumber>
    <ProductName>Carbidopa/Levodopa Orion 12.5 mg/50 mg tablets</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>16/12/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carbidopa monohydrate</ActiveSubstance>
      <ActiveSubstance>Levodopa</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1327/021/002</DrugIDPK>
    <LicenceNumber>PA1327/021/002</LicenceNumber>
    <ProductName>Carbidopa/Levodopa Orion 25 mg/100 mg tablets</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>16/12/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carbidopa monohydrate</ActiveSubstance>
      <ActiveSubstance>Levodopa</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/029/001</DrugIDPK>
    <LicenceNumber>PA0021/029/001</LicenceNumber>
    <ProductName>CARBO CORT 0.25%</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR1149/010/001</DrugIDPK>
    <LicenceNumber>HOR1149/010/001</LicenceNumber>
    <ProductName>Carbo veg</ProductName>
    <PAHolder>A. Nelson &amp; Company Limited</PAHolder>
    <AuthorisedDate>21/04/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Infus/Pdr/Oral Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carbo vegetabilis</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/04/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR0407/003/001</DrugIDPK>
    <LicenceNumber>HOR0407/003/001</LicenceNumber>
    <ProductName>Carbo vegetabilis (Carbo. veg.)</ProductName>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>20/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carbo vegetabilis</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0343/008/001</DrugIDPK>
    <LicenceNumber>PA0343/008/001</LicenceNumber>
    <ProductName>Carbocisteine 375 mg Capsules, Hard</ProductName>
    <PAHolder>Key Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>06/03/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carbocisteine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0688/045/001</DrugIDPK>
    <LicenceNumber>PA0688/045/001</LicenceNumber>
    <ProductName>Carbocisteine 375mg Hard Capsules</ProductName>
    <PAHolder>Chanelle Medical Unlimited Company</PAHolder>
    <AuthorisedDate>09/12/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carbocisteine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/05/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/066/001</DrugIDPK>
    <LicenceNumber>PA0237/066/001</LicenceNumber>
    <ProductName>Carbocisteine Teva</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>19/10/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carbocisteine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/06/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0585/024/001</DrugIDPK>
    <LicenceNumber>PA0585/024/001</LicenceNumber>
    <ProductName>Carboplatin</ProductName>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>27/04/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carboplatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1897/008/001</DrugIDPK>
    <LicenceNumber>PA1897/008/001</LicenceNumber>
    <ProductName>Carboplatin</ProductName>
    <PAHolder>Amneal Pharma Europe Limited</PAHolder>
    <AuthorisedDate>04/10/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carboplatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/017/001</DrugIDPK>
    <LicenceNumber>PA0437/017/001</LicenceNumber>
    <ProductName>CARBOPLATIN</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>13/04/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBOPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0789/003/001</DrugIDPK>
    <LicenceNumber>PA0789/003/001</LicenceNumber>
    <ProductName>CARBOPLATIN "EBEWE"</ProductName>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>23/08/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carboplatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/06/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/017/002A</DrugIDPK>
    <LicenceNumber>PA0437/017/002A</LicenceNumber>
    <ProductName>Carboplatin 10mg/ml Concentrate for Solution for Infusion</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>20/07/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carboplatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/03/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1963/008/001</DrugIDPK>
    <LicenceNumber>PA1963/008/001</LicenceNumber>
    <ProductName>Carboplatin Cipla</ProductName>
    <PAHolder>Cipla Europe NV</PAHolder>
    <AuthorisedDate>18/12/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carboplatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0056/013/001</DrugIDPK>
    <LicenceNumber>PA0056/013/001</LicenceNumber>
    <ProductName>CARBRITAL</ProductName>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>04/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTOBARBITAL SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/08/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/037/001</DrugIDPK>
    <LicenceNumber>PA0062/037/001</LicenceNumber>
    <ProductName>Cardene</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nicardipine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/037/002</DrugIDPK>
    <LicenceNumber>PA0062/037/002</LicenceNumber>
    <ProductName>Cardene</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nicardipine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0033/025/006</DrugIDPK>
    <LicenceNumber>PA0033/025/006</LicenceNumber>
    <ProductName>CARDENE I.V.</ProductName>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>21/07/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICARDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/07/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0033/025/005</DrugIDPK>
    <LicenceNumber>PA0033/025/005</LicenceNumber>
    <ProductName>CARDENE I.V.</ProductName>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>21/07/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICARDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/07/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0033/025/004</DrugIDPK>
    <LicenceNumber>PA0033/025/004</LicenceNumber>
    <ProductName>CARDENE I.V.</ProductName>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>21/07/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICARDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/07/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0033/025/003</DrugIDPK>
    <LicenceNumber>PA0033/025/003</LicenceNumber>
    <ProductName>CARDENE I.V.</ProductName>
    <PAHolder>Syntex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>21/07/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICARDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/07/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/037/003</DrugIDPK>
    <LicenceNumber>PA0062/037/003</LicenceNumber>
    <ProductName>Cardene SR</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nicardipine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/037/004</DrugIDPK>
    <LicenceNumber>PA0062/037/004</LicenceNumber>
    <ProductName>Cardene SR</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nicardipine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/127/005</DrugIDPK>
    <LicenceNumber>PA0050/127/005</LicenceNumber>
    <ProductName>CARDENE SR</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>20/03/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NICARDIPINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0132/002/001</DrugIDPK>
    <LicenceNumber>PA0132/002/001</LicenceNumber>
    <ProductName>CARDIACAP</ProductName>
    <PAHolder>Consolidated Chemicals Limited</PAHolder>
    <AuthorisedDate>16/07/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENTAERITHRITYL TETRANITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/07/1981</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0425/003/003</DrugIDPK>
    <LicenceNumber>PA0425/003/003</LicenceNumber>
    <ProductName>CARDIAGUTT</ProductName>
    <PAHolder>Karl Engelhard</PAHolder>
    <AuthorisedDate>07/03/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0425/003/002</DrugIDPK>
    <LicenceNumber>PA0425/003/002</LicenceNumber>
    <ProductName>CARDIAGUTT</ProductName>
    <PAHolder>Karl Engelhard</PAHolder>
    <AuthorisedDate>07/03/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/11/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0425/003/001</DrugIDPK>
    <LicenceNumber>PA0425/003/001</LicenceNumber>
    <ProductName>CARDIAGUTT</ProductName>
    <PAHolder>Karl Engelhard</PAHolder>
    <AuthorisedDate>07/03/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VERAPAMIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/11/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/005/001</DrugIDPK>
    <LicenceNumber>DPR0465/005/001</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>11/04/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR0465/005/002</DrugIDPK>
    <LicenceNumber>DPR0465/005/002</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>11/04/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR0465/005/003</DrugIDPK>
    <LicenceNumber>DPR0465/005/003</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>11/04/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR0465/005/004</DrugIDPK>
    <LicenceNumber>DPR0465/005/004</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>24/04/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR0465/005/006</DrugIDPK>
    <LicenceNumber>DPR0465/005/006</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>13/03/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/001/001</DrugIDPK>
    <LicenceNumber>DPR1392/001/001</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>05/02/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/001/002</DrugIDPK>
    <LicenceNumber>DPR1392/001/002</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>05/02/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/001/003</DrugIDPK>
    <LicenceNumber>DPR1392/001/003</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>05/02/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/001/004</DrugIDPK>
    <LicenceNumber>DPR1392/001/004</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>05/02/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/001/005</DrugIDPK>
    <LicenceNumber>DPR1392/001/005</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>05/02/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1463/006/001</DrugIDPK>
    <LicenceNumber>DPR1463/006/001</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>01/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1463/006/002</DrugIDPK>
    <LicenceNumber>DPR1463/006/002</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>01/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1463/006/003</DrugIDPK>
    <LicenceNumber>DPR1463/006/003</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>01/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1463/006/004</DrugIDPK>
    <LicenceNumber>DPR1463/006/004</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>27/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1463/006/005</DrugIDPK>
    <LicenceNumber>DPR1463/006/005</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>27/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1463/006/006</DrugIDPK>
    <LicenceNumber>DPR1463/006/006</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>27/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/006/001</DrugIDPK>
    <LicenceNumber>DPR1473/006/001</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>26/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/006/002</DrugIDPK>
    <LicenceNumber>DPR1473/006/002</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>26/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/006/003</DrugIDPK>
    <LicenceNumber>DPR1473/006/003</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>26/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/006/004</DrugIDPK>
    <LicenceNumber>DPR1473/006/004</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>26/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/006/005</DrugIDPK>
    <LicenceNumber>DPR1473/006/005</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>26/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/006/006</DrugIDPK>
    <LicenceNumber>DPR1473/006/006</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>05/03/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1500/002/001</DrugIDPK>
    <LicenceNumber>DPR1500/002/001</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>22/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1500/002/002</DrugIDPK>
    <LicenceNumber>DPR1500/002/002</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>22/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1500/002/003</DrugIDPK>
    <LicenceNumber>DPR1500/002/003</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>22/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1500/002/004</DrugIDPK>
    <LicenceNumber>DPR1500/002/004</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>22/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1500/002/005</DrugIDPK>
    <LicenceNumber>DPR1500/002/005</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>22/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1562/001/001</DrugIDPK>
    <LicenceNumber>DPR1562/001/001</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>21/01/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1562/001/002</DrugIDPK>
    <LicenceNumber>DPR1562/001/002</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>21/01/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1562/001/003</DrugIDPK>
    <LicenceNumber>DPR1562/001/003</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>21/01/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1562/001/004</DrugIDPK>
    <LicenceNumber>DPR1562/001/004</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>21/01/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1562/001/005</DrugIDPK>
    <LicenceNumber>DPR1562/001/005</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>26/02/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1562/001/006</DrugIDPK>
    <LicenceNumber>DPR1562/001/006</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>26/02/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1596/001/001</DrugIDPK>
    <LicenceNumber>DPR1596/001/001</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>24/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1596/001/002</DrugIDPK>
    <LicenceNumber>DPR1596/001/002</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>24/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1596/001/003</DrugIDPK>
    <LicenceNumber>DPR1596/001/003</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>24/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1596/001/004</DrugIDPK>
    <LicenceNumber>DPR1596/001/004</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>24/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1596/001/005</DrugIDPK>
    <LicenceNumber>DPR1596/001/005</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>24/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1596/001/006</DrugIDPK>
    <LicenceNumber>DPR1596/001/006</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>24/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA0465/204/003</DrugIDPK>
    <LicenceNumber>PPA0465/204/003</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>25/01/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/12/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/204/004</DrugIDPK>
    <LicenceNumber>PPA0465/204/004</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>25/01/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/12/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/204/005</DrugIDPK>
    <LicenceNumber>PPA0465/204/005</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>05/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/12/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/204/006</DrugIDPK>
    <LicenceNumber>PPA0465/204/006</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>05/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/12/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/013/001</DrugIDPK>
    <LicenceNumber>PPA1328/013/001</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>06/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/013/002</DrugIDPK>
    <LicenceNumber>PPA1328/013/002</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>08/09/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/013/003</DrugIDPK>
    <LicenceNumber>PPA1328/013/003</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>08/09/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/013/004</DrugIDPK>
    <LicenceNumber>PPA1328/013/004</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>08/09/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/013/005</DrugIDPK>
    <LicenceNumber>PPA1328/013/005</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>08/09/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/09/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/013/006</DrugIDPK>
    <LicenceNumber>PPA1328/013/006</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>12/03/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/047/001</DrugIDPK>
    <LicenceNumber>PPA1447/047/001</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/07/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/047/002</DrugIDPK>
    <LicenceNumber>PPA1447/047/002</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/07/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/036/001</DrugIDPK>
    <LicenceNumber>PPA1500/036/001</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>07/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/036/002</DrugIDPK>
    <LicenceNumber>PPA1500/036/002</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>04/02/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/036/003</DrugIDPK>
    <LicenceNumber>PPA1500/036/003</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>04/02/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/036/004</DrugIDPK>
    <LicenceNumber>PPA1500/036/004</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>04/02/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/036/005</DrugIDPK>
    <LicenceNumber>PPA1500/036/005</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>04/02/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/036/006</DrugIDPK>
    <LicenceNumber>PPA1500/036/006</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>04/02/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/024/001</DrugIDPK>
    <LicenceNumber>PPA1562/024/001</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>18/02/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/024/002</DrugIDPK>
    <LicenceNumber>PPA1562/024/002</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>18/02/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/021/001</DrugIDPK>
    <LicenceNumber>PPA1659/021/001</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>30/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/021/002</DrugIDPK>
    <LicenceNumber>PPA1659/021/002</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>30/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/021/003</DrugIDPK>
    <LicenceNumber>PPA1659/021/003</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>30/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/021/004</DrugIDPK>
    <LicenceNumber>PPA1659/021/004</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>30/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/021/005</DrugIDPK>
    <LicenceNumber>PPA1659/021/005</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>30/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/021/006</DrugIDPK>
    <LicenceNumber>PPA1659/021/006</LicenceNumber>
    <ProductName>Cardicor</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>30/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/005/005</DrugIDPK>
    <LicenceNumber>DPR0465/005/005</LicenceNumber>
    <ProductName>CARDICOR</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>01/06/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1463/085/001</DrugIDPK>
    <LicenceNumber>PPA1463/085/001</LicenceNumber>
    <InterchangeableListCode>IC0065-044-014</InterchangeableListCode>
    <ProductName>Cardicor 1.25 mg film-coated tablets</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>25/10/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/08/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/142/001</DrugIDPK>
    <LicenceNumber>PPA1562/142/001</LicenceNumber>
    <InterchangeableListCode>IC0065-044-014</InterchangeableListCode>
    <ProductName>Cardicor 1.25 mg film-coated tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>23/01/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/204/001</DrugIDPK>
    <LicenceNumber>PPA0465/204/001</LicenceNumber>
    <ProductName>Cardicor 1.25mg Film-coated tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>25/01/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/048/001</DrugIDPK>
    <LicenceNumber>PPA1151/048/001</LicenceNumber>
    <InterchangeableListCode>IC0065-044-014</InterchangeableListCode>
    <ProductName>Cardicor 1.25mg Film-coated tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>02/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/048/006</DrugIDPK>
    <LicenceNumber>PPA1151/048/006</LicenceNumber>
    <InterchangeableListCode>IC0065-002-014</InterchangeableListCode>
    <ProductName>Cardicor 10mg Film-coated tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>02/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/204/002</DrugIDPK>
    <LicenceNumber>PPA0465/204/002</LicenceNumber>
    <ProductName>Cardicor 2.5 mg film-coated tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>25/01/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/085/002</DrugIDPK>
    <LicenceNumber>PPA1463/085/002</LicenceNumber>
    <InterchangeableListCode>IC0065-018-014</InterchangeableListCode>
    <ProductName>Cardicor 2.5 mg film-coated tablets</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>25/10/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/08/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/142/002</DrugIDPK>
    <LicenceNumber>PPA1562/142/002</LicenceNumber>
    <InterchangeableListCode>IC0065-018-014</InterchangeableListCode>
    <ProductName>Cardicor 2.5 mg film-coated tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>23/01/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/048/002</DrugIDPK>
    <LicenceNumber>PPA1151/048/002</LicenceNumber>
    <InterchangeableListCode>IC0065-018-014</InterchangeableListCode>
    <ProductName>Cardicor 2.5 mg Film-Coated Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>02/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/048/003</DrugIDPK>
    <LicenceNumber>PPA1151/048/003</LicenceNumber>
    <InterchangeableListCode>IC0065-108-014</InterchangeableListCode>
    <ProductName>Cardicor 3.75mg Film-coated tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>02/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/048/004</DrugIDPK>
    <LicenceNumber>PPA1151/048/004</LicenceNumber>
    <InterchangeableListCode>IC0065-001-014</InterchangeableListCode>
    <ProductName>Cardicor 5mg Film-coated tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>02/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/142/003</DrugIDPK>
    <LicenceNumber>PPA1562/142/003</LicenceNumber>
    <InterchangeableListCode>IC0065-041-003</InterchangeableListCode>
    <ProductName>Cardicor 7.5 mg film-coated tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>23/01/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/048/005</DrugIDPK>
    <LicenceNumber>PPA1151/048/005</LicenceNumber>
    <InterchangeableListCode>IC0065-041-003</InterchangeableListCode>
    <ProductName>Cardicor 7.5mg Film-coated tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>02/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1601/016/001</DrugIDPK>
    <LicenceNumber>DPR1601/016/001</LicenceNumber>
    <ProductName>Cardicor Tablets</ProductName>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>03/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1601/016/002</DrugIDPK>
    <LicenceNumber>DPR1601/016/002</LicenceNumber>
    <ProductName>Cardicor Tablets</ProductName>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>03/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1601/016/003</DrugIDPK>
    <LicenceNumber>DPR1601/016/003</LicenceNumber>
    <ProductName>Cardicor Tablets</ProductName>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>03/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1601/016/004</DrugIDPK>
    <LicenceNumber>DPR1601/016/004</LicenceNumber>
    <ProductName>Cardicor Tablets</ProductName>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>03/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0282/070/001</DrugIDPK>
    <LicenceNumber>PA0282/070/001</LicenceNumber>
    <ProductName>Cardilate 10mg</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>26/06/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/070/002</DrugIDPK>
    <LicenceNumber>PA0282/070/002</LicenceNumber>
    <ProductName>Cardilate 20mg</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>26/06/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/070/003</DrugIDPK>
    <LicenceNumber>PA0282/070/003</LicenceNumber>
    <ProductName>Cardilate XL 40mg</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>27/07/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nifedipine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/056/002</DrugIDPK>
    <LicenceNumber>PA0040/056/002</LicenceNumber>
    <ProductName>CARDIO CONRAY</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/056/001</DrugIDPK>
    <LicenceNumber>PA0040/056/001</LicenceNumber>
    <ProductName>CARDIO CONRAY</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1052/001/001</DrugIDPK>
    <LicenceNumber>PA1052/001/001</LicenceNumber>
    <ProductName>Cardiolite</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharma</PAHolder>
    <AuthorisedDate>26/08/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Kit for radiopharmaceutical preparation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Stannous chloride dihydrate Ph. Eur.</ActiveSubstance>
      <ActiveSubstance>Tetrakis (2-methoxy isobutyl isonitrile) copper (i) tetrafluorolborate</ActiveSubstance>
      <ActiveSubstance>Cysteine hydrochloride monohydrate </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/174/001</DrugIDPK>
    <LicenceNumber>PA0577/174/001</LicenceNumber>
    <ProductName>Cardioplast 0.2mg/h transdermal patches</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>19/07/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nitroglycerin (glyceryl trinitrate)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/174/002</DrugIDPK>
    <LicenceNumber>PA0577/174/002</LicenceNumber>
    <ProductName>Cardioplast 0.4mg/h transdermal patches</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>19/07/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nitroglycerin (glyceryl trinitrate)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/174/003</DrugIDPK>
    <LicenceNumber>PA0577/174/003</LicenceNumber>
    <ProductName>Cardioplast 0.6mg/h transdermal patches</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>19/07/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Nitroglycerin (glyceryl trinitrate)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0361/014/001</DrugIDPK>
    <LicenceNumber>PA0361/014/001</LicenceNumber>
    <ProductName>Cardioplegia Concentrate for Solution for Infusion (163mg/60mg/14mg per ml)</ProductName>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>07/09/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Procaine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/07/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/035/003</DrugIDPK>
    <LicenceNumber>PA0019/035/003</LicenceNumber>
    <ProductName>CARDIOVAR</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>14/01/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/01/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/035/002</DrugIDPK>
    <LicenceNumber>PA0019/035/002</LicenceNumber>
    <ProductName>CARDIOVAR</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>05/11/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/01/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/035/001</DrugIDPK>
    <LicenceNumber>PA0019/035/001</LicenceNumber>
    <ProductName>CARDIOVAR</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>27/11/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIMAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/01/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/121/001</DrugIDPK>
    <LicenceNumber>PA0013/121/001</LicenceNumber>
    <ProductName>Cardioxane 500mg Powder for Concentrate for Soluti</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>29/09/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dexrazoxane</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/003/001</DrugIDPK>
    <LicenceNumber>PA0549/003/001</LicenceNumber>
    <ProductName>Cardox SR</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>13/10/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/003/002</DrugIDPK>
    <LicenceNumber>PA0549/003/002</LicenceNumber>
    <ProductName>Cardox SR</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>13/10/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/003/003</DrugIDPK>
    <LicenceNumber>PA0549/003/003</LicenceNumber>
    <ProductName>Cardox SR</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>13/10/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/063/002A</DrugIDPK>
    <LicenceNumber>PPA0465/063/002A</LicenceNumber>
    <ProductName>Cardura</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>18/08/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/079/003</DrugIDPK>
    <LicenceNumber>PPA1328/079/003</LicenceNumber>
    <ProductName>Cardura</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>20/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/035/001</DrugIDPK>
    <LicenceNumber>PPA1447/035/001</LicenceNumber>
    <ProductName>Cardura</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>22/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/012/003</DrugIDPK>
    <LicenceNumber>PPA1659/012/003</LicenceNumber>
    <ProductName>Cardura</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/012/004</DrugIDPK>
    <LicenceNumber>PPA1659/012/004</LicenceNumber>
    <ProductName>Cardura</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/043/003</DrugIDPK>
    <LicenceNumber>PA0019/043/003</LicenceNumber>
    <ProductName>CARDURA</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/12/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/043/004</DrugIDPK>
    <LicenceNumber>PA0019/043/004</LicenceNumber>
    <ProductName>CARDURA</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/12/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/063/003D</DrugIDPK>
    <LicenceNumber>PPA0465/063/003D</LicenceNumber>
    <ProductName>CARDURA</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>18/08/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/12/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/063/003C</DrugIDPK>
    <LicenceNumber>PPA0465/063/003C</LicenceNumber>
    <ProductName>CARDURA</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>18/08/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/12/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/063/003B</DrugIDPK>
    <LicenceNumber>PPA0465/063/003B</LicenceNumber>
    <ProductName>CARDURA</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>18/08/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/12/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/063/003A</DrugIDPK>
    <LicenceNumber>PPA0465/063/003A</LicenceNumber>
    <ProductName>CARDURA</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>18/08/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/12/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/063/001A</DrugIDPK>
    <LicenceNumber>PPA0465/063/001A</LicenceNumber>
    <ProductName>CARDURA</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>18/08/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXAZOSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/12/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/095/001</DrugIDPK>
    <LicenceNumber>PPA0465/095/001</LicenceNumber>
    <ProductName>Cardura XL</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>17/10/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/095/002</DrugIDPK>
    <LicenceNumber>PPA0465/095/002</LicenceNumber>
    <ProductName>Cardura XL</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>17/10/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/022/001</DrugIDPK>
    <LicenceNumber>PPA1151/022/001</LicenceNumber>
    <ProductName>Cardura XL</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>11/05/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/09/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/079/001</DrugIDPK>
    <LicenceNumber>PPA1328/079/001</LicenceNumber>
    <ProductName>Cardura XL</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>20/03/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/079/002</DrugIDPK>
    <LicenceNumber>PPA1328/079/002</LicenceNumber>
    <ProductName>Cardura XL</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>20/03/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/035/002</DrugIDPK>
    <LicenceNumber>PPA1447/035/002</LicenceNumber>
    <ProductName>Cardura XL</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>22/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/035/003</DrugIDPK>
    <LicenceNumber>PPA1447/035/003</LicenceNumber>
    <ProductName>Cardura XL</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>08/06/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/005/001</DrugIDPK>
    <LicenceNumber>PPA1463/005/001</LicenceNumber>
    <ProductName>Cardura XL</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>20/06/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/005/002</DrugIDPK>
    <LicenceNumber>PPA1463/005/002</LicenceNumber>
    <ProductName>Cardura XL</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>20/06/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1473/006/001</DrugIDPK>
    <LicenceNumber>PPA1473/006/001</LicenceNumber>
    <ProductName>Cardura XL</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>20/02/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/05/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/001/001</DrugIDPK>
    <LicenceNumber>PPA1500/001/001</LicenceNumber>
    <ProductName>Cardura XL</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>15/05/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/001/002</DrugIDPK>
    <LicenceNumber>PPA1500/001/002</LicenceNumber>
    <ProductName>Cardura XL</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>15/05/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/003/001</DrugIDPK>
    <LicenceNumber>PPA1562/003/001</LicenceNumber>
    <InterchangeableListCode>IC0021-008-024</InterchangeableListCode>
    <ProductName>Cardura XL</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>28/05/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/05/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/003/002</DrugIDPK>
    <LicenceNumber>PPA1562/003/002</LicenceNumber>
    <ProductName>Cardura XL</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>31/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/003/003</DrugIDPK>
    <LicenceNumber>PPA1562/003/003</LicenceNumber>
    <InterchangeableListCode>IC0021-009-024</InterchangeableListCode>
    <ProductName>Cardura XL</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>20/10/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/05/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1633/012/001</DrugIDPK>
    <LicenceNumber>PPA1633/012/001</LicenceNumber>
    <ProductName>Cardura XL</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>28/05/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1633/012/002</DrugIDPK>
    <LicenceNumber>PPA1633/012/002</LicenceNumber>
    <ProductName>Cardura XL</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>28/05/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/012/001</DrugIDPK>
    <LicenceNumber>PPA1659/012/001</LicenceNumber>
    <ProductName>Cardura XL</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/012/002</DrugIDPK>
    <LicenceNumber>PPA1659/012/002</LicenceNumber>
    <ProductName>Cardura XL</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/024/001</DrugIDPK>
    <LicenceNumber>PPA1596/024/001</LicenceNumber>
    <InterchangeableListCode>IC0021-008-024</InterchangeableListCode>
    <ProductName>Cardura XL 4mg Prolonged-release tablets</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>05/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/140/001</DrugIDPK>
    <LicenceNumber>PPA1463/140/001</LicenceNumber>
    <InterchangeableListCode>IC0021-009-024</InterchangeableListCode>
    <ProductName>Cardura XL 8 mg Prolonged-release tablets</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>25/09/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/03/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/479/001</DrugIDPK>
    <LicenceNumber>PPA0465/479/001</LicenceNumber>
    <InterchangeableListCode>IC0021-009-024</InterchangeableListCode>
    <ProductName>Cardura XL 8 mg Prolonged-release tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>24/08/2021</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/022/002</DrugIDPK>
    <LicenceNumber>PPA1151/022/002</LicenceNumber>
    <InterchangeableListCode>IC0021-009-024</InterchangeableListCode>
    <ProductName>Cardura XL 8mg Prolonged-release tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>11/05/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1473/006/002</DrugIDPK>
    <LicenceNumber>PPA1473/006/002</LicenceNumber>
    <ProductName>Cardura XL 8mg Prolonged-release tablets</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>20/02/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/03/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/024/002</DrugIDPK>
    <LicenceNumber>PPA1596/024/002</LicenceNumber>
    <InterchangeableListCode>IC0021-009-024</InterchangeableListCode>
    <ProductName>Cardura XL 8mg Prolonged-release tablets</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>05/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/209/001</DrugIDPK>
    <LicenceNumber>PA2315/209/001</LicenceNumber>
    <InterchangeableListCode>IC0025-006-032</InterchangeableListCode>
    <ProductName>Caristenol 2 mg, prolonged-release capsules</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>10/06/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/209/002</DrugIDPK>
    <LicenceNumber>PA2315/209/002</LicenceNumber>
    <InterchangeableListCode>IC0025-008-032</InterchangeableListCode>
    <ProductName>Caristenol 4 mg, prolonged-release capsules</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>10/06/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/254/001</DrugIDPK>
    <LicenceNumber>PA0126/254/001</LicenceNumber>
    <ProductName>Carmen</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>23/08/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Drospirenone</ActiveSubstance>
      <ActiveSubstance>Ethinyl estradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/06/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/253/001</DrugIDPK>
    <LicenceNumber>PA0126/253/001</LicenceNumber>
    <ProductName>Carmenelle</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>23/08/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Drospirenone</ActiveSubstance>
      <ActiveSubstance>Ethinylestradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/06/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/064/003</DrugIDPK>
    <LicenceNumber>PA0281/064/003</LicenceNumber>
    <ProductName>CARPINE</ProductName>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>14/11/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/02/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/064/002</DrugIDPK>
    <LicenceNumber>PA0281/064/002</LicenceNumber>
    <ProductName>CARPINE</ProductName>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>14/11/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/02/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/064/001</DrugIDPK>
    <LicenceNumber>PA0281/064/001</LicenceNumber>
    <ProductName>CARPINE</ProductName>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>14/11/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBAMAZEPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/02/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/072/001</DrugIDPK>
    <LicenceNumber>PA0749/072/001</LicenceNumber>
    <InterchangeableListCode>IC0021-008-024</InterchangeableListCode>
    <ProductName>Carsem XL 4 mg Prolonged-release tablets</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>17/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1107/016/001</DrugIDPK>
    <LicenceNumber>PA1107/016/001</LicenceNumber>
    <ProductName>Carteolol hydrochloride Thea 20 mg/ml eye drops, solution</ProductName>
    <PAHolder>Laboratoires Thea</PAHolder>
    <AuthorisedDate>30/11/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carteolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/053/001</DrugIDPK>
    <LicenceNumber>PA0577/053/001</LicenceNumber>
    <ProductName>CARVEDILOL</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>04/06/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carvedilol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/09/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/053/002</DrugIDPK>
    <LicenceNumber>PA0577/053/002</LicenceNumber>
    <ProductName>CARVEDILOL</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>04/06/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carvedilol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/09/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/053/003</DrugIDPK>
    <LicenceNumber>PA0577/053/003</LicenceNumber>
    <ProductName>CARVEDILOL</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>04/06/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carvedilol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/09/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/053/004</DrugIDPK>
    <LicenceNumber>PA0577/053/004</LicenceNumber>
    <ProductName>CARVEDILOL</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>04/06/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carvedilol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/09/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/010/003</DrugIDPK>
    <LicenceNumber>PA0749/010/003</LicenceNumber>
    <ProductName>Carvedilol 12.5 mg Tablets</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>21/10/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carvedilol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/05/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/010/004</DrugIDPK>
    <LicenceNumber>PA0749/010/004</LicenceNumber>
    <ProductName>Carvedilol 25 mg Tablets</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>21/10/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carvedilol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/05/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/010/001</DrugIDPK>
    <LicenceNumber>PA0749/010/001</LicenceNumber>
    <ProductName>Carvedilol 3.125 mg Tablets</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>21/10/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carvedilol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/05/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/010/002</DrugIDPK>
    <LicenceNumber>PA0749/010/002</LicenceNumber>
    <ProductName>Carvedilol 6.25 mg Tablets</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>21/10/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carvedilol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/05/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/044/001</DrugIDPK>
    <LicenceNumber>PA0822/044/001</LicenceNumber>
    <ProductName>Carvedilol Pfizer</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>25/02/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carvedilol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/044/002</DrugIDPK>
    <LicenceNumber>PA0822/044/002</LicenceNumber>
    <ProductName>Carvedilol Pfizer</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>25/02/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carvedilol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/044/003</DrugIDPK>
    <LicenceNumber>PA0822/044/003</LicenceNumber>
    <ProductName>Carvedilol Pfizer</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>25/02/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carvedilol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/044/004</DrugIDPK>
    <LicenceNumber>PA0822/044/004</LicenceNumber>
    <ProductName>Carvedilol Pfizer</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>25/02/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carvedilol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0618/017/002</DrugIDPK>
    <LicenceNumber>PA0618/017/002</LicenceNumber>
    <ProductName>Carylderm</ProductName>
    <PAHolder>Seton Products Ltd</PAHolder>
    <AuthorisedDate>13/07/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carbaryl</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/07/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0618/017/001</DrugIDPK>
    <LicenceNumber>PA0618/017/001</LicenceNumber>
    <ProductName>CARYLDERM LOTION</ProductName>
    <PAHolder>Seton Products Ltd</PAHolder>
    <AuthorisedDate>13/07/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carbaryl</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/07/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/125/001</DrugIDPK>
    <LicenceNumber>PA0073/125/001</LicenceNumber>
    <ProductName>CASCARA</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>16/06/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0409/013/003</DrugIDPK>
    <LicenceNumber>PA0409/013/003</LicenceNumber>
    <ProductName>CASMIN</ProductName>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>10/06/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0409/013/002</DrugIDPK>
    <LicenceNumber>PA0409/013/002</LicenceNumber>
    <ProductName>CASMIN</ProductName>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>10/06/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0409/013/001</DrugIDPK>
    <LicenceNumber>PA0409/013/001</LicenceNumber>
    <ProductName>CASMIN</ProductName>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>10/06/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/146/001</DrugIDPK>
    <LicenceNumber>PPA1328/146/001</LicenceNumber>
    <ProductName>Casodex</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>06/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/02/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/073/001</DrugIDPK>
    <LicenceNumber>PPA1500/073/001</LicenceNumber>
    <ProductName>Casodex</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>12/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/025/001</DrugIDPK>
    <LicenceNumber>PPA1562/025/001</LicenceNumber>
    <ProductName>Casodex</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>08/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/192/001</DrugIDPK>
    <LicenceNumber>PPA1562/192/001</LicenceNumber>
    <ProductName>Casodex</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>20/01/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/08/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/017/001</DrugIDPK>
    <LicenceNumber>PPA1447/017/001</LicenceNumber>
    <ProductName>CASODEX</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>16/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>ZZZ Not applicable</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/07/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23176/037/001</DrugIDPK>
    <LicenceNumber>PPA23176/037/001</LicenceNumber>
    <InterchangeableListCode>IC0137-023-003</InterchangeableListCode>
    <ProductName>Casodex 50 mg film-coated tablets</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>06/11/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/104/001</DrugIDPK>
    <LicenceNumber>PPA1151/104/001</LicenceNumber>
    <ProductName>Casodex 50 mg Film-coated Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>24/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1633/068/001</DrugIDPK>
    <LicenceNumber>PPA1633/068/001</LicenceNumber>
    <ProductName>Casodex 50 mg Film-coated Tablets</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>09/03/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/06/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/049/001</DrugIDPK>
    <LicenceNumber>PPA1596/049/001</LicenceNumber>
    <ProductName>Casodex 50mg Film-coated Tablets</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>01/04/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/174/001</DrugIDPK>
    <LicenceNumber>PA0126/174/001</LicenceNumber>
    <ProductName>Casomide 50 mg film-coated tablet</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>04/07/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bicalutamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/11/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/022/001</DrugIDPK>
    <LicenceNumber>PA0549/022/001</LicenceNumber>
    <ProductName>Caspofungin 50 mg powder for concentrate for solution for infusion</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>12/05/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Caspofungin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/06/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/022/002</DrugIDPK>
    <LicenceNumber>PA0549/022/002</LicenceNumber>
    <ProductName>Caspofungin 70 mg powder for concentrate for solution for infusion</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>12/05/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Caspofungin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/06/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/146/001</DrugIDPK>
    <LicenceNumber>PA2315/146/001</LicenceNumber>
    <ProductName>Caspofungin Actavis 50 mg Powder for Concentrate for Solution for Infusion</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>14/10/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Caspofungin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/09/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/146/002</DrugIDPK>
    <LicenceNumber>PA2315/146/002</LicenceNumber>
    <ProductName>Caspofungin Actavis 70 mg Powder for Concentrate for Solution for Infusion</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>14/10/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Caspofungin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/09/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/287/001</DrugIDPK>
    <LicenceNumber>PA0126/287/001</LicenceNumber>
    <ProductName>Caspofungin Clonmel 50 mg powder for concentrate for solution for infusion</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>25/11/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Caspofungin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/287/002</DrugIDPK>
    <LicenceNumber>PA0126/287/002</LicenceNumber>
    <ProductName>Caspofungin Clonmel 70 mg powder for concentrate for solution for infusion</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>25/11/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Caspofungin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2059/005/001</DrugIDPK>
    <LicenceNumber>PA2059/005/001</LicenceNumber>
    <ProductName>Caspofungin Fresenius Kabi 50 mg powder for concentrate for solution for infusion</ProductName>
    <PAHolder>Fresenius Kabi Deutschland GmbH</PAHolder>
    <AuthorisedDate>02/12/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Caspofungin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/01/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2059/005/002</DrugIDPK>
    <LicenceNumber>PA2059/005/002</LicenceNumber>
    <ProductName>Caspofungin Fresenius Kabi 70 mg powder for concentrate for solution for  infusion</ProductName>
    <PAHolder>Fresenius Kabi Deutschland GmbH</PAHolder>
    <AuthorisedDate>02/12/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Caspofungin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/01/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/184/001</DrugIDPK>
    <LicenceNumber>PA0577/184/001</LicenceNumber>
    <ProductName>Caspofungin Mylan 50 mg powder for concentrate for solution for infusion</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>28/07/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Caspofungin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>04/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/184/002</DrugIDPK>
    <LicenceNumber>PA0577/184/002</LicenceNumber>
    <ProductName>Caspofungin Mylan 70 mg powder for concentrate for solution for infusion</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>28/07/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Caspofungin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>04/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/249/001</DrugIDPK>
    <LicenceNumber>PA0711/249/001</LicenceNumber>
    <ProductName>Caspofungin Rowex</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>02/09/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Caspofungin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/10/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/249/002</DrugIDPK>
    <LicenceNumber>PA0711/249/002</LicenceNumber>
    <ProductName>Caspofungin Rowex</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>02/09/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Caspofungin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/10/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/009/001</DrugIDPK>
    <LicenceNumber>PA1986/009/001</LicenceNumber>
    <ProductName>Caspofungin Teva 50 mg Powder for Concentrate for Solution for Infusion</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>12/08/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Caspofungin acetate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/08/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/009/002</DrugIDPK>
    <LicenceNumber>PA1986/009/002</LicenceNumber>
    <ProductName>Caspofungin Teva 70 mg Powder for Concentrate for Solution for Infusion</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>12/08/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Caspofungin acetate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/08/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1982/004/001</DrugIDPK>
    <LicenceNumber>PA1982/004/001</LicenceNumber>
    <ProductName>Caspofungin Xellia</ProductName>
    <PAHolder>Xellia Pharmaceuticals ApS</PAHolder>
    <AuthorisedDate>03/02/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Caspofungin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/10/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1982/004/002</DrugIDPK>
    <LicenceNumber>PA1982/004/002</LicenceNumber>
    <ProductName>Caspofungin Xellia</ProductName>
    <PAHolder>Xellia Pharmaceuticals ApS</PAHolder>
    <AuthorisedDate>03/02/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Caspofungin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/10/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2161/001/001</DrugIDPK>
    <LicenceNumber>PA2161/001/001</LicenceNumber>
    <ProductName>Catacrom 2% w/v eye drops, solution</ProductName>
    <PAHolder>Rayner Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>27/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium cromoglicate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/088/001</DrugIDPK>
    <LicenceNumber>PA0013/088/001</LicenceNumber>
    <ProductName>Cataflam</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>13/03/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/079/001A</DrugIDPK>
    <LicenceNumber>PPA0465/079/001A</LicenceNumber>
    <ProductName>Cataflam</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>07/09/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac potassium</ActiveSubstance>
      <ActiveSubstance>Titanium dioxide (E171)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/079/001B</DrugIDPK>
    <LicenceNumber>PPA0465/079/001B</LicenceNumber>
    <ProductName>CATAFLAM</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>07/09/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0013/088/003</DrugIDPK>
    <LicenceNumber>PA0013/088/003</LicenceNumber>
    <ProductName>Cataflam Sachets</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>14/07/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/014/004</DrugIDPK>
    <LicenceNumber>PA0007/014/004</LicenceNumber>
    <ProductName>CATAPRES PL PERLONGETS</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>19/05/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLONIDINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/05/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/014/002</DrugIDPK>
    <LicenceNumber>PA0007/014/002</LicenceNumber>
    <ProductName>Catapres Tablets 300 micrograms.</ProductName>
    <PAHolder>Boehringer Ingelheim Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clonidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/02/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/134/004</DrugIDPK>
    <LicenceNumber>PA0711/134/004</LicenceNumber>
    <ProductName>Catasart</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>04/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/134/003</DrugIDPK>
    <LicenceNumber>PA0711/134/003</LicenceNumber>
    <InterchangeableListCode>IC0009-038-002</InterchangeableListCode>
    <ProductName>Catasart 16 mg Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>04/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/134/001</DrugIDPK>
    <LicenceNumber>PA0711/134/001</LicenceNumber>
    <InterchangeableListCode>IC0009-008-002</InterchangeableListCode>
    <ProductName>Catasart 4 mg Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>04/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/134/002</DrugIDPK>
    <LicenceNumber>PA0711/134/002</LicenceNumber>
    <InterchangeableListCode>IC0009-009-002</InterchangeableListCode>
    <ProductName>Catasart 8 mg Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>04/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Candesartan cilexetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/068/002</DrugIDPK>
    <LicenceNumber>PA0022/068/002</LicenceNumber>
    <ProductName>Cathate</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>19/09/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Conjugated estrogens</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/10/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/091/001</DrugIDPK>
    <LicenceNumber>PA0822/091/001</LicenceNumber>
    <ProductName>Cathate</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>12/10/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Conjugated estrogens</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0078/009/001</DrugIDPK>
    <LicenceNumber>PA0078/009/001</LicenceNumber>
    <ProductName>CATHEJELL TUBES</ProductName>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>18/10/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/09/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR0407/022/001</DrugIDPK>
    <LicenceNumber>HOR0407/022/001</LicenceNumber>
    <ProductName>Causticum (Caust.)(6C &amp; 30C)</ProductName>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>20/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Causticum hahnemanni</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0360/023/001</DrugIDPK>
    <LicenceNumber>PA0360/023/001</LicenceNumber>
    <ProductName>CAVED-S</ProductName>
    <PAHolder>J B Tillotts Limited</PAHolder>
    <AuthorisedDate>29/01/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEGLYCYRRHIZINIZED EXTRACT OF LIQUORICE</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/115/001</DrugIDPK>
    <LicenceNumber>PA0822/115/001</LicenceNumber>
    <ProductName>Caverject</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>14/02/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alprostadil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/06/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/009/006</DrugIDPK>
    <LicenceNumber>PA0936/009/006</LicenceNumber>
    <ProductName>Caverject</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alprostadil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/009/001</DrugIDPK>
    <LicenceNumber>PA0936/009/001</LicenceNumber>
    <ProductName>Caverject Dual Chamber</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alprostadil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/009/002</DrugIDPK>
    <LicenceNumber>PA0936/009/002</LicenceNumber>
    <ProductName>Caverject Dual Chamber</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Alprostadil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0623/002/001</DrugIDPK>
    <LicenceNumber>PA0623/002/001</LicenceNumber>
    <ProductName>CCNU</ProductName>
    <PAHolder>medac Gesellschaft für klinische Spezialpräparate mbH</PAHolder>
    <AuthorisedDate>16/09/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lomustine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Not applicable</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Not applicable</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/07/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0115/006/002</DrugIDPK>
    <LicenceNumber>PA0115/006/002</LicenceNumber>
    <ProductName>CCNU LUNDBECK CAPSULES</ProductName>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>14/01/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOMUSTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0764/001/001</DrugIDPK>
    <LicenceNumber>PA0764/001/001</LicenceNumber>
    <ProductName>CDP - 50 ANTICOAGULANT</ProductName>
    <PAHolder>Parkfields Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>12/10/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/09/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/96/023/001</DrugIDPK>
    <LicenceNumber>EU/1/96/023/001</LicenceNumber>
    <ProductName>CEA-SCAN</ProductName>
    <PAHolder>Immunomedics Inc</PAHolder>
    <AuthorisedDate>04/10/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA1155/004/001</DrugIDPK>
    <LicenceNumber>PA1155/004/001</LicenceNumber>
    <ProductName>Ceanel Concentrate</ProductName>
    <PAHolder>Ferndale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>27/05/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cetrimide</ActiveSubstance>
      <ActiveSubstance>Phenylethyl alcohol</ActiveSubstance>
      <ActiveSubstance>Undecylenic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/07/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/021/001</DrugIDPK>
    <LicenceNumber>PA0711/021/001</LicenceNumber>
    <ProductName>CEC</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefaclor monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/03/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/021/002</DrugIDPK>
    <LicenceNumber>PA0711/021/002</LicenceNumber>
    <ProductName>CEC</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefaclor monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/03/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22984/001/001</DrugIDPK>
    <LicenceNumber>PA22984/001/001</LicenceNumber>
    <ProductName>Ceclova 75 mg/20 mg modified-release hard capsules</ProductName>
    <PAHolder>Aenova IP GmbH</PAHolder>
    <AuthorisedDate>20/07/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
      <ActiveSubstance>Omeprazole </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/07/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0277/066/004</DrugIDPK>
    <LicenceNumber>PA0277/066/004</LicenceNumber>
    <ProductName>CEDAX</ProductName>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>03/01/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTIBUTEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0277/066/003</DrugIDPK>
    <LicenceNumber>PA0277/066/003</LicenceNumber>
    <ProductName>CEDAX</ProductName>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>03/01/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTIBUTEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0277/066/002</DrugIDPK>
    <LicenceNumber>PA0277/066/002</LicenceNumber>
    <ProductName>CEDAX</ProductName>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>03/01/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTIBUTEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0277/066/001</DrugIDPK>
    <LicenceNumber>PA0277/066/001</LicenceNumber>
    <ProductName>CEDAX</ProductName>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>03/01/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTIBUTEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/027/001</DrugIDPK>
    <LicenceNumber>PA0013/027/001</LicenceNumber>
    <ProductName>CEDILANID</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANATOSIDE C</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/044/002</DrugIDPK>
    <LicenceNumber>PA0711/044/002</LicenceNumber>
    <ProductName>Cedine</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>27/02/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cimetidine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/044/003</DrugIDPK>
    <LicenceNumber>PA0711/044/003</LicenceNumber>
    <ProductName>CEDINE</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>27/02/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/044/001</DrugIDPK>
    <LicenceNumber>PA0711/044/001</LicenceNumber>
    <ProductName>Cedine 200 mg Film-coated Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>27/02/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cimetidine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0360/021/005</DrugIDPK>
    <LicenceNumber>PA0360/021/005</LicenceNumber>
    <ProductName>CEDOCARD 20</ProductName>
    <PAHolder>J B Tillotts Limited</PAHolder>
    <AuthorisedDate>24/02/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0360/021/006</DrugIDPK>
    <LicenceNumber>PA0360/021/006</LicenceNumber>
    <ProductName>CEDOCARD 40</ProductName>
    <PAHolder>J B Tillotts Limited</PAHolder>
    <AuthorisedDate>24/02/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0360/021/004</DrugIDPK>
    <LicenceNumber>PA0360/021/004</LicenceNumber>
    <ProductName>CEDOCARD 5</ProductName>
    <PAHolder>J B Tillotts Limited</PAHolder>
    <AuthorisedDate>18/10/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0360/021/007</DrugIDPK>
    <LicenceNumber>PA0360/021/007</LicenceNumber>
    <ProductName>CEDOCARD RETARD 20</ProductName>
    <PAHolder>J B Tillotts Limited</PAHolder>
    <AuthorisedDate>24/02/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE DINITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/012/003</DrugIDPK>
    <LicenceNumber>PA0048/012/003</LicenceNumber>
    <ProductName>CEENU</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>30/11/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOMUSTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/012/002</DrugIDPK>
    <LicenceNumber>PA0048/012/002</LicenceNumber>
    <ProductName>CEENU</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>09/12/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOMUSTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/05/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/012/001</DrugIDPK>
    <LicenceNumber>PA0048/012/001</LicenceNumber>
    <ProductName>CEENU</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>30/11/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOMUSTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/05/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/019/003</DrugIDPK>
    <LicenceNumber>PA0048/019/003</LicenceNumber>
    <ProductName>CEFACIDAL</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>11/08/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFAZOLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/05/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/019/002</DrugIDPK>
    <LicenceNumber>PA0048/019/002</LicenceNumber>
    <ProductName>CEFACIDAL</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>11/08/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFAZOLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/05/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/019/001</DrugIDPK>
    <LicenceNumber>PA0048/019/001</LicenceNumber>
    <ProductName>CEFACIDAL</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>11/08/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFAZOLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/05/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0688/013/001</DrugIDPK>
    <LicenceNumber>PA0688/013/001</LicenceNumber>
    <ProductName>Cefaclor 250mg Capsules</ProductName>
    <PAHolder>Chanelle Medical Unlimited Company</PAHolder>
    <AuthorisedDate>13/04/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefaclor</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/03/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0688/013/002</DrugIDPK>
    <LicenceNumber>PA0688/013/002</LicenceNumber>
    <ProductName>Cefaclor 500 mg Capsules</ProductName>
    <PAHolder>Chanelle Medical Unlimited Company</PAHolder>
    <AuthorisedDate>13/04/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefaclor</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/03/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/045/001</DrugIDPK>
    <LicenceNumber>PA0577/045/001</LicenceNumber>
    <ProductName>Cefager Powder for Oral Suspension 125 mg/5 ml</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>08/03/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefaclor monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/045/002</DrugIDPK>
    <LicenceNumber>PA0577/045/002</LicenceNumber>
    <ProductName>Cefager Powder for Oral Suspension 250 mg/5 ml</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>08/03/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefaclor monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/041/001</DrugIDPK>
    <LicenceNumber>PA1380/041/001</LicenceNumber>
    <ProductName>Cefalexin</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>03/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/041/002</DrugIDPK>
    <LicenceNumber>PA1380/041/002</LicenceNumber>
    <ProductName>Cefalexin</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>03/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/002/002</DrugIDPK>
    <LicenceNumber>PA0048/002/002</LicenceNumber>
    <ProductName>CEFATREXYL</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>19/09/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFAPIRIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/002/001</DrugIDPK>
    <LicenceNumber>PA0048/002/001</LicenceNumber>
    <ProductName>CEFATREXYL</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>19/09/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFAPIRIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/12/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/087/003</DrugIDPK>
    <LicenceNumber>PA0017/087/003</LicenceNumber>
    <ProductName>CEFIZOX</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>15/03/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTIZOXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/087/002</DrugIDPK>
    <LicenceNumber>PA0017/087/002</LicenceNumber>
    <ProductName>CEFIZOX</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>15/03/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTIZOXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/03/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/087/001</DrugIDPK>
    <LicenceNumber>PA0017/087/001</LicenceNumber>
    <ProductName>CEFIZOX</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>15/03/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFTIZOXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/032/003</DrugIDPK>
    <LicenceNumber>PA0019/032/003</LicenceNumber>
    <ProductName>CEFOBID</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>01/11/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFOPERAZONE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/08/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/032/001</DrugIDPK>
    <LicenceNumber>PA0019/032/001</LicenceNumber>
    <ProductName>CEFOBID</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>01/11/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFOPERAZONE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/08/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/033/002</DrugIDPK>
    <LicenceNumber>PA0540/033/002</LicenceNumber>
    <ProductName>Cefodox</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>11/10/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefpodoxime proxetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/01/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/033/001</DrugIDPK>
    <LicenceNumber>PA0540/033/001</LicenceNumber>
    <ProductName>Cefodox Paediatric 40mg/5ml Granules for Oral Suspension</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>21/07/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefpodoxime proxetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/06/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0111/005/001</DrugIDPK>
    <LicenceNumber>PA0111/005/001</LicenceNumber>
    <ProductName>Cefotaxime</ProductName>
    <PAHolder>Sandoz GmbH</PAHolder>
    <AuthorisedDate>06/12/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefotaxime</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0111/005/002</DrugIDPK>
    <LicenceNumber>PA0111/005/002</LicenceNumber>
    <ProductName>Cefotaxime</ProductName>
    <PAHolder>Sandoz GmbH</PAHolder>
    <AuthorisedDate>06/12/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefotaxime</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0111/005/003</DrugIDPK>
    <LicenceNumber>PA0111/005/003</LicenceNumber>
    <ProductName>Cefotaxime</ProductName>
    <PAHolder>Sandoz GmbH</PAHolder>
    <AuthorisedDate>06/12/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefotaxime</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/012/001</DrugIDPK>
    <LicenceNumber>PA0749/012/001</LicenceNumber>
    <ProductName>Cefotaxime</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>10/11/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefotaxime sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/04/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/012/002</DrugIDPK>
    <LicenceNumber>PA0749/012/002</LicenceNumber>
    <ProductName>Cefotaxime</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>10/11/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefotaxime sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/04/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/012/003</DrugIDPK>
    <LicenceNumber>PA0749/012/003</LicenceNumber>
    <ProductName>Cefotaxime</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>10/11/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefotaxime sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/002/003</DrugIDPK>
    <LicenceNumber>PA1339/002/003</LicenceNumber>
    <ProductName>Cefotaxime 2g Powder for solution for injection or infusion</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>19/09/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefotaxime sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/045/004</DrugIDPK>
    <LicenceNumber>PA0006/045/004</LicenceNumber>
    <ProductName>CEFROM</ProductName>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>19/05/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFPIROME SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/10/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/045/003</DrugIDPK>
    <LicenceNumber>PA0006/045/003</LicenceNumber>
    <ProductName>CEFROM</ProductName>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>19/05/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFPIROME SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/10/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/045/002</DrugIDPK>
    <LicenceNumber>PA0006/045/002</LicenceNumber>
    <ProductName>CEFROM</ProductName>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>19/05/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFPIROME SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/10/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/045/001</DrugIDPK>
    <LicenceNumber>PA0006/045/001</LicenceNumber>
    <ProductName>CEFROM</ProductName>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>19/05/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFPIROME SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/10/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/045/006</DrugIDPK>
    <LicenceNumber>PA0006/045/006</LicenceNumber>
    <ProductName>CEFROM POWDER</ProductName>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>19/05/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFPIROME SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/10/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/045/005</DrugIDPK>
    <LicenceNumber>PA0006/045/005</LicenceNumber>
    <ProductName>CEFROM POWDER</ProductName>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>19/05/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFPIROME</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/10/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/101/001</DrugIDPK>
    <LicenceNumber>PA0711/101/001</LicenceNumber>
    <ProductName>Ceftal</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>13/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime axetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/07/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/178/001</DrugIDPK>
    <LicenceNumber>PA0126/178/001</LicenceNumber>
    <ProductName>Ceftazidime</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>06/03/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ceftazidime</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/08/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/178/002</DrugIDPK>
    <LicenceNumber>PA0126/178/002</LicenceNumber>
    <ProductName>Ceftazidime</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>06/03/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ceftazidime</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/08/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/178/003</DrugIDPK>
    <LicenceNumber>PA0126/178/003</LicenceNumber>
    <ProductName>Ceftazidime</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>06/03/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ceftazidime</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/08/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/178/004</DrugIDPK>
    <LicenceNumber>PA0126/178/004</LicenceNumber>
    <ProductName>Ceftazidime</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>06/03/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ceftazidime</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/08/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0361/033/001</DrugIDPK>
    <LicenceNumber>PA0361/033/001</LicenceNumber>
    <ProductName>Ceftazidime</ProductName>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>08/07/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ceftazidime pentahydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0361/033/002</DrugIDPK>
    <LicenceNumber>PA0361/033/002</LicenceNumber>
    <ProductName>Ceftazidime</ProductName>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>08/07/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ceftazidime pentahydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0361/033/003</DrugIDPK>
    <LicenceNumber>PA0361/033/003</LicenceNumber>
    <ProductName>Ceftazidime</ProductName>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>08/07/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ceftazidime pentahydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0361/033/004</DrugIDPK>
    <LicenceNumber>PA0361/033/004</LicenceNumber>
    <ProductName>Ceftazidime</ProductName>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>03/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ceftazidime pentahydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/074/001</DrugIDPK>
    <LicenceNumber>PA0437/074/001</LicenceNumber>
    <ProductName>Ceftazidime</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>08/01/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ceftazidime pentahydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/08/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/074/002</DrugIDPK>
    <LicenceNumber>PA0437/074/002</LicenceNumber>
    <ProductName>Ceftazidime</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>08/01/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ceftazidime pentahydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/08/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/074/003</DrugIDPK>
    <LicenceNumber>PA0437/074/003</LicenceNumber>
    <ProductName>Ceftazidime</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>08/01/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ceftazidime pentahydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/08/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/070/001</DrugIDPK>
    <LicenceNumber>PA0437/070/001</LicenceNumber>
    <ProductName>Ceftriaxone Hospira</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>19/09/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ceftriaxone sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/08/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0372/009/001</DrugIDPK>
    <LicenceNumber>PA0372/009/001</LicenceNumber>
    <ProductName>Cefuroxime</ProductName>
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate>08/12/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime axetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/06/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0372/009/002</DrugIDPK>
    <LicenceNumber>PA0372/009/002</LicenceNumber>
    <ProductName>Cefuroxime</ProductName>
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate>08/12/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime axetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/06/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/059/001</DrugIDPK>
    <LicenceNumber>PA0711/059/001</LicenceNumber>
    <ProductName>Cefuroxime</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>24/09/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime axetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/059/002</DrugIDPK>
    <LicenceNumber>PA0711/059/002</LicenceNumber>
    <ProductName>Cefuroxime</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>24/09/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime axetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1897/002/001</DrugIDPK>
    <LicenceNumber>PA1897/002/001</LicenceNumber>
    <ProductName>Cefuroxime</ProductName>
    <PAHolder>Amneal Pharma Europe Limited</PAHolder>
    <AuthorisedDate>28/06/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime Sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1897/002/002</DrugIDPK>
    <LicenceNumber>PA1897/002/002</LicenceNumber>
    <ProductName>Cefuroxime</ProductName>
    <PAHolder>Amneal Pharma Europe Limited</PAHolder>
    <AuthorisedDate>28/06/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime Sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1897/002/003</DrugIDPK>
    <LicenceNumber>PA1897/002/003</LicenceNumber>
    <ProductName>Cefuroxime</ProductName>
    <PAHolder>Amneal Pharma Europe Limited</PAHolder>
    <AuthorisedDate>28/06/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime Sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/045/001</DrugIDPK>
    <LicenceNumber>PA0437/045/001</LicenceNumber>
    <ProductName>CEFUROXIME</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>23/06/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime Sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/06/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/045/004</DrugIDPK>
    <LicenceNumber>PA0437/045/004</LicenceNumber>
    <ProductName>CEFUROXIME</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>23/06/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime Sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/06/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/045/005</DrugIDPK>
    <LicenceNumber>PA0437/045/005</LicenceNumber>
    <ProductName>CEFUROXIME</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>23/06/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime Sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/06/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/066/001</DrugIDPK>
    <LicenceNumber>PA1380/066/001</LicenceNumber>
    <ProductName>Cefuroxime Actavis</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime Sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/066/002</DrugIDPK>
    <LicenceNumber>PA1380/066/002</LicenceNumber>
    <ProductName>Cefuroxime Actavis</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime Sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/066/003</DrugIDPK>
    <LicenceNumber>PA1380/066/003</LicenceNumber>
    <ProductName>Cefuroxime Actavis</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime sodium (sterile)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/055/001</DrugIDPK>
    <LicenceNumber>PA1380/055/001</LicenceNumber>
    <ProductName>Cefuroxime Actavis 250 mg Film-coated Tablets</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>31/03/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime axetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/055/002</DrugIDPK>
    <LicenceNumber>PA1380/055/002</LicenceNumber>
    <ProductName>Cefuroxime Actavis 500 mg Film-coated Tablets</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>31/03/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime axetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1050/021/001</DrugIDPK>
    <LicenceNumber>PA1050/021/001</LicenceNumber>
    <ProductName>Cefuroxime Aurobindo</ProductName>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>03/08/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime axetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/04/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1050/021/002</DrugIDPK>
    <LicenceNumber>PA1050/021/002</LicenceNumber>
    <ProductName>Cefuroxime Aurobindo</ProductName>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>03/08/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime axetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/04/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1050/021/003</DrugIDPK>
    <LicenceNumber>PA1050/021/003</LicenceNumber>
    <ProductName>Cefuroxime Aurobindo</ProductName>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>03/08/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime axetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/04/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1675/002/001</DrugIDPK>
    <LicenceNumber>PA1675/002/001</LicenceNumber>
    <ProductName>Cefuroxime Glob Limited</ProductName>
    <PAHolder>Glob Limited</PAHolder>
    <AuthorisedDate>30/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1675/002/002</DrugIDPK>
    <LicenceNumber>PA1675/002/002</LicenceNumber>
    <ProductName>Cefuroxime Glob Limited</ProductName>
    <PAHolder>Glob Limited</PAHolder>
    <AuthorisedDate>30/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1675/002/003</DrugIDPK>
    <LicenceNumber>PA1675/002/003</LicenceNumber>
    <ProductName>Cefuroxime Glob Limited</ProductName>
    <PAHolder>Glob Limited</PAHolder>
    <AuthorisedDate>30/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0361/030/001</DrugIDPK>
    <LicenceNumber>PA0361/030/001</LicenceNumber>
    <ProductName>Cefuroxime Martindale Pharma</ProductName>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>18/06/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime Sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0361/030/002</DrugIDPK>
    <LicenceNumber>PA0361/030/002</LicenceNumber>
    <ProductName>Cefuroxime Martindale Pharma</ProductName>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>18/06/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime Sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0372/007/001</DrugIDPK>
    <LicenceNumber>PA0372/007/001</LicenceNumber>
    <ProductName>Cefuroxime Sodium</ProductName>
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate>25/08/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime Sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/03/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0372/007/002</DrugIDPK>
    <LicenceNumber>PA0372/007/002</LicenceNumber>
    <ProductName>Cefuroxime Sodium</ProductName>
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate>25/08/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime Sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/03/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0372/007/003</DrugIDPK>
    <LicenceNumber>PA0372/007/003</LicenceNumber>
    <ProductName>Cefuroxime Sodium</ProductName>
    <PAHolder>Sandoz Ltd</PAHolder>
    <AuthorisedDate>25/08/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime Sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/03/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/082/001</DrugIDPK>
    <LicenceNumber>PA0749/082/001</LicenceNumber>
    <ProductName>Cefuroxime Teva</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>12/02/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime axetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/082/002</DrugIDPK>
    <LicenceNumber>PA0749/082/002</LicenceNumber>
    <ProductName>Cefuroxime Teva</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>12/02/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime axetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0749/082/003</DrugIDPK>
    <LicenceNumber>PA0749/082/003</LicenceNumber>
    <ProductName>Cefuroxime Teva</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>12/02/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefuroxime axetil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0002/065/001</DrugIDPK>
    <LicenceNumber>PA0002/065/001</LicenceNumber>
    <ProductName>Cefzil</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefprozil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/10/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/065/002</DrugIDPK>
    <LicenceNumber>PA0002/065/002</LicenceNumber>
    <ProductName>Cefzil</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefprozil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/10/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/065/003</DrugIDPK>
    <LicenceNumber>PA0002/065/003</LicenceNumber>
    <ProductName>Cefzil</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefprozil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/10/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/065/004</DrugIDPK>
    <LicenceNumber>PA0002/065/004</LicenceNumber>
    <ProductName>Cefzil</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefprozil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/10/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/073/001</DrugIDPK>
    <LicenceNumber>PA0047/073/001</LicenceNumber>
    <ProductName>Celance</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>18/10/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pergolide mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/073/002</DrugIDPK>
    <LicenceNumber>PA0047/073/002</LicenceNumber>
    <ProductName>Celance</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>18/10/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pergolide mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/073/003</DrugIDPK>
    <LicenceNumber>PA0047/073/003</LicenceNumber>
    <ProductName>Celance</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>18/10/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pergolide mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0049/008/001</DrugIDPK>
    <LicenceNumber>PA0049/008/001</LicenceNumber>
    <ProductName>CELBENIN</ProductName>
    <PAHolder>SmithKline Beecham Pharm Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/22/1666/001-004</DrugIDPK>
    <LicenceNumber>EU/1/22/1666/001-004</LicenceNumber>
    <ProductName>Celdoxome pegylated liposomal 2 mg/mL concentrate for dispersion for infusion</ProductName>
    <PAHolder>Yes Pharmaceutical Development Services GmbH</PAHolder>
    <AuthorisedDate>15/09/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for dispersion for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>22/09/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/057/002</DrugIDPK>
    <LicenceNumber>PPA1328/057/002</LicenceNumber>
    <ProductName>Celebrex</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>04/12/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Celecoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/038/001</DrugIDPK>
    <LicenceNumber>PPA1500/038/001</LicenceNumber>
    <ProductName>Celebrex</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>12/03/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Celecoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/057/001</DrugIDPK>
    <LicenceNumber>PPA1328/057/001</LicenceNumber>
    <ProductName>Celebrex 100 mg capsules.</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>29/09/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Celecoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/118/001</DrugIDPK>
    <LicenceNumber>PPA0465/118/001</LicenceNumber>
    <ProductName>Celebrex 100 mg hard capsules</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>19/03/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Celecoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/034/001</DrugIDPK>
    <LicenceNumber>PPA1596/034/001</LicenceNumber>
    <ProductName>Celebrex 200 mg capsule, hard</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Celecoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/070/001</DrugIDPK>
    <LicenceNumber>PPA1151/070/001</LicenceNumber>
    <ProductName>Celebrex 200mg Hard Capsules</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>01/08/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Celecoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/143/001</DrugIDPK>
    <LicenceNumber>PA1380/143/001</LicenceNumber>
    <ProductName>Celecoxib</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>30/05/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Celecoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/07/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/143/002</DrugIDPK>
    <LicenceNumber>PA1380/143/002</LicenceNumber>
    <ProductName>Celecoxib</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>30/05/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Celecoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/07/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/071/001</DrugIDPK>
    <LicenceNumber>PA0405/071/001</LicenceNumber>
    <ProductName>Celecoxib 100 mg capsules, hard</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>24/11/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Celecoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/04/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA23176/002/001</DrugIDPK>
    <LicenceNumber>PA23176/002/001</LicenceNumber>
    <ProductName>Celecoxib 100 mg hard capsules</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>30/06/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Celecoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/10/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/071/002</DrugIDPK>
    <LicenceNumber>PA0405/071/002</LicenceNumber>
    <ProductName>Celecoxib 200 mg capsules, hard</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>24/11/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Celecoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/04/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA23176/002/002</DrugIDPK>
    <LicenceNumber>PA23176/002/002</LicenceNumber>
    <ProductName>Celecoxib 200 mg hard capsules</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>30/06/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Celecoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/10/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/083/001</DrugIDPK>
    <LicenceNumber>PA0822/083/001</LicenceNumber>
    <ProductName>Celecoxib Pfizer 100 mg capsules, hard</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>16/03/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Celecoxib</ActiveSubstance>
      <ActiveSubstance>Gelatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/06/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/083/002</DrugIDPK>
    <LicenceNumber>PA0822/083/002</LicenceNumber>
    <ProductName>Celecoxib Pfizer 200 mg capsules, hard</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>16/03/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Celecoxib</ActiveSubstance>
      <ActiveSubstance>Gelatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/06/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/241/001</DrugIDPK>
    <LicenceNumber>PA0711/241/001</LicenceNumber>
    <ProductName>Celecoxib Rowex 100 mg capsules, hard</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>03/10/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Celecoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/06/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/241/002</DrugIDPK>
    <LicenceNumber>PA0711/241/002</LicenceNumber>
    <ProductName>Celecoxib Rowex 200 mg capsules, hard</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>03/10/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Celecoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/06/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/036/001</DrugIDPK>
    <LicenceNumber>PA0007/036/001</LicenceNumber>
    <ProductName>CELEVAC</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>07/01/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLCELLULOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1142/010/001</DrugIDPK>
    <LicenceNumber>PA1142/010/001</LicenceNumber>
    <ProductName>Celevac 500mg Tablets</ProductName>
    <PAHolder>Amdipharm Limited</PAHolder>
    <AuthorisedDate>07/01/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methylcellulose</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/058/001</DrugIDPK>
    <LicenceNumber>PA0408/058/001</LicenceNumber>
    <ProductName>Celiprolol Hydrochloride</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>18/12/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Celiprolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/058/002</DrugIDPK>
    <LicenceNumber>PA0408/058/002</LicenceNumber>
    <ProductName>Celiprolol Hydrochloride</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>18/12/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Celiprolol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/031/001</DrugIDPK>
    <LicenceNumber>DPR0465/031/001</LicenceNumber>
    <ProductName>Celluvisc</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>04/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carmellose sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/01/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/031/002</DrugIDPK>
    <LicenceNumber>DPR0465/031/002</LicenceNumber>
    <ProductName>Celluvisc</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>04/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carmellose sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/01/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1328/027/001</DrugIDPK>
    <LicenceNumber>DPR1328/027/001</LicenceNumber>
    <ProductName>Celluvisc</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>03/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carmellose sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1392/040/001</DrugIDPK>
    <LicenceNumber>DPR1392/040/001</LicenceNumber>
    <ProductName>Celluvisc</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>26/05/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carmellose sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1463/039/001</DrugIDPK>
    <LicenceNumber>DPR1463/039/001</LicenceNumber>
    <ProductName>Celluvisc</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>18/07/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carmellose sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/07/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1463/039/002</DrugIDPK>
    <LicenceNumber>DPR1463/039/002</LicenceNumber>
    <ProductName>Celluvisc</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>18/07/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carmellose sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/07/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1633/014/001</DrugIDPK>
    <LicenceNumber>DPR1633/014/001</LicenceNumber>
    <ProductName>Celluvisc</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>15/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carmellose sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/028/001</DrugIDPK>
    <LicenceNumber>PPA1562/028/001</LicenceNumber>
    <ProductName>Celluvisc</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>12/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carmellose sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1562/004/001</DrugIDPK>
    <LicenceNumber>DPR1562/004/001</LicenceNumber>
    <ProductName>CELLUVISC</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>26/02/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carmellose sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA23176/016/001</DrugIDPK>
    <LicenceNumber>PPA23176/016/001</LicenceNumber>
    <ProductName>Celluvisc 1% w/v Eye drops, solution, unit dose</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>17/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carmellose sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Unknown</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1473/052/001</DrugIDPK>
    <LicenceNumber>DPR1473/052/001</LicenceNumber>
    <ProductName>Celluvisc Eye Drops Solution</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>19/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carmellose sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/052/002</DrugIDPK>
    <LicenceNumber>DPR1473/052/002</LicenceNumber>
    <ProductName>Celluvisc Eye Drops Solution</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carmellose sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/04/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1500/031/001</DrugIDPK>
    <LicenceNumber>DPR1500/031/001</LicenceNumber>
    <ProductName>Celluvisc Eye Drops Solution</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>19/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carmellose sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1596/016/001</DrugIDPK>
    <LicenceNumber>DPR1596/016/001</LicenceNumber>
    <ProductName>Celluvisc Eye Drops Solution</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>30/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carmellose sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1601/005/001</DrugIDPK>
    <LicenceNumber>DPR1601/005/001</LicenceNumber>
    <ProductName>Celluvisc Eye Drops Solution</ProductName>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>28/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carmellose sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/08/506/001</DrugIDPK>
    <LicenceNumber>EU/1/08/506/001</LicenceNumber>
    <ProductName>Celvapan</ProductName>
    <PAHolder>Nanotherapeutics Bohumil S.R.O</PAHolder>
    <AuthorisedDate>04/03/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/california/07/2009 (h1n1)v</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/11/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0060/018/002</DrugIDPK>
    <LicenceNumber>PA0060/018/002</LicenceNumber>
    <ProductName>CENDEVAX RUBELLA VACCINE</ProductName>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>04/07/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/08/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0060/018/001</DrugIDPK>
    <LicenceNumber>PA0060/018/001</LicenceNumber>
    <ProductName>CENDEVAX RUBELLA VACCINE</ProductName>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>04/07/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/08/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0502/002/001</DrugIDPK>
    <LicenceNumber>PA0502/002/001</LicenceNumber>
    <ProductName>CENTOXIN</ProductName>
    <PAHolder>Janssen Biologics B.V.</PAHolder>
    <AuthorisedDate>11/10/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1032/002/001</DrugIDPK>
    <LicenceNumber>PA1032/002/001</LicenceNumber>
    <ProductName>Centradol</ProductName>
    <PAHolder>Grünenthal GmbH</PAHolder>
    <AuthorisedDate>03/05/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Buprenorphine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate>01/06/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1032/002/002</DrugIDPK>
    <LicenceNumber>PA1032/002/002</LicenceNumber>
    <ProductName>Centradol</ProductName>
    <PAHolder>Grünenthal GmbH</PAHolder>
    <AuthorisedDate>03/05/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Buprenorphine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate>01/06/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1032/002/003</DrugIDPK>
    <LicenceNumber>PA1032/002/003</LicenceNumber>
    <ProductName>Centradol</ProductName>
    <PAHolder>Grünenthal GmbH</PAHolder>
    <AuthorisedDate>03/05/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Buprenorphine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 of the Misuse of Drugs Act 1977 and 1984.</SupplyComments>
    <WithdrawalDate>01/06/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/010/001</DrugIDPK>
    <LicenceNumber>PA0822/010/001</LicenceNumber>
    <ProductName>Centrax 10mg Tablets</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>07/07/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Prazepam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/09/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/018/001</DrugIDPK>
    <LicenceNumber>PA0046/018/001</LicenceNumber>
    <ProductName>Centyl</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bendroflumethiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/018/002</DrugIDPK>
    <LicenceNumber>PA0046/018/002</LicenceNumber>
    <ProductName>Centyl</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bendroflumethiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/092/001</DrugIDPK>
    <LicenceNumber>PA0035/092/001</LicenceNumber>
    <ProductName>CEOXX</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rofecoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/10/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/092/002</DrugIDPK>
    <LicenceNumber>PA0035/092/002</LicenceNumber>
    <ProductName>CEOXX</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rofecoxib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/10/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0041/021/001</DrugIDPK>
    <LicenceNumber>PA0041/021/001</LicenceNumber>
    <ProductName>CEPASTAT</ProductName>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>14/02/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/056/002</DrugIDPK>
    <LicenceNumber>PA0282/056/002</LicenceNumber>
    <ProductName>CEPHALEXIN</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>21/10/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/08/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/056/001</DrugIDPK>
    <LicenceNumber>PA0282/056/001</LicenceNumber>
    <ProductName>CEPHALEXIN</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>21/10/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/08/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0903/003/001</DrugIDPK>
    <LicenceNumber>PA0903/003/001</LicenceNumber>
    <ProductName>Ceplac</ProductName>
    <PAHolder>Manx Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Erythrosine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/004/001</DrugIDPK>
    <LicenceNumber>PA0044/004/001</LicenceNumber>
    <ProductName>CEPORACIN</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>30/01/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALOTIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/12/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/009/002</DrugIDPK>
    <LicenceNumber>PA0044/009/002</LicenceNumber>
    <ProductName>Ceporex</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefalexin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/11/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/009/003</DrugIDPK>
    <LicenceNumber>PA0044/009/003</LicenceNumber>
    <ProductName>Ceporex</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cephalexin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/11/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/009/004</DrugIDPK>
    <LicenceNumber>PA0044/009/004</LicenceNumber>
    <ProductName>CEPOREX</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>18/11/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cephalexin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/08/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/009/005</DrugIDPK>
    <LicenceNumber>PA0044/009/005</LicenceNumber>
    <ProductName>CEPOREX</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>18/11/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cephalexin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/08/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/009/008</DrugIDPK>
    <LicenceNumber>PA0044/009/008</LicenceNumber>
    <ProductName>CEPOREX</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>16/01/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALEXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/008/002</DrugIDPK>
    <LicenceNumber>PA0044/008/002</LicenceNumber>
    <ProductName>CEPORIN</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALORIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/08/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/008/001</DrugIDPK>
    <LicenceNumber>PA0044/008/001</LicenceNumber>
    <ProductName>CEPORIN</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALORIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/008/003</DrugIDPK>
    <LicenceNumber>PA0044/008/003</LicenceNumber>
    <ProductName>CEPORIN (A-FORM)</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALORIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/008/004</DrugIDPK>
    <LicenceNumber>PA0044/008/004</LicenceNumber>
    <ProductName>CEPORIN (S-FORM)</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFALORIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/08/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0187/007/002</DrugIDPK>
    <LicenceNumber>PA0187/007/002</LicenceNumber>
    <ProductName>CEPTIPRIN</ProductName>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0051/014/003</DrugIDPK>
    <LicenceNumber>PA0051/014/003</LicenceNumber>
    <ProductName>CEPTON CLENSING MILK</ProductName>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>15/03/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0739/003/001</DrugIDPK>
    <LicenceNumber>PA0739/003/001</LicenceNumber>
    <ProductName>Cepton Medicated Clear Gel</ProductName>
    <PAHolder>Eastern Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>20/08/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chlorhexidine gluconate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0739/003/002</DrugIDPK>
    <LicenceNumber>PA0739/003/002</LicenceNumber>
    <ProductName>Cepton Medicated Lotion</ProductName>
    <PAHolder>Eastern Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>26/06/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chlorhexidine gluconate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0739/003/003</DrugIDPK>
    <LicenceNumber>PA0739/003/003</LicenceNumber>
    <ProductName>Cepton Medicated Skin Wash</ProductName>
    <PAHolder>Eastern Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>26/06/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chlorhexidine gluconate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/307/001</DrugIDPK>
    <LicenceNumber>PPA0465/307/001</LicenceNumber>
    <ProductName>Cerazette</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>17/05/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desogestrel</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/222/001</DrugIDPK>
    <LicenceNumber>PPA1151/222/001</LicenceNumber>
    <ProductName>Cerazette 75 microgram film-coated tablet</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>13/06/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desogestrel</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/10/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/071/001</DrugIDPK>
    <LicenceNumber>PPA1463/071/001</LicenceNumber>
    <ProductName>Cerazette 75 microgram film-coated tablets</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>08/02/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desogestrel</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/10/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0235/008/007</DrugIDPK>
    <LicenceNumber>PA0235/008/007</LicenceNumber>
    <ProductName>CEREBRAL 280 MG</ProductName>
    <PAHolder>Nycomed (UK) Limited</PAHolder>
    <AuthorisedDate>14/06/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0235/008/006</DrugIDPK>
    <LicenceNumber>PA0235/008/006</LicenceNumber>
    <ProductName>CEREBRAL 280 MG</ProductName>
    <PAHolder>Nycomed (UK) Limited</PAHolder>
    <AuthorisedDate>14/06/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0735/013/001</DrugIDPK>
    <LicenceNumber>PA0735/013/001</LicenceNumber>
    <ProductName>Ceretec 500 micrograms kit for radiopharmaceutical preparation</ProductName>
    <PAHolder>GE Healthcare AS</PAHolder>
    <AuthorisedDate>19/04/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Kit for radiopharmaceutical preparation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Exametazime</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/04/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/053/001</DrugIDPK>
    <LicenceNumber>EU/1/97/053/001</LicenceNumber>
    <ProductName>Cerezyme</ProductName>
    <PAHolder>Sanofi B.V.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Imiglucerase</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>29/04/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/053/002</DrugIDPK>
    <LicenceNumber>EU/1/97/053/002</LicenceNumber>
    <ProductName>Cerezyme</ProductName>
    <PAHolder>Sanofi B.V.</PAHolder>
    <AuthorisedDate>17/11/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Imiglucerase</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>29/04/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/097/002</DrugIDPK>
    <LicenceNumber>PA0167/097/002</LicenceNumber>
    <ProductName>Cernevit, Bioset,Powder for Solution for Injection or Infusion</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>22/06/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Retinol palmitate</ActiveSubstance>
      <ActiveSubstance>Colecalciferol</ActiveSubstance>
      <ActiveSubstance>Dl-alfa-tocoferol</ActiveSubstance>
      <ActiveSubstance>Ascorbic acid</ActiveSubstance>
      <ActiveSubstance>Cocarboxylase tetrahydrate</ActiveSubstance>
      <ActiveSubstance>Riboflavin sodium phosphate</ActiveSubstance>
      <ActiveSubstance>Pyridoxine hydrochloride </ActiveSubstance>
      <ActiveSubstance>Cyanocobalamin</ActiveSubstance>
      <ActiveSubstance>Folic acid</ActiveSubstance>
      <ActiveSubstance>Dexpantenol</ActiveSubstance>
      <ActiveSubstance>Biotin</ActiveSubstance>
      <ActiveSubstance>Nicotinamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/04/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0896/005/005</DrugIDPK>
    <LicenceNumber>PA0896/005/005</LicenceNumber>
    <ProductName>Certican 0.1mg Dispersible Tablets</ProductName>
    <PAHolder>Novartis Ireland Limited</PAHolder>
    <AuthorisedDate>12/12/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Everolimus</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0896/005/006</DrugIDPK>
    <LicenceNumber>PA0896/005/006</LicenceNumber>
    <ProductName>Certican 0.25mg Dispersible Tablets</ProductName>
    <PAHolder>Novartis Ireland Limited</PAHolder>
    <AuthorisedDate>12/12/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Everolimus</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0896/005/002</DrugIDPK>
    <LicenceNumber>PA0896/005/002</LicenceNumber>
    <ProductName>Certican 0.5mg Tablets</ProductName>
    <PAHolder>Novartis Ireland Limited</PAHolder>
    <AuthorisedDate>12/12/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Everolimus</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0896/005/004</DrugIDPK>
    <LicenceNumber>PA0896/005/004</LicenceNumber>
    <ProductName>Certican 1 mg Tablets</ProductName>
    <PAHolder>Novartis Ireland Limited</PAHolder>
    <AuthorisedDate>12/12/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Everolimus</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/026/001</DrugIDPK>
    <LicenceNumber>DPR0465/026/001</LicenceNumber>
    <ProductName>Cerumol</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>27/02/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chlorobutanol</ActiveSubstance>
      <ActiveSubstance>Arachis oil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/025/001</DrugIDPK>
    <LicenceNumber>DPR1473/025/001</LicenceNumber>
    <ProductName>CERUMOL</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>01/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chlorobutanol</ActiveSubstance>
      <ActiveSubstance>Arachis oil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0610/018/001</DrugIDPK>
    <LicenceNumber>PA0610/018/001</LicenceNumber>
    <ProductName>Cerumol Ear Drops Solution</ProductName>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>26/08/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Arachis oil</ActiveSubstance>
      <ActiveSubstance>Chlorobutanol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/09/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0261/027/001</DrugIDPK>
    <LicenceNumber>PA0261/027/001</LicenceNumber>
    <ProductName>CERVIPROST</ProductName>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>05/06/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DINOPROSTONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/06/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/056/001</DrugIDPK>
    <LicenceNumber>PA0047/056/001</LicenceNumber>
    <ProductName>CESAMET</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>23/06/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NABILONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/06/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/016/002</DrugIDPK>
    <LicenceNumber>PA0073/016/002</LicenceNumber>
    <ProductName>CETAMOL</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/016/001</DrugIDPK>
    <LicenceNumber>PA0073/016/001</LicenceNumber>
    <ProductName>CETAMOL</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0469/030/001</DrugIDPK>
    <LicenceNumber>PA0469/030/001</LicenceNumber>
    <ProductName>Cetavlex Antiseptic</ProductName>
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate>01/04/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cetrimide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0051/051/001</DrugIDPK>
    <LicenceNumber>PA0051/051/001</LicenceNumber>
    <ProductName>CETAVLON</ProductName>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/12/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0051/044/001</DrugIDPK>
    <LicenceNumber>PA0051/044/001</LicenceNumber>
    <ProductName>CETAVLON</ProductName>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0187/007/001</DrugIDPK>
    <LicenceNumber>PA0187/007/001</LicenceNumber>
    <ProductName>CETIPRIN</ProductName>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EMEPRONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/10/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0187/014/002</DrugIDPK>
    <LicenceNumber>PA0187/014/002</LicenceNumber>
    <ProductName>Cetiprin Novum</ProductName>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Emepronium carrageenate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/05/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0187/014/001</DrugIDPK>
    <LicenceNumber>PA0187/014/001</LicenceNumber>
    <ProductName>CETIPRIN NOVUM</ProductName>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>24/05/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EMEPRONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/10/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/018/001</DrugIDPK>
    <LicenceNumber>PA0819/018/001</LicenceNumber>
    <ProductName>Cetirizine</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cetirizine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/085/001</DrugIDPK>
    <LicenceNumber>PA0577/085/001</LicenceNumber>
    <ProductName>Cetirizine 10mg film-coated tablets.</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>13/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cetirizine dihydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1445/004/001</DrugIDPK>
    <LicenceNumber>PA1445/004/001</LicenceNumber>
    <ProductName>Cetirizine Aurobindo</ProductName>
    <PAHolder>Aurobindo Pharma (Malta) Limited</PAHolder>
    <AuthorisedDate>03/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cetirizine dihydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/01/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1186/015/001</DrugIDPK>
    <LicenceNumber>PA1186/015/001</LicenceNumber>
    <ProductName>Cetirizine dihydrochloride 10mg Film-coated Tablets</ProductName>
    <PAHolder>Chefaro Ireland DAC</PAHolder>
    <AuthorisedDate>26/05/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cetirizine dihydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>None</SupplyComments>
    <WithdrawalDate>27/05/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/085/002</DrugIDPK>
    <LicenceNumber>PA0577/085/002</LicenceNumber>
    <ProductName>Cetirizine Mylan 10mg film-coated tablets.</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>13/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cetirizine dihydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>Product not subject to medical prescription (if compliant with restrictions outlined below). 
Retail sale through pharmacies only with the following restrictions: maximum pack size: 10 unit dosage forms, maximum strength: 10 mg, maximum daily dose: 10 mg.</SupplyComments>
    <WithdrawalDate>30/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/087/001</DrugIDPK>
    <LicenceNumber>PA0073/087/001</LicenceNumber>
    <ProductName>CETRAM</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>14/05/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBUPROFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/01/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0518/003/001</DrugIDPK>
    <LicenceNumber>PA0518/003/001</LicenceNumber>
    <ProductName>CETRICLENS</ProductName>
    <PAHolder>T.J. Smith &amp; Nephew</PAHolder>
    <AuthorisedDate>10/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0518/003/002</DrugIDPK>
    <LicenceNumber>PA0518/003/002</LicenceNumber>
    <ProductName>CETRICLENS FORTE</ProductName>
    <PAHolder>T.J. Smith &amp; Nephew</PAHolder>
    <AuthorisedDate>10/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/99/100/003</DrugIDPK>
    <LicenceNumber>EU/1/99/100/003</LicenceNumber>
    <ProductName>Cetrotide</ProductName>
    <PAHolder>Merck Europe B.V.</PAHolder>
    <AuthorisedDate>13/04/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cetrorelix acetate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR0407/018/001</DrugIDPK>
    <LicenceNumber>HOR0407/018/001</LicenceNumber>
    <ProductName>Chamomilla Tablets</ProductName>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>11/06/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chamomilla recutita</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>TR0688/001/003</DrugIDPK>
    <LicenceNumber>TR0688/001/003</LicenceNumber>
    <ProductName>Chanelle ivy leaf lozenges</ProductName>
    <PAHolder>Chanelle Medical Unlimited Company</PAHolder>
    <AuthorisedDate>19/07/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenge</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/02/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>TR0688/001/002</DrugIDPK>
    <LicenceNumber>TR0688/001/002</LicenceNumber>
    <ProductName>Chanelle ivy leaf syrup</ProductName>
    <PAHolder>Chanelle Medical Unlimited Company</PAHolder>
    <AuthorisedDate>19/07/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/02/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/021/003</DrugIDPK>
    <LicenceNumber>PA0086/021/003</LicenceNumber>
    <ProductName>CHAPSTICK - CHERRY</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/05/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/021/004</DrugIDPK>
    <LicenceNumber>PA0086/021/004</LicenceNumber>
    <ProductName>CHAPSTICK - GRAPE</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/05/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/021/006</DrugIDPK>
    <LicenceNumber>PA0086/021/006</LicenceNumber>
    <ProductName>CHAPSTICK - LEMON-LIME</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/05/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/021/002</DrugIDPK>
    <LicenceNumber>PA0086/021/002</LicenceNumber>
    <ProductName>CHAPSTICK - MINT</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/05/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/021/005</DrugIDPK>
    <LicenceNumber>PA0086/021/005</LicenceNumber>
    <ProductName>CHAPSTICK - ORANGE</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/05/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/021/001</DrugIDPK>
    <LicenceNumber>PA0086/021/001</LicenceNumber>
    <ProductName>CHAPSTICK - REGULAR</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LANOLIN</ActiveSubstance>
      <ActiveSubstance>CAMPHOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0409/004/001</DrugIDPK>
    <LicenceNumber>PA0409/004/001</LicenceNumber>
    <ProductName>Chendol</ProductName>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chenodeoxycholic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0409/004/002</DrugIDPK>
    <LicenceNumber>PA0409/004/002</LicenceNumber>
    <ProductName>Chendol</ProductName>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chenodeoxycholic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/007/001</DrugIDPK>
    <LicenceNumber>PA0073/007/001</LicenceNumber>
    <ProductName>CHENOFALK</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>10/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHENODEOXYCHOLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/11/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/071/001</DrugIDPK>
    <LicenceNumber>PA0038/071/001</LicenceNumber>
    <ProductName>CHIROCAINE</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>04/02/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution injection or concentrate for solution infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levobupivacaine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/04/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/071/002</DrugIDPK>
    <LicenceNumber>PA0038/071/002</LicenceNumber>
    <ProductName>CHIROCAINE</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>04/02/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution injection or concentrate for solution infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levobupivacaine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/04/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/071/003</DrugIDPK>
    <LicenceNumber>PA0038/071/003</LicenceNumber>
    <ProductName>CHIROCAINE</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>04/02/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution injection or concentrate for solution infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levobupivacaine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/04/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1824/003/004</DrugIDPK>
    <LicenceNumber>PA1824/003/004</LicenceNumber>
    <ProductName>Chirocaine 0.625 mg/ml solution for infusion</ProductName>
    <PAHolder>AbbVie Limited</PAHolder>
    <AuthorisedDate>08/06/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levobupivacaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/03/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1824/003/005</DrugIDPK>
    <LicenceNumber>PA1824/003/005</LicenceNumber>
    <ProductName>Chirocaine 1.25 mg/ml solution for infusion</ProductName>
    <PAHolder>AbbVie Limited</PAHolder>
    <AuthorisedDate>08/06/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levobupivacaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1824/003/001</DrugIDPK>
    <LicenceNumber>PA1824/003/001</LicenceNumber>
    <ProductName>Chirocaine 2.5 mg/ml solution for injection/concentrate for solution for infusion</ProductName>
    <PAHolder>AbbVie Limited</PAHolder>
    <AuthorisedDate>08/06/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levobupivacaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1824/003/002</DrugIDPK>
    <LicenceNumber>PA1824/003/002</LicenceNumber>
    <ProductName>Chirocaine 5 mg/ml solution for injection/concentrate for solution for infusion</ProductName>
    <PAHolder>AbbVie Limited</PAHolder>
    <AuthorisedDate>08/06/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levobupivacaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1824/003/003</DrugIDPK>
    <LicenceNumber>PA1824/003/003</LicenceNumber>
    <ProductName>Chirocaine 7.5 mg/ml solution for injection/concentrate for solution for infusion</ProductName>
    <PAHolder>AbbVie Limited</PAHolder>
    <AuthorisedDate>08/06/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levobupivacaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0157/005/001</DrugIDPK>
    <LicenceNumber>PA0157/005/001</LicenceNumber>
    <ProductName>CHLORAMBID</ProductName>
    <PAHolder>Controlled Medications Limited</PAHolder>
    <AuthorisedDate>12/01/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0277/011/001</DrugIDPK>
    <LicenceNumber>PA0277/011/001</LicenceNumber>
    <ProductName>CHLORAMPHENICOL</ProductName>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>25/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/031/002</DrugIDPK>
    <LicenceNumber>PA0006/031/002</LicenceNumber>
    <ProductName>CHLORAMPHENICOL</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>26/03/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/03/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/031/001</DrugIDPK>
    <LicenceNumber>PA0006/031/001</LicenceNumber>
    <ProductName>CHLORAMPHENICOL</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>26/03/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/12/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0361/013/001</DrugIDPK>
    <LicenceNumber>PA0361/013/001</LicenceNumber>
    <ProductName>Chloramphenicol 0.5% w/v Eye Drops</ProductName>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>26/01/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chloramphenicol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/07/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/025/002</DrugIDPK>
    <LicenceNumber>PA0549/025/002</LicenceNumber>
    <ProductName>Chloramphenicol 1% w/w Eye Ointment</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>26/01/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chloramphenicol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/07/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0277/011/002</DrugIDPK>
    <LicenceNumber>PA0277/011/002</LicenceNumber>
    <ProductName>CHLORAMPHENICOL EYE OINTMENT</ProductName>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>25/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0100/003/002</DrugIDPK>
    <LicenceNumber>PA0100/003/002</LicenceNumber>
    <ProductName>CHLORAMPHENICOL OPULETS</ProductName>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0100/003/001</DrugIDPK>
    <LicenceNumber>PA0100/003/001</LicenceNumber>
    <ProductName>CHLORAMPHENICOL OPULETS</ProductName>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/069/011</DrugIDPK>
    <LicenceNumber>PA0167/069/011</LicenceNumber>
    <ProductName>CHLORASEPT 2000</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>20/01/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/069/010</DrugIDPK>
    <LicenceNumber>PA0167/069/010</LicenceNumber>
    <ProductName>CHLORASEPT 2000</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>20/01/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/069/009</DrugIDPK>
    <LicenceNumber>PA0167/069/009</LicenceNumber>
    <ProductName>CHLORASEPT 2000</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>20/01/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/069/014</DrugIDPK>
    <LicenceNumber>PA0167/069/014</LicenceNumber>
    <ProductName>Chlorasept 2000 Antiseptic</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>20/01/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chlorhexidine acetate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/01/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/069/012</DrugIDPK>
    <LicenceNumber>PA0167/069/012</LicenceNumber>
    <ProductName>CHLORASEPT 2000 ANTISEPTIC SOLUTION</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>20/01/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chlorhexidine acetate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/01/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/069/003</DrugIDPK>
    <LicenceNumber>PA0167/069/003</LicenceNumber>
    <ProductName>CHLORASEPT 5000</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>19/09/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/069/002</DrugIDPK>
    <LicenceNumber>PA0167/069/002</LicenceNumber>
    <ProductName>CHLORASEPT 5000</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>19/09/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/069/001</DrugIDPK>
    <LicenceNumber>PA0167/069/001</LicenceNumber>
    <ProductName>CHLORASEPT 5000</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>19/09/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/069/006</DrugIDPK>
    <LicenceNumber>PA0167/069/006</LicenceNumber>
    <ProductName>CHLORASEPT 5000 ANTISEPTIC</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>19/09/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/069/005</DrugIDPK>
    <LicenceNumber>PA0167/069/005</LicenceNumber>
    <ProductName>CHLORASEPT 5000 ANTISEPTIC</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>19/09/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/069/004</DrugIDPK>
    <LicenceNumber>PA0167/069/004</LicenceNumber>
    <ProductName>CHLORASEPT 5000 ANTISEPTIC</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>19/09/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0298/005/001</DrugIDPK>
    <LicenceNumber>PA0298/005/001</LicenceNumber>
    <ProductName>CHLORDIAZEPOXIDE</ProductName>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate>26/06/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORDIAZEPOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/048/001</DrugIDPK>
    <LicenceNumber>PA0126/048/001</LicenceNumber>
    <ProductName>CHLORDIAZEPOXIDE</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>11/05/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORDIAZEPOXIDE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/11/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/061/001</DrugIDPK>
    <LicenceNumber>PA0073/061/001</LicenceNumber>
    <ProductName>CHLORHEXAMED</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>02/07/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/11/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/061/002</DrugIDPK>
    <LicenceNumber>PA0073/061/002</LicenceNumber>
    <ProductName>CHLORHEXAMED CONCENTRATE</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>02/07/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/11/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/010/015</DrugIDPK>
    <LicenceNumber>PA0167/010/015</LicenceNumber>
    <ProductName>Chlorhexidine Acetate</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>30/09/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chlorhexidine acetate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/09/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/010/016</DrugIDPK>
    <LicenceNumber>PA0167/010/016</LicenceNumber>
    <ProductName>Chlorhexidine Acetate</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>30/09/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chlorhexidine acetate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/09/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/010/008</DrugIDPK>
    <LicenceNumber>PA0167/010/008</LicenceNumber>
    <ProductName>CHLORHEXIDINE ACETATE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/05/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/010/005</DrugIDPK>
    <LicenceNumber>PA0167/010/005</LicenceNumber>
    <ProductName>CHLORHEXIDINE ACETATE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>08/01/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/08/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/010/007</DrugIDPK>
    <LicenceNumber>PA0167/010/007</LicenceNumber>
    <ProductName>CHLORHEXIDINE ACETATE B P C</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>31/03/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/12/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/010/002</DrugIDPK>
    <LicenceNumber>PA0167/010/002</LicenceNumber>
    <ProductName>CHLORHEXIDINE ACETATE B P C  0.02%</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>07/11/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/010/003</DrugIDPK>
    <LicenceNumber>PA0167/010/003</LicenceNumber>
    <ProductName>CHLORHEXIDINE ACETATE B P C  0.05%</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>07/11/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/010/006</DrugIDPK>
    <LicenceNumber>PA0167/010/006</LicenceNumber>
    <ProductName>CHLORHEXIDINE ACETATE B P C 0.02% FOR IRRIGATION</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>31/03/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/12/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/010/004</DrugIDPK>
    <LicenceNumber>PA0167/010/004</LicenceNumber>
    <ProductName>CHLORHEXIDINE ACETATE B P C 0.05%</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>07/11/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/010/001</DrugIDPK>
    <LicenceNumber>PA0167/010/001</LicenceNumber>
    <ProductName>CHLORHEXIDINE ACETATE B. P. C. 0.02%</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>07/11/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORHEXIDINE DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/010/009A</DrugIDPK>
    <LicenceNumber>PA0167/010/009A</LicenceNumber>
    <ProductName>Chlorhexidine Acetate BP 0.02% w/v Irrigation solu</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Irrigation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chlorhexidine acetate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1843/003/001</DrugIDPK>
    <LicenceNumber>PA1843/003/001</LicenceNumber>
    <ProductName>Chlorhexidine Gluconate Antiseptic Mouthwash Original Flavour 0.2% w/v Oromucosal Solution</ProductName>
    <PAHolder>Ecolab Deutschland GmbH</PAHolder>
    <AuthorisedDate>18/02/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chlorhexidine gluconate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1843/003/002</DrugIDPK>
    <LicenceNumber>PA1843/003/002</LicenceNumber>
    <ProductName>Chlorhexidine Gluconate Antiseptic Mouthwash Peppermint Flavour 0.2% w/v Oromucosal Solution</ProductName>
    <PAHolder>Ecolab Deutschland GmbH</PAHolder>
    <AuthorisedDate>18/02/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chlorhexidine gluconate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1392/075/001</DrugIDPK>
    <LicenceNumber>DPR1392/075/001</LicenceNumber>
    <ProductName>Chlorhexidine Original 0.2% Mouthwash</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>04/08/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chlorhexidine gluconate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1392/075/002</DrugIDPK>
    <LicenceNumber>DPR1392/075/002</LicenceNumber>
    <ProductName>Chlorhexidine Peppermint 0.2% Mouthwash</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>04/08/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chlorhexidine gluconate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0056/015/008</DrugIDPK>
    <LicenceNumber>PA0056/015/008</LicenceNumber>
    <ProductName>CHLOROMYCETIN</ProductName>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>01/09/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL SODIUM SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/05/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0056/015/003</DrugIDPK>
    <LicenceNumber>PA0056/015/003</LicenceNumber>
    <ProductName>CHLOROMYCETIN</ProductName>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0056/015/002</DrugIDPK>
    <LicenceNumber>PA0056/015/002</LicenceNumber>
    <ProductName>CHLOROMYCETIN</ProductName>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0056/002/002</DrugIDPK>
    <LicenceNumber>PA0056/002/002</LicenceNumber>
    <ProductName>CHLOROMYCETIN</ProductName>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0899/028/001</DrugIDPK>
    <LicenceNumber>PA0899/028/001</LicenceNumber>
    <ProductName>Chloromycetin 1% w/w Ophthalmic Ointment</ProductName>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>04/08/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chloramphenicol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/08/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0056/015/007</DrugIDPK>
    <LicenceNumber>PA0056/015/007</LicenceNumber>
    <ProductName>CHLOROMYCETIN OPHTHALMIC</ProductName>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL SODIUM SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/05/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0056/015/004</DrugIDPK>
    <LicenceNumber>PA0056/015/004</LicenceNumber>
    <ProductName>CHLOROMYCETIN OPHTHALMIC</ProductName>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0056/015/006</DrugIDPK>
    <LicenceNumber>PA0056/015/006</LicenceNumber>
    <ProductName>CHLOROMYCETIN OPHTHALMIC (SUSPENSION)</ProductName>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/048/001</DrugIDPK>
    <LicenceNumber>PA0073/048/001</LicenceNumber>
    <ProductName>CHLOROPHENIRAMINE</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>02/07/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/09/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0148/023/001</DrugIDPK>
    <LicenceNumber>PA0148/023/001</LicenceNumber>
    <ProductName>CHLOROPTIC</ProductName>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/020/001</DrugIDPK>
    <LicenceNumber>PA0137/020/001</LicenceNumber>
    <ProductName>CHLOROPTIC OPHTHALMIC</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/06/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0432/002/001</DrugIDPK>
    <LicenceNumber>PA0432/002/001</LicenceNumber>
    <ProductName>CHLOROQUINE</ProductName>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>16/05/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLOROQUINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0176/043/001</DrugIDPK>
    <LicenceNumber>PA0176/043/001</LicenceNumber>
    <ProductName>CHLORPHENIRAMINE</ProductName>
    <PAHolder>Accord-UK Ltd</PAHolder>
    <AuthorisedDate>08/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/048/002</DrugIDPK>
    <LicenceNumber>PA0073/048/002</LicenceNumber>
    <ProductName>CHLORPHENIRAMINE</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>25/08/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/09/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/104/001A</DrugIDPK>
    <LicenceNumber>PA0073/104/001A</LicenceNumber>
    <ProductName>Chlorpromazine 1 ml</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>01/04/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/104/003</DrugIDPK>
    <LicenceNumber>PA0073/104/003</LicenceNumber>
    <ProductName>Chlorpromazine BP</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>01/04/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/104/004</DrugIDPK>
    <LicenceNumber>PA0073/104/004</LicenceNumber>
    <ProductName>Chlorpromazine BP</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>01/04/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/104/005</DrugIDPK>
    <LicenceNumber>PA0073/104/005</LicenceNumber>
    <ProductName>Chlorpromazine BP</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>01/04/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROMAZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/007/002</DrugIDPK>
    <LicenceNumber>PA0282/007/002</LicenceNumber>
    <ProductName>CHLORPROPAMIDE</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>09/10/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/007/001</DrugIDPK>
    <LicenceNumber>PA0282/007/001</LicenceNumber>
    <ProductName>CHLORPROPAMIDE</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>09/10/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/030/002</DrugIDPK>
    <LicenceNumber>PA0237/030/002</LicenceNumber>
    <ProductName>CHLORPROPAMIDE</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>09/11/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/030/001</DrugIDPK>
    <LicenceNumber>PA0237/030/001</LicenceNumber>
    <ProductName>CHLORPROPAMIDE</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>09/11/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0114/030/001</DrugIDPK>
    <LicenceNumber>PA0114/030/001</LicenceNumber>
    <ProductName>CHOLEBRIN</ProductName>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOCETAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1229/001/001</DrugIDPK>
    <LicenceNumber>PA1229/001/001</LicenceNumber>
    <ProductName>CHOLEDIAM Kit for radiopharmaceutical preparation of technetium [99mTc] mebrofenin injection</ProductName>
    <PAHolder>MEDiAM</PAHolder>
    <AuthorisedDate>13/07/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mebrofenin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>For hospital use only.
To the professions as an item for hospital use only.</SupplyComments>
    <WithdrawalDate>20/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0856/013/003</DrugIDPK>
    <LicenceNumber>PA0856/013/003</LicenceNumber>
    <ProductName>CHOLEDYL</ProductName>
    <PAHolder>Warner Lambert (UK) Limited</PAHolder>
    <AuthorisedDate>25/05/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHOLINE THEOPHYLLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0856/013/002</DrugIDPK>
    <LicenceNumber>PA0856/013/002</LicenceNumber>
    <ProductName>CHOLEDYL</ProductName>
    <PAHolder>Warner Lambert (UK) Limited</PAHolder>
    <AuthorisedDate>25/05/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHOLINE THEOPHYLLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0056/062/001</DrugIDPK>
    <LicenceNumber>PA0056/062/001</LicenceNumber>
    <ProductName>CHOLEDYL</ProductName>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>25/05/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHOLINE THEOPHYLLINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/024/003</DrugIDPK>
    <LicenceNumber>PA0017/024/003</LicenceNumber>
    <ProductName>CHOLERA VACCINE</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHOLERA VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/06/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/024/002</DrugIDPK>
    <LicenceNumber>PA0017/024/002</LicenceNumber>
    <ProductName>CHOLERA VACCINE</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHOLERA VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/06/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0365/062/001</DrugIDPK>
    <LicenceNumber>PA0365/062/001</LicenceNumber>
    <ProductName>CHOLERA VACCINE B.P.</ProductName>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>02/12/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHOLERA VACCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0585/019/001</DrugIDPK>
    <LicenceNumber>PA0585/019/001</LicenceNumber>
    <ProductName>Cholstat 10mg tablets</ProductName>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>08/04/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pravastatin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0585/019/002</DrugIDPK>
    <LicenceNumber>PA0585/019/002</LicenceNumber>
    <ProductName>Cholstat 20mg tablets</ProductName>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>08/04/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pravastatin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/07/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0585/019/003</DrugIDPK>
    <LicenceNumber>PA0585/019/003</LicenceNumber>
    <ProductName>Cholstat 40mg tablets</ProductName>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>08/04/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pravastatin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/07/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/09/563/001</DrugIDPK>
    <LicenceNumber>EU/1/09/563/001</LicenceNumber>
    <ProductName>ChondroCelect</ProductName>
    <PAHolder>TiGenix nv</PAHolder>
    <AuthorisedDate>05/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Implantation suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Characterized autologous cartilage</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>30/11/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1009/011/002</DrugIDPK>
    <LicenceNumber>PA1009/011/002</LicenceNumber>
    <ProductName>Choragon 5000 u and Choragon Solvent</ProductName>
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>01/04/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chorionic gonadotrophin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0240/020/001</DrugIDPK>
    <LicenceNumber>PA0240/020/001</LicenceNumber>
    <ProductName>Chromium [51Cr] EDTA Injection ,Chromium [51Cr] ED</ProductName>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>05/02/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chromium [cr-51] edta</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Hospital use only radiopharmaceutical agent</SupplyComments>
    <WithdrawalDate>31/12/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0010/008/004</DrugIDPK>
    <LicenceNumber>PA0010/008/004</LicenceNumber>
    <ProductName>CHYMACORT</ProductName>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHYMOTRYPSIN</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0010/008/003</DrugIDPK>
    <LicenceNumber>PA0010/008/003</LicenceNumber>
    <ProductName>CHYMACORT</ProductName>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHYMOTRYPSIN</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0010/008/002</DrugIDPK>
    <LicenceNumber>PA0010/008/002</LicenceNumber>
    <ProductName>CHYMACORT</ProductName>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>CHYMOTRYPSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0010/008/001</DrugIDPK>
    <LicenceNumber>PA0010/008/001</LicenceNumber>
    <ProductName>CHYMACORT</ProductName>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>01/03/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN PALMITATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/010/001</DrugIDPK>
    <LicenceNumber>PA0468/010/001</LicenceNumber>
    <ProductName>CHYMAR</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/04/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHYMOTRYPSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/033/001</DrugIDPK>
    <LicenceNumber>PA0468/033/001</LicenceNumber>
    <ProductName>CHYMAR ZON</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>24/07/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHYMOTRYPSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/07/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0010/005/002</DrugIDPK>
    <LicenceNumber>PA0010/005/002</LicenceNumber>
    <ProductName>CHYMAR-F</ProductName>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTICLOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/05/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0010/005/001</DrugIDPK>
    <LicenceNumber>PA0010/005/001</LicenceNumber>
    <ProductName>CHYMAR-F</ProductName>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENTICLOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/05/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0010/007/001</DrugIDPK>
    <LicenceNumber>PA0010/007/001</LicenceNumber>
    <ProductName>CHYMOCYCLAR</ProductName>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0769/001/001</DrugIDPK>
    <LicenceNumber>PA0769/001/001</LicenceNumber>
    <ProductName>CHYMODIACTIN</ProductName>
    <PAHolder>Knoll Limited</PAHolder>
    <AuthorisedDate>06/02/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHYMOPAPAIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/03/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/026/001</DrugIDPK>
    <LicenceNumber>PA0468/026/001</LicenceNumber>
    <ProductName>CHYMORAL</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/04/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/026/002</DrugIDPK>
    <LicenceNumber>PA0468/026/002</LicenceNumber>
    <ProductName>CHYMORAL FORTE</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/04/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRYPSIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0028/005/001</DrugIDPK>
    <LicenceNumber>PA0028/005/001</LicenceNumber>
    <ProductName>CIBACALCIN</ProductName>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>07/07/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCITONIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/11/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/078/003</DrugIDPK>
    <LicenceNumber>PA0013/078/003</LicenceNumber>
    <ProductName>CIBACEN</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>16/06/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENAZEPRIL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/03/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2010/029/002</DrugIDPK>
    <LicenceNumber>PA2010/029/002</LicenceNumber>
    <ProductName>Cibacen 10 mg Film Coated Tablets</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>16/06/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/08/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2010/029/001</DrugIDPK>
    <LicenceNumber>PA2010/029/001</LicenceNumber>
    <ProductName>Cibacen 5 mg Film Coated Tablet</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>16/06/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benazepril hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/09/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/019/002</DrugIDPK>
    <LicenceNumber>PA0017/019/002</LicenceNumber>
    <ProductName>Cicatrin</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Neomycin sulfate</ActiveSubstance>
      <ActiveSubstance>Cysteine</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
      <ActiveSubstance>Threonine</ActiveSubstance>
      <ActiveSubstance>BACITRACIN ZINC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Not applicable</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/054/001</DrugIDPK>
    <LicenceNumber>PA1077/054/001</LicenceNumber>
    <ProductName>Cicatrin</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Neomycin sulfate</ActiveSubstance>
      <ActiveSubstance>BACITRACIN ZINC</ActiveSubstance>
      <ActiveSubstance>L-cysteine</ActiveSubstance>
      <ActiveSubstance>Threonine</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/054/002</DrugIDPK>
    <LicenceNumber>PA1077/054/002</LicenceNumber>
    <ProductName>CICATRIN</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Neomycin sulfate</ActiveSubstance>
      <ActiveSubstance>BACITRACIN ZINC</ActiveSubstance>
      <ActiveSubstance>L-cysteine</ActiveSubstance>
      <ActiveSubstance>Threonine</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/009/001</DrugIDPK>
    <LicenceNumber>PA0017/009/001</LicenceNumber>
    <ProductName>CICATRIN</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>BACITRACIN ZINC</ActiveSubstance>
      <ActiveSubstance>CYSTEINE</ActiveSubstance>
      <ActiveSubstance>AMINOACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/028/001</DrugIDPK>
    <LicenceNumber>PA1380/028/001</LicenceNumber>
    <ProductName>Ciclosporin Dumex</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>11/01/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciclosporin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/028/002</DrugIDPK>
    <LicenceNumber>PA1380/028/002</LicenceNumber>
    <ProductName>Ciclosporin Dumex</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>11/01/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciclosporin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/028/003</DrugIDPK>
    <LicenceNumber>PA1380/028/003</LicenceNumber>
    <ProductName>Ciclosporin Dumex</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>11/01/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciclosporin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/030/001</DrugIDPK>
    <LicenceNumber>PA1380/030/001</LicenceNumber>
    <ProductName>Ciclosporin Genfarma</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>11/01/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciclosporin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/030/002</DrugIDPK>
    <LicenceNumber>PA1380/030/002</LicenceNumber>
    <ProductName>Ciclosporin Genfarma</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>11/01/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciclosporin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/030/003</DrugIDPK>
    <LicenceNumber>PA1380/030/003</LicenceNumber>
    <ProductName>Ciclosporin Genfarma</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>11/01/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciclosporin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/029/001</DrugIDPK>
    <LicenceNumber>PA1380/029/001</LicenceNumber>
    <ProductName>Ciclosporin Pharmachemie</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>11/01/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciclosporin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/029/002</DrugIDPK>
    <LicenceNumber>PA1380/029/002</LicenceNumber>
    <ProductName>Ciclosporin Pharmachemie</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>11/01/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciclosporin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/029/003</DrugIDPK>
    <LicenceNumber>PA1380/029/003</LicenceNumber>
    <ProductName>Ciclosporin Pharmachemie</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>11/01/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciclosporin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/029/001</DrugIDPK>
    <LicenceNumber>PA0126/029/001</LicenceNumber>
    <ProductName>Cidomel</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Indometacin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/12/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/029/002</DrugIDPK>
    <LicenceNumber>PA0126/029/002</LicenceNumber>
    <ProductName>CIDOMEL 50</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>01/09/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/003/006</DrugIDPK>
    <LicenceNumber>PA0006/003/006</LicenceNumber>
    <ProductName>CIDOMYCIN</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>13/06/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/08/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/036/001</DrugIDPK>
    <LicenceNumber>PA0540/036/001</LicenceNumber>
    <ProductName>Cidomycin Adult</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>09/03/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Gentamicin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/036/002</DrugIDPK>
    <LicenceNumber>PA0540/036/002</LicenceNumber>
    <ProductName>Cidomycin Adult</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>09/03/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Gentamicin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/003/015</DrugIDPK>
    <LicenceNumber>PA0006/003/015</LicenceNumber>
    <ProductName>CIDOMYCIN EAR</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>21/11/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/003/014</DrugIDPK>
    <LicenceNumber>PA0006/003/014</LicenceNumber>
    <ProductName>CIDOMYCIN EYE</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>21/11/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/003/013</DrugIDPK>
    <LicenceNumber>PA0006/003/013</LicenceNumber>
    <ProductName>CIDOMYCIN GENTAMICIN</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>28/02/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/02/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/003/012</DrugIDPK>
    <LicenceNumber>PA0006/003/012</LicenceNumber>
    <ProductName>CIDOMYCIN GENTAMICIN</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>27/02/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/02/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/003/011</DrugIDPK>
    <LicenceNumber>PA0006/003/011</LicenceNumber>
    <ProductName>CIDOMYCIN GENTAMICIN</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>27/02/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0006/003/010</DrugIDPK>
    <LicenceNumber>PA0006/003/010</LicenceNumber>
    <ProductName>CIDOMYCIN GENTAMICIN</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>27/02/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0006/003/009</DrugIDPK>
    <LicenceNumber>PA0006/003/009</LicenceNumber>
    <ProductName>CIDOMYCIN GENTAMICIN</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>30/11/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/003/008</DrugIDPK>
    <LicenceNumber>PA0006/003/008</LicenceNumber>
    <ProductName>CIDOMYCIN GENTAMICIN</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>30/11/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/003/001</DrugIDPK>
    <LicenceNumber>PA0006/003/001</LicenceNumber>
    <ProductName>Cidomycin Intrathecal</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>10/06/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Gentamicin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/06/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/036/004</DrugIDPK>
    <LicenceNumber>PA0540/036/004</LicenceNumber>
    <ProductName>Cidomycin Paediatric 20mg/2ml Solution for Injection</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>09/03/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Gentamicin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/06/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/069/003</DrugIDPK>
    <LicenceNumber>PA0577/069/003</LicenceNumber>
    <ProductName>Cifloxager</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>04/02/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/04/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/168/001</DrugIDPK>
    <LicenceNumber>PA0711/168/001</LicenceNumber>
    <ProductName>Cifox</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>05/09/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/108/001</DrugIDPK>
    <LicenceNumber>PPA1151/108/001</LicenceNumber>
    <ProductName>Cilest</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>24/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Norgestimate</ActiveSubstance>
      <ActiveSubstance>Ethinylestradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/08/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/102/001</DrugIDPK>
    <LicenceNumber>PPA1328/102/001</LicenceNumber>
    <ProductName>CILEST</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>05/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Norgestimate</ActiveSubstance>
      <ActiveSubstance>Ethinylestradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/06/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/217/001</DrugIDPK>
    <LicenceNumber>PPA0465/217/001</LicenceNumber>
    <ProductName>Cilest 250/35 microgram Tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>03/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Norgestimate</ActiveSubstance>
      <ActiveSubstance>Ethinylestradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0748/029/001</DrugIDPK>
    <LicenceNumber>PA0748/029/001</LicenceNumber>
    <ProductName>CILEST 250/35 microgram tablets</ProductName>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>23/08/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Norgestimate</ActiveSubstance>
      <ActiveSubstance>Ethinylestradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/10/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1338/014/001</DrugIDPK>
    <LicenceNumber>PA1338/014/001</LicenceNumber>
    <ProductName>Cilostazol 100mg Tablets</ProductName>
    <PAHolder>Focus Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>22/08/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cilostazol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0290/069/001</DrugIDPK>
    <LicenceNumber>PA0290/069/001</LicenceNumber>
    <ProductName>Ciloxan 0.3% w/v Eye Drops Solution</ProductName>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>13/11/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/07/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0290/069/002</DrugIDPK>
    <LicenceNumber>PA0290/069/002</LicenceNumber>
    <ProductName>Ciloxan 3 mg/g Eye Ointment</ProductName>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>05/11/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/07/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0117/012/003</DrugIDPK>
    <LicenceNumber>PA0117/012/003</LicenceNumber>
    <ProductName>CILPEN</ProductName>
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>07/01/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0117/012/002</DrugIDPK>
    <LicenceNumber>PA0117/012/002</LicenceNumber>
    <ProductName>CILPEN POWDER</ProductName>
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>14/03/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0117/012/005</DrugIDPK>
    <LicenceNumber>PA0117/012/005</LicenceNumber>
    <ProductName>CILPEN SYRUP FORTE</ProductName>
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>09/02/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0117/012/004</DrugIDPK>
    <LicenceNumber>PA0117/012/004</LicenceNumber>
    <ProductName>CILPEN SYRUP FORTE</ProductName>
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>09/02/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMPICILLIN TRIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/128/001</DrugIDPK>
    <LicenceNumber>PA0073/128/001</LicenceNumber>
    <ProductName>Cimagen</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cimetidine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/128/002</DrugIDPK>
    <LicenceNumber>PA0073/128/002</LicenceNumber>
    <ProductName>Cimagen</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cimetidine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/128/003</DrugIDPK>
    <LicenceNumber>PA0073/128/003</LicenceNumber>
    <ProductName>Cimagen</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cimetidine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/077/001</DrugIDPK>
    <LicenceNumber>PA0126/077/001</LicenceNumber>
    <ProductName>Cimeldine</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>06/11/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cimetidine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/11/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/077/003</DrugIDPK>
    <LicenceNumber>PA0126/077/003</LicenceNumber>
    <ProductName>Cimeldine</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>06/11/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cimetidine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/025/001</DrugIDPK>
    <LicenceNumber>PA0405/025/001</LicenceNumber>
    <ProductName>Cimetidine</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cimetidine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/025/002</DrugIDPK>
    <LicenceNumber>PA0405/025/002</LicenceNumber>
    <ProductName>Cimetidine</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cimetidine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/025/003</DrugIDPK>
    <LicenceNumber>PA0405/025/003</LicenceNumber>
    <ProductName>Cimetidine</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cimetidine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0476/004/001</DrugIDPK>
    <LicenceNumber>PA0476/004/001</LicenceNumber>
    <ProductName>Cimetidine</ProductName>
    <PAHolder>Olinka (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cimetidine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0476/004/002</DrugIDPK>
    <LicenceNumber>PA0476/004/002</LicenceNumber>
    <ProductName>Cimetidine</ProductName>
    <PAHolder>Olinka (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cimetidine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA1046/009/001</DrugIDPK>
    <LicenceNumber>PA1046/009/001</LicenceNumber>
    <ProductName>Cimetidine</ProductName>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>14/03/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cimetidine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1046/009/002</DrugIDPK>
    <LicenceNumber>PA1046/009/002</LicenceNumber>
    <ProductName>Cimetidine</ProductName>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>14/03/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cimetidine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1046/009/003</DrugIDPK>
    <LicenceNumber>PA1046/009/003</LicenceNumber>
    <ProductName>Cimetidine</ProductName>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>14/03/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cimetidine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/012/003</DrugIDPK>
    <LicenceNumber>PA0436/012/003</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>22/08/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/01/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/012/002</DrugIDPK>
    <LicenceNumber>PA0436/012/002</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>22/08/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/01/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/012/001</DrugIDPK>
    <LicenceNumber>PA0436/012/001</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>22/08/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/01/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0310/002/004</DrugIDPK>
    <LicenceNumber>PA0310/002/004</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <PAHolder>A/S GEA Farmaceutisk Fabrik</PAHolder>
    <AuthorisedDate>04/01/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/11/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0310/002/002</DrugIDPK>
    <LicenceNumber>PA0310/002/002</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <PAHolder>A/S GEA Farmaceutisk Fabrik</PAHolder>
    <AuthorisedDate>04/01/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/11/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0310/002/001</DrugIDPK>
    <LicenceNumber>PA0310/002/001</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <PAHolder>A/S GEA Farmaceutisk Fabrik</PAHolder>
    <AuthorisedDate>04/01/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/11/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/050/003</DrugIDPK>
    <LicenceNumber>PA0282/050/003</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>27/11/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/050/002</DrugIDPK>
    <LicenceNumber>PA0282/050/002</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>27/11/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/050/001</DrugIDPK>
    <LicenceNumber>PA0282/050/001</LicenceNumber>
    <ProductName>CIMETIDINE</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>27/11/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0593/007/001</DrugIDPK>
    <LicenceNumber>PA0593/007/001</LicenceNumber>
    <ProductName>Cimetidine 200</ProductName>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>25/06/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cimetidine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/06/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0593/007/002</DrugIDPK>
    <LicenceNumber>PA0593/007/002</LicenceNumber>
    <ProductName>Cimetidine 400</ProductName>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>25/06/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cimetidine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/06/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0593/007/003</DrugIDPK>
    <LicenceNumber>PA0593/007/003</LicenceNumber>
    <ProductName>Cimetidine 800</ProductName>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>25/06/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cimetidine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/06/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/006/002</DrugIDPK>
    <LicenceNumber>PA0540/006/002</LicenceNumber>
    <ProductName>CIMETIDINE RHONE POULENC RORER</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>13/12/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/03/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/006/001</DrugIDPK>
    <LicenceNumber>PA0540/006/001</LicenceNumber>
    <ProductName>CIMETIDINE RHONE POULENC RORER</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>13/12/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/03/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/196/001</DrugIDPK>
    <LicenceNumber>PA2315/196/001</LicenceNumber>
    <ProductName>Cinacalcet Accord 30 mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>02/12/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cinacalcet</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/08/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/196/002</DrugIDPK>
    <LicenceNumber>PA2315/196/002</LicenceNumber>
    <ProductName>Cinacalcet Accord 60 mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>02/12/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cinacalcet</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/08/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/196/003</DrugIDPK>
    <LicenceNumber>PA2315/196/003</LicenceNumber>
    <ProductName>Cinacalcet Accord 90 mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>02/12/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cinacalcet</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/08/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1513/009/001</DrugIDPK>
    <LicenceNumber>PA1513/009/001</LicenceNumber>
    <ProductName>Cinacalcet Apotex 30 mg Film Coated Tablets</ProductName>
    <PAHolder>Apotex Europe B.V.</PAHolder>
    <AuthorisedDate>02/06/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cinacalcet hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1513/009/002</DrugIDPK>
    <LicenceNumber>PA1513/009/002</LicenceNumber>
    <ProductName>Cinacalcet Apotex 60 mg Film Coated Tablets</ProductName>
    <PAHolder>Apotex Europe B.V.</PAHolder>
    <AuthorisedDate>02/06/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cinacalcet hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1513/009/003</DrugIDPK>
    <LicenceNumber>PA1513/009/003</LicenceNumber>
    <ProductName>Cinacalcet Apotex 90 mg Film Coated Tablets</ProductName>
    <PAHolder>Apotex Europe B.V.</PAHolder>
    <AuthorisedDate>02/06/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cinacalcet hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/311/001</DrugIDPK>
    <LicenceNumber>PA0711/311/001</LicenceNumber>
    <ProductName>Cinacalcet Rowex 30 mg film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>26/03/2021</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cinacalcet</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/285/001</DrugIDPK>
    <LicenceNumber>PA0711/285/001</LicenceNumber>
    <ProductName>Cinacalcet Rowex 30 mg Film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>26/01/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cinacalcet hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/07/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/311/002</DrugIDPK>
    <LicenceNumber>PA0711/311/002</LicenceNumber>
    <ProductName>Cinacalcet Rowex 60 mg film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>26/03/2021</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cinacalcet</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/285/002</DrugIDPK>
    <LicenceNumber>PA0711/285/002</LicenceNumber>
    <ProductName>Cinacalcet Rowex 60 mg Film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>26/01/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cinacalcet hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/07/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/311/003</DrugIDPK>
    <LicenceNumber>PA0711/311/003</LicenceNumber>
    <ProductName>Cinacalcet Rowex 90 mg film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>26/03/2021</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cinacalcet</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/285/003</DrugIDPK>
    <LicenceNumber>PA0711/285/003</LicenceNumber>
    <ProductName>Cinacalcet Rowex 90 mg Film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>26/01/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cinacalcet hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/07/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/041/002</DrugIDPK>
    <LicenceNumber>PA0047/041/002</LicenceNumber>
    <ProductName>CINOBAC</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>19/09/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CINOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/01/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/041/001</DrugIDPK>
    <LicenceNumber>PA0047/041/001</LicenceNumber>
    <ProductName>CINOBAC</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>19/09/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CINOXACIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/01/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/026/002</DrugIDPK>
    <LicenceNumber>PA0137/026/002</LicenceNumber>
    <ProductName>CINOPAL</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENBUFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/026/001</DrugIDPK>
    <LicenceNumber>PA0137/026/001</LicenceNumber>
    <ProductName>CINOPAL</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENBUFEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/049/001</DrugIDPK>
    <LicenceNumber>PA1380/049/001</LicenceNumber>
    <ProductName>Ciplox</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>16/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/100/001</DrugIDPK>
    <LicenceNumber>PA2315/100/001</LicenceNumber>
    <InterchangeableListCode>IC0185-130-003</InterchangeableListCode>
    <ProductName>Ciplox 250 mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>02/07/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/100/002</DrugIDPK>
    <LicenceNumber>PA2315/100/002</LicenceNumber>
    <InterchangeableListCode>IC0185-117-003</InterchangeableListCode>
    <ProductName>Ciplox 500 mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>02/07/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/100/003</DrugIDPK>
    <LicenceNumber>PA2315/100/003</LicenceNumber>
    <InterchangeableListCode>IC0185-141-003</InterchangeableListCode>
    <ProductName>Ciplox 750 mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>02/07/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/027/003</DrugIDPK>
    <LicenceNumber>PA1380/027/003</LicenceNumber>
    <ProductName>Cipralam 40 mg Film-coated tablets</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>14/12/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide’</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/10/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/021/001</DrugIDPK>
    <LicenceNumber>PPA1328/021/001</LicenceNumber>
    <ProductName>Cipramil</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>25/08/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide’</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/01/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/021/002</DrugIDPK>
    <LicenceNumber>PPA1328/021/002</LicenceNumber>
    <ProductName>Cipramil</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>25/08/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/01/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/051/001</DrugIDPK>
    <LicenceNumber>PPA1500/051/001</LicenceNumber>
    <ProductName>Cipramil</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>05/02/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/022/001</DrugIDPK>
    <LicenceNumber>PPA1659/022/001</LicenceNumber>
    <ProductName>Cipramil</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>21/12/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/022/002</DrugIDPK>
    <LicenceNumber>PPA1659/022/002</LicenceNumber>
    <ProductName>Cipramil</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>21/12/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/068/003B</DrugIDPK>
    <LicenceNumber>PPA0465/068/003B</LicenceNumber>
    <ProductName>CIPRAMIL</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>24/08/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/01/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/068/003A</DrugIDPK>
    <LicenceNumber>PPA0465/068/003A</LicenceNumber>
    <ProductName>CIPRAMIL</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>24/08/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/01/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0776/001/003</DrugIDPK>
    <LicenceNumber>PA0776/001/003</LicenceNumber>
    <ProductName>CIPRAMIL</ProductName>
    <PAHolder>Lundbeck ( Ireland ) Limited</PAHolder>
    <AuthorisedDate>22/09/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CITALOPRAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/09/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/068/001A</DrugIDPK>
    <LicenceNumber>PPA0465/068/001A</LicenceNumber>
    <ProductName>Cipramil 10 mg Film-Coated Tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>24/08/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/049/002</DrugIDPK>
    <LicenceNumber>PPA1151/049/002</LicenceNumber>
    <ProductName>Cipramil 10mg Film-coated Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>24/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/10/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/068/002</DrugIDPK>
    <LicenceNumber>PPA0465/068/002</LicenceNumber>
    <InterchangeableListCode>IC0073-003-003</InterchangeableListCode>
    <ProductName>Cipramil 20 mg film-coated tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>24/08/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/049/001</DrugIDPK>
    <LicenceNumber>PPA1151/049/001</LicenceNumber>
    <ProductName>Cipramil 20 mg Film-coated Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>25/01/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/10/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/117/001</DrugIDPK>
    <LicenceNumber>PA0281/117/001</LicenceNumber>
    <ProductName>CIPRAPINE</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>18/06/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/10/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/117/002</DrugIDPK>
    <LicenceNumber>PA0281/117/002</LicenceNumber>
    <ProductName>CIPRAPINE</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>18/06/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/10/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/117/003</DrugIDPK>
    <LicenceNumber>PA0281/117/003</LicenceNumber>
    <ProductName>CIPRAPINE</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>18/06/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/10/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/063/001</DrugIDPK>
    <LicenceNumber>PA0237/063/001</LicenceNumber>
    <ProductName>Ciprofloxacin</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>20/08/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/07/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/237/001</DrugIDPK>
    <LicenceNumber>PA0822/237/001</LicenceNumber>
    <ProductName>Ciprofloxacin 2 mg/ml solution for infusion</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>01/06/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin lactate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/06/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/237/002</DrugIDPK>
    <LicenceNumber>PA0822/237/002</LicenceNumber>
    <ProductName>Ciprofloxacin 2 mg/ml solution for infusion</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>01/06/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin lactate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/06/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2299/034/001</DrugIDPK>
    <LicenceNumber>PA2299/034/001</LicenceNumber>
    <ProductName>Ciprofloxacin 2mg/ml, Solution for Infusion</ProductName>
    <PAHolder>Baxter Holding B.V.</PAHolder>
    <AuthorisedDate>20/06/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin lactate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/05/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1897/003/001</DrugIDPK>
    <LicenceNumber>PA1897/003/001</LicenceNumber>
    <ProductName>Ciprofloxacin Amneal</ProductName>
    <PAHolder>Amneal Pharma Europe Limited</PAHolder>
    <AuthorisedDate>28/06/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin lactate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/197/001</DrugIDPK>
    <LicenceNumber>PA0577/197/001</LicenceNumber>
    <ProductName>Ciprofloxacin Mylan 2mg/1ml solution for infusion</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>02/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/06/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/037/001</DrugIDPK>
    <LicenceNumber>PA1063/037/001</LicenceNumber>
    <ProductName>Ciprofloxacin Niche</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>09/01/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/07/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/028/001</DrugIDPK>
    <LicenceNumber>PA0822/028/001</LicenceNumber>
    <ProductName>Ciprofloxacin Pfizer</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>08/07/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/028/002</DrugIDPK>
    <LicenceNumber>PA0822/028/002</LicenceNumber>
    <ProductName>Ciprofloxacin Pfizer 500 mg film-coated tablets</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>08/07/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/028/003</DrugIDPK>
    <LicenceNumber>PA0822/028/003</LicenceNumber>
    <ProductName>Ciprofloxacin Pfizer 750 mg film-coated tablets</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>08/07/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/130/001</DrugIDPK>
    <LicenceNumber>PA0167/130/001</LicenceNumber>
    <ProductName>Ciprofloxacin Redibag 2 mg/ml, Solution for Infusion</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>17/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/04/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/031/004</DrugIDPK>
    <LicenceNumber>PA0749/031/004</LicenceNumber>
    <ProductName>Ciprofloxacin Teva</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>20/04/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/031/005</DrugIDPK>
    <LicenceNumber>PA0749/031/005</LicenceNumber>
    <ProductName>Ciprofloxacin Teva 2 mg/ml Solution for Infusion</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>18/12/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/01/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/131/003</DrugIDPK>
    <LicenceNumber>PA0126/131/003</LicenceNumber>
    <ProductName>Ciprotan 40mg film-coated tablets</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>17/11/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide’</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/02/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/028/001</DrugIDPK>
    <LicenceNumber>PA1410/028/001</LicenceNumber>
    <ProductName>Ciproxin</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>02/11/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/028/005</DrugIDPK>
    <LicenceNumber>PA1410/028/005</LicenceNumber>
    <ProductName>Ciproxin</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>02/11/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin lactate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/082/002A</DrugIDPK>
    <LicenceNumber>PPA0465/082/002A</LicenceNumber>
    <ProductName>Ciproxin</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>22/03/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/074/001</DrugIDPK>
    <LicenceNumber>PPA1328/074/001</LicenceNumber>
    <ProductName>CIPROXIN</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>13/04/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/06/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/036/003</DrugIDPK>
    <LicenceNumber>PA0021/036/003</LicenceNumber>
    <ProductName>CIPROXIN</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>20/12/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIPROFLOXACIN LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/12/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/028/002</DrugIDPK>
    <LicenceNumber>PA1410/028/002</LicenceNumber>
    <ProductName>Ciproxin 250 mg Film-coated Tablets</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>20/12/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/082/001A</DrugIDPK>
    <LicenceNumber>PPA0465/082/001A</LicenceNumber>
    <ProductName>Ciproxin 250 mg Film-coated Tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>22/03/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/028/003</DrugIDPK>
    <LicenceNumber>PA1410/028/003</LicenceNumber>
    <ProductName>Ciproxin 500 mg Film-coated Tablets</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>20/12/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/028/004</DrugIDPK>
    <LicenceNumber>PA1410/028/004</LicenceNumber>
    <ProductName>Ciproxin 750 mg Film-coated Tablets</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>20/12/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/028/010</DrugIDPK>
    <LicenceNumber>PA1410/028/010</LicenceNumber>
    <ProductName>Ciproxin IV Flexibag</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>02/11/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin lactate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/028/008</DrugIDPK>
    <LicenceNumber>PA1410/028/008</LicenceNumber>
    <ProductName>Ciproxin Oral Suspension 250mg/5ml</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>02/11/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not Currently Available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/028/009</DrugIDPK>
    <LicenceNumber>PA1410/028/009</LicenceNumber>
    <ProductName>Ciproxin Oral Suspension Forte 500 mg/5ml</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>02/11/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not Currently Available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/028/006</DrugIDPK>
    <LicenceNumber>PA1410/028/006</LicenceNumber>
    <ProductName>Ciproxin Solution for Infusion 2 mg/ml, 100 ml</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>20/12/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/028/007</DrugIDPK>
    <LicenceNumber>PA1410/028/007</LicenceNumber>
    <ProductName>Ciproxin Solution for Infusion 2 mg/ml, 200 ml</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>26/06/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ciprofloxacin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1286/049/001</DrugIDPK>
    <LicenceNumber>PA1286/049/001</LicenceNumber>
    <ProductName>Circlet</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>13/06/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not Currently Available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etonogestrel</ActiveSubstance>
      <ActiveSubstance>Ethinylestradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/02/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/082/001</DrugIDPK>
    <LicenceNumber>PA0405/082/001</LicenceNumber>
    <ProductName>Cisplatin</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>05/12/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cisplatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/05/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1399/005/001</DrugIDPK>
    <LicenceNumber>PA1399/005/001</LicenceNumber>
    <ProductName>Cisplatin</ProductName>
    <PAHolder>Caduceus Pharma Ltd</PAHolder>
    <AuthorisedDate>25/10/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cisplatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/11/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/004/008</DrugIDPK>
    <LicenceNumber>PA0437/004/008</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>19/11/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/004/006</DrugIDPK>
    <LicenceNumber>PA0437/004/006</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>21/05/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/004/005</DrugIDPK>
    <LicenceNumber>PA0437/004/005</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>21/05/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/004/004</DrugIDPK>
    <LicenceNumber>PA0437/004/004</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>21/05/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/004/003</DrugIDPK>
    <LicenceNumber>PA0437/004/003</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>21/05/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/05/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/004/002</DrugIDPK>
    <LicenceNumber>PA0437/004/002</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>21/05/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/004/001</DrugIDPK>
    <LicenceNumber>PA0437/004/001</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>21/05/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/05/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0236/013/006</DrugIDPK>
    <LicenceNumber>PA0236/013/006</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>09/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/04/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0236/013/005</DrugIDPK>
    <LicenceNumber>PA0236/013/005</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>09/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0236/013/004</DrugIDPK>
    <LicenceNumber>PA0236/013/004</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>09/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/04/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0236/013/003</DrugIDPK>
    <LicenceNumber>PA0236/013/003</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>04/05/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0236/013/001</DrugIDPK>
    <LicenceNumber>PA0236/013/001</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>04/05/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/057/002</DrugIDPK>
    <LicenceNumber>PA0047/057/002</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>23/06/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/06/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/057/001</DrugIDPK>
    <LicenceNumber>PA0047/057/001</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>23/06/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/06/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/021/003</DrugIDPK>
    <LicenceNumber>PA0037/021/003</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>16/09/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/021/002</DrugIDPK>
    <LicenceNumber>PA0037/021/002</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>23/02/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/021/001</DrugIDPK>
    <LicenceNumber>PA0037/021/001</LicenceNumber>
    <ProductName>CISPLATIN</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>23/02/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0789/002/001</DrugIDPK>
    <LicenceNumber>PA0789/002/001</LicenceNumber>
    <ProductName>Cisplatin 'Ebewe'</ProductName>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>25/07/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cisplatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/06/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0789/002/005</DrugIDPK>
    <LicenceNumber>PA0789/002/005</LicenceNumber>
    <ProductName>Cisplatin "Ebewe"</ProductName>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>02/11/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cisplatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/06/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2059/033/001</DrugIDPK>
    <LicenceNumber>PA2059/033/001</LicenceNumber>
    <ProductName>Cisplatin 1 mg/ml concentrate for solution for infusion</ProductName>
    <PAHolder>Fresenius Kabi Deutschland GmbH</PAHolder>
    <AuthorisedDate>02/05/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cisplatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/08/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/119/001</DrugIDPK>
    <LicenceNumber>PA0749/119/001</LicenceNumber>
    <ProductName>Cisplatin Teva</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>26/02/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cisplatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/119/002</DrugIDPK>
    <LicenceNumber>PA0749/119/002</LicenceNumber>
    <ProductName>Cisplatin Teva 1 mg/ml, concentrate for solution for infusion</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>30/01/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cisplatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/09/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0236/013/002</DrugIDPK>
    <LicenceNumber>PA0236/013/002</LicenceNumber>
    <ProductName>CISPLATIN VIALS</ProductName>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>04/05/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0382/003/002</DrugIDPK>
    <LicenceNumber>PA0382/003/002</LicenceNumber>
    <ProductName>CISPLATINUM LYOPHILISED</ProductName>
    <PAHolder>H.N. Norton &amp; Company Ltd</PAHolder>
    <AuthorisedDate>28/03/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/01/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0382/003/001</DrugIDPK>
    <LicenceNumber>PA0382/003/001</LicenceNumber>
    <ProductName>CISPLATINUM LYOPHILISED</ProductName>
    <PAHolder>H.N. Norton &amp; Company Ltd</PAHolder>
    <AuthorisedDate>28/03/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CISPLATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/01/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/145/001</DrugIDPK>
    <LicenceNumber>PA0126/145/001</LicenceNumber>
    <ProductName>Citalopram</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/12/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/145/002</DrugIDPK>
    <LicenceNumber>PA0126/145/002</LicenceNumber>
    <ProductName>Citalopram</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/12/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/145/003</DrugIDPK>
    <LicenceNumber>PA0126/145/003</LicenceNumber>
    <ProductName>Citalopram</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/12/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/072/001</DrugIDPK>
    <LicenceNumber>PA0577/072/001</LicenceNumber>
    <ProductName>Citalopram</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>13/10/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0585/018/001</DrugIDPK>
    <LicenceNumber>PA0585/018/001</LicenceNumber>
    <ProductName>Citalopram</ProductName>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>09/09/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0585/018/002</DrugIDPK>
    <LicenceNumber>PA0585/018/002</LicenceNumber>
    <ProductName>Citalopram</ProductName>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>09/09/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0585/018/003</DrugIDPK>
    <LicenceNumber>PA0585/018/003</LicenceNumber>
    <ProductName>Citalopram</ProductName>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>09/09/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/048/001</DrugIDPK>
    <LicenceNumber>PA0711/048/001</LicenceNumber>
    <ProductName>Citalopram</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>30/06/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/017/001</DrugIDPK>
    <LicenceNumber>PA1063/017/001</LicenceNumber>
    <ProductName>Citalopram</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>04/02/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
      <ActiveSubstance>Citalopram</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/017/002</DrugIDPK>
    <LicenceNumber>PA1063/017/002</LicenceNumber>
    <ProductName>Citalopram</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>04/02/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
      <ActiveSubstance>Citalopram</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0565/031/001</DrugIDPK>
    <LicenceNumber>PPA0565/031/001</LicenceNumber>
    <ProductName>Citalopram</ProductName>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>05/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/042/001</DrugIDPK>
    <LicenceNumber>PA2315/042/001</LicenceNumber>
    <InterchangeableListCode>IC0073-002-003</InterchangeableListCode>
    <ProductName>Citalopram 10 mg Film-coated tablet</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>10/03/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/05/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0688/008/001</DrugIDPK>
    <LicenceNumber>PA0688/008/001</LicenceNumber>
    <ProductName>Citalopram 10mg Film-coated Tablets</ProductName>
    <PAHolder>Chanelle Medical Unlimited Company</PAHolder>
    <AuthorisedDate>07/07/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/03/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/042/002</DrugIDPK>
    <LicenceNumber>PA2315/042/002</LicenceNumber>
    <InterchangeableListCode>IC0073-003-003</InterchangeableListCode>
    <ProductName>Citalopram 20 mg Film-coated tablet</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>10/03/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/05/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0565/062/001</DrugIDPK>
    <LicenceNumber>PPA0565/062/001</LicenceNumber>
    <InterchangeableListCode>IC0073-003-003</InterchangeableListCode>
    <ProductName>Citalopram 20 mg Film-coated Tablets</ProductName>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>20/01/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/12/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0688/008/002</DrugIDPK>
    <LicenceNumber>PA0688/008/002</LicenceNumber>
    <ProductName>Citalopram 20mg Film-coated Tablets</ProductName>
    <PAHolder>Chanelle Medical Unlimited Company</PAHolder>
    <AuthorisedDate>07/07/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/03/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0312/012/001</DrugIDPK>
    <LicenceNumber>PA0312/012/001</LicenceNumber>
    <ProductName>Citalopram 40 mg/ml Oral Drops, Solution</ProductName>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>23/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/11/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1338/003/001</DrugIDPK>
    <LicenceNumber>PA1338/003/001</LicenceNumber>
    <ProductName>Citalopram 40mg/ml Oral Drops, solution</ProductName>
    <PAHolder>Focus Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>03/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0688/008/003</DrugIDPK>
    <LicenceNumber>PA0688/008/003</LicenceNumber>
    <ProductName>Citalopram 40mg Film-coated Tablets</ProductName>
    <PAHolder>Chanelle Medical Unlimited Company</PAHolder>
    <AuthorisedDate>07/07/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/03/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1436/018/001</DrugIDPK>
    <LicenceNumber>PA1436/018/001</LicenceNumber>
    <InterchangeableListCode>IC0073-002-003</InterchangeableListCode>
    <ProductName>Citalopram Bluefish 10 mg film-coated tablets</ProductName>
    <PAHolder>Bluefish Pharmaceuticals AB</PAHolder>
    <AuthorisedDate>09/04/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/05/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1436/018/002</DrugIDPK>
    <LicenceNumber>PA1436/018/002</LicenceNumber>
    <InterchangeableListCode>IC0073-003-003</InterchangeableListCode>
    <ProductName>Citalopram Bluefish 20 mg film-coated tablets</ProductName>
    <PAHolder>Bluefish Pharmaceuticals AB</PAHolder>
    <AuthorisedDate>09/04/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/05/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1436/018/003</DrugIDPK>
    <LicenceNumber>PA1436/018/003</LicenceNumber>
    <InterchangeableListCode>IC0073-004-003</InterchangeableListCode>
    <ProductName>Citalopram Bluefish 40 mg film-coated tablets</ProductName>
    <PAHolder>Bluefish Pharmaceuticals AB</PAHolder>
    <AuthorisedDate>09/04/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/05/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/034/001</DrugIDPK>
    <LicenceNumber>PA0822/034/001</LicenceNumber>
    <ProductName>Citalopram Pfizer</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>16/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/034/002</DrugIDPK>
    <LicenceNumber>PA0822/034/002</LicenceNumber>
    <ProductName>Citalopram Pfizer</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>16/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/034/003</DrugIDPK>
    <LicenceNumber>PA0822/034/003</LicenceNumber>
    <ProductName>Citalopram Pfizer</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>16/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Citalopram hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0009/021/007</DrugIDPK>
    <LicenceNumber>PA0009/021/007</LicenceNumber>
    <ProductName>CITANEST</ProductName>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>20/11/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRILOCAINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0009/021/002</DrugIDPK>
    <LicenceNumber>PA0009/021/002</LicenceNumber>
    <ProductName>CITANEST 0.5%</ProductName>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>01/04/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRILOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0009/021/001</DrugIDPK>
    <LicenceNumber>PA0009/021/001</LicenceNumber>
    <ProductName>CITANEST 0.5%</ProductName>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>01/04/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRILOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1045/001/002</DrugIDPK>
    <LicenceNumber>PA1045/001/002</LicenceNumber>
    <ProductName>Citanest 3% with Octapressin self aspirating</ProductName>
    <PAHolder>DENTSPLY DeTrey GmbH</PAHolder>
    <AuthorisedDate>01/04/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Prilocaine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Felypressin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1045/002/001</DrugIDPK>
    <LicenceNumber>PA1045/002/001</LicenceNumber>
    <ProductName>CITANEST 4% DENTAL INJECTION</ProductName>
    <PAHolder>DENTSPLY DeTrey GmbH</PAHolder>
    <AuthorisedDate>01/04/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not Currently Available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Prilocaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0009/021/003</DrugIDPK>
    <LicenceNumber>PA0009/021/003</LicenceNumber>
    <ProductName>CITANEST PLAIN SOLUTION 1.0% - 20 ML. VIALS</ProductName>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>01/04/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRILOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0009/021/004</DrugIDPK>
    <LicenceNumber>PA0009/021/004</LicenceNumber>
    <ProductName>CITANEST PLAIN SOLUTION 1.0% - 50 ML. VIALS</ProductName>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>01/04/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRILOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/034/005</DrugIDPK>
    <LicenceNumber>PA0137/034/005</LicenceNumber>
    <ProductName>CITOCILLIN</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>10/11/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLACILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/11/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/034/003</DrugIDPK>
    <LicenceNumber>PA0137/034/003</LicenceNumber>
    <ProductName>CITOCILLIN</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>10/11/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLACILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/02/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/034/002</DrugIDPK>
    <LicenceNumber>PA0137/034/002</LicenceNumber>
    <ProductName>CITOCILLIN</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>10/11/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLACILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/04/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/034/001</DrugIDPK>
    <LicenceNumber>PA0137/034/001</LicenceNumber>
    <ProductName>CITOCILLIN</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>10/11/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLACILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/04/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/034/004</DrugIDPK>
    <LicenceNumber>PA0137/034/004</LicenceNumber>
    <ProductName>CITOCILLIN (SUSPENSION)</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/11/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CICLACILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/04/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/083/001</DrugIDPK>
    <LicenceNumber>PA0167/083/001</LicenceNumber>
    <ProductName>CITRATE PHOSPHATE DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>13/07/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>ADENINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/09/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/082/001</DrugIDPK>
    <LicenceNumber>PA0167/082/001</LicenceNumber>
    <ProductName>CITRATE PHOSPHATE DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>13/07/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Unknown</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM DIHYDROGEN PHOSPHATE DIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/09/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/014/001</DrugIDPK>
    <LicenceNumber>PA0167/014/001</LicenceNumber>
    <ProductName>CITRATE PHOSPHATE DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>22/04/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACID PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/09/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/022/001</DrugIDPK>
    <LicenceNumber>PA0167/022/001</LicenceNumber>
    <ProductName>CITRATE PHOSPHATE DEXTROSE ANTICOAGULANT</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>05/07/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM ACID PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/07/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/064/001</DrugIDPK>
    <LicenceNumber>PA0073/064/001</LicenceNumber>
    <ProductName>CITRAZINE</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>15/01/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PIPERAZINE CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/01/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0004/002/002</DrugIDPK>
    <LicenceNumber>PA0004/002/002</LicenceNumber>
    <ProductName>CITROSAN</ProductName>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>31/12/1974</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/01/1981</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0004/002/001</DrugIDPK>
    <LicenceNumber>PA0004/002/001</LicenceNumber>
    <ProductName>CITROSAN</ProductName>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>31/12/1974</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/01/1980</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0041/039/001</DrugIDPK>
    <LicenceNumber>PA0041/039/001</LicenceNumber>
    <ProductName>CITRUCEL</ProductName>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>06/02/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLCELLULOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/037/001</DrugIDPK>
    <LicenceNumber>PA0540/037/001</LicenceNumber>
    <ProductName>Claforan</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>04/07/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefotaxime sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/07/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/037/004</DrugIDPK>
    <LicenceNumber>PA0540/037/004</LicenceNumber>
    <ProductName>Claforan</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>09/01/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefotaxime sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/024/001</DrugIDPK>
    <LicenceNumber>PA0006/024/001</LicenceNumber>
    <ProductName>CLAFORAN</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>13/05/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFOTAXIME SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/05/1981</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0032/009/001</DrugIDPK>
    <LicenceNumber>PA0032/009/001</LicenceNumber>
    <ProductName>CLARADIN</ProductName>
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/03/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1230/001/001</DrugIDPK>
    <LicenceNumber>PA1230/001/001</LicenceNumber>
    <ProductName>CLARELUX</ProductName>
    <PAHolder>PIERRE FABRE DERMATOLOGIE</PAHolder>
    <AuthorisedDate>18/03/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous foam</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clobetasol propionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/125/001</DrugIDPK>
    <LicenceNumber>PA0749/125/001</LicenceNumber>
    <ProductName>Clarie LA</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0408/063/003</DrugIDPK>
    <LicenceNumber>PA0408/063/003</LicenceNumber>
    <ProductName>Clarithromycin</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>02/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/05/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/063/004</DrugIDPK>
    <LicenceNumber>PA0408/063/004</LicenceNumber>
    <ProductName>Clarithromycin</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>02/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/05/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/103/001</DrugIDPK>
    <LicenceNumber>PA0822/103/001</LicenceNumber>
    <ProductName>Clarithromycin</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>29/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/103/002</DrugIDPK>
    <LicenceNumber>PA0822/103/002</LicenceNumber>
    <ProductName>Clarithromycin</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>29/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0585/011/001</DrugIDPK>
    <LicenceNumber>PA0585/011/001</LicenceNumber>
    <ProductName>CLARITHROMYCIN</ProductName>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>31/03/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0585/011/002</DrugIDPK>
    <LicenceNumber>PA0585/011/002</LicenceNumber>
    <ProductName>CLARITHROMYCIN</ProductName>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>31/03/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/197/001</DrugIDPK>
    <LicenceNumber>PA0711/197/001</LicenceNumber>
    <ProductName>Clarithromycin 125mg/5ml Granules for Oral Suspension</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>03/02/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/09/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/250/001</DrugIDPK>
    <LicenceNumber>PA0281/250/001</LicenceNumber>
    <InterchangeableListCode>IC0072-130-003</InterchangeableListCode>
    <ProductName>Clarithromycin 250 mg film-coated tablets</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>11/01/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/01/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/136/003</DrugIDPK>
    <LicenceNumber>PA2315/136/003</LicenceNumber>
    <InterchangeableListCode>IC0072-130-003</InterchangeableListCode>
    <ProductName>Clarithromycin 250 mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>26/01/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/05/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/197/002</DrugIDPK>
    <LicenceNumber>PA0711/197/002</LicenceNumber>
    <ProductName>Clarithromycin 250mg/5ml Granules for Oral Suspension</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>03/02/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/09/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/250/002</DrugIDPK>
    <LicenceNumber>PA0281/250/002</LicenceNumber>
    <InterchangeableListCode>IC0072-117-003</InterchangeableListCode>
    <ProductName>Clarithromycin 500 mg film-coated tablets</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>11/01/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/04/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/136/004</DrugIDPK>
    <LicenceNumber>PA2315/136/004</LicenceNumber>
    <InterchangeableListCode>IC0072-117-003</InterchangeableListCode>
    <ProductName>Clarithromycin 500 mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>26/01/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/05/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1050/023/001</DrugIDPK>
    <LicenceNumber>PA1050/023/001</LicenceNumber>
    <ProductName>Clarithromycin Aurobindo 250 mg film-coated tablets</ProductName>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>23/05/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1050/023/002</DrugIDPK>
    <LicenceNumber>PA1050/023/002</LicenceNumber>
    <ProductName>Clarithromycin Aurobindo 500 mg film-coated tablets</ProductName>
    <PAHolder>Milpharm Limited</PAHolder>
    <AuthorisedDate>23/05/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/062/001</DrugIDPK>
    <LicenceNumber>PA0038/062/001</LicenceNumber>
    <ProductName>CLARITHROMYCIN GRANULES</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>11/07/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLARITHROMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1189/003/001</DrugIDPK>
    <LicenceNumber>PA1189/003/001</LicenceNumber>
    <ProductName>Clarithromycin Grunenthal</ProductName>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>09/09/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/06/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1189/003/002</DrugIDPK>
    <LicenceNumber>PA1189/003/002</LicenceNumber>
    <ProductName>Clarithromycin Grunenthal</ProductName>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>09/09/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/06/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1189/003/003</DrugIDPK>
    <LicenceNumber>PA1189/003/003</LicenceNumber>
    <ProductName>Clarithromycin Grunenthal</ProductName>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>09/09/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/06/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0361/025/001</DrugIDPK>
    <LicenceNumber>PA0361/025/001</LicenceNumber>
    <ProductName>Clarithromycin Martindale Pharma 500 mg Powder for Concentrate for Solution for Infusion</ProductName>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>16/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/07/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/077/001</DrugIDPK>
    <LicenceNumber>PPA1447/077/001</LicenceNumber>
    <ProductName>Clarityn</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>17/12/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Loratadine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/05/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/049/001</DrugIDPK>
    <LicenceNumber>PPA0465/049/001</LicenceNumber>
    <ProductName>CLARITYN</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>15/06/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Loratadine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>Pack sizes not exceeding 30 tablets: Promotion to the public. 
Pack sizes exceeding 30 tablets: Promotion to healthcare professionals.</SupplyComments>
    <WithdrawalDate>30/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/049/001E</DrugIDPK>
    <LicenceNumber>PPA0465/049/001E</LicenceNumber>
    <ProductName>CLARITYN</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>15/06/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORATADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/06/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/049/001C</DrugIDPK>
    <LicenceNumber>PPA0465/049/001C</LicenceNumber>
    <ProductName>CLARITYN</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>15/06/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/06/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/049/001A</DrugIDPK>
    <LicenceNumber>PPA0465/049/001A</LicenceNumber>
    <ProductName>CLARITYN</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>15/06/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LORATADINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/06/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/336/001</DrugIDPK>
    <LicenceNumber>PPA0465/336/001</LicenceNumber>
    <ProductName>Clarityn 10 mg Tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>08/08/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Loratadine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>For pack sizes of up to 30 tablets, product not subject to prescription. For pack sizes of more than 30 tablets, product subject to medical prescription.
Pack sizes not exceeding 30 tablets: Promotion to the public. 
Pack sizes exceeding 30 tablets: Prom</SupplyComments>
    <WithdrawalDate>31/01/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23176/060/001</DrugIDPK>
    <LicenceNumber>PPA23176/060/001</LicenceNumber>
    <ProductName>Clarityn 10 mg Tablets</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>12/05/2023</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Loratadine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>For pack sizes of up to 30 tablets: 
Product not subject to medical prescription. 
Supply as an over the counter item through pharmacies only. 

For pack sizes of more than 30 tablets: 
Product subject to medical prescription 


Supply through phar</SupplyComments>
    <WithdrawalDate>18/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0277/053/003</DrugIDPK>
    <LicenceNumber>PA0277/053/003</LicenceNumber>
    <ProductName>Clarityn Rapide</ProductName>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>26/11/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Loratadine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/08/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/075/003</DrugIDPK>
    <LicenceNumber>PA1410/075/003</LicenceNumber>
    <ProductName>Clarityn Rapide Allergy 10 mg Tablets</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>26/11/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral lyophilisate</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Loratadine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/227/001</DrugIDPK>
    <LicenceNumber>PA0126/227/001</LicenceNumber>
    <ProductName>Claropt</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>25/11/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide hydrochloride</ActiveSubstance>
      <ActiveSubstance>Timolol Maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/02/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1189/002/001</DrugIDPK>
    <LicenceNumber>PA1189/002/001</LicenceNumber>
    <ProductName>Clarosip</ProductName>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>09/09/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1189/002/002</DrugIDPK>
    <LicenceNumber>PA1189/002/002</LicenceNumber>
    <ProductName>Clarosip</ProductName>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>09/09/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1189/002/003</DrugIDPK>
    <LicenceNumber>PA1189/002/003</LicenceNumber>
    <ProductName>Clarosip</ProductName>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>09/09/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/131/001</DrugIDPK>
    <LicenceNumber>PA0281/131/001</LicenceNumber>
    <ProductName>Claryl</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>19/05/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/01/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/131/002</DrugIDPK>
    <LicenceNumber>PA0281/131/002</LicenceNumber>
    <ProductName>Claryl</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>19/05/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/01/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1312/012/001</DrugIDPK>
    <LicenceNumber>PA1312/012/001</LicenceNumber>
    <ProductName>Clasteon 800mg Film-coated Tablets</ProductName>
    <PAHolder>Beacon Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>11/11/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium clodronate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/229/001</DrugIDPK>
    <LicenceNumber>PA0711/229/001</LicenceNumber>
    <ProductName>Clavamel</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>28/11/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/05/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/103/001</DrugIDPK>
    <LicenceNumber>PA0126/103/001</LicenceNumber>
    <ProductName>CLAVAMEL</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>17/09/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/08/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/103/005</DrugIDPK>
    <LicenceNumber>PA0126/103/005</LicenceNumber>
    <InterchangeableListCode>IC0037-073-014</InterchangeableListCode>
    <ProductName>CLAVAMEL</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>19/10/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/103/003</DrugIDPK>
    <LicenceNumber>PA0126/103/003</LicenceNumber>
    <ProductName>CLAVAMEL 125mg/62.5mg per 5ml Junior Powder for Or</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>17/09/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/09/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/103/004</DrugIDPK>
    <LicenceNumber>PA0126/103/004</LicenceNumber>
    <ProductName>CLAVAMEL PAEDIATRIC SACHETS</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/07/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/103/002</DrugIDPK>
    <LicenceNumber>PA0126/103/002</LicenceNumber>
    <ProductName>Clavamel Pediatric</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>17/09/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/08/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/132/001</DrugIDPK>
    <LicenceNumber>PA1380/132/001</LicenceNumber>
    <ProductName>Cleonita 0.02 mg/3 mg film-coated tablets</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>17/01/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Drospirenone</ActiveSubstance>
      <ActiveSubstance>Ethinyl estradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/132/002</DrugIDPK>
    <LicenceNumber>PA1380/132/002</LicenceNumber>
    <ProductName>Cleosensa 0.03 mg/3 mg film-coated tablets</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>17/01/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Drospirenone</ActiveSubstance>
      <ActiveSubstance>Ethinyl estradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/251/001</DrugIDPK>
    <LicenceNumber>PPA0465/251/001</LicenceNumber>
    <ProductName>Clexane</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>09/03/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enoxaparin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/064/001</DrugIDPK>
    <LicenceNumber>PPA1328/064/001</LicenceNumber>
    <ProductName>CLEXANE</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>21/12/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enoxaparin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/081/002</DrugIDPK>
    <LicenceNumber>PA0040/081/002</LicenceNumber>
    <ProductName>CLEXANE</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>22/08/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENOXAPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/03/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/081/001</DrugIDPK>
    <LicenceNumber>PA0040/081/001</LicenceNumber>
    <ProductName>CLEXANE</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>22/08/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENOXAPARIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/03/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/477/006</DrugIDPK>
    <LicenceNumber>PPA0465/477/006</LicenceNumber>
    <ProductName>Clexane 2,000 IU (20mg) /0.2 ml Solution for Injection in pre-filled syringes</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>16/12/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection in pre-filled syringe</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enoxaparin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/097/003</DrugIDPK>
    <LicenceNumber>PA0540/097/003</LicenceNumber>
    <ProductName>Clexane Multi Dose</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>19/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enoxaparin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/10/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0486/002/001</DrugIDPK>
    <LicenceNumber>PA0486/002/001</LicenceNumber>
    <ProductName>CLICKHALER BECLOMETASONE</ProductName>
    <PAHolder>Innovata Biomed Ltd</PAHolder>
    <AuthorisedDate>07/09/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0486/002/002</DrugIDPK>
    <LicenceNumber>PA0486/002/002</LicenceNumber>
    <ProductName>CLICKHALER BECLOMETASONE</ProductName>
    <PAHolder>Innovata Biomed Ltd</PAHolder>
    <AuthorisedDate>07/09/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0486/002/003</DrugIDPK>
    <LicenceNumber>PA0486/002/003</LicenceNumber>
    <ProductName>CLICKHALER BECLOMETASONE</ProductName>
    <PAHolder>Innovata Biomed Ltd</PAHolder>
    <AuthorisedDate>07/09/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Beclometasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0486/001/001</DrugIDPK>
    <LicenceNumber>PA0486/001/001</LicenceNumber>
    <ProductName>CLICKHALER SALBUTAMOL</ProductName>
    <PAHolder>Innovata Biomed Ltd</PAHolder>
    <AuthorisedDate>17/04/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/052/002</DrugIDPK>
    <LicenceNumber>PA0013/052/002</LicenceNumber>
    <ProductName>CLIMACTOL</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>12/07/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/03/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/052/001</DrugIDPK>
    <LicenceNumber>PA0013/052/001</LicenceNumber>
    <ProductName>CLIMACTOL</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>12/07/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/03/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/015/003</DrugIDPK>
    <LicenceNumber>PA1410/015/003</LicenceNumber>
    <ProductName>Climara 25 micrograms/24 hours Transdermal Patch</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>05/05/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Estradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/05/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/015/001</DrugIDPK>
    <LicenceNumber>PA1410/015/001</LicenceNumber>
    <ProductName>Climara 50 micrograms/24 hours Transdermal Patch</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>25/07/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Estradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Patient Information
Warning for Patients
 
 
1.  While you are receiving this medication, you should see your doctor regularly, at least every 6 to 12 months.

2.  If you have any unusual symptoms such as unexplained pains in the chest, abdomen or le</SupplyComments>
    <WithdrawalDate>01/10/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0012/087/001</DrugIDPK>
    <LicenceNumber>PA0012/087/001</LicenceNumber>
    <ProductName>CLIMARA DUO</ProductName>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>19/03/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>LEVONORGESTREL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/06/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/015/002</DrugIDPK>
    <LicenceNumber>PA1410/015/002</LicenceNumber>
    <ProductName>Climara Forte 100 micrograms/24 hours Transdermal Patch</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>25/07/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Estradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/049/002</DrugIDPK>
    <LicenceNumber>PA0013/049/002</LicenceNumber>
    <ProductName>CLIMAVAL</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>14/03/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/08/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/049/001</DrugIDPK>
    <LicenceNumber>PA0013/049/001</LicenceNumber>
    <ProductName>CLIMAVAL</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>14/03/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/08/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/055/001</DrugIDPK>
    <LicenceNumber>PA0013/055/001</LicenceNumber>
    <ProductName>CLIMESSE</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>09/01/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/01/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/188/001</DrugIDPK>
    <LicenceNumber>PA1380/188/001</LicenceNumber>
    <ProductName>Clindamycin</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>26/02/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLINDAMYCIN  (AS HYDROCHLORIDE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/03/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/060/001</DrugIDPK>
    <LicenceNumber>PA0408/060/001</LicenceNumber>
    <ProductName>CLINDAMYCIN</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>03/03/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/10/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/156/001</DrugIDPK>
    <LicenceNumber>PPA1151/156/001</LicenceNumber>
    <ProductName>Clindamycin 150 mg/ml solution for injection or infusion</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>03/02/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLINDAMYCIN PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1585/001/001</DrugIDPK>
    <LicenceNumber>PA1585/001/001</LicenceNumber>
    <ProductName>Clindamycin 150 mg/ml Solution for Injection or Infusion</ProductName>
    <PAHolder>Fannin (UK) Ltd</PAHolder>
    <AuthorisedDate>05/12/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0688/044/001</DrugIDPK>
    <LicenceNumber>PA0688/044/001</LicenceNumber>
    <ProductName>Clindamycin 150 mg Capsule</ProductName>
    <PAHolder>Chanelle Medical Unlimited Company</PAHolder>
    <AuthorisedDate>04/07/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/07/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1338/004/001</DrugIDPK>
    <LicenceNumber>PA1338/004/001</LicenceNumber>
    <ProductName>Clindamycin 150mg/ml Solution for Injection or Infusion</ProductName>
    <PAHolder>Focus Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>12/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1960/001/001</DrugIDPK>
    <LicenceNumber>PA1960/001/001</LicenceNumber>
    <ProductName>Clindamycin Villerton 300 mg solution for infusion</ProductName>
    <PAHolder>Villerton Invest S.A.</PAHolder>
    <AuthorisedDate>19/07/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/07/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1960/001/002</DrugIDPK>
    <LicenceNumber>PA1960/001/002</LicenceNumber>
    <ProductName>Clindamycin Villerton 600 mg solution for infusion</ProductName>
    <PAHolder>Villerton Invest S.A.</PAHolder>
    <AuthorisedDate>19/07/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/07/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/004/003</DrugIDPK>
    <LicenceNumber>PA0035/004/003</LicenceNumber>
    <ProductName>CLINGRIL</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>29/09/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULINDAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0299/010/001</DrugIDPK>
    <LicenceNumber>PA0299/010/001</LicenceNumber>
    <ProductName>Clinicide Lotion</ProductName>
    <PAHolder>E.C. De Witt &amp; Company Limited</PAHolder>
    <AuthorisedDate>20/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carbaryl</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0299/011/001</DrugIDPK>
    <LicenceNumber>PA0299/011/001</LicenceNumber>
    <ProductName>CLINIMAL LOTION</ProductName>
    <PAHolder>E.C. De Witt &amp; Company Limited</PAHolder>
    <AuthorisedDate>22/10/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Malathion</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/098/006</DrugIDPK>
    <LicenceNumber>PA0167/098/006</LicenceNumber>
    <ProductName>Clinimix N12G20</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>30/04/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>L-leucine</ActiveSubstance>
      <ActiveSubstance>L-phenylalanine</ActiveSubstance>
      <ActiveSubstance>L-methionine</ActiveSubstance>
      <ActiveSubstance>L-lysine</ActiveSubstance>
      <ActiveSubstance>L-isoleucine</ActiveSubstance>
      <ActiveSubstance>L-valine</ActiveSubstance>
      <ActiveSubstance>L-histidine</ActiveSubstance>
      <ActiveSubstance>L-threonine</ActiveSubstance>
      <ActiveSubstance>L-tryptophan</ActiveSubstance>
      <ActiveSubstance>L-alanine</ActiveSubstance>
      <ActiveSubstance>L-arginine</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
      <ActiveSubstance>L-proline</ActiveSubstance>
      <ActiveSubstance>L-serine</ActiveSubstance>
      <ActiveSubstance>L-tyrosine</ActiveSubstance>
      <ActiveSubstance>Glucose</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/12/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/098/003</DrugIDPK>
    <LicenceNumber>PA0167/098/003</LicenceNumber>
    <ProductName>Clinimix N12G20E</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>30/04/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>L-leucine</ActiveSubstance>
      <ActiveSubstance>L-phenylalanine</ActiveSubstance>
      <ActiveSubstance>L-methionine</ActiveSubstance>
      <ActiveSubstance>L-lysine</ActiveSubstance>
      <ActiveSubstance>L-isoleucine</ActiveSubstance>
      <ActiveSubstance>L-valine</ActiveSubstance>
      <ActiveSubstance>L-histidine</ActiveSubstance>
      <ActiveSubstance>L-threonine</ActiveSubstance>
      <ActiveSubstance>L-tryptophan</ActiveSubstance>
      <ActiveSubstance>L-alanine</ActiveSubstance>
      <ActiveSubstance>L-arginine</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
      <ActiveSubstance>L-proline</ActiveSubstance>
      <ActiveSubstance>L-serine</ActiveSubstance>
      <ActiveSubstance>L-tyrosine</ActiveSubstance>
      <ActiveSubstance>Sodium acetate trihydrate </ActiveSubstance>
      <ActiveSubstance>Potassium phosphate dibasic</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Glucose</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/12/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/098/007</DrugIDPK>
    <LicenceNumber>PA0167/098/007</LicenceNumber>
    <ProductName>Clinimix N14G30</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>30/04/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>L-leucine</ActiveSubstance>
      <ActiveSubstance>L-phenylalanine</ActiveSubstance>
      <ActiveSubstance>L-methionine</ActiveSubstance>
      <ActiveSubstance>L-lysine</ActiveSubstance>
      <ActiveSubstance>L-isoleucine</ActiveSubstance>
      <ActiveSubstance>L-valine</ActiveSubstance>
      <ActiveSubstance>L-histidine</ActiveSubstance>
      <ActiveSubstance>L-threonine</ActiveSubstance>
      <ActiveSubstance>L-tryptophan</ActiveSubstance>
      <ActiveSubstance>L-alanine</ActiveSubstance>
      <ActiveSubstance>L-arginine</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
      <ActiveSubstance>L-proline</ActiveSubstance>
      <ActiveSubstance>L-serine</ActiveSubstance>
      <ActiveSubstance>L-tyrosine</ActiveSubstance>
      <ActiveSubstance>Glucose</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/12/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/098/008</DrugIDPK>
    <LicenceNumber>PA0167/098/008</LicenceNumber>
    <ProductName>Clinimix N17G35</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>30/04/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>L-leucine</ActiveSubstance>
      <ActiveSubstance>L-phenylalanine</ActiveSubstance>
      <ActiveSubstance>L-methionine</ActiveSubstance>
      <ActiveSubstance>L-lysine</ActiveSubstance>
      <ActiveSubstance>L-isoleucine</ActiveSubstance>
      <ActiveSubstance>L-valine</ActiveSubstance>
      <ActiveSubstance>L-histidine</ActiveSubstance>
      <ActiveSubstance>L-threonine</ActiveSubstance>
      <ActiveSubstance>L-tryptophan</ActiveSubstance>
      <ActiveSubstance>L-alanine</ActiveSubstance>
      <ActiveSubstance>L-arginine</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
      <ActiveSubstance>L-proline</ActiveSubstance>
      <ActiveSubstance>L-serine</ActiveSubstance>
      <ActiveSubstance>L-tyrosine</ActiveSubstance>
      <ActiveSubstance>Glucose</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/12/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/098/005</DrugIDPK>
    <LicenceNumber>PA0167/098/005</LicenceNumber>
    <ProductName>Clinimix N17G35E</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>30/04/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>L-leucine</ActiveSubstance>
      <ActiveSubstance>L-phenylalanine</ActiveSubstance>
      <ActiveSubstance>L-methionine</ActiveSubstance>
      <ActiveSubstance>L-lysine</ActiveSubstance>
      <ActiveSubstance>L-isoleucine</ActiveSubstance>
      <ActiveSubstance>L-valine</ActiveSubstance>
      <ActiveSubstance>L-histidine</ActiveSubstance>
      <ActiveSubstance>L-threonine</ActiveSubstance>
      <ActiveSubstance>L-tryptophan</ActiveSubstance>
      <ActiveSubstance>L-alanine</ActiveSubstance>
      <ActiveSubstance>L-arginine</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
      <ActiveSubstance>L-proline</ActiveSubstance>
      <ActiveSubstance>L-serine</ActiveSubstance>
      <ActiveSubstance>L-tyrosine</ActiveSubstance>
      <ActiveSubstance>Sodium acetate trihydrate </ActiveSubstance>
      <ActiveSubstance>Potassium phosphate dibasic</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Glucose</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/12/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/098/001</DrugIDPK>
    <LicenceNumber>PA0167/098/001</LicenceNumber>
    <ProductName>Clinimix N9G15E</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>30/04/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>L-leucine</ActiveSubstance>
      <ActiveSubstance>L-phenylalanine</ActiveSubstance>
      <ActiveSubstance>L-methionine</ActiveSubstance>
      <ActiveSubstance>L-lysine</ActiveSubstance>
      <ActiveSubstance>L-isoleucine</ActiveSubstance>
      <ActiveSubstance>L-valine</ActiveSubstance>
      <ActiveSubstance>L-histidine</ActiveSubstance>
      <ActiveSubstance>L-threonine</ActiveSubstance>
      <ActiveSubstance>L-tryptophan</ActiveSubstance>
      <ActiveSubstance>L-alanine</ActiveSubstance>
      <ActiveSubstance>L-arginine</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
      <ActiveSubstance>L-proline</ActiveSubstance>
      <ActiveSubstance>L-serine</ActiveSubstance>
      <ActiveSubstance>L-tyrosine</ActiveSubstance>
      <ActiveSubstance>Sodium acetate trihydrate </ActiveSubstance>
      <ActiveSubstance>Potassium phosphate dibasic</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Glucose</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/12/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/098/002</DrugIDPK>
    <LicenceNumber>PA0167/098/002</LicenceNumber>
    <ProductName>Clinimix N9G20E</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>30/04/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>L-leucine</ActiveSubstance>
      <ActiveSubstance>L-phenylalanine</ActiveSubstance>
      <ActiveSubstance>L-methionine</ActiveSubstance>
      <ActiveSubstance>L-lysine</ActiveSubstance>
      <ActiveSubstance>L-isoleucine</ActiveSubstance>
      <ActiveSubstance>L-valine</ActiveSubstance>
      <ActiveSubstance>L-histidine</ActiveSubstance>
      <ActiveSubstance>L-threonine</ActiveSubstance>
      <ActiveSubstance>L-tryptophan</ActiveSubstance>
      <ActiveSubstance>L-alanine</ActiveSubstance>
      <ActiveSubstance>L-arginine</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
      <ActiveSubstance>L-proline</ActiveSubstance>
      <ActiveSubstance>L-serine</ActiveSubstance>
      <ActiveSubstance>L-tyrosine</ActiveSubstance>
      <ActiveSubstance>Sodium acetate trihydrate </ActiveSubstance>
      <ActiveSubstance>Potassium phosphate dibasic</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
      <ActiveSubstance>Glucose</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0185/033/001</DrugIDPK>
    <LicenceNumber>PA0185/033/001</LicenceNumber>
    <ProductName>Clinimycin</ProductName>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Oxytetracycline dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/019/002</DrugIDPK>
    <LicenceNumber>PA0044/019/002</LicenceNumber>
    <ProductName>CLINIMYCIN</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/019/003</DrugIDPK>
    <LicenceNumber>PA0044/019/003</LicenceNumber>
    <ProductName>CLINIMYCIN SYRUP</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYTETRACYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0980/001/002</DrugIDPK>
    <LicenceNumber>PA0980/001/002</LicenceNumber>
    <ProductName>CLINITAR</ProductName>
    <PAHolder>Cambridge Healthcare Supplies Limited</PAHolder>
    <AuthorisedDate>07/07/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR EXTRACT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/07/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0980/001/001</DrugIDPK>
    <LicenceNumber>PA0980/001/001</LicenceNumber>
    <ProductName>CLINITAR</ProductName>
    <PAHolder>Cambridge Healthcare Supplies Limited</PAHolder>
    <AuthorisedDate>07/07/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR EXTRACT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/07/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/141/001</DrugIDPK>
    <LicenceNumber>PA0167/141/001</LicenceNumber>
    <ProductName>ClinOleic 20%, emulsion for infusion</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>09/01/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Refined olive oil</ActiveSubstance>
      <ActiveSubstance>SOYA BEAN OIL, REFINED PH. EUR.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/05/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/141/002</DrugIDPK>
    <LicenceNumber>PA0167/141/002</LicenceNumber>
    <ProductName>ClinOleicÂ 20%, emulsion for infusion</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>25/10/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Refined olive oil</ActiveSubstance>
      <ActiveSubstance>SOYA BEAN OIL, REFINED PH. EUR.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/05/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/100/001</DrugIDPK>
    <LicenceNumber>PA0167/100/001</LicenceNumber>
    <ProductName>Clinomel N4-550</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>L-alanine</ActiveSubstance>
      <ActiveSubstance>L-arginine</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
      <ActiveSubstance>L-histidine</ActiveSubstance>
      <ActiveSubstance>L-isoleucine</ActiveSubstance>
      <ActiveSubstance>L-lysine hydrochloride</ActiveSubstance>
      <ActiveSubstance>L-methionine</ActiveSubstance>
      <ActiveSubstance>L-phenylalanine</ActiveSubstance>
      <ActiveSubstance>L-proline</ActiveSubstance>
      <ActiveSubstance>L-serine</ActiveSubstance>
      <ActiveSubstance>L-threonine</ActiveSubstance>
      <ActiveSubstance>L-tryptophan</ActiveSubstance>
      <ActiveSubstance>L-tyrosine</ActiveSubstance>
      <ActiveSubstance>L-valine</ActiveSubstance>
      <ActiveSubstance>Sodium acetate trihydrate </ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Soybean oil</ActiveSubstance>
      <ActiveSubstance>L-leucine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/10/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/100/002</DrugIDPK>
    <LicenceNumber>PA0167/100/002</LicenceNumber>
    <ProductName>Clinomel N5-800</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>L-alanine</ActiveSubstance>
      <ActiveSubstance>L-arginine</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
      <ActiveSubstance>L-histidine</ActiveSubstance>
      <ActiveSubstance>L-isoleucine</ActiveSubstance>
      <ActiveSubstance>L-lysine hydrochloride</ActiveSubstance>
      <ActiveSubstance>L-methionine</ActiveSubstance>
      <ActiveSubstance>L-phenylalanine</ActiveSubstance>
      <ActiveSubstance>L-proline</ActiveSubstance>
      <ActiveSubstance>L-serine</ActiveSubstance>
      <ActiveSubstance>L-threonine</ActiveSubstance>
      <ActiveSubstance>L-tryptophan</ActiveSubstance>
      <ActiveSubstance>L-tyrosine</ActiveSubstance>
      <ActiveSubstance>L-valine</ActiveSubstance>
      <ActiveSubstance>Sodium acetate trihydrate </ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Soybean oil</ActiveSubstance>
      <ActiveSubstance>L-leucine</ActiveSubstance>
      <ActiveSubstance>Dipotassium phosphate </ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/10/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/100/003</DrugIDPK>
    <LicenceNumber>PA0167/100/003</LicenceNumber>
    <ProductName>Clinomel N6-900</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>L-alanine</ActiveSubstance>
      <ActiveSubstance>L-arginine</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
      <ActiveSubstance>L-histidine</ActiveSubstance>
      <ActiveSubstance>L-isoleucine</ActiveSubstance>
      <ActiveSubstance>L-lysine hydrochloride</ActiveSubstance>
      <ActiveSubstance>L-methionine</ActiveSubstance>
      <ActiveSubstance>L-phenylalanine</ActiveSubstance>
      <ActiveSubstance>L-proline</ActiveSubstance>
      <ActiveSubstance>L-serine</ActiveSubstance>
      <ActiveSubstance>L-threonine</ActiveSubstance>
      <ActiveSubstance>L-tryptophan</ActiveSubstance>
      <ActiveSubstance>L-tyrosine</ActiveSubstance>
      <ActiveSubstance>L-valine</ActiveSubstance>
      <ActiveSubstance>Sodium acetate trihydrate </ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Soybean oil</ActiveSubstance>
      <ActiveSubstance>L-leucine</ActiveSubstance>
      <ActiveSubstance>Dipotassium phosphate </ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/10/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/100/004</DrugIDPK>
    <LicenceNumber>PA0167/100/004</LicenceNumber>
    <ProductName>Clinomel N7-1000</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>L-alanine</ActiveSubstance>
      <ActiveSubstance>L-arginine</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
      <ActiveSubstance>L-histidine</ActiveSubstance>
      <ActiveSubstance>L-isoleucine</ActiveSubstance>
      <ActiveSubstance>L-lysine hydrochloride</ActiveSubstance>
      <ActiveSubstance>L-methionine</ActiveSubstance>
      <ActiveSubstance>L-phenylalanine</ActiveSubstance>
      <ActiveSubstance>L-proline</ActiveSubstance>
      <ActiveSubstance>L-serine</ActiveSubstance>
      <ActiveSubstance>L-threonine</ActiveSubstance>
      <ActiveSubstance>L-tryptophan</ActiveSubstance>
      <ActiveSubstance>L-tyrosine</ActiveSubstance>
      <ActiveSubstance>L-valine</ActiveSubstance>
      <ActiveSubstance>Sodium acetate trihydrate </ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Soybean oil</ActiveSubstance>
      <ActiveSubstance>L-leucine</ActiveSubstance>
      <ActiveSubstance>Dipotassium phosphate </ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/10/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/004/001</DrugIDPK>
    <LicenceNumber>PA0035/004/001</LicenceNumber>
    <ProductName>CLINORIL</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>29/09/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sulindac</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/004/002</DrugIDPK>
    <LicenceNumber>PA0035/004/002</LicenceNumber>
    <ProductName>CLINORIL</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>29/09/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sulindac</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/004/004</DrugIDPK>
    <LicenceNumber>PA0035/004/004</LicenceNumber>
    <ProductName>CLINORIL</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>14/04/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULINDAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/02/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0301/006/001</DrugIDPK>
    <LicenceNumber>PA0301/006/001</LicenceNumber>
    <ProductName>CLIOTOPIC H CREAM</ProductName>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>19/02/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/05/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0769/014/001</DrugIDPK>
    <LicenceNumber>PA0769/014/001</LicenceNumber>
    <ProductName>CLIVARINE</ProductName>
    <PAHolder>Knoll Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Reviparin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/01/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/057/002</DrugIDPK>
    <LicenceNumber>PA1986/057/002</LicenceNumber>
    <ProductName>ClobaDerm 0.5 mg/g Ointment</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>20/07/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clobetasol propionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/03/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/057/001</DrugIDPK>
    <LicenceNumber>PA1986/057/001</LicenceNumber>
    <ProductName>ClobaDerm 0.5mg/g Cream</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>20/07/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clobetasol propionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/03/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1352/019/002</DrugIDPK>
    <LicenceNumber>PA1352/019/002</LicenceNumber>
    <ProductName>Clobavate</ProductName>
    <PAHolder>Auden Mckenzie (Pharma Division) Ltd</PAHolder>
    <AuthorisedDate>18/01/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOBETASONE BUTYRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/04/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/234/001</DrugIDPK>
    <LicenceNumber>PA2315/234/001</LicenceNumber>
    <ProductName>Clofarabine 1 mg/ml concentrate for solution for infusion</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>31/01/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clofarabine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex 1: Summary of Product Characteristics)</SupplyComments>
    <WithdrawalDate>10/04/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1473/026/001</DrugIDPK>
    <LicenceNumber>DPR1473/026/001</LicenceNumber>
    <ProductName>Clomid</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>21/04/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clomiphene citrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0515/002/001</DrugIDPK>
    <LicenceNumber>PA0515/002/001</LicenceNumber>
    <ProductName>CLOMIPHENE CITRATE</ProductName>
    <PAHolder>Hogens Limited</PAHolder>
    <AuthorisedDate>04/07/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/02/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/024/001</DrugIDPK>
    <LicenceNumber>PA0126/024/001</LicenceNumber>
    <ProductName>CLONALIN</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/031/003</DrugIDPK>
    <LicenceNumber>PA0126/031/003</LicenceNumber>
    <ProductName>Clonamox 125 mg/5 ml Powder for Oral Suspension</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>23/06/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/05/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/031/004</DrugIDPK>
    <LicenceNumber>PA0126/031/004</LicenceNumber>
    <ProductName>Clonamox 250 mg/5 ml Powder for Oral Suspension</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>14/05/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/05/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/031/001</DrugIDPK>
    <LicenceNumber>PA0126/031/001</LicenceNumber>
    <ProductName>Clonamox 250 mg Hard Capsules</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>14/02/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/05/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/031/002</DrugIDPK>
    <LicenceNumber>PA0126/031/002</LicenceNumber>
    <ProductName>Clonamox 500 mg Hard Capsules</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>14/02/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/05/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/015/001</DrugIDPK>
    <LicenceNumber>PA0126/015/001</LicenceNumber>
    <ProductName>Clonamp</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>02/07/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ampicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/01/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/015/002</DrugIDPK>
    <LicenceNumber>PA0126/015/002</LicenceNumber>
    <ProductName>Clonamp</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>02/07/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ampicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/015/003</DrugIDPK>
    <LicenceNumber>PA0126/015/003</LicenceNumber>
    <ProductName>Clonamp</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>02/07/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ampicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/015/004</DrugIDPK>
    <LicenceNumber>PA0126/015/004</LicenceNumber>
    <ProductName>Clonamp</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>02/07/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ampicillin trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22741/007/002</DrugIDPK>
    <LicenceNumber>PA22741/007/002</LicenceNumber>
    <ProductName>Clonazepam Rosemont 2 mg/5 ml oral solution</ProductName>
    <PAHolder>Perrigo Pharma International Designated Activity Company</PAHolder>
    <AuthorisedDate>24/02/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clonazepam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/093/001</DrugIDPK>
    <LicenceNumber>PA0126/093/001</LicenceNumber>
    <ProductName>CLONDEPRYL</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>19/01/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SELEGILINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/12/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/058/001</DrugIDPK>
    <LicenceNumber>PA1986/058/001</LicenceNumber>
    <ProductName>Clonidine Hydrochloride 25 microgram Tablets</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>12/12/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clonidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/03/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/087/001</DrugIDPK>
    <LicenceNumber>PA0126/087/001</LicenceNumber>
    <ProductName>CLONIFED SR</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>17/10/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/088/001</DrugIDPK>
    <LicenceNumber>PA0126/088/001</LicenceNumber>
    <ProductName>CLONILIX</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>14/04/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>INDAPAMIDE HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/12/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/136/003</DrugIDPK>
    <LicenceNumber>PA0126/136/003</LicenceNumber>
    <ProductName>Clonocid</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>15/04/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/04/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/136/004</DrugIDPK>
    <LicenceNumber>PA0126/136/004</LicenceNumber>
    <ProductName>Clonocid</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>15/04/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/04/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/072/001</DrugIDPK>
    <LicenceNumber>PA0126/072/001</LicenceNumber>
    <ProductName>CLONOFILIN SR</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>05/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMINOPHYLLINE HYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/04/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/091/004</DrugIDPK>
    <LicenceNumber>PA0126/091/004</LicenceNumber>
    <ProductName>CLONORAX COLD SORE</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>12/07/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACICLOVIR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/092/002</DrugIDPK>
    <LicenceNumber>PA0126/092/002</LicenceNumber>
    <ProductName>CLONOXIFEN</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>10/10/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/092/001</DrugIDPK>
    <LicenceNumber>PA0126/092/001</LicenceNumber>
    <ProductName>CLONOXIFEN</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>10/10/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TAMOXIFEN CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0732/001/001</DrugIDPK>
    <LicenceNumber>PA0732/001/001</LicenceNumber>
    <ProductName>CLONTERIC</ProductName>
    <PAHolder>Dallas Burston Healthcare Ltd</PAHolder>
    <AuthorisedDate>30/04/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/061/001</DrugIDPK>
    <LicenceNumber>PA0126/061/001</LicenceNumber>
    <ProductName>CLONURETIC</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>13/10/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/10/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/157/001</DrugIDPK>
    <LicenceNumber>PA0577/157/001</LicenceNumber>
    <ProductName>Clopidogrel</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>23/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel hydrobromide monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/12/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/060/001</DrugIDPK>
    <LicenceNumber>PA0822/060/001</LicenceNumber>
    <ProductName>Clopidogrel</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>20/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/026/001</DrugIDPK>
    <LicenceNumber>PA1339/026/001</LicenceNumber>
    <ProductName>Clopidogrel</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>04/02/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/02/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/14/942/001-005</DrugIDPK>
    <LicenceNumber>EU/1/14/942/001-005</LicenceNumber>
    <ProductName>Clopidogrel/Acetylsalicylic acid Teva</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>01/09/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel hydrogensulfate</ActiveSubstance>
      <ActiveSubstance>Acetylsalicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/06/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/14/942/006-014</DrugIDPK>
    <LicenceNumber>EU/1/14/942/006-014</LicenceNumber>
    <ProductName>Clopidogrel/Acetylsalicylic acid Teva</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>01/09/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel hydrogensulfate</ActiveSubstance>
      <ActiveSubstance>Acetylsalicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/06/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/09/542/1-7</DrugIDPK>
    <LicenceNumber>EU/1/09/542/1-7</LicenceNumber>
    <ProductName>Clopidogrel 1A Pharma</ProductName>
    <PAHolder>Acino Pharma GmbH</PAHolder>
    <AuthorisedDate>28/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel besilate</ActiveSubstance>
      <ActiveSubstance>Macrogol 6000</ActiveSubstance>
      <ActiveSubstance>Carbon dioxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/01/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/054/001</DrugIDPK>
    <LicenceNumber>PA2315/054/001</LicenceNumber>
    <InterchangeableListCode>IC0005-028-003</InterchangeableListCode>
    <ProductName>Clopidogrel 75 mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>27/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1473/053/001</DrugIDPK>
    <LicenceNumber>PPA1473/053/001</LicenceNumber>
    <ProductName>Clopidogrel 75 mg Film-Coated Tablets</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>09/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/03/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/09/532/1-7</DrugIDPK>
    <LicenceNumber>EU/1/09/532/1-7</LicenceNumber>
    <ProductName>Clopidogrel Acino</ProductName>
    <PAHolder>Luye Pharma AG</PAHolder>
    <AuthorisedDate>28/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel besilate</ActiveSubstance>
      <ActiveSubstance>Macrogol 6000</ActiveSubstance>
      <ActiveSubstance>Carbon dioxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/01/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/09/549/1-7</DrugIDPK>
    <LicenceNumber>EU/1/09/549/1-7</LicenceNumber>
    <ProductName>Clopidogrel Acino Pharma</ProductName>
    <PAHolder>Acino Pharma GmbH</PAHolder>
    <AuthorisedDate>28/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel besilate</ActiveSubstance>
      <ActiveSubstance>Macrogol 6000</ActiveSubstance>
      <ActiveSubstance>Carbon dioxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/01/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/09/548/1-7</DrugIDPK>
    <LicenceNumber>EU/1/09/548/1-7</LicenceNumber>
    <ProductName>Clopidogrel Acino Pharma GmbH</ProductName>
    <PAHolder>Acino Pharma GmbH</PAHolder>
    <AuthorisedDate>21/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel besilate</ActiveSubstance>
      <ActiveSubstance>Macrogol 6000</ActiveSubstance>
      <ActiveSubstance>Carbon dioxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/01/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1436/026/001</DrugIDPK>
    <LicenceNumber>PA1436/026/001</LicenceNumber>
    <InterchangeableListCode>IC0005-028-003</InterchangeableListCode>
    <ProductName>Clopidogrel Bluefish 75 mg Film-coated Tablets</ProductName>
    <PAHolder>Bluefish Pharmaceuticals AB</PAHolder>
    <AuthorisedDate>09/04/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/05/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/08/464/15-17</DrugIDPK>
    <LicenceNumber>EU/1/08/464/15-17</LicenceNumber>
    <ProductName>Clopidogrel BMS 300 mg film-coated tablets</ProductName>
    <PAHolder>Bristol-Myers Squibb/AstraZeneca EEIG</PAHolder>
    <AuthorisedDate>16/07/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Not applicable</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Not applicable</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/01/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/08/464/1-14, 18-19</DrugIDPK>
    <LicenceNumber>EU/1/08/464/1-14, 18-19</LicenceNumber>
    <ProductName>Clopidogrel BMS 75 mg film-coated tablets</ProductName>
    <PAHolder>Bristol-Myers Squibb/AstraZeneca EEIG</PAHolder>
    <AuthorisedDate>16/07/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel hydrogensulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Not applicable</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Not applicable</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/01/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/204/001</DrugIDPK>
    <LicenceNumber>PA0126/204/001</LicenceNumber>
    <ProductName>Clopidogrel Clonmel</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>04/02/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/11/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/09/560/001-9</DrugIDPK>
    <LicenceNumber>EU/1/09/560/001-9</LicenceNumber>
    <ProductName>Clopidogrel Dura</ProductName>
    <PAHolder>Mylan dura GmbH</PAHolder>
    <AuthorisedDate>21/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/05/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1505/002/001</DrugIDPK>
    <LicenceNumber>PA1505/002/001</LicenceNumber>
    <ProductName>Clopidogrel ESP Pharma</ProductName>
    <PAHolder>ESP Pharma Limited</PAHolder>
    <AuthorisedDate>19/03/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/11/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/10/651/001-015</DrugIDPK>
    <LicenceNumber>EU/1/10/651/001-015</LicenceNumber>
    <ProductName>Clopidogrel HCS</ProductName>
    <PAHolder>HCS bvba</PAHolder>
    <AuthorisedDate>28/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/06/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/09/534/1-7</DrugIDPK>
    <LicenceNumber>EU/1/09/534/1-7</LicenceNumber>
    <ProductName>Clopidogrel Hexal</ProductName>
    <PAHolder>Acino Pharma GmbH</PAHolder>
    <AuthorisedDate>28/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/01/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/039/001</DrugIDPK>
    <LicenceNumber>PA1063/039/001</LicenceNumber>
    <ProductName>Clopidogrel Niche</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>19/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1369/005/001</DrugIDPK>
    <LicenceNumber>PA1369/005/001</LicenceNumber>
    <ProductName>Clopidogrel Nucleus</ProductName>
    <PAHolder>Nucleus ehf.</PAHolder>
    <AuthorisedDate>23/04/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1647/004/001</DrugIDPK>
    <LicenceNumber>PA1647/004/001</LicenceNumber>
    <ProductName>Clopidogrel Pensa</ProductName>
    <PAHolder>Pensa Pharma AB</PAHolder>
    <AuthorisedDate>26/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/09/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/09/557/1-9</DrugIDPK>
    <LicenceNumber>EU/1/09/557/1-9</LicenceNumber>
    <ProductName>Clopidogrel Qualimed</ProductName>
    <PAHolder>Qualimed</PAHolder>
    <AuthorisedDate>23/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/09/554/1-6</DrugIDPK>
    <LicenceNumber>EU/1/09/554/1-6</LicenceNumber>
    <ProductName>CLOPIDOGREL RATIOPHARM</ProductName>
    <PAHolder>Archie Samuel s.r.o.</PAHolder>
    <AuthorisedDate>23/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL BESILATE</ActiveSubstance>
      <ActiveSubstance>MACROGOL 6000</ActiveSubstance>
      <ActiveSubstance>CARBON DIOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/11/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/09/554/007</DrugIDPK>
    <LicenceNumber>EU/1/09/554/007</LicenceNumber>
    <ProductName>CLOPIDOGREL RATIOPHARM</ProductName>
    <PAHolder>Archie Samuel s.r.o.</PAHolder>
    <AuthorisedDate>23/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL BESILATE</ActiveSubstance>
      <ActiveSubstance>MACROGOL 6000</ActiveSubstance>
      <ActiveSubstance>CARBON DIOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/11/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/09/554/002</DrugIDPK>
    <LicenceNumber>EU/1/09/554/002</LicenceNumber>
    <ProductName>CLOPIDOGREL RATIOPHARM</ProductName>
    <PAHolder>Archie Samuel s.r.o.</PAHolder>
    <AuthorisedDate>23/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film Coated Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPIDOGREL BESILATE</ActiveSubstance>
      <ActiveSubstance>MACROGOL 6000</ActiveSubstance>
      <ActiveSubstance>CARBON DIOXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/11/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/09/541/1-8</DrugIDPK>
    <LicenceNumber>EU/1/09/541/1-8</LicenceNumber>
    <InterchangeableListCode>IC0005-028-003</InterchangeableListCode>
    <ProductName>Clopidogrel ratiopharm GmbH</ProductName>
    <PAHolder>Archie Samuel s.r.o.</PAHolder>
    <AuthorisedDate>28/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel besilate</ActiveSubstance>
      <ActiveSubstance>Macrogol 6000</ActiveSubstance>
      <ActiveSubstance>Carbon dioxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/01/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/167/001</DrugIDPK>
    <LicenceNumber>PA0711/167/001</LicenceNumber>
    <ProductName>Clopidogrel Rowex</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>09/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/09/547/1-7</DrugIDPK>
    <LicenceNumber>EU/1/09/547/1-7</LicenceNumber>
    <ProductName>Clopidogrel Sandoz</ProductName>
    <PAHolder>Acino Pharma GmbH</PAHolder>
    <AuthorisedDate>21/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel besilate</ActiveSubstance>
      <ActiveSubstance>Macrogol 6000</ActiveSubstance>
      <ActiveSubstance>Carbon dioxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/01/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/10/650/001-015</DrugIDPK>
    <LicenceNumber>EU/1/10/650/001-015</LicenceNumber>
    <ProductName>Clopidogrel Teva Generics B.V.</ProductName>
    <PAHolder>Teva Generics B.V.</PAHolder>
    <AuthorisedDate>28/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/09/561/001-9</DrugIDPK>
    <LicenceNumber>EU/1/09/561/001-9</LicenceNumber>
    <ProductName>Clopidogrel Teva Pharma</ProductName>
    <PAHolder>HCS bvba</PAHolder>
    <AuthorisedDate>21/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/06/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/10/649/001-016</DrugIDPK>
    <LicenceNumber>EU/1/10/649/001-016</LicenceNumber>
    <ProductName>Clopidogrel Teva Pharma B.V.</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>16/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/10/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1772/001/001</DrugIDPK>
    <LicenceNumber>PA1772/001/001</LicenceNumber>
    <ProductName>Clopidogrel-Splendris 75mg Film-coated Tablets</ProductName>
    <PAHolder>Splendris Pharmaceuticals GmbH</PAHolder>
    <AuthorisedDate>18/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel hydrogensulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/05/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0115/005/006</DrugIDPK>
    <LicenceNumber>PA0115/005/006</LicenceNumber>
    <ProductName>CLOPIXOL</ProductName>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>01/11/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Zuclopenthixol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>ZZZ Not applicable</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0115/005/004</DrugIDPK>
    <LicenceNumber>PA0115/005/004</LicenceNumber>
    <ProductName>Clopixol 25mg Film-coated Tablets</ProductName>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>01/11/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Zuclopenthixol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/06/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0115/005/010</DrugIDPK>
    <LicenceNumber>PA0115/005/010</LicenceNumber>
    <ProductName>Clopixol Acuphase 100 mg/2ml Solution for Injectio</ProductName>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>18/10/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Zuclopenthixol acetate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0115/005/009</DrugIDPK>
    <LicenceNumber>PA0115/005/009</LicenceNumber>
    <ProductName>Clopixol Acuphase 50 mg/ml Solution for Injection</ProductName>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>18/10/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Zuclopenthixol acetate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0115/005/005</DrugIDPK>
    <LicenceNumber>PA0115/005/005</LicenceNumber>
    <ProductName>CLOPIXOL INJECTION</ProductName>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>18/05/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOPENTHIXOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/119/001</DrugIDPK>
    <LicenceNumber>PPA1151/119/001</LicenceNumber>
    <ProductName>Clorom</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>25/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/12/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/061/003</DrugIDPK>
    <LicenceNumber>PA0711/061/003</LicenceNumber>
    <ProductName>Clorom 125 mg/5 ml granules for oral suspension</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>13/04/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/04/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/061/004</DrugIDPK>
    <LicenceNumber>PA0711/061/004</LicenceNumber>
    <ProductName>Clorom 250 mg/5 ml granules for oral suspension</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>13/04/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clarithromycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/04/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/009/002</DrugIDPK>
    <LicenceNumber>PA0405/009/002</LicenceNumber>
    <ProductName>CLOXACILLIN</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>06/09/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOXACILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/009/001</DrugIDPK>
    <LicenceNumber>PA0405/009/001</LicenceNumber>
    <ProductName>CLOXACILLIN</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>06/09/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOXACILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/040/003</DrugIDPK>
    <LicenceNumber>PA0282/040/003</LicenceNumber>
    <ProductName>CLOXACILLIN</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>08/10/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/040/002</DrugIDPK>
    <LicenceNumber>PA0282/040/002</LicenceNumber>
    <ProductName>CLOXACILLIN</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>08/10/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/040/001</DrugIDPK>
    <LicenceNumber>PA0282/040/001</LicenceNumber>
    <ProductName>CLOXACILLIN</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>08/10/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLOXACILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/064/001</DrugIDPK>
    <LicenceNumber>PA0126/064/001</LicenceNumber>
    <ProductName>CLOXCIL 250</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>19/04/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/064/002</DrugIDPK>
    <LicenceNumber>PA0126/064/002</LicenceNumber>
    <ProductName>CLOXCIL 500</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>19/04/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/125/003</DrugIDPK>
    <LicenceNumber>PA0711/125/003</LicenceNumber>
    <ProductName>Clozalux 100 mg tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>14/09/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clozapine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Clozapine must be dispensed under strict medical supervision in accordance with official recommendations (see SmPC).  


A monitoring service has been established by the Marketing Authorisation Holder (MAH) to manage the risk of agranulocytosis associat</SupplyComments>
    <WithdrawalDate>04/02/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/125/001</DrugIDPK>
    <LicenceNumber>PA0711/125/001</LicenceNumber>
    <ProductName>Clozalux 25 mg tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>14/09/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clozapine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Clozapine must be dispensed under strict medical supervision in accordance with official recommendations (see SmPC).  


A monitoring service has been established by the Marketing Authorisation Holder (MAH) to manage the risk of agranulocytosis associat</SupplyComments>
    <WithdrawalDate>04/02/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/125/002</DrugIDPK>
    <LicenceNumber>PA0711/125/002</LicenceNumber>
    <ProductName>Clozalux 50 mg tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>14/09/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clozapine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Clozapine must be dispensed under strict medical supervision in accordance with official recommendations (see SmPC).      


A monitoring service has been established by the Marketing Authorisation Holder (MAH) to manage the risk of agranulocytosis asso</SupplyComments>
    <WithdrawalDate>04/02/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0715/001/001</DrugIDPK>
    <LicenceNumber>PA0715/001/001</LicenceNumber>
    <ProductName>CMW 1 - G GENTAMICIN BONE CEMENT</ProductName>
    <PAHolder>DePuy International Ltd</PAHolder>
    <AuthorisedDate>14/06/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0715/001/002</DrugIDPK>
    <LicenceNumber>PA0715/001/002</LicenceNumber>
    <ProductName>CMW 3 - G GENTAMICIN BONE CEMENT</ProductName>
    <PAHolder>DePuy International Ltd</PAHolder>
    <AuthorisedDate>14/06/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/029/002</DrugIDPK>
    <LicenceNumber>PA0006/029/002</LicenceNumber>
    <ProductName>CO TRIMOXAZOLE</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>08/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/02/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/103/006</DrugIDPK>
    <LicenceNumber>PA0126/103/006</LicenceNumber>
    <ProductName>Co-Amoxiclav</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>10/09/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/08/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0074/001/001</DrugIDPK>
    <LicenceNumber>PPA0074/001/001</LicenceNumber>
    <ProductName>Co-Amoxiclav</ProductName>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>25/10/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/10/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/021/004</DrugIDPK>
    <LicenceNumber>PA1077/021/004</LicenceNumber>
    <ProductName>CO-AMOXICLAV</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>17/09/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/12/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1457/001/002</DrugIDPK>
    <LicenceNumber>PA1457/001/002</LicenceNumber>
    <ProductName>Co-Amoxiclav 1000 mg/200 mg Powder for Solution for Injection and Infusion</ProductName>
    <PAHolder>Fannin Limited</PAHolder>
    <AuthorisedDate>19/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin sodium</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/226/002</DrugIDPK>
    <LicenceNumber>PA0281/226/002</LicenceNumber>
    <ProductName>Co-amoxiclav 1000mg/200mg Powder for Solution for Injection or Infusion</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>03/12/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/11/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1217/007/001</DrugIDPK>
    <LicenceNumber>PA1217/007/001</LicenceNumber>
    <InterchangeableListCode>IC0037-074-003</InterchangeableListCode>
    <ProductName>Co-Amoxiclav 250 mg/125 mg film-coated tablets</ProductName>
    <PAHolder>Hikma Farmacêutica (Portugal) S.A.</PAHolder>
    <AuthorisedDate>23/09/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/09/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/001/001</DrugIDPK>
    <LicenceNumber>PA2315/001/001</LicenceNumber>
    <InterchangeableListCode>IC0037-073-003</InterchangeableListCode>
    <ProductName>Co-amoxiclav 500 mg/125 mg, film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>27/09/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
      <ActiveSubstance>Potassium clavulanate &amp; avicel (1:1) ph. eur. equivalent to clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/07/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1457/001/001</DrugIDPK>
    <LicenceNumber>PA1457/001/001</LicenceNumber>
    <ProductName>Co-Amoxiclav 500mg/100mg Powder for Solution for Injection and Infusion</ProductName>
    <PAHolder>Fannin Limited</PAHolder>
    <AuthorisedDate>19/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin sodium</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/226/001</DrugIDPK>
    <LicenceNumber>PA0281/226/001</LicenceNumber>
    <ProductName>Co-amoxiclav 500mg/100mg Powder for Solution for Injection or Infusion</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>03/12/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin</ActiveSubstance>
      <ActiveSubstance>Clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/11/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/001/002</DrugIDPK>
    <LicenceNumber>PA2315/001/002</LicenceNumber>
    <InterchangeableListCode>IC0037-072-003</InterchangeableListCode>
    <ProductName>Co-amoxiclav 875 mg/125 mg, film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>27/09/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>Potassium clavulanate &amp; avicel (1:1) ph. eur. equivalent to clavulanic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/07/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1311/016/001</DrugIDPK>
    <LicenceNumber>PA1311/016/001</LicenceNumber>
    <InterchangeableListCode>IC0037-073-014</InterchangeableListCode>
    <ProductName>Co-Amoxiclav Aurobindo</ProductName>
    <PAHolder>Aurobindo Pharma Limited</PAHolder>
    <AuthorisedDate>27/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>Potassium clavulanate, diluted (with microcrystalline cellulose in a ratio of 1:1)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/07/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1311/016/002</DrugIDPK>
    <LicenceNumber>PA1311/016/002</LicenceNumber>
    <ProductName>Co-Amoxiclav Aurobindo</ProductName>
    <PAHolder>Aurobindo Pharma Limited</PAHolder>
    <AuthorisedDate>27/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>Potassium clavulanate, diluted (with microcrystalline cellulose in a ratio of 1:1)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/07/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/022/002</DrugIDPK>
    <LicenceNumber>PA1077/022/002</LicenceNumber>
    <ProductName>Co-Amoxiclav Duo 400 mg/57 mg per 5 ml Powder fo</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>20/04/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>CLAVULANATE POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/12/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/022/003</DrugIDPK>
    <LicenceNumber>PA1077/022/003</LicenceNumber>
    <ProductName>Co-Amoxiclav Duo 500 mg/125 mg Film-coated Table</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>20/04/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/12/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/022/001</DrugIDPK>
    <LicenceNumber>PA1077/022/001</LicenceNumber>
    <ProductName>CO-AMOXICLAV DUO SACHETS</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/07/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/021/002</DrugIDPK>
    <LicenceNumber>PA1077/021/002</LicenceNumber>
    <ProductName>CO-AMOXICLAV JUNIOR SUSPENSION</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>17/09/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/12/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/021/001</DrugIDPK>
    <LicenceNumber>PA1077/021/001</LicenceNumber>
    <ProductName>CO-AMOXICLAV PAEDIATRIC</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>17/09/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/12/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/021/003</DrugIDPK>
    <LicenceNumber>PA1077/021/003</LicenceNumber>
    <ProductName>CO-AMOXICLAV PAEDIATRIC SACHET</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxycillin trihydrate</ActiveSubstance>
      <ActiveSubstance>potassium clavulanate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/07/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/085/001</DrugIDPK>
    <LicenceNumber>PA0822/085/001</LicenceNumber>
    <ProductName>Co-amoxiclav Pfizer</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>26/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>Potassium clavulanate, diluted (with microcrystalline cellulose in a ratio of 1:1)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/085/002</DrugIDPK>
    <LicenceNumber>PA0822/085/002</LicenceNumber>
    <ProductName>Co-amoxiclav Pfizer</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>26/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amoxicillin trihydrate</ActiveSubstance>
      <ActiveSubstance>Potassium clavulanate, diluted (with microcrystalline cellulose in a ratio of 1:1)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/021/001</DrugIDPK>
    <LicenceNumber>PA0936/021/001</LicenceNumber>
    <ProductName>CO-BETALOC</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
      <ActiveSubstance>Hydrochlorthiazidum</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0009/010/002</DrugIDPK>
    <LicenceNumber>PA0009/010/002</LicenceNumber>
    <ProductName>CO-BETALOC SA</ProductName>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>18/07/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOPROLOL TARTRATE</ActiveSubstance>
      <ActiveSubstance>HYDROCHLOROTHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/078/001</DrugIDPK>
    <LicenceNumber>PA0038/078/001</LicenceNumber>
    <ProductName>Co-Brufen</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
      <ActiveSubstance>Codeine phosphate hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/03/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1142/024/001</DrugIDPK>
    <LicenceNumber>PA1142/024/001</LicenceNumber>
    <ProductName>Co-Codamol 30mg/500mg Effervescent Tablets</ProductName>
    <PAHolder>Amdipharm Limited</PAHolder>
    <AuthorisedDate>08/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
      <ActiveSubstance>Codeine phosphate hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/12/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/046/001</DrugIDPK>
    <LicenceNumber>PA0126/046/001</LicenceNumber>
    <ProductName>CO-CODAPRIN</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>06/09/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/12/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/080/001</DrugIDPK>
    <LicenceNumber>PA0281/080/001</LicenceNumber>
    <ProductName>Co-Danthramer 25mg/200mg per 5ml Oral Suspension</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>08/12/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dantron</ActiveSubstance>
      <ActiveSubstance>Poloxamer 188</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/080/002</DrugIDPK>
    <LicenceNumber>PA0281/080/002</LicenceNumber>
    <ProductName>Co-Danthramer 75mg/1000mg per 5ml Oral Suspension</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>08/12/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dantron</ActiveSubstance>
      <ActiveSubstance>Poloxamer 188</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/173/001</DrugIDPK>
    <LicenceNumber>PPA1151/173/001</LicenceNumber>
    <ProductName>Co-Diovan</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>25/05/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/173/002</DrugIDPK>
    <LicenceNumber>PPA1151/173/002</LicenceNumber>
    <ProductName>Co-Diovan</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>25/05/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/173/003</DrugIDPK>
    <LicenceNumber>PPA1151/173/003</LicenceNumber>
    <ProductName>Co-Diovan</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>25/05/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/178/001</DrugIDPK>
    <LicenceNumber>PPA1328/178/001</LicenceNumber>
    <ProductName>Co-Diovan</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>11/01/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/178/002</DrugIDPK>
    <LicenceNumber>PPA1328/178/002</LicenceNumber>
    <ProductName>Co-Diovan</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>11/01/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/178/003</DrugIDPK>
    <LicenceNumber>PPA1328/178/003</LicenceNumber>
    <ProductName>Co-Diovan</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>11/01/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/059/001</DrugIDPK>
    <LicenceNumber>PPA1500/059/001</LicenceNumber>
    <ProductName>Co-Diovan</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>09/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/059/002</DrugIDPK>
    <LicenceNumber>PPA1500/059/002</LicenceNumber>
    <ProductName>Co-Diovan</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>09/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/059/003</DrugIDPK>
    <LicenceNumber>PPA1500/059/003</LicenceNumber>
    <ProductName>Co-Diovan</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>29/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/029/001</DrugIDPK>
    <LicenceNumber>PPA1596/029/001</LicenceNumber>
    <ProductName>Co-Diovan</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>15/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/029/002</DrugIDPK>
    <LicenceNumber>PPA1596/029/002</LicenceNumber>
    <ProductName>Co-Diovan</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>15/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/029/003</DrugIDPK>
    <LicenceNumber>PPA1596/029/003</LicenceNumber>
    <ProductName>Co-Diovan</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>15/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23176/046/001</DrugIDPK>
    <LicenceNumber>PPA23176/046/001</LicenceNumber>
    <InterchangeableListCode>IC0040-078-003</InterchangeableListCode>
    <ProductName>Co-Diovan 160 mg/25 mg film-coated tablets</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>24/06/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/025/001</DrugIDPK>
    <LicenceNumber>PA0038/025/001</LicenceNumber>
    <ProductName>CO-FRAM</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>25/08/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/118/001</DrugIDPK>
    <LicenceNumber>PA0013/118/001</LicenceNumber>
    <ProductName>Co-Tareg</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>07/10/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/118/002</DrugIDPK>
    <LicenceNumber>PA0013/118/002</LicenceNumber>
    <ProductName>Co-Tareg</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>07/10/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/118/003</DrugIDPK>
    <LicenceNumber>PA0013/118/003</LicenceNumber>
    <ProductName>Co-Tareg</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>07/10/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/118/004</DrugIDPK>
    <LicenceNumber>PA0013/118/004</LicenceNumber>
    <ProductName>Co-Tareg</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>01/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/118/005</DrugIDPK>
    <LicenceNumber>PA0013/118/005</LicenceNumber>
    <ProductName>Co-Tareg</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>01/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/030/001</DrugIDPK>
    <LicenceNumber>PA0436/030/001</LicenceNumber>
    <ProductName>Co-Tenidone BP</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>10/10/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
      <ActiveSubstance>Chlorthalidone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/03/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/030/002</DrugIDPK>
    <LicenceNumber>PA0436/030/002</LicenceNumber>
    <ProductName>Co-Tenidone BP</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>10/10/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Atenolol</ActiveSubstance>
      <ActiveSubstance>Chlorthalidone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/03/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/098/002</DrugIDPK>
    <LicenceNumber>PA0126/098/002</LicenceNumber>
    <ProductName>CO-TENOMEL</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>05/09/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/098/001</DrugIDPK>
    <LicenceNumber>PA0126/098/001</LicenceNumber>
    <ProductName>CO-TENOMEL</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>05/09/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0298/011/001</DrugIDPK>
    <LicenceNumber>PA0298/011/001</LicenceNumber>
    <ProductName>Co-Trimoxazole</ProductName>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
      <ActiveSubstance>Sulfamethoxazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0282/020/001</DrugIDPK>
    <LicenceNumber>PA0282/020/001</LicenceNumber>
    <ProductName>CO-TRIMOXAZOLE</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>01/10/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/029/004</DrugIDPK>
    <LicenceNumber>PA0006/029/004</LicenceNumber>
    <ProductName>CO-TRIMOXAZOLE</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>08/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/02/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/029/003</DrugIDPK>
    <LicenceNumber>PA0006/029/003</LicenceNumber>
    <ProductName>CO-TRIMOXAZOLE</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>08/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/02/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/021/001</DrugIDPK>
    <LicenceNumber>PA0405/021/001</LicenceNumber>
    <ProductName>CO-TRIMOXAZOLE 800/160</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>24/02/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHIZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/029/001</DrugIDPK>
    <LicenceNumber>PA0006/029/001</LicenceNumber>
    <ProductName>CO-TRIMOXAZOLE DISPERSIBLE TABLETS B.P.</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>08/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/02/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0298/011/002</DrugIDPK>
    <LicenceNumber>PA0298/011/002</LicenceNumber>
    <ProductName>Co-Trimoxazole Paediatric</ProductName>
    <PAHolder>Athlone Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not Currently Available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Trimethoprim</ActiveSubstance>
      <ActiveSubstance>Sulfamethoxazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0282/020/002</DrugIDPK>
    <LicenceNumber>PA0282/020/002</LicenceNumber>
    <ProductName>CO-TRIMOXAZOLE PAEDIATRIC B.P.C.</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>10/01/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/090/001</DrugIDPK>
    <LicenceNumber>PA0050/090/001</LicenceNumber>
    <ProductName>CO-VASCACE</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>15/02/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CILAZAPRIL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/10/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/182/004</DrugIDPK>
    <LicenceNumber>PA0711/182/004</LicenceNumber>
    <ProductName>Co-Vatan 320 mg/12.5 mg Film-coated Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/10/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/182/005</DrugIDPK>
    <LicenceNumber>PA0711/182/005</LicenceNumber>
    <ProductName>Co-Vatan 320 mg/25 mg Film-coated Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
      <ActiveSubstance>Valsartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/10/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0484/019/001</DrugIDPK>
    <LicenceNumber>PA0484/019/001</LicenceNumber>
    <ProductName>COAL TAR OINTMENT</ProductName>
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>29/01/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR SOLUTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/98/086/002</DrugIDPK>
    <LicenceNumber>EU/1/98/086/002</LicenceNumber>
    <ProductName>CoAprovel</ProductName>
    <PAHolder>Sanofi Winthrop Industrie</PAHolder>
    <AuthorisedDate>15/10/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Irbesartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/98/086/003</DrugIDPK>
    <LicenceNumber>EU/1/98/086/003</LicenceNumber>
    <ProductName>CoAprovel</ProductName>
    <PAHolder>Sanofi Winthrop Industrie</PAHolder>
    <AuthorisedDate>15/10/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Irbesartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/98/086/005</DrugIDPK>
    <LicenceNumber>EU/1/98/086/005</LicenceNumber>
    <ProductName>CoAprovel</ProductName>
    <PAHolder>Sanofi Winthrop Industrie</PAHolder>
    <AuthorisedDate>15/10/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Irbesartan</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0176/030/002</DrugIDPK>
    <LicenceNumber>PA0176/030/002</LicenceNumber>
    <ProductName>COBADEX</ProductName>
    <PAHolder>Accord-UK Ltd</PAHolder>
    <AuthorisedDate>05/06/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/04/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0176/030/001</DrugIDPK>
    <LicenceNumber>PA0176/030/001</LicenceNumber>
    <ProductName>COBADEX</ProductName>
    <PAHolder>Accord-UK Ltd</PAHolder>
    <AuthorisedDate>05/06/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/04/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0176/016/003</DrugIDPK>
    <LicenceNumber>PA0176/016/003</LicenceNumber>
    <ProductName>COBUTOLIN</ProductName>
    <PAHolder>Accord-UK Ltd</PAHolder>
    <AuthorisedDate>21/01/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/11/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0176/016/002</DrugIDPK>
    <LicenceNumber>PA0176/016/002</LicenceNumber>
    <ProductName>COBUTOLIN</ProductName>
    <PAHolder>Accord-UK Ltd</PAHolder>
    <AuthorisedDate>21/01/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/11/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0176/016/004</DrugIDPK>
    <LicenceNumber>PA0176/016/004</LicenceNumber>
    <ProductName>COBUTOLIN INHALER</ProductName>
    <PAHolder>Accord-UK Ltd</PAHolder>
    <AuthorisedDate>21/01/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/11/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR0407/050/001</DrugIDPK>
    <LicenceNumber>HOR0407/050/001</LicenceNumber>
    <ProductName>Cocculus Tablets</ProductName>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>28/09/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anamirta cocculus fruct.sic.</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0913/009/001</DrugIDPK>
    <LicenceNumber>PA0913/009/001</LicenceNumber>
    <ProductName>CODAFEN CONTINUS</ProductName>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
      <ActiveSubstance>Codeine phosphate hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1688/003/001</DrugIDPK>
    <LicenceNumber>PA1688/003/001</LicenceNumber>
    <ProductName>Codalax</ProductName>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>20/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Danthron</ActiveSubstance>
      <ActiveSubstance>Poloxamer 188</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/08/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1688/003/003</DrugIDPK>
    <LicenceNumber>PA1688/003/003</LicenceNumber>
    <ProductName>Codalax</ProductName>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>07/01/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Danthron</ActiveSubstance>
      <ActiveSubstance>Poloxamer 188</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1688/003/002</DrugIDPK>
    <LicenceNumber>PA1688/003/002</LicenceNumber>
    <ProductName>Codalax Forte</ProductName>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>20/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Danthron</ActiveSubstance>
      <ActiveSubstance>Poloxamer 188</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/08/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1688/003/004</DrugIDPK>
    <LicenceNumber>PA1688/003/004</LicenceNumber>
    <ProductName>Codalax Forte 1000mg/75mg per 5ml suspension</ProductName>
    <PAHolder>Mundipharma Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>07/01/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Danthron</ActiveSubstance>
      <ActiveSubstance>Poloxamer 188</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0959/003/001</DrugIDPK>
    <LicenceNumber>PA0959/003/001</LicenceNumber>
    <ProductName>Codalux 50 microgram/ml + 5 mg/ml Eye Drops, Solution</ProductName>
    <PAHolder>Aziende Chimiche Riunite Angelini Francesco</PAHolder>
    <AuthorisedDate>27/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Latanoprost</ActiveSubstance>
      <ActiveSubstance>Timolol Maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/09/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0172/002/001</DrugIDPK>
    <LicenceNumber>PA0172/002/001</LicenceNumber>
    <ProductName>CODANIN</ProductName>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>14/01/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/027/001</DrugIDPK>
    <LicenceNumber>PA0073/027/001</LicenceNumber>
    <ProductName>CODEINE LINCTUS</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/03/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/028/001</DrugIDPK>
    <LicenceNumber>PA0073/028/001</LicenceNumber>
    <ProductName>CODEINE PHOSPHATE</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/03/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/042/001</DrugIDPK>
    <LicenceNumber>PA0408/042/001</LicenceNumber>
    <ProductName>Codeine Phosphate Tablets BP 15 mg</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>24/02/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Codeine phosphate hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/042/002</DrugIDPK>
    <LicenceNumber>PA0408/042/002</LicenceNumber>
    <ProductName>Codeine Phosphate Tablets BP 30 mg</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>24/02/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Codeine phosphate hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/042/003</DrugIDPK>
    <LicenceNumber>PA0408/042/003</LicenceNumber>
    <ProductName>Codeine Phosphate Tablets BP 60 mg</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>24/02/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Codeine phosphate hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/018/001</DrugIDPK>
    <LicenceNumber>PA0035/018/001</LicenceNumber>
    <ProductName>CODELCORTONE</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/02/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0618/007/001</DrugIDPK>
    <LicenceNumber>PA0618/007/001</LicenceNumber>
    <ProductName>Codella</ProductName>
    <PAHolder>Seton Products Ltd</PAHolder>
    <AuthorisedDate>25/11/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Wool alcohols</ActiveSubstance>
      <ActiveSubstance>Kaolin, light</ActiveSubstance>
      <ActiveSubstance>Povidone-iodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/11/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/015/001</DrugIDPK>
    <LicenceNumber>PA0035/015/001</LicenceNumber>
    <ProductName>CODELSOL</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/02/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1142/023/001</DrugIDPK>
    <LicenceNumber>PA1142/023/001</LicenceNumber>
    <ProductName>Codipar 15mg/500mg Effervescent Tablets</ProductName>
    <PAHolder>Amdipharm Limited</PAHolder>
    <AuthorisedDate>08/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
      <ActiveSubstance>Codeine phosphate hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/12/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0979/003/001</DrugIDPK>
    <LicenceNumber>PA0979/003/001</LicenceNumber>
    <ProductName>Codis Dispersible Tablets 500mg Aspirin8mg Codeine phosphate</ProductName>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aspirin</ActiveSubstance>
      <ActiveSubstance>Codeine phosphate hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>6. Retail sale through pharmacies only in blister packs containing not more than 24 unit dosage forms and subject to the following restrictions: aspirin - maximum dose: 650 mg, aspirin maximum daily dose: 4.0 g; codeine: maximum dose: 20 mg.  

The indic</SupplyComments>
    <WithdrawalDate>14/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/014/002</DrugIDPK>
    <LicenceNumber>PA0057/014/002</LicenceNumber>
    <ProductName>CODURAL (BLISTER PACK)</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/03/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0108/029/001</DrugIDPK>
    <LicenceNumber>PA0108/029/001</LicenceNumber>
    <ProductName>Coepratenz Plus 600 mg/12.5 mg film-coated tablets</ProductName>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>10/03/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Eprosartan mesylate</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/025/003</DrugIDPK>
    <LicenceNumber>PA0002/025/003</LicenceNumber>
    <ProductName>COGARD</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>28/07/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NADOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/07/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/046/001</DrugIDPK>
    <LicenceNumber>PA0035/046/001</LicenceNumber>
    <ProductName>Cogentin</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benztropine mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/046/002</DrugIDPK>
    <LicenceNumber>PA0035/046/002</LicenceNumber>
    <ProductName>COGENTIN</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benztropine mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0018/036/001</DrugIDPK>
    <LicenceNumber>PA0018/036/001</LicenceNumber>
    <ProductName>COJENE</ProductName>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAFFEINE CITRATE</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0069/013/001</DrugIDPK>
    <LicenceNumber>PA0069/013/001</LicenceNumber>
    <ProductName>COLAVAGE</ProductName>
    <PAHolder>Stafford Miller Limited</PAHolder>
    <AuthorisedDate>30/10/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MACROGOL 3350</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>SODIUM SULFATE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/013/001</DrugIDPK>
    <LicenceNumber>PA0035/013/001</LicenceNumber>
    <ProductName>COLBENEMID</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROBENECID</ActiveSubstance>
      <ActiveSubstance>COLCHICINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/04/1980</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0379/003/002</DrugIDPK>
    <LicenceNumber>PA0379/003/002</LicenceNumber>
    <ProductName>COLD RELIEF HOT LEMON</ProductName>
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate>01/04/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0258/036/001</DrugIDPK>
    <LicenceNumber>PA0258/036/001</LicenceNumber>
    <ProductName>Cold Sore Lotion</ProductName>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Povidone-iodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/01/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0159/002/001</DrugIDPK>
    <LicenceNumber>PA0159/002/001</LicenceNumber>
    <ProductName>COLDPRIN</ProductName>
    <PAHolder>Menley &amp; James Laboratories</PAHolder>
    <AuthorisedDate>30/01/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/01/1981</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/027/001</DrugIDPK>
    <LicenceNumber>PA0077/027/001</LicenceNumber>
    <ProductName>COLDREX</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>NOSCAPINE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22697/007/001</DrugIDPK>
    <LicenceNumber>PA22697/007/001</LicenceNumber>
    <ProductName>Colecalciferol 3000 IU/ml oral solution</ProductName>
    <PAHolder>Syri Pharma Limited t/a Thame Laboratories</PAHolder>
    <AuthorisedDate>30/01/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Colecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/01/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22639/002/001</DrugIDPK>
    <LicenceNumber>PA22639/002/001</LicenceNumber>
    <ProductName>Colecalciferol 800 IU capsules, soft</ProductName>
    <PAHolder>Strides Pharma (Cyprus) Limited</PAHolder>
    <AuthorisedDate>30/06/2023</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Colecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/08/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/004/003</DrugIDPK>
    <LicenceNumber>PA0016/004/003</LicenceNumber>
    <ProductName>Colestid</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/05/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/004/001</DrugIDPK>
    <LicenceNumber>PA0016/004/001</LicenceNumber>
    <ProductName>COLESTID</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Colestipol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/07/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/004/002</DrugIDPK>
    <LicenceNumber>PA0016/004/002</LicenceNumber>
    <ProductName>Colestid Orange</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Colestipol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/05/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0320/001/001</DrugIDPK>
    <LicenceNumber>PA0320/001/001</LicenceNumber>
    <ProductName>COLGATE FLUORIGARD (GRAPE)</ProductName>
    <PAHolder>Colgate-Palmolive (U.K.) Ltd</PAHolder>
    <AuthorisedDate>19/09/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM FLUORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0320/001/002</DrugIDPK>
    <LicenceNumber>PA0320/001/002</LicenceNumber>
    <ProductName>COLGATE FLUORIGARD (ORANGE)</ProductName>
    <PAHolder>Colgate-Palmolive (U.K.) Ltd</PAHolder>
    <AuthorisedDate>19/09/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM FLUORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0320/003/001</DrugIDPK>
    <LicenceNumber>PA0320/003/001</LicenceNumber>
    <ProductName>COLGATE SENSITIVE CARE</ProductName>
    <PAHolder>Colgate-Palmolive (U.K.) Ltd</PAHolder>
    <AuthorisedDate>06/06/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Toothpaste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM MONOFLUORO PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/06/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0320/005/002</DrugIDPK>
    <LicenceNumber>PA0320/005/002</LicenceNumber>
    <ProductName>Colgate TOTAL Fresh Stripe Toothpaste</ProductName>
    <PAHolder>Colgate-Palmolive (U.K.) Ltd</PAHolder>
    <AuthorisedDate>20/12/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Toothpaste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium fluoride (equivalent to 1450 ppm fluoride)</ActiveSubstance>
      <ActiveSubstance>Triclosan</ActiveSubstance>
      <ActiveSubstance>Triclosan</ActiveSubstance>
      <ActiveSubstance>Sodium fluoride (equivalent to 1450 ppm fluoride)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/06/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22581/002/002</DrugIDPK>
    <LicenceNumber>PA22581/002/002</LicenceNumber>
    <ProductName>Colgate TOTAL Pro Gum Health Tartar Control Toothpaste</ProductName>
    <PAHolder>Colgate-Palmolive A/S</PAHolder>
    <AuthorisedDate>02/04/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Toothpaste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium fluoride</ActiveSubstance>
      <ActiveSubstance>Triclosan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/09/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22581/002/001</DrugIDPK>
    <LicenceNumber>PA22581/002/001</LicenceNumber>
    <ProductName>Colgate TOTAL Pro Gum Health Toothpaste</ProductName>
    <PAHolder>Colgate-Palmolive A/S</PAHolder>
    <AuthorisedDate>01/04/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Toothpaste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Triclosan</ActiveSubstance>
      <ActiveSubstance>Sodium fluoride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/09/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2010/021/001</DrugIDPK>
    <LicenceNumber>PA2010/021/001</LicenceNumber>
    <ProductName>Colifoam 10% w/w Rectal Foam</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal foam</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/07/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0095/014/001</DrugIDPK>
    <LicenceNumber>PA0095/014/001</LicenceNumber>
    <ProductName>COLOCLER</ProductName>
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>21/08/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/122/001</DrugIDPK>
    <LicenceNumber>PPA1151/122/001</LicenceNumber>
    <ProductName>Colofac 135mg tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>14/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mebeverine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1288/003/001</DrugIDPK>
    <LicenceNumber>PA1288/003/001</LicenceNumber>
    <ProductName>Colofibre</ProductName>
    <PAHolder>Madaus GmbH</PAHolder>
    <AuthorisedDate>30/11/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ispaghula husks</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/041/002</DrugIDPK>
    <LicenceNumber>DPR0465/041/002</LicenceNumber>
    <ProductName>Colomycin</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Colistimethate sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1463/043/001</DrugIDPK>
    <LicenceNumber>DPR1463/043/001</LicenceNumber>
    <ProductName>Colomycin</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>20/09/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Colistimethate sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/06/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0100/001/007</DrugIDPK>
    <LicenceNumber>PA0100/001/007</LicenceNumber>
    <ProductName>Colomycin</ProductName>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>07/06/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Colistimethate sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0100/001/001</DrugIDPK>
    <LicenceNumber>PA0100/001/001</LicenceNumber>
    <ProductName>COLOMYCIN</ProductName>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Colistimethate sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0100/001/005</DrugIDPK>
    <LicenceNumber>PA0100/001/005</LicenceNumber>
    <ProductName>COLOMYCIN</ProductName>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Colistimethate sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0100/001/006</DrugIDPK>
    <LicenceNumber>PA0100/001/006</LicenceNumber>
    <ProductName>COLOMYCIN</ProductName>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/12/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0100/001/004</DrugIDPK>
    <LicenceNumber>PA0100/001/004</LicenceNumber>
    <ProductName>COLOMYCIN</ProductName>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COLISTIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/041/001</DrugIDPK>
    <LicenceNumber>DPR0465/041/001</LicenceNumber>
    <ProductName>Colomycin Injection</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>24/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Colistimethate sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1473/059/001</DrugIDPK>
    <LicenceNumber>DPR1473/059/001</LicenceNumber>
    <ProductName>Colomycin Injection</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Colistimethate sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/04/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0100/001/002</DrugIDPK>
    <LicenceNumber>PA0100/001/002</LicenceNumber>
    <ProductName>Colomycin Tablets 1,500,000 Units</ProductName>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Colistin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0100/001/003</DrugIDPK>
    <LicenceNumber>PA0100/001/003</LicenceNumber>
    <ProductName>Colomycin Units/5ml</ProductName>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Colistin sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1993/003/001</DrugIDPK>
    <LicenceNumber>PA1993/003/001</LicenceNumber>
    <ProductName>Coloprep 1500 mg Tablets</ProductName>
    <PAHolder>Laboratoires Mayoly Spindler</PAHolder>
    <AuthorisedDate>01/09/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium phosphate monobasic</ActiveSubstance>
      <ActiveSubstance>Sodium phosphate dibasic, anhydrous</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/02/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/087/001</DrugIDPK>
    <LicenceNumber>PPA1151/087/001</LicenceNumber>
    <ProductName>Colpermin IBS Relief Capsules</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>06/03/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Peppermint oil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0157/002/001</DrugIDPK>
    <LicenceNumber>PA0157/002/001</LicenceNumber>
    <ProductName>COLSPAN</ProductName>
    <PAHolder>Concept Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>23/04/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1328/028/001</DrugIDPK>
    <LicenceNumber>DPR1328/028/001</LicenceNumber>
    <ProductName>Combigan</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>03/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Brimonidine tartrate</ActiveSubstance>
      <ActiveSubstance>Timolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1392/059/001</DrugIDPK>
    <LicenceNumber>DPR1392/059/001</LicenceNumber>
    <ProductName>Combigan</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>16/12/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Brimonidine tartrate</ActiveSubstance>
      <ActiveSubstance>Timolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1831/003/001</DrugIDPK>
    <LicenceNumber>PA1831/003/001</LicenceNumber>
    <ProductName>Combineb</ProductName>
    <PAHolder>Breath Limited</PAHolder>
    <AuthorisedDate>28/09/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ipratropium bromide</ActiveSubstance>
      <ActiveSubstance>Salbutamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/01/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/105/001A</DrugIDPK>
    <LicenceNumber>PPA0465/105/001A</LicenceNumber>
    <ProductName>Combivent Metered</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>20/02/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ipratropium bromide</ActiveSubstance>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/052/001</DrugIDPK>
    <LicenceNumber>PA0007/052/001</LicenceNumber>
    <ProductName>Combivent Metered Aerosol 20 micrograms/100 microg</ProductName>
    <PAHolder>Boehringer Ingelheim Ltd</PAHolder>
    <AuthorisedDate>14/04/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ipratropium bromide</ActiveSubstance>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/11/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/032/001</DrugIDPK>
    <LicenceNumber>PPA1151/032/001</LicenceNumber>
    <ProductName>Combivent Metered Aersol</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>22/06/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not Currently Available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ipratropium bromide/salbutamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/02/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/052/002</DrugIDPK>
    <LicenceNumber>PA0007/052/002</LicenceNumber>
    <ProductName>Combivent UDVs</ProductName>
    <PAHolder>Boehringer Ingelheim Ltd</PAHolder>
    <AuthorisedDate>07/03/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ipratropium bromide monohydrate</ActiveSubstance>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/02/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/123/001</DrugIDPK>
    <LicenceNumber>PPA1328/123/001</LicenceNumber>
    <ProductName>Combivent UDVs</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>08/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ipratropium bromide monohydrate</ActiveSubstance>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/105/002A</DrugIDPK>
    <LicenceNumber>PPA0465/105/002A</LicenceNumber>
    <ProductName>Combivent UDVs 500 micrograms/2.5mg per 2.5ml Nebu</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>05/03/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ipratropium bromide monohydrate</ActiveSubstance>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/293/001</DrugIDPK>
    <LicenceNumber>PPA0465/293/001</LicenceNumber>
    <ProductName>Combodart</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>30/11/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dutasteride</ActiveSubstance>
      <ActiveSubstance>Tamsulosin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/171/001</DrugIDPK>
    <LicenceNumber>PPA1151/171/001</LicenceNumber>
    <InterchangeableListCode>IC0036-065-001</InterchangeableListCode>
    <ProductName>Combodart 0.5 mg/0.4 mg hard capsules</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>10/02/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dutasteride</ActiveSubstance>
      <ActiveSubstance>Tamsulosin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0407/007/001</DrugIDPK>
    <LicenceNumber>PA0407/007/001</LicenceNumber>
    <ProductName>COMBUDORON</ProductName>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>18/02/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Arnica montana</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/01/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/20/1528/006-007</DrugIDPK>
    <LicenceNumber>EU/1/20/1528/006-007</LicenceNumber>
    <ProductName>Comirnaty Original/Omicron BA.1</ProductName>
    <PAHolder>BioNTech Manufacturing GmbH</PAHolder>
    <AuthorisedDate>03/11/2021</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for dispersion for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tozinameran</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/20/1528/008-009</DrugIDPK>
    <LicenceNumber>EU/1/20/1528/008-009</LicenceNumber>
    <ProductName>Comirnaty Original/Omicron BA.4-5</ProductName>
    <PAHolder>BioNTech Manufacturing GmbH</PAHolder>
    <AuthorisedDate>03/11/2021</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersion for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tozinameran</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/20/1258/008-009</DrugIDPK>
    <LicenceNumber>EU/1/20/1258/008-009</LicenceNumber>
    <ProductName>Comirnaty Original/Omicron BA.4-5</ProductName>
    <PAHolder>BioNTech Manufacturing GmbH</PAHolder>
    <AuthorisedDate>10/11/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersion for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tozinameran</ActiveSubstance>
      <ActiveSubstance>COVID-19 mRNA vaccine (nucleoside-modified)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/20/1528/011</DrugIDPK>
    <LicenceNumber>EU/1/20/1528/011</LicenceNumber>
    <ProductName>Comirnaty Original/Omicron BA.4-5</ProductName>
    <PAHolder>BioNTech Manufacturing GmbH</PAHolder>
    <AuthorisedDate>10/11/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for dispersion for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tozinameran</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/20/1528/012</DrugIDPK>
    <LicenceNumber>EU/1/20/1528/012</LicenceNumber>
    <ProductName>Comirnaty Original/Omicron BA.4-5</ProductName>
    <PAHolder>BioNTech Manufacturing GmbH</PAHolder>
    <AuthorisedDate>10/11/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for dispersion for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tozinameran</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/20/1528/015-016</DrugIDPK>
    <LicenceNumber>EU/1/20/1528/015-016</LicenceNumber>
    <ProductName>Comirnaty Original/Omicron BA.4-5</ProductName>
    <PAHolder>BioNTech Manufacturing GmbH</PAHolder>
    <AuthorisedDate>08/08/2023</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for dispersion for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tozinameran</ActiveSubstance>
      <ActiveSubstance>Famtozinameran</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/20/1528/017</DrugIDPK>
    <LicenceNumber>EU/1/20/1528/017</LicenceNumber>
    <ProductName>Comirnaty Original/Omicron BA.4-5</ProductName>
    <PAHolder>BioNTech Manufacturing GmbH</PAHolder>
    <AuthorisedDate>08/08/2023</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dispersion for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tozinameran</ActiveSubstance>
      <ActiveSubstance>Famtozinameran</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/06/354/10-12</DrugIDPK>
    <LicenceNumber>EU/1/06/354/10-12</LicenceNumber>
    <ProductName>Competact</ProductName>
    <PAHolder>Takeda Pharma A/S</PAHolder>
    <AuthorisedDate>28/07/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pioglitazone</ActiveSubstance>
      <ActiveSubstance>Metformin Hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0566/004/001</DrugIDPK>
    <LicenceNumber>PA0566/004/001</LicenceNumber>
    <ProductName>COMPLEVEN</ProductName>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>12/11/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>L-isoleucine</ActiveSubstance>
      <ActiveSubstance>L-leucine</ActiveSubstance>
      <ActiveSubstance>Lysine</ActiveSubstance>
      <ActiveSubstance>Methionine</ActiveSubstance>
      <ActiveSubstance>L-phenylalanine</ActiveSubstance>
      <ActiveSubstance>L-threonine</ActiveSubstance>
      <ActiveSubstance>L-tryptophan</ActiveSubstance>
      <ActiveSubstance>L-valine</ActiveSubstance>
      <ActiveSubstance>L-tyrosine</ActiveSubstance>
      <ActiveSubstance>L-arginine</ActiveSubstance>
      <ActiveSubstance>L-histidine</ActiveSubstance>
      <ActiveSubstance>Taurine</ActiveSubstance>
      <ActiveSubstance>Glycine</ActiveSubstance>
      <ActiveSubstance>L-alanine</ActiveSubstance>
      <ActiveSubstance>L-proline</ActiveSubstance>
      <ActiveSubstance>L-serine</ActiveSubstance>
      <ActiveSubstance>Malic acid</ActiveSubstance>
      <ActiveSubstance>Glycerol</ActiveSubstance>
      <ActiveSubstance>Potassium hydroxide</ActiveSubstance>
      <ActiveSubstance>Sodium hydroxide </ActiveSubstance>
      <ActiveSubstance>Calcium chloride</ActiveSubstance>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Manganese chloride</ActiveSubstance>
      <ActiveSubstance>Zinc chloride</ActiveSubstance>
      <ActiveSubstance>Soya bean oil epoxidised</ActiveSubstance>
      <ActiveSubstance>Lecithin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/03/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0618/012/001</DrugIDPK>
    <LicenceNumber>PA0618/012/001</LicenceNumber>
    <ProductName>COMPLOMENT</ProductName>
    <PAHolder>Seton Products Ltd</PAHolder>
    <AuthorisedDate>06/02/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pyridoxine hydrochloride </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/02/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/023/001</DrugIDPK>
    <LicenceNumber>PA0408/023/001</LicenceNumber>
    <ProductName>Compound Magnesium Trisilicate</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Magnesium trisilicate</ActiveSubstance>
      <ActiveSubstance>Aluminium hydroxide gel, dried</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/04/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/063/001</DrugIDPK>
    <LicenceNumber>PA0167/063/001</LicenceNumber>
    <ProductName>COMPOUND SODIUM/LACTATE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE COMPOUND INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/063/004</DrugIDPK>
    <LicenceNumber>PA0167/063/004</LicenceNumber>
    <ProductName>COMPOUND SODIUM/LACTATE/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE COMPOUND INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/05/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/063/003</DrugIDPK>
    <LicenceNumber>PA0167/063/003</LicenceNumber>
    <ProductName>COMPOUND SODIUM/LACTATE/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE COMPOUND INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/05/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/063/002</DrugIDPK>
    <LicenceNumber>PA0167/063/002</LicenceNumber>
    <ProductName>COMPOUND SODIUM/LACTATE/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE COMPOUND INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0295/006/001</DrugIDPK>
    <LicenceNumber>PA0295/006/001</LicenceNumber>
    <ProductName>COMPOUND SODIUM LACTATE</ProductName>
    <PAHolder>Galen Research Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium lactate </ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/004/007</DrugIDPK>
    <LicenceNumber>PA0179/004/007</LicenceNumber>
    <ProductName>COMPOUND SODIUM LACTATE</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>25/02/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/004/006</DrugIDPK>
    <LicenceNumber>PA0179/004/006</LicenceNumber>
    <ProductName>COMPOUND SODIUM LACTATE</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>25/02/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/004/005</DrugIDPK>
    <LicenceNumber>PA0179/004/005</LicenceNumber>
    <ProductName>COMPOUND SODIUM LACTATE</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/004/002</DrugIDPK>
    <LicenceNumber>PA0179/004/002</LicenceNumber>
    <ProductName>COMPOUND SODIUM LACTATE</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/004/001</DrugIDPK>
    <LicenceNumber>PA0179/004/001</LicenceNumber>
    <ProductName>COMPOUND SODIUM LACTATE</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/055/004</DrugIDPK>
    <LicenceNumber>PA0167/055/004</LicenceNumber>
    <ProductName>COMPOUND SODIUM LACTATE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE COMPOUND INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/05/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/055/003</DrugIDPK>
    <LicenceNumber>PA0167/055/003</LicenceNumber>
    <ProductName>COMPOUND SODIUM LACTATE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM LACTATE COMPOUND INJECTION</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/05/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/063/005</DrugIDPK>
    <LicenceNumber>PA0167/063/005</LicenceNumber>
    <ProductName>Compound Sodium Lactate &amp; Glucose 5% w/v Solution for Infusion</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>17/04/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Sodium lactate </ActiveSubstance>
      <ActiveSubstance>Glucose monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/05/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/055/001</DrugIDPK>
    <LicenceNumber>PA0167/055/001</LicenceNumber>
    <ProductName>Compound Sodium Lactate Intravenous Infusion BP, (Hartmann’s Solution)</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium lactate </ActiveSubstance>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Calcium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/12/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0618/043/001</DrugIDPK>
    <LicenceNumber>PA0618/043/001</LicenceNumber>
    <ProductName>COMPOUND W</ProductName>
    <PAHolder>Seton Products Ltd</PAHolder>
    <AuthorisedDate>01/04/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Salicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/98/081/001</DrugIDPK>
    <LicenceNumber>EU/1/98/081/001</LicenceNumber>
    <ProductName>Comtan</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>22/09/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/06/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/98/081/002</DrugIDPK>
    <LicenceNumber>EU/1/98/081/002</LicenceNumber>
    <ProductName>Comtan</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>22/09/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/06/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/98/081/003</DrugIDPK>
    <LicenceNumber>EU/1/98/081/003</LicenceNumber>
    <ProductName>Comtan</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/06/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/98/081/004</DrugIDPK>
    <LicenceNumber>EU/1/98/081/004</LicenceNumber>
    <ProductName>Comtan</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/06/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/98/082/004</DrugIDPK>
    <LicenceNumber>EU/1/98/082/004</LicenceNumber>
    <ProductName>Comtess</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/06/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/037/003</DrugIDPK>
    <LicenceNumber>PA0048/037/003</LicenceNumber>
    <ProductName>COMTREX</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>15/03/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/03/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/037/002</DrugIDPK>
    <LicenceNumber>PA0048/037/002</LicenceNumber>
    <ProductName>COMTREX</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>02/08/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/08/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/037/001</DrugIDPK>
    <LicenceNumber>PA0048/037/001</LicenceNumber>
    <ProductName>COMTREX</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>15/03/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/03/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/417/001</DrugIDPK>
    <LicenceNumber>PPA0465/417/001</LicenceNumber>
    <ProductName>Concerta XL</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>19/11/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methylphenidate hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988) as amended</SupplyComments>
    <WithdrawalDate>31/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/417/002</DrugIDPK>
    <LicenceNumber>PPA0465/417/002</LicenceNumber>
    <ProductName>Concerta XL</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>19/11/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methylphenidate hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988) as amended</SupplyComments>
    <WithdrawalDate>31/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/243/001</DrugIDPK>
    <LicenceNumber>PPA1151/243/001</LicenceNumber>
    <ProductName>Concerta XL 18 mg prolonged-release tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>02/04/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methylphenidate hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, 4.2).
This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/243/002</DrugIDPK>
    <LicenceNumber>PPA1151/243/002</LicenceNumber>
    <ProductName>Concerta XL 27 mg prolonged-release tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>02/04/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methylphenidate hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, 4.2).
This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/243/003</DrugIDPK>
    <LicenceNumber>PPA1151/243/003</LicenceNumber>
    <ProductName>Concerta XL 36 mg prolonged-release tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>02/04/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methylphenidate hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, 4.2).
This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0748/049/003</DrugIDPK>
    <LicenceNumber>PA0748/049/003</LicenceNumber>
    <ProductName>Concerta XL 54 mg prolonged-release tablets</ProductName>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>22/11/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methylphenidate hydrochloride</ActiveSubstance>
      <ActiveSubstance>Methylphenidate hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988) as amended.</SupplyComments>
    <WithdrawalDate>27/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/041/002</DrugIDPK>
    <LicenceNumber>PA0035/041/002</LicenceNumber>
    <ProductName>CONCORDIN</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROTRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/041/001</DrugIDPK>
    <LicenceNumber>PA0035/041/001</LicenceNumber>
    <ProductName>CONCORDIN</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROTRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2229/006/001</DrugIDPK>
    <LicenceNumber>PA2229/006/001</LicenceNumber>
    <ProductName>Condyline 5 mg/ml Cutaneous Solution</ProductName>
    <PAHolder>Takeda Products Ireland Ltd</PAHolder>
    <AuthorisedDate>11/04/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Podophyllotoxin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0277/035/002</DrugIDPK>
    <LicenceNumber>PA0277/035/002</LicenceNumber>
    <ProductName>CONGESTEZE</ProductName>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>16/06/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZATADINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/06/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0277/035/001</DrugIDPK>
    <LicenceNumber>PA0277/035/001</LicenceNumber>
    <ProductName>CONGESTEZE</ProductName>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>07/11/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZATADINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/06/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0277/035/003</DrugIDPK>
    <LicenceNumber>PA0277/035/003</LicenceNumber>
    <ProductName>CONGESTEZE PAEDIATRIC</ProductName>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>24/07/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AZATADINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/12/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0148/019/001</DrugIDPK>
    <LicenceNumber>PA0148/019/001</LicenceNumber>
    <ProductName>CONJUNCTIN LIQUIFILM</ProductName>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYMYXIN B SULFATE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0079/013/001</DrugIDPK>
    <LicenceNumber>PA0079/013/001</LicenceNumber>
    <ProductName>CONJUVAC</ProductName>
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>11/03/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/038/001</DrugIDPK>
    <LicenceNumber>PA0062/038/001</LicenceNumber>
    <ProductName>Conotrane</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzalkonium chloride</ActiveSubstance>
      <ActiveSubstance>Dimeticone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/11/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0098/018/001</DrugIDPK>
    <LicenceNumber>PA0098/018/001</LicenceNumber>
    <ProductName>CONOTRANE</ProductName>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0001/015/001</DrugIDPK>
    <LicenceNumber>PA0001/015/001</LicenceNumber>
    <ProductName>CONOVA 30</ProductName>
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>08/03/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
      <ActiveSubstance>ETYNODIOL DIACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/03/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1850/001/001</DrugIDPK>
    <LicenceNumber>PA1850/001/001</LicenceNumber>
    <ProductName>CONRAY 280</ProductName>
    <PAHolder>Mallinckrodt UK Commercial Ltd</PAHolder>
    <AuthorisedDate>22/03/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0199/003/001</DrugIDPK>
    <LicenceNumber>PA0199/003/001</LicenceNumber>
    <ProductName>CONRAY 280</ProductName>
    <PAHolder>Mallinckrodt UK Limited</PAHolder>
    <AuthorisedDate>08/05/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/05/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/051/002</DrugIDPK>
    <LicenceNumber>PA0040/051/002</LicenceNumber>
    <ProductName>CONRAY 280</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/051/001</DrugIDPK>
    <LicenceNumber>PA0040/051/001</LicenceNumber>
    <ProductName>CONRAY 280</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE MEGLUMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0199/004/002</DrugIDPK>
    <LicenceNumber>PA0199/004/002</LicenceNumber>
    <ProductName>CONRAY 325</ProductName>
    <PAHolder>Mallinckrodt UK Limited</PAHolder>
    <AuthorisedDate>08/05/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/10/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0199/004/001</DrugIDPK>
    <LicenceNumber>PA0199/004/001</LicenceNumber>
    <ProductName>CONRAY 325</ProductName>
    <PAHolder>Mallinckrodt UK Limited</PAHolder>
    <AuthorisedDate>08/05/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/05/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/054/002</DrugIDPK>
    <LicenceNumber>PA0040/054/002</LicenceNumber>
    <ProductName>CONRAY 325</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/054/001</DrugIDPK>
    <LicenceNumber>PA0040/054/001</LicenceNumber>
    <ProductName>CONRAY 325</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0199/005/002</DrugIDPK>
    <LicenceNumber>PA0199/005/002</LicenceNumber>
    <ProductName>CONRAY 420</ProductName>
    <PAHolder>Mallinckrodt UK Limited</PAHolder>
    <AuthorisedDate>07/05/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/05/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0199/005/001</DrugIDPK>
    <LicenceNumber>PA0199/005/001</LicenceNumber>
    <ProductName>CONRAY 420</ProductName>
    <PAHolder>Mallinckrodt UK Limited</PAHolder>
    <AuthorisedDate>07/05/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/05/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/053/002</DrugIDPK>
    <LicenceNumber>PA0040/053/002</LicenceNumber>
    <ProductName>CONRAY 420</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/053/001</DrugIDPK>
    <LicenceNumber>PA0040/053/001</LicenceNumber>
    <ProductName>CONRAY 420</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IOTALAMATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/052/001</DrugIDPK>
    <LicenceNumber>PA0040/052/001</LicenceNumber>
    <ProductName>CONRAY 480</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/047/001</DrugIDPK>
    <LicenceNumber>PA0678/047/001</LicenceNumber>
    <ProductName>CONTAC 400</ProductName>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/08/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1189/004/001</DrugIDPK>
    <LicenceNumber>PA1189/004/001</LicenceNumber>
    <ProductName>Contramal retard</ProductName>
    <PAHolder>Grünenthal Ltd</PAHolder>
    <AuthorisedDate>27/07/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tramadol hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/09/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/09/515/002</DrugIDPK>
    <LicenceNumber>EU/1/09/515/002</LicenceNumber>
    <ProductName>Controloc Control</ProductName>
    <PAHolder>Takeda GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pantoprazole sodium sesquihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/05/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/09/515/003</DrugIDPK>
    <LicenceNumber>EU/1/09/515/003</LicenceNumber>
    <ProductName>Controloc Control</ProductName>
    <PAHolder>Takeda GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pantoprazole sodium sesquihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/05/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/09/515/004</DrugIDPK>
    <LicenceNumber>EU/1/09/515/004</LicenceNumber>
    <ProductName>Controloc Control</ProductName>
    <PAHolder>Takeda GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pantoprazole sodium sesquihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/083/001</DrugIDPK>
    <LicenceNumber>PA0017/083/001</LicenceNumber>
    <ProductName>COPARVAX-VIAL</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>02/07/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CORYNEBACTERIUM PARVUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/06/1986</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1014/001/001</DrugIDPK>
    <LicenceNumber>PA1014/001/001</LicenceNumber>
    <ProductName>Copaxone</ProductName>
    <PAHolder>Teva Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>07/09/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glatiramer acetate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/10/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/432/001</DrugIDPK>
    <LicenceNumber>PPA0465/432/001</LicenceNumber>
    <ProductName>Copaxone 20 mg/ml solution for injection in pre-filled syringe</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>03/11/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection in pre-filled syringe</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glatiramer acetate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/194/001</DrugIDPK>
    <LicenceNumber>PPA0465/194/001</LicenceNumber>
    <ProductName>Copegus</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>06/07/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ribavirin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/153/001</DrugIDPK>
    <LicenceNumber>PA0050/153/001</LicenceNumber>
    <ProductName>Copegus 200 mg film-coated tablets</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>04/04/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ribavirin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/153/002</DrugIDPK>
    <LicenceNumber>PA0050/153/002</LicenceNumber>
    <ProductName>Copegus 400mg film-coated tablets</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>08/12/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ribavirin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/044/001</DrugIDPK>
    <LicenceNumber>PA0137/044/001</LicenceNumber>
    <ProductName>COPHOLCO COUGH SYRUP</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>09/08/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
      <ActiveSubstance>TERPIN HYDRATE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0005/003/001</DrugIDPK>
    <LicenceNumber>PA0005/003/001</LicenceNumber>
    <ProductName>COPHOLCO COUGH SYRUP</ProductName>
    <PAHolder>Wade Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>12/10/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
      <ActiveSubstance>TERPIN HYDRATE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CINEOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/09/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0005/007/001</DrugIDPK>
    <LicenceNumber>PA0005/007/001</LicenceNumber>
    <ProductName>COPHOLCOIDS</ProductName>
    <PAHolder>Wade Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>23/06/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHOLCODINE</ActiveSubstance>
      <ActiveSubstance>TERPIN HYDRATE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
      <ActiveSubstance>CINEOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/09/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/21/1542/001</DrugIDPK>
    <LicenceNumber>EU/1/21/1542/001</LicenceNumber>
    <ProductName>Copiktra 15 mg hard capsules</ProductName>
    <PAHolder>Secura Bio Limited</PAHolder>
    <AuthorisedDate>19/05/2021</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duvelisib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>19/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/21/1542/002</DrugIDPK>
    <LicenceNumber>EU/1/21/1542/002</LicenceNumber>
    <ProductName>Copiktra 25 mg hard capsules</ProductName>
    <PAHolder>Secura Bio Limited</PAHolder>
    <AuthorisedDate>19/05/2021</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duvelisib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>19/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/028/001</DrugIDPK>
    <LicenceNumber>PA0019/028/001</LicenceNumber>
    <ProductName>COPTIN</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>02/07/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0021/031/001</DrugIDPK>
    <LicenceNumber>PA0021/031/001</LicenceNumber>
    <ProductName>COR-TAR-QUIN</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0060/048/002</DrugIDPK>
    <LicenceNumber>PA0060/048/002</LicenceNumber>
    <ProductName>CORACTEN SPANSULE</ProductName>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>14/08/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/08/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0060/048/001</DrugIDPK>
    <LicenceNumber>PA0060/048/001</LicenceNumber>
    <ProductName>CORACTEN SPANSULE</ProductName>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>25/07/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/07/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/052/001</DrugIDPK>
    <LicenceNumber>PPA1447/052/001</LicenceNumber>
    <ProductName>Cordarone X</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>26/02/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amiodarone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/02/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/044/001</DrugIDPK>
    <LicenceNumber>PPA1500/044/001</LicenceNumber>
    <ProductName>Cordarone X</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>07/01/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amiodarone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/112/001</DrugIDPK>
    <LicenceNumber>PPA1562/112/001</LicenceNumber>
    <ProductName>Cordarone X</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>02/05/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amiodarone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/05/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/112/002</DrugIDPK>
    <LicenceNumber>PPA1562/112/002</LicenceNumber>
    <ProductName>Cordarone X</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>02/05/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amiodarone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/05/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/119/002</DrugIDPK>
    <LicenceNumber>PPA0465/119/002</LicenceNumber>
    <ProductName>Cordarone X 100 mg tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>24/10/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amiodarone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1097/051/001</DrugIDPK>
    <LicenceNumber>PPA1097/051/001</LicenceNumber>
    <ProductName>Cordarone X 100 mg Tablets</ProductName>
    <PAHolder>Lexon (UK) Ltd</PAHolder>
    <AuthorisedDate>03/08/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amiodarone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/09/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/084/001</DrugIDPK>
    <LicenceNumber>PPA1151/084/001</LicenceNumber>
    <ProductName>Cordarone X 100mg Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>03/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amiodarone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/094/001</DrugIDPK>
    <LicenceNumber>PPA1463/094/001</LicenceNumber>
    <ProductName>Cordarone X 100mg Tablets</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>17/01/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amiodarone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/08/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/119/001</DrugIDPK>
    <LicenceNumber>PPA0465/119/001</LicenceNumber>
    <ProductName>Cordarone X 200 mg tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>05/03/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amiodarone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/058/001</DrugIDPK>
    <LicenceNumber>PPA1328/058/001</LicenceNumber>
    <ProductName>Cordarone X 200 mg Tablets</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>21/12/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amiodarone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/05/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23176/020/002</DrugIDPK>
    <LicenceNumber>PPA23176/020/002</LicenceNumber>
    <ProductName>Cordarone X 200 mg Tablets</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>17/07/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amiodarone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/084/002</DrugIDPK>
    <LicenceNumber>PPA1151/084/002</LicenceNumber>
    <ProductName>Cordarone X 200mg Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>03/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amiodarone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/094/002</DrugIDPK>
    <LicenceNumber>PPA1463/094/002</LicenceNumber>
    <ProductName>Cordarone X 200mg Tablets</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>17/01/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amiodarone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/08/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/176/001</DrugIDPK>
    <LicenceNumber>PPA1562/176/001</LicenceNumber>
    <ProductName>Cordarone X 200mg Tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>02/09/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amiodarone hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/04/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0261/024/003</DrugIDPK>
    <LicenceNumber>PA0261/024/003</LicenceNumber>
    <ProductName>CORDIUM</ProductName>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>20/05/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BEPRIDIL HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/10/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0261/024/002</DrugIDPK>
    <LicenceNumber>PA0261/024/002</LicenceNumber>
    <ProductName>CORDIUM</ProductName>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>20/05/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BEPRIDIL HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/10/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0261/024/001</DrugIDPK>
    <LicenceNumber>PA0261/024/001</LicenceNumber>
    <ProductName>CORDIUM</ProductName>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>20/05/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BEPRIDIL HYDROCHLORIDE MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/10/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/025/002</DrugIDPK>
    <LicenceNumber>PA0002/025/002</LicenceNumber>
    <ProductName>CORGARD</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>28/07/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NADOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/025/001</DrugIDPK>
    <LicenceNumber>PA0002/025/001</LicenceNumber>
    <ProductName>CORGARD</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>28/07/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NADOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/047/002</DrugIDPK>
    <LicenceNumber>PA0002/047/002</LicenceNumber>
    <ProductName>CORGARETIC</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>12/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NADOLOL</ActiveSubstance>
      <ActiveSubstance>BENDROFLUMETHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/047/001</DrugIDPK>
    <LicenceNumber>PA0002/047/001</LicenceNumber>
    <ProductName>CORGARETIC</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>12/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NADOLOL</ActiveSubstance>
      <ActiveSubstance>BENDROFLUMETHIAZIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0365/049/001</DrugIDPK>
    <LicenceNumber>PA0365/049/001</LicenceNumber>
    <ProductName>Corlan</ProductName>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>07/07/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Buccal tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE SODIUM SUCCINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/01/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0872/003/001</DrugIDPK>
    <LicenceNumber>PA0872/003/001</LicenceNumber>
    <ProductName>CORLOPAM</ProductName>
    <PAHolder>Elan Pharma International Ltd</PAHolder>
    <AuthorisedDate>05/02/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FENOLDOPAM MESYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/02/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0455/006/001</DrugIDPK>
    <LicenceNumber>PA0455/006/001</LicenceNumber>
    <ProductName>Corn Removal Pads</ProductName>
    <PAHolder>Scholl Consumer Products Limited</PAHolder>
    <AuthorisedDate>24/06/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated plaster</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Salicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/12/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1465/039/002</DrugIDPK>
    <LicenceNumber>DPR1465/039/002</LicenceNumber>
    <ProductName>Corn Removal Plasters</ProductName>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>18/12/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated plaster</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Salicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0235/008/008</DrugIDPK>
    <LicenceNumber>PA0235/008/008</LicenceNumber>
    <ProductName>CORONAR 370 MG</ProductName>
    <PAHolder>Nycomed (UK) Limited</PAHolder>
    <AuthorisedDate>14/06/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1465/004/001</DrugIDPK>
    <LicenceNumber>DPR1465/004/001</LicenceNumber>
    <ProductName>Corsodyl</ProductName>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>25/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dental gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chlorhexidine gluconate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/061/001</DrugIDPK>
    <LicenceNumber>DPR1392/061/001</LicenceNumber>
    <ProductName>Corsodyl Dental Gel</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dental gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chlorhexidine gluconate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1465/030/001</DrugIDPK>
    <LicenceNumber>DPR1465/030/001</LicenceNumber>
    <ProductName>Corsodyl Dental Gel</ProductName>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>04/12/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dental gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chlorhexidine gluconate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0678/002/002</DrugIDPK>
    <LicenceNumber>PA0678/002/002</LicenceNumber>
    <ProductName>Corsodyl Mint 0.2% w/v Mouthwash</ProductName>
    <PAHolder>Haleon Ireland Limited</PAHolder>
    <AuthorisedDate>30/09/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Mouthwash</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chlorhexidine gluconate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/05/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/112/001</DrugIDPK>
    <LicenceNumber>PA0050/112/001</LicenceNumber>
    <ProductName>CORSYM</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>03/04/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0072/010/001</DrugIDPK>
    <LicenceNumber>PA0072/010/001</LicenceNumber>
    <ProductName>CORSYM (SUSPENSION)</ProductName>
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>26/03/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHLORPHENAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/06/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0096/003/001</DrugIDPK>
    <LicenceNumber>PA0096/003/001</LicenceNumber>
    <ProductName>CORTENEMA</ProductName>
    <PAHolder>Bengue &amp; Company Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/01/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0141/005/001</DrugIDPK>
    <LicenceNumber>PA0141/005/001</LicenceNumber>
    <ProductName>CORTI FLEXIOLE</ProductName>
    <PAHolder>Pharma-Global Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
      <ActiveSubstance>CHLORAMPHENICOL</ActiveSubstance>
      <ActiveSubstance>RETINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/10/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/013/001</DrugIDPK>
    <LicenceNumber>PA0006/013/001</LicenceNumber>
    <ProductName>CORTISYL</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CORTISONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/08/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/071/001</DrugIDPK>
    <LicenceNumber>PA0281/071/001</LicenceNumber>
    <ProductName>Cortopin Hydrocortisone B.P.</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Hydrocortisone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/07/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/018/004</DrugIDPK>
    <LicenceNumber>PA0019/018/004</LicenceNumber>
    <ProductName>CORTRIL</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/018/003</DrugIDPK>
    <LicenceNumber>PA0019/018/003</LicenceNumber>
    <ProductName>CORTRIL</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/018/002</DrugIDPK>
    <LicenceNumber>PA0019/018/002</LicenceNumber>
    <ProductName>CORTRIL</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/02/1980</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/018/001</DrugIDPK>
    <LicenceNumber>PA0019/018/001</LicenceNumber>
    <ProductName>CORTRIL  (SPRAY)</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0032/025/001</DrugIDPK>
    <LicenceNumber>PA0032/025/001</LicenceNumber>
    <ProductName>CORTUCID EYE</ProductName>
    <PAHolder>Nicholas Laboratories</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFACETAMIDE SODIUM</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/01/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/088/001</DrugIDPK>
    <LicenceNumber>PA0936/088/001</LicenceNumber>
    <ProductName>CORVERT</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibutilide fumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0484/012/001</DrugIDPK>
    <LicenceNumber>PA0484/012/001</LicenceNumber>
    <ProductName>COSAL S</ProductName>
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>22/10/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COAL TAR SOLUTION</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>SULFUR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/08/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0176/034/001</DrugIDPK>
    <LicenceNumber>PA0176/034/001</LicenceNumber>
    <ProductName>Cosalgesic</ProductName>
    <PAHolder>Actavis UK Limited</PAHolder>
    <AuthorisedDate>08/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dextropropoxyphene hydrochloride</ActiveSubstance>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/02/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/046/001</DrugIDPK>
    <LicenceNumber>PA1380/046/001</LicenceNumber>
    <ProductName>Cosartal</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>11/04/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/10/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/046/002</DrugIDPK>
    <LicenceNumber>PA1380/046/002</LicenceNumber>
    <ProductName>Cosartal</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>11/04/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/10/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/047/002</DrugIDPK>
    <LicenceNumber>PA2315/047/002</LicenceNumber>
    <ProductName>Cosartal 100 mg Film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>02/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/07/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/047/001</DrugIDPK>
    <LicenceNumber>PA2315/047/001</LicenceNumber>
    <ProductName>Cosartal 50 mg Film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>02/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/07/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/190/003</DrugIDPK>
    <LicenceNumber>PA2315/190/003</LicenceNumber>
    <InterchangeableListCode>IC0031-026-003</InterchangeableListCode>
    <ProductName>Cosartal Plus 100 mg/12.5 mg Film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>02/03/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/10/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/190/002</DrugIDPK>
    <LicenceNumber>PA2315/190/002</LicenceNumber>
    <InterchangeableListCode>IC0031-027-003</InterchangeableListCode>
    <ProductName>Cosartal Plus 100 mg/25 mg Film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>04/06/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/10/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/190/001</DrugIDPK>
    <LicenceNumber>PA2315/190/001</LicenceNumber>
    <InterchangeableListCode>IC0031-025-003</InterchangeableListCode>
    <ProductName>Cosartal Plus 50 mg/12.5 mg Film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>04/06/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/10/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/14/980/008-011</DrugIDPK>
    <LicenceNumber>EU/1/14/980/008-011</LicenceNumber>
    <ProductName>Cosentyx</ProductName>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>20/11/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion in pre-filled syringe</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Secukinumab</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1301/003/001</DrugIDPK>
    <LicenceNumber>PA1301/003/001</LicenceNumber>
    <ProductName>Cosmegen® Lyovac* 500 micrograms Powder for Solution for Injection</ProductName>
    <PAHolder>Lundbeck Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dactinomycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1097/034/001</DrugIDPK>
    <LicenceNumber>PPA1097/034/001</LicenceNumber>
    <ProductName>CosmoFer 50mg/ml solution for infusion and injection</ProductName>
    <PAHolder>Lexon (UK) Ltd</PAHolder>
    <AuthorisedDate>09/02/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Iron</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/09/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0054/019/001</DrugIDPK>
    <LicenceNumber>PA0054/019/001</LicenceNumber>
    <ProductName>COSOME</ProductName>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>01/04/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ETHYLMORPHINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/10/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1328/029/001</DrugIDPK>
    <LicenceNumber>DPR1328/029/001</LicenceNumber>
    <ProductName>Cosopt</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>03/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide</ActiveSubstance>
      <ActiveSubstance>Timol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/018/001</DrugIDPK>
    <LicenceNumber>DPR1392/018/001</LicenceNumber>
    <ProductName>Cosopt</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>23/11/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide</ActiveSubstance>
      <ActiveSubstance>Timolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/072/001</DrugIDPK>
    <LicenceNumber>DPR1392/072/001</LicenceNumber>
    <ProductName>Cosopt</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>04/08/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide</ActiveSubstance>
      <ActiveSubstance>Timolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1463/046/001</DrugIDPK>
    <LicenceNumber>DPR1463/046/001</LicenceNumber>
    <ProductName>Cosopt</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>15/03/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide</ActiveSubstance>
      <ActiveSubstance>Timolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1473/041/001</DrugIDPK>
    <LicenceNumber>DPR1473/041/001</LicenceNumber>
    <ProductName>Cosopt</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide</ActiveSubstance>
      <ActiveSubstance>Timolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/04/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/145/001</DrugIDPK>
    <LicenceNumber>PPA1328/145/001</LicenceNumber>
    <ProductName>Cosopt</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>01/04/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide hydrochloride</ActiveSubstance>
      <ActiveSubstance>Timolol Maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/040/001</DrugIDPK>
    <LicenceNumber>PPA1447/040/001</LicenceNumber>
    <ProductName>Cosopt</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>31/03/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide hydrochloride</ActiveSubstance>
      <ActiveSubstance>Timolol Maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/043/001</DrugIDPK>
    <LicenceNumber>PPA1562/043/001</LicenceNumber>
    <ProductName>Cosopt</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>11/02/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide</ActiveSubstance>
      <ActiveSubstance>Timolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/043/002</DrugIDPK>
    <LicenceNumber>PPA1562/043/002</LicenceNumber>
    <ProductName>Cosopt</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>08/06/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide hydrochloride</ActiveSubstance>
      <ActiveSubstance>Timolol Maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/03/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/049/001</DrugIDPK>
    <LicenceNumber>PPA1659/049/001</LicenceNumber>
    <ProductName>Cosopt</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>19/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide hydrochloride</ActiveSubstance>
      <ActiveSubstance>Timolol Maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/013/001</DrugIDPK>
    <LicenceNumber>DPR0465/013/001</LicenceNumber>
    <ProductName>COSOPT</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>10/10/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide</ActiveSubstance>
      <ActiveSubstance>Timolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/01/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1151/001/001</DrugIDPK>
    <LicenceNumber>DPR1151/001/001</LicenceNumber>
    <ProductName>COSOPT</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>11/04/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide</ActiveSubstance>
      <ActiveSubstance>Timolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1463/012/001</DrugIDPK>
    <LicenceNumber>DPR1463/012/001</LicenceNumber>
    <ProductName>COSOPT</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>13/03/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide</ActiveSubstance>
      <ActiveSubstance>Timolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1151/159/001</DrugIDPK>
    <LicenceNumber>PPA1151/159/001</LicenceNumber>
    <ProductName>Cosopt 20 mg/ml + 5 mg/ml eye drops, solution</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>23/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Timolol</ActiveSubstance>
      <ActiveSubstance>Dorzolamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/060/001</DrugIDPK>
    <LicenceNumber>PPA1596/060/001</LicenceNumber>
    <ProductName>COSOPT 20 mg/ml + 5 mg/ml, eye drops, solution</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>13/01/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide</ActiveSubstance>
      <ActiveSubstance>Timolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/043/003</DrugIDPK>
    <LicenceNumber>PPA1562/043/003</LicenceNumber>
    <ProductName>COSOPT 20mg/ml + 5mg/ml eye drops, solution</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>20/06/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Timolol Maleate</ActiveSubstance>
      <ActiveSubstance>Dorzolamide hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/11/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1500/019/001</DrugIDPK>
    <LicenceNumber>DPR1500/019/001</LicenceNumber>
    <ProductName>Cosopt Eye Drops Solution</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>29/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide</ActiveSubstance>
      <ActiveSubstance>Timolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1596/013/001</DrugIDPK>
    <LicenceNumber>DPR1596/013/001</LicenceNumber>
    <ProductName>Cosopt Eye Drops Solution</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>30/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide</ActiveSubstance>
      <ActiveSubstance>Timolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1601/006/001</DrugIDPK>
    <LicenceNumber>DPR1601/006/001</LicenceNumber>
    <ProductName>Cosopt Eye Drops Solution</ProductName>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>28/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide</ActiveSubstance>
      <ActiveSubstance>Timolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0879/005/003</DrugIDPK>
    <LicenceNumber>PA0879/005/003</LicenceNumber>
    <ProductName>Cosopt Multi preservative-free 20mg/ml+5mg/ml eye drops, solution</ProductName>
    <PAHolder>Santen OY</PAHolder>
    <AuthorisedDate>01/06/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide hydrochloride</ActiveSubstance>
      <ActiveSubstance>Timolol Maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>None</SupplyComments>
    <WithdrawalDate>13/05/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0879/005/002</DrugIDPK>
    <LicenceNumber>PA0879/005/002</LicenceNumber>
    <ProductName>COSOPT Preservative-Free 20 mg/ml + 5 mg/ml, eye drops, solution in single-dose container</ProductName>
    <PAHolder>Santen OY</PAHolder>
    <AuthorisedDate>01/09/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution in single-dose container</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide hydrochloride</ActiveSubstance>
      <ActiveSubstance>Timolol Maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/10/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0176/042/001</DrugIDPK>
    <LicenceNumber>PA0176/042/001</LicenceNumber>
    <ProductName>COSOVAL</ProductName>
    <PAHolder>Accord-UK Ltd</PAHolder>
    <AuthorisedDate>01/02/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/08/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0056/009/001</DrugIDPK>
    <LicenceNumber>PA0056/009/001</LicenceNumber>
    <ProductName>COSYLAN</ProductName>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>07/07/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/02/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0261/022/001</DrugIDPK>
    <LicenceNumber>PA0261/022/001</LicenceNumber>
    <ProductName>COTAZYM</ProductName>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIPASE</ActiveSubstance>
      <ActiveSubstance>AMYLASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0261/023/001</DrugIDPK>
    <LicenceNumber>PA0261/023/001</LicenceNumber>
    <ProductName>COTAZYM B</ProductName>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>15/03/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIPASE</ActiveSubstance>
      <ActiveSubstance>AMYLASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/04/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/065/002</DrugIDPK>
    <LicenceNumber>PA0281/065/002</LicenceNumber>
    <ProductName>COTENT 100</ProductName>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>10/10/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/065/001</DrugIDPK>
    <LicenceNumber>PA0281/065/001</LicenceNumber>
    <ProductName>COTENT 50</ProductName>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>10/10/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ATENOLOL</ActiveSubstance>
      <ActiveSubstance>CHLORTALIDONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0399/004/001</DrugIDPK>
    <LicenceNumber>PA0399/004/001</LicenceNumber>
    <ProductName>COTRIFAN</ProductName>
    <PAHolder>Fannin &amp; Company Ltd</PAHolder>
    <AuthorisedDate>13/08/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>COTRIMOXAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/09/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/033/001</DrugIDPK>
    <LicenceNumber>PA0126/033/001</LicenceNumber>
    <ProductName>COTRIMEL</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>23/06/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/12/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/033/002</DrugIDPK>
    <LicenceNumber>PA0126/033/002</LicenceNumber>
    <ProductName>COTRIMEL (SUSPENSION)</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>06/03/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/06/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/033/003</DrugIDPK>
    <LicenceNumber>PA0126/033/003</LicenceNumber>
    <ProductName>COTRIMEL FORTE</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>05/06/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/12/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/99/106/001</DrugIDPK>
    <LicenceNumber>EU/1/99/106/001</LicenceNumber>
    <ProductName>COTRONAK</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ribavirin</ActiveSubstance>
      <ActiveSubstance>Interferon alfa-2b</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/99/106/003</DrugIDPK>
    <LicenceNumber>EU/1/99/106/003</LicenceNumber>
    <ProductName>COTRONAK</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>07/05/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIBAVIRIN</ActiveSubstance>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/99/106/002</DrugIDPK>
    <LicenceNumber>EU/1/99/106/002</LicenceNumber>
    <ProductName>COTRONAK</ProductName>
    <PAHolder>Schering Plough Europe</PAHolder>
    <AuthorisedDate>07/05/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RIBAVIRIN</ActiveSubstance>
      <ActiveSubstance>INTERFERON ALFA-2B</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA23176/022/003</DrugIDPK>
    <LicenceNumber>PPA23176/022/003</LicenceNumber>
    <ProductName>Coverdine 10 mg/2.5 mg/10 mg film-coated tablets</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>31/08/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Indapamide</ActiveSubstance>
      <ActiveSubstance>Amlodipine</ActiveSubstance>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23176/022/002</DrugIDPK>
    <LicenceNumber>PPA23176/022/002</LicenceNumber>
    <ProductName>Coverdine 10 mg/2.5 mg/5 mg film-coated tablets</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>31/08/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine</ActiveSubstance>
      <ActiveSubstance>Indapamide</ActiveSubstance>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0568/024/001</DrugIDPK>
    <LicenceNumber>PA0568/024/001</LicenceNumber>
    <ProductName>Coverdine 2.5mg/0.625mg/5mg film-coated tablets</ProductName>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>16/04/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Indapamide</ActiveSubstance>
      <ActiveSubstance>Amlodipine besilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23176/022/001</DrugIDPK>
    <LicenceNumber>PPA23176/022/001</LicenceNumber>
    <ProductName>Coverdine 5 mg/1.25 mg/5 mg film-coated tablets</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>31/08/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Amlodipine</ActiveSubstance>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Indapamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/067/001A</DrugIDPK>
    <LicenceNumber>PPA0465/067/001A</LicenceNumber>
    <ProductName>Coversyl</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>23/03/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril tert-butylamine salt</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/067/002</DrugIDPK>
    <LicenceNumber>PPA0465/067/002</LicenceNumber>
    <ProductName>Coversyl</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>13/05/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1071/003/001A</DrugIDPK>
    <LicenceNumber>PPA1071/003/001A</LicenceNumber>
    <ProductName>Coversyl</ProductName>
    <PAHolder>Primecrown Ltd.</PAHolder>
    <AuthorisedDate>11/11/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril tert-butylamine salt</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/10/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/014/001</DrugIDPK>
    <LicenceNumber>PPA1151/014/001</LicenceNumber>
    <ProductName>Coversyl</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>05/01/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril tert-butylamine salt</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/01/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/014/002</DrugIDPK>
    <LicenceNumber>PPA1151/014/002</LicenceNumber>
    <ProductName>Coversyl</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>05/01/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril tert-butylamine salt</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/01/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/022/001</DrugIDPK>
    <LicenceNumber>PPA1328/022/001</LicenceNumber>
    <ProductName>Coversyl</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>15/09/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril tert-butylamine salt</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/022/002</DrugIDPK>
    <LicenceNumber>PPA1328/022/002</LicenceNumber>
    <ProductName>Coversyl</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>10/11/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril tert-butylamine salt</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/05/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/067/001C</DrugIDPK>
    <LicenceNumber>PPA0465/067/001C</LicenceNumber>
    <ProductName>COVERSYL</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril tert-butylamine salt</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA0465/067/001B</DrugIDPK>
    <LicenceNumber>PPA0465/067/001B</LicenceNumber>
    <ProductName>COVERSYL</ProductName>
    <PAHolder>PCO Manufacturing</PAHolder>
    <AuthorisedDate>23/03/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PERINDOPRIL TERT-BUTYLAMINE SALT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0568/002/001</DrugIDPK>
    <LicenceNumber>PA0568/002/001</LicenceNumber>
    <ProductName>Coversyl 2 mg Tablets</ProductName>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>03/07/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril tert-butylamine salt</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/10/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0568/002/002</DrugIDPK>
    <LicenceNumber>PA0568/002/002</LicenceNumber>
    <ProductName>Coversyl 4 mg Tablets</ProductName>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>03/07/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril tert-butylamine salt</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/10/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0568/002/007</DrugIDPK>
    <LicenceNumber>PA0568/002/007</LicenceNumber>
    <ProductName>Coversyl Arginine</ProductName>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>09/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/02/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/014/003</DrugIDPK>
    <LicenceNumber>PPA1151/014/003</LicenceNumber>
    <InterchangeableListCode>IC0002-001-015</InterchangeableListCode>
    <ProductName>Coversyl Arginine</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>09/11/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/014/004</DrugIDPK>
    <LicenceNumber>PPA1151/014/004</LicenceNumber>
    <InterchangeableListCode>IC0002-002-015</InterchangeableListCode>
    <ProductName>Coversyl Arginine</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>09/11/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/080/001</DrugIDPK>
    <LicenceNumber>PPA1328/080/001</LicenceNumber>
    <InterchangeableListCode>IC0002-001-015</InterchangeableListCode>
    <ProductName>Coversyl Arginine</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>08/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/080/002</DrugIDPK>
    <LicenceNumber>PPA1328/080/002</LicenceNumber>
    <InterchangeableListCode>IC0002-002-015</InterchangeableListCode>
    <ProductName>Coversyl Arginine</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>08/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/060/001</DrugIDPK>
    <LicenceNumber>PPA1447/060/001</LicenceNumber>
    <ProductName>Coversyl Arginine</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>08/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/060/002</DrugIDPK>
    <LicenceNumber>PPA1447/060/002</LicenceNumber>
    <ProductName>Coversyl Arginine</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>08/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/024/001</DrugIDPK>
    <LicenceNumber>PPA1463/024/001</LicenceNumber>
    <InterchangeableListCode>IC0002-001-015</InterchangeableListCode>
    <ProductName>Coversyl Arginine</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>22/05/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/06/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/024/002</DrugIDPK>
    <LicenceNumber>PPA1463/024/002</LicenceNumber>
    <InterchangeableListCode>IC0002-002-015</InterchangeableListCode>
    <ProductName>Coversyl Arginine</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>22/05/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/06/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1473/027/001</DrugIDPK>
    <LicenceNumber>PPA1473/027/001</LicenceNumber>
    <ProductName>Coversyl Arginine</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>31/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/05/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1473/027/002</DrugIDPK>
    <LicenceNumber>PPA1473/027/002</LicenceNumber>
    <ProductName>Coversyl Arginine</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>31/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/05/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/011/001</DrugIDPK>
    <LicenceNumber>PPA1500/011/001</LicenceNumber>
    <ProductName>Coversyl Arginine</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>14/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/011/002</DrugIDPK>
    <LicenceNumber>PPA1500/011/002</LicenceNumber>
    <ProductName>Coversyl Arginine</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>14/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/079/001</DrugIDPK>
    <LicenceNumber>PPA1562/079/001</LicenceNumber>
    <InterchangeableListCode>IC0002-001-015</InterchangeableListCode>
    <ProductName>Coversyl Arginine</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>20/07/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/079/002</DrugIDPK>
    <LicenceNumber>PPA1562/079/002</LicenceNumber>
    <InterchangeableListCode>IC0002-002-015</InterchangeableListCode>
    <ProductName>Coversyl Arginine</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>20/07/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1593/001/001</DrugIDPK>
    <LicenceNumber>PPA1593/001/001</LicenceNumber>
    <ProductName>Coversyl Arginine</ProductName>
    <PAHolder>S.C.A.C Limited</PAHolder>
    <AuthorisedDate>11/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/05/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1593/001/002</DrugIDPK>
    <LicenceNumber>PPA1593/001/002</LicenceNumber>
    <ProductName>Coversyl Arginine</ProductName>
    <PAHolder>S.C.A.C Limited</PAHolder>
    <AuthorisedDate>11/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/05/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/002/001</DrugIDPK>
    <LicenceNumber>PPA1659/002/001</LicenceNumber>
    <ProductName>Coversyl Arginine</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>22/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/002/002</DrugIDPK>
    <LicenceNumber>PPA1659/002/002</LicenceNumber>
    <ProductName>Coversyl Arginine</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>22/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/067/005</DrugIDPK>
    <LicenceNumber>PPA0465/067/005</LicenceNumber>
    <InterchangeableListCode>IC0002-002-015</InterchangeableListCode>
    <ProductName>Coversyl Arginine 10 mg film-coated tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>31/08/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/007/002</DrugIDPK>
    <LicenceNumber>PPA1596/007/002</LicenceNumber>
    <InterchangeableListCode>IC0002-002-015</InterchangeableListCode>
    <ProductName>Coversyl Arginine 10 mg film-coated tablets</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>19/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0568/002/009</DrugIDPK>
    <LicenceNumber>PA0568/002/009</LicenceNumber>
    <ProductName>Coversyl Arginine 10 mg orodispersible tablets</ProductName>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>09/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/04/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/067/004</DrugIDPK>
    <LicenceNumber>PPA0465/067/004</LicenceNumber>
    <InterchangeableListCode>IC0002-001-015</InterchangeableListCode>
    <ProductName>Coversyl Arginine 5 mg film-coated tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>31/08/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/007/001</DrugIDPK>
    <LicenceNumber>PPA1596/007/001</LicenceNumber>
    <InterchangeableListCode>IC0002-001-015</InterchangeableListCode>
    <ProductName>Coversyl Arginine 5 mg film-coated tablets</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>19/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0568/002/008</DrugIDPK>
    <LicenceNumber>PA0568/002/008</LicenceNumber>
    <ProductName>Coversyl Arginine 5 mg orodispersible tablets</ProductName>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>09/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/04/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/122/001</DrugIDPK>
    <LicenceNumber>PPA1328/122/001</LicenceNumber>
    <InterchangeableListCode>IC0039-020-003</InterchangeableListCode>
    <ProductName>Coversyl Arginine Plus</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>06/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Indapamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/039/001</DrugIDPK>
    <LicenceNumber>PPA1463/039/001</LicenceNumber>
    <InterchangeableListCode>IC0039-020-003</InterchangeableListCode>
    <ProductName>Coversyl Arginine Plus</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>27/08/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Indapamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/06/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/039/002</DrugIDPK>
    <LicenceNumber>PPA1463/039/002</LicenceNumber>
    <InterchangeableListCode>IC0039-015-003</InterchangeableListCode>
    <ProductName>Coversyl Arginine Plus</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>05/10/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Indapamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/06/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/063/001</DrugIDPK>
    <LicenceNumber>PPA1562/063/001</LicenceNumber>
    <InterchangeableListCode>IC0039-020-003</InterchangeableListCode>
    <ProductName>Coversyl Arginine Plus</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>04/11/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Indapamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/09/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/085/001</DrugIDPK>
    <LicenceNumber>PPA1151/085/001</LicenceNumber>
    <InterchangeableListCode>IC0039-020-003</InterchangeableListCode>
    <ProductName>COVERSYL ARGININE PLUS</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>14/11/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Indapamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/067/007</DrugIDPK>
    <LicenceNumber>PPA0465/067/007</LicenceNumber>
    <InterchangeableListCode>IC0039-015-003</InterchangeableListCode>
    <ProductName>Coversyl Arginine Plus 10mg/2.5mg film-coated tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>08/06/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Indapamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/063/002</DrugIDPK>
    <LicenceNumber>PPA1562/063/002</LicenceNumber>
    <ProductName>Coversyl Arginine Plus 10mg/2.5mg film-coated tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>01/03/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Indapamide</ActiveSubstance>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/067/006</DrugIDPK>
    <LicenceNumber>PPA0465/067/006</LicenceNumber>
    <InterchangeableListCode>IC0039-020-003</InterchangeableListCode>
    <ProductName>Coversyl Arginine Plus 5mg/ 1.25mg Film-coated Tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>06/06/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Indapamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/012/001</DrugIDPK>
    <LicenceNumber>PPA1500/012/001</LicenceNumber>
    <ProductName>Coversyl Arginine Plus 5mg/1.25mg film-coated tabl</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>31/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Indapamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/031/001</DrugIDPK>
    <LicenceNumber>PPA1596/031/001</LicenceNumber>
    <InterchangeableListCode>IC0039-020-003</InterchangeableListCode>
    <ProductName>COVERSYL ARGININE PLUS 5mg/1.25mg Film-coated Tablets</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>05/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril arginine</ActiveSubstance>
      <ActiveSubstance>Indapamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/067/003</DrugIDPK>
    <LicenceNumber>PPA0465/067/003</LicenceNumber>
    <ProductName>Coversyl Plus</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>03/08/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril tert-butylamine</ActiveSubstance>
      <ActiveSubstance>Indapamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0568/016/001</DrugIDPK>
    <LicenceNumber>PA0568/016/001</LicenceNumber>
    <ProductName>Coversyl Plus 4mg/1.25mg tablets</ProductName>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>14/08/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril tert-butylamine salt</ActiveSubstance>
      <ActiveSubstance>Indapamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/10/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0568/002/003</DrugIDPK>
    <LicenceNumber>PA0568/002/003</LicenceNumber>
    <ProductName>Coversyl Tablets 8 mg</ProductName>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>25/06/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Perindopril tert-butylamine salt</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/10/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/24/1624/001</DrugIDPK>
    <LicenceNumber>EU/1/24/1624/001</LicenceNumber>
    <ProductName>COVID-19 Vaccine (inactivated, adjuvanted) Valneva</ProductName>
    <PAHolder>Valneva Austria GmbH</PAHolder>
    <AuthorisedDate>24/06/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SARS-CoV-2 virus, beta-propiolactone inactivated</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/10/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0176/012/001</DrugIDPK>
    <LicenceNumber>PA0176/012/001</LicenceNumber>
    <ProductName>COX CETRIMIDE ANTISEPTIC</ProductName>
    <PAHolder>Accord-UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/08/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/083/001</DrugIDPK>
    <LicenceNumber>PPA1447/083/001</LicenceNumber>
    <ProductName>Cozaar</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>15/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1473/017/001</DrugIDPK>
    <LicenceNumber>PPA1473/017/001</LicenceNumber>
    <ProductName>Cozaar</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>19/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/10/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1473/017/002</DrugIDPK>
    <LicenceNumber>PPA1473/017/002</LicenceNumber>
    <ProductName>Cozaar</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>19/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/076/001</DrugIDPK>
    <LicenceNumber>PPA1562/076/001</LicenceNumber>
    <ProductName>Cozaar</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>20/04/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/076/002</DrugIDPK>
    <LicenceNumber>PPA1562/076/002</LicenceNumber>
    <ProductName>Cozaar</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>20/04/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1633/013/001</DrugIDPK>
    <LicenceNumber>PPA1633/013/001</LicenceNumber>
    <ProductName>Cozaar</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>07/05/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1633/013/002</DrugIDPK>
    <LicenceNumber>PPA1633/013/002</LicenceNumber>
    <ProductName>Cozaar</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>07/05/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/017/001</DrugIDPK>
    <LicenceNumber>PPA1659/017/001</LicenceNumber>
    <ProductName>Cozaar</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>08/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/017/002</DrugIDPK>
    <LicenceNumber>PPA1659/017/002</LicenceNumber>
    <ProductName>Cozaar</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>08/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/017/003</DrugIDPK>
    <LicenceNumber>PPA1659/017/003</LicenceNumber>
    <ProductName>Cozaar</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>08/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/020/001</DrugIDPK>
    <LicenceNumber>PPA1500/020/001</LicenceNumber>
    <ProductName>COZAAR</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>19/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/020/002</DrugIDPK>
    <LicenceNumber>PPA1500/020/002</LicenceNumber>
    <ProductName>COZAAR</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>19/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/081/002</DrugIDPK>
    <LicenceNumber>PPA1328/081/002</LicenceNumber>
    <ProductName>Cozaar 100mg Film-coated Tablets</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>19/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/003/002</DrugIDPK>
    <LicenceNumber>PPA1596/003/002</LicenceNumber>
    <ProductName>Cozaar 100mg Film-coated Tablets</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/005/002</DrugIDPK>
    <LicenceNumber>PPA1151/005/002</LicenceNumber>
    <ProductName>Cozaar 100mg Film-Coated Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>22/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1286/004/004</DrugIDPK>
    <LicenceNumber>PA1286/004/004</LicenceNumber>
    <ProductName>Cozaar 2.5mg/ml Powder and Solvent for Oral Suspension</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>27/02/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/005/001</DrugIDPK>
    <LicenceNumber>PPA1151/005/001</LicenceNumber>
    <ProductName>Cozaar 50 mg Film-Coated Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>30/07/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/081/001</DrugIDPK>
    <LicenceNumber>PPA1328/081/001</LicenceNumber>
    <ProductName>Cozaar 50mg Film-coated Tablets</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>19/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/003/001</DrugIDPK>
    <LicenceNumber>PPA1596/003/001</LicenceNumber>
    <ProductName>Cozaar 50mg Film-coated Tablets</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/080/001</DrugIDPK>
    <LicenceNumber>PPA1447/080/001</LicenceNumber>
    <ProductName>Cozaar Comp</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>15/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/092/001</DrugIDPK>
    <LicenceNumber>PPA1463/092/001</LicenceNumber>
    <ProductName>Cozaar Comp</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>07/03/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/05/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/092/002</DrugIDPK>
    <LicenceNumber>PPA1463/092/002</LicenceNumber>
    <ProductName>Cozaar Comp</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>07/03/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/05/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/038/001</DrugIDPK>
    <LicenceNumber>PPA1596/038/001</LicenceNumber>
    <ProductName>Cozaar Comp</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>21/01/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/038/002</DrugIDPK>
    <LicenceNumber>PPA1596/038/002</LicenceNumber>
    <ProductName>Cozaar Comp</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>21/01/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/016/001</DrugIDPK>
    <LicenceNumber>PPA1659/016/001</LicenceNumber>
    <ProductName>Cozaar Comp</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>08/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/016/002</DrugIDPK>
    <LicenceNumber>PPA1659/016/002</LicenceNumber>
    <ProductName>Cozaar Comp</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>08/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/016/003</DrugIDPK>
    <LicenceNumber>PPA1659/016/003</LicenceNumber>
    <ProductName>Cozaar Comp</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>08/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
      <ActiveSubstance>Hydrocholothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/091/001</DrugIDPK>
    <LicenceNumber>PPA1328/091/001</LicenceNumber>
    <ProductName>COZAAR Comp</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>03/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/091/002</DrugIDPK>
    <LicenceNumber>PPA1328/091/002</LicenceNumber>
    <ProductName>COZAAR Comp</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>03/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA013639/048/478</DrugIDPK>
    <LicenceNumber>PA013639/048/478</LicenceNumber>
    <ProductName>Cozaar Comp 100 mg/12.5 mg film-coated tablets</ProductName>
    <PAHolder>IMB- Test Agent Company</PAHolder>
    <AuthorisedDate>22/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Infus/Pdr/Oral Soln</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1151/095/001</DrugIDPK>
    <LicenceNumber>PPA1151/095/001</LicenceNumber>
    <ProductName>Cozaar Comp 100mg/25mg film-coated tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>24/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/095/002</DrugIDPK>
    <LicenceNumber>PPA1151/095/002</LicenceNumber>
    <ProductName>Cozaar Comp 50mg/12.5mg film-coated tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/082/002</DrugIDPK>
    <LicenceNumber>PA0035/082/002</LicenceNumber>
    <ProductName>Cozaar Initiation Pack for Heart Failure</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>21/12/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/06/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/167/002</DrugIDPK>
    <LicenceNumber>PA0126/167/002</LicenceNumber>
    <InterchangeableListCode>IC0003-024-003</InterchangeableListCode>
    <ProductName>Cozatan 100 mg Film-coated Tablets</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>14/09/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/03/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/167/001</DrugIDPK>
    <LicenceNumber>PA0126/167/001</LicenceNumber>
    <InterchangeableListCode>IC0003-023-003</InterchangeableListCode>
    <ProductName>Cozatan 50 mg Film-coated Tablets</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>14/09/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/03/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/184/002</DrugIDPK>
    <LicenceNumber>PA0126/184/002</LicenceNumber>
    <InterchangeableListCode>IC0031-027-003</InterchangeableListCode>
    <ProductName>Cozatan Comp 100 mg/25 mg film-coated tablets</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>23/01/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/03/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/184/001</DrugIDPK>
    <LicenceNumber>PA0126/184/001</LicenceNumber>
    <InterchangeableListCode>IC0031-025-003</InterchangeableListCode>
    <ProductName>Cozatan Comp 50 mg/12.5 mg film-coated tablets</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>23/01/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Losartan potassium</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/03/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0114/035/001</DrugIDPK>
    <LicenceNumber>PA0114/035/001</LicenceNumber>
    <ProductName>CRADOCAP SHAMPOO</ProductName>
    <PAHolder>Napp Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/01/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0294/008/002</DrugIDPK>
    <LicenceNumber>PA0294/008/002</LicenceNumber>
    <ProductName>CREANOL</ProductName>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>08/08/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0294/008/001</DrugIDPK>
    <LicenceNumber>PA0294/008/001</LicenceNumber>
    <ProductName>CREANOL</ProductName>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>08/08/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPRANOLOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0294/014/002</DrugIDPK>
    <LicenceNumber>PA0294/014/002</LicenceNumber>
    <ProductName>CREFED</ProductName>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>20/04/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0294/014/001</DrugIDPK>
    <LicenceNumber>PA0294/014/001</LicenceNumber>
    <ProductName>CREFED</ProductName>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>20/04/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NIFEDIPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0894/001/001</DrugIDPK>
    <LicenceNumber>PA0894/001/001</LicenceNumber>
    <ProductName>Cremalgin Balm</ProductName>
    <PAHolder>Co-Pharma Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methyl nicotinate</ActiveSubstance>
      <ActiveSubstance>Capsicum frutescens</ActiveSubstance>
      <ActiveSubstance>Glycol monosalicylate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0082/045/001</DrugIDPK>
    <LicenceNumber>PA0082/045/001</LicenceNumber>
    <ProductName>CREMALGIN BALM</ProductName>
    <PAHolder>Berk Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAPSAICIN</ActiveSubstance>
      <ActiveSubstance>METHYL NICOTINATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/10/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/092/001</DrugIDPK>
    <LicenceNumber>PA0040/092/001</LicenceNumber>
    <ProductName>CREMALGIN BALM</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>25/03/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYL NICOTINATE</ActiveSubstance>
      <ActiveSubstance>GLYCOL MONOSALICYLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/05/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/006/001</DrugIDPK>
    <LicenceNumber>PA0035/006/001</LicenceNumber>
    <ProductName>CREMOMYCIN  (SUSPENSION)</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEOMYCIN</ActiveSubstance>
      <ActiveSubstance>SUCCINYLSULFATHIAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/04/1980</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/005/001</DrugIDPK>
    <LicenceNumber>PA0035/005/001</LicenceNumber>
    <ProductName>CREMOSTREP  (SUSPENSION)</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUCCINYLSULFATHIAZOLE</ActiveSubstance>
      <ActiveSubstance>STREPTOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/04/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/007/001</DrugIDPK>
    <LicenceNumber>PA0035/007/001</LicenceNumber>
    <ProductName>CREMOSUXIDINE  (SUSPENSION)</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SUCCINYLSULFATHIAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/04/1980</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1392/017/001</DrugIDPK>
    <LicenceNumber>DPR1392/017/001</LicenceNumber>
    <ProductName>Creon</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>29/11/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pancreatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/007/001</DrugIDPK>
    <LicenceNumber>DPR1473/007/001</LicenceNumber>
    <ProductName>Creon</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>26/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pancreas powder</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1473/018/001</DrugIDPK>
    <LicenceNumber>PPA1473/018/001</LicenceNumber>
    <ProductName>Creon</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>22/05/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pancreatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/08/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/081/001</DrugIDPK>
    <LicenceNumber>PPA1500/081/001</LicenceNumber>
    <ProductName>Creon</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>06/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pancreatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/008/001</DrugIDPK>
    <LicenceNumber>PPA1562/008/001</LicenceNumber>
    <ProductName>Creon</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>18/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pancreatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/11/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/008/002</DrugIDPK>
    <LicenceNumber>PPA1562/008/002</LicenceNumber>
    <ProductName>Creon</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>14/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pancreatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/11/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1463/009/001</DrugIDPK>
    <LicenceNumber>DPR1463/009/001</LicenceNumber>
    <ProductName>CREON</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>13/03/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pancreas powder</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1328/065/002</DrugIDPK>
    <LicenceNumber>PPA1328/065/002</LicenceNumber>
    <ProductName>CREON</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>15/12/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pancreatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0410/001/001</DrugIDPK>
    <LicenceNumber>PA0410/001/001</LicenceNumber>
    <ProductName>CREON</ProductName>
    <PAHolder>Abbott Products GmbH</PAHolder>
    <AuthorisedDate>08/08/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/03/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1473/018/002</DrugIDPK>
    <LicenceNumber>PPA1473/018/002</LicenceNumber>
    <ProductName>Creon 10000</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>09/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/08/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1151/002/001</DrugIDPK>
    <LicenceNumber>DPR1151/002/001</LicenceNumber>
    <ProductName>CREON 10000</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>11/04/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pancreatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1328/065/001</DrugIDPK>
    <LicenceNumber>PPA1328/065/001</LicenceNumber>
    <ProductName>CREON 10000</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>15/12/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pancreatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1596/017/001</DrugIDPK>
    <LicenceNumber>DPR1596/017/001</LicenceNumber>
    <ProductName>Creon 10000 Capsules</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pancreas powder</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1601/007/001</DrugIDPK>
    <LicenceNumber>DPR1601/007/001</LicenceNumber>
    <ProductName>Creon 10000 Capsules</ProductName>
    <PAHolder>Belfast Drug Ltd.</PAHolder>
    <AuthorisedDate>28/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pancreas powder</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1463/033/001</DrugIDPK>
    <LicenceNumber>PPA1463/033/001</LicenceNumber>
    <ProductName>Creon 10000 Gastro-resistant Capsules</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>12/02/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pancreatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/143/002</DrugIDPK>
    <LicenceNumber>PPA1562/143/002</LicenceNumber>
    <ProductName>Creon 10000 Gastro-resistant Capsules</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>13/02/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pancreatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/04/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23080/019/001</DrugIDPK>
    <LicenceNumber>PPA23080/019/001</LicenceNumber>
    <ProductName>Creon 10000 Gastro-resistant Capsules</ProductName>
    <PAHolder>Merit Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>16/02/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lipase</ActiveSubstance>
      <ActiveSubstance>Amylase</ActiveSubstance>
      <ActiveSubstance>Protease</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/05/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0108/025/003</DrugIDPK>
    <LicenceNumber>PA0108/025/003</LicenceNumber>
    <ProductName>CREON 20000</ProductName>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>18/05/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Gastro-Resistant</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/02/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1915/007/001</DrugIDPK>
    <LicenceNumber>PPA1915/007/001</LicenceNumber>
    <ProductName>Creon 25000 300 mg Gastro-Resistant Capsules</ProductName>
    <PAHolder>Chemilines Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>02/08/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pancreatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1562/143/001</DrugIDPK>
    <LicenceNumber>PPA1562/143/001</LicenceNumber>
    <ProductName>Creon 25000 gastro-resistant capsules</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>13/02/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pancreatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/065/002</DrugIDPK>
    <LicenceNumber>PPA1151/065/002</LicenceNumber>
    <ProductName>Creon 25000 Gastro-resistant Capsules</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>20/06/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pancreatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2010/008/003</DrugIDPK>
    <LicenceNumber>PA2010/008/003</LicenceNumber>
    <ProductName>Creon 40000 Gastro-resistant Capsules</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>08/09/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pancreas powder</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/11/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0187/006/001</DrugIDPK>
    <LicenceNumber>PA0187/006/001</LicenceNumber>
    <ProductName>CRESCORMON</ProductName>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>26/11/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GROWTH HORMONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/04/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0196/008/001</DrugIDPK>
    <LicenceNumber>PA0196/008/001</LicenceNumber>
    <ProductName>CRESOPHENE</ProductName>
    <PAHolder>Septodont</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
      <ActiveSubstance>THYMOL</ActiveSubstance>
      <ActiveSubstance>PARACHLOROPHENOL, CAMPHORATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1392/062/001</DrugIDPK>
    <LicenceNumber>DPR1392/062/001</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>19/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/062/002</DrugIDPK>
    <LicenceNumber>DPR1392/062/002</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>19/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/062/003</DrugIDPK>
    <LicenceNumber>DPR1392/062/003</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>19/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/062/004</DrugIDPK>
    <LicenceNumber>DPR1392/062/004</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>19/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA0465/140/001</DrugIDPK>
    <LicenceNumber>PPA0465/140/001</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>07/06/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/140/002</DrugIDPK>
    <LicenceNumber>PPA0465/140/002</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>07/06/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/059/001</DrugIDPK>
    <LicenceNumber>PPA1328/059/001</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>08/09/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/059/002</DrugIDPK>
    <LicenceNumber>PPA1328/059/002</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>27/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/059/003</DrugIDPK>
    <LicenceNumber>PPA1328/059/003</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>22/12/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/059/004</DrugIDPK>
    <LicenceNumber>PPA1328/059/004</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>13/08/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/03/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/089/001</DrugIDPK>
    <LicenceNumber>PPA1447/089/001</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>27/01/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/089/002</DrugIDPK>
    <LicenceNumber>PPA1447/089/002</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>27/01/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/030/001</DrugIDPK>
    <LicenceNumber>PPA1463/030/001</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>29/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin calcium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/05/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/030/002</DrugIDPK>
    <LicenceNumber>PPA1463/030/002</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>08/06/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/05/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/030/003</DrugIDPK>
    <LicenceNumber>PPA1463/030/003</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>24/09/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/05/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/002/001</DrugIDPK>
    <LicenceNumber>PPA1500/002/001</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>08/05/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/002/002</DrugIDPK>
    <LicenceNumber>PPA1500/002/002</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>18/06/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1592/002/001</DrugIDPK>
    <LicenceNumber>PPA1592/002/001</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>Pharma First Limited</PAHolder>
    <AuthorisedDate>16/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/09/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1592/002/002</DrugIDPK>
    <LicenceNumber>PPA1592/002/002</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>Pharma First Limited</PAHolder>
    <AuthorisedDate>16/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/09/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1592/002/003</DrugIDPK>
    <LicenceNumber>PPA1592/002/003</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>Pharma First Limited</PAHolder>
    <AuthorisedDate>16/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/09/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1633/005/001</DrugIDPK>
    <LicenceNumber>PPA1633/005/001</LicenceNumber>
    <InterchangeableListCode>IC0006-002-003</InterchangeableListCode>
    <ProductName>Crestor</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>20/08/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1633/005/002</DrugIDPK>
    <LicenceNumber>PPA1633/005/002</LicenceNumber>
    <InterchangeableListCode>IC0006-003-003</InterchangeableListCode>
    <ProductName>Crestor</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>20/08/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1633/005/003</DrugIDPK>
    <LicenceNumber>PPA1633/005/003</LicenceNumber>
    <InterchangeableListCode>IC0006-004-003</InterchangeableListCode>
    <ProductName>Crestor</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>20/08/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/003/001</DrugIDPK>
    <LicenceNumber>PPA1659/003/001</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>08/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/003/002</DrugIDPK>
    <LicenceNumber>PPA1659/003/002</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>08/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/003/003</DrugIDPK>
    <LicenceNumber>PPA1659/003/003</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>08/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/003/004</DrugIDPK>
    <LicenceNumber>PPA1659/003/004</LicenceNumber>
    <ProductName>Crestor</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>08/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/044/002</DrugIDPK>
    <LicenceNumber>PPA1151/044/002</LicenceNumber>
    <InterchangeableListCode>IC0006-002-003</InterchangeableListCode>
    <ProductName>Crestor 10 mg film-coated tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>02/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/025/002</DrugIDPK>
    <LicenceNumber>PPA1596/025/002</LicenceNumber>
    <ProductName>Crestor 10 mg film-coated tablets</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/044/001</DrugIDPK>
    <LicenceNumber>PPA1151/044/001</LicenceNumber>
    <InterchangeableListCode>IC0006-003-003</InterchangeableListCode>
    <ProductName>Crestor 20 mg film-coated tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>09/11/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/025/001</DrugIDPK>
    <LicenceNumber>PPA1596/025/001</LicenceNumber>
    <ProductName>Crestor 20 mg film-coated tablets</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>08/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/044/004</DrugIDPK>
    <LicenceNumber>PPA1151/044/004</LicenceNumber>
    <InterchangeableListCode>IC0006-004-003</InterchangeableListCode>
    <ProductName>Crestor 40 mg film-coated tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>27/03/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/140/003</DrugIDPK>
    <LicenceNumber>PPA0465/140/003</LicenceNumber>
    <ProductName>Crestor 40mg Film-coated Tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>07/06/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/12/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/044/003</DrugIDPK>
    <LicenceNumber>PPA1151/044/003</LicenceNumber>
    <InterchangeableListCode>IC0006-001-003</InterchangeableListCode>
    <ProductName>Crestor 5 mg film-coated tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>27/03/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/140/004</DrugIDPK>
    <LicenceNumber>PPA0465/140/004</LicenceNumber>
    <ProductName>Crestor 5mg Film-coated Tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>06/08/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/12/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/239/001</DrugIDPK>
    <LicenceNumber>PA0126/239/001</LicenceNumber>
    <ProductName>Crevastin</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>20/07/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/03/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/239/002</DrugIDPK>
    <LicenceNumber>PA0126/239/002</LicenceNumber>
    <ProductName>Crevastin</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>20/07/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/03/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/239/003</DrugIDPK>
    <LicenceNumber>PA0126/239/003</LicenceNumber>
    <ProductName>Crevastin</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>20/07/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/03/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/239/004</DrugIDPK>
    <LicenceNumber>PA0126/239/004</LicenceNumber>
    <ProductName>Crevastin</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>20/07/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/03/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/239/005</DrugIDPK>
    <LicenceNumber>PA0126/239/005</LicenceNumber>
    <ProductName>Crevastin</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>20/07/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rosuvastatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/03/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0285/013/001</DrugIDPK>
    <LicenceNumber>PA0285/013/001</LicenceNumber>
    <ProductName>Crinone 4% w/w progesterone vaginal gel</ProductName>
    <PAHolder>Serono Limited</PAHolder>
    <AuthorisedDate>25/07/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Progesterone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1151/235/001</DrugIDPK>
    <LicenceNumber>PPA1151/235/001</LicenceNumber>
    <ProductName>Crinone 8% w/w progesterone vaginal gel</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>15/08/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Progesterone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/146/001</DrugIDPK>
    <LicenceNumber>PPA1562/146/001</LicenceNumber>
    <ProductName>Crinone 8% w/w progesterone vaginal gel</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>06/03/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Progesterone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This authorisation permits the holder to parallel-distribute product marketed in Ireland under the product authorisation number PA654/021/001.</SupplyComments>
    <WithdrawalDate>30/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23176/031/001</DrugIDPK>
    <LicenceNumber>PPA23176/031/001</LicenceNumber>
    <ProductName>Crinone 8% w/w progesterone vaginal gel</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>10/07/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Progesterone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/96/024/001</DrugIDPK>
    <LicenceNumber>EU/1/96/024/001</LicenceNumber>
    <ProductName>Crixivan</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme BV</PAHolder>
    <AuthorisedDate>04/10/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Indinavir sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>26/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/96/024/002</DrugIDPK>
    <LicenceNumber>EU/1/96/024/002</LicenceNumber>
    <ProductName>Crixivan</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme BV</PAHolder>
    <AuthorisedDate>04/10/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Indinavir sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>26/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/96/024/003</DrugIDPK>
    <LicenceNumber>EU/1/96/024/003</LicenceNumber>
    <ProductName>Crixivan</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme BV</PAHolder>
    <AuthorisedDate>04/10/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Indinavir sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>26/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/96/024/004</DrugIDPK>
    <LicenceNumber>EU/1/96/024/004</LicenceNumber>
    <ProductName>Crixivan</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme BV</PAHolder>
    <AuthorisedDate>04/10/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Indinavir sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>26/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/96/024/005</DrugIDPK>
    <LicenceNumber>EU/1/96/024/005</LicenceNumber>
    <ProductName>Crixivan</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme BV</PAHolder>
    <AuthorisedDate>04/10/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Indinavir sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>26/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/96/024/006</DrugIDPK>
    <LicenceNumber>EU/1/96/024/006</LicenceNumber>
    <ProductName>Crixivan</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Indinavir sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/96/024/007</DrugIDPK>
    <LicenceNumber>EU/1/96/024/007</LicenceNumber>
    <ProductName>Crixivan</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme BV</PAHolder>
    <AuthorisedDate>13/04/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Indinavir sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>26/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/96/024/008</DrugIDPK>
    <LicenceNumber>EU/1/96/024/008</LicenceNumber>
    <ProductName>Crixivan</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme BV</PAHolder>
    <AuthorisedDate>13/04/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Indinavir sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>26/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/96/024/010</DrugIDPK>
    <LicenceNumber>EU/1/96/024/010</LicenceNumber>
    <ProductName>Crixivan</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme BV</PAHolder>
    <AuthorisedDate>16/11/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Indinavir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>26/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0072/027/001</DrugIDPK>
    <LicenceNumber>PA0072/027/001</LicenceNumber>
    <ProductName>CROMAIR</ProductName>
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>19/04/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/04/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/022/003</DrugIDPK>
    <LicenceNumber>PA0436/022/003</LicenceNumber>
    <ProductName>Cromogen Easi-Breathe Inhaler</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium cromoglycate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Not applicable</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Unknown</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/11/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/022/002</DrugIDPK>
    <LicenceNumber>PA0436/022/002</LicenceNumber>
    <ProductName>Cromogen Inhaler</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium cromoglycate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Not applicable</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Unknown</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/11/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/022/001</DrugIDPK>
    <LicenceNumber>PA0436/022/001</LicenceNumber>
    <ProductName>CROMOGEN INHALER</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>26/11/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/11/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/059/001</DrugIDPK>
    <LicenceNumber>PA0282/059/001</LicenceNumber>
    <ProductName>CROMOGEN STERI-NEB</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>08/01/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/01/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0043/001/001</DrugIDPK>
    <LicenceNumber>PA0043/001/001</LicenceNumber>
    <ProductName>CROOKES HALIBUT LIVER OIL</ProductName>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>21/07/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0043/037/001</DrugIDPK>
    <LicenceNumber>PA0043/037/001</LicenceNumber>
    <ProductName>Crookes Ibuprofen Liquid</ProductName>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>14/12/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>ZZZ Not applicable</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/12/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0043/002/001</DrugIDPK>
    <LicenceNumber>PA0043/002/001</LicenceNumber>
    <ProductName>CROOKES ONE-A-DAY WITH IRON</ProductName>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>16/03/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/01/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0043/005/001</DrugIDPK>
    <LicenceNumber>PA0043/005/001</LicenceNumber>
    <ProductName>CROOKES ONE-A-DAY WITHOUT IRON</ProductName>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>05/03/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL PALMITATE</ActiveSubstance>
      <ActiveSubstance>THIAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/01/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0043/038/001</DrugIDPK>
    <LicenceNumber>PA0043/038/001</LicenceNumber>
    <ProductName>Crookes Spot Treatment Cream Regular - Colourless</ProductName>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sulfur</ActiveSubstance>
      <ActiveSubstance>Triclosan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0043/038/002</DrugIDPK>
    <LicenceNumber>PA0043/038/002</LicenceNumber>
    <ProductName>Crookes Spot Treatment Cream Regular - Cover Up</ProductName>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sulfur</ActiveSubstance>
      <ActiveSubstance>Triclosan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0072/011/001</DrugIDPK>
    <LicenceNumber>PA0072/011/001</LicenceNumber>
    <ProductName>CRUEX MEDICATED</ProductName>
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>26/03/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALCIUM UNDECYLEN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/02/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0023/051/001</DrugIDPK>
    <LicenceNumber>PA0023/051/001</LicenceNumber>
    <ProductName>CRYPTOCUR</ProductName>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>07/05/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GONADORELIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/02/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0469/016/001</DrugIDPK>
    <LicenceNumber>PA0469/016/001</LicenceNumber>
    <ProductName>Crystacide</ProductName>
    <PAHolder>Bioglan Laboratories Ltd</PAHolder>
    <AuthorisedDate>03/01/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Hydrogen peroxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/016/001</DrugIDPK>
    <LicenceNumber>PA0044/016/001</LicenceNumber>
    <ProductName>CRYSTAMYCIN</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZYLPENICILLIN</ActiveSubstance>
      <ActiveSubstance>STREPTOMYCIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/017/002</DrugIDPK>
    <LicenceNumber>PA0044/017/002</LicenceNumber>
    <ProductName>CRYSTAPEN INJECTION</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>26/10/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GRISEOFULVIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/017/001</DrugIDPK>
    <LicenceNumber>PA0044/017/001</LicenceNumber>
    <ProductName>CRYSTAPEN INJECTION</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>26/10/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZYLPENICILLIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/10/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1239/009/001</DrugIDPK>
    <LicenceNumber>PA1239/009/001</LicenceNumber>
    <ProductName>Cuenca</ProductName>
    <PAHolder>Laboratorios LICONSA, S.A.</PAHolder>
    <AuthorisedDate>20/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1239/009/002</DrugIDPK>
    <LicenceNumber>PA1239/009/002</LicenceNumber>
    <ProductName>Cuenca</ProductName>
    <PAHolder>Laboratorios LICONSA, S.A.</PAHolder>
    <AuthorisedDate>20/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1239/009/003</DrugIDPK>
    <LicenceNumber>PA1239/009/003</LicenceNumber>
    <ProductName>Cuenca</ProductName>
    <PAHolder>Laboratorios LICONSA, S.A.</PAHolder>
    <AuthorisedDate>20/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1239/009/004</DrugIDPK>
    <LicenceNumber>PA1239/009/004</LicenceNumber>
    <ProductName>Cuenca</ProductName>
    <PAHolder>Laboratorios LICONSA, S.A.</PAHolder>
    <AuthorisedDate>20/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/004/001</DrugIDPK>
    <LicenceNumber>PA0073/004/001</LicenceNumber>
    <ProductName>CULANT</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>11/10/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENHYDRAMINE</ActiveSubstance>
      <ActiveSubstance>CALAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/08/1981</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0294/005/002</DrugIDPK>
    <LicenceNumber>PA0294/005/002</LicenceNumber>
    <ProductName>Cunil</ProductName>
    <PAHolder>Helsinn Birex Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/05/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ibuprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/05/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0258/007/001</DrugIDPK>
    <LicenceNumber>PA0258/007/001</LicenceNumber>
    <ProductName>Cupal</ProductName>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
      <ActiveSubstance>Caffeine</ActiveSubstance>
      <ActiveSubstance>Phenylephrine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0258/011/001</DrugIDPK>
    <LicenceNumber>PA0258/011/001</LicenceNumber>
    <ProductName>Cupal Cold/Flu with Cough Suppressant</ProductName>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
      <ActiveSubstance>Dextromethorphan hydrobromide</ActiveSubstance>
      <ActiveSubstance>Phenylephrine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0258/039/001</DrugIDPK>
    <LicenceNumber>PA0258/039/001</LicenceNumber>
    <ProductName>Cupal Decongestant Inhalent</ProductName>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation vapour, capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Camphor</ActiveSubstance>
      <ActiveSubstance>Menthol</ActiveSubstance>
      <ActiveSubstance>Turpentine oil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/11/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0710/002/001</DrugIDPK>
    <LicenceNumber>PA0710/002/001</LicenceNumber>
    <ProductName>Cuplex</ProductName>
    <PAHolder>Smith &amp; Nephew Pharmaceuticals</PAHolder>
    <AuthorisedDate>30/09/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Salicylic acid</ActiveSubstance>
      <ActiveSubstance>Lactic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/04/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/011/002</DrugIDPK>
    <LicenceNumber>PA0035/011/002</LicenceNumber>
    <ProductName>CUPRIMINE</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENICILLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/03/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/011/001</DrugIDPK>
    <LicenceNumber>PA0035/011/001</LicenceNumber>
    <ProductName>CUPRIMINE (PENICILLLAMINE)</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>14/03/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENICILLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/1986</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>HOR0407/023/001</DrugIDPK>
    <LicenceNumber>HOR0407/023/001</LicenceNumber>
    <ProductName>Cuprum metallicum (Cuprum. met.) (6C &amp; 30C)</ProductName>
    <PAHolder>Weleda (UK) Limited</PAHolder>
    <AuthorisedDate>20/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cuprum metallicum</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0012/081/001</DrugIDPK>
    <LicenceNumber>PA0012/081/001</LicenceNumber>
    <ProductName>Curandron</ProductName>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>26/11/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cyproterone acetate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/08/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0043/027/002</DrugIDPK>
    <LicenceNumber>PA0043/027/002</LicenceNumber>
    <ProductName>Curatoderm</ProductName>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>02/12/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tacalcitol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/09/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0043/027/001</DrugIDPK>
    <LicenceNumber>PA0043/027/001</LicenceNumber>
    <ProductName>Curatoderm Ointment 4 mcg/g</ProductName>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>13/11/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tacalcitol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/11/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0484/013/001</DrugIDPK>
    <LicenceNumber>PA0484/013/001</LicenceNumber>
    <ProductName>CUREA</ProductName>
    <PAHolder>Foran Healthcare Limited,</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Coal tar solution</ActiveSubstance>
      <ActiveSubstance>Urea</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/11/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/094/002</DrugIDPK>
    <LicenceNumber>PA0044/094/002</LicenceNumber>
    <ProductName>CUTIVATE</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>16/11/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/11/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/094/001</DrugIDPK>
    <LicenceNumber>PA0044/094/001</LicenceNumber>
    <ProductName>CUTIVATE</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>16/11/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUTICASONE PROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/11/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA011836/062/096</DrugIDPK>
    <LicenceNumber>PA011836/062/096</LicenceNumber>
    <ProductName>cvgdfg</ProductName>
    <PAHolder>IMB Test Pharmaceutical Company</PAHolder>
    <AuthorisedDate>09/01/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/001/001</DrugIDPK>
    <LicenceNumber>PA0038/001/001</LicenceNumber>
    <ProductName>CVK 250</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/06/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0240/016/001</DrugIDPK>
    <LicenceNumber>PA0240/016/001</LicenceNumber>
    <ProductName>CYANOCOBALAMIN</ProductName>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>26/11/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cyanocobalamin (57 co)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1809/011/001</DrugIDPK>
    <LicenceNumber>PA1809/011/001</LicenceNumber>
    <ProductName>Cyclizine hydrochloride</ProductName>
    <PAHolder>Cipla (EU) Limited</PAHolder>
    <AuthorisedDate>09/01/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLIZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/05/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/033/001</DrugIDPK>
    <LicenceNumber>PA0549/033/001</LicenceNumber>
    <ProductName>Cyclizine Lactate 50 mg/ml Solution for Injection</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>13/08/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cyclizine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/07/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0012/023/001</DrugIDPK>
    <LicenceNumber>PA0012/023/001</LicenceNumber>
    <ProductName>CYCLO PROGYNOVA</ProductName>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>NORGESTREL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0102/005/001</DrugIDPK>
    <LicenceNumber>PA0102/005/001</LicenceNumber>
    <ProductName>CYCLOBRAL</ProductName>
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>12/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLANDELATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/04/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0236/010/001</DrugIDPK>
    <LicenceNumber>PA0236/010/001</LicenceNumber>
    <ProductName>Cyclophosphamide</ProductName>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cyclophosphamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0236/010/005</DrugIDPK>
    <LicenceNumber>PA0236/010/005</LicenceNumber>
    <ProductName>CYCLOPHOSPHAMIDE</ProductName>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>08/05/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLOPHOSPHAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/01/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0236/010/004</DrugIDPK>
    <LicenceNumber>PA0236/010/004</LicenceNumber>
    <ProductName>CYCLOPHOSPHAMIDE</ProductName>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>08/05/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLOPHOSPHAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/01/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0236/010/003</DrugIDPK>
    <LicenceNumber>PA0236/010/003</LicenceNumber>
    <ProductName>CYCLOPHOSPHAMIDE</ProductName>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>08/05/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLOPHOSPHAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/01/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0236/010/002</DrugIDPK>
    <LicenceNumber>PA0236/010/002</LicenceNumber>
    <ProductName>CYCLOPHOSPHAMIDE</ProductName>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>08/05/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLOPHOSPHAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/01/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0208/010/001</DrugIDPK>
    <LicenceNumber>PA0208/010/001</LicenceNumber>
    <ProductName>CYCLOPROPANE</ProductName>
    <PAHolder>BOC Gases Ireland Ltd</PAHolder>
    <AuthorisedDate>01/04/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/018/002</DrugIDPK>
    <LicenceNumber>PA0047/018/002</LicenceNumber>
    <ProductName>CYCLOSERINE</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/018/001</DrugIDPK>
    <LicenceNumber>PA0047/018/001</LicenceNumber>
    <ProductName>CYCLOSERINE</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/001/002</DrugIDPK>
    <LicenceNumber>PA0062/001/002</LicenceNumber>
    <ProductName>CYCLOSPASMOL</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>15/05/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/001/001</DrugIDPK>
    <LicenceNumber>PA0062/001/001</LicenceNumber>
    <ProductName>CYCLOSPASMOL (SUSPENSION)</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>17/01/1974</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/001/004</DrugIDPK>
    <LicenceNumber>PA0062/001/004</LicenceNumber>
    <ProductName>CYCLOSPASMOL DISPERSIBLE</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>26/06/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/12/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0508/004/001</DrugIDPK>
    <LicenceNumber>PA0508/004/001</LicenceNumber>
    <ProductName>CYCROMATE 20</ProductName>
    <PAHolder>B.V. Pharbita</PAHolder>
    <AuthorisedDate>24/03/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation powder, hard capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/08/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0003/003/001</DrugIDPK>
    <LicenceNumber>PA0003/003/001</LicenceNumber>
    <ProductName>CYFOL</ProductName>
    <PAHolder>Rybar Laboratories Ltd</PAHolder>
    <AuthorisedDate>01/04/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FERROUS GLUCONATE</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/001/002</DrugIDPK>
    <LicenceNumber>PA0936/001/002</LicenceNumber>
    <ProductName>CYKLO Q</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>25/06/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRANEXAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/001/001</DrugIDPK>
    <LicenceNumber>PA0936/001/001</LicenceNumber>
    <ProductName>CYKLO-F</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>23/03/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRANEXAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/12/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/008/003</DrugIDPK>
    <LicenceNumber>PA0936/008/003</LicenceNumber>
    <ProductName>Cyklokapron</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tranexamic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/12/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/17/1240/001-004</DrugIDPK>
    <LicenceNumber>EU/1/17/1240/001-004</LicenceNumber>
    <ProductName>Cyltezo</ProductName>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection in pre-filled syringe</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Adalimumab</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>15/01/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/17/1240/005-008</DrugIDPK>
    <LicenceNumber>EU/1/17/1240/005-008</LicenceNumber>
    <ProductName>Cyltezo</ProductName>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>10/11/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection in pre-filled pen</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Adalimumab</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>15/01/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/051/001</DrugIDPK>
    <LicenceNumber>PA1380/051/001</LicenceNumber>
    <ProductName>Cymalon granules for oral solution</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>08/02/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium bicarbonate</ActiveSubstance>
      <ActiveSubstance>Sodium citrate dihydrate</ActiveSubstance>
      <ActiveSubstance>Sodium carbonate anhydrous</ActiveSubstance>
      <ActiveSubstance>Citric acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/11/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/125/001</DrugIDPK>
    <LicenceNumber>PA0050/125/001</LicenceNumber>
    <ProductName>Cymevene</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ganciclovir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/07/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1465/005/001</DrugIDPK>
    <LicenceNumber>DPR1465/005/001</LicenceNumber>
    <ProductName>Cymex</ProductName>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>25/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Urea</ActiveSubstance>
      <ActiveSubstance>Cetrimide</ActiveSubstance>
      <ActiveSubstance>Chlorocresol</ActiveSubstance>
      <ActiveSubstance>Dimethicone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0405/032/001</DrugIDPK>
    <LicenceNumber>PA0405/032/001</LicenceNumber>
    <ProductName>Cyproterone Acetate</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cyproterone acetate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/032/002</DrugIDPK>
    <LicenceNumber>PA0405/032/002</LicenceNumber>
    <ProductName>Cyproterone Acetate/Ethinylestradiol</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>10/12/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cyproterone acetate</ActiveSubstance>
      <ActiveSubstance>Ethinylestradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/11/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/045/004</DrugIDPK>
    <LicenceNumber>PA0007/045/004</LicenceNumber>
    <ProductName>CYSTOGARD</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>03/01/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESNA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/045/003</DrugIDPK>
    <LicenceNumber>PA0007/045/003</LicenceNumber>
    <ProductName>CYSTOGARD</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>03/01/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESNA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/045/002</DrugIDPK>
    <LicenceNumber>PA0007/045/002</LicenceNumber>
    <ProductName>CYSTOGARD</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>03/01/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESNA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/045/001</DrugIDPK>
    <LicenceNumber>PA0007/045/001</LicenceNumber>
    <ProductName>CYSTOGARD</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>03/01/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MESNA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0258/034/001</DrugIDPK>
    <LicenceNumber>PA0258/034/001</LicenceNumber>
    <ProductName>Cystoleve Sachets</ProductName>
    <PAHolder>Cupal Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium citrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/01/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/280/001</DrugIDPK>
    <LicenceNumber>PPA0465/280/001</LicenceNumber>
    <ProductName>Cystopurin</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>19/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Potassium citrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/069/001</DrugIDPK>
    <LicenceNumber>PPA1447/069/001</LicenceNumber>
    <ProductName>Cystopurin</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>16/04/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Potassium citrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0018/043/001</DrugIDPK>
    <LicenceNumber>PA0018/043/001</LicenceNumber>
    <ProductName>CYSTOPURIN</ProductName>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>26/07/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/09/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0018/027/001</DrugIDPK>
    <LicenceNumber>PA0018/027/001</LicenceNumber>
    <ProductName>CYSTOPURIN</ProductName>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>10/10/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHENAMINE HIPPURATE</ActiveSubstance>
      <ActiveSubstance>SODIUM ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/03/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/144/001</DrugIDPK>
    <LicenceNumber>PPA1151/144/001</LicenceNumber>
    <ProductName>Cystopurin 3g Granules for Oral Solution</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>08/04/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Potassium citrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0360/005/001</DrugIDPK>
    <LicenceNumber>PA0360/005/001</LicenceNumber>
    <ProductName>CYSTRIN</ProductName>
    <PAHolder>J B Tillotts Limited</PAHolder>
    <AuthorisedDate>13/03/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/143/001</DrugIDPK>
    <LicenceNumber>PA0540/143/001</LicenceNumber>
    <ProductName>Cystrin 3mg Tablets</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>26/03/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Oxybutynin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/04/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/143/002</DrugIDPK>
    <LicenceNumber>PA0540/143/002</LicenceNumber>
    <ProductName>Cystrin 5mg Tablets</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>11/10/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Oxybutynin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/04/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/156/003</DrugIDPK>
    <LicenceNumber>PA0077/156/003</LicenceNumber>
    <ProductName>CYSTRIN CR</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>18/09/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYBUTYNIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/07/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1638/003/001</DrugIDPK>
    <LicenceNumber>PA1638/003/001</LicenceNumber>
    <ProductName>Cytamen</ProductName>
    <PAHolder>RPH Pharmaceuticals AB</PAHolder>
    <AuthorisedDate>21/03/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cyanocobalamin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/08/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/006/008</DrugIDPK>
    <LicenceNumber>PA0437/006/008</LicenceNumber>
    <ProductName>CYTARABINE</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>20/11/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/006/007</DrugIDPK>
    <LicenceNumber>PA0437/006/007</LicenceNumber>
    <ProductName>CYTARABINE</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>20/11/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/006/006</DrugIDPK>
    <LicenceNumber>PA0437/006/006</LicenceNumber>
    <ProductName>CYTARABINE</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>20/11/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/006/001</DrugIDPK>
    <LicenceNumber>PA0437/006/001</LicenceNumber>
    <ProductName>CYTARABINE</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>19/11/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/01/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/047/003</DrugIDPK>
    <LicenceNumber>PA0016/047/003</LicenceNumber>
    <ProductName>CYTARABINE</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>04/03/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/047/001</DrugIDPK>
    <LicenceNumber>PA0016/047/001</LicenceNumber>
    <ProductName>CYTARABINE</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>04/03/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYTARABINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1457/007/003</DrugIDPK>
    <LicenceNumber>PA1457/007/003</LicenceNumber>
    <ProductName>Cytarabine Ebewe 100mg/ml solution for injection or infusion</ProductName>
    <PAHolder>Fannin Limited</PAHolder>
    <AuthorisedDate>10/11/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cytarabine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product
Characteristics).</SupplyComments>
    <WithdrawalDate>14/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1457/007/001</DrugIDPK>
    <LicenceNumber>PA1457/007/001</LicenceNumber>
    <ProductName>Cytarabine Ebewe 20mg/ml solution for injection or infusion</ProductName>
    <PAHolder>Fannin Limited</PAHolder>
    <AuthorisedDate>10/11/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cytarabine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product
Characteristics).</SupplyComments>
    <WithdrawalDate>14/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1457/007/002</DrugIDPK>
    <LicenceNumber>PA1457/007/002</LicenceNumber>
    <ProductName>Cytarabine Ebewe 50mg/ml solution for injection or infusion</ProductName>
    <PAHolder>Fannin Limited</PAHolder>
    <AuthorisedDate>10/11/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cytarabine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product
Characteristics).</SupplyComments>
    <WithdrawalDate>14/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/041/001</DrugIDPK>
    <LicenceNumber>PA1986/041/001</LicenceNumber>
    <ProductName>Cytarabine Teva</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>10/02/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Infus/Pdr/Oral Soln</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cytarabine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>13/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/025/001</DrugIDPK>
    <LicenceNumber>PA0016/025/001</LicenceNumber>
    <ProductName>Cytosar</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cytarabine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/025/003</DrugIDPK>
    <LicenceNumber>PA0016/025/003</LicenceNumber>
    <ProductName>Cytosar</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cytarabine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/04/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0778/004/003</DrugIDPK>
    <LicenceNumber>PA0778/004/003</LicenceNumber>
    <ProductName>Cytotec</ProductName>
    <PAHolder>Monsanto PLC</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Misoprostol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/04/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/040/001</DrugIDPK>
    <LicenceNumber>PA0437/040/001</LicenceNumber>
    <ProductName>DACARBAZINE</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>15/05/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dacarbazine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/08/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/040/002</DrugIDPK>
    <LicenceNumber>PA0437/040/002</LicenceNumber>
    <ProductName>Dacarbazine for Injection BP</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>15/05/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dacarbazine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/08/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0623/003/001</DrugIDPK>
    <LicenceNumber>PA0623/003/001</LicenceNumber>
    <ProductName>Dacarbazine medac</ProductName>
    <PAHolder>medac Gesellschaft für klinische Spezialpräparate mbH</PAHolder>
    <AuthorisedDate>14/11/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dacarbazine citrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/11/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1774/001/001</DrugIDPK>
    <LicenceNumber>PA1774/001/001</LicenceNumber>
    <ProductName>Dacepton</ProductName>
    <PAHolder>EVER Valinject GmbH</PAHolder>
    <AuthorisedDate>18/12/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Apomorphine hydrochloride hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0130/004/001</DrugIDPK>
    <LicenceNumber>PA0130/004/001</LicenceNumber>
    <ProductName>DACTIL</ProductName>
    <PAHolder>Boehringer Mannheim</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/04/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/294/001</DrugIDPK>
    <LicenceNumber>PA0711/294/001</LicenceNumber>
    <ProductName>Dailiport 0.5 mg Prolonged-release hard capsules</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>17/01/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tacrolimus</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>12/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/294/002</DrugIDPK>
    <LicenceNumber>PA0711/294/002</LicenceNumber>
    <ProductName>Dailiport 1 mg Prolonged-release hard capsules</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>17/01/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tacrolimus</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>12/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/294/003</DrugIDPK>
    <LicenceNumber>PA0711/294/003</LicenceNumber>
    <ProductName>Dailiport 2 mg Prolonged-release hard capsules</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>17/01/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tacrolimus</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>12/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/294/004</DrugIDPK>
    <LicenceNumber>PA0711/294/004</LicenceNumber>
    <ProductName>Dailiport 3 mg Prolonged-release hard capsules</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>17/01/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tacrolimus</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>12/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/294/005</DrugIDPK>
    <LicenceNumber>PA0711/294/005</LicenceNumber>
    <ProductName>Dailiport 5 mg Prolonged-release hard capsules</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>17/01/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tacrolimus</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>12/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/14/939/001-002</DrugIDPK>
    <LicenceNumber>EU/1/14/939/001-002</LicenceNumber>
    <ProductName>Daklinza</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharma EEIG</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Daclatasvir dihydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>30/08/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/14/939/003-004</DrugIDPK>
    <LicenceNumber>EU/1/14/939/003-004</LicenceNumber>
    <ProductName>Daklinza</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharma EEIG</PAHolder>
    <AuthorisedDate>22/08/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Daclatasvir dihydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>30/08/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/14/939/005-006</DrugIDPK>
    <LicenceNumber>EU/1/14/939/005-006</LicenceNumber>
    <ProductName>Daklinza</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharma EEIG</PAHolder>
    <AuthorisedDate>24/06/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Declatasvir dihydrochloride (bms-790052-05)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>30/08/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/004/001A</DrugIDPK>
    <LicenceNumber>PPA0465/004/001A</LicenceNumber>
    <ProductName>Daktacort</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Miconazole nitrate </ActiveSubstance>
      <ActiveSubstance>Hydrocortisone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/12/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22612/003/001</DrugIDPK>
    <LicenceNumber>PA22612/003/001</LicenceNumber>
    <ProductName>Daktacort 2%/1% w/w Cream</ProductName>
    <PAHolder>Janssen Sciences Ireland UC</PAHolder>
    <AuthorisedDate>16/12/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Hydrocortisone</ActiveSubstance>
      <ActiveSubstance>Miconazole nitrate </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/12/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0545/008/005</DrugIDPK>
    <LicenceNumber>PA0545/008/005</LicenceNumber>
    <ProductName>DAKTARIN</ProductName>
    <PAHolder>Janssen Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>10/07/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/02/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0545/008/004</DrugIDPK>
    <LicenceNumber>PA0545/008/004</LicenceNumber>
    <ProductName>DAKTARIN</ProductName>
    <PAHolder>Janssen Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>10/07/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/02/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0045/013/007</DrugIDPK>
    <LicenceNumber>PA0045/013/007</LicenceNumber>
    <ProductName>DAKTARIN</ProductName>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>01/05/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/02/1986</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0045/013/003</DrugIDPK>
    <LicenceNumber>PA0045/013/003</LicenceNumber>
    <ProductName>DAKTARIN</ProductName>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>10/07/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0045/013/005</DrugIDPK>
    <LicenceNumber>PA0045/013/005</LicenceNumber>
    <ProductName>DAKTARIN TABLETS 250MG</ProductName>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>10/07/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0045/013/006</DrugIDPK>
    <LicenceNumber>PA0045/013/006</LicenceNumber>
    <ProductName>DAKTARIN TINCTURE</ProductName>
    <PAHolder>Janssen Pharmaceutica</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/01/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/162/001</DrugIDPK>
    <LicenceNumber>PPA1562/162/001</LicenceNumber>
    <ProductName>Dalacin 2% Vaginal Cream</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>19/06/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/04/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/132/001</DrugIDPK>
    <LicenceNumber>PPA1328/132/001</LicenceNumber>
    <ProductName>Dalacin C</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>08/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/002/002</DrugIDPK>
    <LicenceNumber>PA0016/002/002</LicenceNumber>
    <ProductName>DALACIN C</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>10/05/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLINDAMYCIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/07/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/002/001</DrugIDPK>
    <LicenceNumber>PA0016/002/001</LicenceNumber>
    <ProductName>DALACIN C PAEDIATRIC</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>14/04/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLINDAMYCIN PALMITATE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/05/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/121/002</DrugIDPK>
    <LicenceNumber>PA0822/121/002</LicenceNumber>
    <ProductName>Dalacin T Topical 10 mg/ml Cutaneous Solution</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>12/04/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLINDAMYCIN PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>None</SupplyComments>
    <WithdrawalDate>03/09/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/11/668/001-003</DrugIDPK>
    <LicenceNumber>EU/1/11/668/001-003</LicenceNumber>
    <ProductName>Daliresp</ProductName>
    <PAHolder>AstraZeneca AB</PAHolder>
    <AuthorisedDate>28/02/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Roflumilast</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/073/001</DrugIDPK>
    <LicenceNumber>PA0281/073/001</LicenceNumber>
    <InterchangeableListCode>IC0093-032-001</InterchangeableListCode>
    <ProductName>Dalmapam 15mg Hard Capsules</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>14/04/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Flurazepam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/02/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/073/002</DrugIDPK>
    <LicenceNumber>PA0281/073/002</LicenceNumber>
    <InterchangeableListCode>IC0093-033-001</InterchangeableListCode>
    <ProductName>Dalmapam 30mg Hard Capsules</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>14/04/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Flurazepam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/02/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/045/001</DrugIDPK>
    <LicenceNumber>PA0436/045/001</LicenceNumber>
    <ProductName>Dalzior</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>29/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cabergoline </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/06/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/096/002</DrugIDPK>
    <LicenceNumber>PA0073/096/002</LicenceNumber>
    <ProductName>DANAZANT</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>03/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DANAZOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/06/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/096/001</DrugIDPK>
    <LicenceNumber>PA0073/096/001</LicenceNumber>
    <ProductName>DANAZANT</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>03/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/06/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/143/005</DrugIDPK>
    <LicenceNumber>PA0711/143/005</LicenceNumber>
    <ProductName>Dancex SR 60 mg Prolonged-Release Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>24/09/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>23/09/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0023/022/001</DrugIDPK>
    <LicenceNumber>PA0023/022/001</LicenceNumber>
    <ProductName>DANERAL ELIXIR</ProductName>
    <PAHolder>Hoechst Ireland Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0855/011/001</DrugIDPK>
    <LicenceNumber>PA0855/011/001</LicenceNumber>
    <ProductName>DANERAL SA</ProductName>
    <PAHolder>Hoechst Marion Roussel Irl Ltd</PAHolder>
    <AuthorisedDate>01/04/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/12/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/002/001</DrugIDPK>
    <LicenceNumber>PA0077/002/001</LicenceNumber>
    <ProductName>DANOL</ProductName>
    <PAHolder>Sanofi-aventis Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Danazol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/002/002</DrugIDPK>
    <LicenceNumber>PA0077/002/002</LicenceNumber>
    <ProductName>DANOL</ProductName>
    <PAHolder>Sanofi-aventis Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Danazol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0170/002/003</DrugIDPK>
    <LicenceNumber>PA0170/002/003</LicenceNumber>
    <ProductName>DANTRIUM (SUSPENSION)</ProductName>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>10/03/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DANTROLENE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1336/004/003</DrugIDPK>
    <LicenceNumber>PA1336/004/003</LicenceNumber>
    <ProductName>Dantrium Intravenous 20 mg powder for solution for injection</ProductName>
    <PAHolder>Norgine B.V.</PAHolder>
    <AuthorisedDate>02/12/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dantrolene sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/039/001</DrugIDPK>
    <LicenceNumber>PA0540/039/001</LicenceNumber>
    <ProductName>Daonil</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>01/04/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glibenclamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/01/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/149/001</DrugIDPK>
    <LicenceNumber>PPA0465/149/001</LicenceNumber>
    <ProductName>Daonil</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>13/01/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glibenclamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/060/001</DrugIDPK>
    <LicenceNumber>PPA1328/060/001</LicenceNumber>
    <ProductName>DAONIL</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>29/09/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glibenclamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0322/001/001</DrugIDPK>
    <LicenceNumber>PA0322/001/001</LicenceNumber>
    <ProductName>DAPTA 12 ORAL</ProductName>
    <PAHolder>Wyeth (Ireland) Ltd</PAHolder>
    <AuthorisedDate>27/11/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MULTIVITAMINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/02/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/286/001</DrugIDPK>
    <LicenceNumber>PA0126/286/001</LicenceNumber>
    <ProductName>Daptomycin Clonmel 350 mg powder for solution injection or infusion</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>14/07/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Daptomycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/04/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/286/002</DrugIDPK>
    <LicenceNumber>PA0126/286/002</LicenceNumber>
    <ProductName>Daptomycin Clonmel 500 mg powder for solution injection or infusion</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>14/07/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Daptomycin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/04/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/052/010</DrugIDPK>
    <LicenceNumber>EU/1/97/052/010</LicenceNumber>
    <ProductName>DAQUIRAN</ProductName>
    <PAHolder>Dr. Karl Thomae GmbH</PAHolder>
    <AuthorisedDate>27/10/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/052/009</DrugIDPK>
    <LicenceNumber>EU/1/97/052/009</LicenceNumber>
    <ProductName>DAQUIRAN</ProductName>
    <PAHolder>Dr. Karl Thomae GmbH</PAHolder>
    <AuthorisedDate>27/10/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/052/008</DrugIDPK>
    <LicenceNumber>EU/1/97/052/008</LicenceNumber>
    <ProductName>DAQUIRAN</ProductName>
    <PAHolder>Dr. Karl Thomae GmbH</PAHolder>
    <AuthorisedDate>27/10/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/052/007</DrugIDPK>
    <LicenceNumber>EU/1/97/052/007</LicenceNumber>
    <ProductName>DAQUIRAN</ProductName>
    <PAHolder>Dr. Karl Thomae GmbH</PAHolder>
    <AuthorisedDate>27/10/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/052/006</DrugIDPK>
    <LicenceNumber>EU/1/97/052/006</LicenceNumber>
    <ProductName>DAQUIRAN</ProductName>
    <PAHolder>Dr. Karl Thomae GmbH</PAHolder>
    <AuthorisedDate>27/10/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/052/005</DrugIDPK>
    <LicenceNumber>EU/1/97/052/005</LicenceNumber>
    <ProductName>DAQUIRAN</ProductName>
    <PAHolder>Dr. Karl Thomae GmbH</PAHolder>
    <AuthorisedDate>27/10/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/052/004</DrugIDPK>
    <LicenceNumber>EU/1/97/052/004</LicenceNumber>
    <ProductName>DAQUIRAN</ProductName>
    <PAHolder>Dr. Karl Thomae GmbH</PAHolder>
    <AuthorisedDate>27/10/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/052/003</DrugIDPK>
    <LicenceNumber>EU/1/97/052/003</LicenceNumber>
    <ProductName>DAQUIRAN</ProductName>
    <PAHolder>Dr. Karl Thomae GmbH</PAHolder>
    <AuthorisedDate>27/10/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/052/002</DrugIDPK>
    <LicenceNumber>EU/1/97/052/002</LicenceNumber>
    <ProductName>DAQUIRAN</ProductName>
    <PAHolder>Dr. Karl Thomae GmbH</PAHolder>
    <AuthorisedDate>27/10/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/97/052/001</DrugIDPK>
    <LicenceNumber>EU/1/97/052/001</LicenceNumber>
    <ProductName>DAQUIRAN</ProductName>
    <PAHolder>Dr. Karl Thomae GmbH</PAHolder>
    <AuthorisedDate>27/10/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PRAMIPEXOLE DIHYDROXHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0035/062/001</DrugIDPK>
    <LicenceNumber>PA0035/062/001</LicenceNumber>
    <ProductName>DARANIDE</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>20/02/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/10/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/004/001</DrugIDPK>
    <LicenceNumber>PA0017/004/001</LicenceNumber>
    <ProductName>DARAPRIM</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PYRIMETHAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/01/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/06/381/1-8</DrugIDPK>
    <LicenceNumber>EU/1/06/381/1-8</LicenceNumber>
    <ProductName>Daronrix</ProductName>
    <PAHolder>GlaxoSmithKline Biologicals S.A.</PAHolder>
    <AuthorisedDate>21/03/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Whole viron, inactivated, of pandemic strain (propagated in eggs) a/hong kong/1073/99(h9n2)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/07/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/053/001</DrugIDPK>
    <LicenceNumber>PA0167/053/001</LicenceNumber>
    <ProductName>Darrows</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium lactate </ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/11/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/007/002</DrugIDPK>
    <LicenceNumber>PA0179/007/002</LicenceNumber>
    <ProductName>DARROWS</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/007/001</DrugIDPK>
    <LicenceNumber>PA0179/007/001</LicenceNumber>
    <ProductName>DARROWS</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0004/036/002</DrugIDPK>
    <LicenceNumber>PA0004/036/002</LicenceNumber>
    <ProductName>DARROWS</ProductName>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>01/04/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/11/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0004/036/001</DrugIDPK>
    <LicenceNumber>PA0004/036/001</LicenceNumber>
    <ProductName>DARROWS</ProductName>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>01/04/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/11/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/053/004</DrugIDPK>
    <LicenceNumber>PA0167/053/004</LicenceNumber>
    <ProductName>DARROWS INJECTION (LACTATED POTASSIC SALINE INJ)</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>28/03/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/053/003</DrugIDPK>
    <LicenceNumber>PA0167/053/003</LicenceNumber>
    <ProductName>DARROWS INJECTION (LACTATED POTASSIC SALINE INJ)</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>28/03/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0001/006/002</DrugIDPK>
    <LicenceNumber>PA0001/006/002</LicenceNumber>
    <ProductName>DARTALAN</ProductName>
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIOPROPAZATE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0001/006/001</DrugIDPK>
    <LicenceNumber>PA0001/006/001</LicenceNumber>
    <ProductName>DARTALAN</ProductName>
    <PAHolder>G.D. Searle &amp; Company Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THIOPROPAZATE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/015/001</DrugIDPK>
    <LicenceNumber>PA1986/015/001</LicenceNumber>
    <ProductName>Darunavir</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>02/06/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>26/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/156/001</DrugIDPK>
    <LicenceNumber>PA2315/156/001</LicenceNumber>
    <ProductName>Darunavir Accord 600 mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>30/08/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Darunavir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>19/07/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/156/002</DrugIDPK>
    <LicenceNumber>PA2315/156/002</LicenceNumber>
    <ProductName>Darunavir Accord 800 mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>30/08/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Darunavir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>19/07/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/299/001</DrugIDPK>
    <LicenceNumber>PA0126/299/001</LicenceNumber>
    <ProductName>Darunavir Clonmel 400 mg film-coated tablets</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>02/06/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Darunavir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>29/05/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/269/002</DrugIDPK>
    <LicenceNumber>PA0711/269/002</LicenceNumber>
    <ProductName>Darunavir Rowex 400 mg Film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>02/06/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Darunavir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>24/02/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/269/003</DrugIDPK>
    <LicenceNumber>PA0711/269/003</LicenceNumber>
    <ProductName>Darunavir Rowex 600 mg Film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>02/06/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Darunavir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>24/02/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/269/001</DrugIDPK>
    <LicenceNumber>PA0711/269/001</LicenceNumber>
    <ProductName>Darunavir Rowex 75 mg Film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>02/06/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Darunavir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>24/02/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/015/002</DrugIDPK>
    <LicenceNumber>PA1986/015/002</LicenceNumber>
    <ProductName>Darunavir Teva 600mg Film-coated Tablets</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>02/06/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Darunavir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>31/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/21/1540/001-004</DrugIDPK>
    <LicenceNumber>EU/1/21/1540/001-004</LicenceNumber>
    <ProductName>Dasatinib Accord</ProductName>
    <PAHolder>Accord Healthcare S.L.U.</PAHolder>
    <AuthorisedDate>24/03/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dasatinib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>25/03/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/21/1540/005-008</DrugIDPK>
    <LicenceNumber>EU/1/21/1540/005-008</LicenceNumber>
    <ProductName>Dasatinib Accord</ProductName>
    <PAHolder>Accord Healthcare S.L.U.</PAHolder>
    <AuthorisedDate>24/03/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dasatinib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>25/03/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/21/1540/009-012</DrugIDPK>
    <LicenceNumber>EU/1/21/1540/009-012</LicenceNumber>
    <ProductName>Dasatinib Accord</ProductName>
    <PAHolder>Accord Healthcare S.L.U.</PAHolder>
    <AuthorisedDate>24/03/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dasatinib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>25/03/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/21/1540/013-016</DrugIDPK>
    <LicenceNumber>EU/1/21/1540/013-016</LicenceNumber>
    <ProductName>Dasatinib Accord</ProductName>
    <PAHolder>Accord Healthcare S.L.U.</PAHolder>
    <AuthorisedDate>24/03/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dasatinib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>25/03/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/21/1540/017-020</DrugIDPK>
    <LicenceNumber>EU/1/21/1540/017-020</LicenceNumber>
    <ProductName>Dasatinib Accord</ProductName>
    <PAHolder>Accord Healthcare S.L.U.</PAHolder>
    <AuthorisedDate>24/03/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dasatinib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>25/03/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/21/1540/021-024</DrugIDPK>
    <LicenceNumber>EU/1/21/1540/021-024</LicenceNumber>
    <ProductName>Dasatinib Accord</ProductName>
    <PAHolder>Accord Healthcare S.L.U.</PAHolder>
    <AuthorisedDate>24/03/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dasatinib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>25/03/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/21/1541/001-004</DrugIDPK>
    <LicenceNumber>EU/1/21/1541/001-004</LicenceNumber>
    <ProductName>Dasatinib Accordpharma</ProductName>
    <PAHolder>Accord Healthcare S.L.U.</PAHolder>
    <AuthorisedDate>24/03/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dasatinib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>25/03/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/21/1541/005-008</DrugIDPK>
    <LicenceNumber>EU/1/21/1541/005-008</LicenceNumber>
    <ProductName>Dasatinib Accordpharma</ProductName>
    <PAHolder>Accord Healthcare S.L.U.</PAHolder>
    <AuthorisedDate>24/03/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dasatinib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>25/03/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/21/1541/009-012</DrugIDPK>
    <LicenceNumber>EU/1/21/1541/009-012</LicenceNumber>
    <ProductName>Dasatinib Accordpharma</ProductName>
    <PAHolder>Accord Healthcare S.L.U.</PAHolder>
    <AuthorisedDate>24/03/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dasatinib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>25/03/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/21/1541/013-016</DrugIDPK>
    <LicenceNumber>EU/1/21/1541/013-016</LicenceNumber>
    <ProductName>Dasatinib Accordpharma</ProductName>
    <PAHolder>Accord Healthcare S.L.U.</PAHolder>
    <AuthorisedDate>24/03/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dasatinib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>25/03/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/21/1541/017-020</DrugIDPK>
    <LicenceNumber>EU/1/21/1541/017-020</LicenceNumber>
    <ProductName>Dasatinib Accordpharma</ProductName>
    <PAHolder>Accord Healthcare S.L.U.</PAHolder>
    <AuthorisedDate>24/03/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dasatinib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>25/03/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/21/1541/021-024</DrugIDPK>
    <LicenceNumber>EU/1/21/1541/021-024</LicenceNumber>
    <ProductName>Dasatinib Accordpharma</ProductName>
    <PAHolder>Accord Healthcare S.L.U.</PAHolder>
    <AuthorisedDate>24/03/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dasatinib</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>25/03/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2096/006/001</DrugIDPK>
    <LicenceNumber>PA2096/006/001</LicenceNumber>
    <ProductName>Dasergin 5 mg film-coated tablets</ProductName>
    <PAHolder>HCS bvba</PAHolder>
    <AuthorisedDate>06/07/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratadine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/07/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2242/002/001</DrugIDPK>
    <LicenceNumber>PA2242/002/001</LicenceNumber>
    <ProductName>Dassan 700 mg Medicated Plaster</ProductName>
    <PAHolder>Grunenthal Pharma Ltd</PAHolder>
    <AuthorisedDate>22/12/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated plaster</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lidocaine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/04/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1329/009/001</DrugIDPK>
    <LicenceNumber>PA1329/009/001</LicenceNumber>
    <ProductName>DaunoXome</ProductName>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>30/03/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Daunorubicin citrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1499/001/001</DrugIDPK>
    <LicenceNumber>PA1499/001/001</LicenceNumber>
    <ProductName>Davliet 10 mg Capsules</ProductName>
    <PAHolder>Volkspharma GmbH</PAHolder>
    <AuthorisedDate>01/06/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Omeprazole </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/07/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1499/001/002</DrugIDPK>
    <LicenceNumber>PA1499/001/002</LicenceNumber>
    <ProductName>Davliet 20 mg Capsules</ProductName>
    <PAHolder>Volkspharma GmbH</PAHolder>
    <AuthorisedDate>01/06/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Omeprazole </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/07/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1499/001/003</DrugIDPK>
    <LicenceNumber>PA1499/001/003</LicenceNumber>
    <ProductName>Davliet 40 mg Capsules</ProductName>
    <PAHolder>Volkspharma GmbH</PAHolder>
    <AuthorisedDate>01/06/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Omeprazole </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/07/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0004/026/001</DrugIDPK>
    <LicenceNumber>PA0004/026/001</LicenceNumber>
    <ProductName>Day Cold Comfort</ProductName>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>13/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
      <ActiveSubstance>Pholcodine</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/11/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/013/001</DrugIDPK>
    <LicenceNumber>PA0678/013/001</LicenceNumber>
    <ProductName>DAY NURSE</ProductName>
    <PAHolder>Haleon Ireland Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
      <ActiveSubstance>Phenylpropanolamine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Dextromethorphan hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/10/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0379/018/001</DrugIDPK>
    <LicenceNumber>PA0379/018/001</LicenceNumber>
    <ProductName>DAY NURSE</ProductName>
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate>18/04/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
      <ActiveSubstance>ETHANOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/04/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0379/017/001</DrugIDPK>
    <LicenceNumber>PA0379/017/001</LicenceNumber>
    <ProductName>DAY NURSE</ProductName>
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate>02/01/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/10/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/100/001</DrugIDPK>
    <LicenceNumber>PA0678/100/001</LicenceNumber>
    <ProductName>Day Nurse Capsules Paracetamol 500mg Pseudoephedrine Hydrochloride 30mg Pholcodine 5mg</ProductName>
    <PAHolder>Haleon Ireland Limited</PAHolder>
    <AuthorisedDate>04/11/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>Pholcodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>None.</SupplyComments>
    <WithdrawalDate>21/04/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0379/018/002</DrugIDPK>
    <LicenceNumber>PA0379/018/002</LicenceNumber>
    <ProductName>DAY NURSE COLD REMEDY</ProductName>
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate>08/02/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEXTROMETHORPHAN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/100/002</DrugIDPK>
    <LicenceNumber>PA0678/100/002</LicenceNumber>
    <ProductName>Day Nurse Liquid</ProductName>
    <PAHolder>Haleon Ireland Limited</PAHolder>
    <AuthorisedDate>12/12/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not Currently Available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>Pholcodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/06/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/252/003</DrugIDPK>
    <LicenceNumber>PA0711/252/003</LicenceNumber>
    <ProductName>Dazonay 100mg/25mg/200mg Film-coated Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>29/01/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levodopa</ActiveSubstance>
      <ActiveSubstance>Carbidopa</ActiveSubstance>
      <ActiveSubstance>Entacapone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/252/004</DrugIDPK>
    <LicenceNumber>PA0711/252/004</LicenceNumber>
    <ProductName>Dazonay 125mg/31.25mg/200mg Film-coated Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>29/01/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levodopa</ActiveSubstance>
      <ActiveSubstance>Carbidopa</ActiveSubstance>
      <ActiveSubstance>Entacapone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/252/005</DrugIDPK>
    <LicenceNumber>PA0711/252/005</LicenceNumber>
    <ProductName>Dazonay 150mg/37.5mg/200mg Film-coated Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>29/01/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levodopa</ActiveSubstance>
      <ActiveSubstance>Carbidopa</ActiveSubstance>
      <ActiveSubstance>Entacapone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/252/006</DrugIDPK>
    <LicenceNumber>PA0711/252/006</LicenceNumber>
    <ProductName>Dazonay 175mg/43.75mg/200mg Film-coated Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>29/01/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levodopa</ActiveSubstance>
      <ActiveSubstance>Carbidopa</ActiveSubstance>
      <ActiveSubstance>Entacapone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/252/007</DrugIDPK>
    <LicenceNumber>PA0711/252/007</LicenceNumber>
    <ProductName>Dazonay 200mg/50mg/200mg Film-coated Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>29/01/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levodopa</ActiveSubstance>
      <ActiveSubstance>Carbidopa</ActiveSubstance>
      <ActiveSubstance>Entacapone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/252/001</DrugIDPK>
    <LicenceNumber>PA0711/252/001</LicenceNumber>
    <ProductName>Dazonay 50mg/12.5mg/200mg Film-coated Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>29/01/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levodopa</ActiveSubstance>
      <ActiveSubstance>Carbidopa</ActiveSubstance>
      <ActiveSubstance>Entacapone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/252/002</DrugIDPK>
    <LicenceNumber>PA0711/252/002</LicenceNumber>
    <ProductName>Dazonay 75mg/18.75mg/200mg Film-coated Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>29/01/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levodopa</ActiveSubstance>
      <ActiveSubstance>Carbidopa</ActiveSubstance>
      <ActiveSubstance>Entacapone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1009/001/003</DrugIDPK>
    <LicenceNumber>PA1009/001/003</LicenceNumber>
    <ProductName>DDAVP/Desmopressin 0.1mg Tablets</ProductName>
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>10/02/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESMOPRESSIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1009/001/004</DrugIDPK>
    <LicenceNumber>PA1009/001/004</LicenceNumber>
    <ProductName>DDAVP Desmopressin</ProductName>
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>10/02/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESMOPRESSIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/08/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1009/001/001</DrugIDPK>
    <LicenceNumber>PA1009/001/001</LicenceNumber>
    <ProductName>DDAVP Desmopressin 100 micrograms/ml Nasal drops, solution</ProductName>
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>25/03/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESMOPRESSIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0302/005/001</DrugIDPK>
    <LicenceNumber>PA0302/005/001</LicenceNumber>
    <ProductName>DDD MEDICATED CREAM</ProductName>
    <PAHolder>D.D.D. Limited</PAHolder>
    <AuthorisedDate>10/10/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>THYMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0302/007/001</DrugIDPK>
    <LicenceNumber>PA0302/007/001</LicenceNumber>
    <ProductName>DDD MEDICATED LOTION</ProductName>
    <PAHolder>D.D.D. Limited</PAHolder>
    <AuthorisedDate>10/08/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYL SALICYLATE</ActiveSubstance>
      <ActiveSubstance>THYMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/02/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0299/003/001</DrugIDPK>
    <LicenceNumber>PA0299/003/001</LicenceNumber>
    <ProductName>DE WITT THROAT</ProductName>
    <PAHolder>E.C. De Witt &amp; Company Limited</PAHolder>
    <AuthorisedDate>27/01/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TYROTHRICIN</ActiveSubstance>
      <ActiveSubstance>BENZOCAINE</ActiveSubstance>
      <ActiveSubstance>CETYLPYRIDINIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/022/001</DrugIDPK>
    <LicenceNumber>PA0062/022/001</LicenceNumber>
    <ProductName>DE- NOLTAB CHEWABLE</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>16/09/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0062/023/001</DrugIDPK>
    <LicenceNumber>PA0062/023/001</LicenceNumber>
    <ProductName>DE-NOL</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>30/07/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISMUTH SUBCITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/07/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/022/002</DrugIDPK>
    <LicenceNumber>PA0062/022/002</LicenceNumber>
    <ProductName>DE-NOLTAB</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>18/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRIPOTASSIUM DICITRATO BISMUTHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/11/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/083/002</DrugIDPK>
    <LicenceNumber>PA0749/083/002</LicenceNumber>
    <ProductName>DEBDOX</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>20/07/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>14/11/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0041/017/001</DrugIDPK>
    <LicenceNumber>PA0041/017/001</LicenceNumber>
    <ProductName>DEBENDOX</ProductName>
    <PAHolder>Marion Merrell Limited</PAHolder>
    <AuthorisedDate>23/02/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICYCLOVERINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DOXYLAMINE SUCCINATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/06/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0187/049/002</DrugIDPK>
    <LicenceNumber>PA0187/049/002</LicenceNumber>
    <ProductName>DEBRISAN</ProductName>
    <PAHolder>Pharmacia Laboratories Limited</PAHolder>
    <AuthorisedDate>24/10/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTRANOMER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/10/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0107/007/003</DrugIDPK>
    <LicenceNumber>PA0107/007/003</LicenceNumber>
    <ProductName>DEBRISAN</ProductName>
    <PAHolder>Pharmacia Biosystems Limited</PAHolder>
    <AuthorisedDate>12/06/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTRANOMER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/10/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0107/007/002</DrugIDPK>
    <LicenceNumber>PA0107/007/002</LicenceNumber>
    <ProductName>DEBRISAN</ProductName>
    <PAHolder>Pharmacia Biosystems Limited</PAHolder>
    <AuthorisedDate>26/03/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTRANOMER</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/05/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0809/002/001</DrugIDPK>
    <LicenceNumber>PA0809/002/001</LicenceNumber>
    <ProductName>Debrisoquine</ProductName>
    <PAHolder>Lifehealth Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Debrisoquine sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0964/008/001</DrugIDPK>
    <LicenceNumber>PA0964/008/001</LicenceNumber>
    <ProductName>Deca Durabolin</ProductName>
    <PAHolder>NV Organon</PAHolder>
    <AuthorisedDate>02/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NANDROLONE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/08/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0964/008/002</DrugIDPK>
    <LicenceNumber>PA0964/008/002</LicenceNumber>
    <ProductName>Deca Durabolin</ProductName>
    <PAHolder>NV Organon</PAHolder>
    <AuthorisedDate>02/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NANDROLONE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0261/003/001</DrugIDPK>
    <LicenceNumber>PA0261/003/001</LicenceNumber>
    <ProductName>Deca Durabolin 100mg/ml, Solution for Injection (a</ProductName>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>29/08/1975</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NANDROLONE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0261/003/002</DrugIDPK>
    <LicenceNumber>PA0261/003/002</LicenceNumber>
    <ProductName>Deca Durabolin 25 mg/ml Solution for Injection (</ProductName>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NANDROLONE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0261/003/005</DrugIDPK>
    <LicenceNumber>PA0261/003/005</LicenceNumber>
    <ProductName>Deca Durabolin 50 mg/ml Solution for Injection (am</ProductName>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>12/02/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NANDROLONE DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/016/003</DrugIDPK>
    <LicenceNumber>PA0035/016/003</LicenceNumber>
    <ProductName>DECADRON</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/016/002</DrugIDPK>
    <LicenceNumber>PA0035/016/002</LicenceNumber>
    <ProductName>DECADRON</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/02/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/016/001</DrugIDPK>
    <LicenceNumber>PA0035/016/001</LicenceNumber>
    <ProductName>DECADRON 500 microgram Tablets</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dexamethasone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/04/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/016/004</DrugIDPK>
    <LicenceNumber>PA0035/016/004</LicenceNumber>
    <ProductName>DECADRON SHOCK PAK</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/102/001</DrugIDPK>
    <LicenceNumber>PA0167/102/001</LicenceNumber>
    <ProductName>DECAN</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>07/07/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ferrous gluconate</ActiveSubstance>
      <ActiveSubstance>Copper gluconate</ActiveSubstance>
      <ActiveSubstance>Manganese Gluconate</ActiveSubstance>
      <ActiveSubstance>Zinc gluconate</ActiveSubstance>
      <ActiveSubstance>Sodium fluoride</ActiveSubstance>
      <ActiveSubstance>Cobalt gluconate</ActiveSubstance>
      <ActiveSubstance>Sodium iodide</ActiveSubstance>
      <ActiveSubstance>Sodium selenite</ActiveSubstance>
      <ActiveSubstance>Ammonium molybdate</ActiveSubstance>
      <ActiveSubstance>Chromium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/08/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0074/014/001</DrugIDPK>
    <LicenceNumber>PA0074/014/001</LicenceNumber>
    <ProductName>DECAVIT</ProductName>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>25/07/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL PALMITATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
      <ActiveSubstance>DL-ALFA-TOCOPHERYL ACETATE</ActiveSubstance>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>CALCIUM PANTOTHENATE</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/07/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/033/002</DrugIDPK>
    <LicenceNumber>PA0050/033/002</LicenceNumber>
    <ProductName>DECLINAX</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEBRISOQUINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0054/010/005</DrugIDPK>
    <LicenceNumber>PA0054/010/005</LicenceNumber>
    <ProductName>DECODERM</ProductName>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPREDNIDENE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/02/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0054/010/004</DrugIDPK>
    <LicenceNumber>PA0054/010/004</LicenceNumber>
    <ProductName>DECODERM</ProductName>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>25/09/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPREDNIDENE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/02/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0054/010/002</DrugIDPK>
    <LicenceNumber>PA0054/010/002</LicenceNumber>
    <ProductName>DECODERM</ProductName>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPREDNIDENE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/02/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0054/010/001</DrugIDPK>
    <LicenceNumber>PA0054/010/001</LicenceNumber>
    <ProductName>DECODERM</ProductName>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPREDNIDENE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/10/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0054/005/001</DrugIDPK>
    <LicenceNumber>PA0054/005/001</LicenceNumber>
    <ProductName>DECODERM COMPOUND</ProductName>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>14/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GENTAMICIN</ActiveSubstance>
      <ActiveSubstance>FLUPREDNIDENE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0054/010/003</DrugIDPK>
    <LicenceNumber>PA0054/010/003</LicenceNumber>
    <ProductName>DECODERM LOTION</ProductName>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPREDNIDENE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/02/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/014/002</DrugIDPK>
    <LicenceNumber>PA0006/014/002</LicenceNumber>
    <ProductName>DECORTISYL</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/11/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/014/001</DrugIDPK>
    <LicenceNumber>PA0006/014/001</LicenceNumber>
    <ProductName>DECORTISYL</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/11/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22761/003/001</DrugIDPK>
    <LicenceNumber>PA22761/003/001</LicenceNumber>
    <ProductName>Deep Freeze Cold Gel 2.0 % w/w</ProductName>
    <PAHolder>Colep Laupheim GmbH &amp; Co KG</PAHolder>
    <AuthorisedDate>19/03/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Racementhol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/04/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0076/001/001</DrugIDPK>
    <LicenceNumber>PA0076/001/001</LicenceNumber>
    <ProductName>Deep Freeze Cutaneous Spray Solution</ProductName>
    <PAHolder>The Mentholatum Company Ltd.</PAHolder>
    <AuthorisedDate>24/10/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous spray, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pentane</ActiveSubstance>
      <ActiveSubstance>Levomenthol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/10/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0048/015/001</DrugIDPK>
    <LicenceNumber>PA0048/015/001</LicenceNumber>
    <ProductName>DEFENCIN CP</ProductName>
    <PAHolder>Bristol-Myers Squibb (Holdings) Limited</PAHolder>
    <AuthorisedDate>09/05/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOXSUPRINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/10/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1368/021/002</DrugIDPK>
    <LicenceNumber>PA1368/021/002</LicenceNumber>
    <InterchangeableListCode>IC0133-135-003</InterchangeableListCode>
    <ProductName>Deferasirox Pharmathen 180 mg film-coated tablets</ProductName>
    <PAHolder>Pharmathen S.A.</PAHolder>
    <AuthorisedDate>04/02/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Deferasirox</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>05/02/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1368/021/003</DrugIDPK>
    <LicenceNumber>PA1368/021/003</LicenceNumber>
    <InterchangeableListCode>IC0133-180-003</InterchangeableListCode>
    <ProductName>Deferasirox Pharmathen 360 mg film-coated tablets</ProductName>
    <PAHolder>Pharmathen S.A.</PAHolder>
    <AuthorisedDate>04/02/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Deferasirox</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>05/02/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1368/021/001</DrugIDPK>
    <LicenceNumber>PA1368/021/001</LicenceNumber>
    <InterchangeableListCode>IC0133-166-003</InterchangeableListCode>
    <ProductName>Deferasirox Pharmathen 90 mg film-coated tablets</ProductName>
    <PAHolder>Pharmathen S.A.</PAHolder>
    <AuthorisedDate>04/02/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Deferasirox</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>05/02/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0059/023/001</DrugIDPK>
    <LicenceNumber>PA0059/023/001</LicenceNumber>
    <ProductName>DELFEN</ProductName>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>02/08/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NONOXINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/03/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0748/006/001</DrugIDPK>
    <LicenceNumber>PA0748/006/001</LicenceNumber>
    <ProductName>DELFEN CONTRACEPTIVE</ProductName>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>02/08/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Vaginal Foam</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NONOXINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/147/001</DrugIDPK>
    <LicenceNumber>PA2315/147/001</LicenceNumber>
    <ProductName>Delmosart PR 18 mg prolonged-release tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>16/09/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methylphenidate hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, 4.2).
This product contains a substance listed in schedule 2, part 6 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>01/04/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/147/002</DrugIDPK>
    <LicenceNumber>PA2315/147/002</LicenceNumber>
    <ProductName>Delmosart PR 27 mg prolonged-release tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>16/09/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methylphenidate hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, 4.2).
This product contains a substance listed in schedule 2, part 6 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>01/04/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/147/003</DrugIDPK>
    <LicenceNumber>PA2315/147/003</LicenceNumber>
    <ProductName>Delmosart PR 36 mg prolonged-release tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>16/09/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methylphenidate hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, 4.2).
This product contains a substance listed in schedule 2, part 6 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>01/04/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/147/004</DrugIDPK>
    <LicenceNumber>PA2315/147/004</LicenceNumber>
    <ProductName>Delmosart PR 54 mg prolonged-release tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>16/09/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methylphenidate hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, 4.2).
This product contains a substance listed in schedule 2, part 6 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>01/04/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0080/007/001</DrugIDPK>
    <LicenceNumber>PA0080/007/001</LicenceNumber>
    <ProductName>DELPHYLLINE</ProductName>
    <PAHolder>Delandale Laboratories Limited</PAHolder>
    <AuthorisedDate>10/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>THEOPHYLLINE SODIUM AMINOACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0387/003/002</DrugIDPK>
    <LicenceNumber>PA0387/003/002</LicenceNumber>
    <ProductName>DELPRAL</ProductName>
    <PAHolder>Delagrange Limited</PAHolder>
    <AuthorisedDate>27/06/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIAPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/06/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0387/003/001</DrugIDPK>
    <LicenceNumber>PA0387/003/001</LicenceNumber>
    <ProductName>DELPRAL</ProductName>
    <PAHolder>Delagrange Limited</PAHolder>
    <AuthorisedDate>27/06/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TIAPRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/06/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/043/001</DrugIDPK>
    <LicenceNumber>PA1410/043/001</LicenceNumber>
    <ProductName>Delsym</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>21/11/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dextromethorphan hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Supply through pharmacies only with the following restrictions: maximum dose: equivalent of 30 mg dextromethorphan, maximum daily dose: equivalent of 75 mg dextromethorphan.</SupplyComments>
    <WithdrawalDate>02/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0072/006/001</DrugIDPK>
    <LicenceNumber>PA0072/006/001</LicenceNumber>
    <ProductName>Delsym</ProductName>
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>04/05/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dextromethorphan hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0011/019/001</DrugIDPK>
    <LicenceNumber>PA0011/019/001</LicenceNumber>
    <ProductName>DELTA-BUTAZOLIDIN</ProductName>
    <PAHolder>Geigy Pharmaceuticals</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
      <ActiveSubstance>PREDNISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/1980</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/017/001</DrugIDPK>
    <LicenceNumber>PA0016/017/001</LicenceNumber>
    <ProductName>DELTA-CORTEF</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/02/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/020/001</DrugIDPK>
    <LicenceNumber>PA0035/020/001</LicenceNumber>
    <ProductName>DELTACORTONE</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/02/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/179/001</DrugIDPK>
    <LicenceNumber>PPA0465/179/001</LicenceNumber>
    <ProductName>Deltacortril Enteric</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>07/07/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Prednisolone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/179/002</DrugIDPK>
    <LicenceNumber>PPA0465/179/002</LicenceNumber>
    <ProductName>Deltacortril Enteric</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>07/07/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Prednisolone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/213/001</DrugIDPK>
    <LicenceNumber>PPA1151/213/001</LicenceNumber>
    <ProductName>Deltacortril Enteric 5mg gastro-resistant tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>23/01/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Prednisolone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0004/008/001</DrugIDPK>
    <LicenceNumber>PA0004/008/001</LicenceNumber>
    <ProductName>DELTASTAB</ProductName>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PREDNISOLONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/039/003</DrugIDPK>
    <LicenceNumber>PA0137/039/003</LicenceNumber>
    <ProductName>DEMOLOX</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>10/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/039/002</DrugIDPK>
    <LicenceNumber>PA0137/039/002</LicenceNumber>
    <ProductName>DEMOLOX</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>10/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/039/001</DrugIDPK>
    <LicenceNumber>PA0137/039/001</LicenceNumber>
    <ProductName>DEMOLOX</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>10/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMOXAPINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/043/001</DrugIDPK>
    <LicenceNumber>PA0035/043/001</LicenceNumber>
    <ProductName>DEMSER</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>05/09/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METIROSINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/03/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/059/001</DrugIDPK>
    <LicenceNumber>PA1986/059/001</LicenceNumber>
    <ProductName>Denela</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>10/11/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lidocaine</ActiveSubstance>
      <ActiveSubstance>Prilocaine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/18/1338/001-0005</DrugIDPK>
    <LicenceNumber>EU/1/18/1338/001-0005</LicenceNumber>
    <ProductName>Dengvaxia</ProductName>
    <PAHolder>Sanofi Winthrop Industrie</PAHolder>
    <AuthorisedDate>12/12/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Live, attenuated, chimeric dengue virus</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/10/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0172/023/001</DrugIDPK>
    <LicenceNumber>PA0172/023/001</LicenceNumber>
    <ProductName>Denorex</ProductName>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>23/03/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Coal tar solution</ActiveSubstance>
      <ActiveSubstance>Menthol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/02/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/071/001</DrugIDPK>
    <LicenceNumber>PA0037/071/001</LicenceNumber>
    <ProductName>DENTOMYCIN</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>18/02/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MINOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/07/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1321/001/001</DrugIDPK>
    <LicenceNumber>PA1321/001/001</LicenceNumber>
    <ProductName>DENTOMYCIN 2% w/w Periodontal Gel</ProductName>
    <PAHolder>Henry Schein UK Holdings Limited</PAHolder>
    <AuthorisedDate>10/12/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Periodontal gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Minocycline hydrochloride dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/12/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0115/001/002</DrugIDPK>
    <LicenceNumber>PA0115/001/002</LicenceNumber>
    <ProductName>Depixol</ProductName>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>21/06/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPENTIXOL DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0115/001/008</DrugIDPK>
    <LicenceNumber>PA0115/001/008</LicenceNumber>
    <ProductName>DEPIXOL</ProductName>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>16/10/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPENTIXOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0115/001/007</DrugIDPK>
    <LicenceNumber>PA0115/001/007</LicenceNumber>
    <ProductName>DEPIXOL</ProductName>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>09/09/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPENTIXOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0115/001/006</DrugIDPK>
    <LicenceNumber>PA0115/001/006</LicenceNumber>
    <ProductName>DEPIXOL</ProductName>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>21/06/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0115/001/005</DrugIDPK>
    <LicenceNumber>PA0115/001/005</LicenceNumber>
    <ProductName>DEPIXOL</ProductName>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>23/06/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0115/001/004</DrugIDPK>
    <LicenceNumber>PA0115/001/004</LicenceNumber>
    <ProductName>DEPIXOL</ProductName>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>16/03/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPENTIXOL DIHYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/03/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0115/001/010</DrugIDPK>
    <LicenceNumber>PA0115/001/010</LicenceNumber>
    <ProductName>Depixol 200 mg/ml Solution for Injection</ProductName>
    <PAHolder>Lundbeck Limited</PAHolder>
    <AuthorisedDate>28/02/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUPENTIXOL DECANOATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/024/007</DrugIDPK>
    <LicenceNumber>PA0016/024/007</LicenceNumber>
    <ProductName>DEPO PROVERA</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>19/01/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/07/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/018/004</DrugIDPK>
    <LicenceNumber>PA0016/018/004</LicenceNumber>
    <ProductName>DEPO-MEDRONE</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLPREDNISOLONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/05/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/018/003</DrugIDPK>
    <LicenceNumber>PA0016/018/003</LicenceNumber>
    <ProductName>DEPO-MEDRONE</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLPREDNISOLONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/05/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/123/001</DrugIDPK>
    <LicenceNumber>PA0822/123/001</LicenceNumber>
    <ProductName>Depo-Medrone 40mg/ml with Lidocaine 10mg/ml Suspension for Injection, 1ml vial</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>05/07/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methylprednisolone acetate</ActiveSubstance>
      <ActiveSubstance>Lidocaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/09/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/175/001</DrugIDPK>
    <LicenceNumber>PPA0465/175/001</LicenceNumber>
    <ProductName>Depo-Provera</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>07/04/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Medroxyprogesterone acetate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/024/005</DrugIDPK>
    <LicenceNumber>PA0016/024/005</LicenceNumber>
    <ProductName>DEPO-PROVERA</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>26/11/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/07/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/024/004</DrugIDPK>
    <LicenceNumber>PA0016/024/004</LicenceNumber>
    <ProductName>DEPO-PROVERA</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>26/11/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/11/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/024/002</DrugIDPK>
    <LicenceNumber>PA0016/024/002</LicenceNumber>
    <ProductName>DEPO-PROVERA</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/07/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/025/001</DrugIDPK>
    <LicenceNumber>PA0017/025/001</LicenceNumber>
    <ProductName>DEPO-PROVERA 50 MG/ML</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/11/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/024/003</DrugIDPK>
    <LicenceNumber>PA0016/024/003</LicenceNumber>
    <ProductName>DEPO-PROVERA 50 MG/ML</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/11/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0016/024/001</DrugIDPK>
    <LicenceNumber>PA0016/024/001</LicenceNumber>
    <ProductName>DEPO-PROVERA 50 MG/ML. 1 ML.</ProductName>
    <PAHolder>Pharmacia Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/11/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0055/001/002</DrugIDPK>
    <LicenceNumber>PA0055/001/002</LicenceNumber>
    <ProductName>DEPOCILLIN</ProductName>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/1986</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0055/001/001</DrugIDPK>
    <LicenceNumber>PA0055/001/001</LicenceNumber>
    <ProductName>DEPOCILLIN</ProductName>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/1986</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/01/187/001</DrugIDPK>
    <LicenceNumber>EU/1/01/187/001</LicenceNumber>
    <ProductName>DepoCyte</ProductName>
    <PAHolder>SkyePharma PLC</PAHolder>
    <AuthorisedDate>11/07/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cytarabine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>06/07/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0365/088/002</DrugIDPK>
    <LicenceNumber>PA0365/088/002</LicenceNumber>
    <ProductName>Deponit 10mg/24 hours Transdermal Patch</ProductName>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>30/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glyceryl trinitrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/08/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0271/007/003</DrugIDPK>
    <LicenceNumber>PA0271/007/003</LicenceNumber>
    <ProductName>Deponit 15</ProductName>
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>16/02/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glyceryl trinitrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0365/088/001</DrugIDPK>
    <LicenceNumber>PA0365/088/001</LicenceNumber>
    <ProductName>Deponit 5mg/24 hours Transdermal Patch</ProductName>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>30/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glyceryl trinitrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/08/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0039/009/001</DrugIDPK>
    <LicenceNumber>PA0039/009/001</LicenceNumber>
    <ProductName>DEPRONAL S.A.</ProductName>
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/03/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0979/035/001</DrugIDPK>
    <LicenceNumber>PA0979/035/001</LicenceNumber>
    <ProductName>Dequacaine Lozenges, Benzocaine 10 mg, Dequalinium</ProductName>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>06/02/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenge</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dequalinium chloride</ActiveSubstance>
      <ActiveSubstance>Benzocaine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/03/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0043/014/003</DrugIDPK>
    <LicenceNumber>PA0043/014/003</LicenceNumber>
    <ProductName>DEQUACETS</ProductName>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>15/04/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEQUALINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0043/014/002</DrugIDPK>
    <LicenceNumber>PA0043/014/002</LicenceNumber>
    <ProductName>DEQUACETS</ProductName>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>15/04/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEQUALINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0043/014/001</DrugIDPK>
    <LicenceNumber>PA0043/014/001</LicenceNumber>
    <ProductName>DEQUACETS</ProductName>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>15/04/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenges</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEQUALINIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0979/036/001</DrugIDPK>
    <LicenceNumber>PA0979/036/001</LicenceNumber>
    <ProductName>Dequadin 0.25 mg Lozenges</ProductName>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>06/02/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Lozenge</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dequalinium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/09/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0618/013/001</DrugIDPK>
    <LicenceNumber>PA0618/013/001</LicenceNumber>
    <ProductName>Derbac C</ProductName>
    <PAHolder>Seton Products Ltd</PAHolder>
    <AuthorisedDate>24/02/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carbaril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/02/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0618/013/002</DrugIDPK>
    <LicenceNumber>PA0618/013/002</LicenceNumber>
    <ProductName>Derbac C Shampoo</ProductName>
    <PAHolder>Seton Products Ltd</PAHolder>
    <AuthorisedDate>24/02/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Shampoo</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Carbaril</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/02/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1465/006/001</DrugIDPK>
    <LicenceNumber>DPR1465/006/001</LicenceNumber>
    <ProductName>Derbac M</ProductName>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Liquid</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Malathion</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1465/031/001</DrugIDPK>
    <LicenceNumber>DPR1465/031/001</LicenceNumber>
    <ProductName>Derbac-M Liquid</ProductName>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>03/12/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Malathion</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA1380/106/001</DrugIDPK>
    <LicenceNumber>PA1380/106/001</LicenceNumber>
    <ProductName>Derinik</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pramipexole dihydrochloride monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/106/002</DrugIDPK>
    <LicenceNumber>PA1380/106/002</LicenceNumber>
    <ProductName>Derinik</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pramipexole dihydrochloride monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/106/003</DrugIDPK>
    <LicenceNumber>PA1380/106/003</LicenceNumber>
    <ProductName>Derinik</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pramipexole dihydrochloride monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/035/001</DrugIDPK>
    <LicenceNumber>PA0062/035/001</LicenceNumber>
    <ProductName>DERMAMIST</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>19/05/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>WHITE SOFT PARAFFIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/05/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0943/015/001</DrugIDPK>
    <LicenceNumber>PA0943/015/001</LicenceNumber>
    <ProductName>Dermamist 10% w/w Dry Skin Spray</ProductName>
    <PAHolder>Alliance Pharmaceuticals Ltd.</PAHolder>
    <AuthorisedDate>04/04/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not Currently Available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>White soft paraffin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/12/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0863/004/001</DrugIDPK>
    <LicenceNumber>PA0863/004/001</LicenceNumber>
    <ProductName>DERMAZOLE</ProductName>
    <PAHolder>Ego Pharmaceuticals (UK) Limited</PAHolder>
    <AuthorisedDate>03/12/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/12/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0868/002/001</DrugIDPK>
    <LicenceNumber>PA0868/002/001</LicenceNumber>
    <ProductName>Dermestril</ProductName>
    <PAHolder>Rottapharm Ltd</PAHolder>
    <AuthorisedDate>23/08/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Oestradiol hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0868/002/002</DrugIDPK>
    <LicenceNumber>PA0868/002/002</LicenceNumber>
    <ProductName>Dermestril</ProductName>
    <PAHolder>Rottapharm Ltd</PAHolder>
    <AuthorisedDate>23/08/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Oestradiol hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0868/002/003</DrugIDPK>
    <LicenceNumber>PA0868/002/003</LicenceNumber>
    <ProductName>Dermestril</ProductName>
    <PAHolder>Rottapharm Ltd</PAHolder>
    <AuthorisedDate>23/08/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Oestradiol hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0868/002/004</DrugIDPK>
    <LicenceNumber>PA0868/002/004</LicenceNumber>
    <ProductName>DERMESTRIL-Septem 25 micrograms/24hours Transdermal Patch</ProductName>
    <PAHolder>Rottapharm Ltd</PAHolder>
    <AuthorisedDate>23/08/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Estradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0868/002/005</DrugIDPK>
    <LicenceNumber>PA0868/002/005</LicenceNumber>
    <ProductName>DERMESTRIL-Septem 50 micrograms/24hours Transdermal Patch</ProductName>
    <PAHolder>Rottapharm Ltd</PAHolder>
    <AuthorisedDate>23/08/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Estradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0868/002/006</DrugIDPK>
    <LicenceNumber>PA0868/002/006</LicenceNumber>
    <ProductName>DERMESTRIL-Septem 75 micrograms/24 hours Transdermal Patch</ProductName>
    <PAHolder>Rottapharm Ltd</PAHolder>
    <AuthorisedDate>23/08/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Estradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0610/002/001</DrugIDPK>
    <LicenceNumber>PA0610/002/001</LicenceNumber>
    <ProductName>DERMIDEX</ProductName>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>19/08/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lidocaine</ActiveSubstance>
      <ActiveSubstance>Cetrimide</ActiveSubstance>
      <ActiveSubstance>Alcloxa</ActiveSubstance>
      <ActiveSubstance>Chlorbutol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/01/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0278/011/001</DrugIDPK>
    <LicenceNumber>PA0278/011/001</LicenceNumber>
    <ProductName>DERMOL</ProductName>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate>16/06/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
      <ActiveSubstance>MENTHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0059/006/001</DrugIDPK>
    <LicenceNumber>PA0059/006/001</LicenceNumber>
    <ProductName>DERMONISTAT</ProductName>
    <PAHolder>Cilag Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23176/005/001</DrugIDPK>
    <LicenceNumber>PPA23176/005/001</LicenceNumber>
    <ProductName>Dermovate 0.05 % w/w Ointment</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>13/04/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clobetasol propionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/093/001</DrugIDPK>
    <LicenceNumber>PPA1562/093/001</LicenceNumber>
    <ProductName>Dermovate Scalp Application</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>07/12/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clobetasol propionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23176/005/002</DrugIDPK>
    <LicenceNumber>PPA23176/005/002</LicenceNumber>
    <ProductName>Dermovate Scalp Application 0.05% w/v cutaneous solution</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>21/07/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clobetasol propionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0072/008/001</DrugIDPK>
    <LicenceNumber>PA0072/008/001</LicenceNumber>
    <ProductName>DESENEX OINTMENT</ProductName>
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>12/02/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZINC UNDECYLENATE</ActiveSubstance>
      <ActiveSubstance>UNDECYLENIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/02/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0072/008/002</DrugIDPK>
    <LicenceNumber>PA0072/008/002</LicenceNumber>
    <ProductName>DESENEX POWDER</ProductName>
    <PAHolder>Fisons Pharmaceuticals (Ireland)</PAHolder>
    <AuthorisedDate>12/02/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ZINC UNDECYLENATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/02/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/014/001</DrugIDPK>
    <LicenceNumber>PA0013/014/001</LicenceNumber>
    <ProductName>DESERIL</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYSERGIDE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0312/037/001</DrugIDPK>
    <LicenceNumber>PA0312/037/001</LicenceNumber>
    <ProductName>Desloratadine</ProductName>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>15/05/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/08/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/012/001</DrugIDPK>
    <LicenceNumber>PA2315/012/001</LicenceNumber>
    <ProductName>Desloratadine 0.5 mg/ml oral solution</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>30/10/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/016/001</DrugIDPK>
    <LicenceNumber>PA2315/016/001</LicenceNumber>
    <InterchangeableListCode>IC0153-001-014</InterchangeableListCode>
    <ProductName>Desloratadine 5 mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>13/09/2019</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratadine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/10/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/122/001</DrugIDPK>
    <LicenceNumber>PA1380/122/001</LicenceNumber>
    <ProductName>Desloratadine Actavis</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>27/07/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/05/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1963/006/001</DrugIDPK>
    <LicenceNumber>PA1963/006/001</LicenceNumber>
    <ProductName>Desloratadine Cipla 5mg film coated tablets</ProductName>
    <PAHolder>Cipla Europe NV</PAHolder>
    <AuthorisedDate>08/01/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/241/001</DrugIDPK>
    <LicenceNumber>PA0126/241/001</LicenceNumber>
    <ProductName>Desloratadine Clonmel</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>25/05/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1009/005/001</DrugIDPK>
    <LicenceNumber>PA1009/005/001</LicenceNumber>
    <ProductName>Desmospray, Desmopressin Nasal Spray</ProductName>
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>09/07/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal spray, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESMOPRESSIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0224/013/001</DrugIDPK>
    <LicenceNumber>PA0224/013/001</LicenceNumber>
    <ProductName>DESMOTABS</ProductName>
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>19/01/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1009/007/001</DrugIDPK>
    <LicenceNumber>PA1009/007/001</LicenceNumber>
    <ProductName>Desmotabs 0.2mg Tablets</ProductName>
    <PAHolder>Ferring Ireland Ltd</PAHolder>
    <AuthorisedDate>19/01/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DESMOPRESSIN ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1380/136/001</DrugIDPK>
    <LicenceNumber>PA1380/136/001</LicenceNumber>
    <ProductName>Desogestrel/ethinylestradiol Actavis</ProductName>
    <PAHolder>Actavis Group hf</PAHolder>
    <AuthorisedDate>28/03/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desogestrel micronized</ActiveSubstance>
      <ActiveSubstance>Ethinylestradiol micronized</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/04/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/96/013/004</DrugIDPK>
    <LicenceNumber>EU/1/96/013/004</LicenceNumber>
    <ProductName>DESTARA</ProductName>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>27/08/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBANDRONIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/96/013/002</DrugIDPK>
    <LicenceNumber>EU/1/96/013/002</LicenceNumber>
    <ProductName>DESTARA</ProductName>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>25/10/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBANDRONIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/96/013/001</DrugIDPK>
    <LicenceNumber>EU/1/96/013/001</LicenceNumber>
    <ProductName>DESTARA</ProductName>
    <PAHolder>Roche Registration Limited</PAHolder>
    <AuthorisedDate>25/06/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Soln for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IBANDRONIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1463/116/001</DrugIDPK>
    <LicenceNumber>PPA1463/116/001</LicenceNumber>
    <ProductName>Desunin 800 IU Tablets</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>06/04/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Colecalciferol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/006/001</DrugIDPK>
    <LicenceNumber>PA0137/006/001</LicenceNumber>
    <ProductName>DETECLO</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/006/001</DrugIDPK>
    <LicenceNumber>PA0037/006/001</LicenceNumber>
    <ProductName>DETECLO</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CHLORTETRACYCLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>DEMECLOCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/144/001</DrugIDPK>
    <LicenceNumber>PA0577/144/001</LicenceNumber>
    <ProductName>Deterodine SR</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>16/03/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/06/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/144/002</DrugIDPK>
    <LicenceNumber>PA0577/144/002</LicenceNumber>
    <ProductName>Deterodine SR</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>16/03/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/03/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/080/001</DrugIDPK>
    <LicenceNumber>PPA0465/080/001</LicenceNumber>
    <ProductName>Detrusitol</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>05/10/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/080/002</DrugIDPK>
    <LicenceNumber>PPA0465/080/002</LicenceNumber>
    <ProductName>Detrusitol</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>05/10/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/061/001</DrugIDPK>
    <LicenceNumber>PPA1328/061/001</LicenceNumber>
    <ProductName>DETRUSITOL</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>29/09/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/061/002</DrugIDPK>
    <LicenceNumber>PPA1328/061/002</LicenceNumber>
    <ProductName>DETRUSITOL</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>29/09/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/060/002</DrugIDPK>
    <LicenceNumber>PPA1562/060/002</LicenceNumber>
    <InterchangeableListCode>IC0025-039-003</InterchangeableListCode>
    <ProductName>Detrusitol 1 mg film-coated tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>12/12/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/11/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/158/001</DrugIDPK>
    <LicenceNumber>PPA1151/158/001</LicenceNumber>
    <InterchangeableListCode>IC0025-039-003</InterchangeableListCode>
    <ProductName>Detrusitol 1mg Film-coated Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>16/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/158/002</DrugIDPK>
    <LicenceNumber>PPA1151/158/002</LicenceNumber>
    <InterchangeableListCode>IC0025-006-003</InterchangeableListCode>
    <ProductName>Detrusitol 2 mg film-coated tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>21/12/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartare</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/060/003</DrugIDPK>
    <LicenceNumber>PPA1562/060/003</LicenceNumber>
    <InterchangeableListCode>IC0025-006-003</InterchangeableListCode>
    <ProductName>Detrusitol 2 mg film-coated tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>12/12/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/11/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/080/003</DrugIDPK>
    <LicenceNumber>PPA0465/080/003</LicenceNumber>
    <ProductName>Detrusitol SR</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>25/07/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/080/004</DrugIDPK>
    <LicenceNumber>PPA0465/080/004</LicenceNumber>
    <ProductName>Detrusitol SR</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>31/03/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartare</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/061/003</DrugIDPK>
    <LicenceNumber>PPA1328/061/003</LicenceNumber>
    <ProductName>Detrusitol SR</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>15/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/040/001</DrugIDPK>
    <LicenceNumber>PPA1463/040/001</LicenceNumber>
    <ProductName>Detrusitol SR</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>06/08/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/06/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/078/001</DrugIDPK>
    <LicenceNumber>PPA1463/078/001</LicenceNumber>
    <ProductName>Detrusitol SR</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>03/05/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartare</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/06/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/021/001</DrugIDPK>
    <LicenceNumber>PPA1500/021/001</LicenceNumber>
    <ProductName>Detrusitol SR</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>24/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartrate</ActiveSubstance>
      <ActiveSubstance>Tolterodine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/060/001</DrugIDPK>
    <LicenceNumber>PPA1562/060/001</LicenceNumber>
    <ProductName>Detrusitol SR</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>09/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/07/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/044/001</DrugIDPK>
    <LicenceNumber>PPA1659/044/001</LicenceNumber>
    <ProductName>Detrusitol SR</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>12/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/164/001</DrugIDPK>
    <LicenceNumber>PPA1151/164/001</LicenceNumber>
    <InterchangeableListCode>IC0025-008-032</InterchangeableListCode>
    <ProductName>Detrusitol SR 4 mg, prolonged-release capsules, hard</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>03/02/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/014/001</DrugIDPK>
    <LicenceNumber>PPA1596/014/001</LicenceNumber>
    <ProductName>Detrusitol SR 4 mg, prolonged-release capsules, hard</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>08/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1473/030/001</DrugIDPK>
    <LicenceNumber>PPA1473/030/001</LicenceNumber>
    <ProductName>Detrusitol SR 4mg, prolonged-release capsules, hard</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>23/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/03/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/013/001</DrugIDPK>
    <LicenceNumber>PA0936/013/001</LicenceNumber>
    <ProductName>Detsel SR</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/013/002</DrugIDPK>
    <LicenceNumber>PA0936/013/002</LicenceNumber>
    <ProductName>Detsel SR</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tolterodine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0027/014/002</DrugIDPK>
    <LicenceNumber>PA0027/014/002</LicenceNumber>
    <ProductName>DETTOL</ProductName>
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLOROXYLENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0979/004/001</DrugIDPK>
    <LicenceNumber>PA0979/004/001</LicenceNumber>
    <ProductName>Dettol Antiseptic</ProductName>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>23/10/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chloroxylenol</ActiveSubstance>
      <ActiveSubstance>Triclosan</ActiveSubstance>
      <ActiveSubstance>Edetate potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0979/018/001</DrugIDPK>
    <LicenceNumber>PA0979/018/001</LicenceNumber>
    <ProductName>DETTOL ANTISEPTIC PAIN RELIEF SPRAY</ProductName>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>10/12/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous spray, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzalkonium chloride</ActiveSubstance>
      <ActiveSubstance>Lidocaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/12/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0027/035/001</DrugIDPK>
    <LicenceNumber>PA0027/035/001</LicenceNumber>
    <ProductName>DETTOL BABY</ProductName>
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>28/08/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIMETHICONE 350</ActiveSubstance>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/08/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0027/042/001</DrugIDPK>
    <LicenceNumber>PA0027/042/001</LicenceNumber>
    <ProductName>DETTOL CLEAR</ProductName>
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>30/01/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLOROXYLENOL</ActiveSubstance>
      <ActiveSubstance>EDETATE DISODIUM</ActiveSubstance>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/08/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0979/005/001</DrugIDPK>
    <LicenceNumber>PA0979/005/001</LicenceNumber>
    <ProductName>DETTOL FRESH</ProductName>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>25/11/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzalkonium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0979/004/003</DrugIDPK>
    <LicenceNumber>PA0979/004/003</LicenceNumber>
    <ProductName>Dettol Med</ProductName>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>16/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chloroxylenol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/05/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0027/014/003</DrugIDPK>
    <LicenceNumber>PA0027/014/003</LicenceNumber>
    <ProductName>DETTOL ORAL ANTISEPTIC</ProductName>
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Mouth Wash</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLOROXYLENOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/08/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0060/005/003</DrugIDPK>
    <LicenceNumber>PA0060/005/003</LicenceNumber>
    <ProductName>DEVRYL</ProductName>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>09/03/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0060/005/002</DrugIDPK>
    <LicenceNumber>PA0060/005/002</LicenceNumber>
    <ProductName>DEVRYL</ProductName>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>09/03/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0060/005/001</DrugIDPK>
    <LicenceNumber>PA0060/005/001</LicenceNumber>
    <ProductName>DEVRYL</ProductName>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>09/03/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/03/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/006/001</DrugIDPK>
    <LicenceNumber>PA0007/006/001</LicenceNumber>
    <ProductName>DEXA-RHINASPRAY</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE ISONICOTINATE</ActiveSubstance>
      <ActiveSubstance>TRAMAZOLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/053/001</DrugIDPK>
    <LicenceNumber>PA0007/053/001</LicenceNumber>
    <ProductName>Dexa-Rhinaspray Duo</ProductName>
    <PAHolder>Boehringer Ingelheim Ltd</PAHolder>
    <AuthorisedDate>04/03/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal spray, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TRAMAZOLINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>Dexamethasone 21-isonicotinate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/08/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0012/006/001</DrugIDPK>
    <LicenceNumber>PA0012/006/001</LicenceNumber>
    <ProductName>DEXA-SCHEROSON AMPS</ProductName>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/02/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/032/005</DrugIDPK>
    <LicenceNumber>PA0002/032/005</LicenceNumber>
    <ProductName>DEXACILLIN</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>29/06/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/08/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/032/004</DrugIDPK>
    <LicenceNumber>PA0002/032/004</LicenceNumber>
    <ProductName>DEXACILLIN</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>29/06/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/08/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/032/003</DrugIDPK>
    <LicenceNumber>PA0002/032/003</LicenceNumber>
    <ProductName>DEXACILLIN</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>29/06/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/08/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/032/002</DrugIDPK>
    <LicenceNumber>PA0002/032/002</LicenceNumber>
    <ProductName>DEXACILLIN</ProductName>
    <PAHolder>Bridge Pharmaceuticals (Ire) Ltd</PAHolder>
    <AuthorisedDate>29/06/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/08/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/032/001</DrugIDPK>
    <LicenceNumber>PA0002/032/001</LicenceNumber>
    <ProductName>DEXACILLIN</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>29/06/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/05/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/032/007</DrugIDPK>
    <LicenceNumber>PA0002/032/007</LicenceNumber>
    <ProductName>DEXACILLIN  (SUSPENSION)</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>29/06/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/09/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/032/006</DrugIDPK>
    <LicenceNumber>PA0002/032/006</LicenceNumber>
    <ProductName>DEXACILLIN  (SUSPENSION)</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>29/06/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/08/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/015/001</DrugIDPK>
    <LicenceNumber>PA0006/015/001</LicenceNumber>
    <ProductName>DEXACORTISYL</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/02/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0061/010/001</DrugIDPK>
    <LicenceNumber>PA0061/010/001</LicenceNumber>
    <ProductName>DEXAMETHASONE</ProductName>
    <PAHolder>Organon (Ireland) Limited</PAHolder>
    <AuthorisedDate>12/01/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dexamethasone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/10/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1887/001/001</DrugIDPK>
    <LicenceNumber>PA1887/001/001</LicenceNumber>
    <ProductName>Dexamethasone phosphate 1 mg/ml eye drops, solution, preservative free</ProductName>
    <PAHolder>Alissa Healthcare Research Limited</PAHolder>
    <AuthorisedDate>13/03/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dexamethasone sodium phosphate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/07/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/052/001</DrugIDPK>
    <LicenceNumber>PA1339/052/001</LicenceNumber>
    <ProductName>Dexamethasone Phosphate 1mg/ml (as sodium phosphate) Eye Drops Solution in a single dose container</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>12/12/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution in single-dose container</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/06/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/262/001</DrugIDPK>
    <LicenceNumber>PA2315/262/001</LicenceNumber>
    <ProductName>Dexamethasone phosphate Accord 4 mg/mL solution for injection/infusion</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>19/07/2024</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dexamethasone sodium phosphate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/014/003</DrugIDPK>
    <LicenceNumber>PA0437/014/003</LicenceNumber>
    <ProductName>DEXAMETHASONE SODIUM PHOSPHATE</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>28/07/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/07/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/014/001</DrugIDPK>
    <LicenceNumber>PA0437/014/001</LicenceNumber>
    <ProductName>DEXAMETHASONE SODIUM PHOSPHATE</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>28/07/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE SODIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/07/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0182/001/001</DrugIDPK>
    <LicenceNumber>PA0182/001/001</LicenceNumber>
    <ProductName>DEXASALYL</ProductName>
    <PAHolder>United Drug Distributors</PAHolder>
    <AuthorisedDate>21/09/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE ACETATE</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/09/1976</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/2/02/033/001</DrugIDPK>
    <LicenceNumber>EU/2/02/033/001</LicenceNumber>
    <ProductName>Dexdomitor</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/05/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0675/002/001</DrugIDPK>
    <LicenceNumber>PA0675/002/001</LicenceNumber>
    <ProductName>DEXEMEL 4%</ProductName>
    <PAHolder>Innovata plc</PAHolder>
    <AuthorisedDate>27/07/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solvent for parenteral use</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Icodextrin</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>S(+) sodium lactate 960%w/w solution</ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/01/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/216/001</DrugIDPK>
    <LicenceNumber>PA0711/216/001</LicenceNumber>
    <ProductName>Dexketoprofen Rowex</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>11/10/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dexketoprofen trometamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/216/002</DrugIDPK>
    <LicenceNumber>PA0711/216/002</LicenceNumber>
    <ProductName>Dexketoprofen Rowex 25 mg Film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>11/10/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dexketoprofen trometamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1864/002/001</DrugIDPK>
    <LicenceNumber>PA1864/002/001</LicenceNumber>
    <ProductName>Dexlansoprazole Takeda</ProductName>
    <PAHolder>Takeda Pharma A/S</PAHolder>
    <AuthorisedDate>25/11/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dexlansoprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/08/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1864/002/002</DrugIDPK>
    <LicenceNumber>PA1864/002/002</LicenceNumber>
    <ProductName>Dexlansoprazole Takeda</ProductName>
    <PAHolder>Takeda Pharma A/S</PAHolder>
    <AuthorisedDate>25/11/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dexlansoprazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/08/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/19/1418/001-010</DrugIDPK>
    <LicenceNumber>EU/1/19/1418/001-010</LicenceNumber>
    <ProductName>Dexmedetomidine Accord</ProductName>
    <PAHolder>Accord Healthcare S.L.U.</PAHolder>
    <AuthorisedDate>13/02/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dexmedetomidine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Dexmedetomidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>13/11/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/026/001A</DrugIDPK>
    <LicenceNumber>PA0167/026/001A</LicenceNumber>
    <ProductName>Dextran 40</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dextran 40</ActiveSubstance>
      <ActiveSubstance>Glucose, anhydrous</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/10/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/028/001A</DrugIDPK>
    <LicenceNumber>PA0167/028/001A</LicenceNumber>
    <ProductName>Dextran 70</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dextran 70</ActiveSubstance>
      <ActiveSubstance>Glucose, anhydrous</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/10/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/118/001</DrugIDPK>
    <LicenceNumber>PA0073/118/001</LicenceNumber>
    <ProductName>Dextrose</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dextrose anhydrid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0255/008/001</DrugIDPK>
    <LicenceNumber>PA0255/008/001</LicenceNumber>
    <ProductName>DEXTROSE</ProductName>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>08/09/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/09/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/001/023</DrugIDPK>
    <LicenceNumber>PA0179/001/023</LicenceNumber>
    <ProductName>DEXTROSE 5%</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>22/05/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/01/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/001/022</DrugIDPK>
    <LicenceNumber>PA0179/001/022</LicenceNumber>
    <ProductName>DEXTROSE 5%</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>22/05/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/01/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/001/021</DrugIDPK>
    <LicenceNumber>PA0179/001/021</LicenceNumber>
    <ProductName>DEXTROSE 5%</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>22/05/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/01/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/001/002</DrugIDPK>
    <LicenceNumber>PA0179/001/002</LicenceNumber>
    <ProductName>DEXTROSE 5%</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>22/02/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0179/001/001</DrugIDPK>
    <LicenceNumber>PA0179/001/001</LicenceNumber>
    <ProductName>DEXTROSE 5%</ProductName>
    <PAHolder>B. Braun Medical Limited</PAHolder>
    <AuthorisedDate>22/02/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0255/008/002</DrugIDPK>
    <LicenceNumber>PA0255/008/002</LicenceNumber>
    <ProductName>DEXTROSE INJECTION 50%</ProductName>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>08/09/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/09/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0185/030/001</DrugIDPK>
    <LicenceNumber>PA0185/030/001</LicenceNumber>
    <ProductName>DF 118</ProductName>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dihydrocodeine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1329/007/001</DrugIDPK>
    <LicenceNumber>PA1329/007/001</LicenceNumber>
    <ProductName>DF 118</ProductName>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>22/05/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dihydrocodeine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>01/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0913/008/002</DrugIDPK>
    <LicenceNumber>PA0913/008/002</LicenceNumber>
    <ProductName>DHC Continus</ProductName>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dihydrocodeine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/09/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0913/008/003</DrugIDPK>
    <LicenceNumber>PA0913/008/003</LicenceNumber>
    <ProductName>DHC Continus</ProductName>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dihydrocodeine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/09/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0913/008/001</DrugIDPK>
    <LicenceNumber>PA0913/008/001</LicenceNumber>
    <ProductName>DHC Continus Prolonged-release Tablets 60 mg</ProductName>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>06/03/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dihydrocodeine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Not applicable</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Not applicable</SupplyLegalStatus>
    <PromotionLegalStatus>Not applicable</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0289/009/001</DrugIDPK>
    <LicenceNumber>PA0289/009/001</LicenceNumber>
    <ProductName>DIABEX</ProductName>
    <PAHolder>Lipha Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>16/11/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Metformin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/05/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/025/002</DrugIDPK>
    <LicenceNumber>PA0019/025/002</LicenceNumber>
    <ProductName>DIABINESE</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/08/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/025/001</DrugIDPK>
    <LicenceNumber>PA0019/025/001</LicenceNumber>
    <ProductName>DIABINESE</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORPROPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/08/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0925/001/001</DrugIDPK>
    <LicenceNumber>PA0925/001/001</LicenceNumber>
    <ProductName>Diabrezide 80 mg tablets</ProductName>
    <PAHolder>L. Molteni &amp; C. dei F.lli Alitti</PAHolder>
    <AuthorisedDate>30/04/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Gliclazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/001/007</DrugIDPK>
    <LicenceNumber>PA0549/001/007</LicenceNumber>
    <ProductName>DIACARDYNE</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>20/02/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/001/006</DrugIDPK>
    <LicenceNumber>PA0549/001/006</LicenceNumber>
    <ProductName>DIACARDYNE</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>20/02/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/001/009</DrugIDPK>
    <LicenceNumber>PA0549/001/009</LicenceNumber>
    <ProductName>DIACARDYNE LA</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>20/02/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/001/008</DrugIDPK>
    <LicenceNumber>PA0549/001/008</LicenceNumber>
    <ProductName>DIACARDYNE LA</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>20/02/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/001/001</DrugIDPK>
    <LicenceNumber>PA0549/001/001</LicenceNumber>
    <ProductName>Diacardyne SR</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>18/01/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/001/002</DrugIDPK>
    <LicenceNumber>PA0549/001/002</LicenceNumber>
    <ProductName>Diacardyne SR</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>18/01/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/001/003</DrugIDPK>
    <LicenceNumber>PA0549/001/003</LicenceNumber>
    <ProductName>Diacardyne SR</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>18/01/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/001/004</DrugIDPK>
    <LicenceNumber>PA0549/001/004</LicenceNumber>
    <ProductName>Diacardyne SR</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>18/01/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/001/010</DrugIDPK>
    <LicenceNumber>PA0549/001/010</LicenceNumber>
    <ProductName>DIACARDYNE SR</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>09/07/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/001/005</DrugIDPK>
    <LicenceNumber>PA0549/001/005</LicenceNumber>
    <ProductName>DIACARDYNE SR</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>22/10/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/10/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0117/013/003</DrugIDPK>
    <LicenceNumber>PA0117/013/003</LicenceNumber>
    <ProductName>DIACEN</ProductName>
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>10/10/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0117/013/002</DrugIDPK>
    <LicenceNumber>PA0117/013/002</LicenceNumber>
    <ProductName>DIACEN</ProductName>
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>26/09/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0117/013/001</DrugIDPK>
    <LicenceNumber>PA0117/013/001</LicenceNumber>
    <ProductName>DIACEN</ProductName>
    <PAHolder>Ticen Limited</PAHolder>
    <AuthorisedDate>26/09/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/030/001</DrugIDPK>
    <LicenceNumber>PA0577/030/001</LicenceNumber>
    <ProductName>Diaclide 80mg Tablets</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>21/07/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Gliclazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0568/007/003</DrugIDPK>
    <LicenceNumber>PA0568/007/003</LicenceNumber>
    <ProductName>Diadeon MR 60 mg modified release tablets</ProductName>
    <PAHolder>Les Laboratoires Servier</PAHolder>
    <AuthorisedDate>18/12/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Gliclazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/12/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0040/058/001</DrugIDPK>
    <LicenceNumber>PA0040/058/001</LicenceNumber>
    <ProductName>DIAGINOL-VISCOUS</ProductName>
    <PAHolder>May &amp; Baker Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/11/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0004/041/001</DrugIDPK>
    <LicenceNumber>PA0004/041/001</LicenceNumber>
    <ProductName>DIALAFLEX NO 61 INTRAPERITONEAL 1.36</ProductName>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0004/041/002</DrugIDPK>
    <LicenceNumber>PA0004/041/002</LicenceNumber>
    <ProductName>DIALAFLEX NO 61 INTRAPERITONEAL 1.36%</ProductName>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0004/042/001</DrugIDPK>
    <LicenceNumber>PA0004/042/001</LicenceNumber>
    <ProductName>DIALAFLEX NO 62 INTRAPERITONEAL</ProductName>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0004/042/002</DrugIDPK>
    <LicenceNumber>PA0004/042/002</LicenceNumber>
    <ProductName>DIALAFLEX NO 62 INTRAPERITONEAL 6.36%</ProductName>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0004/043/002</DrugIDPK>
    <LicenceNumber>PA0004/043/002</LicenceNumber>
    <ProductName>DIALAFLEX NO 63 INTRAPERITONEAL</ProductName>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0004/043/001</DrugIDPK>
    <LicenceNumber>PA0004/043/001</LicenceNumber>
    <ProductName>DIALAFLEX NO 63 INTRAPERITONEAL</ProductName>
    <PAHolder>The Boots Company Plc</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0367/013/001</DrugIDPK>
    <LicenceNumber>PA0367/013/001</LicenceNumber>
    <ProductName>DIALITE 134</ProductName>
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate>24/09/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM</ActiveSubstance>
      <ActiveSubstance>CALCIUM</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM</ActiveSubstance>
      <ActiveSubstance>POTASSIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0367/013/002</DrugIDPK>
    <LicenceNumber>PA0367/013/002</LicenceNumber>
    <ProductName>DIALITE 136</ProductName>
    <PAHolder>Galway Laboratories</PAHolder>
    <AuthorisedDate>20/12/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM</ActiveSubstance>
      <ActiveSubstance>CALCIUM</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM</ActiveSubstance>
      <ActiveSubstance>POTASSIUM</ActiveSubstance>
      <ActiveSubstance>CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0010/023/001</DrugIDPK>
    <LicenceNumber>PA0010/023/001</LicenceNumber>
    <ProductName>DIALUME</ProductName>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>26/02/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/05/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0079/014/001</DrugIDPK>
    <LicenceNumber>PA0079/014/001</LicenceNumber>
    <ProductName>DIALYSED DIAGNOSTIC</ProductName>
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>24/05/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/045/001A</DrugIDPK>
    <LicenceNumber>PPA0465/045/001A</LicenceNumber>
    <ProductName>Diamicron</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>01/05/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Gliclazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0068/002/001</DrugIDPK>
    <LicenceNumber>PA0068/002/001</LicenceNumber>
    <ProductName>Diamicron 80mg Tablets</ProductName>
    <PAHolder>Servier Laboratories (Ireland) Ltd</PAHolder>
    <AuthorisedDate>30/01/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Gliclazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/01/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/026/002</DrugIDPK>
    <LicenceNumber>PPA1151/026/002</LicenceNumber>
    <ProductName>Diamicron 80mg Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>19/12/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Gliclazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/045/002A</DrugIDPK>
    <LicenceNumber>PPA0465/045/002A</LicenceNumber>
    <ProductName>Diamicron MR</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>01/08/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Gliclazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/010/002</DrugIDPK>
    <LicenceNumber>PPA1328/010/002</LicenceNumber>
    <ProductName>Diamicron MR</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>22/09/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Gliclazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1473/031/001</DrugIDPK>
    <LicenceNumber>PPA1473/031/001</LicenceNumber>
    <ProductName>Diamicron MR</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>09/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Gliclazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/10/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/026/001</DrugIDPK>
    <LicenceNumber>PPA1151/026/001</LicenceNumber>
    <InterchangeableListCode>IC0086-033-050</InterchangeableListCode>
    <ProductName>Diamicron MR 30 mg tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>18/01/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Gliclazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1142/020/002</DrugIDPK>
    <LicenceNumber>PA1142/020/002</LicenceNumber>
    <ProductName>Diamox Powder for Solution for Injection 500 mg/vial</ProductName>
    <PAHolder>Amdipharm Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acetazolamide sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/12/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0037/029/002</DrugIDPK>
    <LicenceNumber>PA0037/029/002</LicenceNumber>
    <ProductName>DIAMOX SUSTETS</ProductName>
    <PAHolder>Cyanamid of Great Britain</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0012/045/001</DrugIDPK>
    <LicenceNumber>PA0012/045/001</LicenceNumber>
    <ProductName>DIANE</ProductName>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>09/07/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYPROTERONE ACETATE</ActiveSubstance>
      <ActiveSubstance>ETHINYLESTRADIOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/11/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/003</DrugIDPK>
    <LicenceNumber>PA0167/064/003</LicenceNumber>
    <ProductName>DIANEAL</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>16/06/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/002</DrugIDPK>
    <LicenceNumber>PA0167/064/002</LicenceNumber>
    <ProductName>DIANEAL</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>16/06/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/001</DrugIDPK>
    <LicenceNumber>PA0167/064/001</LicenceNumber>
    <ProductName>DIANEAL</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>16/06/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/044/001</DrugIDPK>
    <LicenceNumber>PA0167/044/001</LicenceNumber>
    <ProductName>Dianeal/Glucose 3.86%</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glucose, anhydrous</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium lactate </ActiveSubstance>
      <ActiveSubstance>Calcium chloride</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/043/001</DrugIDPK>
    <LicenceNumber>PA0167/043/001</LicenceNumber>
    <ProductName>Dianeal 130/Glucose 1.36 % w/v/13.6 mg/ml</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glucose, anhydrous</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium lactate </ActiveSubstance>
      <ActiveSubstance>Calcium chloride</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/045/001</DrugIDPK>
    <LicenceNumber>PA0167/045/001</LicenceNumber>
    <ProductName>Dianeal 130/Glucose 1.36%/Potassium 2.5mmol/l</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glucose, anhydrous</ActiveSubstance>
      <ActiveSubstance>Sodium acetate</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Calcium chloride</ActiveSubstance>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0107/017/020</DrugIDPK>
    <LicenceNumber>PA0107/017/020</LicenceNumber>
    <ProductName>DIANEAL 137/GLUCOSE</ProductName>
    <PAHolder>Pharmacia Biosystems Limited</PAHolder>
    <AuthorisedDate>01/08/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/08/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/019/015</DrugIDPK>
    <LicenceNumber>PA0167/019/015</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>09/07/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/019/014</DrugIDPK>
    <LicenceNumber>PA0167/019/014</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>09/07/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/019/013</DrugIDPK>
    <LicenceNumber>PA0167/019/013</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>09/07/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/019/012</DrugIDPK>
    <LicenceNumber>PA0167/019/012</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>09/07/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/019/011</DrugIDPK>
    <LicenceNumber>PA0167/019/011</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>09/07/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/019/010</DrugIDPK>
    <LicenceNumber>PA0167/019/010</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>09/07/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/019/009</DrugIDPK>
    <LicenceNumber>PA0167/019/009</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>09/07/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/019/008</DrugIDPK>
    <LicenceNumber>PA0167/019/008</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>09/07/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/019/007</DrugIDPK>
    <LicenceNumber>PA0167/019/007</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>09/07/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/019/006</DrugIDPK>
    <LicenceNumber>PA0167/019/006</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>09/07/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/019/004</DrugIDPK>
    <LicenceNumber>PA0167/019/004</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>09/07/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/019/003</DrugIDPK>
    <LicenceNumber>PA0167/019/003</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>09/07/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/019/002</DrugIDPK>
    <LicenceNumber>PA0167/019/002</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>09/07/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/019/001</DrugIDPK>
    <LicenceNumber>PA0167/019/001</LicenceNumber>
    <ProductName>DIANEAL K139/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>09/07/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/019/005</DrugIDPK>
    <LicenceNumber>PA0167/019/005</LicenceNumber>
    <ProductName>DIANEAL K139/GLUCOSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>09/07/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/024</DrugIDPK>
    <LicenceNumber>PA0167/064/024</LicenceNumber>
    <ProductName>DIANEAL PD 2 PERITONEAL DIALYSIS</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/022</DrugIDPK>
    <LicenceNumber>PA0167/064/022</LicenceNumber>
    <ProductName>DIANEAL PD 2 PERITONEAL DIALYSIS</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/021</DrugIDPK>
    <LicenceNumber>PA0167/064/021</LicenceNumber>
    <ProductName>DIANEAL PD 2 PERITONEAL DIALYSIS</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/020</DrugIDPK>
    <LicenceNumber>PA0167/064/020</LicenceNumber>
    <ProductName>DIANEAL PD 2 PERITONEAL DIALYSIS</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/019</DrugIDPK>
    <LicenceNumber>PA0167/064/019</LicenceNumber>
    <ProductName>DIANEAL PD 2 PERITONEAL DIALYSIS</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/017</DrugIDPK>
    <LicenceNumber>PA0167/064/017</LicenceNumber>
    <ProductName>DIANEAL PD 2 PERITONEAL DIALYSIS</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/016</DrugIDPK>
    <LicenceNumber>PA0167/064/016</LicenceNumber>
    <ProductName>DIANEAL PD 2 PERITONEAL DIALYSIS</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/015</DrugIDPK>
    <LicenceNumber>PA0167/064/015</LicenceNumber>
    <ProductName>DIANEAL PD 2 PERITONEAL DIALYSIS</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/004</DrugIDPK>
    <LicenceNumber>PA0167/064/004</LicenceNumber>
    <ProductName>DIANEAL PD 2 PERITONEAL DIALYSIS</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/005</DrugIDPK>
    <LicenceNumber>PA0167/064/005</LicenceNumber>
    <ProductName>DIANEAL PD PERITONEAL DIALYSIS</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/017/001</DrugIDPK>
    <LicenceNumber>PA0167/017/001</LicenceNumber>
    <ProductName>Dianeal PD1 Glucose 1.36% w/v 13.6 mg/ml Solution for Peritoneal Dialysis</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>18/12/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glucose, anhydrous</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium lactate </ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/017/011</DrugIDPK>
    <LicenceNumber>PA0167/017/011</LicenceNumber>
    <ProductName>Dianeal PD1 Glucose 2.27% w/v 22.7 mg/ml Solution for Peritoneal Dialysis</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>11/07/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glucose, anhydrous</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium lactate </ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/017/002</DrugIDPK>
    <LicenceNumber>PA0167/017/002</LicenceNumber>
    <ProductName>Dianeal PD1 Glucose 3.86% w/v 38.6 mg/ml Solution for Peritoneal Dialysis</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>18/12/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glucose, anhydrous</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium lactate </ActiveSubstance>
      <ActiveSubstance>Calcium chloride dihydrate</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride hexahydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/008</DrugIDPK>
    <LicenceNumber>PA0167/064/008</LicenceNumber>
    <ProductName>DIANEAL PD2</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>25/07/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/023</DrugIDPK>
    <LicenceNumber>PA0167/064/023</LicenceNumber>
    <ProductName>DIANEAL PD2 PERITONEAL DIALYSIS</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/018</DrugIDPK>
    <LicenceNumber>PA0167/064/018</LicenceNumber>
    <ProductName>DIANEAL PD2 PERITONEAL DIALYSIS</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/014</DrugIDPK>
    <LicenceNumber>PA0167/064/014</LicenceNumber>
    <ProductName>DIANEAL PD2 PERITONEAL DIALYSIS</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/013</DrugIDPK>
    <LicenceNumber>PA0167/064/013</LicenceNumber>
    <ProductName>DIANEAL PD2 PERITONEAL DIALYSIS</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/012</DrugIDPK>
    <LicenceNumber>PA0167/064/012</LicenceNumber>
    <ProductName>DIANEAL PD2 PERITONEAL DIALYSIS</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/011</DrugIDPK>
    <LicenceNumber>PA0167/064/011</LicenceNumber>
    <ProductName>DIANEAL PD2 PERITONEAL DIALYSIS</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/010</DrugIDPK>
    <LicenceNumber>PA0167/064/010</LicenceNumber>
    <ProductName>DIANEAL PD2 PERITONEAL DIALYSIS</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/009</DrugIDPK>
    <LicenceNumber>PA0167/064/009</LicenceNumber>
    <ProductName>DIANEAL PD2 PERITONEAL DIALYSIS</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/007</DrugIDPK>
    <LicenceNumber>PA0167/064/007</LicenceNumber>
    <ProductName>DIANEAL PD2 PERITONEAL DIALYSIS</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/064/006</DrugIDPK>
    <LicenceNumber>PA0167/064/006</LicenceNumber>
    <ProductName>DIANEAL PD2 PERITONEAL DIALYSIS</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>25/07/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/024</DrugIDPK>
    <LicenceNumber>PA0167/049/024</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>23/06/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/023</DrugIDPK>
    <LicenceNumber>PA0167/049/023</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>23/06/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/022</DrugIDPK>
    <LicenceNumber>PA0167/049/022</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>23/06/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/021</DrugIDPK>
    <LicenceNumber>PA0167/049/021</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>23/06/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/020</DrugIDPK>
    <LicenceNumber>PA0167/049/020</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>23/06/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/019</DrugIDPK>
    <LicenceNumber>PA0167/049/019</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>23/06/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/017</DrugIDPK>
    <LicenceNumber>PA0167/049/017</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>23/06/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/016</DrugIDPK>
    <LicenceNumber>PA0167/049/016</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>23/06/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/015</DrugIDPK>
    <LicenceNumber>PA0167/049/015</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>23/06/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/014</DrugIDPK>
    <LicenceNumber>PA0167/049/014</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>23/06/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/013</DrugIDPK>
    <LicenceNumber>PA0167/049/013</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>23/06/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/012</DrugIDPK>
    <LicenceNumber>PA0167/049/012</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>23/06/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/011</DrugIDPK>
    <LicenceNumber>PA0167/049/011</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>23/06/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/010</DrugIDPK>
    <LicenceNumber>PA0167/049/010</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/009</DrugIDPK>
    <LicenceNumber>PA0167/049/009</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/008</DrugIDPK>
    <LicenceNumber>PA0167/049/008</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/006</DrugIDPK>
    <LicenceNumber>PA0167/049/006</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/005</DrugIDPK>
    <LicenceNumber>PA0167/049/005</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/004</DrugIDPK>
    <LicenceNumber>PA0167/049/004</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/003</DrugIDPK>
    <LicenceNumber>PA0167/049/003</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/002</DrugIDPK>
    <LicenceNumber>PA0167/049/002</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/001</DrugIDPK>
    <LicenceNumber>PA0167/049/001</LicenceNumber>
    <ProductName>DIANEAL PD3/DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/018</DrugIDPK>
    <LicenceNumber>PA0167/049/018</LicenceNumber>
    <ProductName>DIANEAL PD3/GLUCOSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>23/06/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/049/007</DrugIDPK>
    <LicenceNumber>PA0167/049/007</LicenceNumber>
    <ProductName>DIANEAL PD3/GLUCOSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE MONOHYDRATE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM LACTATE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/042/001</DrugIDPK>
    <LicenceNumber>PA0167/042/001</LicenceNumber>
    <ProductName>Dianeal With Glucose 1.36 %</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Dialysis</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glucose, anhydrous</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium lactate </ActiveSubstance>
      <ActiveSubstance>Calcium chloride</ActiveSubstance>
      <ActiveSubstance>Magnesium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/050/001</DrugIDPK>
    <LicenceNumber>PPA1463/050/001</LicenceNumber>
    <ProductName>Dianette</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>30/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cyproterone acetate</ActiveSubstance>
      <ActiveSubstance>Ethinylestradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1473/032/001</DrugIDPK>
    <LicenceNumber>PPA1473/032/001</LicenceNumber>
    <ProductName>DIANETTE</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>29/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cyproterone acetate</ActiveSubstance>
      <ActiveSubstance>Ethinylestradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/181/001</DrugIDPK>
    <LicenceNumber>PPA1151/181/001</LicenceNumber>
    <ProductName>Dianette 2 mg/35 microgram coated tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>13/07/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cyproterone acetate</ActiveSubstance>
      <ActiveSubstance>Ethinylestradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This authorisation permits the holder to parallel distribute only product authorised in Ireland under the product authorisation PA1410/3/1.</SupplyComments>
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23176/033/001</DrugIDPK>
    <LicenceNumber>PPA23176/033/001</LicenceNumber>
    <ProductName>Dianette 2 mg/35 microgram coated tablets</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>14/08/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cyproterone acetate</ActiveSubstance>
      <ActiveSubstance>Ethinylestradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/154/001</DrugIDPK>
    <LicenceNumber>PPA1562/154/001</LicenceNumber>
    <ProductName>Dianette 2mg/35 microgram coated tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>27/03/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cyproterone acetate</ActiveSubstance>
      <ActiveSubstance>Ethinylestradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/10/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1823/001/001</DrugIDPK>
    <LicenceNumber>PPA1823/001/001</LicenceNumber>
    <ProductName>Dianette 2mg/35 microgram coated tablets</ProductName>
    <PAHolder>Clear Pharma Limited</PAHolder>
    <AuthorisedDate>11/04/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cyproterone acetate</ActiveSubstance>
      <ActiveSubstance>Ethinylestradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0102/009/001</DrugIDPK>
    <LicenceNumber>PA0102/009/001</LicenceNumber>
    <ProductName>DIARPHEN</ProductName>
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>01/09/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENOXYLATE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ATROPINE SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0185/010/001</DrugIDPK>
    <LicenceNumber>PA0185/010/001</LicenceNumber>
    <ProductName>DIARREST</ProductName>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>21/04/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>DICYCLOVERINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/10/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0185/036/001</DrugIDPK>
    <LicenceNumber>PA0185/036/001</LicenceNumber>
    <ProductName>DIARREST RF</ProductName>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>27/11/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Loperamide hydrochloride</ActiveSubstance>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium citrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/04/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/144/002</DrugIDPK>
    <LicenceNumber>PA0540/144/002</LicenceNumber>
    <ProductName>Diastabol 100 mg tablet</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>04/04/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Miglitol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/04/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/144/001</DrugIDPK>
    <LicenceNumber>PA0540/144/001</LicenceNumber>
    <ProductName>Diastabol 50 mg tablet</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>04/04/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Miglitol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/04/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/098/001</DrugIDPK>
    <LicenceNumber>PA2315/098/001</LicenceNumber>
    <ProductName>Diazemuls Emulsion for Injection 5 mg/ml</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>11/08/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diazepam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 4 Part 1 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>20/12/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/007/002</DrugIDPK>
    <LicenceNumber>PA0281/007/002</LicenceNumber>
    <ProductName>Diazepam</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>15/04/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diazepam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/02/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0565/001/001</DrugIDPK>
    <LicenceNumber>PA0565/001/001</LicenceNumber>
    <ProductName>Diazepam</ProductName>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>18/04/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diazepam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/04/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0565/001/002</DrugIDPK>
    <LicenceNumber>PA0565/001/002</LicenceNumber>
    <ProductName>Diazepam</ProductName>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>18/04/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diazepam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/04/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0565/001/003</DrugIDPK>
    <LicenceNumber>PA0565/001/003</LicenceNumber>
    <ProductName>Diazepam</ProductName>
    <PAHolder>WPR Healthcare Limited</PAHolder>
    <AuthorisedDate>18/04/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diazepam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/04/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/002/003</DrugIDPK>
    <LicenceNumber>PA0436/002/003</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>26/02/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/002/002</DrugIDPK>
    <LicenceNumber>PA0436/002/002</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>26/02/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0436/002/001</DrugIDPK>
    <LicenceNumber>PA0436/002/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>26/02/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0365/008/003</DrugIDPK>
    <LicenceNumber>PA0365/008/003</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>27/08/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0365/008/002</DrugIDPK>
    <LicenceNumber>PA0365/008/002</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>27/08/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0365/008/001</DrugIDPK>
    <LicenceNumber>PA0365/008/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>27/08/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0337/008/003</DrugIDPK>
    <LicenceNumber>PA0337/008/003</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>06/06/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0337/008/002</DrugIDPK>
    <LicenceNumber>PA0337/008/002</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>06/06/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0337/008/001</DrugIDPK>
    <LicenceNumber>PA0337/008/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>United Pharmacists CoOp Ltd</PAHolder>
    <AuthorisedDate>06/06/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0301/028/005</DrugIDPK>
    <LicenceNumber>PA0301/028/005</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>26/02/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/05/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0301/028/004</DrugIDPK>
    <LicenceNumber>PA0301/028/004</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>26/02/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/05/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0301/028/003</DrugIDPK>
    <LicenceNumber>PA0301/028/003</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>26/02/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/05/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0301/028/002</DrugIDPK>
    <LicenceNumber>PA0301/028/002</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>15/03/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/05/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0301/028/001</DrugIDPK>
    <LicenceNumber>PA0301/028/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>Ashford Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>15/03/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/05/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/001/003</DrugIDPK>
    <LicenceNumber>PA0282/001/003</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>25/08/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/001/002</DrugIDPK>
    <LicenceNumber>PA0282/001/002</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>19/12/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/001/001</DrugIDPK>
    <LicenceNumber>PA0282/001/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>19/12/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/007/003</DrugIDPK>
    <LicenceNumber>PA0281/007/003</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>15/04/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/01/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/007/001</DrugIDPK>
    <LicenceNumber>PA0281/007/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>15/04/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/01/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0211/002/003</DrugIDPK>
    <LicenceNumber>PA0211/002/003</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>08/05/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0211/002/002</DrugIDPK>
    <LicenceNumber>PA0211/002/002</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>08/05/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0211/002/001</DrugIDPK>
    <LicenceNumber>PA0211/002/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>Company Liquidated M123</PAHolder>
    <AuthorisedDate>08/05/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0176/001/003</DrugIDPK>
    <LicenceNumber>PA0176/001/003</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>Accord-UK Ltd</PAHolder>
    <AuthorisedDate>18/01/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0176/001/002</DrugIDPK>
    <LicenceNumber>PA0176/001/002</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>Accord-UK Ltd</PAHolder>
    <AuthorisedDate>18/01/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0176/001/001</DrugIDPK>
    <LicenceNumber>PA0176/001/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>Accord-UK Ltd</PAHolder>
    <AuthorisedDate>18/01/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/034/003</DrugIDPK>
    <LicenceNumber>PA0006/034/003</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>08/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/034/002</DrugIDPK>
    <LicenceNumber>PA0006/034/002</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>08/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/034/001</DrugIDPK>
    <LicenceNumber>PA0006/034/001</LicenceNumber>
    <ProductName>DIAZEPAM</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>08/04/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/055/003</DrugIDPK>
    <LicenceNumber>PA2315/055/003</LicenceNumber>
    <ProductName>Diazepam 10 mg Tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>24/02/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diazepam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 4, part 1 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>22/11/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/055/001</DrugIDPK>
    <LicenceNumber>PA2315/055/001</LicenceNumber>
    <ProductName>Diazepam 2 mg Tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>24/02/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diazepam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 4, part 1 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>22/11/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/006/001</DrugIDPK>
    <LicenceNumber>PA1339/006/001</LicenceNumber>
    <ProductName>Diazepam 5 mg/ml Solution for Injection</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>15/08/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diazepam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/006/002</DrugIDPK>
    <LicenceNumber>PA1339/006/002</LicenceNumber>
    <ProductName>Diazepam 5 mg/ml Solution for Injection</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>15/08/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diazepam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/055/002</DrugIDPK>
    <LicenceNumber>PA2315/055/002</LicenceNumber>
    <ProductName>Diazepam 5 mg Tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>24/02/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diazepam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 4, part 1 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>22/11/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0176/001/004</DrugIDPK>
    <LicenceNumber>PA0176/001/004</LicenceNumber>
    <ProductName>DIAZEPAM ELIXIR</ProductName>
    <PAHolder>Accord-UK Ltd</PAHolder>
    <AuthorisedDate>18/12/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/01/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0409/003/002</DrugIDPK>
    <LicenceNumber>PA0409/003/002</LicenceNumber>
    <ProductName>DIAZEPAM RECTAL TUBES</ProductName>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>10/07/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0409/003/001</DrugIDPK>
    <LicenceNumber>PA0409/003/001</LicenceNumber>
    <ProductName>DIAZEPAM RECTAL TUBES</ProductName>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>10/07/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/006/005</DrugIDPK>
    <LicenceNumber>PA1339/006/005</LicenceNumber>
    <ProductName>Diazepam RecTube 10 mg Rectal Solution</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>09/05/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diazepam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/006/004</DrugIDPK>
    <LicenceNumber>PA1339/006/004</LicenceNumber>
    <ProductName>Diazepam RecTube 5 mg Rectal Solution</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>09/05/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diazepam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0409/003/008</DrugIDPK>
    <LicenceNumber>PA0409/003/008</LicenceNumber>
    <ProductName>DIAZEPAM RECTUBES</ProductName>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>05/09/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diazepam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/08/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/006/003</DrugIDPK>
    <LicenceNumber>PA1339/006/003</LicenceNumber>
    <ProductName>Diazepam RecTubes 2.5mg Rectal Solution</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>05/09/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Rectal solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diazepam</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/018/001</DrugIDPK>
    <LicenceNumber>PA0086/018/001</LicenceNumber>
    <ProductName>DIBAN</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>01/11/1982</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYCARBOPHIL CALCIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/05/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0060/030/002</DrugIDPK>
    <LicenceNumber>PA0060/030/002</LicenceNumber>
    <ProductName>DIBENYLINE</ProductName>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>01/04/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0060/030/001</DrugIDPK>
    <LicenceNumber>PA0060/030/001</LicenceNumber>
    <ProductName>DIBENYLINE</ProductName>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>01/04/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/007/002</DrugIDPK>
    <LicenceNumber>PA0077/007/002</LicenceNumber>
    <ProductName>DIBOTIN SR</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>12/07/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENFORMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/007/001</DrugIDPK>
    <LicenceNumber>PA0077/007/001</LicenceNumber>
    <ProductName>DIBOTIN SR</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>12/07/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENFORMIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/057/003</DrugIDPK>
    <LicenceNumber>PA0046/057/003</LicenceNumber>
    <ProductName>DICAPEN</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>29/11/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULBACTAM</ActiveSubstance>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/057/002</DrugIDPK>
    <LicenceNumber>PA0046/057/002</LicenceNumber>
    <ProductName>DICAPEN</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>29/11/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULBACTAM</ActiveSubstance>
      <ActiveSubstance>AMPICILLIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/009/004</DrugIDPK>
    <LicenceNumber>PA0711/009/004</LicenceNumber>
    <ProductName>Diclac 150 mg Prolonged-release Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>20/03/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/009/007</DrugIDPK>
    <LicenceNumber>PA0711/009/007</LicenceNumber>
    <ProductName>Diclac 25 mg Gastro-resistant Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>05/03/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/10/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/085/002</DrugIDPK>
    <LicenceNumber>PA0281/085/002</LicenceNumber>
    <ProductName>Diclo (Enteric-Coated)</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>22/03/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/01/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/085/001</DrugIDPK>
    <LicenceNumber>PA0281/085/001</LicenceNumber>
    <ProductName>DICLO (ENTERIC-COATED)</ProductName>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>22/03/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/05/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/106/001</DrugIDPK>
    <LicenceNumber>PA0281/106/001</LicenceNumber>
    <InterchangeableListCode>IC0056-028-024</InterchangeableListCode>
    <ProductName>Diclo 75mg prolonged release tablets</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>27/05/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This authorisation permits the holder to market only product authorised in Ireland under product authorisation number PA0711/009/003.</SupplyComments>
    <WithdrawalDate>14/12/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/058/002</DrugIDPK>
    <LicenceNumber>PA0281/058/002</LicenceNumber>
    <ProductName>DICLO-DICLOFENAC ENTERIC COATED</ProductName>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>29/11/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/02/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/058/001</DrugIDPK>
    <LicenceNumber>PA0281/058/001</LicenceNumber>
    <ProductName>DICLO-DICLOFENAC ENTERIC COATED</ProductName>
    <PAHolder>Pinewood Laboratories Ltd,</PAHolder>
    <AuthorisedDate>29/11/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/02/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/019/001</DrugIDPK>
    <LicenceNumber>PA0577/019/001</LicenceNumber>
    <ProductName>Diclofenac</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/019/002</DrugIDPK>
    <LicenceNumber>PA0577/019/002</LicenceNumber>
    <ProductName>Diclofenac</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0476/010/001</DrugIDPK>
    <LicenceNumber>PA0476/010/001</LicenceNumber>
    <ProductName>Diclofenac 100 mg Prolonged Release Tablets</ProductName>
    <PAHolder>Olinka (UK) Limited</PAHolder>
    <AuthorisedDate>05/09/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/04/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0593/008/004</DrugIDPK>
    <LicenceNumber>PA0593/008/004</LicenceNumber>
    <ProductName>Diclofenac 25</ProductName>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>18/02/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/02/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0593/008/005</DrugIDPK>
    <LicenceNumber>PA0593/008/005</LicenceNumber>
    <ProductName>Diclofenac 50</ProductName>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>18/02/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/02/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1333/014/001</DrugIDPK>
    <LicenceNumber>PA1333/014/001</LicenceNumber>
    <InterchangeableListCode>IC0058-109-021</InterchangeableListCode>
    <ProductName>Diclofenac 50 mg/Misoprostol 200 micrograms modified release tablets</ProductName>
    <PAHolder>Morningside Healthcare Ltd</PAHolder>
    <AuthorisedDate>18/01/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
      <ActiveSubstance>Misoprostol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1333/014/002</DrugIDPK>
    <LicenceNumber>PA1333/014/002</LicenceNumber>
    <InterchangeableListCode>IC0058-113-021</InterchangeableListCode>
    <ProductName>Diclofenac 75 mg/Misoprostol 200 micrograms modified release tablets</ProductName>
    <PAHolder>Morningside Healthcare Ltd</PAHolder>
    <AuthorisedDate>18/01/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Modified-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
      <ActiveSubstance>Misoprostol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/138/001</DrugIDPK>
    <LicenceNumber>PA2315/138/001</LicenceNumber>
    <InterchangeableListCode>IC0057-023-040</InterchangeableListCode>
    <ProductName>Diclofenac Potassium 50 mg Film-coated Tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>26/09/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>None</SupplyComments>
    <WithdrawalDate>20/12/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/129/001</DrugIDPK>
    <LicenceNumber>PA0678/129/001</LicenceNumber>
    <ProductName>Diclofenac potassium NCH 12.5mg Film-coated Tablets</ProductName>
    <PAHolder>Haleon Ireland Limited</PAHolder>
    <AuthorisedDate>22/12/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac potassium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/009/001</DrugIDPK>
    <LicenceNumber>PA0436/009/001</LicenceNumber>
    <ProductName>Diclofenac Sodium</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>27/11/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/11/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/009/002</DrugIDPK>
    <LicenceNumber>PA0436/009/002</LicenceNumber>
    <ProductName>Diclofenac Sodium</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>27/11/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/11/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1046/007/001</DrugIDPK>
    <LicenceNumber>PA1046/007/001</LicenceNumber>
    <ProductName>Diclofenac Sodium</ProductName>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>13/07/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1046/007/002</DrugIDPK>
    <LicenceNumber>PA1046/007/002</LicenceNumber>
    <ProductName>Diclofenac Sodium</ProductName>
    <PAHolder>Winthrop Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>13/07/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1329/001/001</DrugIDPK>
    <LicenceNumber>PA1329/001/001</LicenceNumber>
    <ProductName>Diclomax</ProductName>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>13/04/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/07/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1329/001/002</DrugIDPK>
    <LicenceNumber>PA1329/001/002</LicenceNumber>
    <ProductName>Diclomax Retard</ProductName>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate>13/04/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/07/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/082/005</DrugIDPK>
    <LicenceNumber>PA0126/082/005</LicenceNumber>
    <ProductName>Diclomel 100</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppository</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/12/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/082/001</DrugIDPK>
    <LicenceNumber>PA0126/082/001</LicenceNumber>
    <ProductName>Diclomel 25</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>19/12/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/10/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/082/004</DrugIDPK>
    <LicenceNumber>PA0126/082/004</LicenceNumber>
    <ProductName>Diclomel 50</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppository</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/12/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/082/002</DrugIDPK>
    <LicenceNumber>PA0126/082/002</LicenceNumber>
    <ProductName>DICLOMEL 50</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>19/12/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/10/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/082/003</DrugIDPK>
    <LicenceNumber>PA0126/082/003</LicenceNumber>
    <ProductName>DICLOMEL SR</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>21/02/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/017/001</DrugIDPK>
    <LicenceNumber>PA0017/017/001</LicenceNumber>
    <ProductName>DICONAL</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPIPANONE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CYCLIZINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0240/002/001</DrugIDPK>
    <LicenceNumber>PA0240/002/001</LicenceNumber>
    <ProductName>DICOPAC (TWO CAPSULES + ONE SOL. FOR INJ.)</ProductName>
    <PAHolder>GE Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYANOCOBALAMIN (57 CO)</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN (58 CO)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22697/008/001</DrugIDPK>
    <LicenceNumber>PA22697/008/001</LicenceNumber>
    <ProductName>Dicycloverine hydrochloride 10 mg/5 ml Oral Solution</ProductName>
    <PAHolder>Syri Pharma Limited t/a Thame Laboratories</PAHolder>
    <AuthorisedDate>30/01/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dicycloverine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/01/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/148/002</DrugIDPK>
    <LicenceNumber>PA0077/148/002</LicenceNumber>
    <ProductName>Dicynene</ProductName>
    <PAHolder>Sanofi-aventis Ireland Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ethamsylate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0080/001/002</DrugIDPK>
    <LicenceNumber>PA0080/001/002</LicenceNumber>
    <ProductName>DICYNENE</ProductName>
    <PAHolder>Delandale Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETAMSILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/02/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0080/001/001</DrugIDPK>
    <LicenceNumber>PA0080/001/001</LicenceNumber>
    <ProductName>DICYNENE</ProductName>
    <PAHolder>Delandale Laboratories Limited</PAHolder>
    <AuthorisedDate>07/03/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETAMSILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0080/001/005</DrugIDPK>
    <LicenceNumber>PA0080/001/005</LicenceNumber>
    <ProductName>DICYNENE 1000</ProductName>
    <PAHolder>Delandale Laboratories Limited</PAHolder>
    <AuthorisedDate>18/05/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETAMSILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1108/001/001</DrugIDPK>
    <LicenceNumber>PA1108/001/001</LicenceNumber>
    <ProductName>Dicynene 250mg/2ml Solution for Injection</ProductName>
    <PAHolder>OM PHARMA SA</PAHolder>
    <AuthorisedDate>01/04/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ethamsylate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0170/014/001</DrugIDPK>
    <LicenceNumber>PA0170/014/001</LicenceNumber>
    <ProductName>DIDRONEL</ProductName>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>23/12/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etidronate disodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0170/014/002</DrugIDPK>
    <LicenceNumber>PA0170/014/002</LicenceNumber>
    <ProductName>DIDRONEL I.V.</ProductName>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>16/01/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETIDRONATE DISODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/12/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/006/001</DrugIDPK>
    <LicenceNumber>DPR0465/006/001</LicenceNumber>
    <ProductName>DIDRONEL PMO</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>11/04/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etidronate disodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0170/017/001</DrugIDPK>
    <LicenceNumber>PA0170/017/001</LicenceNumber>
    <ProductName>DIDRONEL PMO</ProductName>
    <PAHolder>Procter &amp; Gamble Pharmaceuticals UK Limited</PAHolder>
    <AuthorisedDate>01/05/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Etidronate disodium</ActiveSubstance>
      <ActiveSubstance>Calcium carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/03/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/185/001</DrugIDPK>
    <LicenceNumber>PPA0465/185/001</LicenceNumber>
    <ProductName>Difene</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>13/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/11/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1241/012/006</DrugIDPK>
    <LicenceNumber>PA1241/012/006</LicenceNumber>
    <ProductName>Difene Ampoules</ProductName>
    <PAHolder>Astellas Pharma Co. Limited</PAHolder>
    <AuthorisedDate>13/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution injection or concentrate for solution infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/01/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/073/001</DrugIDPK>
    <LicenceNumber>PPA1151/073/001</LicenceNumber>
    <ProductName>Difene Dual Release</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>30/01/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diclofenac sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0473/001/004</DrugIDPK>
    <LicenceNumber>PA0473/001/004</LicenceNumber>
    <ProductName>DIFENE SUSTAINED</ProductName>
    <PAHolder>Fujisawa Deutschland GmbH</PAHolder>
    <AuthorisedDate>28/08/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DICLOFENAC SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/07/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/136/002</DrugIDPK>
    <LicenceNumber>PPA1562/136/002</LicenceNumber>
    <ProductName>Differin 0.1% w/w Cream</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>09/01/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Adapalene</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/198/002</DrugIDPK>
    <LicenceNumber>PPA1151/198/002</LicenceNumber>
    <ProductName>Differin 0.1% w/w Gel</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>15/05/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Adapalene</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/136/001</DrugIDPK>
    <LicenceNumber>PPA1562/136/001</LicenceNumber>
    <ProductName>Differin 0.1% w/w Gel</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>09/01/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Adapalene</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0590/006/001</DrugIDPK>
    <LicenceNumber>PA0590/006/001</LicenceNumber>
    <ProductName>Differin Cutaneous Solution 0.1 % w/w</ProductName>
    <PAHolder>Galderma (UK) Ltd</PAHolder>
    <AuthorisedDate>19/10/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Adapalene</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2010/030/001</DrugIDPK>
    <LicenceNumber>PA2010/030/001</LicenceNumber>
    <ProductName>Difflam 3 % w/w Cream</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>06/07/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZYDAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/228/001</DrugIDPK>
    <LicenceNumber>PPA0465/228/001</LicenceNumber>
    <ProductName>Difflam Spray</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>20/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal spray</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZYDAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/127/001</DrugIDPK>
    <LicenceNumber>PPA1151/127/001</LicenceNumber>
    <ProductName>Difflam Spray</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>06/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal spray</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZYDAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/08/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/425/001</DrugIDPK>
    <LicenceNumber>PPA0465/425/001</LicenceNumber>
    <ProductName>Difflam Spray, 0.15% w/v, Oromucosal Spray</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>01/03/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal spray</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZYDAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/127/002</DrugIDPK>
    <LicenceNumber>PA0749/127/002</LicenceNumber>
    <ProductName>Diflazole 150 mg Capsules, hard</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>08/10/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fluconazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/127/003</DrugIDPK>
    <LicenceNumber>PA0749/127/003</LicenceNumber>
    <ProductName>Diflazole 200mg Capsules, hard</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>08/10/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fluconazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/127/001</DrugIDPK>
    <LicenceNumber>PA0749/127/001</LicenceNumber>
    <ProductName>Diflazole 50mg Capsules, hard</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>08/10/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fluconazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/093/001</DrugIDPK>
    <LicenceNumber>PPA0465/093/001</LicenceNumber>
    <ProductName>Diflucan</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>19/09/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fluconazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/12/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/093/002</DrugIDPK>
    <LicenceNumber>PPA0465/093/002</LicenceNumber>
    <ProductName>Diflucan</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>31/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fluconazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/12/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/044/003</DrugIDPK>
    <LicenceNumber>PA0019/044/003</LicenceNumber>
    <ProductName>DIFLUCAN</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fluconazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/04/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/044/005</DrugIDPK>
    <LicenceNumber>PA0019/044/005</LicenceNumber>
    <ProductName>DIFLUCAN</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fluconazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/08/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/211/005</DrugIDPK>
    <LicenceNumber>PA0822/211/005</LicenceNumber>
    <ProductName>Diflucan 2 mg/ml solution for infusion</ProductName>
    <PAHolder>Pfizer Healthcare Ireland Unlimited Company</PAHolder>
    <AuthorisedDate>24/09/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fluconazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/044/006</DrugIDPK>
    <LicenceNumber>PA0019/044/006</LicenceNumber>
    <ProductName>Diflucan 2 mg/ml Solution for Infusion</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>22/08/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fluconazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/044/007</DrugIDPK>
    <LicenceNumber>PA0019/044/007</LicenceNumber>
    <ProductName>Diflucan Solution for Infusion 2 mg/ml (100mg/50ml</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>22/08/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fluconazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0019/044/009</DrugIDPK>
    <LicenceNumber>PA0019/044/009</LicenceNumber>
    <ProductName>Diflucan Solution for Infusion 2 mg/ml (400mg/200m</ProductName>
    <PAHolder>Pfizer Limited</PAHolder>
    <AuthorisedDate>22/08/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fluconazole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0544/018/003</DrugIDPK>
    <LicenceNumber>PA0544/018/003</LicenceNumber>
    <ProductName>DIFTAVAX</ProductName>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>30/03/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0544/018/001</DrugIDPK>
    <LicenceNumber>PA0544/018/001</LicenceNumber>
    <ProductName>DIFTAVAX</ProductName>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>30/03/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0544/018/002</DrugIDPK>
    <LicenceNumber>PA0544/018/002</LicenceNumber>
    <ProductName>DIFTAVAX SYRINGE</ProductName>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>30/03/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diphtheria toxoid</ActiveSubstance>
      <ActiveSubstance>Tetanus toxoid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/021/001</DrugIDPK>
    <LicenceNumber>PA0126/021/001</LicenceNumber>
    <ProductName>DIGAMEL</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>10/02/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/11/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0233/001/001</DrugIDPK>
    <LicenceNumber>PA0233/001/001</LicenceNumber>
    <ProductName>DIGANOX BP</ProductName>
    <PAHolder>Wilcox Laboratories Limited</PAHolder>
    <AuthorisedDate>10/06/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIGOXIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/07/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>TR2309/007/001</DrugIDPK>
    <LicenceNumber>TR2309/007/001</LicenceNumber>
    <ProductName>Digestisan oral drops</ProductName>
    <PAHolder>A.Vogel Ireland Limited</PAHolder>
    <AuthorisedDate>07/02/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral drops, solution</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/056/001</DrugIDPK>
    <LicenceNumber>PA0073/056/001</LicenceNumber>
    <ProductName>Digoxin</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>01/04/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Digoxin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/015/001</DrugIDPK>
    <LicenceNumber>PA0013/015/001</LicenceNumber>
    <ProductName>DIHYDERGOT</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROERGOTAMINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/05/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/015/002</DrugIDPK>
    <LicenceNumber>PA0013/015/002</LicenceNumber>
    <ProductName>DIHYDERGOT NASAL</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate>28/05/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal Spray Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROERGOTAMINE MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/04/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0176/051/001</DrugIDPK>
    <LicenceNumber>PA0176/051/001</LicenceNumber>
    <ProductName>DIHYDROCODEINE</ProductName>
    <PAHolder>Accord-UK Ltd</PAHolder>
    <AuthorisedDate>02/02/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIHYDROCODEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0043/008/001</DrugIDPK>
    <LicenceNumber>PA0043/008/001</LicenceNumber>
    <ProductName>DIJEX  (SUSPENSION)</ProductName>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>14/08/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0069/008/001</DrugIDPK>
    <LicenceNumber>PA0069/008/001</LicenceNumber>
    <ProductName>DILATRATE-SR</ProductName>
    <PAHolder>Stafford Miller Limited</PAHolder>
    <AuthorisedDate>26/10/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/10/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0769/009/001</DrugIDPK>
    <LicenceNumber>PA0769/009/001</LicenceNumber>
    <ProductName>DILAUDID</ProductName>
    <PAHolder>Knoll Limited</PAHolder>
    <AuthorisedDate>01/04/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROMORPHONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/03/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0058/003/001</DrugIDPK>
    <LicenceNumber>PA0058/003/001</LicenceNumber>
    <ProductName>DILAUDID</ProductName>
    <PAHolder>Knoll A.G. (Clissmann)</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROMORPHONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/02/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0065/006/001</DrugIDPK>
    <LicenceNumber>PA0065/006/001</LicenceNumber>
    <ProductName>DILOPECT</ProductName>
    <PAHolder>Duncan, Flockhard &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/08/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0087/001/002</DrugIDPK>
    <LicenceNumber>PA0087/001/002</LicenceNumber>
    <ProductName>DILORAN</ProductName>
    <PAHolder>Rona Laboratories Limited</PAHolder>
    <AuthorisedDate>05/08/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/02/1986</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0087/001/001</DrugIDPK>
    <LicenceNumber>PA0087/001/001</LicenceNumber>
    <ProductName>DILORAN (SUSPENSION)</ProductName>
    <PAHolder>Rona Laboratories Limited</PAHolder>
    <AuthorisedDate>05/08/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM OXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/02/1986</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/058/001</DrugIDPK>
    <LicenceNumber>PA0007/058/001</LicenceNumber>
    <ProductName>DILOSPIR</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>31/03/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CROMOGLICATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/08/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/004/001</DrugIDPK>
    <LicenceNumber>PA0711/004/001</LicenceNumber>
    <ProductName>DILTAM</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/11/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/004/002</DrugIDPK>
    <LicenceNumber>PA0711/004/002</LicenceNumber>
    <ProductName>Diltam 90 mg Prolonged release tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>12/12/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/049/001</DrugIDPK>
    <LicenceNumber>PA0282/049/001</LicenceNumber>
    <ProductName>Diltiazem Hydrochloride</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>10/06/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/017/001</DrugIDPK>
    <LicenceNumber>PA0436/017/001</LicenceNumber>
    <ProductName>DILTIAZEM HYDROCHLORIDE</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>26/06/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/10/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/145/001</DrugIDPK>
    <LicenceNumber>PA0540/145/001</LicenceNumber>
    <ProductName>Diltiazem Hydrochloride 60mg Prolonged - Release T</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>28/11/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/030/001</DrugIDPK>
    <LicenceNumber>PA0405/030/001</LicenceNumber>
    <ProductName>Diltiazem Hydrochloride Tablets 60 mg (Prolonged r</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>18/12/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/09/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0516/016/001</DrugIDPK>
    <LicenceNumber>PA0516/016/001</LicenceNumber>
    <ProductName>Dilzem Once Daily</ProductName>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/08/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/027/001</DrugIDPK>
    <LicenceNumber>DPR0465/027/001</LicenceNumber>
    <ProductName>Dilzem SR</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>07/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR0465/027/002</DrugIDPK>
    <LicenceNumber>DPR0465/027/002</LicenceNumber>
    <ProductName>Dilzem SR</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>07/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR0465/027/006</DrugIDPK>
    <LicenceNumber>DPR0465/027/006</LicenceNumber>
    <ProductName>Dilzem SR</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>07/05/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1328/038/001</DrugIDPK>
    <LicenceNumber>DPR1328/038/001</LicenceNumber>
    <ProductName>Dilzem SR</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>11/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/045/001</DrugIDPK>
    <LicenceNumber>DPR1392/045/001</LicenceNumber>
    <ProductName>Dilzem SR</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>10/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/045/002</DrugIDPK>
    <LicenceNumber>DPR1392/045/002</LicenceNumber>
    <ProductName>Dilzem SR</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>10/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/045/003</DrugIDPK>
    <LicenceNumber>DPR1392/045/003</LicenceNumber>
    <ProductName>Dilzem SR</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>10/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/044/001</DrugIDPK>
    <LicenceNumber>DPR1473/044/001</LicenceNumber>
    <ProductName>Dilzem SR</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>30/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/044/002</DrugIDPK>
    <LicenceNumber>DPR1473/044/002</LicenceNumber>
    <ProductName>Dilzem SR</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>30/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/044/003</DrugIDPK>
    <LicenceNumber>DPR1473/044/003</LicenceNumber>
    <ProductName>Dilzem SR</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>30/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1500/027/001</DrugIDPK>
    <LicenceNumber>DPR1500/027/001</LicenceNumber>
    <ProductName>Dilzem SR</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1500/027/002</DrugIDPK>
    <LicenceNumber>DPR1500/027/002</LicenceNumber>
    <ProductName>Dilzem SR</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1500/027/003</DrugIDPK>
    <LicenceNumber>DPR1500/027/003</LicenceNumber>
    <ProductName>Dilzem SR</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1562/017/001</DrugIDPK>
    <LicenceNumber>DPR1562/017/001</LicenceNumber>
    <ProductName>Dilzem SR</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>31/08/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0827/006/001</DrugIDPK>
    <LicenceNumber>PA0827/006/001</LicenceNumber>
    <ProductName>Dilzem SR</ProductName>
    <PAHolder>Cephalon UK Limited</PAHolder>
    <AuthorisedDate>19/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0827/006/002</DrugIDPK>
    <LicenceNumber>PA0827/006/002</LicenceNumber>
    <ProductName>Dilzem SR</ProductName>
    <PAHolder>Cephalon UK Limited</PAHolder>
    <AuthorisedDate>19/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0827/006/003</DrugIDPK>
    <LicenceNumber>PA0827/006/003</LicenceNumber>
    <ProductName>Dilzem SR</ProductName>
    <PAHolder>Cephalon UK Limited</PAHolder>
    <AuthorisedDate>19/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0516/012/004</DrugIDPK>
    <LicenceNumber>PA0516/012/004</LicenceNumber>
    <ProductName>DILZEM SR 180</ProductName>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>06/02/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DILTIAZEM HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/10/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/164/001</DrugIDPK>
    <LicenceNumber>PPA0465/164/001</LicenceNumber>
    <ProductName>Dilzem SR 60mg Prolonged-release hard capsules</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>26/08/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/08/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/164/002</DrugIDPK>
    <LicenceNumber>PPA0465/164/002</LicenceNumber>
    <ProductName>Dilzem SR 90mg Prolonged-release hard capsules</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>26/08/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/08/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1328/038/002</DrugIDPK>
    <LicenceNumber>DPR1328/038/002</LicenceNumber>
    <ProductName>Dilzem XL</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>11/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/045/004</DrugIDPK>
    <LicenceNumber>DPR1392/045/004</LicenceNumber>
    <ProductName>Dilzem XL</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>10/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/045/005</DrugIDPK>
    <LicenceNumber>DPR1392/045/005</LicenceNumber>
    <ProductName>Dilzem XL</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>10/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/045/006</DrugIDPK>
    <LicenceNumber>DPR1392/045/006</LicenceNumber>
    <ProductName>Dilzem XL</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>10/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA0465/164/003</DrugIDPK>
    <LicenceNumber>PPA0465/164/003</LicenceNumber>
    <ProductName>Dilzem XL</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>26/08/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/08/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/164/004</DrugIDPK>
    <LicenceNumber>PPA0465/164/004</LicenceNumber>
    <ProductName>Dilzem XL</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>26/08/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/08/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/026/001</DrugIDPK>
    <LicenceNumber>PPA1562/026/001</LicenceNumber>
    <ProductName>Dilzem XL</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>12/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/089/004</DrugIDPK>
    <LicenceNumber>PA1986/089/004</LicenceNumber>
    <ProductName>Dilzem XL 120mg Prolonged-release hard capsules</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>19/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/089/005</DrugIDPK>
    <LicenceNumber>PA1986/089/005</LicenceNumber>
    <ProductName>Dilzem XL 180mg Prolonged-release Hard Capsules</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>19/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/089/006</DrugIDPK>
    <LicenceNumber>PA1986/089/006</LicenceNumber>
    <ProductName>Dilzem XL 240mg Prolonged-release Hard Capsules</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>19/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/08/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/027/003</DrugIDPK>
    <LicenceNumber>DPR0465/027/003</LicenceNumber>
    <ProductName>Dilzem XL Prolonged Release Hard Capsules</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>07/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR0465/027/004</DrugIDPK>
    <LicenceNumber>DPR0465/027/004</LicenceNumber>
    <ProductName>Dilzem XL Prolonged Release Hard Capsules</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>07/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/06/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/027/005</DrugIDPK>
    <LicenceNumber>DPR0465/027/005</LicenceNumber>
    <ProductName>Dilzem XL Prolonged Release Hard Capsules</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>07/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1500/027/004</DrugIDPK>
    <LicenceNumber>DPR1500/027/004</LicenceNumber>
    <ProductName>Dilzem XL Prolonged Release Hard Capsules</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1500/027/005</DrugIDPK>
    <LicenceNumber>DPR1500/027/005</LicenceNumber>
    <ProductName>Dilzem XL Prolonged Release Hard Capsules</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1500/027/006</DrugIDPK>
    <LicenceNumber>DPR1500/027/006</LicenceNumber>
    <ProductName>Dilzem XL Prolonged Release Hard Capsules</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/044/004</DrugIDPK>
    <LicenceNumber>DPR1473/044/004</LicenceNumber>
    <ProductName>Dilzem XL Prolonged-release</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>30/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/044/005</DrugIDPK>
    <LicenceNumber>DPR1473/044/005</LicenceNumber>
    <ProductName>Dilzem XL Prolonged-release</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>30/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/044/006</DrugIDPK>
    <LicenceNumber>DPR1473/044/006</LicenceNumber>
    <ProductName>Dilzem XL Prolonged-release</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>30/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0047/044/001</DrugIDPK>
    <LicenceNumber>PA0047/044/001</LicenceNumber>
    <ProductName>DIMELOR</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0769/007/001</DrugIDPK>
    <LicenceNumber>PA0769/007/001</LicenceNumber>
    <ProductName>DIMERCAPROL BP (BAL)</ProductName>
    <PAHolder>Knoll Limited</PAHolder>
    <AuthorisedDate>01/04/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIMERCAPROL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/10/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/22/1711/001</DrugIDPK>
    <LicenceNumber>EU/1/22/1711/001</LicenceNumber>
    <ProductName>Dimethyl fumarate Accord</ProductName>
    <PAHolder>Accord Healthcare S.L.U.</PAHolder>
    <AuthorisedDate>15/02/2023</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dimethyl Fumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>13/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/22/1711/002-003</DrugIDPK>
    <LicenceNumber>EU/1/22/1711/002-003</LicenceNumber>
    <ProductName>Dimethyl fumarate Accord</ProductName>
    <PAHolder>Accord Healthcare S.L.U.</PAHolder>
    <AuthorisedDate>15/02/2023</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dimethyl Fumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>13/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/22/1634/001-0004</DrugIDPK>
    <LicenceNumber>EU/1/22/1634/001-0004</LicenceNumber>
    <ProductName>Dimethyl Fumarate Mylan</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>13/05/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dimethyl Fumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>13/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/22/1634/005-010</DrugIDPK>
    <LicenceNumber>EU/1/22/1634/005-010</LicenceNumber>
    <ProductName>Dimethyl Fumarate Mylan</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>13/05/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dimethyl Fumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>13/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1368/023/001</DrugIDPK>
    <LicenceNumber>PA1368/023/001</LicenceNumber>
    <InterchangeableListCode>IC0165-167-006</InterchangeableListCode>
    <ProductName>Dimethyl fumarate Pharmathen 120 mg gastro-resistant hard capsules</ProductName>
    <PAHolder>Pharmathen S.A.</PAHolder>
    <AuthorisedDate>26/07/2024</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dimethyl Fumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>17/02/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1368/023/002</DrugIDPK>
    <LicenceNumber>PA1368/023/002</LicenceNumber>
    <InterchangeableListCode>IC0165-203-006</InterchangeableListCode>
    <ProductName>Dimethyl fumarate Pharmathen 240 mg gastro-resistant hard capsules</ProductName>
    <PAHolder>Pharmathen S.A.</PAHolder>
    <AuthorisedDate>26/07/2024</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dimethyl Fumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>17/02/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/22/1635/001-002</DrugIDPK>
    <LicenceNumber>EU/1/22/1635/001-002</LicenceNumber>
    <ProductName>Dimethyl Fumarate Polpharma</ProductName>
    <PAHolder>Zaklady Farmaceutyczne Polpharma S.A.</PAHolder>
    <AuthorisedDate>13/05/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dimethyl Fumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>13/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/22/1635/003-004</DrugIDPK>
    <LicenceNumber>EU/1/22/1635/003-004</LicenceNumber>
    <ProductName>Dimethyl Fumarate Polpharma</ProductName>
    <PAHolder>Zaklady Farmaceutyczne Polpharma S.A.</PAHolder>
    <AuthorisedDate>13/05/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dimethyl Fumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>13/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/22/1702/001-003</DrugIDPK>
    <LicenceNumber>EU/1/22/1702/001-003</LicenceNumber>
    <ProductName>Dimethyl fumarate Teva</ProductName>
    <PAHolder>TEVA GmbH</PAHolder>
    <AuthorisedDate>12/12/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dimethyl Fumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>13/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/22/1702/004-008</DrugIDPK>
    <LicenceNumber>EU/1/22/1702/004-008</LicenceNumber>
    <ProductName>Dimethyl fumarate Teva</ProductName>
    <PAHolder>TEVA GmbH</PAHolder>
    <AuthorisedDate>12/12/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dimethyl Fumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>13/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/22/1637/001-002</DrugIDPK>
    <LicenceNumber>EU/1/22/1637/001-002</LicenceNumber>
    <ProductName>Dimethyl Fumurate Neuraxpharm</ProductName>
    <PAHolder>Laboratorios Lesvi, S.L.</PAHolder>
    <AuthorisedDate>13/05/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dimethyl Fumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>13/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/22/1637/003-005</DrugIDPK>
    <LicenceNumber>EU/1/22/1637/003-005</LicenceNumber>
    <ProductName>Dimethyl Fumurate Neuraxpharm</ProductName>
    <PAHolder>Laboratorios Lesvi, S.L.</PAHolder>
    <AuthorisedDate>13/05/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dimethyl Fumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>13/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/039/001</DrugIDPK>
    <LicenceNumber>PA0006/039/001</LicenceNumber>
    <ProductName>DIMETRIOSE</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>03/04/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GESTRINONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/09/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/013/001</DrugIDPK>
    <LicenceNumber>PA0086/013/001</LicenceNumber>
    <ProductName>Dimotane</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/06/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/013/002</DrugIDPK>
    <LicenceNumber>PA0086/013/002</LicenceNumber>
    <ProductName>Dimotane</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/06/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/004/001</DrugIDPK>
    <LicenceNumber>PA0086/004/001</LicenceNumber>
    <ProductName>DIMOTANE</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>15/03/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0172/032/001</DrugIDPK>
    <LicenceNumber>PA0172/032/001</LicenceNumber>
    <ProductName>DIMOTANE CO</ProductName>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>14/03/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>Codeine phosphate hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/11/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0172/032/002</DrugIDPK>
    <LicenceNumber>PA0172/032/002</LicenceNumber>
    <ProductName>DIMOTANE CO PAEDIATRIC</ProductName>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>14/03/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>Codeine phosphate hemihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/11/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/013/007</DrugIDPK>
    <LicenceNumber>PA0086/013/007</LicenceNumber>
    <ProductName>DIMOTANE EXPECTORANT</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>12/03/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/03/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/014/001</DrugIDPK>
    <LicenceNumber>PA0086/014/001</LicenceNumber>
    <ProductName>DIMOTANE EXPECTORANT DC</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/013/004</DrugIDPK>
    <LicenceNumber>PA0086/013/004</LicenceNumber>
    <ProductName>DIMOTANE EXPECTORANT PAEDIATRIC</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/015/001</DrugIDPK>
    <LicenceNumber>PA0086/015/001</LicenceNumber>
    <ProductName>DIMOTANE L.A.</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/03/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/011/001</DrugIDPK>
    <LicenceNumber>PA0086/011/001</LicenceNumber>
    <ProductName>DIMOTAPP</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/09/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/011/005</DrugIDPK>
    <LicenceNumber>PA0086/011/005</LicenceNumber>
    <ProductName>DIMOTAPP CO</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>15/03/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/03/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/011/006</DrugIDPK>
    <LicenceNumber>PA0086/011/006</LicenceNumber>
    <ProductName>DIMOTAPP CO PAEDIATRIC</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>15/09/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
      <ActiveSubstance>CODEINE PHOSPHATE</ActiveSubstance>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/09/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/011/007</DrugIDPK>
    <LicenceNumber>PA0086/011/007</LicenceNumber>
    <ProductName>DIMOTAPP EXPECTORANT</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>19/04/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GUAIFENESIN</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/03/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/012/001</DrugIDPK>
    <LicenceNumber>PA0086/012/001</LicenceNumber>
    <ProductName>DIMOTAPP L.A.</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/09/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/016/001</DrugIDPK>
    <LicenceNumber>PA0086/016/001</LicenceNumber>
    <ProductName>DIMOTAPP P</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>08/06/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/06/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/011/003</DrugIDPK>
    <LicenceNumber>PA0086/011/003</LicenceNumber>
    <ProductName>DIMOTAPP PAEDIATRIC</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>18/09/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>PHENYLPROPANOLAMINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>BROMPHENIRAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1239/016/001</DrugIDPK>
    <LicenceNumber>PA1239/016/001</LicenceNumber>
    <ProductName>Dinortes</ProductName>
    <PAHolder>Laboratorios LICONSA, S.A.</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Telmisartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1239/016/002</DrugIDPK>
    <LicenceNumber>PA1239/016/002</LicenceNumber>
    <ProductName>Dinortes</ProductName>
    <PAHolder>Laboratorios LICONSA, S.A.</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Telmisartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1239/016/003</DrugIDPK>
    <LicenceNumber>PA1239/016/003</LicenceNumber>
    <ProductName>Dinortes</ProductName>
    <PAHolder>Laboratorios LICONSA, S.A.</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Telmisartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0379/006/002</DrugIDPK>
    <LicenceNumber>PA0379/006/002</LicenceNumber>
    <ProductName>DIOCALM (II)</ProductName>
    <PAHolder>SmithKlineBeecham Consumer Brand</PAHolder>
    <AuthorisedDate>16/04/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MORPHINE SULFATE</ActiveSubstance>
      <ActiveSubstance>ATTAPULGITE</ActiveSubstance>
      <ActiveSubstance>ACTIVATED ATTAPULGITE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0278/003/001</DrugIDPK>
    <LicenceNumber>PA0278/003/001</LicenceNumber>
    <ProductName>Dioderm 0.1% w/w Cream</ProductName>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate>01/12/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Hydrocortisone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/02/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/073/001</DrugIDPK>
    <LicenceNumber>PA0044/073/001</LicenceNumber>
    <ProductName>DIONOSIL OILY -  (SUSPENSION)</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PROPYLIODONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1447/072/001</DrugIDPK>
    <LicenceNumber>PPA1447/072/001</LicenceNumber>
    <ProductName>Dioralyte Blackcurrant</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>25/06/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Glucose</ActiveSubstance>
      <ActiveSubstance>Disodium hydrogen citrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/05/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/001/002</DrugIDPK>
    <LicenceNumber>PA0468/001/002</LicenceNumber>
    <ProductName>DIORALYTE CHERRY</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>13/07/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/002/003</DrugIDPK>
    <LicenceNumber>PA0468/002/003</LicenceNumber>
    <ProductName>DIORALYTE EFFERVESCENT</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>07/01/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/002/002</DrugIDPK>
    <LicenceNumber>PA0468/002/002</LicenceNumber>
    <ProductName>DIORALYTE EFFERVESCENT</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>07/01/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/002/001</DrugIDPK>
    <LicenceNumber>PA0468/002/001</LicenceNumber>
    <ProductName>DIORALYTE EFFERVESCENT</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>07/01/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE</ActiveSubstance>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0468/001/003</DrugIDPK>
    <LicenceNumber>PA0468/001/003</LicenceNumber>
    <ProductName>DIORALYTE PINEAPPLE</ProductName>
    <PAHolder>Rorer Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>19/07/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/079/001</DrugIDPK>
    <LicenceNumber>PA0013/079/001</LicenceNumber>
    <ProductName>Diovan</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/02/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0013/079/002</DrugIDPK>
    <LicenceNumber>PA0013/079/002</LicenceNumber>
    <ProductName>Diovan</ProductName>
    <PAHolder>Novartis Pharmaceuticals UK Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/02/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/067/001</DrugIDPK>
    <LicenceNumber>PPA1500/067/001</LicenceNumber>
    <ProductName>Diovan</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>01/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/030/001</DrugIDPK>
    <LicenceNumber>PPA1659/030/001</LicenceNumber>
    <ProductName>Diovan</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>03/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/030/002</DrugIDPK>
    <LicenceNumber>PPA1659/030/002</LicenceNumber>
    <ProductName>Diovan</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>03/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/030/003</DrugIDPK>
    <LicenceNumber>PPA1659/030/003</LicenceNumber>
    <ProductName>Diovan</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>03/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/180/002</DrugIDPK>
    <LicenceNumber>PPA0465/180/002</LicenceNumber>
    <InterchangeableListCode>IC0038-082-003</InterchangeableListCode>
    <ProductName>Diovan 160 mg film-coated tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>31/08/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/077/002</DrugIDPK>
    <LicenceNumber>PPA1463/077/002</LicenceNumber>
    <InterchangeableListCode>IC0038-082-003</InterchangeableListCode>
    <ProductName>Diovan 160 mg film-coated tablets</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>15/03/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/08/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/067/002</DrugIDPK>
    <LicenceNumber>PPA1151/067/002</LicenceNumber>
    <InterchangeableListCode>IC0038-082-003</InterchangeableListCode>
    <ProductName>Diovan 160mg Film-coated Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>03/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/067/003</DrugIDPK>
    <LicenceNumber>PPA1151/067/003</LicenceNumber>
    <InterchangeableListCode>IC0038-004-003</InterchangeableListCode>
    <ProductName>Diovan 40mg film-coated tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>11/05/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/180/001</DrugIDPK>
    <LicenceNumber>PPA0465/180/001</LicenceNumber>
    <InterchangeableListCode>IC0038-005-003</InterchangeableListCode>
    <ProductName>Diovan 80 mg film-coated tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>01/09/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/077/001</DrugIDPK>
    <LicenceNumber>PPA1463/077/001</LicenceNumber>
    <InterchangeableListCode>IC0038-005-003</InterchangeableListCode>
    <ProductName>Diovan 80 mg film-coated tablets</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>25/01/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/08/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/067/001</DrugIDPK>
    <LicenceNumber>PPA1151/067/001</LicenceNumber>
    <InterchangeableListCode>IC0038-005-003</InterchangeableListCode>
    <ProductName>Diovan 80mg Film-coated Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>03/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Valsartan</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0100/036/002</DrugIDPK>
    <LicenceNumber>PA0100/036/002</LicenceNumber>
    <ProductName>DIOVOL</ProductName>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>07/07/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE-MAGNESIUM CARBONATE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/06/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0100/036/001</DrugIDPK>
    <LicenceNumber>PA0100/036/001</LicenceNumber>
    <ProductName>DIOVOL</ProductName>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>07/05/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ALUMINIUM HYDROXIDE-MAGNESIUM CARBONATE GEL</ActiveSubstance>
      <ActiveSubstance>MAGNESIUM HYDROXIDE</ActiveSubstance>
      <ActiveSubstance>DIMETICONE, ACTIVATED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0544/004/004</DrugIDPK>
    <LicenceNumber>PA0544/004/004</LicenceNumber>
    <ProductName>DIP-TET VAX 20 DOSE</ProductName>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>20/09/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/021/002</DrugIDPK>
    <LicenceNumber>PA0046/021/002</LicenceNumber>
    <ProductName>DIPHEBUZOL</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/021/001</DrugIDPK>
    <LicenceNumber>PA0046/021/001</LicenceNumber>
    <ProductName>DIPHEBUZOL</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYLBUTAZONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0255/014/001</DrugIDPK>
    <LicenceNumber>PA0255/014/001</LicenceNumber>
    <ProductName>DIPHENHYDRAMINE</ProductName>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>10/10/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/10/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/028/002</DrugIDPK>
    <LicenceNumber>PA0017/028/002</LicenceNumber>
    <ProductName>DIPHTHERIA &amp; TETANUS</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA AND TETANUS TOXOIDS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0108/006/003</DrugIDPK>
    <LicenceNumber>PA0108/006/003</LicenceNumber>
    <ProductName>DIPHTHERIA &amp; TETANUS TOXOIDS</ProductName>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>14/02/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/02/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/036/002</DrugIDPK>
    <LicenceNumber>PA0044/036/002</LicenceNumber>
    <ProductName>DIPHTHERIA TETANUS</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/07/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0544/013/003</DrugIDPK>
    <LicenceNumber>PA0544/013/003</LicenceNumber>
    <ProductName>DIPHTHERIA TETANUS PERTUSSIS 10 DOSE</ProductName>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>22/03/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>BORDETELLA PERTUSSIS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0544/013/001</DrugIDPK>
    <LicenceNumber>PA0544/013/001</LicenceNumber>
    <ProductName>DIPHTHERIA TETANUS PERTUSSIS SINGLE DOSE</ProductName>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>22/03/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>BORDETELLA PERTUSSIS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0544/013/002</DrugIDPK>
    <LicenceNumber>PA0544/013/002</LicenceNumber>
    <ProductName>DIPHTHERIA TETANUS PERTUSSIS SINGLE DOSE SYRINGE</ProductName>
    <PAHolder>Sanofi Pasteur MSD Ltd</PAHolder>
    <AuthorisedDate>22/03/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>BORDETELLA PERTUSSIS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/09/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0108/006/001</DrugIDPK>
    <LicenceNumber>PA0108/006/001</LicenceNumber>
    <ProductName>DIPHTHERIA TOXOID &amp; TETANUS</ProductName>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>23/11/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/10/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0108/006/002</DrugIDPK>
    <LicenceNumber>PA0108/006/002</LicenceNumber>
    <ProductName>DIPHTHERIA TOXOID &amp; TETANUS TOXOID</ProductName>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>23/11/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
      <ActiveSubstance>TETANUS TOXOID</ActiveSubstance>
      <ActiveSubstance>ALUMINIUM PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/10/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/026/002</DrugIDPK>
    <LicenceNumber>PA0017/026/002</LicenceNumber>
    <ProductName>DIPHTHERIA VACCINE P T A P</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/07/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/026/001</DrugIDPK>
    <LicenceNumber>PA0017/026/001</LicenceNumber>
    <ProductName>DIPHTHERIA VACCINE P T A P</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHTHERIA TOXOID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/02/1977</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0290/071/001</DrugIDPK>
    <LicenceNumber>PA0290/071/001</LicenceNumber>
    <ProductName>DIPIVEFRIN HYDROCHLORIDE OPHTHALMIC</ProductName>
    <PAHolder>Alcon Laboratories (UK) Ltd</PAHolder>
    <AuthorisedDate>03/10/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye Drops Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPIVEFRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/12/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/005/002</DrugIDPK>
    <LicenceNumber>PA0970/005/002</LicenceNumber>
    <ProductName>Diprivan 1% w/v Emulsion for Injection or Infusion</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>25/05/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Propofol </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/005/001</DrugIDPK>
    <LicenceNumber>PA0970/005/001</LicenceNumber>
    <ProductName>Diprivan 1% w/v Emulsion for Intravenous Injection or Infusion, 20ml ampoule</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>06/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Propofol </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/06/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/005/006</DrugIDPK>
    <LicenceNumber>PA0970/005/006</LicenceNumber>
    <ProductName>DIPRIVAN 2% PRE-FILLED SYRINGE</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>19/10/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Propofol </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/06/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/005/007</DrugIDPK>
    <LicenceNumber>PA0970/005/007</LicenceNumber>
    <ProductName>DIPRIVAN 2% PRE-FILLED SYRINGE</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>19/10/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for injection/infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Propofol </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/06/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/044/001</DrugIDPK>
    <LicenceNumber>DPR0465/044/001</LicenceNumber>
    <ProductName>Diprobase</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>07/08/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not assigned</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1463/032/001</DrugIDPK>
    <LicenceNumber>DPR1463/032/001</LicenceNumber>
    <ProductName>Diprobase</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>08/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1473/051/001</DrugIDPK>
    <LicenceNumber>DPR1473/051/001</LicenceNumber>
    <ProductName>Diprobase</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/04/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/182/001</DrugIDPK>
    <LicenceNumber>PPA1328/182/001</LicenceNumber>
    <ProductName>Diprobase</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>22/02/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1410/076/001</DrugIDPK>
    <LicenceNumber>PA1410/076/001</LicenceNumber>
    <ProductName>Diprobase Ointment</ProductName>
    <PAHolder>Bayer Limited</PAHolder>
    <AuthorisedDate>05/10/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1286/036/001</DrugIDPK>
    <LicenceNumber>PA1286/036/001</LicenceNumber>
    <ProductName>Diprobath</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Bath additive</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Liquid paraffin light</ActiveSubstance>
      <ActiveSubstance>Isopropyl myristate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0277/038/002</DrugIDPK>
    <LicenceNumber>PA0277/038/002</LicenceNumber>
    <ProductName>DIPROCEL</ProductName>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>20/11/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/11/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0277/038/001</DrugIDPK>
    <LicenceNumber>PA0277/038/001</LicenceNumber>
    <ProductName>DIPROCEL</ProductName>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>29/12/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/06/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/075/001</DrugIDPK>
    <LicenceNumber>PPA1328/075/001</LicenceNumber>
    <ProductName>Diprosalic</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>13/07/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone dipropionate</ActiveSubstance>
      <ActiveSubstance>Salicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1286/029/002</DrugIDPK>
    <LicenceNumber>PA1286/029/002</LicenceNumber>
    <ProductName>Diprosalic 0.05% w/w +</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone dipropionate</ActiveSubstance>
      <ActiveSubstance>Salicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/151/001</DrugIDPK>
    <LicenceNumber>PPA1562/151/001</LicenceNumber>
    <ProductName>DiproSalic 0.05% w/w + 2% w/w Scalp Application</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>06/03/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone</ActiveSubstance>
      <ActiveSubstance>Salicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/487/001</DrugIDPK>
    <LicenceNumber>PPA0465/487/001</LicenceNumber>
    <ProductName>DiproSalic 0.05% w/w + 2% w/w Scalp Application</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>07/01/2022</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone dipropionate</ActiveSubstance>
      <ActiveSubstance>Salicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1286/027/001</DrugIDPK>
    <LicenceNumber>PA1286/027/001</LicenceNumber>
    <ProductName>Diprosone</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1286/027/002</DrugIDPK>
    <LicenceNumber>PA1286/027/002</LicenceNumber>
    <ProductName>DIPROSONE</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0277/034/005</DrugIDPK>
    <LicenceNumber>PA0277/034/005</LicenceNumber>
    <ProductName>DIPROSONE 5 MG/ML</ProductName>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>01/07/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/09/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0277/034/004</DrugIDPK>
    <LicenceNumber>PA0277/034/004</LicenceNumber>
    <ProductName>DIPROSONE 5 MG/ML</ProductName>
    <PAHolder>Schering-Plough Limited</PAHolder>
    <AuthorisedDate>01/07/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BETAMETHASONE DIPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/09/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1286/027/003</DrugIDPK>
    <LicenceNumber>PA1286/027/003</LicenceNumber>
    <ProductName>Diprosone Lotion 0.05 % (w/w)</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>25/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/006/002</DrugIDPK>
    <LicenceNumber>PA0405/006/002</LicenceNumber>
    <ProductName>DIPYRIDAMOLE</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>07/05/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/006/001</DrugIDPK>
    <LicenceNumber>PA0405/006/001</LicenceNumber>
    <ProductName>DIPYRIDAMOLE</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>21/10/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPYRIDAMOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22697/009/001</DrugIDPK>
    <LicenceNumber>PA22697/009/001</LicenceNumber>
    <ProductName>Dipyridamole 200mg/5ml Oral Suspension</ProductName>
    <PAHolder>Syri Pharma Limited t/a Thame Laboratories</PAHolder>
    <AuthorisedDate>15/01/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dipyridamole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/06/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/149/001</DrugIDPK>
    <LicenceNumber>PA0281/149/001</LicenceNumber>
    <ProductName>Dipyridamole 50 mg/5 ml Oral Suspension</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>02/05/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dipyridamole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0009/033/002</DrugIDPK>
    <LicenceNumber>PA0009/033/002</LicenceNumber>
    <ProductName>DIRYTHMIN</ProductName>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>18/03/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0009/033/001</DrugIDPK>
    <LicenceNumber>PA0009/033/001</LicenceNumber>
    <ProductName>DIRYTHMIN</ProductName>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>18/03/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0009/033/004</DrugIDPK>
    <LicenceNumber>PA0009/033/004</LicenceNumber>
    <ProductName>DIRYTHMIN I.V.</ProductName>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>18/03/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0009/033/003</DrugIDPK>
    <LicenceNumber>PA0009/033/003</LicenceNumber>
    <ProductName>DIRYTHMIN I.V.</ProductName>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>18/03/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0009/025/001</DrugIDPK>
    <LicenceNumber>PA0009/025/001</LicenceNumber>
    <ProductName>DIRYTHMIN SA</ProductName>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>14/06/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/08/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0051/045/001</DrugIDPK>
    <LicenceNumber>PA0051/045/001</LicenceNumber>
    <ProductName>DISADINE DP</ProductName>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POVIDONE-IODINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/007/002</DrugIDPK>
    <LicenceNumber>PA0057/007/002</LicenceNumber>
    <ProductName>DISALCID</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>20/07/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALSALATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/10/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/007/001</DrugIDPK>
    <LicenceNumber>PA0057/007/001</LicenceNumber>
    <ProductName>DISALCID</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>10/05/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/01/1981</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/018/001</DrugIDPK>
    <LicenceNumber>PA0167/018/001</LicenceNumber>
    <ProductName>DISCASE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>14/04/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHYMOPAPAIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/01/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/010/002</DrugIDPK>
    <LicenceNumber>PA0062/010/002</LicenceNumber>
    <ProductName>DISIPAL</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/010/001</DrugIDPK>
    <LicenceNumber>PA0062/010/001</LicenceNumber>
    <ProductName>DISIPAL</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ORPHENADRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0090/008/001</DrugIDPK>
    <LicenceNumber>PA0090/008/001</LicenceNumber>
    <ProductName>DISIPIDIN</ProductName>
    <PAHolder>Paines and Byrne Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/007/001</DrugIDPK>
    <LicenceNumber>PA1339/007/001</LicenceNumber>
    <ProductName>Disodium Pamidronate 15mg/ml Concentrate for Solution for Infusion, 1ml</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>26/08/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pamidronic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/227/001</DrugIDPK>
    <LicenceNumber>PA0281/227/001</LicenceNumber>
    <ProductName>Disodium Pamidronate 15mg/ml Concentrate for Solution for Infusion, 2ml</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>26/08/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pamidronic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/007/003</DrugIDPK>
    <LicenceNumber>PA1339/007/003</LicenceNumber>
    <ProductName>Disodium Pamidronate 15mg/ml Concentrate for Solution for Infusion, 4ml</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>26/08/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pamidronic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/227/002</DrugIDPK>
    <LicenceNumber>PA0281/227/002</LicenceNumber>
    <ProductName>Disodium Pamidronate 15mg/ml Concentrate for Solution for Infusion, 6ml</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>26/08/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pamidronic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0472/002/003</DrugIDPK>
    <LicenceNumber>PA0472/002/003</LicenceNumber>
    <ProductName>DISOGRAM</ProductName>
    <PAHolder>Prographarm Laboratories</PAHolder>
    <AuthorisedDate>20/04/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE</ActiveSubstance>
      <ActiveSubstance>DISOPYRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/04/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0472/002/002</DrugIDPK>
    <LicenceNumber>PA0472/002/002</LicenceNumber>
    <ProductName>DISOGRAM CR CAPSULES</ProductName>
    <PAHolder>Prographarm Laboratories</PAHolder>
    <AuthorisedDate>20/04/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DISOPYRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/04/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0176/015/001</DrugIDPK>
    <LicenceNumber>PA0176/015/001</LicenceNumber>
    <ProductName>DISPERSIBLE ASPIRIN</ProductName>
    <PAHolder>Accord-UK Ltd</PAHolder>
    <AuthorisedDate>04/05/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/02/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/091/001</DrugIDPK>
    <LicenceNumber>PA0077/091/001</LicenceNumber>
    <ProductName>DISPERSIBLE ASPRIN</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>15/11/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/11/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0979/019/001</DrugIDPK>
    <LicenceNumber>PA0979/019/001</LicenceNumber>
    <ProductName>Disprin Extra</ProductName>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>10/08/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aspirin</ActiveSubstance>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/08/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0027/005/002</DrugIDPK>
    <LicenceNumber>PA0027/005/002</LicenceNumber>
    <ProductName>DISPRIN FOILSTRIP</ProductName>
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/10/1980</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0027/036/003</DrugIDPK>
    <LicenceNumber>PA0027/036/003</LicenceNumber>
    <ProductName>DISPROL PAEDIATRIC</ProductName>
    <PAHolder>Reckitt's (Ireland) Limited</PAHolder>
    <AuthorisedDate>07/05/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/08/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0979/008/001</DrugIDPK>
    <LicenceNumber>PA0979/008/001</LicenceNumber>
    <ProductName>Disprol Paracetamol Oral Suspension</ProductName>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>19/11/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0979/008/002</DrugIDPK>
    <LicenceNumber>PA0979/008/002</LicenceNumber>
    <ProductName>DISPROL SOLUBLE PARACETAMOL</ProductName>
    <PAHolder>Reckitt Benckiser Ireland Ltd</PAHolder>
    <AuthorisedDate>19/11/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/04/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0447/007/001</DrugIDPK>
    <LicenceNumber>PA0447/007/001</LicenceNumber>
    <ProductName>DISTACLOR</ProductName>
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate>16/11/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFACLOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/01/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/039/006</DrugIDPK>
    <LicenceNumber>PA0047/039/006</LicenceNumber>
    <ProductName>DISTACLOR (SUSPENSION)</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>09/01/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFACLOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/01/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/039/005</DrugIDPK>
    <LicenceNumber>PA0047/039/005</LicenceNumber>
    <ProductName>DISTACLOR (SUSPENSION)</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>09/01/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFACLOR</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/01/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1226/001/001</DrugIDPK>
    <LicenceNumber>PA1226/001/001</LicenceNumber>
    <ProductName>Distaclor 500mg Hard Capsules</ProductName>
    <PAHolder>Flynn Pharma Limited</PAHolder>
    <AuthorisedDate>16/11/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cefaclor</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0447/007/009</DrugIDPK>
    <LicenceNumber>PA0447/007/009</LicenceNumber>
    <ProductName>DISTACLOR GRANULES</ProductName>
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate>30/03/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFACLOR MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/01/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0447/007/008</DrugIDPK>
    <LicenceNumber>PA0447/007/008</LicenceNumber>
    <ProductName>DISTACLOR GRANULES</ProductName>
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate>30/03/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for Oral Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFACLOR MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/01/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/078/003</DrugIDPK>
    <LicenceNumber>PA0047/078/003</LicenceNumber>
    <ProductName>DISTACLOR LA</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>16/06/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CEFACLOR MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/01/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0913/020/001</DrugIDPK>
    <LicenceNumber>PA0913/020/001</LicenceNumber>
    <ProductName>Distalgesic</ProductName>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dextropropoxyphene hydrochloride</ActiveSubstance>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/027/001</DrugIDPK>
    <LicenceNumber>PA0047/027/001</LicenceNumber>
    <ProductName>DISTALGESIC</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTROPROPOXYPHENE NAPSILATE</ActiveSubstance>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/04/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0943/003/001</DrugIDPK>
    <LicenceNumber>PA0943/003/001</LicenceNumber>
    <ProductName>Distamine</ProductName>
    <PAHolder>Alliance Pharmaceuticals Ltd.</PAHolder>
    <AuthorisedDate>21/02/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Penicillamine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/08/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0943/003/002</DrugIDPK>
    <LicenceNumber>PA0943/003/002</LicenceNumber>
    <ProductName>Distamine</ProductName>
    <PAHolder>Alliance Pharmaceuticals Ltd.</PAHolder>
    <AuthorisedDate>01/10/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Penicillamine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/08/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0447/001/003</DrugIDPK>
    <LicenceNumber>PA0447/001/003</LicenceNumber>
    <ProductName>DISTAMINE</ProductName>
    <PAHolder>Dista Products Limited</PAHolder>
    <AuthorisedDate>28/06/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PENICILLAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/07/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0051/034/001</DrugIDPK>
    <LicenceNumber>PA0051/034/001</LicenceNumber>
    <ProductName>DISULPHINE BLUE INTRAVENOUS</ProductName>
    <PAHolder>Zeneca Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULPHAN BLUE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/08/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0798/003/001</DrugIDPK>
    <LicenceNumber>PA0798/003/001</LicenceNumber>
    <ProductName>diTeBooster, suspension for injection.Diphtheria and tetanus vaccine (absorbed, reduced antigen content)</ProductName>
    <PAHolder>Statens Serum Institute</PAHolder>
    <AuthorisedDate>11/03/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diphtheria toxoid</ActiveSubstance>
      <ActiveSubstance>Tetanus toxoid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/04/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0278/001/001</DrugIDPK>
    <LicenceNumber>PA0278/001/001</LicenceNumber>
    <ProductName>Dithrocream 0.1%w/w</ProductName>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate>01/12/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dithranol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/05/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0278/001/002</DrugIDPK>
    <LicenceNumber>PA0278/001/002</LicenceNumber>
    <ProductName>Dithrocream 0.25%w/w</ProductName>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate>01/12/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dithranol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0278/001/003</DrugIDPK>
    <LicenceNumber>PA0278/001/003</LicenceNumber>
    <ProductName>Dithrocream 0.5%w/w</ProductName>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate>01/12/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dithranol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0278/001/004</DrugIDPK>
    <LicenceNumber>PA0278/001/004</LicenceNumber>
    <ProductName>Dithrocream 1% w/w</ProductName>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate>17/04/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dithranol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0278/001/005</DrugIDPK>
    <LicenceNumber>PA0278/001/005</LicenceNumber>
    <ProductName>Dithrocream 2% w/w</ProductName>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate>03/07/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dithranol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0278/018/001</DrugIDPK>
    <LicenceNumber>PA0278/018/001</LicenceNumber>
    <ProductName>Dithrogel</ProductName>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dithranol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0278/018/002</DrugIDPK>
    <LicenceNumber>PA0278/018/002</LicenceNumber>
    <ProductName>Dithrogel</ProductName>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dithranol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0278/018/003</DrugIDPK>
    <LicenceNumber>PA0278/018/003</LicenceNumber>
    <ProductName>Dithrogel</ProductName>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dithranol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0278/018/004</DrugIDPK>
    <LicenceNumber>PA0278/018/004</LicenceNumber>
    <ProductName>Dithrogel</ProductName>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dithranol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0278/018/005</DrugIDPK>
    <LicenceNumber>PA0278/018/005</LicenceNumber>
    <ProductName>Dithrogel</ProductName>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dithranol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0278/018/006</DrugIDPK>
    <LicenceNumber>PA0278/018/006</LicenceNumber>
    <ProductName>Dithrogel</ProductName>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dithranol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0278/002/001</DrugIDPK>
    <LicenceNumber>PA0278/002/001</LicenceNumber>
    <ProductName>DITHROLAN</ProductName>
    <PAHolder>Dermal Laboratories Ltd</PAHolder>
    <AuthorisedDate>01/12/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DITHRANOL</ActiveSubstance>
      <ActiveSubstance>SALICYLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/092/001</DrugIDPK>
    <LicenceNumber>PPA1328/092/001</LicenceNumber>
    <ProductName>Ditropan</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>25/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Oxybutynin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/092/002</DrugIDPK>
    <LicenceNumber>PPA1328/092/002</LicenceNumber>
    <ProductName>Ditropan</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>25/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Oxybutynin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/146/001</DrugIDPK>
    <LicenceNumber>PA0540/146/001</LicenceNumber>
    <ProductName>Ditropan 2.5mg/5ml Oral Solution</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>04/01/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Oxybutynin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/05/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/146/002</DrugIDPK>
    <LicenceNumber>PA0540/146/002</LicenceNumber>
    <ProductName>Ditropan 2.5mg Tablets</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>24/08/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Oxybutynin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/04/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/252/001</DrugIDPK>
    <LicenceNumber>PPA0465/252/001</LicenceNumber>
    <ProductName>Ditropan 5 mg tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>27/08/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Oxybutynin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/180/001</DrugIDPK>
    <LicenceNumber>PPA1562/180/001</LicenceNumber>
    <ProductName>Ditropan 5 mg Tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>07/10/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Oxybutynin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/04/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/146/003</DrugIDPK>
    <LicenceNumber>PA0540/146/003</LicenceNumber>
    <ProductName>Ditropan 5mg Tablets</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>24/08/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Oxybutynin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/04/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0913/004/001</DrugIDPK>
    <LicenceNumber>PA0913/004/001</LicenceNumber>
    <ProductName>DIUMIDE-K</ProductName>
    <PAHolder>Napp Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>04/01/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Furosemide </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Not applicable</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Not applicable</SupplyLegalStatus>
    <PromotionLegalStatus>Not applicable</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1058/003/001</DrugIDPK>
    <LicenceNumber>PA1058/003/001</LicenceNumber>
    <ProductName>DIUREXAN</ProductName>
    <PAHolder>MEDA Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>24/07/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>XIPAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/07/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0303/033/001</DrugIDPK>
    <LicenceNumber>PA0303/033/001</LicenceNumber>
    <ProductName>DIVINA</ProductName>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>22/07/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/10/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0795/003/001</DrugIDPK>
    <LicenceNumber>PA0795/003/001</LicenceNumber>
    <ProductName>DIVISEQ</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>13/10/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
      <ActiveSubstance>MEDROXYPROGESTERONE ACETATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL VALERATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/12/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/032/001</DrugIDPK>
    <LicenceNumber>PA0007/032/001</LicenceNumber>
    <ProductName>Dixarit Tablets 25 micrograms</ProductName>
    <PAHolder>Boehringer Ingelheim Ltd</PAHolder>
    <AuthorisedDate>07/05/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clonidine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/10/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1217/001/003</DrugIDPK>
    <LicenceNumber>PA1217/001/003</LicenceNumber>
    <ProductName>Dobutamin Hikma 250/20 ml ampoule</ProductName>
    <PAHolder>Hikma Farmacêutica (Portugal) S.A.</PAHolder>
    <AuthorisedDate>17/12/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/08/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1217/001/004</DrugIDPK>
    <LicenceNumber>PA1217/001/004</LicenceNumber>
    <ProductName>Dobutamin Hikma 250 mg/ 5 ml ampoule</ProductName>
    <PAHolder>Hikma Farmacêutica (Portugal) S.A.</PAHolder>
    <AuthorisedDate>17/12/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/08/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1217/001/001</DrugIDPK>
    <LicenceNumber>PA1217/001/001</LicenceNumber>
    <ProductName>Dobutamin Hikma 250 mg/ 50 ml ampoule</ProductName>
    <PAHolder>Hikma Farmacêutica (Portugal) S.A.</PAHolder>
    <AuthorisedDate>17/12/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/08/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1217/001/002</DrugIDPK>
    <LicenceNumber>PA1217/001/002</LicenceNumber>
    <ProductName>Dobutamin Hikma 250 mg/50 ml vial</ProductName>
    <PAHolder>Hikma Farmacêutica (Portugal) S.A.</PAHolder>
    <AuthorisedDate>17/12/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/08/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/061/004</DrugIDPK>
    <LicenceNumber>PA0038/061/004</LicenceNumber>
    <ProductName>DOBUTAMINE</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>07/02/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/08/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/061/003</DrugIDPK>
    <LicenceNumber>PA0038/061/003</LicenceNumber>
    <ProductName>DOBUTAMINE</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>07/02/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/08/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/061/002</DrugIDPK>
    <LicenceNumber>PA0038/061/002</LicenceNumber>
    <ProductName>DOBUTAMINE</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>07/02/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/08/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/036/001</DrugIDPK>
    <LicenceNumber>PA0437/036/001</LicenceNumber>
    <ProductName>Dobutamine 12.5 mg/ml Concentrate for Solution for Infusion</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>03/01/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/03/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2299/039/001</DrugIDPK>
    <LicenceNumber>PA2299/039/001</LicenceNumber>
    <ProductName>Dobutamine 12.5mg/ml Concentrate for solution for infusion</ProductName>
    <PAHolder>Baxter Holding B.V.</PAHolder>
    <AuthorisedDate>22/07/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dobutamine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/06/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/046/001</DrugIDPK>
    <LicenceNumber>PA0822/046/001</LicenceNumber>
    <ProductName>Dobutamine Pfizer</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>19/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0971/002/004</DrugIDPK>
    <LicenceNumber>PA0971/002/004</LicenceNumber>
    <ProductName>Dobutamine-hameln 250 mg/ 5 ml ampoule</ProductName>
    <PAHolder>Hameln Pharmaceuticals GmbH</PAHolder>
    <AuthorisedDate>04/11/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/11/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0971/002/002</DrugIDPK>
    <LicenceNumber>PA0971/002/002</LicenceNumber>
    <ProductName>Dobutamine-hameln 250 mg/ 50 ml vial</ProductName>
    <PAHolder>Hameln Pharmaceuticals GmbH</PAHolder>
    <AuthorisedDate>04/11/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/11/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0971/002/003</DrugIDPK>
    <LicenceNumber>PA0971/002/003</LicenceNumber>
    <ProductName>Dobutamine-hameln 250 mg/20 ml ampoule</ProductName>
    <PAHolder>Hameln Pharmaceuticals GmbH</PAHolder>
    <AuthorisedDate>04/11/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/11/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0971/002/001</DrugIDPK>
    <LicenceNumber>PA0971/002/001</LicenceNumber>
    <ProductName>Dobutamine-hameln 250 mg/50 ml ampoule</ProductName>
    <PAHolder>Hameln Pharmaceuticals GmbH</PAHolder>
    <AuthorisedDate>04/11/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/11/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1226/003/001</DrugIDPK>
    <LicenceNumber>PA1226/003/001</LicenceNumber>
    <ProductName>Dobutrex</ProductName>
    <PAHolder>Flynn Pharma Limited</PAHolder>
    <AuthorisedDate>02/12/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/08/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/014/002</DrugIDPK>
    <LicenceNumber>PA0047/014/002</LicenceNumber>
    <ProductName>DOBUTREX</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>18/01/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOBUTAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/09/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/10/630/001</DrugIDPK>
    <LicenceNumber>EU/1/10/630/001</LicenceNumber>
    <ProductName>Docefrez</ProductName>
    <PAHolder>Sun Phamaceutical Industries Europe B.V.</PAHolder>
    <AuthorisedDate>10/05/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Docetaxel (anhydrous)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/10/630/002</DrugIDPK>
    <LicenceNumber>EU/1/10/630/002</LicenceNumber>
    <ProductName>Docefrez</ProductName>
    <PAHolder>Sun Phamaceutical Industries Europe B.V.</PAHolder>
    <AuthorisedDate>10/05/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Docetaxel (anhydrous)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/09/611/1-2</DrugIDPK>
    <LicenceNumber>EU/1/09/611/1-2</LicenceNumber>
    <ProductName>Docetaxel</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>26/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate and solvent for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Docetaxel</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1840/003/002</DrugIDPK>
    <LicenceNumber>PA1840/003/002</LicenceNumber>
    <ProductName>Docetaxel</ProductName>
    <PAHolder>Seacross Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>17/05/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Docetaxel</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/125/001</DrugIDPK>
    <LicenceNumber>PA2315/125/001</LicenceNumber>
    <ProductName>Docetaxel 20mg/ml concentrate for solution for infusion</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>24/09/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Docetaxel</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>08/12/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0789/017/001</DrugIDPK>
    <LicenceNumber>PA0789/017/001</LicenceNumber>
    <ProductName>Docetaxel Ebewe</ProductName>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>16/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Docetaxel</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>01/07/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/067/001</DrugIDPK>
    <LicenceNumber>PA0437/067/001</LicenceNumber>
    <ProductName>Docetaxel Hospira 10 mg/ml Concentrate for Solution for Infusion</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>22/12/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Docetaxel</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>22/03/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/077/001</DrugIDPK>
    <LicenceNumber>PA0405/077/001</LicenceNumber>
    <ProductName>Docetaxel Mylan</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>05/12/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate and solvent for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Docetaxel (anhydrous)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>25/05/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/077/002</DrugIDPK>
    <LicenceNumber>PA0405/077/002</LicenceNumber>
    <ProductName>Docetaxel Mylan</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>05/12/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate and solvent for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Docetaxel (anhydrous)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>25/05/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/146/001</DrugIDPK>
    <LicenceNumber>PA0822/146/001</LicenceNumber>
    <ProductName>Docetaxel Pfizer 10 mg/mL concentrate for solution for infusion</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>16/11/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Docetaxel</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>01/07/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1557/001/001</DrugIDPK>
    <LicenceNumber>PA1557/001/001</LicenceNumber>
    <ProductName>Docetaxel Teva Generics</ProductName>
    <PAHolder>Teva Generics B.V.</PAHolder>
    <AuthorisedDate>20/07/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for conc/solv for inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Docetaxel</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>06/11/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1557/001/002</DrugIDPK>
    <LicenceNumber>PA1557/001/002</LicenceNumber>
    <ProductName>Docetaxel Teva Generics</ProductName>
    <PAHolder>Teva Generics B.V.</PAHolder>
    <AuthorisedDate>20/07/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr+Solv for conc/solv for inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Docetaxel</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>06/11/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/10/662/001</DrugIDPK>
    <LicenceNumber>EU/1/10/662/001</LicenceNumber>
    <ProductName>Docetaxel Teva Pharma</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>21/01/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate and solvent for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Docetaxel</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>02/04/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/10/662/002</DrugIDPK>
    <LicenceNumber>EU/1/10/662/002</LicenceNumber>
    <ProductName>Docetaxel Teva Pharma</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>21/01/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate and solvent for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Docetaxel</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>02/04/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/07/384/001</DrugIDPK>
    <LicenceNumber>EU/1/07/384/001</LicenceNumber>
    <ProductName>Docetaxel Winthrop</ProductName>
    <PAHolder>Zentiva k.s.</PAHolder>
    <AuthorisedDate>20/04/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Docetaxel trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>25/04/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/07/384/002</DrugIDPK>
    <LicenceNumber>EU/1/07/384/002</LicenceNumber>
    <ProductName>Docetaxel Winthrop</ProductName>
    <PAHolder>Zentiva k.s.</PAHolder>
    <AuthorisedDate>20/04/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Docetaxel trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>25/04/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/07/384/003</DrugIDPK>
    <LicenceNumber>EU/1/07/384/003</LicenceNumber>
    <ProductName>Docetaxel Winthrop</ProductName>
    <PAHolder>Zentiva k.s.</PAHolder>
    <AuthorisedDate>30/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Docetaxel trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>25/04/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/07/384/004</DrugIDPK>
    <LicenceNumber>EU/1/07/384/004</LicenceNumber>
    <ProductName>Docetaxel Winthrop</ProductName>
    <PAHolder>Zentiva k.s.</PAHolder>
    <AuthorisedDate>30/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Docetaxel trihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>25/04/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0566/059/001</DrugIDPK>
    <LicenceNumber>PA0566/059/001</LicenceNumber>
    <ProductName>Docirena</ProductName>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>26/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Docetaxel</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/01/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0566/059/002</DrugIDPK>
    <LicenceNumber>PA0566/059/002</LicenceNumber>
    <ProductName>Docirena</ProductName>
    <PAHolder>Fresenius Kabi Limited</PAHolder>
    <AuthorisedDate>26/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Docetaxel</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/01/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0549/011/001</DrugIDPK>
    <LicenceNumber>PA0549/011/001</LicenceNumber>
    <ProductName>Dolflash</ProductName>
    <PAHolder>Ethypharm</PAHolder>
    <AuthorisedDate>07/03/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>Section 6:
General sale in blister packs containing not more than 12 unit dosage forms.   The product concerned should contain paracetamol as its only active analgesic substance and only one pack should be supplied in the course of any one retail transact</SupplyComments>
    <WithdrawalDate>01/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/167/001</DrugIDPK>
    <LicenceNumber>PPA1328/167/001</LicenceNumber>
    <ProductName>Dolmatil</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>24/02/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sulpiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/122/001</DrugIDPK>
    <LicenceNumber>PPA1562/122/001</LicenceNumber>
    <ProductName>Dolmatil</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>11/07/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sulpiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/09/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/122/002</DrugIDPK>
    <LicenceNumber>PPA1562/122/002</LicenceNumber>
    <ProductName>Dolmatil</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>11/07/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sulpiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/09/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/155/002</DrugIDPK>
    <LicenceNumber>PA0077/155/002</LicenceNumber>
    <ProductName>DOLMATIL</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>03/04/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/01/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/155/001</DrugIDPK>
    <LicenceNumber>PA0077/155/001</LicenceNumber>
    <ProductName>DOLMATIL</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>03/04/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULPIRIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/01/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/183/001</DrugIDPK>
    <LicenceNumber>PPA1151/183/001</LicenceNumber>
    <ProductName>Dolmatil 200 mg tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>18/07/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sulpiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/147/002</DrugIDPK>
    <LicenceNumber>PA0540/147/002</LicenceNumber>
    <ProductName>Dolmatil 400mg Film-Coated Tablets</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>23/03/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sulpiride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/06/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/014/004</DrugIDPK>
    <LicenceNumber>PA0035/014/004</LicenceNumber>
    <ProductName>Dolobid</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diflunisal</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/06/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/014/002</DrugIDPK>
    <LicenceNumber>PA0035/014/002</LicenceNumber>
    <ProductName>DOLOBID</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diflunisal</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/11/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1780/001/001</DrugIDPK>
    <LicenceNumber>PA1780/001/001</LicenceNumber>
    <ProductName>Doloritis</ProductName>
    <PAHolder>AHA Medical Services Ltd</PAHolder>
    <AuthorisedDate>25/11/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glucosamine sulfate sodium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0047/028/001</DrugIDPK>
    <LicenceNumber>PA0047/028/001</LicenceNumber>
    <ProductName>Doloxene</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTROPROPOXYPHENE NAPSILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/09/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/029/001</DrugIDPK>
    <LicenceNumber>PA0047/029/001</LicenceNumber>
    <ProductName>DOLOXENE COMPOUND</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXTROPROPOXYPHENE NAPSILATE</ActiveSubstance>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/07/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/030/001</DrugIDPK>
    <LicenceNumber>PA0021/030/001</LicenceNumber>
    <ProductName>DOME CORT</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>10/12/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0079/011/001</DrugIDPK>
    <LicenceNumber>PA0079/011/001</LicenceNumber>
    <ProductName>DOME GLYCERINATED SKIN TESTING SOLUTIONS</ProductName>
    <PAHolder>Bayer Diagnostics Manufacturing</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/033/003</DrugIDPK>
    <LicenceNumber>PA0237/033/003</LicenceNumber>
    <ProductName>DOMICAL</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>04/01/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/033/002</DrugIDPK>
    <LicenceNumber>PA0237/033/002</LicenceNumber>
    <ProductName>DOMICAL</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>04/01/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/033/001</DrugIDPK>
    <LicenceNumber>PA0237/033/001</LicenceNumber>
    <ProductName>DOMICAL</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>04/01/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>AMITRIPTYLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1287/002/001</DrugIDPK>
    <LicenceNumber>PA1287/002/001</LicenceNumber>
    <ProductName>Domperidone</ProductName>
    <PAHolder>PIERRE FABRE Ltd</PAHolder>
    <AuthorisedDate>12/09/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Domperidone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/07/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/050/001</DrugIDPK>
    <LicenceNumber>PA1339/050/001</LicenceNumber>
    <InterchangeableListCode>IC0085-047-027</InterchangeableListCode>
    <ProductName>Domperidone 1mg/ml Oral Suspension</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>05/12/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Domperidone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/133/001</DrugIDPK>
    <LicenceNumber>PPA1328/133/001</LicenceNumber>
    <ProductName>Dona</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>12/02/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glucosamine sulfate</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/02/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/401/001</DrugIDPK>
    <LicenceNumber>PPA0465/401/001</LicenceNumber>
    <ProductName>Dona 1500 mg powder for oral solution</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>12/09/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glucosamine sulfate sodium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>This authorisation permits the holder to parallel-distribute product marketed in Ireland under the product authorisation number PA0868/001/001.</SupplyComments>
    <WithdrawalDate>31/12/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23176/035/001</DrugIDPK>
    <LicenceNumber>PPA23176/035/001</LicenceNumber>
    <ProductName>Dona 1500 mg Powder for oral solution</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>18/09/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glucosamine sulfate</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/191/001</DrugIDPK>
    <LicenceNumber>PPA0465/191/001</LicenceNumber>
    <ProductName>Dona 1500mg Powder for Oral Solution</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>05/01/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glucosamine sulfate</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/12/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/056/001</DrugIDPK>
    <LicenceNumber>PPA1151/056/001</LicenceNumber>
    <ProductName>Dona 1500mg Powder for Oral Solution</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>30/11/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Glucosamine sulfate as crystalline glucosamine sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/231/002</DrugIDPK>
    <LicenceNumber>PA2315/231/002</LicenceNumber>
    <InterchangeableListCode>IC0062-002-015</InterchangeableListCode>
    <ProductName>Donecept 10 mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>21/11/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/11/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/231/001</DrugIDPK>
    <LicenceNumber>PA2315/231/001</LicenceNumber>
    <InterchangeableListCode>IC0062-001-015</InterchangeableListCode>
    <ProductName>Donecept 5mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>21/11/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/11/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/020/002</DrugIDPK>
    <LicenceNumber>PA0915/020/002</LicenceNumber>
    <ProductName>Donelinn 10mg film-coated tablets</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>11/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/020/001</DrugIDPK>
    <LicenceNumber>PA0915/020/001</LicenceNumber>
    <ProductName>Donelinn 5 mg film-coated tablets</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>11/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/04/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1470/001/001</DrugIDPK>
    <LicenceNumber>PA1470/001/001</LicenceNumber>
    <ProductName>Donepezil hydrochloride</ProductName>
    <PAHolder>EGIS Pharmaceuticals PLC</PAHolder>
    <AuthorisedDate>17/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/04/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1470/001/002</DrugIDPK>
    <LicenceNumber>PA1470/001/002</LicenceNumber>
    <ProductName>Donepezil hydrochloride</ProductName>
    <PAHolder>EGIS Pharmaceuticals PLC</PAHolder>
    <AuthorisedDate>17/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/04/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0312/029/001</DrugIDPK>
    <LicenceNumber>PA0312/029/001</LicenceNumber>
    <ProductName>Donepezil Hydrochloride</ProductName>
    <PAHolder>Rosemont Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>11/04/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/10/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/039/002</DrugIDPK>
    <LicenceNumber>PA1339/039/002</LicenceNumber>
    <InterchangeableListCode>IC0062-002-015</InterchangeableListCode>
    <ProductName>Donepezil Hydrochloride 10mg Film-Coated Tablets</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>17/05/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/039/001</DrugIDPK>
    <LicenceNumber>PA1339/039/001</LicenceNumber>
    <InterchangeableListCode>IC0062-001-015</InterchangeableListCode>
    <ProductName>Donepezil Hydrochloride 5mg Film-Coated Tablets</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>17/05/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1436/015/002</DrugIDPK>
    <LicenceNumber>PA1436/015/002</LicenceNumber>
    <InterchangeableListCode>IC0062-002-015</InterchangeableListCode>
    <ProductName>Donepezil Hydrochloride Bluefish 10mg Film-coated Tablet</ProductName>
    <PAHolder>Bluefish Pharmaceuticals AB</PAHolder>
    <AuthorisedDate>09/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/05/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1436/015/001</DrugIDPK>
    <LicenceNumber>PA1436/015/001</LicenceNumber>
    <InterchangeableListCode>IC0062-001-015</InterchangeableListCode>
    <ProductName>Donepezil Hydrochloride Bluefish 5mg Film-coated Tablet</ProductName>
    <PAHolder>Bluefish Pharmaceuticals AB</PAHolder>
    <AuthorisedDate>09/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/05/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/077/001</DrugIDPK>
    <LicenceNumber>PA0408/077/001</LicenceNumber>
    <ProductName>Donepezil hydrochloride Ranbaxy</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>13/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/10/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0408/077/002</DrugIDPK>
    <LicenceNumber>PA0408/077/002</LicenceNumber>
    <ProductName>Donepezil hydrochloride Ranbaxy</ProductName>
    <PAHolder>Ranbaxy Ireland Limited</PAHolder>
    <AuthorisedDate>13/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/10/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1327/011/001</DrugIDPK>
    <LicenceNumber>PA1327/011/001</LicenceNumber>
    <ProductName>Donepezil hydrochoride</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>20/02/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1327/011/002</DrugIDPK>
    <LicenceNumber>PA1327/011/002</LicenceNumber>
    <ProductName>Donepezil hydrochoride</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>20/02/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1347/014/001</DrugIDPK>
    <LicenceNumber>PA1347/014/001</LicenceNumber>
    <ProductName>Donepezil Krka</ProductName>
    <PAHolder>KRKA, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>20/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/04/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1347/014/002</DrugIDPK>
    <LicenceNumber>PA1347/014/002</LicenceNumber>
    <ProductName>Donepezil Krka</ProductName>
    <PAHolder>KRKA, d.d., Novo mesto</PAHolder>
    <AuthorisedDate>20/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/04/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/046/001</DrugIDPK>
    <LicenceNumber>PA1063/046/001</LicenceNumber>
    <ProductName>Donepezil Niche</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>20/01/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/01/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/046/002</DrugIDPK>
    <LicenceNumber>PA1063/046/002</LicenceNumber>
    <ProductName>Donepezil Niche</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>20/01/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/01/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/043/002</DrugIDPK>
    <LicenceNumber>PA1063/043/002</LicenceNumber>
    <ProductName>Donepezil Niche 10mg film-coated tablets</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>19/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/043/001</DrugIDPK>
    <LicenceNumber>PA1063/043/001</LicenceNumber>
    <ProductName>Donepezil Niche 5mg film-coated tablets</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>19/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/076/001</DrugIDPK>
    <LicenceNumber>PA0822/076/001</LicenceNumber>
    <ProductName>Donepezil Pfizer</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>21/10/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/07/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/076/002</DrugIDPK>
    <LicenceNumber>PA0822/076/002</LicenceNumber>
    <ProductName>Donepezil Pfizer</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>21/10/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/07/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/076/003</DrugIDPK>
    <LicenceNumber>PA0822/076/003</LicenceNumber>
    <ProductName>Donepezil Pfizer</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>21/10/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/02/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0822/076/004</DrugIDPK>
    <LicenceNumber>PA0822/076/004</LicenceNumber>
    <ProductName>Donepezil Pfizer</ProductName>
    <PAHolder>Pfizer Healthcare Ireland</PAHolder>
    <AuthorisedDate>21/10/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/02/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0840/007/001</DrugIDPK>
    <LicenceNumber>PA0840/007/001</LicenceNumber>
    <ProductName>Donepezil Synthon</ProductName>
    <PAHolder>Synthon BV</PAHolder>
    <AuthorisedDate>02/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0840/007/002</DrugIDPK>
    <LicenceNumber>PA0840/007/002</LicenceNumber>
    <ProductName>Donepezil Synthon</ProductName>
    <PAHolder>Synthon BV</PAHolder>
    <AuthorisedDate>02/05/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/10/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/214/002</DrugIDPK>
    <LicenceNumber>PA0126/214/002</LicenceNumber>
    <ProductName>Donesyn 10mg Orodispersible Tablets</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>27/01/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/214/001</DrugIDPK>
    <LicenceNumber>PA0126/214/001</LicenceNumber>
    <ProductName>Donesyn 5mg Orodispersible Tablets</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>27/01/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Orodispersible tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Donepezil hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/006/001</DrugIDPK>
    <LicenceNumber>PA0086/006/001</LicenceNumber>
    <ProductName>DONNATAL</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
      <ActiveSubstance>HYOSCYAMINE</ActiveSubstance>
      <ActiveSubstance>ATROPINE</ActiveSubstance>
      <ActiveSubstance>HYOSCINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/02/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/006/003</DrugIDPK>
    <LicenceNumber>PA0086/006/003</LicenceNumber>
    <ProductName>DONNATAL ELIXIR</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
      <ActiveSubstance>HYOSCYAMINE</ActiveSubstance>
      <ActiveSubstance>ATROPINE</ActiveSubstance>
      <ActiveSubstance>HYOSCINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/02/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0086/006/002</DrugIDPK>
    <LicenceNumber>PA0086/006/002</LicenceNumber>
    <ProductName>DONNATAL LA</ProductName>
    <PAHolder>A.H. Robins Company Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
      <ActiveSubstance>HYOSCYAMINE</ActiveSubstance>
      <ActiveSubstance>ATROPINE</ActiveSubstance>
      <ActiveSubstance>HYOSCINE HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/02/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0583/008/002</DrugIDPK>
    <LicenceNumber>PA0583/008/002</LicenceNumber>
    <ProductName>DOPACARD</ProductName>
    <PAHolder>Ipsen Limited</PAHolder>
    <AuthorisedDate>14/06/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/06/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0583/003/003</DrugIDPK>
    <LicenceNumber>PA0583/003/003</LicenceNumber>
    <ProductName>DOPACARD</ProductName>
    <PAHolder>Ipsen Limited</PAHolder>
    <AuthorisedDate>14/06/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOPEXAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/06/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0583/003/002</DrugIDPK>
    <LicenceNumber>PA0583/003/002</LicenceNumber>
    <ProductName>DOPACARD</ProductName>
    <PAHolder>Ipsen Limited</PAHolder>
    <AuthorisedDate>14/06/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOPEXAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/06/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1260/004/001</DrugIDPK>
    <LicenceNumber>PA1260/004/001</LicenceNumber>
    <ProductName>Dopacard 10mg/ml Concentrate for Solution for Infusion</ProductName>
    <PAHolder>Cephalon Limited</PAHolder>
    <AuthorisedDate>12/10/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dopexamine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0677/019/001</DrugIDPK>
    <LicenceNumber>PA0677/019/001</LicenceNumber>
    <ProductName>Dopacis</ProductName>
    <PAHolder>CIS bio International</PAHolder>
    <AuthorisedDate>11/03/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fluorodopa (18 f)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Restricted to hospital dispensing</SupplyComments>
    <WithdrawalDate>01/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/051/001</DrugIDPK>
    <LicenceNumber>PA0073/051/001</LicenceNumber>
    <ProductName>Dopagen</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>04/11/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methyldopa</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/11/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/051/002</DrugIDPK>
    <LicenceNumber>PA0073/051/002</LicenceNumber>
    <ProductName>Dopagen</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>04/11/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methyldopa</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/11/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/051/003</DrugIDPK>
    <LicenceNumber>PA0073/051/003</LicenceNumber>
    <ProductName>Dopagen</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>30/05/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Methyldopa</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/05/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/040/003</DrugIDPK>
    <LicenceNumber>PA0237/040/003</LicenceNumber>
    <ProductName>DOPAMET</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>14/07/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/01/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/040/002</DrugIDPK>
    <LicenceNumber>PA0237/040/002</LicenceNumber>
    <ProductName>DOPAMET</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>14/07/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/01/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/040/001</DrugIDPK>
    <LicenceNumber>PA0237/040/001</LicenceNumber>
    <ProductName>DOPAMET</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>14/07/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METHYLDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/01/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/003/003</DrugIDPK>
    <LicenceNumber>PA0437/003/003</LicenceNumber>
    <ProductName>Dopamine 160 mg/ml Sterile Concentrate</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>21/05/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOPAMINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/05/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0255/011/006</DrugIDPK>
    <LicenceNumber>PA0255/011/006</LicenceNumber>
    <ProductName>DOPAMINE HYDROCHLORIDE</ProductName>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>21/05/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0255/011/004</DrugIDPK>
    <LicenceNumber>PA0255/011/004</LicenceNumber>
    <ProductName>DOPAMINE HYDROCHLORIDE</ProductName>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>21/05/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0255/011/003</DrugIDPK>
    <LicenceNumber>PA0255/011/003</LicenceNumber>
    <ProductName>DOPAMINE HYDROCHLORIDE</ProductName>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>10/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/11/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0255/011/002</DrugIDPK>
    <LicenceNumber>PA0255/011/002</LicenceNumber>
    <ProductName>DOPAMINE HYDROCHLORIDE</ProductName>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>10/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/11/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0255/011/001</DrugIDPK>
    <LicenceNumber>PA0255/011/001</LicenceNumber>
    <ProductName>DOPAMINE HYDROCHLORIDE</ProductName>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>08/09/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/09/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/038/003</DrugIDPK>
    <LicenceNumber>PA0038/038/003</LicenceNumber>
    <ProductName>DOPAMINE HYDROCHLORIDE IN 5% DEXTROSE</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>18/12/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/12/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/038/002</DrugIDPK>
    <LicenceNumber>PA0038/038/002</LicenceNumber>
    <ProductName>DOPAMINE HYDROCHLORIDE IN 5% DEXTROSE</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>18/12/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/12/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/038/001</DrugIDPK>
    <LicenceNumber>PA0038/038/001</LicenceNumber>
    <ProductName>DOPAMINE HYDROCHLORIDE IN 5% DEXTROSE</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>18/12/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/12/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0255/011/005</DrugIDPK>
    <LicenceNumber>PA0255/011/005</LicenceNumber>
    <ProductName>DOPAMINE HYDROCHLORIDE STERILE POWDER</ProductName>
    <PAHolder>International Medication Systems (UK) Ltd</PAHolder>
    <AuthorisedDate>21/05/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0303/013/001</DrugIDPK>
    <LicenceNumber>PA0303/013/001</LicenceNumber>
    <ProductName>DOPMIN</ProductName>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>09/05/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOPAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0060/052/001</DrugIDPK>
    <LicenceNumber>PA0060/052/001</LicenceNumber>
    <ProductName>DORALESE TILTAB</ProductName>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>21/02/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/08/467/002</DrugIDPK>
    <LicenceNumber>EU/1/08/467/002</LicenceNumber>
    <ProductName>Doribax</ProductName>
    <PAHolder>Janssen-Cilag International NV</PAHolder>
    <AuthorisedDate>15/03/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doripenem monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/08/467/001</DrugIDPK>
    <LicenceNumber>EU/1/08/467/001</LicenceNumber>
    <ProductName>Doribax 500 mg powder for solution for infusion</ProductName>
    <PAHolder>Janssen-Cilag International NV</PAHolder>
    <AuthorisedDate>25/07/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doripenem monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/08/467/1</DrugIDPK>
    <LicenceNumber>EU/1/08/467/1</LicenceNumber>
    <ProductName>Doribax 500 mg powder for solution for infusion</ProductName>
    <PAHolder>Janssen-Cilag International NV</PAHolder>
    <AuthorisedDate>25/07/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doripenem monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0028/011/001</DrugIDPK>
    <LicenceNumber>PA0028/011/001</LicenceNumber>
    <ProductName>DORIDEN</ProductName>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUTETHIMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/07/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/052/002</DrugIDPK>
    <LicenceNumber>PA0073/052/002</LicenceNumber>
    <ProductName>DORMIGEN</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>11/06/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/04/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/052/001</DrugIDPK>
    <LicenceNumber>PA0073/052/001</LicenceNumber>
    <ProductName>DORMIGEN</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>11/06/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NITRAZEPAM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0006/027/001</DrugIDPK>
    <LicenceNumber>PA0006/027/001</LicenceNumber>
    <ProductName>DORMONOCT</ProductName>
    <PAHolder>Roussel Laboratories Limited</PAHolder>
    <AuthorisedDate>01/09/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LOPRAZOLAM MESILATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/079/001</DrugIDPK>
    <LicenceNumber>PA0749/079/001</LicenceNumber>
    <ProductName>Dortim 20mg/ml + 5mg/ml Eye Drops Solution</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>02/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide hydrochloride</ActiveSubstance>
      <ActiveSubstance>Timolol Maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/06/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/037/001</DrugIDPK>
    <LicenceNumber>PA0437/037/001</LicenceNumber>
    <ProductName>DORYX</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>09/01/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/08/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/037/002</DrugIDPK>
    <LicenceNumber>PA0437/037/002</LicenceNumber>
    <ProductName>DORYX</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>09/01/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxycycline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/08/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1859/001/001</DrugIDPK>
    <LicenceNumber>PA1859/001/001</LicenceNumber>
    <ProductName>Dorzolamide</ProductName>
    <PAHolder>Blumont Pharma</PAHolder>
    <AuthorisedDate>31/01/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/135/001</DrugIDPK>
    <LicenceNumber>PA2315/135/001</LicenceNumber>
    <ProductName>Dorzolamide/Timolol 20 mg/ml + 5 mg/ml eye drops, solution</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>12/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide</ActiveSubstance>
      <ActiveSubstance>Timolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/06/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/124/001</DrugIDPK>
    <LicenceNumber>PA0577/124/001</LicenceNumber>
    <ProductName>Dorzolamide/Timolol Mylan</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>12/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide hydrochloride</ActiveSubstance>
      <ActiveSubstance>Timolol Maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/06/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA23259/003/001</DrugIDPK>
    <LicenceNumber>PA23259/003/001</LicenceNumber>
    <ProductName>Dorzolamide + Timolol PharmaSwiss 20 mg/ml + 5 mg/ml, eye drops solution</ProductName>
    <PAHolder>Bausch + Lomb Ireland Limited</PAHolder>
    <AuthorisedDate>14/10/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide</ActiveSubstance>
      <ActiveSubstance>Timolol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/08/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/126/001</DrugIDPK>
    <LicenceNumber>PA2315/126/001</LicenceNumber>
    <ProductName>Dorzolamide 20mg/ml eye drops, solution</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>14/01/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/06/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/052/001</DrugIDPK>
    <LicenceNumber>PA0405/052/001</LicenceNumber>
    <ProductName>Dorzolamide Mylan 20 mg/ml Eye Drops Solution</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>10/09/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/09/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA23259/002/001</DrugIDPK>
    <LicenceNumber>PA23259/002/001</LicenceNumber>
    <ProductName>Dorzolamide PharmaSwiss 20 mg/ml eye drops solution</ProductName>
    <PAHolder>Bausch + Lomb Ireland Limited</PAHolder>
    <AuthorisedDate>25/11/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dorzolamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/08/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1097/029/001</DrugIDPK>
    <LicenceNumber>PPA1097/029/001</LicenceNumber>
    <ProductName>Dostinex 500 microgram Tablets</ProductName>
    <PAHolder>Lexon (UK) Ltd</PAHolder>
    <AuthorisedDate>29/09/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cabergoline </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/10/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/108/001</DrugIDPK>
    <LicenceNumber>PPA1562/108/001</LicenceNumber>
    <ProductName>Dostinex 500 microgram Tablets</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>28/02/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cabergoline </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0686/003/001</DrugIDPK>
    <LicenceNumber>PA0686/003/001</LicenceNumber>
    <ProductName>Dotarem (Vial)</ProductName>
    <PAHolder>Guerbet</PAHolder>
    <AuthorisedDate>10/06/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Gadoteric acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/06/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/189/001</DrugIDPK>
    <LicenceNumber>PA0749/189/001</LicenceNumber>
    <ProductName>Dotevatrol 50 micrograms/g + 0.5 mg/g Ointment</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>09/12/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone</ActiveSubstance>
      <ActiveSubstance>Calcipotriol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/020/001</DrugIDPK>
    <LicenceNumber>PA0577/020/001</LicenceNumber>
    <ProductName>Dothep</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>05/09/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dosulepin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/020/002</DrugIDPK>
    <LicenceNumber>PA0577/020/002</LicenceNumber>
    <ProductName>DOTHEP</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>12/05/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dosulepin hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0376/001/001</DrugIDPK>
    <LicenceNumber>PA0376/001/001</LicenceNumber>
    <ProductName>DOUBLE CHECK</ProductName>
    <PAHolder>Family Planning Sales Ltd</PAHolder>
    <AuthorisedDate>30/08/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NONOXINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/05/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/213/001</DrugIDPK>
    <LicenceNumber>PPA0465/213/001</LicenceNumber>
    <ProductName>Dovobet</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>10/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol</ActiveSubstance>
      <ActiveSubstance>Betamethasone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/066/002</DrugIDPK>
    <LicenceNumber>PPA1328/066/002</LicenceNumber>
    <ProductName>Dovobet</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>12/09/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol</ActiveSubstance>
      <ActiveSubstance>Betamethasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/062/001</DrugIDPK>
    <LicenceNumber>PPA1500/062/001</LicenceNumber>
    <ProductName>Dovobet</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>25/06/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol</ActiveSubstance>
      <ActiveSubstance>Betamethasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/103/001</DrugIDPK>
    <LicenceNumber>PPA1562/103/001</LicenceNumber>
    <ProductName>Dovobet</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>31/01/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol</ActiveSubstance>
      <ActiveSubstance>Betamethasone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1633/003/001</DrugIDPK>
    <LicenceNumber>PPA1633/003/001</LicenceNumber>
    <ProductName>Dovobet</ProductName>
    <PAHolder>Primecrown 2010 Limited</PAHolder>
    <AuthorisedDate>30/04/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol hydrate</ActiveSubstance>
      <ActiveSubstance>Betametasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/03/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/018/001</DrugIDPK>
    <LicenceNumber>PPA1659/018/001</LicenceNumber>
    <ProductName>Dovobet</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>08/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol</ActiveSubstance>
      <ActiveSubstance>Betamethasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/213/002</DrugIDPK>
    <LicenceNumber>PPA0465/213/002</LicenceNumber>
    <ProductName>Dovobet 50 microgram/g + 0.5 mg/g gel</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>06/07/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol</ActiveSubstance>
      <ActiveSubstance>Betamethasone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/053/001</DrugIDPK>
    <LicenceNumber>PPA1151/053/001</LicenceNumber>
    <ProductName>Dovobet 50 microgram/g + 0.5 mg/g ointment</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>18/01/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol</ActiveSubstance>
      <ActiveSubstance>Betamethasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/004/001</DrugIDPK>
    <LicenceNumber>PPA1596/004/001</LicenceNumber>
    <ProductName>Dovobet 50 microgram/g + 0.5 mg/g ointment</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>29/10/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol hydrate</ActiveSubstance>
      <ActiveSubstance>Betamethasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/066/001</DrugIDPK>
    <LicenceNumber>PPA1328/066/001</LicenceNumber>
    <ProductName>Dovobet 50 microgram/g + 0.5 mg/g Ointment</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>05/01/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol</ActiveSubstance>
      <ActiveSubstance>Betamethasone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1473/047/001</DrugIDPK>
    <LicenceNumber>PPA1473/047/001</LicenceNumber>
    <ProductName>Dovobet 50 microgram/g + 0.5 mg/g Ointment</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>12/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol hydrate</ActiveSubstance>
      <ActiveSubstance>Betamethasone dipropionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/03/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/022/001</DrugIDPK>
    <LicenceNumber>PPA1463/022/001</LicenceNumber>
    <ProductName>Dovobet Ointment</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>08/05/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol</ActiveSubstance>
      <ActiveSubstance>Betamethasone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/06/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/023/001</DrugIDPK>
    <LicenceNumber>PPA1328/023/001</LicenceNumber>
    <ProductName>Dovonex</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>01/09/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/01/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/023/002</DrugIDPK>
    <LicenceNumber>PPA1328/023/002</LicenceNumber>
    <ProductName>Dovonex</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>13/10/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/023/003</DrugIDPK>
    <LicenceNumber>PPA1328/023/003</LicenceNumber>
    <ProductName>Dovonex</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>26/01/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/10/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/020/001</DrugIDPK>
    <LicenceNumber>PPA1463/020/001</LicenceNumber>
    <ProductName>Dovonex</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>08/05/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/06/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/059/001</DrugIDPK>
    <LicenceNumber>PPA1562/059/001</LicenceNumber>
    <ProductName>Dovonex</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>26/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/045/001</DrugIDPK>
    <LicenceNumber>PPA1659/045/001</LicenceNumber>
    <ProductName>Dovonex</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>09/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol hydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/132/002A</DrugIDPK>
    <LicenceNumber>PPA0465/132/002A</LicenceNumber>
    <ProductName>DOVONEX</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>11/06/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/06/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/061/003</DrugIDPK>
    <LicenceNumber>PA0046/061/003</LicenceNumber>
    <ProductName>Dovonex  50 micrograms/ml Scalp Solution</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>08/09/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/08/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/132/001</DrugIDPK>
    <LicenceNumber>PPA0465/132/001</LicenceNumber>
    <ProductName>Dovonex 50 micrograms/g Cream</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>11/06/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1473/049/001</DrugIDPK>
    <LicenceNumber>PPA1473/049/001</LicenceNumber>
    <ProductName>Dovonex 50 micrograms/g Cream</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>12/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol hydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/03/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1596/039/001</DrugIDPK>
    <LicenceNumber>PPA1596/039/001</LicenceNumber>
    <ProductName>Dovonex 50 micrograms/g Cream</ProductName>
    <PAHolder>Clear Pharmacy</PAHolder>
    <AuthorisedDate>21/12/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/132/003</DrugIDPK>
    <LicenceNumber>PPA0465/132/003</LicenceNumber>
    <ProductName>Dovonex 50 micrograms/ml Scalp Solution</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>11/06/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0046/064/001</DrugIDPK>
    <LicenceNumber>PA0046/064/001</LicenceNumber>
    <ProductName>Dovonex Psoriasis 50 microgram/g ointment</ProductName>
    <PAHolder>Leo Laboratories Limited</PAHolder>
    <AuthorisedDate>08/04/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Calcipotriol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA23266/060/001</DrugIDPK>
    <LicenceNumber>PA23266/060/001</LicenceNumber>
    <InterchangeableListCode>IC0021-008-024</InterchangeableListCode>
    <ProductName>Doxacar 4 mg Prolonged release Tablets</ProductName>
    <PAHolder>Viatris Limited</PAHolder>
    <AuthorisedDate>02/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/098/001</DrugIDPK>
    <LicenceNumber>PA0711/098/001</LicenceNumber>
    <ProductName>DOXANE</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>09/01/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/10/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/098/002</DrugIDPK>
    <LicenceNumber>PA0711/098/002</LicenceNumber>
    <ProductName>DOXANE</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>09/01/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/11/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/098/003</DrugIDPK>
    <LicenceNumber>PA0711/098/003</LicenceNumber>
    <ProductName>DOXANE</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>09/01/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/10/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1140/005/001</DrugIDPK>
    <LicenceNumber>PA1140/005/001</LicenceNumber>
    <ProductName>Doxapram</ProductName>
    <PAHolder>Taro Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>22/12/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxapram hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1140/005/002</DrugIDPK>
    <LicenceNumber>PA1140/005/002</LicenceNumber>
    <ProductName>Doxapram</ProductName>
    <PAHolder>Taro Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>22/12/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxapram hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0176/021/001</DrugIDPK>
    <LicenceNumber>PA0176/021/001</LicenceNumber>
    <ProductName>DOXATET</ProductName>
    <PAHolder>Accord-UK Ltd</PAHolder>
    <AuthorisedDate>28/06/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/03/1990</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/003/001</DrugIDPK>
    <LicenceNumber>PA0819/003/001</LicenceNumber>
    <ProductName>DOXAZIN</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/003/002</DrugIDPK>
    <LicenceNumber>PA0819/003/002</LicenceNumber>
    <ProductName>DOXAZIN</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/003/003</DrugIDPK>
    <LicenceNumber>PA0819/003/003</LicenceNumber>
    <ProductName>DOXAZIN</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1445/006/001</DrugIDPK>
    <LicenceNumber>PA1445/006/001</LicenceNumber>
    <ProductName>Doxazosin Aurobindo</ProductName>
    <PAHolder>Aurobindo Pharma (Malta) Limited</PAHolder>
    <AuthorisedDate>11/03/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1445/006/002</DrugIDPK>
    <LicenceNumber>PA1445/006/002</LicenceNumber>
    <ProductName>Doxazosin Aurobindo</ProductName>
    <PAHolder>Aurobindo Pharma (Malta) Limited</PAHolder>
    <AuthorisedDate>11/03/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1445/006/003</DrugIDPK>
    <LicenceNumber>PA1445/006/003</LicenceNumber>
    <ProductName>Doxazosin Aurobindo</ProductName>
    <PAHolder>Aurobindo Pharma (Malta) Limited</PAHolder>
    <AuthorisedDate>11/03/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/03/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/012/001</DrugIDPK>
    <LicenceNumber>PA0915/012/001</LicenceNumber>
    <ProductName>DOXAZOSIN DISPHAR</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>27/05/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/08/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/012/002</DrugIDPK>
    <LicenceNumber>PA0915/012/002</LicenceNumber>
    <ProductName>DOXAZOSIN DISPHAR</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>27/05/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/08/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/012/003</DrugIDPK>
    <LicenceNumber>PA0915/012/003</LicenceNumber>
    <ProductName>DOXAZOSIN DISPHAR</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>27/05/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/08/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/002/001</DrugIDPK>
    <LicenceNumber>PA0819/002/001</LicenceNumber>
    <ProductName>Doxazosin-ratiopharm</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/002/002</DrugIDPK>
    <LicenceNumber>PA0819/002/002</LicenceNumber>
    <ProductName>Doxazosin-ratiopharm</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/002/003</DrugIDPK>
    <LicenceNumber>PA0819/002/003</LicenceNumber>
    <ProductName>Doxazosin-ratiopharm</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1124/001/001</DrugIDPK>
    <LicenceNumber>PA1124/001/001</LicenceNumber>
    <ProductName>Doxel</ProductName>
    <PAHolder>Clarendon Pharma Limited</PAHolder>
    <AuthorisedDate>18/11/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/08/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/097/001</DrugIDPK>
    <LicenceNumber>PA0405/097/001</LicenceNumber>
    <ProductName>Doxorubicin</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>19/06/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>25/05/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/097/002</DrugIDPK>
    <LicenceNumber>PA0405/097/002</LicenceNumber>
    <ProductName>Doxorubicin</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>19/06/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>25/05/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/097/003</DrugIDPK>
    <LicenceNumber>PA0405/097/003</LicenceNumber>
    <ProductName>Doxorubicin</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>19/06/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr/Conc/Soln for Infus</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see  Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>25/05/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/034/001</DrugIDPK>
    <LicenceNumber>PA0936/034/001</LicenceNumber>
    <ProductName>DOXORUBICIN</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/034/002</DrugIDPK>
    <LicenceNumber>PA0936/034/002</LicenceNumber>
    <ProductName>DOXORUBICIN</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/034/003</DrugIDPK>
    <LicenceNumber>PA0936/034/003</LicenceNumber>
    <ProductName>DOXORUBICIN</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/034/004</DrugIDPK>
    <LicenceNumber>PA0936/034/004</LicenceNumber>
    <ProductName>DOXORUBICIN</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/034/007</DrugIDPK>
    <LicenceNumber>PA0936/034/007</LicenceNumber>
    <ProductName>DOXORUBICIN</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/034/008</DrugIDPK>
    <LicenceNumber>PA0936/034/008</LicenceNumber>
    <ProductName>DOXORUBICIN</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1070/003/001</DrugIDPK>
    <LicenceNumber>PA1070/003/001</LicenceNumber>
    <ProductName>Doxorubicin 2 mg/ml solution for injection</ProductName>
    <PAHolder>Cell Pharm GmbH</PAHolder>
    <AuthorisedDate>19/03/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/09/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1658/001/001</DrugIDPK>
    <LicenceNumber>PA1658/001/001</LicenceNumber>
    <ProductName>Doxorubicin 2mg/ml Concentrate for Solution for Infusion</ProductName>
    <PAHolder>Genepharm (Europe) Trading Ltd</PAHolder>
    <AuthorisedDate>13/11/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0789/001/001</DrugIDPK>
    <LicenceNumber>PA0789/001/001</LicenceNumber>
    <ProductName>DOXORUBICIN EBEWE</ProductName>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>22/01/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/06/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/026/002</DrugIDPK>
    <LicenceNumber>PA0437/026/002</LicenceNumber>
    <ProductName>Doxorubicin Hydrochloride</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate>25/06/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0499/002/003</DrugIDPK>
    <LicenceNumber>PA0499/002/003</LicenceNumber>
    <ProductName>DOXORUBICIN HYDROCHLORIDE</ProductName>
    <PAHolder>Chiron B.V.</PAHolder>
    <AuthorisedDate>21/06/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/03/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0499/002/001</DrugIDPK>
    <LicenceNumber>PA0499/002/001</LicenceNumber>
    <ProductName>DOXORUBICIN HYDROCHLORIDE</ProductName>
    <PAHolder>Chiron B.V.</PAHolder>
    <AuthorisedDate>21/06/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/03/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0236/023/003</DrugIDPK>
    <LicenceNumber>PA0236/023/003</LicenceNumber>
    <ProductName>DOXORUBICIN HYDROCHLORIDE</ProductName>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/10/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0236/023/002</DrugIDPK>
    <LicenceNumber>PA0236/023/002</LicenceNumber>
    <ProductName>DOXORUBICIN HYDROCHLORIDE</ProductName>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/10/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0236/023/001</DrugIDPK>
    <LicenceNumber>PA0236/023/001</LicenceNumber>
    <ProductName>DOXORUBICIN HYDROCHLORIDE</ProductName>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>06/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/10/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0437/026/001</DrugIDPK>
    <LicenceNumber>PA0437/026/001</LicenceNumber>
    <ProductName>Doxorubicin Hydrochloride for Injection</ProductName>
    <PAHolder>Hospira  UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/12/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0361/024/001</DrugIDPK>
    <LicenceNumber>PA0361/024/001</LicenceNumber>
    <ProductName>Doxorubicin Martindale Pharma</ProductName>
    <PAHolder>Martindale Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>04/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/034/005</DrugIDPK>
    <LicenceNumber>PA0936/034/005</LicenceNumber>
    <ProductName>DOXORUBICIN RAPID DISSOLUTION</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/034/006</DrugIDPK>
    <LicenceNumber>PA0936/034/006</LicenceNumber>
    <ProductName>DOXORUBICIN RAPID DISSOLUTION</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/08/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0236/023/010</DrugIDPK>
    <LicenceNumber>PA0236/023/010</LicenceNumber>
    <ProductName>DOXORUBICIN RAPID DISSOLUTION</ProductName>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>11/10/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/07/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0236/023/005</DrugIDPK>
    <LicenceNumber>PA0236/023/005</LicenceNumber>
    <ProductName>DOXORUBICIN RAPID DISSOLUTION</ProductName>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>22/10/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0236/023/011</DrugIDPK>
    <LicenceNumber>PA0236/023/011</LicenceNumber>
    <ProductName>DOXORUBICIN SOLUTION</ProductName>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>13/04/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/07/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0236/023/008</DrugIDPK>
    <LicenceNumber>PA0236/023/008</LicenceNumber>
    <ProductName>DOXORUBICIN SOLUTION</ProductName>
    <PAHolder>Farmitalia Carlo Erba Ltd</PAHolder>
    <AuthorisedDate>26/05/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0425/001/001</DrugIDPK>
    <LicenceNumber>PA0425/001/001</LicenceNumber>
    <ProductName>DOXY 100</ProductName>
    <PAHolder>Karl Engelhard</PAHolder>
    <AuthorisedDate>13/03/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/11/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0425/002/002</DrugIDPK>
    <LicenceNumber>PA0425/002/002</LicenceNumber>
    <ProductName>DOXY KOMB</ProductName>
    <PAHolder>Karl Engelhard</PAHolder>
    <AuthorisedDate>13/03/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/11/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0425/002/001</DrugIDPK>
    <LicenceNumber>PA0425/002/001</LicenceNumber>
    <ProductName>DOXY KOMB</ProductName>
    <PAHolder>Karl Engelhard</PAHolder>
    <AuthorisedDate>13/03/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE HYCLATE</ActiveSubstance>
      <ActiveSubstance>DOXYCYCLINE HYCLATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0078/004/001</DrugIDPK>
    <LicenceNumber>PA0078/004/001</LicenceNumber>
    <ProductName>DOXYSCHEL</ProductName>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXYCYCLINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/09/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0998/001/001</DrugIDPK>
    <LicenceNumber>PA0998/001/001</LicenceNumber>
    <ProductName>DR. SCHEFFLER VITAMIN C</ProductName>
    <PAHolder>Dr. B. Scheffler Nachf GmbH</PAHolder>
    <AuthorisedDate>19/10/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Effervescent tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ascorbic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/03/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/005/001</DrugIDPK>
    <LicenceNumber>PA0936/005/001</LicenceNumber>
    <ProductName>Dramamine</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dimenhydrinate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/12/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1465/007/001</DrugIDPK>
    <LicenceNumber>DPR1465/007/001</LicenceNumber>
    <ProductName>Drapolene</ProductName>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzalkonium chloride</ActiveSubstance>
      <ActiveSubstance>Cetrimide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA1419/001/001</DrugIDPK>
    <LicenceNumber>PA1419/001/001</LicenceNumber>
    <ProductName>Draxmibi</ProductName>
    <PAHolder>DRAXIMAGE (UK) Limited</PAHolder>
    <AuthorisedDate>10/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Kit for radiopharmaceutical preparation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tetrakis (2-methoxy isobutyl isonitrile) copper (i) tetrafluorolborate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/12/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0144/012/002</DrugIDPK>
    <LicenceNumber>PA0144/012/002</LicenceNumber>
    <ProductName>Driclor</ProductName>
    <PAHolder>Stiefel Laboratories (U.K.) Ltd.</PAHolder>
    <AuthorisedDate>01/10/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aldioxa</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/05/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0010/030/001</DrugIDPK>
    <LicenceNumber>PA0010/030/001</LicenceNumber>
    <ProductName>DRIED FACTOR VIII FRACTION B.P. HEAT TREATED</ProductName>
    <PAHolder>Aventis Behring Limited</PAHolder>
    <AuthorisedDate>07/03/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FACTOR VIII (ANTIHAEMOPHILIC FACTOR)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0172/005/002</DrugIDPK>
    <LicenceNumber>PA0172/005/002</LicenceNumber>
    <ProductName>DRISTAN DECONGESTANT</ProductName>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>30/05/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>CHLORPHENAMINE MALEATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0172/005/001</DrugIDPK>
    <LicenceNumber>PA0172/005/001</LicenceNumber>
    <ProductName>DRISTAN DECONGESTANT</ProductName>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CAFFEINE</ActiveSubstance>
      <ActiveSubstance>ACETYLSALICYLIC ACID</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE</ActiveSubstance>
      <ActiveSubstance>PHENINDAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/02/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0172/007/001</DrugIDPK>
    <LicenceNumber>PA0172/007/001</LicenceNumber>
    <ProductName>Dristan Nasal Spray</ProductName>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal spray, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Oxymetazoline hydrochloride</ActiveSubstance>
      <ActiveSubstance>Levomenthol</ActiveSubstance>
      <ActiveSubstance>Eucalyptol</ActiveSubstance>
      <ActiveSubstance>Camphor</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1286/026/001</DrugIDPK>
    <LicenceNumber>PA1286/026/001</LicenceNumber>
    <ProductName>Drogenil</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme Ireland (Human Health) Limited</PAHolder>
    <AuthorisedDate>10/12/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Flutamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0748/018/001</DrugIDPK>
    <LicenceNumber>PA0748/018/001</LicenceNumber>
    <ProductName>DROLEPTAN</ProductName>
    <PAHolder>Janssen-Cilag Ltd</PAHolder>
    <AuthorisedDate>01/04/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DROPERIDOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/02/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/023/002</DrugIDPK>
    <LicenceNumber>PA0050/023/002</LicenceNumber>
    <ProductName>DROMORAN</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVORPHANOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/01/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/023/001</DrugIDPK>
    <LicenceNumber>PA0050/023/001</LicenceNumber>
    <ProductName>DROMORAN</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVORPHANOL TARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/01/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2161/003/001</DrugIDPK>
    <LicenceNumber>PA2161/003/001</LicenceNumber>
    <ProductName>Dropodex 0.1% w/v Eye Drops, solution</ProductName>
    <PAHolder>Rayner Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>03/05/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0206/006/003</DrugIDPK>
    <LicenceNumber>PA0206/006/003</LicenceNumber>
    <ProductName>DROXARYL</ProductName>
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUFEXAMAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0206/006/002</DrugIDPK>
    <LicenceNumber>PA0206/006/002</LicenceNumber>
    <ProductName>DROXARYL</ProductName>
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUFEXAMAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/03/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0206/006/001</DrugIDPK>
    <LicenceNumber>PA0206/006/001</LicenceNumber>
    <ProductName>DROXARYL</ProductName>
    <PAHolder>Ovelle Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BUFEXAMAC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/02/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0172/008/001</DrugIDPK>
    <LicenceNumber>PA0172/008/001</LicenceNumber>
    <ProductName>DRY CLEAR ACNE LOTION</ProductName>
    <PAHolder>Pfizer Consumer Healthcare Ltd</PAHolder>
    <AuthorisedDate>26/06/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BENZOYL PEROXIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/1986</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/424/001</DrugIDPK>
    <LicenceNumber>PPA0465/424/001</LicenceNumber>
    <ProductName>Drynol 20mg Tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>01/03/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bilastine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/034/005</DrugIDPK>
    <LicenceNumber>PA0237/034/005</LicenceNumber>
    <ProductName>DRYPTAL</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>13/11/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/034/004</DrugIDPK>
    <LicenceNumber>PA0237/034/004</LicenceNumber>
    <ProductName>DRYPTAL</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>13/11/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/034/003</DrugIDPK>
    <LicenceNumber>PA0237/034/003</LicenceNumber>
    <ProductName>DRYPTAL</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>13/11/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0237/034/002</DrugIDPK>
    <LicenceNumber>PA0237/034/002</LicenceNumber>
    <ProductName>DRYPTAL</ProductName>
    <PAHolder>Teva UK Limited</PAHolder>
    <AuthorisedDate>16/08/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FUROSEMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22734/002/001</DrugIDPK>
    <LicenceNumber>PA22734/002/001</LicenceNumber>
    <ProductName>Drytec 2.5-100 GBq radionuclide generator</ProductName>
    <PAHolder>GE Healthcare B.V.</PAHolder>
    <AuthorisedDate>23/08/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Radionuclide generator</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium molybdate (99mo)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/07/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/025/002</DrugIDPK>
    <LicenceNumber>PA0021/025/002</LicenceNumber>
    <ProductName>DTIC DOME</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>02/05/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DACARBAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/02/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/025/001</DrugIDPK>
    <LicenceNumber>PA0021/025/001</LicenceNumber>
    <ProductName>DTIC DOME</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>07/05/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DACARBAZINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/04/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0877/002/001</DrugIDPK>
    <LicenceNumber>PA0877/002/001</LicenceNumber>
    <ProductName>DTP Vaccine Behring single dose ampoule</ProductName>
    <PAHolder>GSK Vaccines GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diphtheria toxoid</ActiveSubstance>
      <ActiveSubstance>Pertussis vaccine</ActiveSubstance>
      <ActiveSubstance>Tetanus toxoid</ActiveSubstance>
      <ActiveSubstance>Aluminium hydroxide</ActiveSubstance>
      <ActiveSubstance>Thimerfonate sodium</ActiveSubstance>
      <ActiveSubstance>Aluminium phosphate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0877/002/002</DrugIDPK>
    <LicenceNumber>PA0877/002/002</LicenceNumber>
    <ProductName>DTP Vaccine Behring Vial</ProductName>
    <PAHolder>GSK Vaccines GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diphtheria toxoid</ActiveSubstance>
      <ActiveSubstance>Pertussis vaccine</ActiveSubstance>
      <ActiveSubstance>Tetanus toxoid</ActiveSubstance>
      <ActiveSubstance>Aluminium hydroxide</ActiveSubstance>
      <ActiveSubstance>Thimerfonate sodium</ActiveSubstance>
      <ActiveSubstance>Aluminium phosphate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0877/002/003</DrugIDPK>
    <LicenceNumber>PA0877/002/003</LicenceNumber>
    <ProductName>DTP Vaccine Behring Vial</ProductName>
    <PAHolder>GSK Vaccines GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diphtheria toxoid</ActiveSubstance>
      <ActiveSubstance>Pertussis vaccine</ActiveSubstance>
      <ActiveSubstance>Tetanus toxoid</ActiveSubstance>
      <ActiveSubstance>Aluminium hydroxide</ActiveSubstance>
      <ActiveSubstance>Thimerfonate sodium</ActiveSubstance>
      <ActiveSubstance>Aluminium phosphate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/005/001</DrugIDPK>
    <LicenceNumber>PA0915/005/001</LicenceNumber>
    <ProductName>DTZ</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>07/09/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/07/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/005/002</DrugIDPK>
    <LicenceNumber>PA0915/005/002</LicenceNumber>
    <ProductName>DTZ</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>07/09/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/07/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0915/005/003</DrugIDPK>
    <LicenceNumber>PA0915/005/003</LicenceNumber>
    <ProductName>DTZ</ProductName>
    <PAHolder>Sinclair IS Pharma Limited</PAHolder>
    <AuthorisedDate>07/09/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsules Modified Release</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/07/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/120/002</DrugIDPK>
    <LicenceNumber>PA1077/120/002</LicenceNumber>
    <ProductName>DUAC Once Daily</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>04/07/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Benzoyl peroxide hydrous</ActiveSubstance>
      <ActiveSubstance>CLINDAMYCIN PHOSPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/457/001</DrugIDPK>
    <LicenceNumber>PPA0465/457/001</LicenceNumber>
    <ProductName>Duac Once Daily 10 mg/g + 50 mg/g Gel</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>13/11/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clindamycin</ActiveSubstance>
      <ActiveSubstance>Anhydrous Benzoyl Peroxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/097/001</DrugIDPK>
    <LicenceNumber>PA0017/097/001</LicenceNumber>
    <ProductName>DUACT</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>28/05/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ACRIVASTINE</ActiveSubstance>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/05/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0017/097/002</DrugIDPK>
    <LicenceNumber>PA0017/097/002</LicenceNumber>
    <ProductName>DUACT LA</ProductName>
    <PAHolder>Wellcome (Ireland) Limited</PAHolder>
    <AuthorisedDate>28/05/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PSEUDOEPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ACRIVASTINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/05/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/105/001</DrugIDPK>
    <LicenceNumber>PA1077/105/001</LicenceNumber>
    <ProductName>Duagen</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>17/12/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dutasteride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/07/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1744/003/001</DrugIDPK>
    <LicenceNumber>PA1744/003/001</LicenceNumber>
    <ProductName>Dubine 10 mg/g cream</ProductName>
    <PAHolder>Ferrer Internacional, S.A</PAHolder>
    <AuthorisedDate>16/06/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ozenoxacin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0430/001/001</DrugIDPK>
    <LicenceNumber>PA0430/001/001</LicenceNumber>
    <ProductName>DUBLIN COUGH MIXTURE</ProductName>
    <PAHolder>Hayes, Conyngham &amp; Robinson Ltd</PAHolder>
    <AuthorisedDate>10/08/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIQUORICE LIQUID EXTRACT</ActiveSubstance>
      <ActiveSubstance>IPECACUANHA FLUID EXTRACT</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/08/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/132/001</DrugIDPK>
    <LicenceNumber>PA0073/132/001</LicenceNumber>
    <ProductName>Dulax (Lactulose Solution B.P.)</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>13/11/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Syrup</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lactulose</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/11/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/022/001</DrugIDPK>
    <LicenceNumber>PA0007/022/001</LicenceNumber>
    <ProductName>DULCODOS</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISACODYL</ActiveSubstance>
      <ActiveSubstance>DOCUSATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/08/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1392/066/001</DrugIDPK>
    <LicenceNumber>DPR1392/066/001</LicenceNumber>
    <ProductName>Dulcolax</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>11/04/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisacodyl</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>To the public for the treatment of constipation for adults only.
To the professions for other age groups and indications.</SupplyComments>
    <WithdrawalDate>12/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1465/032/001</DrugIDPK>
    <LicenceNumber>DPR1465/032/001</LicenceNumber>
    <ProductName>Dulcolax</ProductName>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate>05/12/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisacodyl</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/06/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/045/002</DrugIDPK>
    <LicenceNumber>PPA1151/045/002</LicenceNumber>
    <ProductName>Dulcolax</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>22/06/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppository</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisacodyl</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/02/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/045/001</DrugIDPK>
    <LicenceNumber>PPA1151/045/001</LicenceNumber>
    <ProductName>Dulcolax 5 mg Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>26/10/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisacodyl</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/184/001</DrugIDPK>
    <LicenceNumber>PA0540/184/001</LicenceNumber>
    <ProductName>Dulcolax 5mg Suppositories for Children</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>05/06/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppository</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisacodyl</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>1.      Not to be given to children except on medical advice.
2.      If laxatives are needed every day or there is persistent abdominal pain, consult your doctor.</SupplyComments>
    <WithdrawalDate>25/09/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1465/008/001</DrugIDPK>
    <LicenceNumber>DPR1465/008/001</LicenceNumber>
    <ProductName>Dulcolax gastro resistant</ProductName>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisacodyl</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/011/001</DrugIDPK>
    <LicenceNumber>DPR1473/011/001</LicenceNumber>
    <ProductName>Dulcolax Liquid 5 mg/5 ml oral solution</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>26/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium picosulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>Promotion to the public only for the short-term management of constipation in adults.

Promotion to healthcare professionals only for all other indications and age groups.</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1562/006/001</DrugIDPK>
    <LicenceNumber>DPR1562/006/001</LicenceNumber>
    <ProductName>Dulcolax Perles</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>25/02/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium picosulphate monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0540/183/001</DrugIDPK>
    <LicenceNumber>PA0540/183/001</LicenceNumber>
    <ProductName>Dulcolax Pico Perles 2.5 mg Capsules, soft</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>01/04/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium picosulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments>Promotion to the public

Promotion to public allowed for adults only.

Children: Promotion to healthcare professionals only.</SupplyComments>
    <WithdrawalDate>25/09/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0429/002/001</DrugIDPK>
    <LicenceNumber>PA0429/002/001</LicenceNumber>
    <ProductName>DULCOLAX RECTAL</ProductName>
    <PAHolder>Windsor Healthcare Ltd</PAHolder>
    <AuthorisedDate>05/06/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISACODYL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/05/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1562/007/002</DrugIDPK>
    <LicenceNumber>DPR1562/007/002</LicenceNumber>
    <ProductName>Dulcolax Suppositories</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>25/02/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppository</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisacodyl</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1562/007/001</DrugIDPK>
    <LicenceNumber>DPR1562/007/001</LicenceNumber>
    <ProductName>Dulcolax Suppositories for Children</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>25/02/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppository</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisacodyl</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA1339/061/001</DrugIDPK>
    <LicenceNumber>PA1339/061/001</LicenceNumber>
    <ProductName>Duloxetine 20 mg Gastro-resistant capsules, hard</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>02/10/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duloxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/006/001</DrugIDPK>
    <LicenceNumber>PA2315/006/001</LicenceNumber>
    <InterchangeableListCode>IC0091-033-006</InterchangeableListCode>
    <ProductName>Duloxetine 30 mg gastro-resistant capsules</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>19/06/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duloxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/08/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/061/002</DrugIDPK>
    <LicenceNumber>PA1339/061/002</LicenceNumber>
    <ProductName>Duloxetine 30 mg Gastro-resistant capsules, hard</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>02/10/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duloxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/061/003</DrugIDPK>
    <LicenceNumber>PA1339/061/003</LicenceNumber>
    <ProductName>Duloxetine 40 mg Gastro-resistant capsules, hard</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>02/10/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duloxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/006/002</DrugIDPK>
    <LicenceNumber>PA2315/006/002</LicenceNumber>
    <InterchangeableListCode>IC0091-127-006</InterchangeableListCode>
    <ProductName>Duloxetine 60 mg gastro-resistant capsules</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>19/06/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duloxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/08/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1339/061/004</DrugIDPK>
    <LicenceNumber>PA1339/061/004</LicenceNumber>
    <ProductName>Duloxetine 60 mg Gastro-resistant capsules, hard</ProductName>
    <PAHolder>Wockhardt UK Limited</PAHolder>
    <AuthorisedDate>02/10/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duloxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/08/471/11-12</DrugIDPK>
    <LicenceNumber>EU/1/08/471/11-12</LicenceNumber>
    <ProductName>Duloxetine Boehringer Ingelheim</ProductName>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>10/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duloxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/08/471/1-2</DrugIDPK>
    <LicenceNumber>EU/1/08/471/1-2</LicenceNumber>
    <ProductName>Duloxetine Boehringer Ingelheim</ProductName>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>10/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duloxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/08/471/3-5</DrugIDPK>
    <LicenceNumber>EU/1/08/471/3-5</LicenceNumber>
    <ProductName>Duloxetine Boehringer Ingelheim</ProductName>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>10/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duloxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/08/471/6-10</DrugIDPK>
    <LicenceNumber>EU/1/08/471/6-10</LicenceNumber>
    <ProductName>Duloxetine Boehringer Ingelheim</ProductName>
    <PAHolder>Boehringer Ingelheim International GmbH</PAHolder>
    <AuthorisedDate>10/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duloxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0126/269/003</DrugIDPK>
    <LicenceNumber>PA0126/269/003</LicenceNumber>
    <ProductName>Duloxetine Clonmel</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>25/09/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duloxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/269/001</DrugIDPK>
    <LicenceNumber>PA0126/269/001</LicenceNumber>
    <ProductName>Duloxetine Clonmel 20mg gastro-resistant capsules, hard</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>25/09/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duloxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0074/077/001</DrugIDPK>
    <LicenceNumber>PA0074/077/001</LicenceNumber>
    <InterchangeableListCode>IC0091-033-006</InterchangeableListCode>
    <ProductName>Duloxetine Rowa 30mg hard gastro-resistant capsules</ProductName>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/09/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duloxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/06/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0074/077/002</DrugIDPK>
    <LicenceNumber>PA0074/077/002</LicenceNumber>
    <InterchangeableListCode>IC0091-127-006</InterchangeableListCode>
    <ProductName>Duloxetine Rowa 60mg hard gastro-resistant capsules</ProductName>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>01/09/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duloxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/06/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/263/001</DrugIDPK>
    <LicenceNumber>PA0711/263/001</LicenceNumber>
    <InterchangeableListCode>IC0091-033-006</InterchangeableListCode>
    <ProductName>Duloxetine Rowex 30 mg Gastro-resistant capsules, hard</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>24/03/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duloxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/263/002</DrugIDPK>
    <LicenceNumber>PA0711/263/002</LicenceNumber>
    <InterchangeableListCode>IC0091-127-006</InterchangeableListCode>
    <ProductName>Duloxetine Rowex 60 mg Gastro-resistant capsules, hard</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>24/03/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duloxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/004/001</DrugIDPK>
    <LicenceNumber>PA1986/004/001</LicenceNumber>
    <InterchangeableListCode>IC0091-033-006</InterchangeableListCode>
    <ProductName>Duloxetine Teva 30 mg Gastro resistant capsules, hard</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>10/07/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duloxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/004/002</DrugIDPK>
    <LicenceNumber>PA1986/004/002</LicenceNumber>
    <InterchangeableListCode>IC0091-127-006</InterchangeableListCode>
    <ProductName>Duloxetine Teva 60 mg Gastro resistant capsules, hard</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>10/07/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Duloxetine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0363/007/001</DrugIDPK>
    <LicenceNumber>PA0363/007/001</LicenceNumber>
    <ProductName>DUMICOAT DENTURE LACQUER</ProductName>
    <PAHolder>Alpharma ApS</PAHolder>
    <AuthorisedDate>12/07/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dental Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/09/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/030/001</DrugIDPK>
    <LicenceNumber>PA0057/030/001</LicenceNumber>
    <ProductName>DUO-AUTOHALER</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOPRENALINE</ActiveSubstance>
      <ActiveSubstance>PHENYLEPHRINE BITARTRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/04/1984</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0303/015/003</DrugIDPK>
    <LicenceNumber>PA0303/015/003</LicenceNumber>
    <ProductName>DUOBACT</ProductName>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>18/04/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/12/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0303/015/001</DrugIDPK>
    <LicenceNumber>PA0303/015/001</LicenceNumber>
    <ProductName>DUOBACT</ProductName>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>18/04/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SULFAMETHOXAZOLE</ActiveSubstance>
      <ActiveSubstance>TRIMETHOPRIM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/02/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/114/001</DrugIDPK>
    <LicenceNumber>PA0678/114/001</LicenceNumber>
    <ProductName>DUOFILM Cutaneous SolutionSalicylic Acid 16.7% w/wLactic Acid 15.0% w/w</ProductName>
    <PAHolder>Haleon Ireland Limited</PAHolder>
    <AuthorisedDate>21/01/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Salicylic acid</ActiveSubstance>
      <ActiveSubstance>Lactic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0077/078/001</DrugIDPK>
    <LicenceNumber>PA0077/078/001</LicenceNumber>
    <ProductName>DUOGASTRONE</ProductName>
    <PAHolder>Sanofi-Synthelabo Ireland Ltd</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CARBENOXOLONE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/02/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/10/619/001</DrugIDPK>
    <LicenceNumber>EU/1/10/619/001</LicenceNumber>
    <ProductName>DuoPlavin</ProductName>
    <PAHolder>Sanofi-Aventis Groupe</PAHolder>
    <AuthorisedDate>15/03/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clopidogrel hydrogensulfate</ActiveSubstance>
      <ActiveSubstance>Acetylsalicylic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/01/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/034/002</DrugIDPK>
    <LicenceNumber>PA0007/034/002</LicenceNumber>
    <ProductName>DUOVENT 100 AEROCAPS</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>20/12/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>FENOTEROL HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/03/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/034/003</DrugIDPK>
    <LicenceNumber>PA0007/034/003</LicenceNumber>
    <ProductName>DUOVENT 200 AEROCAPS</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>20/12/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>FENOTEROL HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/03/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/034/005</DrugIDPK>
    <LicenceNumber>PA0007/034/005</LicenceNumber>
    <ProductName>DUOVENT AUTOHALER</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>13/06/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>FENOTEROL HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/10/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/021/001</DrugIDPK>
    <LicenceNumber>PA0007/021/001</LicenceNumber>
    <ProductName>DUOVENT INHALER</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>16/01/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>FENOTEROL HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0007/034/001</DrugIDPK>
    <LicenceNumber>PA0007/034/001</LicenceNumber>
    <ProductName>DUOVENT MDI</ProductName>
    <PAHolder>Boehringer Ingelheim Limited</PAHolder>
    <AuthorisedDate>07/05/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised Inhalation Suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IPRATROPIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>FENOTEROL HYDROBROMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/09/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0007/034/004</DrugIDPK>
    <LicenceNumber>PA0007/034/004</LicenceNumber>
    <ProductName>Duovent Unit Dose Vials</ProductName>
    <PAHolder>Boehringer Ingelheim Ltd</PAHolder>
    <AuthorisedDate>04/12/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nebuliser solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ipratropium bromide</ActiveSubstance>
      <ActiveSubstance>Fenoterol hydrobromide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/02/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0108/015/002</DrugIDPK>
    <LicenceNumber>PA0108/015/002</LicenceNumber>
    <ProductName>DUPHALAC</ProductName>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>18/10/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral Powder</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LACTULOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2010/009/001</DrugIDPK>
    <LicenceNumber>PA2010/009/001</LicenceNumber>
    <InterchangeableListCode>IC0099-151-019</InterchangeableListCode>
    <ProductName>Duphalac 3.335 g/5 ml Oral Solution</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lactulose</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/05/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0261/013/004</DrugIDPK>
    <LicenceNumber>PA0261/013/004</LicenceNumber>
    <ProductName>DURABOLIN</ProductName>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NANDROLONE PHENPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0261/013/001</DrugIDPK>
    <LicenceNumber>PA0261/013/001</LicenceNumber>
    <ProductName>DURABOLIN 25MG/ML</ProductName>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NANDROLONE PHENPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/11/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0261/013/003</DrugIDPK>
    <LicenceNumber>PA0261/013/003</LicenceNumber>
    <ProductName>DURABOLIN 50 MG/ML SYRINGE</ProductName>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NANDROLONE PHENPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0261/013/002</DrugIDPK>
    <LicenceNumber>PA0261/013/002</LicenceNumber>
    <ProductName>DURABOLIN SYRINGE</ProductName>
    <PAHolder>Organon Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NANDROLONE PHENPROPIONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0148/053/001</DrugIDPK>
    <LicenceNumber>PA0148/053/001</LicenceNumber>
    <ProductName>DURACARE STORING &amp; WETTING</ProductName>
    <PAHolder>Allergan Pharmaceuticals Ireland</PAHolder>
    <AuthorisedDate>26/08/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POLYVINYL ALCOHOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1035/001/001</DrugIDPK>
    <LicenceNumber>PA1035/001/001</LicenceNumber>
    <ProductName>Duraglan</ProductName>
    <PAHolder>Jacobsen Pharma &amp; MedTech Advice AS</PAHolder>
    <AuthorisedDate>23/11/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Doxazosin mesilate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0516/002/004</DrugIDPK>
    <LicenceNumber>PA0516/002/004</LicenceNumber>
    <ProductName>DURANOL</ProductName>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>04/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0516/002/003</DrugIDPK>
    <LicenceNumber>PA0516/002/003</LicenceNumber>
    <ProductName>DURANOL</ProductName>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>04/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0516/002/002</DrugIDPK>
    <LicenceNumber>PA0516/002/002</LicenceNumber>
    <ProductName>DURANOL</ProductName>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>04/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0516/002/001</DrugIDPK>
    <LicenceNumber>PA0516/002/001</LicenceNumber>
    <ProductName>DURANOL</ProductName>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>04/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/123/001</DrugIDPK>
    <LicenceNumber>PPA1562/123/001</LicenceNumber>
    <ProductName>Duraphat</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>15/08/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Toothpaste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium fluoride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/12/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0320/008/001</DrugIDPK>
    <LicenceNumber>PA0320/008/001</LicenceNumber>
    <ProductName>DURAPHAT 2800 PPM FLUORIDE</ProductName>
    <PAHolder>Colgate-Palmolive (U.K.) Ltd</PAHolder>
    <AuthorisedDate>04/03/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Toothpaste</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium fluoride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/09/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/187/001</DrugIDPK>
    <LicenceNumber>PPA1151/187/001</LicenceNumber>
    <ProductName>Durogesic DTrans</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>18/01/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fentanyl</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>17/11/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/187/002</DrugIDPK>
    <LicenceNumber>PPA1151/187/002</LicenceNumber>
    <ProductName>Durogesic DTrans</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>18/01/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fentanyl</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>17/11/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/187/003</DrugIDPK>
    <LicenceNumber>PPA1151/187/003</LicenceNumber>
    <ProductName>Durogesic DTrans</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>18/01/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fentanyl</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>17/11/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/187/004</DrugIDPK>
    <LicenceNumber>PPA1151/187/004</LicenceNumber>
    <ProductName>Durogesic DTrans</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>18/01/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fentanyl</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>17/11/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/252/004</DrugIDPK>
    <LicenceNumber>PPA1151/252/004</LicenceNumber>
    <ProductName>Durogesic DTrans 100 micrograms/hour transdermal patch</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>23/10/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fentanyl</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/252/003</DrugIDPK>
    <LicenceNumber>PPA1151/252/003</LicenceNumber>
    <ProductName>Durogesic DTrans 25 micrograms/hour transdermal patch</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>23/10/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fentanyl</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/252/001</DrugIDPK>
    <LicenceNumber>PPA1151/252/001</LicenceNumber>
    <ProductName>Durogesic DTrans 50 micrograms/hour transdermal patch</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>13/11/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fentanyl</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/252/002</DrugIDPK>
    <LicenceNumber>PPA1151/252/002</LicenceNumber>
    <ProductName>Durogesic DTrans 75 micrograms/hour transdermal patch</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>13/11/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fentanyl</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/063/002</DrugIDPK>
    <LicenceNumber>PA0057/063/002</LicenceNumber>
    <ProductName>DUROMINE</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>22/07/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENTERMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/063/001</DrugIDPK>
    <LicenceNumber>PA0057/063/001</LicenceNumber>
    <ProductName>DUROMINE</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>22/07/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENTERMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0405/098/001</DrugIDPK>
    <LicenceNumber>PA0405/098/001</LicenceNumber>
    <ProductName>Dutasteride</ProductName>
    <PAHolder>Generics (UK) Limited</PAHolder>
    <AuthorisedDate>01/03/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dutasteride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/07/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/220/001</DrugIDPK>
    <LicenceNumber>PA0711/220/001</LicenceNumber>
    <ProductName>Dutasteride</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>24/01/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dutasteride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/08/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1963/005/001</DrugIDPK>
    <LicenceNumber>PA1963/005/001</LicenceNumber>
    <ProductName>Dutasteride 0.5 mg soft capsules</ProductName>
    <PAHolder>Cipla Europe NV</PAHolder>
    <AuthorisedDate>05/12/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dutasteride (dmf)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/06/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/027/001</DrugIDPK>
    <LicenceNumber>PA1986/027/001</LicenceNumber>
    <ProductName>Dutasteride 0.5 mg Soft Capsules</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>14/10/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dutasteride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/07/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/029/001</DrugIDPK>
    <LicenceNumber>PA2315/029/001</LicenceNumber>
    <ProductName>Dutasteride 0.5mg Soft Capsules</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>26/06/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, soft</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dutasteride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/02/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/060/004</DrugIDPK>
    <LicenceNumber>PA0002/060/004</LicenceNumber>
    <ProductName>DUTONIN</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>17/10/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEFAZODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/10/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/060/003</DrugIDPK>
    <LicenceNumber>PA0002/060/003</LicenceNumber>
    <ProductName>DUTONIN</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>17/10/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEFAZODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/10/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/060/002</DrugIDPK>
    <LicenceNumber>PA0002/060/002</LicenceNumber>
    <ProductName>DUTONIN</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>17/10/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEFAZODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/10/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/060/001</DrugIDPK>
    <LicenceNumber>PA0002/060/001</LicenceNumber>
    <ProductName>DUTONIN</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>17/10/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>NEFAZODONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/10/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/15/995/001</DrugIDPK>
    <LicenceNumber>EU/1/15/995/001</LicenceNumber>
    <ProductName>DUTREBIS</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme Ltd</PAHolder>
    <AuthorisedDate>26/06/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Raltegravir</ActiveSubstance>
      <ActiveSubstance>Lamivudine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product
Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0108/001/003</DrugIDPK>
    <LicenceNumber>PA0108/001/003</LicenceNumber>
    <ProductName>DUVADILAN</ProductName>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOXSUPRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/04/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0108/001/002</DrugIDPK>
    <LicenceNumber>PA0108/001/002</LicenceNumber>
    <ProductName>DUVADILAN</ProductName>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>09/02/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOXSUPRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/02/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0108/001/001</DrugIDPK>
    <LicenceNumber>PA0108/001/001</LicenceNumber>
    <ProductName>DUVADILAN OBSTETRIC</ProductName>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>01/10/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOXSUPRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0384/008/001</DrugIDPK>
    <LicenceNumber>PPA0384/008/001</LicenceNumber>
    <ProductName>DUVADILAN RETARD</ProductName>
    <PAHolder>Parallel Lines Ltd</PAHolder>
    <AuthorisedDate>02/12/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOXSUPRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/10/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0108/012/001</DrugIDPK>
    <LicenceNumber>PA0108/012/001</LicenceNumber>
    <ProductName>DUVADILAN RETARD</ProductName>
    <PAHolder>Abbott Healthcare Products Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOXSUPRINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/11/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/18/1300/001-002</DrugIDPK>
    <LicenceNumber>EU/1/18/1300/001-002</LicenceNumber>
    <ProductName>Duzallo</ProductName>
    <PAHolder>Grünenthal GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lesinurad</ActiveSubstance>
      <ActiveSubstance>Allopurinol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/18/1300/003-004</DrugIDPK>
    <LicenceNumber>EU/1/18/1300/003-004</LicenceNumber>
    <ProductName>Duzallo</ProductName>
    <PAHolder>Grünenthal GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Allopurinol</ActiveSubstance>
      <ActiveSubstance>Lesinurad</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/116/001</DrugIDPK>
    <LicenceNumber>PPA1328/116/001</LicenceNumber>
    <ProductName>Dyazide</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>25/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Triamterene</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/05/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/126/001A</DrugIDPK>
    <LicenceNumber>PPA0465/126/001A</LicenceNumber>
    <ProductName>DYAZIDE</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>11/06/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Triamterene</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0899/009/001</DrugIDPK>
    <LicenceNumber>PA0899/009/001</LicenceNumber>
    <ProductName>Dyazide 50mg/25mg Tablets.</ProductName>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>01/04/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Triamterene</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/09/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/151/001</DrugIDPK>
    <LicenceNumber>PPA1463/151/001</LicenceNumber>
    <ProductName>Dymista 137 micrograms/50 micrograms per actuation nasal spray, suspension</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>27/10/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal spray, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Azelastine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Fluticasone propionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/07/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA23176/024/001</DrugIDPK>
    <LicenceNumber>PPA23176/024/001</LicenceNumber>
    <InterchangeableListCode>IC0166-204-070</InterchangeableListCode>
    <ProductName>Dymista 137 micrograms/50 micrograms per actuation, Nasal Spray Suspension</ProductName>
    <PAHolder>Lexon Pharmaceuticals (Ireland) Limited</PAHolder>
    <AuthorisedDate>19/10/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal spray, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fluticasone propionate</ActiveSubstance>
      <ActiveSubstance>Azelastine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/114/001</DrugIDPK>
    <LicenceNumber>PPA1463/114/001</LicenceNumber>
    <ProductName>Dymista 137 micrograms/50 micrograms per actuation, Nasal Spray Suspension</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>21/04/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal spray, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Azelastine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Fluticasone propionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/02/209/001</DrugIDPK>
    <LicenceNumber>EU/1/02/209/001</LicenceNumber>
    <ProductName>Dynastat</ProductName>
    <PAHolder>Pfizer Europe MA EEIG</PAHolder>
    <AuthorisedDate>22/03/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Parecoxib Sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/06/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/02/209/002</DrugIDPK>
    <LicenceNumber>EU/1/02/209/002</LicenceNumber>
    <ProductName>Dynastat</ProductName>
    <PAHolder>Pfizer Europe MA EEIG</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Parecoxib Sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/06/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/02/209/003</DrugIDPK>
    <LicenceNumber>EU/1/02/209/003</LicenceNumber>
    <ProductName>Dynastat</ProductName>
    <PAHolder>Pfizer Europe MA EEIG</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Parecoxib Sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/06/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/02/209/004</DrugIDPK>
    <LicenceNumber>EU/1/02/209/004</LicenceNumber>
    <ProductName>Dynastat</ProductName>
    <PAHolder>Pfizer Europe MA EEIG</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Parecoxib Sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/06/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/02/211/001</DrugIDPK>
    <LicenceNumber>EU/1/02/211/001</LicenceNumber>
    <ProductName>Dynepo</ProductName>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>18/03/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Epoetin delta</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/02/211/002</DrugIDPK>
    <LicenceNumber>EU/1/02/211/002</LicenceNumber>
    <ProductName>Dynepo</ProductName>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>18/03/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/02/211/003</DrugIDPK>
    <LicenceNumber>EU/1/02/211/003</LicenceNumber>
    <ProductName>Dynepo</ProductName>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>18/03/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/02/211/004</DrugIDPK>
    <LicenceNumber>EU/1/02/211/004</LicenceNumber>
    <ProductName>Dynepo</ProductName>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>18/03/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/02/211/005</DrugIDPK>
    <LicenceNumber>EU/1/02/211/005</LicenceNumber>
    <ProductName>Dynepo</ProductName>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>18/03/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/02/211/006</DrugIDPK>
    <LicenceNumber>EU/1/02/211/006</LicenceNumber>
    <ProductName>Dynepo</ProductName>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/02/211/007</DrugIDPK>
    <LicenceNumber>EU/1/02/211/007</LicenceNumber>
    <ProductName>Dynepo</ProductName>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/02/211/008</DrugIDPK>
    <LicenceNumber>EU/1/02/211/008</LicenceNumber>
    <ProductName>Dynepo</ProductName>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/02/211/009</DrugIDPK>
    <LicenceNumber>EU/1/02/211/009</LicenceNumber>
    <ProductName>Dynepo</ProductName>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/02/211/010</DrugIDPK>
    <LicenceNumber>EU/1/02/211/010</LicenceNumber>
    <ProductName>Dynepo</ProductName>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>02/04/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Epoetin delta</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/02/211/011</DrugIDPK>
    <LicenceNumber>EU/1/02/211/011</LicenceNumber>
    <ProductName>Dynepo</ProductName>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>02/04/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Epoetin delta</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/02/211/012</DrugIDPK>
    <LicenceNumber>EU/1/02/211/012</LicenceNumber>
    <ProductName>Dynepo</ProductName>
    <PAHolder>Aventis Pharma S.A.</PAHolder>
    <AuthorisedDate>02/04/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Epoetin delta</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0185/015/001</DrugIDPK>
    <LicenceNumber>PA0185/015/001</LicenceNumber>
    <ProductName>Dynese Antacid</ProductName>
    <PAHolder>Galen Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Magaldrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/06/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1352/012/001</DrugIDPK>
    <LicenceNumber>PA1352/012/001</LicenceNumber>
    <ProductName>Dypracet</ProductName>
    <PAHolder>Auden Mckenzie (Pharma Division) Ltd</PAHolder>
    <AuthorisedDate>30/03/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
      <ActiveSubstance>Dihydrocodeine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>29/03/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1352/012/002</DrugIDPK>
    <LicenceNumber>PA1352/012/002</LicenceNumber>
    <ProductName>Dypracet</ProductName>
    <PAHolder>Auden Mckenzie (Pharma Division) Ltd</PAHolder>
    <AuthorisedDate>30/03/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paracetamol</ActiveSubstance>
      <ActiveSubstance>Dihydrocodeine tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>29/03/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0899/010/001</DrugIDPK>
    <LicenceNumber>PA0899/010/001</LicenceNumber>
    <ProductName>Dyspamet</ProductName>
    <PAHolder>Mercury Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>24/04/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cimetidine </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/04/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0560/001/004</DrugIDPK>
    <LicenceNumber>PA0560/001/004</LicenceNumber>
    <ProductName>DYSPAMET</ProductName>
    <PAHolder>Bridge Pharmaceuticals (Ire) Ltd</PAHolder>
    <AuthorisedDate>05/07/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/07/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0560/001/003</DrugIDPK>
    <LicenceNumber>PA0560/001/003</LicenceNumber>
    <ProductName>DYSPAMET</ProductName>
    <PAHolder>Bridge Pharmaceuticals (Ire) Ltd</PAHolder>
    <AuthorisedDate>05/07/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets Effervescent</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CIMETIDINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/07/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0583/001/002</DrugIDPK>
    <LicenceNumber>PA0583/001/002</LicenceNumber>
    <ProductName>Dysport</ProductName>
    <PAHolder>Ipsen Limited</PAHolder>
    <AuthorisedDate>08/12/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Clostridium botulinum typ a-antitoxin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/11/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0060/019/001</DrugIDPK>
    <LicenceNumber>PA0060/019/001</LicenceNumber>
    <ProductName>DYTAC</ProductName>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/01/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0060/020/001</DrugIDPK>
    <LicenceNumber>PA0060/020/001</LicenceNumber>
    <ProductName>DYTIDE</ProductName>
    <PAHolder>SmithKline and French Laboratories Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1332/047/001</DrugIDPK>
    <LicenceNumber>PA1332/047/001</LicenceNumber>
    <ProductName>Dyvistanil</ProductName>
    <PAHolder>Meda Health Sales Ireland Limited</PAHolder>
    <AuthorisedDate>22/02/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Nasal spray, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Azelastine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Fluticasone propionate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/04/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0078/002/001</DrugIDPK>
    <LicenceNumber>PA0078/002/001</LicenceNumber>
    <ProductName>E MYCIN</ProductName>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>08/03/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ERYTHROMYCIN STEARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/09/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/083/001</DrugIDPK>
    <LicenceNumber>PA0678/083/001</LicenceNumber>
    <ProductName>Earcalm</ProductName>
    <PAHolder>Haleon Ireland Limited</PAHolder>
    <AuthorisedDate>28/04/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear spray, emulsion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Acetic acid, glacial</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/01/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1465/009/001</DrugIDPK>
    <LicenceNumber>DPR1465/009/001</LicenceNumber>
    <ProductName>Earex</ProductName>
    <PAHolder>Boots (UK) Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Almond oil</ActiveSubstance>
      <ActiveSubstance>Arachis oil</ActiveSubstance>
      <ActiveSubstance>Camphor oil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0547/001/001</DrugIDPK>
    <LicenceNumber>PA0547/001/001</LicenceNumber>
    <ProductName>Earex</ProductName>
    <PAHolder>Pharmalab Limited</PAHolder>
    <AuthorisedDate>19/08/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ear drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Almond oil</ActiveSubstance>
      <ActiveSubstance>Arachis oil</ActiveSubstance>
      <ActiveSubstance>Camphor oil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/08/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1599/001/001</DrugIDPK>
    <LicenceNumber>PA1599/001/001</LicenceNumber>
    <ProductName>Ebastion</ProductName>
    <PAHolder>Lindopharm GmbH</PAHolder>
    <AuthorisedDate>26/02/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ebastine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1599/001/002</DrugIDPK>
    <LicenceNumber>PA1599/001/002</LicenceNumber>
    <ProductName>Ebastion</ProductName>
    <PAHolder>Lindopharm GmbH</PAHolder>
    <AuthorisedDate>26/02/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ebastine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/11/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0789/010/001</DrugIDPK>
    <LicenceNumber>PA0789/010/001</LicenceNumber>
    <ProductName>Ebedox</ProductName>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DOXORUBICIN HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/04/2005</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0789/014/001</DrugIDPK>
    <LicenceNumber>PA0789/014/001</LicenceNumber>
    <ProductName>Ebetaxel</ProductName>
    <PAHolder>Ebewe Pharma Ges.m.b.H  Nfg. KG</PAHolder>
    <AuthorisedDate>27/04/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Paclitaxel</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/06/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/02/219/004</DrugIDPK>
    <LicenceNumber>EU/1/02/219/004</LicenceNumber>
    <ProductName>Ebixa</ProductName>
    <PAHolder>H. Lundbeck A/S</PAHolder>
    <AuthorisedDate>04/12/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Memantine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/07/416/001</DrugIDPK>
    <LicenceNumber>EU/1/07/416/001</LicenceNumber>
    <ProductName>Ecalta</ProductName>
    <PAHolder>Pfizer Europe MA EEIG</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Anidulafungin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>03/06/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>TR2309/009/003</DrugIDPK>
    <LicenceNumber>TR2309/009/003</LicenceNumber>
    <ProductName>Echinaforce Cold and Flu chewable tablets</ProductName>
    <PAHolder>A.Vogel Ireland Limited</PAHolder>
    <AuthorisedDate>05/11/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Chewable tablet</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through non-pharmacy outlets and pharmacies</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to the general public</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/98/072/001</DrugIDPK>
    <LicenceNumber>EU/1/98/072/001</LicenceNumber>
    <ProductName>ECHOGEN</ProductName>
    <PAHolder>Sonus Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>17/07/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Emulsion for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DODECAFLUOROPENTANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0012/075/001</DrugIDPK>
    <LicenceNumber>PA0012/075/001</LicenceNumber>
    <ProductName>ECHOVIST 200</ProductName>
    <PAHolder>HE Clissmann</PAHolder>
    <AuthorisedDate>19/09/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GALACTOSE</ActiveSubstance>
      <ActiveSubstance>GALACTOSE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/06/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/96/017/001</DrugIDPK>
    <LicenceNumber>EU/1/96/017/001</LicenceNumber>
    <ProductName>ECOKINASE</ProductName>
    <PAHolder>Galenus Mannheim GmbH</PAHolder>
    <AuthorisedDate>29/08/1996</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETEPLASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/07/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/024/001</DrugIDPK>
    <LicenceNumber>PA0002/024/001</LicenceNumber>
    <ProductName>Ecostatin</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>30/01/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/01/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/024/002</DrugIDPK>
    <LicenceNumber>PA0002/024/002</LicenceNumber>
    <ProductName>Ecostatin</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>30/01/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/01/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/024/007</DrugIDPK>
    <LicenceNumber>PA0002/024/007</LicenceNumber>
    <ProductName>ECOSTATIN 1</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>06/02/1989</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pessary</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/024/006</DrugIDPK>
    <LicenceNumber>PA0002/024/006</LicenceNumber>
    <ProductName>ECOSTATIN LOTION</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>07/02/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/024/003</DrugIDPK>
    <LicenceNumber>PA0002/024/003</LicenceNumber>
    <ProductName>ECOSTATIN POWDER</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>07/02/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/024/004</DrugIDPK>
    <LicenceNumber>PA0002/024/004</LicenceNumber>
    <ProductName>ECOSTATIN SPRAY POWDER</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>07/02/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/024/005</DrugIDPK>
    <LicenceNumber>PA0002/024/005</LicenceNumber>
    <ProductName>ECOSTATIN SPRAY SOLUTION</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>07/02/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ECONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/05/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0308/003/001</DrugIDPK>
    <LicenceNumber>PA0308/003/001</LicenceNumber>
    <ProductName>ECZEDERM</ProductName>
    <PAHolder>Quinoderm Ltd</PAHolder>
    <AuthorisedDate>24/04/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0308/004/001</DrugIDPK>
    <LicenceNumber>PA0308/004/001</LicenceNumber>
    <ProductName>ECZEDERM CREAM WITH HYDROCORTISONE</ProductName>
    <PAHolder>Quinoderm Ltd</PAHolder>
    <AuthorisedDate>24/04/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CALAMINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/11/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0145/001/002</DrugIDPK>
    <LicenceNumber>PA0145/001/002</LicenceNumber>
    <ProductName>ECZENSA</ProductName>
    <PAHolder>Hadensa (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
      <ActiveSubstance>FRAMYCETIN</ActiveSubstance>
      <ActiveSubstance>RETINOL ACETATE</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
      <ActiveSubstance>TOCOPHERYL ACETATE</ActiveSubstance>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/10/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0145/001/001</DrugIDPK>
    <LicenceNumber>PA0145/001/001</LicenceNumber>
    <ProductName>ECZENSA</ProductName>
    <PAHolder>Hadensa (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
      <ActiveSubstance>RETINOL</ActiveSubstance>
      <ActiveSubstance>COLECALCIFEROL</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
      <ActiveSubstance>TOCOPHEROL</ActiveSubstance>
      <ActiveSubstance>NEOMYCIN SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0145/002/001</DrugIDPK>
    <LicenceNumber>PA0145/002/001</LicenceNumber>
    <ProductName>ECZENSA - S</ProductName>
    <PAHolder>Hadensa (Ireland) Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DIPHENYLPYRALINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/10/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA23266/065/001</DrugIDPK>
    <LicenceNumber>PA23266/065/001</LicenceNumber>
    <ProductName>Eczibet 20 mg/g + 1 mg/g cream</ProductName>
    <PAHolder>Viatris Limited</PAHolder>
    <AuthorisedDate>19/06/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Betamethasone</ActiveSubstance>
      <ActiveSubstance>Fusidic acid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/02/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/024/002</DrugIDPK>
    <LicenceNumber>PA0035/024/002</LicenceNumber>
    <ProductName>EDECRIN</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETACRYNIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0035/024/001</DrugIDPK>
    <LicenceNumber>PA0035/024/001</LicenceNumber>
    <ProductName>EDECRIN</ProductName>
    <PAHolder>Merck Sharp and Dohme Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ETACRYNATE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0677/021/001</DrugIDPK>
    <LicenceNumber>PA0677/021/001</LicenceNumber>
    <ProductName>Edicis 2mg kit for radiopharmaceutical preparation</ProductName>
    <PAHolder>CIS bio International</PAHolder>
    <AuthorisedDate>15/11/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Kit for radiopharmaceutical preparation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>N'n'-ethylene-(l,l) -dicysteine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/07/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2010/050/002</DrugIDPK>
    <LicenceNumber>PA2010/050/002</LicenceNumber>
    <ProductName>Edluar 10 mg sublingual tablets</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>24/09/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Sublingual tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Zolpidem tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 4, part 1 to the Misuse of Drugs Regulations 2017.</SupplyComments>
    <WithdrawalDate>22/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2010/050/001</DrugIDPK>
    <LicenceNumber>PA2010/050/001</LicenceNumber>
    <ProductName>Edluar 5 mg sublingual tablets</ProductName>
    <PAHolder>Mylan IRE Healthcare Limited</PAHolder>
    <AuthorisedDate>24/09/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Sublingual tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Zolpidem tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 4, part 1 to the Misuse of Drugs Regulations 2017</SupplyComments>
    <WithdrawalDate>22/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0969/001/001</DrugIDPK>
    <LicenceNumber>PA0969/001/001</LicenceNumber>
    <ProductName>EDNYT</ProductName>
    <PAHolder>Geodeon Richter France</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enalapril maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/11/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0969/001/002</DrugIDPK>
    <LicenceNumber>PA0969/001/002</LicenceNumber>
    <ProductName>EDNYT</ProductName>
    <PAHolder>Geodeon Richter France</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enalapril maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/11/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0969/001/003</DrugIDPK>
    <LicenceNumber>PA0969/001/003</LicenceNumber>
    <ProductName>EDNYT</ProductName>
    <PAHolder>Geodeon Richter France</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enalapril maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/11/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0969/001/004</DrugIDPK>
    <LicenceNumber>PA0969/001/004</LicenceNumber>
    <ProductName>EDNYT</ProductName>
    <PAHolder>Geodeon Richter France</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enalapril maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/11/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/062/001</DrugIDPK>
    <LicenceNumber>PA0970/062/001</LicenceNumber>
    <ProductName>Edoflo</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Budesonide</ActiveSubstance>
      <ActiveSubstance>Formoterol fumatrate dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/062/002</DrugIDPK>
    <LicenceNumber>PA0970/062/002</LicenceNumber>
    <ProductName>Edoflo</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Budesonide</ActiveSubstance>
      <ActiveSubstance>Formoterol fumatrate dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/062/003</DrugIDPK>
    <LicenceNumber>PA0970/062/003</LicenceNumber>
    <ProductName>Edoflo</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>26/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Inhalation</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Budesonide</ActiveSubstance>
      <ActiveSubstance>Formoterol fumatrate dihydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/07/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0936/089/001</DrugIDPK>
    <LicenceNumber>PA0936/089/001</LicenceNumber>
    <ProductName>Edronax</ProductName>
    <PAHolder>Pharmacia Healthcare Ireland</PAHolder>
    <AuthorisedDate>10/04/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Reboxetine mesylate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/09/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0044/041/001</DrugIDPK>
    <LicenceNumber>PA0044/041/001</LicenceNumber>
    <ProductName>EF CORTELAN</ProductName>
    <PAHolder>Glaxo Laboratories Limited</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>HYDROCORTISONE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1994</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0457/002/002</DrugIDPK>
    <LicenceNumber>PA0457/002/002</LicenceNumber>
    <ProductName>Efalith</ProductName>
    <PAHolder>Scotia Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>07/03/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lithium succinate</ActiveSubstance>
      <ActiveSubstance>Zinc sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0457/002/001</DrugIDPK>
    <LicenceNumber>PA0457/002/001</LicenceNumber>
    <ProductName>Efalith Ointment</ProductName>
    <PAHolder>Scotia Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>29/01/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Lithium succinate</ActiveSubstance>
      <ActiveSubstance>Zinc sulfate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0126/301/001</DrugIDPK>
    <LicenceNumber>PA0126/301/001</LicenceNumber>
    <ProductName>Efavirenz/Emtricitabine/Tenofovir Disoproxil Clonmel 600 mg/200 mg/245 mg film-coated tablets</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>22/12/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Efavirenz</ActiveSubstance>
      <ActiveSubstance>Emtricitabine</ActiveSubstance>
      <ActiveSubstance>Tenofovir disoproxil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/08/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/156/001</DrugIDPK>
    <LicenceNumber>PA0577/156/001</LicenceNumber>
    <ProductName>Efavirenz Mylan 600 mg Film-coated Tablets</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>12/10/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Efavirenz</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/12/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/207/001</DrugIDPK>
    <LicenceNumber>PA0711/207/001</LicenceNumber>
    <ProductName>Efavirenz Rowex 600mg Film-coated Tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>25/10/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Efavirenz</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/136/003</DrugIDPK>
    <LicenceNumber>PA0281/136/003</LicenceNumber>
    <ProductName>Efaxil</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>14/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/136/001</DrugIDPK>
    <LicenceNumber>PA0281/136/001</LicenceNumber>
    <ProductName>Efaxil XL</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>02/12/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0281/136/002</DrugIDPK>
    <LicenceNumber>PA0281/136/002</LicenceNumber>
    <ProductName>Efaxil XL</ProductName>
    <PAHolder>Pinewood Laboratories Ltd</PAHolder>
    <AuthorisedDate>02/12/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>25/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0582/002/001</DrugIDPK>
    <LicenceNumber>PA0582/002/001</LicenceNumber>
    <ProductName>EFEMOLINE EYE</ProductName>
    <PAHolder>Dispersa (UK) Ltd</PAHolder>
    <AuthorisedDate>22/08/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FLUOROMETHOLONE</ActiveSubstance>
      <ActiveSubstance>TETRYZOLINE</ActiveSubstance>
      <ActiveSubstance>BENZALKONIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/10/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0126/223/001</DrugIDPK>
    <LicenceNumber>PA0126/223/001</LicenceNumber>
    <ProductName>Efestad 5mg film-coated tablets</ProductName>
    <PAHolder>Clonmel Healthcare Ltd</PAHolder>
    <AuthorisedDate>25/05/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Desloratidine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/02/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/085/001A</DrugIDPK>
    <LicenceNumber>PPA0465/085/001A</LicenceNumber>
    <ProductName>Efexor</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>22/02/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/085/002A</DrugIDPK>
    <LicenceNumber>PPA0465/085/002A</LicenceNumber>
    <ProductName>Efexor</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>22/02/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/118/001</DrugIDPK>
    <LicenceNumber>PPA1328/118/001</LicenceNumber>
    <ProductName>Efexor</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>31/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/07/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/065/001</DrugIDPK>
    <LicenceNumber>PA0022/065/001</LicenceNumber>
    <ProductName>EFEXOR</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>27/07/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/05/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/065/003</DrugIDPK>
    <LicenceNumber>PA0022/065/003</LicenceNumber>
    <ProductName>EFEXOR</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>27/07/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/05/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0022/065/002</DrugIDPK>
    <LicenceNumber>PA0022/065/002</LicenceNumber>
    <ProductName>Efexor 37.5 mg Tablets</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>27/07/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/08/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/076/001</DrugIDPK>
    <LicenceNumber>PPA1151/076/001</LicenceNumber>
    <ProductName>Efexor 37.5 mg Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>21/11/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/04/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/085/001B</DrugIDPK>
    <LicenceNumber>PPA0465/085/001B</LicenceNumber>
    <ProductName>Efexor 37.5mg Tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>22/02/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0022/065/004</DrugIDPK>
    <LicenceNumber>PA0022/065/004</LicenceNumber>
    <ProductName>Efexor 75 mg Tablets</ProductName>
    <PAHolder>John Wyeth &amp; Brother Limited</PAHolder>
    <AuthorisedDate>27/07/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/08/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/076/002</DrugIDPK>
    <LicenceNumber>PPA1151/076/002</LicenceNumber>
    <ProductName>Efexor 75 mg Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>21/11/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/04/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/118/002</DrugIDPK>
    <LicenceNumber>PPA1328/118/002</LicenceNumber>
    <ProductName>Efexor XL</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>23/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/118/003</DrugIDPK>
    <LicenceNumber>PPA1328/118/003</LicenceNumber>
    <ProductName>Efexor XL</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>23/10/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/004/001</DrugIDPK>
    <LicenceNumber>PPA1659/004/001</LicenceNumber>
    <ProductName>Efexor XL</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>19/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/004/002</DrugIDPK>
    <LicenceNumber>PPA1659/004/002</LicenceNumber>
    <ProductName>Efexor XL</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>19/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/146/002</DrugIDPK>
    <LicenceNumber>PPA1463/146/002</LicenceNumber>
    <InterchangeableListCode>IC0026-062-030</InterchangeableListCode>
    <ProductName>Efexor XL 150 mg  prolonged-release capsules, hard</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>31/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/085/004</DrugIDPK>
    <LicenceNumber>PPA0465/085/004</LicenceNumber>
    <InterchangeableListCode>IC0026-062-030</InterchangeableListCode>
    <ProductName>Efexor XL 150 mg prolonged-release capsules, hard</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>03/06/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/075/001</DrugIDPK>
    <LicenceNumber>PPA1463/075/001</LicenceNumber>
    <InterchangeableListCode>IC0026-062-030</InterchangeableListCode>
    <ProductName>Efexor XL 150 mg prolonged-release capsules, hard</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>01/02/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/058/002</DrugIDPK>
    <LicenceNumber>PPA1500/058/002</LicenceNumber>
    <InterchangeableListCode>IC0026-062-030</InterchangeableListCode>
    <ProductName>Efexor XL 150mg hard prolonged-release capsules</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>14/05/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/146/001</DrugIDPK>
    <LicenceNumber>PPA1463/146/001</LicenceNumber>
    <InterchangeableListCode>IC0026-028-030</InterchangeableListCode>
    <ProductName>Efexor XL 75 mg prolonged-release capsules, hard</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>31/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This authorisation permits the holder to parallel-distribute only the product marketed in Ireland under the product authorisation PA0822/072/002.</SupplyComments>
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/075/002</DrugIDPK>
    <LicenceNumber>PPA1463/075/002</LicenceNumber>
    <InterchangeableListCode>IC0026-028-030</InterchangeableListCode>
    <ProductName>Efexor XL 75 mg prolonged-release capsules, hard</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>14/05/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/03/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/209/001</DrugIDPK>
    <LicenceNumber>PPA1463/209/001</LicenceNumber>
    <InterchangeableListCode>IC0026-028-030</InterchangeableListCode>
    <ProductName>Efexor XL 75 mg prolonged-release capsules, hard</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>14/08/2023</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Venlafaxine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/07/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0078/006/001</DrugIDPK>
    <LicenceNumber>PA0078/006/001</LicenceNumber>
    <ProductName>EFFERALGAN</ProductName>
    <PAHolder>Mayne Pharma (Ireland) Limited</PAHolder>
    <AuthorisedDate>18/10/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PARACETAMOL</ActiveSubstance>
      <ActiveSubstance>ASCORBIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/09/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0100/045/001</DrugIDPK>
    <LicenceNumber>PA0100/045/001</LicenceNumber>
    <ProductName>Effico Tonic, Oral Solution</ProductName>
    <PAHolder>Forest Laboratories UK Ltd</PAHolder>
    <AuthorisedDate>27/11/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Thiamine hydrochloride</ActiveSubstance>
      <ActiveSubstance>Nicotinamide</ActiveSubstance>
      <ActiveSubstance>Caffeine</ActiveSubstance>
      <ActiveSubstance>Gentian compound infusion</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/03/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/044/001</DrugIDPK>
    <LicenceNumber>PA0436/044/001</LicenceNumber>
    <ProductName>Eflavex 1 mg Tablets</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>29/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cabergoline </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/044/002</DrugIDPK>
    <LicenceNumber>PA0436/044/002</LicenceNumber>
    <ProductName>Eflavex 2 mg Tablets</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>29/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cabergoline </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0436/044/003</DrugIDPK>
    <LicenceNumber>PA0436/044/003</LicenceNumber>
    <ProductName>Eflavex 4 mg Tablets</ProductName>
    <PAHolder>Norton Waterford</PAHolder>
    <AuthorisedDate>29/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cabergoline </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/12/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/119/001</DrugIDPK>
    <LicenceNumber>PPA1562/119/001</LicenceNumber>
    <ProductName>Efudix 5 % w/w Cream</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>08/08/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Fluorouracil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0863/003/001</DrugIDPK>
    <LicenceNumber>PA0863/003/001</LicenceNumber>
    <ProductName>Egoderm</ProductName>
    <PAHolder>Ego Pharmaceuticals (UK) Limited</PAHolder>
    <AuthorisedDate>07/07/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ichthammol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0863/003/002</DrugIDPK>
    <LicenceNumber>PA0863/003/002</LicenceNumber>
    <ProductName>Egoderm</ProductName>
    <PAHolder>Ego Pharmaceuticals (UK) Limited</PAHolder>
    <AuthorisedDate>16/10/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ichthammol</ActiveSubstance>
      <ActiveSubstance>Zinc oxide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0074/066/001</DrugIDPK>
    <LicenceNumber>PA0074/066/001</LicenceNumber>
    <InterchangeableListCode>IC0117-018-003</InterchangeableListCode>
    <ProductName>Eirfem 2.5 mg film-coated tablets</ProductName>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>28/08/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Letrozole</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0585/032/001</DrugIDPK>
    <LicenceNumber>PA0585/032/001</LicenceNumber>
    <ProductName>Eironil</ProductName>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>12/12/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ropinirole (as hydrochloride)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0585/032/002</DrugIDPK>
    <LicenceNumber>PA0585/032/002</LicenceNumber>
    <ProductName>Eironil</ProductName>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>12/12/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ropinirole (as hydrochloride)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0585/032/003</DrugIDPK>
    <LicenceNumber>PA0585/032/003</LicenceNumber>
    <ProductName>Eironil</ProductName>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>12/12/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ropinirole (as hydrochloride)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0585/032/004</DrugIDPK>
    <LicenceNumber>PA0585/032/004</LicenceNumber>
    <ProductName>Eironil</ProductName>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>12/12/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ropinirole (as hydrochloride)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0585/032/005</DrugIDPK>
    <LicenceNumber>PA0585/032/005</LicenceNumber>
    <ProductName>Eironil</ProductName>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>12/12/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ropinirole (as hydrochloride)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/24/1858/003</DrugIDPK>
    <LicenceNumber>EU/1/24/1858/003</LicenceNumber>
    <ProductName>Eksunbi 130 mg concentrate for solution for infusion</ProductName>
    <PAHolder>Samsung Bioepis NL B.V.</PAHolder>
    <AuthorisedDate>12/09/2024</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ustekinumab</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>18/08/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/24/1858/001</DrugIDPK>
    <LicenceNumber>EU/1/24/1858/001</LicenceNumber>
    <ProductName>Eksunbi 45 mg solution for injection in pre-filled syringe</ProductName>
    <PAHolder>Samsung Bioepis NL B.V.</PAHolder>
    <AuthorisedDate>12/09/2024</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection in pre-filled syringe</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ustekinumab</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>18/08/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/24/1858/002</DrugIDPK>
    <LicenceNumber>EU/1/24/1858/002</LicenceNumber>
    <ProductName>Eksunbi 90 mg solution for injection in pre-filled syringe</ProductName>
    <PAHolder>Samsung Bioepis NL B.V.</PAHolder>
    <AuthorisedDate>12/09/2024</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection in pre-filled syringe</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ustekinumab</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>18/08/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0062/005/001</DrugIDPK>
    <LicenceNumber>PA0062/005/001</LicenceNumber>
    <ProductName>ELAMOL</ProductName>
    <PAHolder>Yamanouchi Pharma Ltd</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/07/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0116/002/003</DrugIDPK>
    <LicenceNumber>PA0116/002/003</LicenceNumber>
    <ProductName>ELANOL</ProductName>
    <PAHolder>Elan Corporation Plc</PAHolder>
    <AuthorisedDate>31/05/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/02/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0516/005/003</DrugIDPK>
    <LicenceNumber>PA0516/005/003</LicenceNumber>
    <ProductName>ELANPRES</ProductName>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>04/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0516/005/002</DrugIDPK>
    <LicenceNumber>PA0516/005/002</LicenceNumber>
    <ProductName>ELANPRES</ProductName>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>04/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0516/005/001</DrugIDPK>
    <LicenceNumber>PA0516/005/001</LicenceNumber>
    <ProductName>ELANPRES</ProductName>
    <PAHolder>Elan Pharma Ltd</PAHolder>
    <AuthorisedDate>04/11/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/050/001</DrugIDPK>
    <LicenceNumber>PPA1659/050/001</LicenceNumber>
    <ProductName>Elantan</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>11/11/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0271/001/005</DrugIDPK>
    <LicenceNumber>PA0271/001/005</LicenceNumber>
    <ProductName>ELANTAN</ProductName>
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>30/11/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/11/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0271/001/004</DrugIDPK>
    <LicenceNumber>PA0271/001/004</LicenceNumber>
    <ProductName>ELANTAN</ProductName>
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>30/11/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/11/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0271/001/007</DrugIDPK>
    <LicenceNumber>PA0271/001/007</LicenceNumber>
    <ProductName>ELANTAN 0.1%</ProductName>
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>30/11/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/11/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0271/001/006</DrugIDPK>
    <LicenceNumber>PA0271/001/006</LicenceNumber>
    <ProductName>ELANTAN 0.1%</ProductName>
    <PAHolder>SCHWARZ PHARMA Limited</PAHolder>
    <AuthorisedDate>30/11/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/11/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2118/002/001</DrugIDPK>
    <LicenceNumber>PA2118/002/001</LicenceNumber>
    <ProductName>Elantan 10 mg Tablets</ProductName>
    <PAHolder>Merus Labs Luxco II S.à.R.L.</PAHolder>
    <AuthorisedDate>11/10/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2118/002/002</DrugIDPK>
    <LicenceNumber>PA2118/002/002</LicenceNumber>
    <ProductName>Elantan 40 mg tablets</ProductName>
    <PAHolder>Merus Labs Luxco II S.à.R.L.</PAHolder>
    <AuthorisedDate>02/08/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Isosorbid-5-mononitrat</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/10/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1473/008/001</DrugIDPK>
    <LicenceNumber>DPR1473/008/001</LicenceNumber>
    <ProductName>Elantan LA</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>26/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA0465/241/001</DrugIDPK>
    <LicenceNumber>PPA0465/241/001</LicenceNumber>
    <ProductName>Elantan LA</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>04/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/241/002</DrugIDPK>
    <LicenceNumber>PPA0465/241/002</LicenceNumber>
    <ProductName>Elantan LA</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>04/09/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/103/001</DrugIDPK>
    <LicenceNumber>PPA1328/103/001</LicenceNumber>
    <ProductName>Elantan LA</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>03/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/103/002</DrugIDPK>
    <LicenceNumber>PPA1328/103/002</LicenceNumber>
    <ProductName>Elantan LA</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>03/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/027/001</DrugIDPK>
    <LicenceNumber>PPA1500/027/001</LicenceNumber>
    <ProductName>Elantan LA</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>24/07/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1500/027/002</DrugIDPK>
    <LicenceNumber>PPA1500/027/002</LicenceNumber>
    <ProductName>Elantan LA</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>25/11/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/05/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/050/002</DrugIDPK>
    <LicenceNumber>PPA1659/050/002</LicenceNumber>
    <ProductName>Elantan LA</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>11/11/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/050/003</DrugIDPK>
    <LicenceNumber>PPA1659/050/003</LicenceNumber>
    <ProductName>Elantan LA</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>11/11/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1392/010/001</DrugIDPK>
    <LicenceNumber>DPR1392/010/001</LicenceNumber>
    <ProductName>ELANTAN LA</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>10/08/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/05/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/078/002</DrugIDPK>
    <LicenceNumber>PPA1151/078/002</LicenceNumber>
    <ProductName>Elantan LA 25 mg Prolonged Release Capsules, hard</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>13/03/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/078/001</DrugIDPK>
    <LicenceNumber>PPA1151/078/001</LicenceNumber>
    <ProductName>Elantan LA 50mg Prolonged-Release Capsules, hard</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>26/09/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ISOSORBIDE MONONITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1463/016/001</DrugIDPK>
    <LicenceNumber>DPR1463/016/001</LicenceNumber>
    <ProductName>Elantan LA Hard</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>02/04/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release capsule, hard</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0378/001/002</DrugIDPK>
    <LicenceNumber>PA0378/001/002</LicenceNumber>
    <ProductName>ELASTOPLAST ANTISEPTIC</ProductName>
    <PAHolder>Smith &amp; Nephew-Southalls (Ire) L</PAHolder>
    <AuthorisedDate>22/08/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cutaneous Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CETRIMONIUM BROMIDE</ActiveSubstance>
      <ActiveSubstance>CHLORHEXIDINE GLUCONATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/08/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0378/001/001</DrugIDPK>
    <LicenceNumber>PA0378/001/001</LicenceNumber>
    <ProductName>ELASTOPLAST ANTISPETIC</ProductName>
    <PAHolder>Smith &amp; Nephew-Southalls (Ire) L</PAHolder>
    <AuthorisedDate>22/08/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CHLOROXYLENOL</ActiveSubstance>
      <ActiveSubstance>TRICLOSAN</ActiveSubstance>
      <ActiveSubstance>EDETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/08/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1106/001/001</DrugIDPK>
    <LicenceNumber>PA1106/001/001</LicenceNumber>
    <ProductName>Elastoplast Back Pain 4.8 mg Medicated Plaster</ProductName>
    <PAHolder>Beiersdorf AG</PAHolder>
    <AuthorisedDate>24/05/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Medicated plaster</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cayenne pepper soft extract 4-7:1</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22680/006/001</DrugIDPK>
    <LicenceNumber>PA22680/006/001</LicenceNumber>
    <ProductName>Elaxigol 13.7g sachet powder for oral solution</ProductName>
    <PAHolder>Galen Pharma Ireland Limited</PAHolder>
    <AuthorisedDate>01/02/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral solution in sachet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Macrogol 3350</ActiveSubstance>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium hydrogen carbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/06/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0303/028/002</DrugIDPK>
    <LicenceNumber>PA0303/028/002</LicenceNumber>
    <ProductName>ELDEPRYL</ProductName>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>27/11/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SELEGILINE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/304/001</DrugIDPK>
    <LicenceNumber>PPA0465/304/001</LicenceNumber>
    <ProductName>Eldepryl 5 mg Tablets</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>22/02/2013</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Selegiline hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in schedule 4, part 2 to the Misuse of Drugs Regulations 2017</SupplyComments>
    <WithdrawalDate>31/01/2022</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/049/004</DrugIDPK>
    <LicenceNumber>PA0047/049/004</LicenceNumber>
    <ProductName>ELDESINE</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>14/12/1981</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINDESINE SULPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/10/1986</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/049/002</DrugIDPK>
    <LicenceNumber>PA0047/049/002</LicenceNumber>
    <ProductName>ELDESINE</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>31/01/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINDESINE SULPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/01/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/049/001</DrugIDPK>
    <LicenceNumber>PA0047/049/001</LicenceNumber>
    <ProductName>ELDESINE</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>31/01/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINDESINE SULPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/01/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0047/049/003</DrugIDPK>
    <LicenceNumber>PA0047/049/003</LicenceNumber>
    <ProductName>ELDISINE</ProductName>
    <PAHolder>Eli Lilly and Company Limited</PAHolder>
    <AuthorisedDate>31/01/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>VINDESINE SULPHATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0303/034/002</DrugIDPK>
    <LicenceNumber>PA0303/034/002</LicenceNumber>
    <ProductName>ELDOPAR</ProductName>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>22/12/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/09/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0303/034/001</DrugIDPK>
    <LicenceNumber>PA0303/034/001</LicenceNumber>
    <ProductName>ELDOPAR</ProductName>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>22/12/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVODOPA</ActiveSubstance>
      <ActiveSubstance>CARBIDOPA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/09/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0610/015/001</DrugIDPK>
    <LicenceNumber>PA0610/015/001</LicenceNumber>
    <ProductName>ELECTROLADE BANANA</ProductName>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>22/10/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium bicarbonate</ActiveSubstance>
      <ActiveSubstance>Dextrose anhydrid</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>22/10/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0610/015/003</DrugIDPK>
    <LicenceNumber>PA0610/015/003</LicenceNumber>
    <ProductName>Electrolade Blackcurrant</ProductName>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>03/10/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium bicarbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/10/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0610/015/002</DrugIDPK>
    <LicenceNumber>PA0610/015/002</LicenceNumber>
    <ProductName>ELECTROLADE MELON</ProductName>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>03/10/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium bicarbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/10/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0610/015/004</DrugIDPK>
    <LicenceNumber>PA0610/015/004</LicenceNumber>
    <ProductName>Electrolade Orange</ProductName>
    <PAHolder>Thornton &amp; Ross Limited</PAHolder>
    <AuthorisedDate>03/10/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium bicarbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/10/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/015/001</DrugIDPK>
    <LicenceNumber>PA0167/015/001</LicenceNumber>
    <ProductName>ELECTROLYTE 20.0% DEXTROSE</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>06/03/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MAGNESIUM CHLORIDE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>CALCIUM CHLORIDE DIHYDRATE</ActiveSubstance>
      <ActiveSubstance>ZINC ACETATE</ActiveSubstance>
      <ActiveSubstance>MANGANESE CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/10/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0167/016/001</DrugIDPK>
    <LicenceNumber>PA0167/016/001</LicenceNumber>
    <ProductName>ELECTROLYTE SOLUTION B</ProductName>
    <PAHolder>Baxter Healthcare Limited</PAHolder>
    <AuthorisedDate>25/02/1980</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>POTASSIUM PHOSPHATE MONOBASIC</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/10/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA23052/001/001</DrugIDPK>
    <LicenceNumber>PA23052/001/001</LicenceNumber>
    <ProductName>Eletriptan Hormosan 20 mg film-coated tablets</ProductName>
    <PAHolder>Hormosan Pharma GmbH</PAHolder>
    <AuthorisedDate>18/12/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ELETRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA23052/001/002</DrugIDPK>
    <LicenceNumber>PA23052/001/002</LicenceNumber>
    <ProductName>Eletriptan Hormosan 40 mg film-coated tablets</ProductName>
    <PAHolder>Hormosan Pharma GmbH</PAHolder>
    <AuthorisedDate>18/12/2020</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ELETRIPTAN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0778/018/004</DrugIDPK>
    <LicenceNumber>PA0778/018/004</LicenceNumber>
    <ProductName>ELLESTE DUET</ProductName>
    <PAHolder>Monsanto PLC</PAHolder>
    <AuthorisedDate>30/10/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/02/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0778/018/005</DrugIDPK>
    <LicenceNumber>PA0778/018/005</LicenceNumber>
    <ProductName>ELLESTE DUET CONTI</ProductName>
    <PAHolder>Monsanto PLC</PAHolder>
    <AuthorisedDate>03/05/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/02/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0778/018/003</DrugIDPK>
    <LicenceNumber>PA0778/018/003</LicenceNumber>
    <ProductName>ELLESTE-DUET</ProductName>
    <PAHolder>Monsanto PLC</PAHolder>
    <AuthorisedDate>20/02/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
      <ActiveSubstance>NORETHISTERONE ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/02/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0778/018/002</DrugIDPK>
    <LicenceNumber>PA0778/018/002</LicenceNumber>
    <ProductName>ELLESTE-SOLO</ProductName>
    <PAHolder>Monsanto PLC</PAHolder>
    <AuthorisedDate>20/02/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/02/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0778/018/001</DrugIDPK>
    <LicenceNumber>PA0778/018/001</LicenceNumber>
    <ProductName>ELLESTE-SOLO</ProductName>
    <PAHolder>Monsanto PLC</PAHolder>
    <AuthorisedDate>20/02/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ESTRADIOL HEMIHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/02/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0449/002/001</DrugIDPK>
    <LicenceNumber>PA0449/002/001</LicenceNumber>
    <ProductName>ELLIMANS UNIVERSAL EMBROCATION</ProductName>
    <PAHolder>Beecham Group Plc</PAHolder>
    <AuthorisedDate>14/05/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TURPENTINE OIL</ActiveSubstance>
      <ActiveSubstance>ACETIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>14/05/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/268/002</DrugIDPK>
    <LicenceNumber>PPA0465/268/002</LicenceNumber>
    <ProductName>Elocon</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>06/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mometasone furoate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/127/001</DrugIDPK>
    <LicenceNumber>PPA1328/127/001</LicenceNumber>
    <ProductName>Elocon</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>08/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mometasone furoate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/127/002</DrugIDPK>
    <LicenceNumber>PPA1328/127/002</LicenceNumber>
    <ProductName>Elocon</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>08/01/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mometasone furoate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>13/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/268/001</DrugIDPK>
    <LicenceNumber>PPA0465/268/001</LicenceNumber>
    <ProductName>Elocon 0.1% w/w Cream</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>06/05/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mometasone furoate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/145/001</DrugIDPK>
    <LicenceNumber>PPA1562/145/001</LicenceNumber>
    <ProductName>Elocon 0.1% w/w Cream</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>04/12/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mometasone furoate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/02/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/145/002</DrugIDPK>
    <LicenceNumber>PPA1562/145/002</LicenceNumber>
    <ProductName>Elocon 0.1% w/w Ointment</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>04/12/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mometasone furoate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/02/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/268/003</DrugIDPK>
    <LicenceNumber>PPA0465/268/003</LicenceNumber>
    <ProductName>Elocon 0.1% w/w Ointment</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>25/06/2021</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Mometasone furoate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/15/1046/009</DrugIDPK>
    <LicenceNumber>EU/1/15/1046/009</LicenceNumber>
    <ProductName>Elocta</ProductName>
    <PAHolder>Swedish Orphan Biovitrum AB(publ)</PAHolder>
    <AuthorisedDate>07/12/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Efmoroctocog alfa</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>29/04/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/15/1046/010</DrugIDPK>
    <LicenceNumber>EU/1/15/1046/010</LicenceNumber>
    <ProductName>Elocta</ProductName>
    <PAHolder>Swedish Orphan Biovitrum AB(publ)</PAHolder>
    <AuthorisedDate>07/12/2018</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Efmoroctocog alfa</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>29/04/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0074/012/001</DrugIDPK>
    <LicenceNumber>PA0074/012/001</LicenceNumber>
    <ProductName>ELOTRANS</ProductName>
    <PAHolder>Rowa Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>26/06/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>GLUCOSE ANHYDROUS</ActiveSubstance>
      <ActiveSubstance>SODIUM CHLORIDE</ActiveSubstance>
      <ActiveSubstance>SODIUM CITRATE</ActiveSubstance>
      <ActiveSubstance>POTASSIUM CHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/08/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/148/002</DrugIDPK>
    <LicenceNumber>PA0540/148/002</LicenceNumber>
    <ProductName>Eloxatin</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>19/01/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Oxaliplatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/09/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0540/148/001</DrugIDPK>
    <LicenceNumber>PA0540/148/001</LicenceNumber>
    <ProductName>Eloxatin 5 mg/ml Concentrate for Solution for Infusion</ProductName>
    <PAHolder>Sanofi-Aventis Ireland Limited T/A SANOFI</PAHolder>
    <AuthorisedDate>05/05/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for solution for infusion</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Oxaliplatin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/04/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0039/032/001</DrugIDPK>
    <LicenceNumber>PA0039/032/001</LicenceNumber>
    <ProductName>ELTOFAN</ProductName>
    <PAHolder>Warner Lambert</PAHolder>
    <AuthorisedDate>16/02/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/06/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1392/002/001</DrugIDPK>
    <LicenceNumber>DPR1392/002/001</LicenceNumber>
    <ProductName>Eltroxin</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>05/02/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Thyroxin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1392/002/002</DrugIDPK>
    <LicenceNumber>DPR1392/002/002</LicenceNumber>
    <ProductName>Eltroxin</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>05/02/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Thyroxin sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA0465/120/001</DrugIDPK>
    <LicenceNumber>PPA0465/120/001</LicenceNumber>
    <ProductName>Eltroxin</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>15/04/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/120/002</DrugIDPK>
    <LicenceNumber>PPA0465/120/002</LicenceNumber>
    <ProductName>Eltroxin</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>15/04/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/162/001</DrugIDPK>
    <LicenceNumber>PPA1328/162/001</LicenceNumber>
    <ProductName>Eltroxin</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>10/02/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR1392/002/003</DrugIDPK>
    <LicenceNumber>DPR1392/002/003</LicenceNumber>
    <ProductName>ELTROXIN</ProductName>
    <PAHolder>Eurodrug Ltd</PAHolder>
    <AuthorisedDate>01/08/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PA0365/051/001</DrugIDPK>
    <LicenceNumber>PA0365/051/001</LicenceNumber>
    <ProductName>ELTROXIN</ProductName>
    <PAHolder>UCB Pharma Limited</PAHolder>
    <AuthorisedDate>07/07/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LEVOTHYROXINE SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/07/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/064/003</DrugIDPK>
    <LicenceNumber>PPA1151/064/003</LicenceNumber>
    <ProductName>Eltroxin 100 microgram Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>07/03/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/064/001</DrugIDPK>
    <LicenceNumber>PPA1151/064/001</LicenceNumber>
    <ProductName>Eltroxin 25 microgram Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>03/10/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/064/002</DrugIDPK>
    <LicenceNumber>PPA1151/064/002</LicenceNumber>
    <ProductName>Eltroxin 50 microgram Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>07/03/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Levothyroxine sodium</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0329/001/001</DrugIDPK>
    <LicenceNumber>PA0329/001/001</LicenceNumber>
    <ProductName>Eludril</ProductName>
    <PAHolder>Pierre Fabre Medicament</PAHolder>
    <AuthorisedDate>25/06/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Mouthwash</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chlorhexidine gluconate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product not subject to medical prescription</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/06/2011</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0329/001/002</DrugIDPK>
    <LicenceNumber>PA0329/001/002</LicenceNumber>
    <ProductName>Eludril</ProductName>
    <PAHolder>Pierre Fabre Medicament</PAHolder>
    <AuthorisedDate>04/10/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oromucosal spray, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Chlorhexidine gluconate</ActiveSubstance>
      <ActiveSubstance>Tetracaine hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/10/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0677/010/001</DrugIDPK>
    <LicenceNumber>PA0677/010/001</LicenceNumber>
    <ProductName>ELUMATIC III  2-20 GBq radionuclide generator</ProductName>
    <PAHolder>CIS bio International</PAHolder>
    <AuthorisedDate>03/04/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not Currently Available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Sodium pertechnetate (99m tc)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to Restricted Prescription (C)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0320/009/001</DrugIDPK>
    <LicenceNumber>PA0320/009/001</LicenceNumber>
    <ProductName>ELYZOL</ProductName>
    <PAHolder>Colgate-Palmolive (U.K.) Ltd</PAHolder>
    <AuthorisedDate>16/08/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Dental gel</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Metronidazole benzoate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/01/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0409/002/004</DrugIDPK>
    <LicenceNumber>PA0409/002/004</LicenceNumber>
    <ProductName>ELYZOL</ProductName>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>02/01/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0409/002/003</DrugIDPK>
    <LicenceNumber>PA0409/002/003</LicenceNumber>
    <ProductName>ELYZOL</ProductName>
    <PAHolder>CP Pharmaceuticals Ltd trading as Wockhardt UK</PAHolder>
    <AuthorisedDate>02/01/1987</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suppositories</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/11/1991</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0363/004/001</DrugIDPK>
    <LicenceNumber>PA0363/004/001</LicenceNumber>
    <ProductName>ELYZOL</ProductName>
    <PAHolder>Alpharma ApS</PAHolder>
    <AuthorisedDate>10/06/1991</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METRONIDAZOLE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/06/2001</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/98/095/002</DrugIDPK>
    <LicenceNumber>EU/1/98/095/002</LicenceNumber>
    <ProductName>Emadine</ProductName>
    <PAHolder>Immedica Pharma AB</PAHolder>
    <AuthorisedDate>27/01/1999</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Eye drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Emedastine difumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/04/2026</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/038/002</DrugIDPK>
    <LicenceNumber>PA0577/038/002</LicenceNumber>
    <ProductName>Emcolol 10 mg Film-coated Tablets</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>12/01/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/04/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/038/001</DrugIDPK>
    <LicenceNumber>PA0577/038/001</LicenceNumber>
    <ProductName>Emcolol 5 mg Film-coated Tablets</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>12/01/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/05/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/087/001</DrugIDPK>
    <LicenceNumber>PPA0465/087/001</LicenceNumber>
    <ProductName>Emcor</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>06/12/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/087/002</DrugIDPK>
    <LicenceNumber>PPA0465/087/002</LicenceNumber>
    <ProductName>Emcor</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>06/12/2002</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/135/001</DrugIDPK>
    <LicenceNumber>PPA1328/135/001</LicenceNumber>
    <InterchangeableListCode>IC0065-001-014</InterchangeableListCode>
    <ProductName>Emcor</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>04/06/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/12/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/135/002</DrugIDPK>
    <LicenceNumber>PPA1328/135/002</LicenceNumber>
    <InterchangeableListCode>IC0065-002-014</InterchangeableListCode>
    <ProductName>Emcor</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>04/06/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/02/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2286/002/002</DrugIDPK>
    <LicenceNumber>PA2286/002/002</LicenceNumber>
    <ProductName>Emcor 10 mg Film-coated tablets</ProductName>
    <PAHolder>Merck Serono (Ireland) Limited</PAHolder>
    <AuthorisedDate>30/06/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>None</SupplyComments>
    <WithdrawalDate>07/04/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2286/002/001</DrugIDPK>
    <LicenceNumber>PA2286/002/001</LicenceNumber>
    <ProductName>Emcor 5 mg Film-coated tablets</ProductName>
    <PAHolder>Merck Serono (Ireland) Limited</PAHolder>
    <AuthorisedDate>30/06/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Bisoprolol hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>None</SupplyComments>
    <WithdrawalDate>07/04/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0654/008/001</DrugIDPK>
    <LicenceNumber>PA0654/008/001</LicenceNumber>
    <ProductName>Emcoretic</ProductName>
    <PAHolder>Merck Serono Limited</PAHolder>
    <AuthorisedDate>27/11/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/11/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/03/262/009-010</DrugIDPK>
    <LicenceNumber>EU/1/03/262/009-010</LicenceNumber>
    <ProductName>Emend</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme BV,</PAHolder>
    <AuthorisedDate>28/11/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aprepitant</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/01/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/03/262/7-8</DrugIDPK>
    <LicenceNumber>EU/1/03/262/7-8</LicenceNumber>
    <ProductName>Emend</ProductName>
    <PAHolder>Merck Sharp &amp; Dohme BV,</PAHolder>
    <AuthorisedDate>29/08/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Aprepitant</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/01/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22698/029/001</DrugIDPK>
    <LicenceNumber>PA22698/029/001</LicenceNumber>
    <ProductName>Emerade 150 micrograms solution for injection in pre-filled pen</ProductName>
    <PAHolder>Bausch Health Ireland Limited</PAHolder>
    <AuthorisedDate>11/09/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection in pre-filled pen</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Adrenaline tartrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22698/029/002</DrugIDPK>
    <LicenceNumber>PA22698/029/002</LicenceNumber>
    <ProductName>Emerade 300 micrograms solution for injection in pre-filled pen</ProductName>
    <PAHolder>Bausch Health Ireland Limited</PAHolder>
    <AuthorisedDate>11/09/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection in pre-filled pen</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Adrenaline</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA22698/029/003</DrugIDPK>
    <LicenceNumber>PA22698/029/003</LicenceNumber>
    <ProductName>Emerade 500 micrograms solution for injection in pre-filled pen</ProductName>
    <PAHolder>Bausch Health Ireland Limited</PAHolder>
    <AuthorisedDate>11/09/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection in pre-filled pen</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Adrenaline</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1390/192/003</DrugIDPK>
    <LicenceNumber>PA1390/192/003</LicenceNumber>
    <ProductName>Emerpand 13.3mg/24h Transdermal Patches</ProductName>
    <PAHolder>Accord  Healthcare Limited</PAHolder>
    <AuthorisedDate>09/01/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rivastigmine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/02/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1390/192/001</DrugIDPK>
    <LicenceNumber>PA1390/192/001</LicenceNumber>
    <ProductName>Emerpand 4.6mg/24h Transdermal Patches</ProductName>
    <PAHolder>Accord  Healthcare Limited</PAHolder>
    <AuthorisedDate>09/01/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rivastigmine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/02/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1390/192/002</DrugIDPK>
    <LicenceNumber>PA1390/192/002</LicenceNumber>
    <ProductName>Emerpand 9.5mg/24h Transdermal Patches</ProductName>
    <PAHolder>Accord  Healthcare Limited</PAHolder>
    <AuthorisedDate>09/01/2015</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Rivastigmine</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/02/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0488/019/001</DrugIDPK>
    <LicenceNumber>PA0488/019/001</LicenceNumber>
    <ProductName>EMINASE</ProductName>
    <PAHolder>Monmouth Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>05/04/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pdr for Soln for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ANISTREPLASE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/04/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0585/021/001</DrugIDPK>
    <LicenceNumber>PA0585/021/001</LicenceNumber>
    <ProductName>Emital 4mg Film-coated Tablets</ProductName>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>08/04/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ondansetron hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0585/021/002</DrugIDPK>
    <LicenceNumber>PA0585/021/002</LicenceNumber>
    <ProductName>Emital 8mg Film-coated Tablets</ProductName>
    <PAHolder>Pliva Pharma Limited</PAHolder>
    <AuthorisedDate>08/04/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ondansetron hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/077/001</DrugIDPK>
    <LicenceNumber>PPA1151/077/001</LicenceNumber>
    <ProductName>Emizof 4mg Film-coated Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>29/08/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ondansetron</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/077/002</DrugIDPK>
    <LicenceNumber>PPA1151/077/002</LicenceNumber>
    <ProductName>Emizof 8mg Film-coated Tablets</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>29/08/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Ondansetron</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/04/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0009/035/002</DrugIDPK>
    <LicenceNumber>PA0009/035/002</LicenceNumber>
    <ProductName>EMLA PATCH</ProductName>
    <PAHolder>Astra Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>13/10/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Transdermal Patch</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>LIDOCAINE</ActiveSubstance>
      <ActiveSubstance>PRILOCAINE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/08/2003</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/045/001</DrugIDPK>
    <LicenceNumber>PA0057/045/001</LicenceNumber>
    <ProductName>EMLAB BREWERS-YEAST</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>YEAST DRIED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/046/001</DrugIDPK>
    <LicenceNumber>PA0057/046/001</LicenceNumber>
    <ProductName>EMLAB IRON &amp; BREWERS-YEAST</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>YEAST DRIED</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/04/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0303/010/001</DrugIDPK>
    <LicenceNumber>PA0303/010/001</LicenceNumber>
    <ProductName>EMPERAL</ProductName>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>09/05/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0303/010/002</DrugIDPK>
    <LicenceNumber>PA0303/010/002</LicenceNumber>
    <ProductName>EMPERAL SOLUTION</ProductName>
    <PAHolder>Orion Pharma A/s</PAHolder>
    <AuthorisedDate>09/05/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>METOCLOPRAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>03/05/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0224/007/006</DrugIDPK>
    <LicenceNumber>PA0224/007/006</LicenceNumber>
    <ProductName>EMTEXATE METHOTREXATE</ProductName>
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>06/05/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0224/007/005</DrugIDPK>
    <LicenceNumber>PA0224/007/005</LicenceNumber>
    <ProductName>EMTEXATE METHOTREXATE</ProductName>
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>06/05/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0224/007/004</DrugIDPK>
    <LicenceNumber>PA0224/007/004</LicenceNumber>
    <ProductName>EMTEXATE METHOTREXATE</ProductName>
    <PAHolder>Ferring Pharmaceuticals Limited</PAHolder>
    <AuthorisedDate>06/05/1985</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/200/001</DrugIDPK>
    <LicenceNumber>PA2315/200/001</LicenceNumber>
    <InterchangeableListCode>IC0107-165-003</InterchangeableListCode>
    <ProductName>Emtricitabine/Tenofovir disoproxil 200 mg/245 mg film-coated tablets</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>05/05/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Emtricitabine</ActiveSubstance>
      <ActiveSubstance>Tenofovir disoproxil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>07/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/271/001</DrugIDPK>
    <LicenceNumber>PA0711/271/001</LicenceNumber>
    <ProductName>Emtricitabine/Tenofovir disoproxil Rowex 200 mg/245 mg film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>12/05/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Emtricitabine</ActiveSubstance>
      <ActiveSubstance>Tenofovir disoproxil</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0095/017/001</DrugIDPK>
    <LicenceNumber>PA0095/017/001</LicenceNumber>
    <ProductName>EMULSIFYING</ProductName>
    <PAHolder>Ricesteele Manufacturing Ltd</PAHolder>
    <AuthorisedDate>21/03/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/12/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0484/008/001</DrugIDPK>
    <LicenceNumber>PA0484/008/001</LicenceNumber>
    <ProductName>EMULSIFYING OINTMENT</ProductName>
    <PAHolder>Foran Healthcare Limited</PAHolder>
    <AuthorisedDate>01/09/1988</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EMULSIFYING WAX</ActiveSubstance>
      <ActiveSubstance>PARAFFIN SOFT</ActiveSubstance>
      <ActiveSubstance>PARAFFIN, LIQUID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/08/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/081/001</DrugIDPK>
    <LicenceNumber>PA0282/081/001</LicenceNumber>
    <ProductName>Emvasc</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>24/01/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/09/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0282/081/002</DrugIDPK>
    <LicenceNumber>PA0282/081/002</LicenceNumber>
    <ProductName>Emvasc</ProductName>
    <PAHolder>Norton Healthcare Limited T/A IVAX Pharmaceuticals UK</PAHolder>
    <AuthorisedDate>24/01/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>BISOPROLOL FUMARATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/09/2009</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0043/034/001</DrugIDPK>
    <LicenceNumber>PA0043/034/001</LicenceNumber>
    <ProductName>EMZOL</ProductName>
    <PAHolder>Crookes Healthcare Ltd</PAHolder>
    <AuthorisedDate>17/12/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Cream</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MICONAZOLE NITRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>11/02/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0069/016/003</DrugIDPK>
    <LicenceNumber>PA0069/016/003</LicenceNumber>
    <ProductName>EN-DE-KAY</ProductName>
    <PAHolder>Stafford Miller Limited</PAHolder>
    <AuthorisedDate>23/02/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0069/016/002</DrugIDPK>
    <LicenceNumber>PA0069/016/002</LicenceNumber>
    <ProductName>EN-DE-KAY</ProductName>
    <PAHolder>Stafford Miller Limited</PAHolder>
    <AuthorisedDate>23/02/1993</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>26/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0069/016/001</DrugIDPK>
    <LicenceNumber>PA0069/016/001</LicenceNumber>
    <ProductName>EN-DE-KAY</ProductName>
    <PAHolder>Stafford Miller Limited</PAHolder>
    <AuthorisedDate>17/12/1992</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/12/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1330/008/002</DrugIDPK>
    <LicenceNumber>PA1330/008/002</LicenceNumber>
    <ProductName>Enador &amp; Placebo 0.02mg/3mg film-coated tablets</ProductName>
    <PAHolder>Gedeon Richter Plc</PAHolder>
    <AuthorisedDate>03/06/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Drospirenone</ActiveSubstance>
      <ActiveSubstance>Ethinylestradiol</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/05/2023</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/005/001</DrugIDPK>
    <LicenceNumber>PA0819/005/001</LicenceNumber>
    <ProductName>Enalapril</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enalapril maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/005/002</DrugIDPK>
    <LicenceNumber>PA0819/005/002</LicenceNumber>
    <ProductName>Enalapril</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enalapril maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/005/003</DrugIDPK>
    <LicenceNumber>PA0819/005/003</LicenceNumber>
    <ProductName>Enalapril</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enalapril maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/013/001</DrugIDPK>
    <LicenceNumber>PA0819/013/001</LicenceNumber>
    <ProductName>ENALAPRIL HCT</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enalapril maleate</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/012/001</DrugIDPK>
    <LicenceNumber>PA0819/012/001</LicenceNumber>
    <ProductName>ENALAPRIL HCT-RATIOPHARM</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enalapril maleate</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0749/029/001</DrugIDPK>
    <LicenceNumber>PA0749/029/001</LicenceNumber>
    <ProductName>Enalapril Maleate Hydrochlorothiazide Teva</ProductName>
    <PAHolder>Teva Pharma B.V.</PAHolder>
    <AuthorisedDate>01/06/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enalapril maleate</ActiveSubstance>
      <ActiveSubstance>Hydrochlorothiazide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/04/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/004/001</DrugIDPK>
    <LicenceNumber>PA0819/004/001</LicenceNumber>
    <ProductName>Enalapril-ratiopharm</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enalapril maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/004/002</DrugIDPK>
    <LicenceNumber>PA0819/004/002</LicenceNumber>
    <ProductName>Enalapril-ratiopharm</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enalapril maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/004/003</DrugIDPK>
    <LicenceNumber>PA0819/004/003</LicenceNumber>
    <ProductName>Enalapril-ratiopharm</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enalapril maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0819/004/004</DrugIDPK>
    <LicenceNumber>PA0819/004/004</LicenceNumber>
    <ProductName>Enalapril-ratiopharm</ProductName>
    <PAHolder>Ratiopharm GmbH</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enalapril maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/09/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0901/001/001</DrugIDPK>
    <LicenceNumber>PA0901/001/001</LicenceNumber>
    <ProductName>Enantyum 12.5 mg film-coated tablets</ProductName>
    <PAHolder>Laboratorios Menarini S.A.</PAHolder>
    <AuthorisedDate>03/04/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dexketoprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/12/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0901/001/004</DrugIDPK>
    <LicenceNumber>PA0901/001/004</LicenceNumber>
    <ProductName>Enantyum 12.5 mg granules for oral solution</ProductName>
    <PAHolder>Laboratorios Menarini S.A.</PAHolder>
    <AuthorisedDate>08/07/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dexketoprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/12/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0901/001/002</DrugIDPK>
    <LicenceNumber>PA0901/001/002</LicenceNumber>
    <ProductName>Enantyum 25 mg film-coated tablets</ProductName>
    <PAHolder>Laboratorios Menarini S.A.</PAHolder>
    <AuthorisedDate>03/04/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dexketoprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/12/2019</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0901/001/005</DrugIDPK>
    <LicenceNumber>PA0901/001/005</LicenceNumber>
    <ProductName>Enantyum 25 mg granules for oral solution</ProductName>
    <PAHolder>Laboratorios Menarini S.A.</PAHolder>
    <AuthorisedDate>08/07/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dexketoprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/01/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0901/001/006</DrugIDPK>
    <LicenceNumber>PA0901/001/006</LicenceNumber>
    <ProductName>Enantyum 25 mg oral solution in sachet</ProductName>
    <PAHolder>Laboratorios Menarini S.A.</PAHolder>
    <AuthorisedDate>12/05/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dexketoprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/01/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0901/001/003</DrugIDPK>
    <LicenceNumber>PA0901/001/003</LicenceNumber>
    <ProductName>Enantyum 50 mg/2ml Solution for injection/infusion</ProductName>
    <PAHolder>Laboratorios Menarini S.A.</PAHolder>
    <AuthorisedDate>19/03/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Dexketoprofen</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/01/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0593/024/001</DrugIDPK>
    <LicenceNumber>PA0593/024/001</LicenceNumber>
    <ProductName>Enapril Stada</ProductName>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>23/03/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enalapril maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/08/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0593/024/002</DrugIDPK>
    <LicenceNumber>PA0593/024/002</LicenceNumber>
    <ProductName>Enapril Stada</ProductName>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>23/03/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enalapril maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/08/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0593/024/003</DrugIDPK>
    <LicenceNumber>PA0593/024/003</LicenceNumber>
    <ProductName>Enapril Stada</ProductName>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>23/03/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enalapril maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/08/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0593/024/004</DrugIDPK>
    <LicenceNumber>PA0593/024/004</LicenceNumber>
    <ProductName>Enapril Stada</ProductName>
    <PAHolder>Stada Arzneimittel AG</PAHolder>
    <AuthorisedDate>23/03/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Enalapril maleate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/08/2012</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0054/004/001</DrugIDPK>
    <LicenceNumber>PA0054/004/001</LicenceNumber>
    <ProductName>ENCEPHABOL AMPOULES</ProductName>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>09/04/1976</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PYRITINOL HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/01/1981</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0054/004/002</DrugIDPK>
    <LicenceNumber>PA0054/004/002</LicenceNumber>
    <ProductName>ENCEPHABOL FORTE</ProductName>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>24/10/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PYRITINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/10/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0054/043/003</DrugIDPK>
    <LicenceNumber>PA0054/043/003</LicenceNumber>
    <ProductName>ENDOBIL</ProductName>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>14/07/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IODOXAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>08/04/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0054/043/002</DrugIDPK>
    <LicenceNumber>PA0054/043/002</LicenceNumber>
    <ProductName>ENDOBIL</ProductName>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>14/07/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IODOXAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/07/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0054/043/001</DrugIDPK>
    <LicenceNumber>PA0054/043/001</LicenceNumber>
    <ProductName>ENDOBIL</ProductName>
    <PAHolder>E. Merck Ltd</PAHolder>
    <AuthorisedDate>14/07/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>IODOXAMIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/07/1988</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0573/006/001</DrugIDPK>
    <LicenceNumber>PA0573/006/001</LicenceNumber>
    <ProductName>Endofalk powder for oral solution</ProductName>
    <PAHolder>Dr. Falk Pharma GmbH</PAHolder>
    <AuthorisedDate>25/03/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for oral solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Macrogol 3350</ActiveSubstance>
      <ActiveSubstance>Potassium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium chloride</ActiveSubstance>
      <ActiveSubstance>Sodium bicarbonate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>15/06/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0196/010/001</DrugIDPK>
    <LicenceNumber>PA0196/010/001</LicenceNumber>
    <ProductName>ENDOMETHASONE</ProductName>
    <PAHolder>Septodont</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
      <ActiveSubstance>THYMOL IODIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1993</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0196/010/002</DrugIDPK>
    <LicenceNumber>PA0196/010/002</LicenceNumber>
    <ProductName>ENDOMETHASONE (PINK)</ProductName>
    <PAHolder>Septodont</PAHolder>
    <AuthorisedDate>01/04/1978</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>DEXAMETHASONE</ActiveSubstance>
      <ActiveSubstance>HYDROCORTISONE ACETATE</ActiveSubstance>
      <ActiveSubstance>THYMOL IODIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1978</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0686/001/001</DrugIDPK>
    <LicenceNumber>PA0686/001/001</LicenceNumber>
    <ProductName>Endorem</ProductName>
    <PAHolder>Guerbet</PAHolder>
    <AuthorisedDate>14/03/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Concentrate for Susp for Inf</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Iron oxide superparomagnetic</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/2010</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0705/001/001</DrugIDPK>
    <LicenceNumber>PA0705/001/001</LicenceNumber>
    <ProductName>ENDOXANA</ProductName>
    <PAHolder>Asta Medica Ltd</PAHolder>
    <AuthorisedDate>10/08/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cyclophosphamide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/06/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0705/001/002</DrugIDPK>
    <LicenceNumber>PA0705/001/002</LicenceNumber>
    <ProductName>ENDOXANA</ProductName>
    <PAHolder>Asta Medica Ltd</PAHolder>
    <AuthorisedDate>10/08/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Cyclophosphamide monohydrate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/06/2008</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0088/003/001</DrugIDPK>
    <LicenceNumber>PA0088/003/001</LicenceNumber>
    <ProductName>ENDOXANA</ProductName>
    <PAHolder>Asta Medica AG</PAHolder>
    <AuthorisedDate>10/08/1990</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CYCLOPHOSPHAMIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/08/1995</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0038/012/001</DrugIDPK>
    <LicenceNumber>PA0038/012/001</LicenceNumber>
    <ProductName>ENDURONYL</ProductName>
    <PAHolder>Abbott Laboratories Ireland Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/06/1985</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0697/005/001</DrugIDPK>
    <LicenceNumber>PA0697/005/001</LicenceNumber>
    <ProductName>ENFLURANE</ProductName>
    <PAHolder>Fresenius AG</PAHolder>
    <AuthorisedDate>19/09/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Inhalation Vapour Liquid</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENFLURANE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/09/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/023/001</DrugIDPK>
    <LicenceNumber>PA1077/023/001</LicenceNumber>
    <ProductName>Engerix B 10 micrograms/0.5 ml Suspension for injection in pre-filled syringe Hepatitis B (rDNA) vaccine (adsorbed) (HBV)</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>26/06/1998</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection in pre-filled syringe</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Hepatitis b surface antigen, recominant</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Batches marketed in Ireland shall be subject to control authority batch release in accordance with Article 114.1 of Directive 2001/83/EC.</SupplyComments>
    <WithdrawalDate>02/12/2025</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1077/023/003</DrugIDPK>
    <LicenceNumber>PA1077/023/003</LicenceNumber>
    <ProductName>ENGERIX B VACCINE</ProductName>
    <PAHolder>GlaxoSmithKline (Ireland) Limited</PAHolder>
    <AuthorisedDate>16/07/2004</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Hepatitis b surface antigen (hbs ag)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/12/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/050/001</DrugIDPK>
    <LicenceNumber>PA0002/050/001</LicenceNumber>
    <ProductName>ENGRAN</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>15/11/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MULTIVITAMINS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>27/05/1992</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0002/051/001</DrugIDPK>
    <LicenceNumber>PA0002/051/001</LicenceNumber>
    <ProductName>ENGRAN-HP</ProductName>
    <PAHolder>Bristol-Myers Squibb Pharmaceuticals uc</PAHolder>
    <AuthorisedDate>15/11/1984</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>RETINOL</ActiveSubstance>
      <ActiveSubstance>VITAMIN D SYNTHETIC CALCIFEROL</ActiveSubstance>
      <ActiveSubstance>THIAMINE MONONITRATE</ActiveSubstance>
      <ActiveSubstance>RIBOFLAVIN</ActiveSubstance>
      <ActiveSubstance>PYRIDOXINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM CARBONATE</ActiveSubstance>
      <ActiveSubstance>FERROUS CARBONATE</ActiveSubstance>
      <ActiveSubstance>IODINE</ActiveSubstance>
      <ActiveSubstance>MANGANESE SULFATE</ActiveSubstance>
      <ActiveSubstance>ZINC SULFATE</ActiveSubstance>
      <ActiveSubstance>COPPER</ActiveSubstance>
      <ActiveSubstance>CYANOCOBALAMIN</ActiveSubstance>
      <ActiveSubstance>SODIUM ASCORBATE</ActiveSubstance>
      <ActiveSubstance>NICOTINAMIDE</ActiveSubstance>
      <ActiveSubstance>CALCIUM PANTOTHENATE</ActiveSubstance>
      <ActiveSubstance>FOLIC ACID</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/01/1997</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0531/002/001</DrugIDPK>
    <LicenceNumber>PA0531/002/001</LicenceNumber>
    <ProductName>ENLON</ProductName>
    <PAHolder>Anaquest Limited</PAHolder>
    <AuthorisedDate>02/05/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Withdrawn Form</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/11/1986</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/041/001</DrugIDPK>
    <LicenceNumber>PA0678/041/001</LicenceNumber>
    <ProductName>ENOS FRUIT SALTS</ProductName>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>18/08/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder for Oral Solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SODIUM BICARBONATE</ActiveSubstance>
      <ActiveSubstance>TARTARIC ACID</ActiveSubstance>
      <ActiveSubstance>CITRIC ACID</ActiveSubstance>
      <ActiveSubstance>SODIUM CARBONATE ANHYDROUS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>18/08/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0577/137/001</DrugIDPK>
    <LicenceNumber>PA0577/137/001</LicenceNumber>
    <ProductName>Entacapone Mylan</ProductName>
    <PAHolder>McDermott Laboratories Ltd., T/A Gerard Laboratories</PAHolder>
    <AuthorisedDate>19/08/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Entacapone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/03/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1063/055/001</DrugIDPK>
    <LicenceNumber>PA1063/055/001</LicenceNumber>
    <ProductName>Entacapone Niche 200 mg film-coated tablets</ProductName>
    <PAHolder>Niche Generics Limited</PAHolder>
    <AuthorisedDate>07/12/2012</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Entacapone</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/08/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0805/003/005</DrugIDPK>
    <LicenceNumber>PA0805/003/005</LicenceNumber>
    <ProductName>Entact</ProductName>
    <PAHolder>H. Lundbeck A/S</PAHolder>
    <AuthorisedDate>09/09/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral drops, solution</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Escitalopram</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/03/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0805/003/001</DrugIDPK>
    <LicenceNumber>PA0805/003/001</LicenceNumber>
    <ProductName>ENTACT</ProductName>
    <PAHolder>H. Lundbeck A/S</PAHolder>
    <AuthorisedDate>07/03/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Escitalopram</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/03/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0805/003/002</DrugIDPK>
    <LicenceNumber>PA0805/003/002</LicenceNumber>
    <ProductName>ENTACT</ProductName>
    <PAHolder>H. Lundbeck A/S</PAHolder>
    <AuthorisedDate>07/03/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Escitalopram</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/03/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0805/003/003</DrugIDPK>
    <LicenceNumber>PA0805/003/003</LicenceNumber>
    <ProductName>ENTACT</ProductName>
    <PAHolder>H. Lundbeck A/S</PAHolder>
    <AuthorisedDate>07/03/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Escitalopram</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/03/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0805/003/004</DrugIDPK>
    <LicenceNumber>PA0805/003/004</LicenceNumber>
    <ProductName>ENTACT</ProductName>
    <PAHolder>H. Lundbeck A/S</PAHolder>
    <AuthorisedDate>07/03/2003</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Escitalopram</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>23/03/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/057/001</DrugIDPK>
    <LicenceNumber>PA2315/057/001</LicenceNumber>
    <ProductName>Entecavir 0.5 mg Film-coated Tablet</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>20/10/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENTECAVIR MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>08/12/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2315/057/002</DrugIDPK>
    <LicenceNumber>PA2315/057/002</LicenceNumber>
    <ProductName>Entecavir 1 mg Film-coated Tablet</ProductName>
    <PAHolder>Accord Healthcare Ireland Ltd.</PAHolder>
    <AuthorisedDate>20/10/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENTECAVIR MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2)</SupplyComments>
    <WithdrawalDate>08/12/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0711/274/002</DrugIDPK>
    <LicenceNumber>PA0711/274/002</LicenceNumber>
    <ProductName>Entecavir Rowex 1 mg Film-coated tablets</ProductName>
    <PAHolder>Rowex Ltd</PAHolder>
    <AuthorisedDate>16/06/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>ENTECAVIR MONOHYDRATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>10/06/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1986/036/001</DrugIDPK>
    <LicenceNumber>PA1986/036/001</LicenceNumber>
    <ProductName>Entecavir Teva 0.5 mg Film-coated Tablets</ProductName>
    <PAHolder>Teva B.V.</PAHolder>
    <AuthorisedDate>23/06/2017</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Entecavir</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).</SupplyComments>
    <WithdrawalDate>31/03/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0018/006/001</DrugIDPK>
    <LicenceNumber>PA0018/006/001</LicenceNumber>
    <ProductName>ENTERFRAM</ProductName>
    <PAHolder>Fisons Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>FRAMYCETIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/09/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/014/003</DrugIDPK>
    <LicenceNumber>PA0137/014/003</LicenceNumber>
    <ProductName>ENTERO-SEDIV</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Granules Effervescent</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/02/1979</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/014/002</DrugIDPK>
    <LicenceNumber>PA0137/014/002</LicenceNumber>
    <ProductName>ENTERO-SEDIV</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/11/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0137/014/001</DrugIDPK>
    <LicenceNumber>PA0137/014/001</LicenceNumber>
    <ProductName>ENTERO-SEDIV</ProductName>
    <PAHolder>T. P. Whelehan Son &amp; Co. Limited</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>20/07/1983</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0028/013/001</DrugIDPK>
    <LicenceNumber>PA0028/013/001</LicenceNumber>
    <ProductName>ENTERO-VIOFORM</ProductName>
    <PAHolder>Ciba Geigy Plc</PAHolder>
    <AuthorisedDate>01/04/1977</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>CLIOQUINOL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/04/1982</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0429/001/001</DrugIDPK>
    <LicenceNumber>PA0429/001/001</LicenceNumber>
    <ProductName>ENTEROSAN</ProductName>
    <PAHolder>Windsor Healthcare Ltd</PAHolder>
    <AuthorisedDate>17/02/1986</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>KAOLIN, LIGHT</ActiveSubstance>
      <ActiveSubstance>MORPHINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>ATROPA BELLADONNA</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/01/1998</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/039/003</DrugIDPK>
    <LicenceNumber>PA0970/039/003</LicenceNumber>
    <ProductName>ENTOCORT</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate>05/09/1997</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Enema</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Budesonide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>30/04/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0970/039/001</DrugIDPK>
    <LicenceNumber>PA0970/039/001</LicenceNumber>
    <ProductName>Entocort CR</ProductName>
    <PAHolder>AstraZeneca UK Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Budesonide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>29/03/2004</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA0465/467/001</DrugIDPK>
    <LicenceNumber>PPA0465/467/001</LicenceNumber>
    <ProductName>Entocort CR 3 mg Gastro-resistant Capsule, Hard</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>01/04/2021</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Budesonide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1463/178/001</DrugIDPK>
    <LicenceNumber>PPA1463/178/001</LicenceNumber>
    <ProductName>Entocort CR 3 mg Gastro-resistant Capsule, Hard</ProductName>
    <PAHolder>IMED Healthcare Ltd.</PAHolder>
    <AuthorisedDate>23/07/2021</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Budesonide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/07/2024</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1327/004/001</DrugIDPK>
    <LicenceNumber>PA1327/004/001</LicenceNumber>
    <ProductName>Entrydil 60mg Modified Release Tablets.</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>30/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1327/004/003</DrugIDPK>
    <LicenceNumber>PA1327/004/003</LicenceNumber>
    <ProductName>Entrydil S.R. 120mg Prolonged Release film-coated</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>30/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1327/004/002</DrugIDPK>
    <LicenceNumber>PA1327/004/002</LicenceNumber>
    <ProductName>Entrydil S.R. 90 mg prolonged-release, film-coated</ProductName>
    <PAHolder>Orion Corporation</PAHolder>
    <AuthorisedDate>30/06/2006</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Diltiazem hydrochloride</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/02/2014</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/07/406/1-10</DrugIDPK>
    <LicenceNumber>EU/1/07/406/1-10</LicenceNumber>
    <ProductName>Enviage</ProductName>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>22/08/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Spp100 hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/07/406/11-20</DrugIDPK>
    <LicenceNumber>EU/1/07/406/11-20</LicenceNumber>
    <ProductName>Enviage</ProductName>
    <PAHolder>Novartis Europharm Limited</PAHolder>
    <AuthorisedDate>22/08/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Film-coated tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Spp100 hemifumarate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>EU/1/16/1113/001-004</DrugIDPK>
    <LicenceNumber>EU/1/16/1113/001-004</LicenceNumber>
    <ProductName>Enzepi</ProductName>
    <PAHolder>Allergan Pharmaceuticals International Limited</PAHolder>
    <AuthorisedDate>19/07/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pancreas powder</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/07/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/16/1113/005-008</DrugIDPK>
    <LicenceNumber>EU/1/16/1113/005-008</LicenceNumber>
    <ProductName>Enzepi</ProductName>
    <PAHolder>Allergan Pharmaceuticals International Limited</PAHolder>
    <AuthorisedDate>19/07/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pancreas powder</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/07/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/16/1113/009-012</DrugIDPK>
    <LicenceNumber>EU/1/16/1113/009-012</LicenceNumber>
    <ProductName>Enzepi</ProductName>
    <PAHolder>Allergan Pharmaceuticals International Limited</PAHolder>
    <AuthorisedDate>19/07/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pancreas powder</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/07/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/16/1113/013-016</DrugIDPK>
    <LicenceNumber>EU/1/16/1113/013-016</LicenceNumber>
    <ProductName>Enzepi</ProductName>
    <PAHolder>Allergan Pharmaceuticals International Limited</PAHolder>
    <AuthorisedDate>19/07/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Gastro-resistant capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Pancreas powder</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>19/07/2017</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1373/001/001</DrugIDPK>
    <LicenceNumber>PA1373/001/001</LicenceNumber>
    <ProductName>Enzira Suspension for injection, pre-filled syringeInfluenza vaccine (split virion, inactivated)</ProductName>
    <PAHolder>Seqirus GmbH</PAHolder>
    <AuthorisedDate>22/06/2007</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>A/MICHIGAN/45/2015 (H1N1) PDM09 - LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180A)</ActiveSubstance>
      <ActiveSubstance>A/SINGAPORE/IMFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016,NIB-104)</ActiveSubstance>
      <ActiveSubstance>B/COLORADO/06/2017-LIKE STRAIN (B/VICTORIA/2/87 LINEAGE)(B/MARYLAND/15/2016,NYMC BX-69A)</ActiveSubstance>
      <ActiveSubstance>B/COLORADO/06/2017 - LIKE STRAIN (B/MARYLAND/15/2016,WILD TYPE)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>Batches marketed in Ireland shall be subject to control authority batch release in accordance with article 114.1 of Directive 2001/83/EC</SupplyComments>
    <WithdrawalDate>01/12/2020</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0102/008/001</DrugIDPK>
    <LicenceNumber>PA0102/008/001</LicenceNumber>
    <ProductName>ENZYPAN FORTE</ProductName>
    <PAHolder>Norgine Limited</PAHolder>
    <AuthorisedDate>16/02/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PANCREATIN</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>10/11/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/006/002</DrugIDPK>
    <LicenceNumber>PA0678/006/002</LicenceNumber>
    <ProductName>EOLARIX VACCINE</ProductName>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>16/02/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEASLES VIRUS - SCHWARZ STRAIN LIVE ATTENUATED</ActiveSubstance>
      <ActiveSubstance>RUBELLA VIRUS (RA 27/3 STRAIN)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/02/2000</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0678/006/001</DrugIDPK>
    <LicenceNumber>PA0678/006/001</LicenceNumber>
    <ProductName>EOLARIX VACCINE</ProductName>
    <PAHolder>GlaxoSmithKline Consumer Healthcare (Ireland) Limited</PAHolder>
    <AuthorisedDate>16/02/1995</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>MEASLES VIRUS - SCHWARZ STRAIN LIVE ATTENUATED</ActiveSubstance>
      <ActiveSubstance>RUBELLA VIRUS (RA 27/3 STRAIN)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>16/10/2002</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA1175/004/001</DrugIDPK>
    <LicenceNumber>PA1175/004/001</LicenceNumber>
    <ProductName>EPADERM</ProductName>
    <PAHolder>Medlock Medical Ltd</PAHolder>
    <AuthorisedDate>11/02/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Ointment</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Emulsifying wax</ActiveSubstance>
      <ActiveSubstance>Yellow soft paraffin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/10/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>DPR0465/033/001</DrugIDPK>
    <LicenceNumber>DPR0465/033/001</LicenceNumber>
    <ProductName>Epanutin</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>18/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR0465/033/002</DrugIDPK>
    <LicenceNumber>DPR0465/033/002</LicenceNumber>
    <ProductName>Epanutin</ProductName>
    <PAHolder>PCO Manufacturing Ltd.</PAHolder>
    <AuthorisedDate>18/06/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1328/031/001</DrugIDPK>
    <LicenceNumber>DPR1328/031/001</LicenceNumber>
    <ProductName>Epanutin</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>06/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1328/031/002</DrugIDPK>
    <LicenceNumber>DPR1328/031/002</LicenceNumber>
    <ProductName>Epanutin</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>06/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1328/031/003</DrugIDPK>
    <LicenceNumber>DPR1328/031/003</LicenceNumber>
    <ProductName>Epanutin</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>06/04/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1447/005/001</DrugIDPK>
    <LicenceNumber>DPR1447/005/001</LicenceNumber>
    <ProductName>Epanutin</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>05/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1447/005/002</DrugIDPK>
    <LicenceNumber>DPR1447/005/002</LicenceNumber>
    <ProductName>Epanutin</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>05/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1447/005/003</DrugIDPK>
    <LicenceNumber>DPR1447/005/003</LicenceNumber>
    <ProductName>Epanutin</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>05/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1447/005/004</DrugIDPK>
    <LicenceNumber>DPR1447/005/004</LicenceNumber>
    <ProductName>Epanutin</ProductName>
    <PAHolder>G &amp; A Licensing Ltd</PAHolder>
    <AuthorisedDate>05/07/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/009/001</DrugIDPK>
    <LicenceNumber>DPR1473/009/001</LicenceNumber>
    <ProductName>Epanutin</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>26/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/009/002</DrugIDPK>
    <LicenceNumber>DPR1473/009/002</LicenceNumber>
    <ProductName>Epanutin</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>26/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1473/009/003</DrugIDPK>
    <LicenceNumber>DPR1473/009/003</LicenceNumber>
    <ProductName>Epanutin</ProductName>
    <PAHolder>McDowell Pharmaceuticals</PAHolder>
    <AuthorisedDate>26/02/2008</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>DPR1500/026/001</DrugIDPK>
    <LicenceNumber>DPR1500/026/001</LicenceNumber>
    <ProductName>Epanutin</ProductName>
    <PAHolder>Profind Wholesale Ltd</PAHolder>
    <AuthorisedDate>23/03/2009</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate xsi:nil="true" />
  </Product>
  <Product>
    <DrugIDPK>PPA1328/147/001</DrugIDPK>
    <LicenceNumber>PPA1328/147/001</LicenceNumber>
    <ProductName>Epanutin</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>15/04/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>28/10/2016</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/147/002</DrugIDPK>
    <LicenceNumber>PPA1328/147/002</LicenceNumber>
    <ProductName>Epanutin</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>15/04/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>09/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1328/147/003</DrugIDPK>
    <LicenceNumber>PPA1328/147/003</LicenceNumber>
    <ProductName>Epanutin</ProductName>
    <PAHolder>B &amp; S Healthcare</PAHolder>
    <AuthorisedDate>15/04/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>05/11/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1562/029/001</DrugIDPK>
    <LicenceNumber>PPA1562/029/001</LicenceNumber>
    <ProductName>Epanutin</ProductName>
    <PAHolder>LTT Pharma Limited</PAHolder>
    <AuthorisedDate>05/11/2010</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>07/03/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/051/001</DrugIDPK>
    <LicenceNumber>PPA1659/051/001</LicenceNumber>
    <ProductName>Epanutin</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>16/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/051/002</DrugIDPK>
    <LicenceNumber>PPA1659/051/002</LicenceNumber>
    <ProductName>Epanutin</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>16/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1659/051/003</DrugIDPK>
    <LicenceNumber>PPA1659/051/003</LicenceNumber>
    <ProductName>Epanutin</ProductName>
    <PAHolder>IPS Healthcare Limited</PAHolder>
    <AuthorisedDate>16/09/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Oral suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Phenytoin</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>02/12/2013</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0056/024/001</DrugIDPK>
    <LicenceNumber>PA0056/024/001</LicenceNumber>
    <ProductName>EPANUTIN/PHENOBARBIT</ProductName>
    <PAHolder>Parke Davis &amp; Company</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENOBARBITAL</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>17/11/1987</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PPA1151/165/001</DrugIDPK>
    <LicenceNumber>PPA1151/165/001</LicenceNumber>
    <ProductName>Epanutin 100mg Hard Capsules</ProductName>
    <PAHolder>Imbat Limited</PAHolder>
    <AuthorisedDate>21/12/2011</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Capsule, hard</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>PHENYTOIN SODIUM</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>06/01/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0057/069/001</DrugIDPK>
    <LicenceNumber>PA0057/069/001</LicenceNumber>
    <ProductName>Epaq</ProductName>
    <PAHolder>3M Health Care Limited</PAHolder>
    <AuthorisedDate>24/08/2001</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Pressurised inhalation, suspension</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>SALBUTAMOL SULFATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>24/08/2006</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0941/001/001</DrugIDPK>
    <LicenceNumber>PA0941/001/001</LicenceNumber>
    <ProductName>Epaxal</ProductName>
    <PAHolder>Crucell Italy S.r.l.</PAHolder>
    <AuthorisedDate>21/01/2000</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Suspension for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Hepatitis a virus (strain rg-sb)</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/01/2015</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/13/908/001</DrugIDPK>
    <LicenceNumber>EU/1/13/908/001</LicenceNumber>
    <ProductName>Eperzan</ProductName>
    <PAHolder>GlaxoSmithKline Trading Services Limited</PAHolder>
    <AuthorisedDate>21/03/2014</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Albiglutide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/11/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>EU/1/13/908/002</DrugIDPK>
    <LicenceNumber>EU/1/13/908/002</LicenceNumber>
    <ProductName>Eperzan</ProductName>
    <PAHolder>GlaxoSmithKline Trading Services Limited</PAHolder>
    <AuthorisedDate xsi:nil="true" />
    <ProductType>HM</ProductType>
    <MarketInfo>Unknown</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Powder and solvent for solution for injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Albiglutide</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may be renewed (B)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>12/11/2018</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2168/001/002</DrugIDPK>
    <LicenceNumber>PA2168/001/002</LicenceNumber>
    <InterchangeableListCode>IC0102-016-024</InterchangeableListCode>
    <ProductName>Epethinan 10 mg/5 mg prolonged release tablet</ProductName>
    <PAHolder>Acino AG</PAHolder>
    <AuthorisedDate>20/05/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NALOXONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>29/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2168/001/003</DrugIDPK>
    <LicenceNumber>PA2168/001/003</LicenceNumber>
    <InterchangeableListCode>IC0102-061-024</InterchangeableListCode>
    <ProductName>Epethinan 20 mg/10 mg prolonged release tablet</ProductName>
    <PAHolder>Acino AG</PAHolder>
    <AuthorisedDate>20/05/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NALOXONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>29/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2168/001/004</DrugIDPK>
    <LicenceNumber>PA2168/001/004</LicenceNumber>
    <InterchangeableListCode>IC0102-160-024</InterchangeableListCode>
    <ProductName>Epethinan 40 mg/20 mg prolonged release tablet</ProductName>
    <PAHolder>Acino AG</PAHolder>
    <AuthorisedDate>20/05/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NALOXONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>29/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA2168/001/001</DrugIDPK>
    <LicenceNumber>PA2168/001/001</LicenceNumber>
    <InterchangeableListCode>IC0102-159-024</InterchangeableListCode>
    <ProductName>Epethinan 5 mg/2.5 mg prolonged release tablet</ProductName>
    <PAHolder>Acino AG</PAHolder>
    <AuthorisedDate>20/05/2016</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Prolonged-release tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>OXYCODONE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>NALOXONE HYDROCHLORIDE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>Product subject to prescription which may not be renewed (A)</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>Supply through pharmacies only</SupplyLegalStatus>
    <PromotionLegalStatus>Advertising to healthcare professionals only</PromotionLegalStatus>
    <SupplyComments>This product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 1988 (S.I. No. 328 of 1988), as amended.</SupplyComments>
    <WithdrawalDate>29/10/2021</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0650/016/001</DrugIDPK>
    <LicenceNumber>PA0650/016/001</LicenceNumber>
    <ProductName>EPHEDRINE HYDROCHLORIDE</ProductName>
    <PAHolder>Penn Pharmaceuticals Ltd</PAHolder>
    <AuthorisedDate>04/01/1994</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Solution for Injection</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>EPHEDRINE HYDROCHLORIDE</ActiveSubstance>
      <ActiveSubstance>WATER FOR INJECTIONS</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>04/01/1999</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0073/038/001</DrugIDPK>
    <LicenceNumber>PA0073/038/001</LicenceNumber>
    <ProductName>EPHEDRINE HYDROCHLORIDE</ProductName>
    <PAHolder>Mercury Pharmaceuticals (Ireland) Ltd</PAHolder>
    <AuthorisedDate>01/04/1979</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Not available</DosageForm>
    <ActiveSubstances xsi:nil="true" />
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>21/03/1989</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/068/001</DrugIDPK>
    <LicenceNumber>PA0021/068/001</LicenceNumber>
    <ProductName>Ephynal</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>29/07/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Vitamin E acetate </ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0021/068/002</DrugIDPK>
    <LicenceNumber>PA0021/068/002</LicenceNumber>
    <ProductName>Ephynal</ProductName>
    <PAHolder>Bayer PLC</PAHolder>
    <AuthorisedDate>29/07/2005</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo>Not marketed</MarketInfo>
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablet</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>Tocopheryl acetate</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus>
      <Status>*** AWAITING VALUE ***</Status>
    </DispensingLegalStatus>
    <SupplyLegalStatus>*** AWAITING VALUE ***</SupplyLegalStatus>
    <PromotionLegalStatus>*** AWAITING VALUE ***</PromotionLegalStatus>
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>01/11/2007</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/057/002</DrugIDPK>
    <LicenceNumber>PA0050/057/002</LicenceNumber>
    <ProductName>EPHYNAL</ProductName>
    <PAHolder>Roche Products Limited</PAHolder>
    <AuthorisedDate>01/04/1983</AuthorisedDate>
    <ProductType>HM</ProductType>
    <MarketInfo xsi:nil="true" />
    <RegistrationStatus>WI</RegistrationStatus>
    <DosageForm>Tablets</DosageForm>
    <ActiveSubstances>
      <ActiveSubstance>TOCOPHERYL ACETATE</ActiveSubstance>
    </ActiveSubstances>
    <DispensingLegalStatus xsi:nil="true" />
    <SupplyLegalStatus xsi:nil="true" />
    <PromotionLegalStatus xsi:nil="true" />
    <SupplyComments xsi:nil="true" />
    <WithdrawalDate>31/12/1996</WithdrawalDate>
  </Product>
  <Product>
    <DrugIDPK>PA0050/057/001</DrugIDPK>
    <LicenceNumber>PA0050/057/001</Licence